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Notice to Readers
This AICPA Audit and Accounting Guide has been prepared by the AICPA 
Health Care Committee to assist preparers of financial statements in preparing 
financial statements in conformity with generally accepted accounting princi­
ples and to assist auditors in auditing and reporting on such financial state­
ments in accordance with generally accepted auditing standards.
Descriptions of accounting principles and financial reporting practices in Au­
dit and Accounting Guides are approved by the affirmative vote of at least 
two-thirds of the members of the Accounting Standards Executive Committee, 
which is the senior technical body of the AICPA authorized to speak for the 
AICPA in the areas of financial accounting and reporting. Statement on Au­
diting Standards (SAS) No. 69, The Meaning of Present Fairly in Conformity 
With Generally Accepted Accounting Principles, identifies AICPA Audit and 
Accounting Guides that have been cleared by the Financial Accounting Stan­
dards Board (for financial statements of entities other than governmental enti­
ties) or Governmental Accounting Standards Board (for financial statements of 
Governmental entities) as sources of accounting principles in category h of the 
hierarchy of generally accepted accounting principles that it establishes. This 
Audit and Accounting Guide has been cleared by the Financial Accounting 
Standards Board and the Governmental Accounting Standards Board. AICPA 
members should consider the accounting principles described in this Audit and 
Accounting Guide if the accounting treatment of a transaction or event is not 
specified by a pronouncement covered by Rule 203 of the AICPA Code of Profes­
sional Conduct. In such circumstances, the accounting treatments specified by 
this Audit and Accounting Guide should be used, or the member should be pre­
pared to justify another treatment, as discussed in paragraph 7 of SAS No. 69. 
This AICPA Audit and Accounting Guide, which contains auditing guidance, 
is an interpretive publication pursuant to SAS No. 95, Generally Accepted Au­
diting Standards. Interpretive publications are recommendations on the appli­
cation of SASs in specific circumstances, including engagements for entities in 
specialized industries. Interpretive publications are issued under the author­
ity of the Auditing Standards Board. The members of the Auditing Standards 
Board have found this Guide to be consistent with existing SASs.
The auditor should be aware of and consider interpretive publications appli­
cable to his or her audit. If the auditor does not apply the auditing guidance 
included in an applicable interpretive publication, the auditor should be pre­
pared to explain how he or she complied with the SAS provisions addressed by 
such auditing guidance.
Public Accounting Firms Registered W ith the PCAOB
Subject to the Securities and Exchange Commission (SEC) oversight, Section 
103 of the Sarbanes-Oxley Act (Act) authorizes the Public Company Accounting 
Oversight Board (PCAOB) to establish auditing and related attestation, quality 
control, ethics, and independence standards to be used by registered public 
accounting firms in the preparation and issuance of audit reports as required by 
the Act or the rules of the SEC. Accordingly, public accounting firms registered 
with the PCAOB are required to adhere to all PCAOB standards in the audits 
of issuers, as defined by the Act, and other entities when prescribed by the rules 
of the SEC.
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This edition of the Audit and Accounting Guide Health Care Organizations, 
has been modified by the AICPA staff to include certain changes necessary 
due to the issuance of authoritative pronouncements since the Guide was orig­
inally issued. Relevant accounting and auditing guidance contained in official 
pronouncements issued through May 1, 2005 have been considered in the de­
velopment of this edition of the Guide. This includes relevant guidance issued 
up to and including the following:
•  FASB Statement No. 153, Exchanges of Nonmonetary Assets—an 
amendment of APB Opinion No. 29, and Revised FASB Statements 
issued through May 1, 2005, including
— FASB Statement No. 123 (revised 2004), Share-Based Payment
•  FASB Interpretation No. 47, Accounting for Conditional Asset Retire­
ment Obligations—an interpretation of FASB Statement No. 143
•  FASB Technical Bulletin 01-1, Effective Date for Certain Financial In­
stitutions of Certain Provisions of Statement 140 Related to the Isola­
tion of Transferred Financial Assets
•  FASB Staff Positions issued through May 1, 2005
•  FASB Emerging Issues Task Force (EITF) consensus positions adopted 
at meetings of the EITF held through March 2005
•  GASB Statement No. 46, Net Assets Restricted by Enabling Legislation
•  GASB Interpretation No. 6, Recognition and Measurement of Certain 
Liabilities and Expenditures in Governmental Fund Financial State­
ments
•  GASB Technical Bulletin 2004-2, Recognition of Pension and Other 
Postemployment Expenditures/Expense and Liabilities by Cost- 
Sharing Employers
•  SOP 04-2, Accounting for Real Estate Time-Sharing Transactions
•  Practice Bulletin No. 15, Accounting by the Issuer of Surplus Notes
•  SAS No. 101, Auditing Fair Value Measurements and Disclosures
•  PCAOB Auditing Standard No. 3, Audit Documentation—And Amend­
ment to Interim Auditing Standards
Users of this Guide should consider pronouncements issued subsequent to those 
listed above to determine their effect on entities covered by this Guide.
The changes made for the current year are identified in a schedule in Appendix 
I of the Guide. The changes do not include all those that might be considered 
necessary if the Guide were subjected to a comprehensive review and revision.
This edition includes Statement of Position 93-2, Accounting for Costs of Activi­
ties of Not-for-Profit Organizations and State and Local Governmental Entities 
That Include Fund Raising (Appendix C), Statement of Position 99-1, Guidance 
to Practitioners in Conducting and Reporting on an Agreed-Upon Procedures 
Engagement to Assist Management in Evaluating the Effectiveness of Its Corpo­
rate Compliance Program (Appendix D), Statement of Position 00-1, Auditing 
Health Care Third-Party Revenues and Related Receivables (Appendix E), and 
Statement of Position 02-2, Accounting for Derivative Instruments and Hedging 
Activities by Not-for-Profit Health Care Organizations, and Clarification of the 
Performance Indicator (Appendix F). In using this Guide, readers should refer 
to the material in these Statements of Position.
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Preface
Purpose
This Guide has been prepared to assist providers of health care services in 
preparing financial statements in conformity with generally accepted account­
ing principles (GAAP) and to assist independent auditors1 in auditing and re­
porting on those financial statements.
Applicability
This Guide applies to health care organizations that are either (a) investor- 
owned businesses or (b) not-for-profit enterprises that have no ownership inter­
est and are essentially self-sustaining from fees charged for goods and services, 
as defined in Financial Accounting Standards Board (FASB) Statement of Fi­
nancial Accounting Concepts No. 4, Objectives of Financial Reporting by Non­
business Organizations, paragraph 8,2 or (c) governmental. This Guide applies 
to organizations whose principal operations consist of providing or agreeing to 
provide health care services and that derive all or almost all of their revenues 
from the sale of goods or services; it also applies to organizations whose primary 
activities are the planning, organization, and oversight of such organizations, 
such as parent or holding companies of health care providers.
This Guide applies to the following types of health care organizations:
•  Clinics, medical group practices, individual practice associations, in­
dividual practitioners, emergency care facilities, laboratories, surgery 
centers, and other ambulatory care organizations
•  Continuing care retirement communities (CCRCs)
•  Health maintenance organizations (HMOs) and similar prepaid health 
care plans
•  Home health agencies
•  Hospitals
•  Nursing homes that provide skilled, intermediate, and less intensive 
levels of health care
•  Drug and alcohol rehabilitation centers and other rehabilitation facil­
ities
This Guide also applies to integrated delivery systems that include one or 
more of the above types of organizations.
This Guide does not apply to voluntary health and welfare organizations, as 
defined in FASB Statement No. 117, Financial Statements of Not-for-Profit Or­
ganizations. These organizations should follow the American Institute of Cer­
tified Public Accountants (AICPA) Audit and Accounting Guide Not-for-Profit 
Organizations. Related fund-raising foundations that meet the definition of a 
not-for-profit organization given in FASB Statement No. 117 also should follow 
the AICPA Audit and Accounting Guide Not-for-Profit Organizations.
1 A member performing an attest engagement must be independent pursuant to Rule 101 of the 
AICPA Code of Professional Conduct. Other applicable independence rules/regulations may also apply 
to members and accountants while performing attest engagements (e.g. Securities and Exchange Com­
mission (SEC), Public Company Accounting Oversight Board (PCAOB), Government Accountability 
Office (GAO), state licensing boards, etc.).
2 See paragraph 1.03 of this Guide.
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When separate financial statements are issued for a state or local govern­
mental health care organization that uses enterprise fund accounting and re­
porting, the accounting, reporting, and disclosure requirements set forth in 
this Guide and by pronouncements of the Governmental Accounting Standards 
Board (GASB) apply. (See Chapter 1 for a discussion of the application of GAAP.) 
GASB Statement No. 34, Basic Financial Statements—and Management's Dis­
cussion and Analysis—for State and Local Governments, replaces the previous 
definition with a new definition of enterprise funds. Based on paragraph 67 of 
GASB Statement No. 34, as amended, any activity that charges a fee to external 
users for goods or services may he reported as an enterprise fund. In addition, 
paragraph 67 requires governments to report activities in enterprise funds if 
any one of the following three criteria, as summarized below, is met:
(а) The activity is financed with debt that is secured solely by a pledge 
of the net revenues from fees and charges of the activity.
(b) Laws or regulations require the activity's costs of providing ser­
vices, including capital costs, to be recovered with fees and charges 
rather than with taxes or similar revenues.
(c) The pricing policies of the activity establish fees and charges that 
are designed to recover the activity's costs of providing services, 
including capital costs.
The primary focus of these criteria is on fees charged to external users. Also, 
paragraph 67 of GASB Statement No. 34 requires that these criteria should be 
applied in the context of the activity's principal revenue sources.
This Guide is not the only industry-specific AICPA Audit and Accounting 
Guide that auditors should consider when performing an audit of a governmen­
tal health care entity. The Audit and Accounting Guide State and Local Govern­
ments, includes governmental health care entities in its scope and was cleared 
by the GASB. Therefore, certain accounting and financial reporting guidance 
in that Guide constitutes category (6) guidance for governmental health care 
entities, and the auditing guidance in that Guide should also be considered 
during an audit of a governmental health care entity that is included in the 
scope of this Guide. In practice, auditors of governmental health care entities 
that issue separate financial statements using enterprise fund accounting and 
reporting may use this Guide as the primary source of guidance because this 
Guide addresses transactions that are unique to or prevalent in the health 
care industry. The Audit and Accounting Guide State and Local Governments, 
however, contains information about governmental accounting and financial 
reporting standards and other matters that are unique to or prevalent in gov­
ernment and not included in this Guide.3
Many governmental health care entities are considered to be special-purpose 
governments as defined in GASB Statement No. 34, paragraph 134.4 Special- 
purpose governments are legally separate entities, as that term is described in
3 See paragraphs 1.21 and 12.11 through 12.13 in the Audit and Accounting Guide State and 
Local Governments.
4 GASB Statement No. 34, Basic Financial Statements—and Management's Discussion and 
Analysis—for State and Local Governments, does not provide guidance on separate reporting by indi­
vidual enterprise funds of a government. Although this discussion of the guidance in GASB Statement 
No. 34 is written in terms of special-purpose business-type activities that are governmental health 
care entities, the accounting, financial reporting, and auditing considerations are usually equally ap­
plicable when the health care activity is conducted as a function or program of a general-purpose 
government and reported in an enterprise fund. See footnote 7 to the section heading "Specific Guid­
ance for Special-Purpose Governments" in Chapter 12 of the Audit and Accounting Guide State and 
Local Governments. Reporting guidance on separate reporting by individual enterprise funds of a 
government is provided in the Audit and Accounting Guide State and Local Governments.
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paragraph 15 of GASB Statement No. 14, The Financial Reporting Entity. They 
may be component units of another governmental entity or they may be other 
stand-alone governments. (Both terms component units and other stand-alone 
governments are also defined by GASB Statement No. 14.) Because GASB State­
ment No. 34 is written from the perspective of general-purpose governments, 
paragraph 138 of GASB Statement No. 34 discusses how those requirements 
apply to special-purpose governments engaged only in business-type activities, 
such as certain governmental health care entities. Governmental health care 
entities that are special-purpose governments engaged only in business-type 
activities should present only the financial statements required for enterprise 
funds. These financial statements are discussed further in paragraph 1.13 of 
this Guide.
Limitations
This Guide does not discuss the application of all GAAP and all generally 
accepted auditing standards (GAAS) that are relevant to the preparation and 
audit of financial statements of health care organizations. The Guide is directed 
primarily to those aspects of the preparation and audit of health care organiza­
tions' financial statements that may be unique to those organizations or areas 
considered particularly significant to them.
Auditing Guidance Included in This Guide and References 
to AICPA and PCAOB Professional Standards
This Guide presents auditing guidance to help you implement auditing stan­
dards included in both AICPA professional standards ("GAAS") and in Public 
Company Accounting Oversight Board (PCAOB) professional standards. In re­
ferring to AICPA professional standards, this Guide cites the applicable sections 
of the AICPA Professional Standards publication. In referring to PCAOB stan­
dards, this Guide cites the applicable sections of the AICPA’s publication titled 
PCAOB Standards and Related Rules. In those cases in which the auditing 
standards of the AICPA and those of the PCAOB are the same, this Guide cites 
the applicable section of the AICPA Professional Standards publication only.
Other Literature
This Guide incorporates certain provisions of FASB Statements No. 116, Ac- 
counting for Contributions Received and Contributions Made, No. 117, No. 124, 
Accounting for Certain Investments Held by a Not-for-Profit Organizations, 136, 
Transfers of Assets to a Not-for-Profit Organization or Charitable Trust That 
Raises or Holds Contributions for Others, GASB Statement No. 33, Account­
ing and Financial Reporting for Nonexchange Transactions, as amended, and 
GASB Statement No. 34 and related pronouncements. Not all guidance included 
in those Statements, however, is incorporated, repeated, or summarized in this 
Guide. Accordingly, those Statements, and all authoritative guidance,5 should 
be read in conjunction with this Guide.
5 Other professional literature and authoritative guidance includes statements issued by the 
AICPA Accounting Standards Executive Committee (AcSEC) and the FASB—including its Emerging 
Issues Task Force (EITF). Authoritative literature for governmental health care entities includes 
GASB pronouncements, FASB and AICPA pronouncements specifically made applicable to state and 
local governmental entities by the GASB, and AICPA Audit and Accounting Guides, Industry Audit 
Guides, Statements of Position, and Practice Bulletins made applicable to governmental entities and 
cleared by the GASB.
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This Guide supersedes the AICPA Audit and Accounting Guide Audits of 
Providers of Health Care Services. This Guide also incorporates and supersedes 
AICPA Statements of Position (SOP) 89-5, Financial Accounting and Reporting 
by Providers of Prepaid Health Care Services, 90-8, Financial Accounting and 
Reporting by Continuing Care Retirement Communities, and 94-2, The Appli­
cation of the Requirements of Accounting Research Bulletins, Opinions of the 
Accounting Principles Board, and Statements and Interpretations of the Finan­
cial Accounting Standards Board to Not-for-Profit Organizations.
Office of Management and Budget (0MB) Circular A-133, Audits of States, Lo­
cal Governments, and Non-Profit Organizations, sets forth audit requirements 
for health care organizations expending federal awards. Institutions covered by 
0MB Circular A-133 include not-for-profit hospitals, public hospitals, and in­
stitutions of higher education, and their affiliated hospitals, voluntary health 
and welfare organizations and other community-based organizations.6 Audi­
tors of health care organizations that are subject to the audit requirements 
of 0MB Circular A-133 should refer to the Audit Guide Government Auditing 
Standards and Circular A-133 Audits.
Effective Date and Transition
The provisions of this Guide, other than those included in paragraphs 1.40 
through 1.51, which are discussed below, are effective for financial statements 
for periods beginning after June 15, 1996.7 Earlier application is permitted.
The provisions included in paragraphs 1.40 through 1.51 are effective for 
financial statements issued for fiscal years beginning after December 15, 1994, 
except for organizations with less than $5 million in total assets and less than $1 
million in annual expenses. For those organizations, the effective date is fiscal 
years beginning after December 15, 1995. Earlier application is permitted.
Unless the provisions of this Guide, other than those included in paragraphs 
1.40 through 1.51, are applied retroactively under the provisions of the follow­
ing paragraph, the effect of initially applying this Guide shall be reported as 
the effect of a change in accounting principle, in a manner similar to the cumu­
lative effect of a change in accounting principle (Accounting Principles Board 
[APB] Opinion No. 20, Accounting Changes, paragraph 19). The amount of the 
cumulative effect should be based on a retroactive computation. A not-for-profit 
organization should report the cumulative effect of a change in accounting on 
each class of net assets in the statement of activities between the captions 
extraordinary items, if any, and change in unrestricted net assets, change in 
temporarily restricted net assets, and change in permanently restricted net as­
sets. The cumulative effect on temporary and permanently restricted net assets 
should be reflected in the statement of changes in net assets. An investor-owned 
business should report the amount of the cumulative effect in the income state­
ment between the captions extraordinary items and net income (APB Opinion 
No. 20, paragraph 20).
6 The Codification of Office of Management and Budget (0MB) Circular A-133 by the U.S. De­
partment of Health and Human Services (HHS) also includes audit requirements for commercial 
organizations (including for-profit hospitals) that receive federal awards under HHS programs. Gen­
erally, the organization has two options regarding audits: (1) a financial-related audit of a particular 
award in accordance with Government Auditing Standards, or (2) an audit that meets the require­
ments of 0MB Circular A-133. See title 45 of the Code of Federal Regulations section 74.26(d) for 
further information.
7 This Guide does not defer the effective date of any pronouncements that cover not-for-profit 
organizations.
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This Guide, other than the guidance in paragraphs 1.40 through 1.51, may 
be applied retroactively by restating the opening net assets for the earliest 
year presented or for the year this Guide is first applied if no prior years are 
presented. In the period in which this Guide is first applied, that organization 
should disclose the nature of any restatement and its effect on the change in net 
assets for each period presented. An investor-owned business should account 
for any restatement as a change in accounting principle applied retroactively 
(APB Opinion No. 20, paragraphs 27 and 28).
In implementing the guidance in paragraphs 1.40 through 1.51, which incor­
porates the provisions of SOP 94-2 into this Guide, the transition rules of the 
APB Opinions and FASB Statements adopted, other than their effective dates, 
should be followed. However, if there is more than one change in accounting 
principle as a result of applying the guidance in paragraphs 1.40 through 1.51, 
organizations have the option of including the cumulative effect of adopting 
those accounting principles in the statement of activity or similar statement 
in the year this Guide is adopted, regardless of the transition rules of the APB 
Opinions and FASB Statements adopted,8 and the financial statements should 
disclose the nature of the cumulative adjustment. (Paragraphs 19 and 20 of 
APB Opinion No. 20 discuss reporting the cumulative effects of changes in ac­
counting principles.) In circumstances in which there is more than one change 
in accounting principle resulting from applying this Guide and the cumulative 
effect of adopting those accounting principles is included in the statement of ac­
tivity or similar statement in the year the guidance in paragraphs 1.40 through 
1.51 is adopted, this Guide does not require the pro forma disclosures required 
by paragraphs 19(d) and 21 of APB Opinion No. 20.
Substantial Changes to Audit Process Proposed
The AICPA's Auditing Standards Board (ASB) issued an exposure draft propos­
ing eight new Statements on Auditing Standards (SASs) relating to the audi­
tor's risk assessment process. The ASB believes that the requirements and 
guidance provided in the proposed SASs, if adopted, would result in a substan­
tial change in audit practice and in more effective audits. The primary objective 
of the proposed SASs is to enhance auditors' application of the audit risk model 
in practice by requiring:
•  More in-depth understanding of the entity and its environment, includ­
ing its internal control, to identify the risks of material misstatement 
in the financial statements and what the entity is doing to mitigate 
them.
•  More rigorous assessment of the risks of material misstatement of the 
financial statements based on that understanding.
•  Improved linkage between the assessed risks and the nature, timing 
and extent of audit procedures performed in response to those risks.
The exposure draft consists of the following proposed SASs:
•  Amendment to Statement on Auditing Standards No. 95, Generally 
Accepted Auditing Standards
8 Organizations that adopt the guidance in paragraphs 1.40 through 1.51 of this Guide in the 
same year in which they adopt FASB Statement No. 116 are permitted to apply the provisions of 
paragraph 17 of that Statement, concerning recognition of expirations of restrictions, prospectively, 
as specified in that Statement, regardless of whether they report the cumulative effect of adopting 
other accounting principles as a result of applying the guidance in paragraphs 1.40 through 1.51 of 
this Guide.
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•  Audit Evidence
•  Audit Risk and Materiality in Conducting an Audit
•  Planning and Supervision
•  Understanding the Entity and Its Environment and Assessing the Risks 
of Material Misstatement
•  Performing Audit Procedures in Response to Assessed Risks and Eval­
uating the Audit Evidence Obtained
•  Amendment to Statement on Auditing Standards No. 39, Audit 
Sampling
•  Amendment to "Due Professional Care in the Performance of Work" 
of Statement on Auditing Standards No. 1, Codification of Auditing 
Standards and Procedures
The proposed SASs establish standards and provide guidance concerning the 
auditor's assessment of the risks of material misstatement in a financial state­
ment audit, and the design and performance of audit procedures whose nature, 
timing, and extent are responsive to the assessed risks. Additionally, the pro­
posed SASs establish standards and provide guidance on planning and super­
vision, the nature of audit evidence, and evaluating whether the audit evidence 
obtained affords a reasonable basis for an opinion regarding the financial state­
ments under audit.
These proposed standards are expected to be issued as final standards at the 
end of 2005. Readers can access the proposed standards at AICPA Online 
(www.aicpa.org) and should be alert to future progress on this project.
Applicability of Requirements of the Sarbanes-O xley  
Act of 2002, Related Securities and Exchange 
Commission Regulations, and Standards of the Public 
Com pany Accounting Oversight Board
Publicly-held companies and other "issuers" (see definition below) are subject 
to the provisions of the Sarbanes-Oxley Act of 2002 (Act) and related Securi­
ties and Exchange Commission (SEC) regulations implementing the Act. Their 
outside auditors are also subject to the provisions of the Act and to the rules 
and standards issued by the PCAOB.
Presented below is a summary of certain key areas addressed by the Act, the 
SEC, and the PCAOB that are particularly relevant to the preparation and 
issuance of an issuer's financial statements and the preparation and issuance 
of an audit report on those financial statements. However, the provisions of the 
Act, the regulations of the SEC, and the rules and standards of the PCAOB are 
numerous and are not all addressed in this section or in this Guide. Issuers and 
their auditors should understand the provisions of the Act, the SEC regulations 
implementing the Act, and the rules and standards of the PCAOB, as applicable 
to their circumstances.
Definition of an Issuer
The Act states that the term "issuer" means an issuer (as defined in 
section 3 of the Securities Exchange Act of 1934 (15 U.S.C. 78c)), the 
securities of which are registered under section 12 of that Act (15 U.S.C. 
781), or that is required to file reports under section 15(d) (15 U.S.C. 
78o(d)), or that files or has filed a registration statement that has not
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yet become effective under the Securities Act of 1933 (15 U.S.C. 77a et 
seq.), and that it has not withdrawn.
Issuers, as defined by the Act, and other entities when prescribed by 
the rules of the SEC (collectively referred to in this Guide as "issuers" 
or "issuer") and their public accounting firms (who must be registered 
with the PCAOB) are subject to the provisions of the Act, implement­
ing SEC regulations, and the rules and standards of the PCAOB, as 
appropriate.
Non-issuers are those entities not subject to the Act or the rules of the 
SEC.
Guidance for Issuers
Management Assessment of Internal Control
As directed by Section 404 of the Act, the SEC adopted final rules requiring 
companies subject to the reporting requirements of the Securities Exchange 
Act of 1934 (Exchange Act), other than registered investment companies and 
certain other entities, to include in their annual reports a report of man­
agement on the company's internal control over financial reporting. See the 
SEC Web site at www.sec.gov/rules/final/33-8238.htm for the full text of the 
regulation.
Companies that are "accelerated filers," as defined in Exchange Act Rule 12b-2, 
are required to comply with these rules for fiscal years ending on or after Novem­
ber 15, 2004. Foreign private issuers that are "accelerated filers" and that file 
their annual reports on Form 20-F or 40-F must begin to comply with the rules 
for the first fiscal year ending on or after July 15, 2006. "Non-accelerated fil­
ers" including foreign private issuers that are not accelerated filers, are re­
quired to comply with the rules for the first fiscal year ending on or after July 
15, 2007. See the SEC Web site at www.sec.gov/rules/final/33-8545.htm and at 
www.sec.gov/rules/final/33-8618.pdf for further information.
The SEC rules clarify that management's assessment and report is limited to 
internal control over financial reporting. The SEC's definition of internal con­
trol encompasses the Committee of Sponsoring Organizations of the Treadway 
Commission (COSO) definition but the SEC does not mandate that the entity 
use COSO as its criteria for judging effectiveness.
Under the SEC rules, the company's annual 10-K must include:
1. Management's Annual Report on Internal Control Over Financial 
Reporting
2. Attestation Report of the Registered Public Accounting Firm
3. Changes in Internal Control Over Financial Reporting
The SEC rules also require management to evaluate any change in the entity's 
internal control that occurred during a fiscal quarter and that has materially 
affected, or is reasonably likely to materially affect, the entity's internal control 
over financial reporting.
Audit Committees and Corporate Governance
Section 301 of the Act establishes requirements related to the makeup and the 
responsibilities of an issuer's audit committee. Among those requirements—
•  Each member of the audit committee must be a member of the board 
of directors of the issuer, and otherwise be independent.
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•  The audit committee of an issuer is directly responsible for the ap­
pointment, compensation, and oversight of the work of any registered 
public accounting firm employed by that issuer.
•  The audit committee shall establish procedures for the "receipt, reten­
tion, and treatment of complaints" received by the issuer regarding 
accounting, internal controls, and auditing.
In April 2003, the SEC adopted a rule to direct the national securities exchanges 
and national securities associations to prohibit the listing of any security of 
an issuer that is not in compliance with the audit committee requirements 
mandated by the Act.
Disclosure of Audit Committee Financial Expert and Code of Ethics
In January 2003, the SEC adopted amendments requiring issuers, other than 
registered investment companies, to include two new types of disclosures in 
their annual reports filed pursuant to the Securities Exchange Act of 1934. 
These amendments conform to Sections 406 and 407 of the Act and relate to 
disclosures concerning the audit committee's financial expert and code of ethics 
relating to the companies' officers. An amendment specifies that these disclo­
sures are only required for annual reports.
Certification of Disclosure in an Issuer's Quarterly and Annual Reports
Section 302 of the Act requires the Chief Executive Officer (CEO) and Chief 
Financial Officer (CFO) of each issuer to prepare a statement to accompany the 
audit report to certify the "appropriateness of the financial statements and dis­
closures contained in the periodic report, and that those financial statements 
and disclosures fairly present, in all material respects, the operations and fi­
nancial condition of the issuer."
In August 2002, the SEC adopted final rules for Certification of Disclosure in 
Companies' Quarterly and Annual Reports in response to Section 302 of the Act. 
CEOs and CFOs are now required to certify the financial and other information 
contained in quarterly and annual reports.
Improper Influence on Conduct of Audits
Section 303 of the Act makes it unlawful for any officer or director of an issuer 
to take any action to fraudulently influence, coerce, manipulate, or mislead any 
auditor engaged in the performance of an audit for the purpose of rendering 
the financial statements materially misleading. In April 2003, the SEC adopted 
rules implementing these provisions of the Act.
Disclosures in Periodic Reports
Section 401(a) of the Act requires that each financial report of an issuer that 
is required to be prepared in accordance with generally accepted accounting 
principles (GAAP) shall "reflect all material correcting adjustments . . . that 
have been identified by a registered accounting firm . . . ." In addition, "each 
annual and quarterly financial report. . .  shall disclose all material off-balance 
sheet transactions" and "other relationships" with "unconsolidated entities" 
that may have a material current or future effect on the financial condition of 
the issuer.
In January 2003, the SEC adopted rules that require disclosure of material off- 
balance sheet transactions, arrangements, obligations, and other relationships 
of the issuer with unconsolidated entities or other persons, that may have a 
material current or future effect on financial condition, changes in financial
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condition, results of operations, liquidity, capital expenditures, capital re­
sources, or significant components of revenues or expenses. The rules require 
an issuer to provide an explanation of its off-balance sheet arrangements in a 
separately captioned subsection of the Management's Discussion and Analysis 
section of an issuer's disclosure documents.
Guidance for Auditors
The Act mandates a number of requirements concerning auditors of issuers, in­
cluding mandatory registration with the PCAOB, the setting of auditing stan­
dards, inspections, investigations, disciplinary proceedings, prohibited activi­
ties, partner rotation, and reports to audit committees, among others. Auditors 
of issuers should familiarize themselves with applicable provisions of the Act 
and the standards of the PCAOB. The PCAOB continues to establish rules 
and standards implementing provisions of the Act concerning the auditors of 
issuers.
Applicability of Generally Accepted Auditing Standards and Public 
Company Accounting Oversight Board Standards
The Act authorizes the PCAOB to establish auditing and related attestation, 
quality control, ethics, and independence standards to be used by registered 
public accounting firms in the preparation and issuance of audit reports for en­
tities subject to the Act or the rules of the SEC. Accordingly, public accounting 
firms registered with the PCAOB are required to adhere to all PCAOB stan­
dards in the audits of "issuers," as defined by the Act, and other entities when 
prescribed by the rules of the SEC.
For those entities not subject to the Act or the rules of the SEC, the prepara­
tion and issuance of audit reports remain governed by GAAS as issued by the 
ASB.
Major Existing Differences Between GAAS and PCAOB Standards
The major differences between GAAS and PCAOB standards are described in 
both Part I of volume one of the AIPCA Professional Standards and in Part I of 
the AICPA publication titled PCAOB Standards and Related Rules.
Auditor Reports to Audit Committees
Section 204 of the Act requires the accounting firm to report to the issuer's 
audit committee all "critical accounting policies and practices to be used ... all 
alternative treatments of financial information within [GAAP] that have been 
discussed with management ... ramifications of the use of such alternative 
disclosures and treatments, and the treatment preferred" by the firm.
Other Requirements
The Act contains requirements in a number of other important areas, and the 
SEC has issued implementing regulations in certain of those areas as well. For 
example,
•  The Act prohibits auditors from performing certain non-audit or non- 
attest services. The SEC adopted amendments to its existing require­
ments regarding auditor independence to enhance the independence 
of accountants that audit and review financial statements and prepare 
attestation reports filed with the SEC. This rule conforms the SEC's 
regulations to Section 208(a) of the Act and, importantly, addresses 
the performance of non-audit services.
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The Act requires the lead audit or coordinating partner and the review­
ing partner to rotate off of the audit every 5 years. (See SEC Releases 
33-8183 and 33-8183A for SEC implementing rules.)
The Act directs the PCAOB to require a second partner review and 
approval of audit reports (concurring review).
The Act states that an accounting firm will not be able to provide 
audit services to an issuer if one of that issuer's top officials (CEO, 
Controller, CFO, Chief Accounting Officer, etc.) was employed by the 
firm and worked on the issuer's audit during the previous year.
AAG-HCO
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Chapter 1
Unique Considerations of Health 
Care Organizations
Note: In referring to AICPA professional standards (GAAS), this chapter 
cites the applicable sections of the AICPA Professional Standards publica­
tion. In referring to Public Company Accounting Oversight Board (PCAOB) 
professional standards, this chapter cites the applicable sections of the 
AICPAs publication titled PCAOB Standards and Related Rules. In those 
cases in which the auditing standards of the AICPA and those of the PCAOB 
are the same, this chapter cites the applicable section of the AICPA Profes­
sional Standards publication only.
Overview
1.01 Financial statements of health care organizations should be prepared 
in conformity with generally accepted accounting principles (GAAP). AICPA 
Statement on Auditing Standards (SAS) No. 69, The Meaning of Present Fairly 
in Conformity With Generally Accepted Accounting Principles (AICPA, Profes­
sional Standards, vol. 1, AU sec. 411), provides the GAAP hierarchy summary 
for both nongovernmental and governmental organizations.*,1
* The Financial Accounting Standards Board (FASB) released an exposure draft of a proposed 
FASB Statement, The Hierarchy of Generally Accepted Accounting Principles, that would supersede 
the hierarchy for nongovernmental entities currently presented in AICPA Statement on Auditing 
Standards (SAS) No. 69, The Meaning of Present Fairly in Conformity With Generally Accepted 
Accounting Principles (AICPA, Professional Standards, vol. 1, AU sec. 411). The proposed standard 
would carry forward the GAAP hierarchy as set forth in SAS No. 69, subject to certain modifications. 
Those modifications are (1) to carry forward the categorization of the sources of accounting principles 
by document type as presented in paragraph .10 of SAS No. 69, and not by their characteristics as 
presented in paragraph .05 of SAS No. 69, and (2) to expand the sources of category (a) to include FASB 
Staff Positions and FASB Statement No. 133 Implementation Issues. In response to the proposed FASB 
Statement, in May 2005, the AICPA released an exposure draft of a proposed SAS, Amendment to 
Statement on Auditing Standards No. 69, The Meaning of Present Fairly in Conformity With Generally 
Accepted Accounting Principles, for Nongovernmental Entities. The proposed SAS would apply to 
nongovernmental entities. Readers should be alert for the issuance of final standards.
1 GASB Statement No. 34, Basic Financial Statements—and Management's Discussion and 
Analysis—for State and Local Governments, paragraphs 93 through 95, indefinitely extend the provi­
sions of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other 
Governmental Entities That Use Proprietary Fund Accounting. GASB Statement No. 20, paragraph 
6, as amended, requires that proprietary funds should apply all applicable GASB pronouncements as 
well as any FASB Statements and Interpretations, Accounting Principles Board (APB) Opinions, and 
Accounting Research Bulletins (ARBs) issued on or before November 30, 1989, that do not conflict 
with or contradict GASB pronouncements. Furthermore, paragraph 7, as amended, of GASB State­
ment No. 20 provides that governmental enterprise funds and activities reported using enterprise 
fund accounting and financial reporting may apply all FASB Statements and Interpretations issued 
after November 3 0 , 1989, that do not conflict with or contradict GASB pronouncements. Entities that 
choose to apply these "new" FASB pronouncements must apply them on an "all or none" basis (that is, 
they may not select which pronouncements to apply). In addition, GASB Statement No. 29, The Use of 
Not-for-Profit Accounting and Financial Reporting Principles by Governmental Entities, provides that 
governmental enterprise funds and activities reported using enterprise fund accounting and financial 
reporting that apply the provisions of paragraph 7, as amended, of GASB Statement No. 20 should 
apply only those FASB Statements and Interpretations issued after November 30, 1989 that are de­
veloped for business enterprises (see paragraph 1.53 in this Guide). They should not apply FASB 
Statements and Interpretations whose provisions are limited to not-for-profit organizations, such as 
FASB Statement No. 117, Financial Statements of Not-for-Profit Organizations, or address issues
(continued)
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Classification of Health Care Organizations
1.02 Health care enterprises usually can be classified into the following 
categories on the basis of their operating characteristics:
a. Investor-Owned Health Care Enterprises. These are owned by in­
vestors or others with a private equity interest and provide goods 
or services with the objective of making a profit.
b. Not-for-Profit, Business-Oriented Organizations. These are char­
acterized by no ownership interests and essentially are self- 
sustaining from fees charged for goods and services. The fees 
charged by such organizations generally are intended to help the or­
ganization maintain its self-sustaining status rather than to max­
imize profits for the owner's benefit. Such organizations often are 
exempt from federal income taxes and may receive contributions of 
relatively small amounts from resource providers that do not expect 
commensurate or proportionate pecuniary return.
c. Governmental Health Care Organizations. These are public 
corporations2 and bodies corporate and politic. Other organizations 
are governmental organizations if they have one or more of the fol­
lowing characteristics:
•  Popular election of officers or appointment (or approval) of 
a controlling majority of the members of the organization's 
governing body by officials of one or more state or local 
governments;
•  The potential for unilateral dissolution by a government 
with the net assets reverting to a government; or
•  The power to enact and enforce a tax levy.
Furthermore, organizations are presumed to be governmental if 
they have the ability to issue directly (rather than through a state 
or municipal authority) debt that pays interest exempt from federal 
taxation. However, organizations possessing only that ability (to is­
sue tax-exempt debt) and none of the other governmental charac­
teristics may rebut the presumption that they are governmental if 
their determination is supported by compelling, relevant evidence.
d. Not-for-Profit, Nonbusiness-Oriented Organizations. These are vol­
untary health and welfare organizations (see the Glossary) as de­
fined in FASB Statement No. 117, Financial Statements of Not-for- 
Profit Organizations. Such organizations are within the scope of
Health Care Organizations
(footnote continued)
concerning primarily such organizations, such as FASB Statement No. 116, Accounting for Contribu­
tions Received and Contributions Made. The requirements set forth in this Guide for governmental 
health care enterprises generally apply to such enterprises that apply paragraph 7, as amended, of 
GASB Statement No. 20.
2  Black's Law Dictionary defines a public corporation as: An artificial person (e.g., [a] municipal­
ity or a governmental corporation) created for the administration of public affairs. Unlike a private 
corporation it has no protection against legislative acts altering or even repealing its charter. Instru­
mentalities created by [the] state, formed and owned by it in [the] public interest, supported in whole 
or part by public funds, and governed by managers deriving their authority from [the] state. Sharon 
Realty Co. v. Westlake, Ohio Com.Pl., 188 N.E.2d 318, 323, 25, 0.0.2d 322. A public corporation is an 
instrumentality of the state, founded and owned in the public interest, supported by public funds and 
governed by those deriving their authority from the state. York County Fair Ass’n v. South Carolina 
Tax Commission, 249 S.C. 337, 154 S.E.2d 361, 362.
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the AICPA Audit and Accounting Guide Not-for-Profit Organiza­
tions rather than this Guide.
Financial Reporting of Nongovernmental Health 
Care Organizations
1.03 The nature of the organization and its operating structure have a sig­
nificant effect on the needs of financial statement users. According to FASB 
Statement of Financial Accounting Concepts (Concepts Statement) No. 4, Ob­
jectives of Financial Reporting by Nonbusiness Organizations, paragraph 8:
Some organizations have no ownership interests but are essentially 
self-sustaining from fees they charge for goods and services. Examples 
are those private nonprofit hospitals . . . that may receive relatively 
small amounts of contributions and grants but finance their capital 
needs largely from the proceeds of debt issues and their operating 
needs largely from service charges rather than from private philan­
thropy or governmental grants. As a result, assessment of amounts, 
timing, and uncertainty of cash flows becomes the dominant interest of 
their creditors and other resource providers and profitability becomes 
an important indicator of performance. Consequently, the objectives 
of FASB Concepts Statement No. 1 [Objectives of Financial Reporting 
by Business Enterprises] may be more appropriate for those organiza­
tions. [Footnote reference omitted.]
1.04 The financial reporting for not-for-profit, business-oriented organiza­
tions and investor-owned health care enterprises generally is consistent except 
for transactions that clearly are not applicable. For example, not-for-profit, busi­
ness organizations would have nothing to report for shareholders' equity. On 
the other hand, investor-owned health care enterprises typically would not have 
anything to report for contributions.
1.05 The basic financial statements of health care organizations generally 
consist of a balance sheet, a statement of operations, a statement of changes 
in equity (or net assets), a statement of cash flows, and notes to the finan­
cial statements.3 The statement of operations for not-for-profit organizations 
should report a performance indicator (see paragraph 10.20) as well as all other 
changes in unrestricted net assets for the period. The statement of operations 
may be combined with the statement of changes in equity (net assets). Illustra­
tive financial statements are included in the Appendix A of this Guide.
1.06 FASB Statement No. 117 requires not-for-profit organizations to pro­
vide information about the liquidity of assets and liabilities in the balance 
sheet. Health care organizations should classify assets and liabilities as current 
and noncurrent. However, rather than presenting a classified balance sheet, a 
continuing care retirement community (CCRC) instead may sequence assets 
according to their nearness of conversion to cash and may sequence liabilities 
according to the nearness of the maturity and resulting use of cash.
1.07 FASB Statement No. 95, Statement of Cash Flows, established 
standards for cash flow reporting for investor-owned organizations. FASB
3 The terms balance sheet and statement of operations indicate the content and purpose of the 
respective statements and serve as possible titles for those statements. Other appropriately descrip­
tive titles may also be used. For example, a statement reporting financial position could be called 
a statement of financial position as well as a balance sheet. Current practice and purpose suggest, 
however, that a statement of cash flows only be titled "Statement of Cash Flows."
Unique Considerations of Health Care Organizations
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Statement No. 95 was amended by FASB Statement No. 117 to include not- 
for-profit organizations. The statement of cash flows may be prepared using 
the direct or indirect method of reporting cash flows.
1.08 A health care organization may be a part of another organization, 
such as a medical school or a university, or a subsidiary of a corporation. The 
recommendations in this Guide apply to the separate financial statements of 
these organizations as defined above.
Financial Reporting of Governmental Health 
Care Organizations
1.09 This section of the Guide discusses the financial reporting require­
ments applicable to governmental health care entities within the scope of 
this Guide, including the financial reporting requirements of GASB Statement 
No. 34, as amended, and GASB Statement No. 38, Certain Financial Statement 
Note Disclosures.
1.10 A health care organization may be a part of another organization, such 
as a general-purpose-government or medical school or a university. The recom­
mendations in this Guide apply to the separate financial statements of these 
organizations. Therefore, when separate financial statements are prepared for 
a governmental health care organization that uses enterprise fund accounting 
and reporting, the accounting and disclosure requirements set forth by GASB 
pronouncements and this Guide apply. The requirements in this Guide pre­
sume that governmental health care organizations apply paragraph 7 of GASB 
Statement No. 20 (see footnote 1 to this chapter).
1.11 This Guide makes various references to implementation guides pub­
lished by the GASB staff. Those implementation guides are category (d) guid­
ance in the hierarchy of GAAP applicable to state and local governments, as 
discussed in SAS No. 69 and in paragraph 1.61 in this chapter. References to 
the guidance in GASB staff implementation guides in this Guide do not ele­
vate that guidance to category (b) guidance. Similarly, references in this Guide 
to discussions or examples in the nonauthoritative appendixes of GASB pro­
nouncements or its staff's implementation guides do not elevate that guidance 
from "other accounting literature."
GASB Statement No. 34 and Related Pronouncements
1.12 Briefly, GASB Statement No. 34 and related pronouncements require 
that the separately issued financial reports of governmental health care entities 
that are special-purpose governments engaged only in business-type activities:
•  Present a management's discussion and analysis (MD&A) before the 
basic financial statements as required supplementary information 
(RSI).
•  Present a classified statement of net assets/balance sheet.
•  Report three categories of net assets—(a) net assets invested in capital 
assets net of related debt, (b) restricted net assets, and (c) unrestricted 
net assets.
•  Apply the definition of restricted provided in GASB Statement No. 34 
in determining restricted assets and restricted net assets.
•  Present a statement of revenues, expenses, and changes in net as- 
sets/equity that reports on changes in net assets, including permanent
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endowments. The focus of this statement is to present all changes in 
net assets.
•  Report transfers as interfund transfers after nonoperating revenues 
and expenses. Under GASB Statement No. 34, there is no distinction 
as to the type of transfer.
•  Report revenues by major source and separately identify revenue used 
as security for revenue bonds.
•  Distinguish between operating and nonoperating revenues and ex­
penses and provide an intermediate total for operating income or loss.
•  Separately report capital contributions and contributions to term and 
permanent endowments as components of the all-inclusive statement 
of revenues, expenses, and changes in net assets/equity.
•  Separately report special items and extraordinary items at the bot­
tom of the statement of revenues, expenses, and changes in net as­
sets/equity.
•  Report operating cash flows using the direct method in the statement 
of cash flows.
•  Present certain note disclosures, including the entity's policy for defin­
ing operating revenues and expenses, policy regarding the use of re­
stricted resources, schedules of changes in capital assets and long-term 
liabilities, disaggregated information about accounts receivable and 
payable, and short-term debt activity during the year. (Disclosure of 
disaggregated information about accounts receivable and payable is 
required by GASB Statement No. 38.)
•  If the entity has segments, present segment information based on the 
definition of a segment in GASB Statement No. 34.
The requirements in this paragraph do not apply to health care units that are 
not legally separate entities.
1.13 GASB Statement No. 34 requires governmental health care entities 
that are special-purpose governments engaged only in business-type activities 
to present three basic financial statements, notes to the financial statements, 
and RSI:4
MD&A as RSI.
A statement of net assets or balance sheet.
A statement of revenues, expenses, and changes in net assets/ 
equity.
A statement of cash flows.
Notes to financial statements.
RSI other than MD&A, as established by GAAP, such as GASB 
Statement No. 27, Accounting for Pensions by State and Local Gov­
ernmental Employers. *
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d.
e.
f .
4 GASB Statement No. 34 does not provide guidance on separate reporting by individual enter­
prise funds of a government. Although this discussion of the guidance in GASB Statement No. 34 is 
written in terms of special-purpose business-type activities that are governmental health care enti­
ties, the accounting, financial reporting, and auditing considerations are usually equally applicable 
when the health care activity is conducted as a function or program of a general-purpose govern­
ment and reported in an enterprise fund. See footnote 7 to the section heading "Specific Guidance for 
Special-Purpose Governments" in Chapter 12 of the Audit and Accounting Guide State and Local Gov­
ernments. Reporting guidance on separate reporting by individual enterprise funds of a government 
is provided in the Audit and Accounting Guide State and Local Governments.
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Management's Discussion and Analysis
1.14 GASB Statement No. 34, paragraphs 8 through 11, as amended, es­
tablish eight required elements of MD&A for general-purpose governments. 
However, certain of those elements are not applicable to governmental health 
care entities that are special-purpose governments engaged only in business- 
type activities. These governmental health care entities should limit their dis­
cussion in MD&A to the elements that are applicable to their entity. Because 
it is RSI, no additional information should be presented within MD&A.
1.15 Many health care entities that are special-purpose governments en­
gaged only in business-type activities present comparative financial state­
ments. When comparative financial statements are presented, MD&A should 
present an analysis of both current- and prior-year net assets and changes 
in them, as discussed in the GASB staff document, Comprehensive Imple­
mentation Guide—2004 (GASB Q&A—2004 Edition), item 7.14. (See para­
graph 1.11 in this chapter regarding references in this Guide to discussions 
in GASB staff implementation guides.) Two completely separate MD&As are 
not required. When comparative financial statements are presented, the MD&A 
should present the current year, prior year, and preceding year financial infor­
mation summarized in the MD&A, and discuss the fluctuations. If comparative 
financial data is presented, as distinguished from a complete set of compara­
tive statements, notes, and RSI, the requirements for MD&A in paragraph 11 
of GASB Statement No. 34 should be met for the current year with comparisons 
to the prior year, as discussed in the GASB Q&A—2004 Edition, item 7.15.
Measurement Focus and Basis of Accounting
1.16 GASB Statement No. 34, paragraph 92, requires activities reported 
using enterprise fund accounting and reporting to use the accrual basis of ac­
counting and the economic resources measurement focus. GASB Statement 
No. 34, paragraphs 93 through 95, indefinitely extend the provisions of GASB 
Statement No. 20, Accounting and Financial Reporting for Proprietary Funds 
and Other Governmental Entities That Use Proprietary Fund Accounting (see 
footnote 1 to paragraph 1.01 in this chapter). GASB Statement No. 20, as 
amended, requires governmental health care entities that use enterprise fund 
accounting and reporting to apply all GASB pronouncements as well as FASB 
pronouncements issued on or before November 30, 1989 that do not conflict with 
or contradict GASB pronouncements. In addition, those entities may also ap­
ply all FASB Statements and Interpretations issued after November 30, 1989, 
except for those that conflict with or contradict GASB pronouncements. Only 
those FASB Statements and Interpretations issued after November 30, 1989 
that are developed for business enterprises should be applied, as discussed in 
GASB Statement No. 29, The Use of Not-for-Profit Accounting and Financial Re­
porting Principles by Governmental Entities, paragraph 7, as amended. GASB 
Statement No. 34, paragraph 115, requires disclosure in the summary of sig­
nificant accounting policies of the policy for applying FASB pronouncements 
issued after November 30, 1989, to business-type activities and to enterprise 
funds. The requirements in this Guide presume that governmental health care 
entities apply paragraph 7 of GASB Statement No. 20.
Statement of Net Assets or Balance Sheet
1.17 GASB Statement No. 34, paragraphs 97 through 99, provide guidance 
on the statement of net assets or balance sheet. Governmental health care
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entities that are special-purpose governments engaged only in business-type ac­
tivities may use either a balance sheet format—assets equal liabilities plus net 
assets/equity—or a net assets format—assets less liabilities equal net assets/ 
equity. Assets and liabilities are required to be presented in a classified format.5
1.18 Either term net assets or equity may be used to refer to the differ­
ence between assets and liabilities. Regardless of the label, net assets/equity 
is required to be reported in three broad components: (a) invested in capital 
assets, net of related debt; (6) restricted, and (c) unrestricted. When permanent 
endowments are reported in restricted net assets, two additional components— 
expendable and nonexpendable are required, as discussed in paragraph 35 of 
GASB Statement No. 34.
1.19 The term restricted is defined by GASB Statement No. 34, paragraphs 
34, as amended, and 99.† A restriction is a constraint placed on the use of assets 
or net assets that is either externally imposed (such as by creditors through debt 
covenants) or imposed by law through constitutional provisions or enabling leg­
islation. Internally designated net assets should be reported as unrestricted net 
assets and should not be displayed separately in the net assets section of the 
statement of net assets/balance sheet, as discussed in paragraph 37 of GASB 
Statement No. 34. (Designated assets, however, may be reported in the state­
ment of net assets/balance sheet, as discussed in paragraph 3.01 in this Guide.)
Statement of Revenues, Expenses, and Changes 
in Net Assets/Equity
1.20 The operating statement of governmental health care entities that 
are special-purpose governments engaged only in business-type activities is the 
statement of revenues, expenses, and changes in net assets/equity. Changes in 
both restricted and unrestricted net assets should be reported in this state­
ment using an all inclusive format, illustrated in GASB Statement No. 34, 
paragraph 101:
Operating revenues (detailed)
Total operating revenues 
Operating expenses (detailed)
Total operating expenses 
Operating income (loss)
Nonoperating revenues and expenses (detailed)
Income before other revenues, expenses, gains, losses, and transfers
Capital contributions (grant, developer, and other), additions to permanent and term 
endowments, special and extraordinary items (detailed) and transfers
Increase (decrease) in net assets
Net assets—beginning of period
Net assets—end of period
5 Guidance regarding the classification of certain specific assets or liabilities can be found in 
the chapters of the Guide. For example, see paragraph 4.16 in this Guide regarding the reporting of 
securities as current and noncurrent.
† GASB Statement No. 46, Net Assets Restricted by Enabling Legislation, amends paragraph 34 
of GASB Statement No. 34, effective for financial statements for periods beginning after June 15, 
2005. Earlier application is encouraged.
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In a change in net assets approach, the increase or decrease in net assets for 
the period and net income are not necessarily the same amount (for example, 
because of capital contributions), as noted in GASB Statement No. 34, para­
graph 433. However, GASB Statement No. 34, paragraph 434, indicates that 
this required format does not preclude governments from presenting different 
subtotals before the comprehensive performance measure—increase (decrease) 
in net assets. (See paragraph 1.11 in this chapter regarding references in this 
Guide to discussions in the nonauthoritative appendixes in GASB pronounce­
ments.) The subtotals required by GASB Statement No. 34 must be presented.
1.21 As discussed in paragraph 100 and footnote 41 in GASB Statement 
No. 34, governmental health care entities are required to report revenues (net 
of discounts and allowances) by major source and separately identify revenues 
that provide security for revenue bonds. (See further discussion in Chapter 10 
of this Guide.) As illustrated in paragraph 1.20 of this Guide, separate subto­
tals are required for operating revenues, operating expenses and operating in­
come (loss). Governmental health care entities are required by GASB Statement 
No. 34, paragraph 102, to establish a policy that defines operating revenues and 
expenses that is appropriate to the nature of the activity being reported and to 
disclose that policy in the notes to the financial statements. Factors that may be 
considered in establishing that policy are discussed in Chapter 10 of this Guide.
1.22 Revenues from capital contributions as well as contributions to the 
principal of permanent and term endowments should be reported after nonop­
erating revenues and expenses, as discussed in GASB Statement No. 34, para­
graph 100. Income from permanent or term endowments should be recorded 
as nonoperating revenue, as discussed in the GASB Q&A—2004 Edition, item 
7.334. (See paragraph 1.11 in this chapter regarding references in this Guide 
to discussions in GASB staff implementation guides.)
1.23 Governmental health care entities that apply paragraph 7 of GASB 
Statement No. 20 should be aware that FASB Statement No. 130, Report­
ing Comprehensive Income, conflicts with the all-inclusive format required by 
GASB Statement No. 34, as discussed in the GASB Q&A—2004 Edition, item 
7.315. (See paragraph 1.11 in this chapter regarding references in this Guide 
to discussions in GASB staff implementation guides.)
Statement of Cash Flows
1.24 GASB Statement No. Reporting Cash Flows of Proprietary and Non­
expendable Trust Funds and Governmental Entities, established standards for 
cash flow reporting for governmental entities. GASB Statement No. 34, para­
graph 105, requires governmental health care entities that are special-purpose 
governments engaged only in business-type activities to present a statement of 
cash flows using the direct method, discussed in GASB Statement No. 9, para­
graph 31, as amended. A reconciliation of operating income (loss) to operating 
cash flows also should be presented.
Revenue From Health Care Services
1.25 In general, gross service revenue is recorded in the accounting records 
on an accrual basis at the provider's established rates, regardless of whether 
the health care organization expects to collect that amount. Provisions recog­
nizing contractual adjustments and other adjustments (see examples in para­
graph 5.02) are recorded on an accrual basis and deducted from gross service
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revenue to determine net service revenue. For financial reporting purposes, 
gross revenue does not include charity care (see discussion in paragraph 10.03) 
and service revenue is reported net of contractual and other adjustments in the 
statement of operations. Accounting and auditing issues related to receivables 
and revenue from health care services are discussed in Chapters 5 and 10.
1.26 In many cases, revenues are generated as a result of an agreement 
to provide health care rather than from the actual provision of services. For 
example, an integrated delivery system may agree to provide all health-related 
services for a specified group residing within its primary service area for an 
agreed-upon amount per member per month (PMPM). These revenues are pre­
mium revenues, not patient service revenues, since they are earned by agreeing 
to provide care, regardless of whether services actually are rendered.
Third-Party Payor Considerations
1.27 Some third-party payors retrospectively determine final amounts re­
imbursable for services rendered to their beneficiaries based on allowable costs. 
These payors reimburse the health care organization on the basis of interim 
payment rates until the retrospective determination of allowable costs can be 
made. In most instances, the accumulation and allocation of allowable costs 
and other factors result in final settlements different from the interim payment 
rates. Final settlements are determined after the close of the fiscal periods to 
which they apply and may affect materially the health care organization's fi­
nancial position and results of operations. Consequently, a reasonable estimate 
of the amount receivable from or payable to these payors should be made in the 
same period that the related services are rendered. Accounting and auditing 
issues related to receivables from third parties are discussed in Chapter 5.
Classification and Reporting of Net Assets
1.28 Currently, many not-for-profit health care organizations use fund ac­
counting for purposes of internal recordkeeping and managerial control. Many 
individual funds may be established by an organization to help in monitoring 
compliance with donor or grantor restrictions due to the fiduciary accountabil­
ity associated with these resources. Each fund consists of a self-balancing group 
of accounts composed of assets, liabilities, and net assets. Consistent with FASB 
Concepts Statement No. 6, Elements of Financial Statements, FASB Statement 
No. 117 concluded that although some not-for-profit organizations may choose to 
classify assets and liabilities into fund groups, information about those group­
ings is not a necessary part of general-purpose external financial reporting. 
Although FASB Statement No. 117 does not preclude not-for-profit organiza­
tions from using fund accounting for internal recordkeeping and reporting, for 
purposes of external financial reporting each of the individual internal funds 
must be classified into one or more of the three broad classes of net assets: 
unrestricted net assets, temporarily restricted net assets, and permanently re­
stricted net assets. These classifications are related to the existence or absence 
of donor-imposed restrictions and are discussed in more detail in paragraphs
1.29 through 1.33 and also Chapter 9.
1.29 Unrestricted Net Assets. These represent the part of net assets that 
have not been externally restricted for identified purposes by donors and 
grantors. Unrestricted net assets also include assets whose use is contractu­
ally limited, such as—
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•  Proceeds of debt issues and funds of the health care organization 
deposited with a trustee and limited to use in accordance with the 
requirements of an indenture or a similar agreement. (See para­
graph 7.18.)
•  Other assets limited to use for identified purposes through an agree­
ment between the health care organization and an outside party other 
than a donor or grantor. Examples include assets set aside under 
debt agreements, assets set aside under self-insurance (risk-retention) 
funding arrangements, and assets set aside to meet statutory reserve 
requirements (such as those required under state law for many health 
maintenance organizations [HMOs]). (See paragraph 8.20.)
1.30 Information about significant contractual limits (for example, debt 
covenants and self-insurance trusts) generally is disclosed in the notes to the 
financial statements. Similarly, internally designated funds should be reported 
separately from externally designated funds either on the face of the balance 
sheet or in the notes to the financial statements.
1.31 Temporarily Restricted and Permanently Restricted Net Assets. FASB 
Statement No. 117 defines two classes of donor-restricted net assets: temporar­
ily restricted and permanently restricted. The distinction between these two 
types of restricted net assets is based on the nature of the donor's restriction. 
Temporarily restricted net assets are those donor-restricted net assets that can 
be used by the not-for-profit organization for their specified purpose once the 
donor's restriction is met. Generally, these restrictions are met either by the 
passage of time or by actions taken by the entity, such as use of the funds 
for the purpose intended. Permanently restricted net assets (for example, en­
dowment funds) are those with donor restrictions that do not expire with the 
passage of time and cannot be removed by any actions taken by the entity. All 
donor-restricted net assets must be classified into one of these two broad cate­
gories for external reporting. Not-for-profit organizations may want to further 
classify temporarily and permanently restricted net assets into distinct groups 
that distinguish the nature or purpose of the donor's restriction. Accounting 
and reporting considerations pertaining to gifts and grants that are externally 
restricted for identified purposes by donors and grantors are discussed in para­
graphs 9.04 through 9.06 and 10.08 through 10.14.
1.32 It should be noted that donor restrictions generally relate to limita­
tions on the use of net assets rather than the use of specific assets. According 
to FASB Concepts Statement No. 6, paragraphs 101 and 102:
Restrictions impose responsibilities on management to ensure that 
the organization uses donated resources in the manner stipulated by 
resource providers. Sometimes donor-imposed restrictions limit an or­
ganization's ability to sell or exchange the particular asset received. 
For example, a donor may give a painting to a museum stipulating that 
it must be publicly displayed, properly maintained, and never sold. 
More commonly, donors' stipulations permit the organization to pool 
the donated assets with other assets and to sell or exchange the do­
nated assets for other suitable assets as long as the economic ben­
efits of the donated assets are not consumed or used for a purpose 
that does not comply with the stipulation. For example, a donor may 
contribute 100 shares of Security A to an organization's endowment, 
thereby requiring that the amount of the gift be retained permanently 
but not requiring that the specified shares be held indefinitely. Thus,
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permanently restricted net assets and temporarily restricted net as­
sets generally refer to amounts of net assets that are restricted by 
donor-imposed limits, not to specific assets.
1.33 A not-for-profit organization can report separate line items within 
any of the three classes of net assets either on the face of the balance sheet 
or in the notes to the financial statements to further distinguish the nature 
of donor restrictions within that category of net assets. For example, a health 
care organization may want to disclose the amount of temporarily restricted net 
assets restricted for a specific purpose such as indigent care. Further examples 
are provided in paragraph 15 of FASB Statement No. 117. An organization's 
internal fund accounting can be used to account for these different types of 
resources within a specific class of net assets.
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Health Care Contracting
1.34 Contracts between a health care provider and a payor based on any­
thing other than full charges requires the provider to accept some financial risk. 
The nature and degree of risk for the provider varies depending on the contract 
terms (for example, the definition of the unit of service or the basis for pay­
ment). In planning the audit of the health care provider, the auditor considers 
the audit risk associated with the entity's health care contracts. For example, 
contracts with payments for services based on a discount from the provider's 
established rates may have different risks than contracts with payments for 
services based on a capitated arrangement.
1.35 Generally, capitation payments are made at the beginning of each 
month and obligate the provider to render covered services during the month. 
Revenue is earned as a result of agreeing to provide services to qualified bene­
ficiaries and not as a result of actually providing the care. If the provider's ac­
counting system records patient charges and establishes patient receivables as 
services are rendered, appropriate valuation allowances or adjustments should 
be recorded so only the amount of contract revenue is recorded.
1.36 A capitation contract may obligate the provider to assume the risk of 
physician referrals and other outside services. In this case, a liability for unpaid 
claims, including incurred but not reported claims, should be established. A lag 
analysis may be helpful in estimating the liability.
1.37 In addition to the capitation payments, the amount of contract rev­
enue may be affected by factors such as reinsurance recoveries, deductibles, 
coinsurance, and risk pool adjustments. Risk pool adjustments may be based 
on factors such as utilization or cost targets.
1.38 Sometimes health care providers enter preferred provider arrange­
ments with self-insured employers whereby the provider guarantees that the 
employer's health care cost will not increase over a specified amount or percent­
age. In substance, these providers may have provided aggregate stop-loss insur­
ance to the self-insured employer, and a material liability to the provider may 
exist. FASB Statement No. 5, Accounting for Contingencies, provides guidance 
on accounting for these contingencies. GASB Statement No. 10, Accounting and 
Financial Reporting for Risk Financing and Related Insurance Issues, provides 
guidance on accounting for contingencies by governmental enterprises.
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GAAP Hierarchy for Not-for-Profit Organizations *
1.39 SAS No. 69 states that the guidance provided by FASB Statements 
and Interpretations, Opinions of the APB, and ARBs shall be considered es­
tablished accounting principles pursuant to Rule 203 of the AICPA Code of 
Professional Conduct. (Appendix G [paragraph 1.61] of this chapter discusses 
SAS No. 69 and the hierarchy of sources of GAAP.)
1.40 Not-for-profit organizations should follow the guidance in effective 
provisions of ARBs, APB Opinions, and FASB Statements and Interpretations 
unless the specific pronouncement explicitly exempts not-for-profit organiza­
tions or their subject matter precludes such applicability. (As noted in para­
graphs 1.45 and 1.46, not-for-profit organizations should follow the guidance 
in FASB Statements No. 116, Accounting for Contributions Received and Con­
tributions Made, No. 117, No. 124, Accounting for Certain Investments Held 
by Not-for-Profit Organizations, and No. 136, Transfers of Assets to a Not-for- 
Profit Organization or Charitable Trust That Raises or Holds Contributions for 
Others, and this Guide in applying the guidance in pronouncements listed in 
Appendixes C and D [paragraphs 1.57 and 1.58] of this chapter.)
1.41 The Appendixes [paragraphs 1.55 through 1.61] of this chapter are 
aids to the implementation of the guidance in this chapter.
1.42 Pronouncements issued by the FASB subsequent to this Guide's ef­
fective date apply to not-for-profit organizations unless those pronouncements 
explicitly exempt not-for-profit organizations or their subject matter precludes 
such applicability.6
1.43 Not-for-profit organizations may follow and are not prohibited from 
following the guidance in effective provisions of the APB Opinions and the 
FASB Statements and Interpretations listed in Appendix A [paragraph 1.55] of 
this chapter, which specifically exempt not-for-profit organizations from their 
application, unless FASB Statements No. 116 or No. 117 or this Guide provide 
different guidance. (However, the guidance included in the effective provisions 
of pronouncements listed in Appendix A [paragraph 1.55] applies to all for-profit 
entities owned, whether owned all or in part, by not-for-profit entities.) The 
discussion in paragraphs 1.45 through 1.51 should be considered in determining 
the hierarchy of such guidance and of guidance issued by the AICPA.
1.44 Certain financial reporting guidance listed in Appendix B [paragraph
1.56] of this chapter, such as that concerning common stock and convertible 
debt, generally does not apply to the kinds of not-for-profit entities covered by 
this Guide, because such entities do not enter into the kinds of transactions 
covered by that guidance. (However, the guidance included in the effective pro­
visions of pronouncements included in Appendix B [paragraph 1.56] applies 
to all for-profit entities owned, whether owned all or in part, by not-for-profit 
entities. Also, not-for-profit organizations should follow the effective provisions 
of pronouncements in Appendix B [paragraph 1.56] if they enter into the kinds 
of transactions covered by that guidance.)
* See footnote * in paragraph 1.01.
® The guidance in paragraphs 1.39 through 1.51 addresses only the pronouncements listed in 
paragraph 1.40. However, not-for-profit organizations are also subject to other pronouncements in­
cluded in categories (b )-(d) of paragraph 5 of SAS No. 69 and should apply AICPA Audit and Accounting 
Guides, Statements of Position (SOPs), and Practice Bulletins and FASB Technical Bulletins and the 
consensus positions of the FASB Emerging Issues Task Force (EITF) that apply to them. (Appendix 
G [paragraph 1.61] of this chapter discusses SAS No. 69 and the GAAP hierarchy.)
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1.45 Other pronouncements, which are listed in Appendix C [paragraph
1.57] of this chapter (ARB No. 51, Consolidated Financial Statements, and APB 
Opinion No. 29, Accounting for Nonmonetary Transactions), do not exempt not- 
for-profit organizations from their scope, hut the transactions they contemplate 
also are covered by FASB Statement No. 116 and this Guide. FASB Statements 
No. 116, No. 117, No. 124, and No. 136 and this Guide provide guidance for 
applying the pronouncements to circumstances unique to not-for-profit orga­
nizations and not contemplated by the pronouncements and therefore should 
be followed to apply the guidance in those pronouncements to not-for-profit or­
ganizations. (However, the guidance included in the effective provisions of pro­
nouncements included in Appendix C [paragraph 1.57] should be followed by all 
for-profit entities owned, whether owned all or in part, by not-for-profit entities.)
1.46 Some pronouncements (listed in Appendix D [paragraph 1.58] of this 
chapter), which may include guidance concerning the recognition and measure­
ment of assets, liabilities, revenues, expenses, gains and losses, and financial 
statement display, state that their provisions apply only to entities operating 
in certain industries. Such entities generally are business enterprises. An ex­
ample of such guidance is FASB Statement No. 63, Financial Reporting by 
Broadcasters. However, some not-for-profit organizations conduct activities7 in 
some of those industries and should apply the guidance in the pronouncements 
concerning the recognition and measurement of assets, liabilities, revenues, 
expenses, and gains and losses to the transactions unique to those industries. 
However, such not-for-profit organizations should follow the financial statement 
display guidance in FASB Statement No. 117 and this Guide, even though it 
may conflict with display that would result from applying the guidance in the 
pronouncements listed in Appendix D [paragraph 1.58].
1.47 Financial reporting pronouncements that have not been superseded 
and are not included in Appendixes A through D [paragraphs 1.55 through
1.58] of this chapter are listed in Appendix E [paragraph 1.59] of this chapter. 
Not-for-profit organizations should follow the effective provisions of the pro­
nouncements listed in Appendix E [paragraph 1.59].8
1.48 Certain other pronouncements, although they do not exempt not-for- 
profit organizations and do cover transactions conducted by not-for-profit orga­
nizations, include some provisions whose application by not-for-profit organiza­
tions may be unclear. Nevertheless, not-for-profit organizations are required to 
follow the effective provisions of those pronouncements. These provisions and 
their applicability are discussed below.
APB Opinion No. 16, Business Combinations‡
1.49 Because the conditions for applying the pooling of interests method of 
accounting for a business combination generally include an exchange of common *‡
7 Such activities may be conducted by (a) for-profit entities owned and consolidated by not-for- 
profit organizations, (b) divisions of not-for-profit organizations, or (c) entire not-for-profit organiza­
tions.
8 See footnote 6.
‡ In June 2001, the FASB issued FASB Statement No. 141, Business Combinations, which su­
persedes several pronouncements including APB Opinion No. 16, Business Combinations. However, 
FASB Statement No. 141 does not apply to certain combinations, including a combination involving 
two or more not-for-profit organizations or the acquisition of a for-profit business entity by a not- 
for-profit organization. For those combinations, the guidance in APB Opinion No. 16 still applies. 
Thus, GAAP does not change for those types of combinations. Not-for-profit health care organizations 
should continue to follow the guidance in this Guide and in APB Opinion No. 16, as amended by
(continued)
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stock of the combining entities, not-for-profit organizations generally would not 
meet the conditions for applying that method. The AICPA Accounting Stan­
dards Executive Committee (AcSEC) believes that circumstances exist under 
which reporting on the combination of two or more not-for-profit organizations 
(or that of a not-for-profit organization with a formerly for-profit entity) by 
the pooling of interests method better reflects the substance of the transac­
tion than reporting by the purchase method. Therefore, not-for-profit organi­
zations are, under certain circumstances, permitted to report by the pooling of 
interests method, even though they generally do not issue common stock. Such 
circumstances include the combination of two or more entities to form a new 
entity without the exchange of consideration. See paragraph 11.38 for further 
guidance.
1.50 An example of acceptable practice, in some circumstances, for report­
ing business combinations by not-for-profit organizations if there has been no 
exchange of consideration is to report the (a) assets, (b) liabilities, and (c) net 
asset balances of the combined entities as of the beginning of the year and dis­
close the information that would be required to be disclosed for a pooling of 
interests under APB Opinion No. 16.
Provisions of Certain Pronouncements Concerning Financial 
Statement Display
1.51 The following pronouncements include provisions specifying the fi­
nancial statement display of certain financial statement elements or items such 
as gains and losses, extraordinary items, translation adjustments, income tax 
expense, and prepaid or deferred income taxes:||
•  APB Opinion No. 9, Reporting the Results of Operations
•  APB Opinion No. 26, Early Extinguishment of Debt, as amended by 
APB Opinion No. 30, Reporting the Results of Operations—Reporting
(footnote continued)
pronouncements prior to the issuance of FASB Statement No. 141. Pronouncements that were 
amended by FASB Statement No. 141 should be applied by those entities as though that Statement 
had not amended them. In addition, in applying the guidance included in APB Opinion No. 16, 
not-for-profit health care organizations should continue to apply the amendments to that Opinion 
that were included in FASB Statement No. 121, Accounting for the Impairment of Long-Lived Assets 
and for Long-Lived Assets to Be Disposed Of, even though FASB Statement No. 121 was superseded 
by FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets. (FASB 
Statement No. 144 did not carry forward those amendments to APB Opinion No. 16 because APB 
Opinion No. 16 had been superseded.) The FASB has on its agenda a project on accounting for 
combinations of not-for-profit organizations, the scope of which also will include the acquisition of a 
for-profit business entity by a not-for-profit organization. An exposure draft of the proposed Standard 
is expected to be released in the fourth quarter of 2005. In June 2005, the FASB released an exposure 
draft of a proposed FASB Statement, Business Combinations, that would replace FASB Statement 
No. 141. The proposed FASB Statement would not apply to combinations between not-for-profit 
organizations and the acquisition of a for-profit business by a not-for-profit organization. Readers 
should be alert to the issuance of final standards. Also, FASB Statement No. 142, Goodwill and Other 
Intangible Assets, is not applicable to goodwill and other intangible assets arising from combinations 
between not-for-profit organizations or arising from the acquisition of a for-profit business entity by 
a not-for-profit organization until the FASB completes its deliberation with respect to application of 
the purchase method by those entities.
|| In May 2005, the FASB issued FASB Statement No. 154, Accounting Changes and Error 
Corrections—a replacement of APB Opinion No. 20 and FASB Statement No. 3, that among other mat­
ters, amends APB Opinion No. 30, Reporting the Results of Operations—Reporting the Effects of Dis­
posal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and 
Transactions, and FASB Statement No. 52, Foreign Currency Translation. FASB Statement No. 154 
is effective for accounting changes and corrections of errors made in fiscal years beginning after De­
cember 15, 2005. Early adoption is permitted for accounting changes and corrections of errors made 
in fiscal years beginning after FASB Statement No. 154 was issued. Conforming changes to reflect the 
issuance of FASB Statement No. 154 will be made in a future edition of this Guide.
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the Effects of Disposal of a Segment of a Business, and Extraordinary, 
Unusual and Infrequently Occurring Events and Transactions; and 
FASB Statement No. 140, Accounting for Transfers and Servicing of 
Financial Assets and Extinguishments of Liabilities
•  APB Opinion No. 30, as amended by FASB Statement No. 128, Earn­
ings per Share, FASB Statement No. 144, Accounting for the Impair­
ment or Disposal of Long-Lived Assets, and FASB Statement No. 145, 
Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB 
Statement No. 13, and Technical Corrections
•  FASB Statement No. 52, Foreign Currency Translation
•  FASB Statement No. 109, Accounting for Income Taxes
None of the preceding pronouncements considers the net asset reporting model 
included in FASB Statement No. 117 and this Guide. Therefore, preparers of 
financial statements of not-for-profit organizations should consider the report­
ing objectives of these APB Opinions and FASB Statements when exercising 
judgment about how to best display elements, such as in which net asset class.
GAAP Hierarchy (or Governmental Organizations
1.52 SAS No. 69 provides that, for state or local governmental entities, 
officially established accounting principles consist of GASB Statements and 
Interpretations as well as AICPA and FASB pronouncements specifically made 
applicable to state and local governmental entities by GASB Statements or 
Interpretations. (Appendix G [paragraph 1.61] of this chapter discusses SAS 
No. 69 and the hierarchy of sources of GAAP for governmental entities.) GASB 
Statements No. 20 and No. 29, The Use of Not-for-Profit Accounting and Fi­
nancial Reporting Principles by Governmental Entities, provide guidance on 
the applicability of FASB and AICPA pronouncements to governmental health 
care enterprises that use enterprise fund accounting and financial reporting. 
Footnote 1 and paragraph 1.16 of this chapter discusses the guidance in GASB 
Statement No. 20.
1.53 GASB Statement No. 29 provides that governmental enterprise funds 
and activities reported using enterprise fund accounting and financial report­
ing that apply the provisions of paragraph 7, as amended, of GASB Statement 
No. 20 should apply only those "new" (issued after November 30, 1989) FASB 
Statements and Interpretations that are developed for business enterprises, 
rather than those whose provisions are limited to not-for-profit organizations or 
address issues primarily concerning such organizations (such as FASB State­
ments No. 116, No. 117, No. 124, and No. 136). (See paragraph 1.16 of this 
chapter.)
1.54 Paragraph 33 in the "Basis for Conclusions" of GASB Statement 
No. 20 also provides that AICPA pronouncements issued after November 30, 
1989 and not specifically made applicable to governmental entities should be 
applied using the same logic used in the application of FASB Standards. That 
is, AICPA pronouncements that do not conflict with or contradict GASB pro­
nouncements should be applied on an "all or none" basis and constitute level 
"b" in the GAAP hierarchy. (See Appendix G [paragraph 1.61] of this chapter.) 
Many of the AICPA pronouncements issued after November 30, 1989 provide 
guidance on specialized industries, including this Guide. However, users of this 
Guide should note the provisions of SOP 94-6, Disclosure of Certain Significant 
Risks and Uncertainties, discussed in paragraph 8.30 of this Guide.
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Appendix A— Financial Reporting Pronouncements 
That Specifically Exempt Not-for-Profit Organizations 
From Their Application *•
Note regarding (1) effective dates of recently issued pronouncements that 
are listed in this Appendix, or that amend pronouncements listed in this 
Appendix; (2) the applicability of FASB Statement No. 141, Business Com­
binations, FASB Statement No. 142, Goodwill and Other Intangible Assets, 
and FASB Interpretation No. 46 (revised December 2003), Consolidation 
of Variable Interest Entities; and (3) outstanding FASB exposure drafts of 
proposed statements of financial accounting standards:
• FASB Statements No. 123 (revised 2004), Share-Based Payment, and 
No. 150, Accounting for Certain Financial Instruments with Characteris­
tics of both Liabilities and Equity, amend certain pronouncements listed 
in this Appendix. See paragraph 1.56 for effective date information.
• FASB Statement No. 154, Accounting Changes and Error Corrections—a 
replacement of APB Opinion No. 20 and FASB Statement No. 3, supersedes 
FASB Statement No. 3 and amends certain pronouncements listed in this 
Appendix. See footnote 11 to paragraph 1.51 for further information about 
that FASB Statement.
• FASB Interpretation No. 46 (revised December 2003), Consolidation of 
Variable Interest Entities—an interpretation of ARB No. 51. In 2003, the 
FASB issued FASB Interpretation No. 46, Consolidation of Variable In­
terest Entities, and FASB Interpretation No. 46(R), which replaced FASB 
Interpretation No. 46, to address consolidation by business enterprises 
of variable interest entities. Special effective date provisions apply to en­
terprises that have fully or partially applied FASB Interpretation No. 46 
prior to the issuance of the revised Interpretation. Otherwise, applica­
tion of FASB Interpretation No. 46(R) or FASB Interpretation No. 46 is 
required in financial statements of public entities that have interests in 
variable interest entities or potential variable interest entities commonly 
referred to as special-purpose entities for periods ending after December 
15, 2003. Application by public entities, other than small business issuers, 
for all other types of entities is required in financial statements for peri­
ods ending after March 15, 2004. Application by small business issuers to 
entities other than special-purpose entities and by nonpublic entities to 
all types of entities is required at various dates in 2004 and 2005. In some 
instances, enterprises have the option of applying or continuing to apply 
FASB Interpretation No. 46 for a short period of time before applying 
the revised Interpretation. Not-for-profit organizations are not subject to 
FASB Interpretation No. 46(R), except that they may be related parties for 
purposes of applying paragraphs 16 and 17 of that Interpretation. Also, if 
a not-for-profit entity is used by business enterprises in a manner similar 
to a variable interest entity in an effort to circumvent the provisions of 
FASB Interpretation No. 46(R), that not-for-profit entity is subject to that 
Interpretation.
(continued)
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FASB Statement No. 141, among other matters, amends APB Opinion 
No. 28 and FASB Statement No. 128. FASB Statement No. 141 applies 
to business combinations initiated after June 30, 2001 and prescribes 
the use of the purchase method for those business combinations. FASB 
Statement No. 141, however, does not apply to certain combinations, in­
cluding a combination involving two or more not-for-profit organizations, 
or the acquisition of a for-profit business entity by a not-for-profit orga­
nization. For those combinations, pronouncements that are amended by 
FASB Statement No. 141 should be applied as though FASB Statement 
No. 141 had not amended them, and this Appendix does not reflect those 
amendments.
The provisions of FASB Statement No. 142 shall be applied in fiscal years 
beginning after December 15, 2001, to all goodwill and other intangi­
ble assets recognized in an entity's statement of financial position at the 
beginning of that fiscal year. Early application is permitted in certain 
circumstances. Certain provisions of FASB Statement No. 142 shall be 
applied to goodwill and other acquired intangible assets for which the ac­
quisition date is after June 30, 2001, even if an entity has not adopted 
FASB Statement No. 142 in its entirety. The provisions of FASB State­
ment No. 141 and FASB Statement No. 142 should not be applied to 
goodwill and intangible assets arising from a combination between two 
or more not-for-profit organizations or acquired in the acquisition of a for- 
profit business entity by a not-for-profit organization until the FASB com­
pletes its project on those types of combinations and acquisitions. Thus, 
the guidance in APB Opinions No. 16 and No. 17 remains in effect for 
such assets. In addition, when applying APB Opinions No. 16 and No. 17, 
not-for-profit organizations should continue to apply the amendments to 
those Opinions found in other literature even though that other literature 
may have been superseded by FASB Statements No. 141, No. 142, and 
No. 144. For example, when applying APB Opinion No. 17, not-for-profit 
organizations should continue to apply the amendments to that Opin­
ion found in FASB Statement No. 121, even though that Statement was 
superseded by FASB Statement No. 144. An exposure draft of a proposed 
Standard on combinations of not-for-profit organizations is expected in the 
fourth quarter of 2005. Readers should be alert to the issuance of a final 
Standard.
FASB exposure drafts. The FASB has released exposure drafts of proposed 
statements of financial accounting standards that would amend or replace 
certain pronouncements that are listed in this Appendix. Readers should 
be alert to the issuance of final Standards.
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Pronouncement
APB Opinion No. 18, The 
Equity Method of 
Accounting for Investments 
in Common Stock, as 
amended by APB Opinions 
No. 23 and No. 30 and 
FASB Statements No. 13, 
No. 58, No. 94, No. 115,
No. 128, No. 142, and 
No. 144, and including 
FASB Interpretation No. 35
APB Opinion No. 28, 
Interim Financial 
Reporting, as amended by 
FASB Statements No. 3,
No. 95, No. 109, No. 123(R), 
No. 128, No. 130, No. 131, 
No. 132(R), No. 135,
No. 144, No. 145, and 
No. 148 and including FASB 
Interpretation No. 18
FASB Statement No. 3, 
Reporting Accounting 
Changes in Interim 
Financial Statements, as 
amended by FASB 
Statement No. 135
FASB Statement No. 89, 
Financial Reporting and 
Changing Prices, as 
amended by FASB 
Statements No. 109,
No. 135, and No. 139
FASB Statement No. 115, 
Accounting for Certain 
Investments in Debt and 
Equity Securities, as 
amended by FASB 
Statements No. 124,
No. 130, No. 133, No. 134, 
No. 135, No. 140, No. 144, 
and No. 145
FASB Statement No. 128, 
Earnings per Share, as 
amended by FASB 
Statements No. 123(R),
No. 135, No. 145, and 
No. 150
Other References, if  Any* 
This Guide
None
Status of Other References
Chapter 11 of this 
Guide provides 
guidance concerning 
the equity method of 
accounting for 
investments in 
common stock
None
None None
None None
FASB Statement 
No. 124, Accounting 
for Certain 
Investments Held by 
Not-for-Profit 
Organizations; 
Chapter 4 of this 
Guide
None
Currently effective
None
(continued)
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Pronouncement
FASB Statement No. 130, 
Reporting Comprehensive 
Income, as amended by 
FASB Statement No. 135
FASB Statement No. 131, 
Disclosures about Segments 
of an Enterprise and 
Related Information
FASB Statement No. 141, 
Business Combinations, as 
amended by FASB 
Statements No. 144,
No. 145, and No. 147
FASB Interpretation 
No. 18, Accounting for 
Income Taxes in Interim 
Periods, as amended by 
FASB Statements No. 71, 
No. 109, No. 111, No. 135, 
and No. 144
FASB Interpretation 
No. 35, Criteria for Applying 
the Equity Method of 
Accounting for Investments 
in Common Stock
FASB Interpretation No. 46 
(revised December 2003), 
Consolidation of Variable 
Interest Entities, as 
amended by FASB 
Statement No. 123(R)
Other References, if  Any*
FASB Statement 
No. 117
None
Chapter 1 and 
Chapter 11 of this 
Guide
None
Status of Other References 
Currently effective
None
Currently effective
None
See APB Opinion 
No. 18
None
See APB Opinion 
No. 18
None
* References in this column are provided as a guide to other sources of infor­
mation about the topic covered by the listed pronouncement.
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Appendix B—Financial Reporting Pronouncements 
That, by the Nature of Their Subject Matter, Generally 
Do Not Apply to No^for-Profit Organizations
Note regarding (1) effective dates of recently issued pronouncements that 
are listed in this Appendix, or that amend pronouncements listed in this 
Appendix; (2) the applicability of FASB Statement No. 141, Business Com­
binations; and (3) outstanding FASB exposure drafts of proposed statements 
of financial accounting standards:
• FASB Statement No. 123 (revised 2004), Share-Based Payment, is effective 
as of the beginning of the first annual reporting period that begins after 
June 15, 2005 for public entities that do not file as small business issuers; 
as of the beginning of the first annual reporting period that begins after 
December 15, 2005 for public entities that file as small business issuers; 
and as of the beginning of the first annual reporting period that begins 
after December 15, 2005 for nonpublic entities. See SEC Release No. 33- 
8568 for the SEC amendment to the compliance dates for implementing 
FASB Statement No. 123(R).
• FASB Statement No. 150, Accounting for Certain Financial Instruments 
with Characteristics of both Liabilities and Equity, is effective for financial 
instruments entered into or modified after May 31, 2003 and otherwise 
at the beginning of the first interim period beginning after June 15, 2003 
except for mandatorily redeemable financial instruments of a nonpublic 
entity. FSP No. FAS 150-3, Effective Date, Disclosures, and Transition 
for Mandatorily Redeemable Financial Instruments of Certain Nonpublic 
Entities and Certain Mandatorily Redeemable Noncontrolling Interests 
under FASB Statement No. 150, Accounting for Certain Financial Instru­
ments with Characteristics of both Liabilities and Equity, defers the ef­
fective date for FASB Statement No. 150 for mandatorily redeemable fi­
nancial instruments of certain nonpublic entities and certain mandatorily 
redeemable noncontrolling interests.
• FASB Statement No. 154, Accounting Changes and Error Corrections—a 
replacement of APB Opinion No. 20 and FASB Statement No. 3, amends 
certain pronouncements listed in this Appendix. See footnote || to para­
graph 1.51 for further information about that FASB Statement.
• FASB Statement No. 141, an amendment of FASB Statement No. 123, 
applies to business combinations initiated after June 30, 2001, and pre­
scribes the use of the purchase method for those combinations. FASB 
Statement No. 141, however, does not apply to certain combinations, in­
cluding a combination involving two or more not-for-profit organizations, 
or the acquisition of a for-profit business entity by a not-for-profit organi­
zation.
• FASB exposure drafts. The FASB has released exposure drafts of proposed 
statements of financial accounting standards that would amend or super­
sede pronouncements that are listed in this Appendix. Readers should be 
alert to the issuance of final Standards.
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APB Opinion No. 14, Accounting for Convertible Debt and Debt Issued 
with Stock Purchase Warrants
APB Opinion No. 25, Accounting for Stock Issued to Employees, as 
amended by FASB Statements No. 109 and No. 123, and including 
FASB Interpretations No. 28, No. 38, and No. 44 (superseded by FASB 
Statement No. 123(R))
FASB Statement No. 84, Induced Conversions of Convertible Debt 
FASB Statement No. 123 (revised 2004), Share-Based Payment (re­
places FASB Statement No. 123, Accounting for Stock-Based Compen­
sation, as amended by FASB Statements No. 128, No. 135, No. 141, 
No. 144, and No. 148)
FASB Statement No. 148 ,Accounting for Stock-Based Compensation— 
Transition and Disclosure (superseded by FASB Statement No. 123(R)) 
FASB Statement No. 150, Accounting for Certain Financial Instru­
ments with Characteristics of both Liabilities and Equity, as amended 
by FASB Statement No. 123(R)
FASB Interpretation No. 28, Accounting for Stock Appreciation Rights 
and Other Variable Stock Option or Award Plans, as amended by 
FASB Statements No. 123 and No. 128 (superseded by FASB State­
ment No. 123(R))
FASB Interpretation No. 38, Determining the Measurement Date for 
Stock Option, Purchase, and Award Plans Involving Junior Stock, as 
amended by FASB Statements No. 123 and No. 128 (superseded by 
FASB Statement No. 123(R))
FASB Interpretation No. 44, Accounting for Certain Transactions in­
volving Stock Compensation, as amended by FASB Statement No. 141 
(superseded by FASB Statement No. 123(R))
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Appendix C —Financial Reporting Pronouncements Whose 
Application to Not-for-Profit Organizations Is Subject to 
Additional FASB or AICPA Guidance
Note regarding (1) effective dates of recently issued pronouncements that 
are listed in this Appendix, or that amend pronouncements listed in this Ap­
pendix; (2) the applicability of FASB Statement No. 141, Business Combina­
tions, and FASB Interpretation No. 46(R), Consolidation of Variable Interest 
Entities; and (3) outstanding FASB exposure drafts of proposed statements 
of financial accounting standards:
• FASB Statement No. 153, Exchanges of Nonmonetary Assets—an amend­
ment of APB Opinion No. 29, is effective for nonmonetary asset exchanges 
occurring in fiscal periods beginning after June 15, 2005.
• FASB Statement No. 123(R) amends a pronouncement listed in this Ap­
pendix. See paragraph 1.56 for effective date information.
• FASB Statement No. 141, among other matters, amends APB Opinion 
No. 29. FASB Statement No. 141 applies to business combinations initi­
ated after June 30, 2001 and prescribes the use of the purchase method for 
those business combinations. FASB Statement No. 141, however, does not 
apply to certain combinations, including a combination involving two or 
more not-for-profit organizations, or the acquisition of a for-profit business 
entity by a not-for-profit organization. For those combinations, pronounce­
ments that are amended by FASB Statement No. 141 should be applied 
as though FASB Statement No. 141 had not amended them, and this Ap­
pendix does not reflect those amendments.
• FASB Interpretation No. 46(R), an interpretation of ARB No. 51, Consoli­
dated Financial Statements, exempts not-for-profit organizations from its 
scope, except that they may be related parties for purposes of applying 
paragraphs 16 and 17 of that Interpretation. Also, if a not-for-profit entity 
is used by business enterprises in a manner similar to a variable interest 
entity in an effort to circumvent the provisions of FASB Interpretation 
No. 46(R), that not-for-profit entity is subject to that Interpretation. For 
information about FASB Interpretation No. 46, Consolidation of Variable 
Interest Entities, which was replaced by FASB Interpretation No. 46(R) 
and information about the effective date of FASB Interpretation No. 46(R), 
see paragraph 1.55 in this chapter.
• FASB exposure drafts. The FASB has released exposure drafts of proposed 
statements of financial accounting standards that would amend or super­
sede certain pronouncements that are listed in this Appendix. Readers 
should be alert to the issuance of final Standards.
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Pronouncement Additional Guidance
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ARB No. 51, Consolidated Financial 
Statements, as amended by APB Opin­
ions No. 10, No. 16, No. 18, and No. 23, 
and FASB Statements No. 58, No. 71, 
No. 94, No. 111, No. 131, and No. 144
This Guide
APB Opinion No. 29, Accounting for 
Nonmonetary Transactions, as amended 
by FASB Statements No. 71, No. 109, 
No. 123, No. 123(R), No. 144, and 
No. 153 and including FASB Interpreta­
tion No. 30
FASB Statement No. 94, Consolidation 
of All Majority-owned Subsidiaries, as 
amended by FASB Statement No. 131
FASB Statement No. 116, Accounting 
for Contributions Received and Contri­
butions Made
FASB Statement No. 117, Financial 
Statements of Not-for-Profit Organiza­
tions, as amended by FASB Statements 
No. 124 and No. 144
FASB Statement No. 124, Accounting 
for Certain Investments Held by Not- 
for-Profit Organizations, as amended by 
FASB Statement No. 133, Accounting for 
Derivative Instruments and Hedging Ac­
tivities, as amended by FASB Statement 
No. 138, Accounting for Certain Deriva­
tive Instruments and Certain Hedging 
Activities
FASB Statement No. 136, Transfers of 
Assets to a Not-for-Profit Organization or 
Charitable Trust That Raises or Holds 
Contributions for Others, as amended by 
FASB Statement No. 140
FASB Statement No. 153, Exchanges of 
Nonmonetary Assets—an amendment of 
APB Opinion No. 29
FASB Interpretation No. 30, Account­
ing for Involuntary Conversions of Non­
monetary Assets to Monetary Assets, as 
amended by FASB Statement No. 109
FASB Statement No. 116 and 
Chapters 5 and 10 of this Guide 
provide accounting guidance for 
contributions
See ARB No. 51
FASB Statement No. 136, this 
Guide and the AICPA Audit and 
Accounting Guide Not-for-Profit Or­
ganizations
This Guide
This Guide
This Guide and the AICPA Au­
dit and Accounting Guide Not-for- 
Profit Organizations
FASB Statement No. 116 and 
Chapters 5 and 10 of this Guide 
provide accounting guidance for 
contributions
See APB Opinion No. 29
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Appendix D—Financial Reporting Pronouncements 
Pertaining to Specialized Industry Practices of 
Business Enterprises *•
Note regarding (1) effective dates of recently issued pronouncements that 
are listed in this Appendix, or that amend pronouncements listed in this 
Appendix; (2) the applicability of FASB Statement No. 141, Business Com­
binations, and FASB Statement No. 142, Goodwill and Other Intangible 
Assets; and (3) outstanding FASB exposure drafts of proposed statements of 
financial accounting standards:
• FASB Statement No. 152, Accounting for Real Estate Time-Sharing 
Transactions—an amendment of FASB Statements No. 66 and 67, is ef­
fective for financial statements for fiscal years beginning after June 15, 
2005.
• FASB Statement No. 153 amends a pronouncement listed in this Ap­
pendix. See paragraph 1.57 for effective date information.
• FASB Statement No. 154 supersedes FASB Statement No. 73 and amends 
certain pronouncements listed in this Appendix. See footnote || to para­
graph 1.51 for further information about that FASB Statement.
• FASB Statement No. 141, among other matters, amends FASB State­
ments No. 44, No. 45, and No. 72 and FASB Interpretation No. 9. FASB 
Statement No. 141 applies to business combinations initiated after June 
30, 2001 and prescribes the use of the purchase method for those busi­
ness combinations. FASB Statement No. 141, however, does not apply to 
certain combinations, including a combination involving two or more not- 
for-profit organizations, or the acquisition of a for-profit business entity 
by a not-for-profit organization. For those combinations, pronouncements 
that are amended by FASB Statement No. 141 should be applied as though 
FASB Statement No. 141 had not amended them, and this Appendix does 
not reflect those amendments.
• The provisions of FASB Statement No. 142 shall be applied in fiscal 
years beginning after December 15, 2001, to all goodwill and other in­
tangible assets recognized in an entity’s statement of financial position 
at the beginning of that fiscal year. Early application is permitted in 
certain circumstances. Certain provisions of FASB Statement No. 142 
shall be applied to goodwill and other acquired intangible assets for 
which the acquisition date is after June 30, 2001, even if an entity 
has not adopted FASB Statement No. 142 in its entirety. The provi­
sions of FASB Statement No. 141 and FASB Statement No. 142 should 
not be applied to goodwill and intangible assets arising from a combi­
nation between two or more not-for-profit organizations or acquired in 
the acquisition of a for-profit business entity by a not-for-profit organi­
zation until the FASB completes its project on those types of combina­
tions and acquisitions. Thus, the guidance in APB Opinions No. 16 and 
No. 17 remains in effect for such assets. In addition, when applying APB 
Opinions No. 16 and No. 17, not-for-profit organizations should continue
(continued)
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to apply the amendments to those Opinions found in other literature even 
though that other literature may have been superseded by FASB State­
ments No. 141, No. 142, and No. 144. For example, when applying APB 
Opinion No. 17, not-for-profit organizations should continue to apply the 
amendments to that Opinion found in FASB Statement No. 121, even 
though that Statement was superseded by FASB Statement No. 144. An 
exposure draft of a proposed Standard on combinations of not-for-profit 
organizations is expected in the fourth quarter of 2005. Readers should 
be alert to the issuance of a final Standard.
FASB exposure drafts. The FASB has released exposure drafts of proposed 
statements of financial accounting standards that would amend or super­
sede certain pronouncements that are listed in this Appendix. Readers 
should be alert to the issuance of final Standards. •
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This Appendix includes pronouncements that apply only to entities operating 
in certain industries, generally business enterprises. However, some not-for- 
profit organizations conduct activities in some of those industries and should 
apply the guidance concerning recognition and measurement of assets, liabili­
ties, revenues, expenses, and gains and losses in those pronouncements to the 
transactions unique to those industries. In addition, those not-for-profit organi­
zations should follow the financial statement display guidance in FASB State­
ment No. 117, Financial Statements of Not-for-Profit Organizations, and this 
Guide, although it may conflict with display that would result from applying 
the guidance in the pronouncements included in this Appendix.
•  APB Opinion No. 12, Omnibus Opinion—1967 (guidance under the 
heading "Capital Changes")
•  APB Opinion No. 13, Amending Paragraph 6 of APB Opinion No. 9, 
Application to Commercial Banks
•  FASB Statement No. 7, Accounting and Reporting by Development 
Stage Enterprises, as amended by FASB Statements No. 71 and No. 95, 
and including FASB Interpretation No. 7
•  FASB Statement No. 19, Financial Accounting and Reporting by Oil 
and Gas Producing Companies, as amended by FASB Statements 
No. 25, No. 69, No. 71, No. 109, No. 143, No. 144, No. 145, and No. 153, 
and including FASB Interpretations No. 33 and No. 36
•  FASB Statement No. 25, Suspension of Certain Accounting Require­
ments for Oil and Gas Producing Companies—an amendment of FASB 
Statement No. 19, as amended by FASB Statement No. 111
•  FASB Statement No. 35, Accounting and Reporting by Defined Bene­
fit Pension Plans, as amended by FASB Statements No. 75, No. 110, 
No. 135, and No. 149
•  FASB Statement No. 45, Accounting for Franchise Fee Revenue
•  FASB Statement No. 50, Financial Reporting in the Record and Music 
Industry
•  FASB Statement No. 51, Financial Reporting by Cable Television Com­
panies, as amended by FASB Statements No. 71, No. 131, No. 142, and 
No. 144
•  FASB Statement No. 60, Accounting and Reporting by Insurance En­
terprises, as amended by FASB Statements No. 91, No. 97, No. 109,
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No. 113, No. 114, No. 115, No. 120, No. 124, No. 133, No. 135, No. 144, 
No. 145, and No. 149, and including FASB Interpretation No. 40
FASB Statement No. 61, Accounting for Title Plant, as amended by 
FASB Statement No. 144
FASB Statement No. 63, Financial Reporting by Broadcasters, as 
amended by FASB Statement No. 139
FASB Statement No. 65, Accounting for Certain Mortgage Banking 
Activities, as amended by FASB Statements No. 91, No. 115, No. 124, 
No. 133, No. 134, No. 140, and No. 149
FASB Statement No. 67, Accounting for Costs and Initial Rental Opera­
tions of Real Estate Projects, as amended by FASB Statements No. 111, 
No. 144, and No. 152
FASB Statement No. 69, Disclosures about Oil and Gas Producing 
Activities—an amendment of FASB Statements 19, 25, 33, and 39, as 
amended by FASB Statements No. 89, No. 95, No. 109, and No. 131 
FASB Statement No. 71, Accounting for the Effects of Certain Types of 
Regulation, as amended by FASB Statements No. 90, No. 92, No. 109, 
No. 135, No. 142, and No. 144
FASB Statement No. 72, Accounting for Certain Acquisitions of Bank­
ing or Thrift Institutions—an amendment of APB Opinion No. 17, an 
interpretation of APB Opinions 16 and 17, and an amendment of FASB 
Interpretation No. 9, as amended by FASB Statements No. 142 and 
No. 147
FASB Statement No. 73, Reporting a Change in Accounting for Rail­
road Track Structures—an amendment of APB Opinion No. 20 
FASB Statement No. 90, Regulated Enterprises—Accounting for Aban­
donments and Disallowances of Plant Costs—an amendment of FASB 
Statement No. 71, as amended by FASB Statements No. 92 and 
No. 109
FASB Statement No. 91, Accounting for Nonrefundable Fees and Costs 
Associated with Originating or Acquiring Loans and Initial Direct 
Costs of Leases—an amendment of FASB Statements No. 13, 60, and 
65 and a rescission of FASB Statement No. 17, as amended by FASB 
Statements No. 98, No. 114, No. 115, No. 124, and No. 149 
FASB Statement No. 92, Regulated Enterprises—Accounting for 
Phase-in Plans—an amendment of FASB Statement No. 71 
FASB Statement No. 97, Accounting and Reporting by Insurance En­
terprises for Certain Long-Duration Contracts and for Realized Gains 
and Losses from the Sale of Investments, as amended by FASB State­
ments No. 113, No. 115, and No. 120
FASB Statement No. 101, Regulated Enterprises—Accounting for the 
Discontinuation of Application of FASB Statement No. 71, as amended 
by FASB Statements No. 109 and No. 144
FASB Statement No. 110, Reporting by Defined Benefit Pension Plans 
of Investment Contracts—an amendment of FASB Statement No. 35 
FASB Statement No. 113, Accounting and Reporting for Reinsurance 
of Short-Duration and Long-Duration Contracts, as amended by FASB 
Statements No. 120 and No. 133, and including FASB Interpretation 
No. 40
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FASB Statement No. 120, Accounting and Reporting by Mutual Life 
Insurance Enterprises and by Insurance Enterprises for Certain Long- 
Duration Participating Contracts—an amendment of FASB State­
ments 60, 97, and 113 and Interpretation No. 40 
FASB Statement No. 134, Accounting for Mortgage-Backed Securities 
Retained after the Securitization of Mortgage Loans Held for Sale by 
a Mortgage Banking Enterprise—an amendment of FASB Statement 
No. 65
FASB Statement No. 139, Rescission of FASB Statement No. 53 and 
amendments to FASB Statements No. 63, 89, and 121 
FASB Statement No. 147, Acquisitions of Certain Financial Institu­
tions
FASB Statement No. 152, Accounting for Real Estate Time-Sharing 
Transactions—an amendment of FASB Statements No. 66 and 67 
FASB Interpretation No. 7, Applying FASB Statement No. 7 in Finan­
cial Statements of Established Operating Enterprises 
FASB Interpretation No. 9, Applying APB Opinions No. 16 and 17 
When a Savings and Loan Association or a Similar Institution is 
Acquired in a Business Combination Accounted for by the Purchase 
Method, as amended by FASB Statements No. 72, No. 142, and No. 147 
FASB Interpretation No. 33, Applying FASB Statement No. 34 to Oil 
and Gas Producing Operations Accounted for by the Full Cost Method 
FASB Interpretation No. 36, Accounting for Exploratory Wells in 
Progress at the End of a Period
FASB Interpretation No. 40, Applicability of Generally Accepted Ac­
counting Principles to Mutual Life Insurance and Other Enterprises, 
as amended by FASB Statements No. 115, No. 120, and No. 135
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Appendix E —Financial Reporting Pronouncements 
Not Subsequently Superseded and Not Included 
in Appendixes A through D of This Chapter *•
Note regarding (1) effective dates of recently issued pronouncements that 
are listed in this Appendix, or that amend pronouncements listed in this 
Appendix; (2) the applicability of FASB Statement No. 141, Business Com­
binations, and FASB Statement No. 142, Goodwill and Other Intangible 
Assets; and (3) outstanding FASB exposure drafts of proposed statements of 
financial accounting standards:
• FASB Statement No. 151, Inventory Costs—an amendment of ARB No. 43, 
Chapter 4, is effective for inventory costs incurred during fiscal years be­
ginning after June 15, 2005.
• FASB Statements No. 123(R), No. 150, No. 152, and No. 153 amend certain 
pronouncements listed in this Appendix. See paragraphs 1.56, 1.57, and 
1.58 for effective date information.
• FASB Interpretation No. 47, Accounting for Conditional Asset Retirement 
Obligations—an interpretation of FASB Statement No. 143, is effective no 
later than the end of fiscal years ending after December 15, 2005 (Decem­
ber 31 for calendar year enterprises).
• FASB Statement No. 154, Accounting Changes and Error Corrections—a 
replacement of APB Opinion No. 20 and FASB Statement No. 3, supersedes 
APB Opinion No. 20, FASB Interpretation No. 20, and amends certain 
pronouncements listed in this Appendix. See footnote || to paragraph 1.51 
for further information about that FASB Statement.
• FASB Statement No. 141, among other matters, supersedes APB Opin­
ion No. 16 and FASB Statements No. 10, No. 38, and No. 79; and amends 
APB Opinions No. 20 and No. 30, FASB Statements No. 15, No. 16, No. 68, 
No. 87, No. 95, No. 106, No. 109, and No. 133 and FASB Interpretations 
No. 4 and No. 21. (The amendment of FASB Statement No. 68 was subse­
quently deleted by the technical corrections in FASB Statement No. 145). 
FASB Statement No. 141 applies to business combinations initiated af­
ter June 30, 2001 and prescribes the use of the purchase method for those 
business combinations. FASB Statement No. 141, however, does not apply 
to certain combinations, including a combination involving two or more 
not-for-profit organizations, or the acquisition of a for-profit business en­
tity by a not-for-profit organization. For those combinations, pronounce­
ments that are superseded or amended by FASB Statement No. 141 should 
be applied as though FASB Statement No. 141 had not superseded or 
amended them, and this Appendix does not reflect those amendments or 
supersessions.
• The provisions of FASB Statement No. 142 shall be applied in fiscal years 
beginning after December 15, 2001, to all goodwill and other intangible 
assets recognized in an entity's statement of financial position at the be­
ginning of that fiscal year. Early application is permitted in certain circum­
stances. Certain provisions of FASB Statement No. 142 shall be applied
(continued)
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to goodwill and other acquired intangible assets for which the acquisition 
date is after June 30, 2001, even if an entity has not adopted FASB State­
ment No. 142 in its entirety. The provisions of FASB Statement No. 141 
and FASB Statement No. 142 should not be applied to goodwill and intan­
gible assets arising from a combination between two or more not-for-profit 
organizations or acquired in the acquisition of a for-profit business entity 
by a not-for-profit organization until the FASB completes its project on 
those types of combinations and acquisitions. Thus, the guidance in APB 
Opinions No. 16 and No. 17 remains in effect for such assets. In addi­
tion, when applying APB Opinions No. 16 and No. 17, not-for-profit or­
ganizations should continue to apply the amendments to those Opinions 
found in other literature even though that other literature may have been 
superseded by FASB Statements No. 141, No. 142, and No. 144. For ex­
ample, when applying APB Opinion No. 17, not-for-profit organizations 
should continue to apply the amendments to that Opinion found in FASB 
Statement No. 121 even though that Statement was superseded by FASB 
Statement No. 144. An exposure draft of a proposed Standard on combi­
nations of not-for-profit organizations is expected in the fourth quarter of 
2005. Readers should be alert to the issuance of a final Standard.
FASB exposure drafts. The FASB has released exposure drafts of proposed 
statements of financial accounting standards that would amend or replace 
certain pronouncements that are listed in this Appendix. Readers should 
be alert to the issuance of final Standards. •
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As stated in paragraph 1.40 of this Guide, not-for-profit organizations should 
follow the guidance in effective provisions of ARBs, APB Opinions, and FASB 
Statements and Interpretations, except for specific pronouncements that ex­
plicitly exempt not-for-profit organizations and pronouncements for which this 
Guide provides guidance. This Appendix includes pronouncements, not subse­
quently superseded, that (a) do not exempt not-for-profit organizations from 
their application, (6) by the nature of their subject matter, apply to the kinds of 
transactions not-for-profit organizations engage in, (c) are subject to no addi­
tional FASB or AICPA guidance, and (d) do not pertain to specialized industry 
practices of business enterprises. Not-for-profit organizations should follow the 
guidance in the effective provisions of the pronouncements included in this 
Appendix.
•  ARB No. 43, Restatement and Revision of Accounting Research Bul­
letins, as amended by APB Opinions No. 6, No. 9, No. 10, No. 16, No. 17, 
No. 20, No. 21, No. 25, and No. 26, and FASB Statements No. 5, No. 6, 
No. 52, No. 78, No. 94, No. 109, No. 111, No. 115, No. 123, No. 123(R), 
No. 131, No. 133, No. 135, No. 142, and No. 151
•  ARB No. 45, Long-Term Construction-Type Contracts
•  ARB No. 46, Discontinuance of Dating Earned Surplus
•  APB Opinion No. 2, Accounting for the "Investment Credit," as amended 
by APB Opinion No. 4 and FASB Statements No. 71 and No. 109
•  APB Opinion No. 4 (amending Opinion No. 2), Accounting for the "In­
vestment Credit”
•  APB Opinion No. 6, Status of Accounting Research Bulletins, as 
amended by APB Opinions No. 16, No. 17, and No. 26, and FASB State­
ments No. 52, No. 71, No. 109, No. 111, and No. 135
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•  APB Opinion No. 9, Reporting the Results of Operations (paragraph
1.51 of this Guide discusses this pronouncement), as amended by APB 
Opinions No. 13, No. 15, No. 20, and No. 30, and FASB Statement 
No. 16
•  APB Opinion No. 10, Omnibus Opinion—1966, as amended by APB 
Opinions No. 12, No. 14, No. 16, and No. 18, and FASB Statements 
No. 111 and No. 129, and including FASB Interpretations No. 39 and 
No. 41
•  APB Opinion No. 12, Omnibus Opinion—1967 (except guidance under 
the heading, "Capital Changes"), as amended by APB Opinion No. 14 
and FASB Statements No. 87, No. 106, and No. 111
•  APB Opinion No. 16, Business Combinations (paragraph 1.49 of this 
Guide discusses this pronouncement), as amended by FASB State­
ments No. 10, No. 38, No. 71, No. 79, No. 87, No. 106, No. 109, No. 121, 
and No. 135, and including FASB Interpretations No. 4, No. 9, and 
No. 21
•  APB Opinion No. 17, Intangible Assets, as amended by APB Opinion 
No. 30 and FASB Statements No. 2, No. 71, No. 72, No. 109, No. 121, 
and No. 135, and including FASB Interpretation No. 9
•  APB Opinion No. 20, Accounting Changes, as amended by FASB State­
ments No. 16, No. 58, No. 71, No. 73, No. 95, No. 111, and No. 128, and 
including FASB Interpretations No. 1 and No. 20
•  APB Opinion No. 21, Interest on Receivables and Payables, as amended 
by FASB Statements No. 34 and No. 109
•  APB Opinion No. 22, Disclosure of Accounting Policies, as amended by 
FASB Statements No. 2, No. 52, No. 95, and No. 111
•  APB Opinion No. 23, Accounting for Income Taxes—Special Areas, as 
amended by FASB Statements No. 60, No. 71, No. 94, and No. 109
•  APB Opinion No. 26, Early Extinguishment of Debt (paragraph 1.51 
of this Guide discusses this pronouncement), as amended by APB 
Opinion No. 30 and FASB Statements No. 15, No. 71, No. 84, and 
No. 140
•  APB Opinion No. 30, Reporting the Results of Operations—Reporting 
the Effects of Disposal of a Segment of a Business, and Extraordinary, 
Unusual and Infrequently Occurring Events and Transactions (para­
graph 1.51 of this Guide discusses this pronouncement), as amended 
by FASB Statements No. 16, No. 60, No. 97, No. 101, No. 109, No. 128, 
No. 144, and No. 145, and including FASB Interpretation No. 27
•  FASB Statement No. 2, Accounting for Research and Development 
Costs, as amended by FASB Statements No. 71, No. 86, and No. 142, 
and including FASB Interpretations No. 4 and No. 6
•  FASB Statement No. 5, Accounting for Contingencies, as amended by 
FASB Statements No. 11, No. 16, No. 60, No. 71, No. 87, No. 111, 
No. 112, No. 113, No. 114, No. 123, and No. 123(R), and including 
FASB Interpretations No. 14, No. 34, and No. 45
•  FASB Statement No. 6, Classification of Short-Term Obligations Ex­
pected to Be Refinanced—(an amendment of ARB No. 43, Chapter 3A, 
and including FASB Interpretation No. 8
•  FASB Statement No. 10, Extension of "Grandfather" Provisions for 
Business Combinations—an amendment of APB Opinion No. 16
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FASB Statement No. 11, Accounting for Contingencies: Transition 
Method—an amendment of FASB Statement No. 5 
FASB Statement No. 13, Accounting for Leases, as amended by FASB 
Statements No. 22, No. 23, No. 27, No. 28, No. 29, No. 34, No. 71, No. 91, 
No. 94, No. 98, No. 109, No. 135, No. 140, and No. 145, and including 
FASB Interpretations No. 19, No. 21, No. 23, No. 24, No. 26, and No. 27 
FASB Statement No. 15, Accounting by Debtors and Creditors for Trou­
bled Debt Restructurings, as amended by FASB Statements No. 71, 
No. 111, No. 114, No. 135, No. 144, No. 145, and No. 149 
FASB Statement No. 16, Prior Period Adjustments, as amended by 
FASB Statements No. 71 and No. 109
FASB Statement No. 22, Changes in the Provisions of Lease Agree­
ments Resulting from Refundings of Tax-Exempt Debt—an amendment 
of FASB Statement No. 13, as amended by FASB Statements No. 71, 
No. 140, and No. 145
FASB Statement No. 23, Inception of the Lease—an amendment of 
FASB Statement No. 13
FASB Statement No. 27, Classification of Renewals or Extensions of Ex­
isting Sales-Type or Direct Financing Leases—an amendment of FASB 
Statement No. 13
FASB Statement No. 28, Accounting for Sales with Leasebacks—an 
amendment of FASB Statement No. 13, as amended by FASB State­
ment No. 66
FASB Statement No. 29, Determining Contingent Rentals—an amend­
ment of FASB Statement No. 13, as amended by FASB Statement 
No. 98
FASB Statement No. 34, Capitalization of Interest Cost, as amended 
by FASB Statements No. 42, No. 58, No. 62, No. 71, and No. 144, and 
including FASB Interpretation No. 33
FASB Statement No. 37, Balance Sheet Classification of Deferred In­
come Taxes—an amendment of APB Opinion No. 11, as amended by 
FASB Statement No. 109
FASB Statement No. 38, Accounting for Preacquisition Contingencies 
of Purchased Enterprises—an amendment of APB Opinion No. 16), as 
amended by FASB Statement No. 109
FASB Statement No. 42, Determining Materiality for Capitalization of 
Interest Cost—an amendment of FASB Statement No. 34 
FASB Statement No. 43, Accounting for Compensated Absences, as 
amended by FASB Statements No. 71, No. 112, No. 123, No. 123(R), 
No. 135, and No. 144
FASB Statement No. 47, Disclosure of Long-Term Obligations 
FASB Statement No. 48, Revenue Recognition When Right of Return 
Exists
FASB Statement No. 49, Accounting for Product Financing Arrange­
ments, as amended by FASB Statement No. 71
FASB Statement No. 52, Foreign Currency Translation (paragraph
1.51 of this Guide discusses this pronouncement), as amended by FASB 
Statements No. 95, No. 109, No. 130, No. 133, No. 135, and No. 142, 
and including FASB Interpretation No. 37
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•  FASB Statement No. 57, Related Party Disclosures, as amended by 
FASB Statements No. 95 and No. 109, and including FASB Interpre­
tation No. 45
FASB Statement No. 58, Capitalization of Interest in Financial State­
ments That Include Investments Accounted for by the Equity Method— 
an amendment of FASB Statement No. 34
FASB Statement No. 62, Capitalization of Interest Cost in Situa­
tions Involving Certain Tax-Exempt Borrowings and Certain Gifts and 
Grants—an amendment of FASB Statement No. 34 
FASB Statement No. 66, Accounting for Sales of Real Estate, as 
amended by FASB Statements No. 98, No. 135, No. 144, and No. 152 
FASB Statement No. 68, Research and Development Arrangements, as 
amended by FASB Statement No. 142
FASB Statement No. 78, Classification of Obligations That Are 
Callable by the Creditor—an amendment of ARB No. 43, Chapter 3A 
FASB Statement No. 79, Elimination of Certain Disclosures for Busi­
ness Combinations by Nonpublic Enterprises—an amendment of APB 
Opinion No. 16
FASB Statement No. 86, Accounting for the Costs of Computer Software 
to Be Sold, Leased, or Otherwise Marketed
FASB Statement No. 87, Employers' Accounting for Pensions, as 
amended by FASB Statements No. 106, No. 109, No. 130, No. 132(R), 
No. 135, and No. 149
FASB Statement No. 88, Employers' Accounting for Settlements and 
Curtailments of Defined Benefit Pension Plans and for Termination 
Benefits, as amended by FASB Statements No. 132(R) and No. 144 
FASB Statement No. 93, Recognition of Depreciation by Not-for-Profit 
Organizations, as amended by FASB Statements No. 99 and No. 135 
FASB Statement No. 95, Statement of Cash Flows, as amended by 
FASB Statements No. 102, No. 104, No. 117, No. 123(R), No. 133, 
No. 145, and No. 149
FASB Statement No. Accounting for Leases: Sale-Leaseback Trans­
actions Involving Real Estate, Sales-Type Leases of Real Estate, Defini­
tion of the Lease Term, Initial Direct Costs of Direct Financing Leases— 
an amendment of FASB Statements No. 13, 66, and 91 and a rescission 
of FASB Statement No. 26 and Technical Bulletin No. 79-11 
FASB Statement No. 99, Deferral of the Effective Date of Recognition of 
Depreciation by Not-for-Profit Organizations—an amendment of FASB 
Statement No. 93
FASB Statement No. 102, Statement of Cash Flows—Exemption of Cer­
tain Enterprises and Classification of Cash Flows from Certain Secu­
rities Acquired for Resale—an amendment of FASB Statement No. 95, 
as amended by FASB Statements No. 115, No. 135, and No. 145 
FASB Statement No. 104, Statement of Cash Flows—Net Reporting of 
Certain Cash Receipts and Cash Payments and Classification of Cash 
Flows from Hedging Transactions—an amendment of FASB Statement 
No. 95
FASB Statement No. 106, Employers' Accounting for Postretirement 
Benefits Other Than Pensions, as amended by FASB Statements 
No. 132(R), No. 135, No. 144, and No. 149
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FASB Statement No. 107, Disclosures about Fair Value of Finan­
cial Instruments, as amended by FASB Statements No. 112, No. 123,
No. 123(R), No. 126, No. 133, and No. 140, and including FASB Inter­
pretation No. 45
FASB Statement No. 109, Accounting for Income Taxes (paragraph
1.51 of this Guide discusses this pronouncement), as amended by FASB 
Statements No. 115, No. 123, No. 123(R), No. 130, and No. 135 
FASB Statement No. 111, Rescission of FASB Statement No. 32 and 
Technical Corrections
FASB Statement No. 112, Employers' Accounting for Postemploy­
ment Benefits—an amendment of FASB Statements No. 5 and 43, as 
amended by FASB Statement No. 123 and No. 123(R)
FASB Statement No. 114, Accounting by Creditors for Impairment of a 
Loan—an amendment of FASB Statements No. 5 and 15, as amended 
by FASB Statement No. 118
FASB Statement No. 118, Accounting by Creditors for Impairment of a 
Loan—Income Recognition and Disclosures—an amendment of FASB 
Statement No. 114
FASB Statement No. 121,Accounting for the Impairment of Long-Lived 
Assets and for Long-Lived Assets to Be Disposed Of, as amended by 
FASB Statements No. 139 and No. 142 (FASB Statement No. 121 was 
superseded by FASB Statement No. 144)
FASB Statement No. 126, Exemption from Certain Required Disclo­
sures about Financial Instruments for Certain Nonpublic Entities, as 
amended by FASB Statements No. 133 and No. 149 
FASB Statement No. 129, Disclosure of Information about Capital 
Structure
FASB Statement No. 132 (revised 2003), Employers' Disclosures about 
Pensions and Other Postretirement Benefits (supersedes FASB State­
ment No. 132)
FASB Statement No. 133, Accounting for Derivative Instruments and 
Hedging Activities, as amended by FASB Statements No. 123(R),
No. 137, No. 138, No. 140, No. 145, No. 149, and No. 150 
FASB Statement No. 135, Rescission of FASB Statement No. 75 and 
Technical Corrections, as amended by FASB Statement No. 145 
FASB Statement No. 137, Accounting for Derivative Instruments and 
Hedging Activities—Deferral of the Effective Date of FASB Statement 
No. 133
FASB Statement No. 138, Accounting for Certain Derivative Instru­
ments and Certain Hedging Activities
FASB Statement No. 140, Accounting for Transfers and Servicing of 
Financial Assets and Extinguishments of Liabilities, as amended by 
FASB Statement No. 153
FASB Statement No. 142, Goodwill and Other Intangible Assets, as 
amended by FASB Statements No. 144, No. 145, and No. 147 
FASB Statement No. 143, Accounting for Asset Retirement Obligations, 
as amended by FASB Statement No. 144
FASB Statement No. 144, Accounting for the Impairment or Disposal of 
Long-Lived Assets, as amended by FASB Statements No. 145, No. 147,
No. 151, and No. 153
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FASB Statement No. Rescission of FASB Statements No. 4 , 44, and
64, Amendment of FASB Statement No. 13, and Technical Corrections
FASB Statement No. 146, Accounting for Costs Associated with Exit or 
Disposal Activities
FASB Statement No. 149,Amendment of Statement No. 133 on Deriva­
tive Instruments and Hedging Activities
FASB Statement No. 151, Inventory Costs—an amendment of ARB 
No. 43, Chapter 4
FASB Interpretation No. 1, Accounting Changes Related to the Cost of 
Inventory
FASB Interpretation No. 4, Applicability of FASB Statement No. 2 to 
Business Combinations Accounted for by the Purchase Method
FASB Interpretation No. 6, Applicability of FASB Statement No. 2 to 
Computer Software, as amended by FASB Statement No. 86 
FASB Interpretation No. 8, Classification of a Short-Term Obligation 
Repaid Prior to Being Replaced by a Long-Term Security
FASB Interpretation No. 14, Reasonable Estimation of the Amount of 
a Loss
FASB Interpretation No. 19, Lessee Guarantee of the Residual Value 
of Leased Property
FASB Interpretation No. 20, Reporting Accounting Changes under 
AICPA Statements of Position, as amended by FASB Statement No. 111 
FASB Interpretation No. 21, Accounting for Leases in a Business Com­
bination, as amended by FASB Statement No. 145 
FASB Interpretation No. 23, Leases of Certain Property Owned by a 
Governmental Unit or Authority
FASB Interpretation No. 24, Leases Involving Only Part of a Building 
FASB Interpretation No. 26, Accounting for Purchase of a Leased Asset 
by the Lessee during the Term of the Lease
FASB Interpretation No. 27, Accounting for a Loss on a Sublease, as 
amended by FASB Statements No. 135 and No. 144 
FASB Interpretation No. 37, Accounting for Translation Adjustments 
upon Sale of Part of an Investment in a Foreign Entity 
FASB Interpretation No. 39, Offsetting of Amounts Related to Certain 
Contracts, as amended by FASB Statements No. 113, No. 135, and 
No. 144 and FASB Interpretation No. 41
FASB Interpretation No. 41, Offsetting of Amounts Related to Certain 
Repurchase and Reverse Repurchase Agreements 
FASB Interpretation No. 43, Real Estate Sales, as amended by FASB 
Statement No. 140
FASB Interpretation No. 45, Guarantor's Accounting and Disclosure 
Requirements for Guarantees, Including Indirect Guarantees of Indebt­
edness of Others
FASB Interpretation No. 47, Accounting for Conditional Asset Retire­
ment Obligations—an interpretation of FASB Statement No. 143
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1.60
Appendix F—All Financial Reporting Pronouncements, 
Cross-Referenced by Appendix
Note regarding effective dates of pronouncements and the applicability of
FASB Statement No. 141, Business Combinations, and FASB Statement
No. 142, Goodwill and Other Intangible Assets:
• See Appendixes A through E of this chapter for effective date information 
for recently issued pronouncements.
• FASB Statement No. 141 supersedes or amends certain pronouncements 
that are listed in this Appendix. FASB Statement No. 141 applies to busi­
ness combinations initiated after June 30, 2001 and prescribes the use 
of the purchase method for those business combinations. FASB State­
ment No. 141, however, does not apply to certain combinations, including 
a combination involving two or more not-for-profit organizations, or the 
acquisition of a for-profit business entity by a not-for-profit organization. 
For those combinations, pronouncements that are superseded or amended 
by FASB Statement No. 141 should be applied as though FASB Statement 
No. 141 had not superseded or amended them.
• The provisions of FASB Statement No. 142 shall be applied in fiscal years 
beginning after December 15, 2001, to all goodwill and other intangible 
assets recognized in an entity's statement of financial position at the be­
ginning of that fiscal year. Early application is permitted in certain circum­
stances. Certain provisions of FASB Statement No. 142 shall be applied 
to goodwill and other acquired intangible assets for which the acquisition 
date is after June 30, 2001, even if an entity has not adopted FASB State­
ment No. 142 in its entirety. The provisions of FASB Statement No. 141 
and FASB Statement No. 142 should not be applied to goodwill and intan­
gible assets arising from a combination between two or more not-for-profit 
organizations or acquired in the acquisition of a for-profit business entity 
by a not-for-profit organization until the FASB completes its project on 
those types of combinations and acquisitions. Thus, the guidance in APB 
Opinions No. 16 and No. 17 remains in effect for such assets. In addi­
tion, when applying APB Opinions No. 16 and No. 17, not-for-profit or­
ganizations should continue to apply the amendments to those Opinions 
found in other literature even though that other literature may have been 
superseded by FASB Statements No. 141, No. 142, and No. 144. For ex­
ample, when applying APB Opinion No. 17, not-for-profit organizations 
should continue to apply the amendments to that Opinion found in FASB 
Statement No. 121, even though that Statement was superseded by FASB 
Statement No. 144. An exposure draft of a proposed Standard on combi­
nations of not-for-profit organizations is expected in the fourth quarter of 
2005. Readers should be alert to the issuance of a final Standard.
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Pronouncement Appendix
ARB No. 1 to ARB No. 42 Superseded
ARB No. 43 E
ARB No. 44 Superseded
ARB No. 44 (Revised) Superseded
ARB No. 45 E
ARB No. 46 E
ARB No. 47 to ARB No. 50 Superseded
ARB No. 51 C
APB Opinion No. 1 Superseded
APB Opinion No. 2 E
APB Opinion No. 3 Superseded
APB Opinion No. 4 E
APB Opinion No. 5 Superseded
APB Opinion No. 6 E
APB Opinions No. 7 and No. 8 Superseded
APB Opinion No. 9 E
APB Opinion No. 10 E
APB Opinion No. 11 Superseded
APB Opinion No. 12 D,E
APB Opinion No. 13 D
APB Opinion No. 14 B
APB Opinion No. 15 Superseded
APB Opinion No. 16 E
APB Opinion No. 17 E
APB Opinion No. 18 A
APB Opinion No. 19 Superseded
APB Opinion No. 20 E
APB Opinion No. 21 E
APB Opinion No. 22 E
APB Opinion No. 23 E
APB Opinion No. 24 Superseded
APB Opinion No. 25 (superseded by FASB 
Statement No. 123(R))
B
APB Opinion No. 26 E
APB Opinion No. 27 Superseded
APB Opinion No. 28 A
APB Opinion No. 29 C
APB Opinion No. 30 E
APB Opinion No. 31 Superseded
FASB Statement No. 1 Superseded
FASB Statement No. 2 E
FASB Statement No. 3 A
FASB Statement No. 4 Superseded
FASB Statement No. 5 E
FASB Statement No. 6 E
FASB Statement No. 7 D
FASB Statements No. 8 and No. 9 Superseded
FASB Statement No. 10 E
FASB Statement No. 11 E
FASB Statement No. 12 Superseded
FASB Statement No. 13 E
FASB Statement No. 14 Superseded
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Pronouncement
FASB Statement No. 15
FASB Statement No. 16
FASB Statement No. 17
FASB Statement No. 18
FASB Statement No. 19
FASB Statement No. 20
FASB Statement No. 21
FASB Statement No. 22
FASB Statement No. 23
FASB Statement No. 24
FASB Statement No. 25
FASB Statement No. 26
FASB Statement No. 27
FASB Statement No. 28
FASB Statement No. 29
FASB Statement No. 30
FASB Statements No. 31 to No. 33
FASB Statement No. 34
FASB Statement No. 35
FASB Statement No. 36
FASB Statement No. 37
FASB Statement No. 38
FASB Statements No. 39 to No. 41
FASB Statement No. 42
FASB Statement No. 43
FASB Statement No. 44
FASB Statement No. 45
FASB Statement No. 46
FASB Statement No. 47
FASB Statement No. 48
FASB Statement No. 49
FASB Statement No. 50
FASB Statement No. 51
FASB Statement No. 52
FASB Statement No. 53
FASB Statements No. 54 to No. 56
FASB Statement No. 57
FASB Statement No. 58
FASB Statement No. 59
FASB Statement No. 60
FASB Statement No. 61
FASB Statement No. 62
FASB Statement No. 63
FASB Statement No. 64
FASB Statement No. 65
FASB Statement No. 66
FASB Statement No. 67
FASB Statement No. 68
FASB Statement No. 69
FASB Statement No. 70
FASB Statement No. 71
FASB Statement No. 72
Appendix
E
E
Superseded
Superseded
D
Superseded
Superseded
E
E
Superseded
D
Superseded
E
E
E
Superseded
Superseded
E
D
Superseded
E
E
Superseded
E
E
Superseded
D
Superseded
E
E
E
D
D
E
Superseded
Superseded
E
E
Superseded
D
D
E
D
Superseded
D
E
D
E
D
Superseded
D
D
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Pronouncement Appendix
FASB Statement No. 73 D
FASB Statement No. 74 Superseded
FASB Statement No. 75 Superseded
FASB Statement No. 76 Superseded
FASB Statement No. 77 Superseded
FASB Statement No. 78 E
FASB Statement No. 79 E
FASB Statement No. 80 Superseded
FASB Statements No. 81 to No. 83 Superseded
FASB Statement No. 84 B
FASB Statement No. 85 Superseded
FASB Statement No. 86 E
FASB Statement No. 87 E
FASB Statement No. 88 E
FASB Statement No. 89 A
FASB Statement No. 90 D
FASB Statement No. 91 D
FASB Statement No. 92 D
FASB Statement No. 93 E
FASB Statement No. 94 C
FASB Statement No. 95 E
FASB Statement No. 96 Superseded
FASB Statement No. 97 D
FASB Statement No. 98 E
FASB Statement No. 99 E
FASB Statement No. 100 Superseded
FASB Statement No. 101 D
FASB Statement No. 102 E
FASB Statement No. 103 Superseded
FASB Statement No. 104 E
FASB Statement No. 105 Superseded
FASB Statement No. 106 E
FASB Statement No. 107 E
FASB Statement No. 108 Superseded
FASB Statement No. 109 E
FASB Statement No. 110 D
FASB Statement No. 111 E
FASB Statement No. 112 E
FASB Statement No. 113 D
FASB Statement No. 114 E
FASB Statement No. 115 A
FASB Statement No. 116 C
FASB Statement No. 117 C
FASB Statement No. 118 E
FASB Statement No. 119 Superseded
FASB Statement No. 120 D
FASB Statement No. 121 E, Superseded
FASB Statement No. 122 Superseded
FASB Statement No. 123 (replaced with FASB 
Statement No. 123(R))
B
FASB Statement No. 124 C
FASB Statement No. 125 Superseded
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Pronouncement Appendix
FASB Statement No. 126 E
FASB Statement No. 127 Superseded
FASB Statement No. 128 A
FASB Statement No. 129 E
FASB Statement No. 130 A
FASB Statement No. 131 A
FASB Statement No. 132(R) E
FASB Statement No. 133 E
FASB Statement No. 134 D
FASB Statement No. 135 E
FASB Statement No. 136 C
FASB Statement No. 137 E
FASB Statement No. 138 E
FASB Statement No. 139 D
FASB Statement No. 140 E
FASB Statement No. 141 A
FASB Statement No. 142 E
FASB Statement No. 143 E
FASB Statement No. 144 E
FASB Statement No. 145 E
FASB Statement No. 146 E
FASB Statement No. 147 D
FASB Statement No. 148 (superseded by FASB B
Statement No. 123(R)) 
FASB Statement No. 149 E
FASB Statement No. 150 B
FASB Statement No. 151 E
FASB Statement No. 152 D
FASB Statement No. 153 C
FASB Interpretation No. 1 E
FASB Interpretations No. 2 and No. 3 Superseded
FASB Interpretation No. 4 E
FASB Interpretation No. 5 Superseded
FASB Interpretation No. 6 E
FASB Interpretation No. 7 D
FASB Interpretation No. 8 E
FASB Interpretation No. 9 D
FASB Interpretations No. 10 to No. 13 Superseded
FASB Interpretation No. 14 E
FASB Interpretations No. 15 to No. 17 Superseded
FASB Interpretation No. 18 A
FASB Interpretation No. 19 E
FASB Interpretation No. 20 E
FASB Interpretation No. 21 E
FASB Interpretation No. 22 Superseded
FASB Interpretation No. 23 E
FASB Interpretation No. 24 E
FASB Interpretation No. 25 Superseded
FASB Interpretation No. 26 E
FASB Interpretation No. 27 E
FASB Interpretation No. 28 (superseded by FASB B
Statement No. 123(R))
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FASB Interpretation No. 29 
FASB Interpretation No. 30 
FASB Interpretation No. 31 
FASB Interpretation No. 32 
FASB Interpretation No. 33 
FASB Interpretation No. 34 
FASB Interpretation No. 35 
FASB Interpretation No. 36 
FASB Interpretation No. 37 
FASB Interpretation No. 38 (superseded by FASB 
Statement No. 123(R))
FASB Interpretation No. 39 
FASB Interpretation No. 40 
FASB Interpretation No. 41 
FASB Interpretation No. 42 
FASB Interpretation No. 43 
FASB Interpretation No. 44 (superseded by FASB 
Statement No. 123(R))
FASB Interpretation No. 45 
FASB Interpretation No. 46(R)
FASB Interpretation No. 47
Appendix
Superseded
C
Superseded
Superseded
D
Superseded
A
D
E
B
E
D
E
Superseded
E
B
E
A
E
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Appendix G —The Hierarchy of GAAP*
SAS No. 69, The Meaning of Present Fairly in Conformity With Generally Ac­
cepted Accounting Principles, establishes the hierarchy of GAAP.
For financial statements of entities other than governmental entities, the 
hierarchy is summarized as follows:
Category (a). Rule 203 literature consists of officially established 
accounting principles, which are FASB Statements and Interpreta­
tions, APB Opinions, and ARBs.
Category (b). This consists of FASB Technical Bulletins and, if 
cleared by the FASB, AICPA Industry Audit and Accounting 
Guides, and AICPA SOPs.
Category (c). This consists of AICPA AcSEC Practice Bulletins that 
have been cleared by the FASB and consensus positions of the FASB 
EITF.
Category (d). This consists of AICPA accounting interpretations 
and implementation guides ("Qs and As") published by the FASB 
staff, and practices that are widely recognized and prevalent either 
generally or in the industry.
If the accounting treatment of a transaction or event is not specified by Rule 
203 literature, the auditor should consider whether the accounting treatment 
is specified by another source of established accounting principles. If an estab­
lished accounting principle from one or more sources in category (b), (c), or (d) is 
relevant to the circumstances, the auditor should be prepared to justify a conclu­
sion that another treatment is generally accepted. If there is a conflict between 
accounting principles relevant to the circumstances from one or more sources in 
category (b), (c), or (d), the auditor should follow the treatment specified by the 
source in the higher category—for example, follow category (b) treatment over 
category (c)—or be prepared to justify a conclusion that a treatment specified by 
a source in the lower category better presents the substance of the transaction 
in the circumstances.
For financial statements of State and  Local governmental entities,1 the
hierarchy is summarized as follows:
* The Financial Accounting Standards Board (FASB) released an exposure draft of a proposed 
FASB Statement, The Hierarchy of Generally Accepted Accounting Principles, that would supersede 
the hierarchy for nongovernmental entities currently presented in AICPA Statement on Auditing 
Standards (SAS) No. 69, The Meaning of Present Fairly in Conformity With Generally Accepted 
Accounting Principles (AICPA, Professional Standards, vol. 1, AU sec. 411). The proposed standard 
would carry forward the GAAP hierarchy as set forth in SAS No. 69, subject to certain modifications. 
Those modifications are (1) to carry forward the categorization of the sources of accounting principles 
by document type as presented in paragraph .10 of SAS No. 69, and not by their characteristics as 
presented in paragraph .05 of SAS No. 69, and (2) to expand the sources of category (a) to include FASB 
Staff Positions and FASB Statement No. 133 Implementation Issues. In response to the proposed FASB 
Statement, in May 2005, the AICPA released an exposure draft of a proposed SAS, Amendment to 
Statement on Auditing Standards No. 69, The Meaning of Present Fairly in Conformity With Generally 
Accepted Accounting Principles, for Nongovernmental Entities. The proposed SAS would apply to 
nongovernmental entities. Readers should be alert for the issuance of final standards.
1 State and local governmental entities include public benefit corporations and authorities; public 
employee retirement systems; and governmental utilities, hospitals and other health care providers, 
and colleges and universities. SAS No. 91, Federal GAAP Hierarchy, amends SAS No. 69 to establish 
a hierarchy for federal governmental entities. Federal health care organizations are not included in 
the scope of this Guide.
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Category (a). Officially established accounting principles, consists 
of GASB Statements and Interpretations, as well as AICPA and 
FASB pronouncements specifically made applicable to state and 
local governmental entities by GASB Statements or Interpreta­
tions. GASB Statements and Interpretations are periodically in­
corporated in the Codification of Governmental Accounting and Fi­
nancial Reporting Standards.
Category (b). This consists of GASB Technical Bulletins and, if 
specifically made applicable to state and local governmental en­
tities by the AICPA and cleared2 by the GASB, AICPA Industry 
Audit and Accounting Guides and AICPA SOPs.
Category (c). This consists of AICPA AcSEC Practice Bulletins if 
specifically made applicable to state and local governmental enti­
ties and cleared3 by the GASB, as well as consensus positions of 
a group of accountants organized by the GASB that attempts to 
reach consensus positions on accounting issues applicable to state 
and local governmental entities.4
Category (d). Includes implementation guides ("Qs and As") pub­
lished by the GASB staff, as well as practices that are widely rec­
ognized and prevalent in state and local government.
In the absence of a pronouncement covered by Rule 203 or another source of es­
tablished accounting principles, the auditor of financial statements of state and 
local governmental entities may consider other accounting literature, depend­
ing on its relevance in the circumstances. Other accounting literature includes, 
for example, GASB Concepts Statements; the pronouncements referred to in 
categories (a) through (d) above that relate to other than governmental entities 
when not specifically made applicable to state and local governmental entities 
either by the GASB or by the organization issuing them; FASB Concepts State­
ments; Federal Accounting Standards Advisory Board (FASAB) Statements, 
Interpretations, Technical Bulletins, and Concepts Statements; AICPA Issues 
Papers; International Accounting Standards of the International Accounting 
Standards Committee; pronouncements of other professional associations or 
regulatory agencies; Technical Information Service Inquiries and Replies in­
cluded in AICPA Technical Practice Aids; and accounting textbooks, handbooks, 
and articles. The appropriateness of other accounting literature depends on its 
relevance to particular circumstances, the specificity of the guidance, and the 
general recognition of the issuer or author as an authority. For example, GASB 
Concepts Statements would normally be more influential than other sources in 
this category.
42 Health Care Organizations
2 The auditor should assume that such pronouncements specifically made applicable to state and 
local governments have been cleared by the GASB unless the pronouncement indicates otherwise.
3 See footnote 2.
4 As of the date of this Guide, the GASB had not organized such a group.
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Chapter 2
General Auditing Considerations
Note: Refer to the Preface of this Guide for important information about 
the applicability of the professional standards to audits of issuers and non­
issuers (see the definitions in the Preface). This chapter presents auditing 
guidance included in both AICPA professional standards (GAAS) and in Pub­
lic Company Accounting Oversight Board (PCAOB) professional standards, 
and dual referencing to both the AICPA and the PCAOB professional stan­
dards. In referring to AICPA professional standards, this chapter cites the 
applicable sections of the AICPA Professional Standards publication. In re­
ferring to PCAOB standards, this chapter cites the applicable sections of the 
AICPA's publication titled PCAOB Standards and Related Rules. In those 
cases in which the auditing standards of the AICPA and those of the PCAOB 
are the same, this chapter cites the applicable section of the AICPA Profes­
sional Standards publication only. Readers should refer to the PCAOB Web 
site at www.pcaobus.org for effective date information for PCOAB Standards 
that are discussed in this chapter.
Auditing Guidance in the Audit and Accounting Guide 
State and Local Governments
2.01 This Guide is not the only industry-specific AICPA Audit and Ac­
counting Guide that auditors should consider when performing an audit of a 
governmental health care entity. The Audit and Accounting Guide State and 
Local Governments, includes governmental health care entities in its scope and 
the auditing guidance in that Guide should also be considered during an audit 
of a governmental health care entity that is included in the scope of this Guide.
Registered Public Accounting Firms
2.02 Registered public accounting firms must comply with the standards of 
the Public Company Accounting Oversight Board (PCAOB) in connection with 
the preparation or issuance of any audit report on the financial statements of 
an issuer, as defined by the Sarbanes-Oxley Act, and other entities when pre­
scribed by the rules of the Securities and Exchange Commission (SEC) (collec­
tively referred to as "issuers"). (See the Preface to this Guide for more detailed 
information.)
Scope of the Engagement
2.03 SAS No. 1, section 310, Appointment of the Independent Auditor 
(AICPA, Professional Standards, vol. 1, AU sec. 310), as amended, provides 
that, for each audit engagement, the independent auditor and the health care 
organization should establish a clear understanding regarding the services to be 
performed. The understanding should include the objectives of the engagement, 
management's responsibilities, the auditor's responsibilities, and limitations of 
the engagement. Such an understanding should be documented in the audit 
documentation preferably through a written communication with the client. 
If the auditor believes an understanding with the client has not been estab­
lished, he or she should decline to accept or perform the engagement. [PCAOB
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Conforming Amendments to PCAOB Interim Standards Resulting from the 
Adoption of PCAOB Auditing Standard No. 2, "An Audit of Internal Control 
Over Financial Reporting Performed in Conjunction With An Audit of Finan­
cial Statements" (AICPA, PCAOB Standards and Related Rules, AU sec. 310), 
amend SAS No. 1, as amended, to include requirements related to an auditor's 
understanding when performing an integrated audit of financial statements 
and internal control over financial reporting or an audit of the financial state­
ments in accordance with PCAOB Standards.]
2.04 In addition to reporting on the entity's basic financial statements, the 
independent auditor may be asked to report on the following special reports: 
(a) cost-reimbursement reports; (6) cost reports related to research grants; 
(c) reports for contributors; (d) reports for local, state, or federal authorities; 
(e) reports related to bond indentures and other debt instruments; and (f) other 
special-purpose reports. The nature, timing, and extent of auditing procedures 
to be performed and the type of reports to be issued are based on the scope of 
services required by the entity.
2.05 Chapter 4 in the Audit and Accounting Guide State and Local Gov­
ernments (see paragraph 2.01 in this chapter of the Guide), also discusses the 
need to establish an understanding with the client. That discussion states that 
the auditor should consider holding a preaudit conference with the auditee to 
discuss the responsibilities of both the auditee and the auditor. That discussion 
also provides a listing of topics for the preaudit conference that have elements 
that are unique to or significant in a governmental audit.
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Planning the Audit
2.06 The nature, timing, and extent of planning usually vary with the 
size and complexity of the entity, as well as with the independent auditor's 
experience with the entity and with the industry. SAS No. 22, Planning and 
Supervision (AICPA, Professional Standards, vol. 1, AU sec. 311), as amended, 
contains guidance on planning an audit in accordance with generally accepted 
auditing standards (GAAS). [PCAOB Conforming Amendments to PCAOB In­
terim Standards Resulting from the Adoption of PCAOB Auditing Standard 
No. 2, "An Audit of Internal Control Over Financial Reporting Performed in 
Conjunction With An Audit of Financial Statements" (AICPA, PCAOB Stan­
dards and Related Rules, AU sec. 311), amend SAS No. 22, as amended, to refer 
to PCAOB Auditing Standard No. 2 for additional planning considerations for 
an integrated audit.]
2.07 The independent auditor's work in forming an opinion on financial 
statements consists of obtaining and evaluating evidential matter regarding 
management's assertions. Assertions are representations by management that 
are embodied in the financial statements. They can be either explicit or implicit 
and can be classified according to the following broad categories: existence and 
occurrence, completeness, rights and obligations, valuation and allocation, and 
presentation and disclosure.
2.08 The purpose of specific audit objectives and examples of control ac­
tivities in the auditing sections of the following chapters is to illustrate how 
the independent auditor might obtain an understanding of internal control, 
assess control risk, and perform audit procedures. There is not necessarily a 
one-to-one relationship between audit objectives and procedures. Some proce­
dures may relate to more than one objective. On the other hand, a combination
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of procedures may be needed to achieve a single objective. The illustrations are 
not intended to be all-inclusive or to suggest that specific audit objectives, con­
trol activities, and audit procedures should be applied. Some of the objectives 
may not be relevant to a particular entity because of the nature of its operations 
or the absence of certain types of transactions. The absence of one or more of 
the illustrative controls would not necessarily indicate a deficiency in internal 
control. The auditor performs procedures that are responsive to the auditor's 
risk assessment.
2.09 The illustrations are arranged by broad audit objectives. These clas­
sifications may be useful in the evaluation process, but the classifications are 
of secondary importance. Some specific objectives may serve to achieve more 
than one broad objective.
2.10 Many of the illustrative control activities are premised on the exis­
tence of certain essential characteristics of internal control (for example, autho­
rization of transactions, segregation of duties, documentation, supervision and 
review, and timeliness of procedures). To avoid repetition, these characteristics 
have not been emphasized in the illustrations.
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Inherent Risk
2.11 In determining the scope of audit procedures to be performed, the in­
dependent auditor should be aware of certain aspects of the health care organi­
zation's operations that are usually subject to higher or lower levels of inherent 
risk. SAS No. 47, Audit Risk and Materiality in Conducting an Audit (AICPA, 
Professional Standards, vol. 1, AU sec. 312), provides guidance on the consid­
eration of audit risk and materiality when planning and performing an audit 
of financial statements. SAS No. 96, Audit Documentation, amends SAS No. 47 
(AICPA, Professional Standards, vol. 1, AU sec. 312.40), to require that the au­
ditor should document the nature and effect of aggregated misstatements, and 
his or her conclusion as to whether the aggregated misstatements cause the 
financial statements to be materially misstated. SAS No. 98, Omnibus State­
ment on Auditing Standards—2002 (AICPA, Professional Standards, vol. 1,
AU sec. 312.34-.41), amends the section "Evaluating Audit Findings" of SAS 
No. 47, to clarify the auditor's responsibility with respect to evaluating auditing 
adjustments. [PCAOB Conforming Amendments to PCAOB Interim Standards 
Resulting from the Adoption of PCAOB Auditing Standard No. 2, "An Audit of 
Internal Control Over Financial Reporting Performed in Conjunction With An 
Audit of Financial Statements" (AICPA, PCAOB Standards and Related Rules,
AU sec. 312), amend SAS No. 47, as amended, to refer to PCAOB Auditing 
Standard No. 2 for further guidance for an integrated audit.]
2.12 SOP 00-1, Auditing Health Care Third-Party Revenues and Related 
Receivables, provides guidance to auditors regarding uncertainties inherent in 
health care third-party revenue recognition. SOP 00-1 is included as Appendix 
E to this Guide. The Audit and Accounting Guide State and Local Governments 
(see paragraph 2.01 in this chapter of the Guide), provides additional guidance 
on audit materiality determinations, including opinion units, as that term is 
described in State and Local Governments.
2.13 In many health care organizations, certain accounts typically (a) 
will have a low volume of transactions, (b) will consist of transactions that 
are not complex, and (c) do not require the use of significant accounting esti­
mates. Accounts such as inventories, marketable securities, assets whose use
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is limited, property and equipment, long-term debt, and equity frequently have 
these characteristics and may allow the auditor to assess inherent risk as be­
ing at a relatively low level. However, in certain circumstances, such as in­
vestments in complex derivative financial instruments, inherent risk may be 
higher. The auditor should use professional judgment in evaluating the fac­
tors relevant to assessments of inherent risk. SAS No. 92. Auditing Derivative 
Instruments, Hedging Activities, and Investments in Securities (AICPA, Profes­
sional Standards, vol. 1, AU sec. 332), among other matters, provides guid­
ance to auditors in planning and performing auditing procedures for assertions 
about derivative instruments that are made in an entity's financial statements, 
and presents examples of factors that affect inherent risk for assertions about 
derivatives. [PCAOB Conforming Amendments to PCAOB Interim Standards 
Resulting from the Adoption of PCAOB Auditing Standard No. 2, "An Audit of 
Internal Control Over Financial Reporting Performed in Conjunction With An 
Audit of Financial Statements" (AICPA, PCAOB Standards and Related Rules, 
AU sec. 332), amend SAS No. 92 to refer to PCAOB Auditing Standard No. 2 
for further guidance for an integrated audit.] In addition, a companion Audit 
Guide, Auditing Derivative Instruments, Hedging Activities, and Investments 
in Securities, provides practical guidance for implementing SAS No. 92, Audit­
ing Interpretation No. 1, "Auditing Investments in Securities Where a Readily 
Determinable Fair Value Does Not Exist" of SAS No. 92 (AICPA, Professional 
Standards, vol. 1, AU sec. 9332.01-04),* provides guidance for auditors of non­
issuers regarding the adequacy of audit evidence with respect to the existence 
and valuation assertions in SAS No. 92, in confirmations received from third 
parties when auditing investments in securities where a readily determinable 
fair value does not exist, and the auditor determines auditing procedures should 
include verifying the existence and testing the measurement of the investments.
2.14 Because of the large monetary amounts and the complexity of deter­
mining health care service revenue and receivables, there are risks associated 
with health care service revenue recognition and the valuation of the related 
receivables. A significant portion of services usually is paid for by third par­
ties such as Medicare, Medicaid, and various health insurance carriers under 
statutory provisions or other arrangements in amounts that can be significantly 
different fr om, and frequently less than, the entity's established rates.
2.15 Risks are associated with recognizing the liability for costs incurred 
by providers of prepaid health care services (for example, HMOs) because such 
costs may have been incurred but not yet reported to the providers. It is there­
fore necessary to estimate the liability for those costs. These estimates often 
require a high degree of management judgment. Management must consider 
historical experience as well as the effects of any changes in conditions such 
as seasonality trends and changes in subscriber population and in the services 
and benefits provided.
2.16 Risks also are associated with contingencies for uninsured medical 
malpractice losses and obligations under continuing care contracts. A high de­
gree of management judgment and complex analyses usually are involved in 
evaluating the related financial statement assertions.
2.17 The risk of material misstatements, whether caused by error or fraud, 
and illegal acts by clients is present in all audit engagements. SAS No. 54, Illegal *
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Acts by Clients (AICPA, Professional Standards, vol. 1, AU sec. 317), describes 
the auditor's responsibilities for detecting illegal acts in an audit of financial 
statements and the auditor's responsibilities for communicating detected illegal 
acts to parties within and external to the entity.
Consideration of Fraud in a Financial Statement Audit
2.18 SAS No. 99, Consideration of Fraud in a Financial Statement Audit 
(AICPA, Professional Standards, vol. 1, AU sec. 316), is the primary source of 
authoritative guidance about an auditor's responsibilities concerning the con­
sideration of fraud in a financial statement audit. SAS No. 99 supersedes SAS 
No. 82, Consideration of Fraud in a Financial Statement Audit, and amends SAS 
No. 1, section 230, Due Professional Care in the Performance of Work (AICPA, 
Professional Standards, vol. 1, AU sec. 230). SAS No. 99 establishes standards 
and provides guidance to auditors in fulfilling their responsibility to plan and 
perform the audit to obtain reasonable assurance about whether the finan­
cial statements are free of material misstatement, whether caused by error or 
fraud as stated in SAS No. 1, section 110, Responsibilities and Functions of the 
Independent Auditor (AICPA, Professional Standards, vol. 1, AU sec. 110.02). 
SAS No. 99 also amends SAS No. 85, Management Representations (AICPA, 
Professional Standards, vol. 1, AU sec. 333), as amended. [PCAOB Conform­
ing Amendments to PCAOB Interim Standards Resulting from the Adoption of 
PCAOB Auditing Standard No. 2, "An Audit of Internal Control Over Financial 
Reporting Performed in Conjunction With An Audit of Financial Statements" 
(AICPA, PCAOB Standards and Related Rules, AU sec. 316), amend SAS No. 99 
to refer to PCAOB Auditing Standard No. 2 for additional fraud considerations 
for an integrated audit. Those Conforming Amendments (AICPA, PCAOB Stan­
dards and Related Rules, AU sec. 333), also amend SAS No. 85, as amended, to 
refer to PCAOB Auditing Standard No. 2 for additional written representations 
required from management for an integrated audit.]
2.19 There are two types of misstatements relevant to the auditor's con­
sideration of fraud in a financial statement audit:
• Misstatements arising from fraudulent financial reporting
•  Misstatements arising from misappropriation of assets
2.20 Three conditions generally are present when fraud occurs. First, man­
agement or other employees have an incentive or are under pressure, which 
provides a reason to commit fraud. Second, circumstances exist—for example, 
the absence of controls, ineffective controls, or the ability of management to 
override controls—that provide an opportunity for a fraud to be perpetrated. 
Third, those involved are able to rationalize committing a fraudulent act.
The Importance of Exercising Professional Skepticism
2.21 Because of the characteristics of fraud, the auditor's exercise of pro­
fessional skepticism is important when considering the risk of material mis­
statement due to fraud. Professional skepticism is an attitude that includes 
a questioning mind and a critical assessment of audit evidence. The auditor 
should conduct the engagement with a mindset that recognizes the possibil­
ity that a material misstatement due to fraud could be present, regardless 
of any past experience with the entity and regardless of the auditor's belief 
about management's honesty and integrity. Furthermore, professional skepti­
cism requires an ongoing questioning of whether the information and evidence 
obtained suggests that a material misstatement due to fraud has occurred.
General Auditing Considerations 47
AAG-HCO 2.21
Discussion Among Engagement Personnel Regarding the Risks 
of M aterial Misstatement Due to Fraud
2.22 Members of the audit team should discuss the potential for material 
misstatement due to fraud in accordance with the requirements of paragraphs 
14 through 18 of SAS No. 99 (AU sec. 316.14-.18). The discussion among the au­
dit team members about the susceptibility of the entity's financial statements 
to material misstatement due to fraud should include a consideration of the 
known external and internal factors affecting the entity that might (a) create 
incentives/pressures for management and others to commit fraud, (b) provide 
the opportunity for fraud to be perpetrated, and (c) indicate a culture or envi­
ronment that enables management to rationalize committing fraud. Communi­
cation among the audit team members about the risks of material misstatement 
due to fraud also should continue throughout the audit.
Obtaining the Information Needed to Identify the Risks 
of M aterial Misstatement Due to Fraud
2.23 SAS No. 22 (AICPA, Professional Standards, vol. 1, AU sec. 311.06- 
.08), provides guidance about how the auditor obtains knowledge about the 
entity's business and the industry in which it operates. In performing that work, 
information may come to the auditor's attention that should be considered in 
identifying risks of material misstatement due to fraud. As part of this work, 
the auditor should perform the following procedures to obtain information that 
is used (as described in paragraphs 35 through 42 of SAS No. 99 [AU sec. 
316.35-.42]) to identify the risks of material misstatement due to fraud:
a. Make inquiries of management and others within the entity to 
obtain their views about the risks of fraud and how they are ad­
dressed. (See paragraphs 20 through 27 of SAS No. 99 [AU sec. 
316.20-.27].)
b. Consider any unusual or unexpected relationships that have been 
identified in performing analytical procedures in planning the au­
dit. (See paragraphs 28 through 30 of SAS No. 99 [AU sec. 316.28- 
.30].)
c. Consider whether one or more fraud risk factors exist. (See para­
graphs 31 through 33 of SAS No. 99 [AU sec. 316.31—.33], the Ap­
pendix to SAS No. 99, and paragraph 2.25 in this chapter.)
d. Consider other information that may be helpful in the identification 
of risks of material misstatement due to fraud. (See paragraph 34 
of SAS No. 99 [AU sec. 316.34].)
2.24 In planning the audit, the auditor also should perform analytical 
procedures relating to revenue with the objective of identifying unusual or un­
expected relationships involving revenue accounts that may indicate a material 
misstatement due to fraudulent financial reporting.
2.25 Considering Fraud Risk Factors. As indicated in paragraph 2.23c in 
this chapter, the auditor may identify events or conditions that indicate in­
centives/pressures to perpetrate fraud, opportunities to carry out the fraud, or 
attitudes/rationalizations to justify a fraudulent action. Such events or condi­
tions are referred to as "fraud risk factors." Fraud risk factors do not necessarily 
indicate the existence of fraud; however, they often are present in circumstances 
where fraud exists.
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2.26 SAS No. 99 provides fraud risk factor examples that have been writ­
ten to apply to most enterprises. Remember that fraud risk factors are only one 
of several sources of information an auditor considers when identifying and 
assessing risk of material misstatement due to fraud.
Identifying Risks That M ay Result in a  Material Misstatement 
Due to Fraud
2.27 In identifying risks of material misstatement due to fraud, it is help­
ful for the auditor to consider the information that has been gathered in accor­
dance with the requirements of paragraphs 19 through 34 of SAS No. 99 (AU 
sec. 316.19-.34). The auditor's identification of fraud risks may be influenced 
by characteristics such as the size, complexity, and ownership attributes of the 
entity. In addition, the auditor should evaluate whether identified risks of ma­
terial misstatement due to fraud can be related to specific financial-statement 
account balances or classes of transactions and related assertions, or whether 
they relate more pervasively to the financial statements as a whole. Certain 
accounts, classes of transactions, and assertions that have high inherent risk 
because they involve a high degree of management judgment and subjectivity 
also may present risks of material misstatement due to fraud because they are 
susceptible to manipulation by management.
A  Presumption That Improper Revenue Recognition Is a  Fraud Risk
2.28 Material misstatements due to fraudulent financial reporting often 
result from an overstatement of revenues (for example, through premature 
revenue recognition or recording fictitious revenues) or an understatement of 
revenues (for example, through improperly shifting revenues to a later period). 
Therefore, the auditor should ordinarily presume that there is a risk of material 
misstatement due to fraud relating to revenue recognition (see paragraph 41 
of SAS No. 99 [AU sec. 316.41]).
A  Consideration of the Risk of M anagem ent O verride of Controls
2.29 Even if specific risks of material misstatement due to fraud are not 
identified by the auditor, there is a possibility that management override of 
controls could occur, and accordingly, the auditor should address that risk (see 
paragraph 57 of SAS No. 99 [AU sec. 316.57]) apart from any conclusions re­
garding the existence of more specifically identifiable risks. Specifically, the 
procedures described in paragraphs 58 through 67 of SAS No. 99 (AU sec. 
316.58-.67) should be performed to further address the risk of management 
override of controls. These procedures include (1) examining journal entries 
and other adjustments for evidence of possible material misstatement due to 
fraud, (2) reviewing accounting estimates for biases that could result in mate­
rial misstatement due to fraud, and (3) evaluating the business rationale for 
significant unusual transactions.
Assessing the Identified Risks After Taking Into Account an  
Evaluation of the Entity's Program s and Controls That 
Address the Risks
2.30 Auditors should comply with the requirements of paragraphs 43 
through 45 of SAS No. 99 (AU sec. 316.43—.45) concerning an entity's programs 
and controls that address identified risks of material misstatement due to fraud.
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2.31 The auditor should consider whether such programs and controls 
mitigate the identified risks of material misstatement due to fraud or whether 
specific control deficiencies exacerbate the risks. After the auditor has evaluated 
whether the entity's programs and controls have been suitably designed and 
placed in operation, the auditor should assess these risks taking into account 
that evaluation. The assessment should be considered when developing the 
auditor's response to the identified risks of material misstatement due to fraud.
Responding to the Results of the Assessm ent
2.32 Paragraphs 46 through 67 of SAS No. 99 (AU sec. 316.46-.67) provide 
requirements and guidance about an auditor's response to the results of the 
assessment of the risks of material misstatement due to fraud. The auditor 
responds to risks of material misstatement due to fraud in the following three 
ways:
a. A response that has an overall effect on how the audit is 
conducted—that is, a response involving more general consid­
erations apart from the specific procedures otherwise planned 
(see paragraph 50 of SAS No. 99 [AU sec. 316.50]).
b. A response to identified risks involving the nature, timing, and 
extent of the auditing procedures to be performed (see para­
graphs 51 through 56 of SAS No. 99 [AU sec. 316.51-.56]).
c. A response involving the performance of certain procedures to 
further address the risk of material misstatement due to fraud 
involving management override of controls, given the unpre­
dictable ways in which such override could occur (see para­
graphs 57 through 67 of SAS No. 99 [AU sec. 316.57—.67] and 
paragraph 2.29 in this chapter).
Evaluating Audit Evidence
2.33 Paragraphs 68 through 78 of SAS No. 99 (AU sec. 316.68—.78) provide 
requirements and guidance for evaluating audit evidence. The auditor should 
evaluate whether analytical procedures that were performed as substantive 
tests or in the overall review stage of the audit indicate a previously unrec­
ognized risk of material misstatement due to fraud. The auditor also should 
consider whether responses to inquiries throughout the audit about analytical 
relationships have been vague or implausible, or have produced evidence that 
is inconsistent with other evidential matter accumulated during the audit.
2.34 At or near the completion of fieldwork, the auditor should evaluate 
whether the accumulated results of auditing procedures and other observa­
tions affect the assessment of the risks of material misstatement due to fraud 
made earlier in the audit. As part of this evaluation, the auditor with final 
responsibility for the audit should ascertain that there has been appropriate 
communication with the other audit team members throughout the audit re­
garding information or conditions indicative of risks of material misstatement 
due to fraud.
Responding to Misstatements That M ay Be the Result of Fraud
2.35 When audit test results identify misstatements in the financial state­
ments, the auditor should consider whether such misstatements may be indica­
tive of fraud. See paragraphs 75 through 78 of SAS No. 99 (AU sec. 316.75-.78)
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for requirements and guidance about an auditor's response to misstatements 
that may be the result of fraud. If the auditor believes that misstatements are 
or may be the result of fraud, but the effect of the misstatements is not mate­
rial to the financial statements, the auditor nevertheless should evaluate the 
implications, especially those dealing with the organizational position of the 
person(s) involved.
2.36 If the auditor believes that the misstatement is or may be the re­
sult of fraud, and either has determined that the effect could be material to 
the financial statements or has been unable to evaluate whether the effect is 
material, the auditor should:
a. Attempt to obtain additional evidential matter to determine 
whether material fraud has occurred or is likely to have occurred, 
and, if so, its effect on the financial statements and the auditor's 
report thereon.1
b. Consider the implications for other aspects of the audit (see para­
graph 76 of SAS No. 99 [AU sec. 316.76]).
c. Discuss the matter and the approach for further investigation with 
an appropriate level of management that is at least one level 
above those involved, and with senior management and the audit 
committee.2
d. If appropriate, suggest that the client consult with legal counsel.
2.37 The auditor's consideration of the risks of material misstatement 
and the results of audit tests may indicate such a significant risk of material 
misstatement due to fraud that the auditor should consider withdrawing from 
the engagement and communicating the reasons for withdrawal to the audit 
committee or others with equivalent authority and responsibility. The auditor 
may wish to consult with legal counsel when considering withdrawal from an 
engagement.
Communicating About Possible Fraud to M anagem ent, the Audit 
Committee, and Others
2.38 Whenever the auditor has determined that there is evidence that 
fraud may exist, that matter should be brought to the attention of an appropri­
ate level of management. See paragraphs 79 through 82 of SAS No. 99 (AU sec. 
316.79-.82) for further requirements and guidance about communications with 
management, the audit committee, and others. [PCAOB Conforming Amend­
ments to PCAOB Interim Standards Resulting from the Adoption of PCAOB 
Auditing Standard No. 2, "An Audit of Internal Control Over Financial Report­
ing Performed in Conjunction With An Audit of Financial Statements" (AICPA, 
PCAOB Standards and Related Rules, AU sec. 316.80), amend paragraph 80 of 
SAS No. 99 for an integrated audit.]
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1 See Statement on Auditing Standards (SAS) No. 58, Reports on Audited Financial Statements 
(AICPA, Professional Standards, vol. 1, AU sec. 508), for guidance on auditor's reports issued in 
connection with audits of financial statements. [PCAOB Conforming Amendments to PCAOB Interim 
Standards Resulting from the Adoption of PCAOB Auditing Standard No. 2, "An Audit of Internal 
Control Over Financial Reporting Performed in Conjunction With An Audit of Financial Statements" 
(AICPA, PCAOB Standards and Related Rules, AU sec. 508), amend SAS No. 58 to provide reporting 
guidance for an integrated audit.]
2 If the auditor believes senior management may be involved, discussion of the matter directly 
with the audit committee may be appropriate.
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Documenting the Auditor's Consideration of Fraud
2.39 Paragraph 83 of SAS No. 99 (AU sec. 316.83) requires certain items 
and events to be documented by the auditor. Auditors should comply with those 
requirements.
Practical Guidance
2.40 The AICPA Practice Aid Fraud Detection in a GAAS Audit—Revised 
Edition, provides a wealth of information and help on complying with the pro­
visions of SAS No. 99. Moreover, this Practice Aid will assist auditors in under­
standing the requirements of SAS No. 99 and whether current audit practices 
effectively incorporate these requirements. This Practice Aid is an Other Au­
diting Publication as defined in SAS No. 95, Generally Accepted Auditing Stan­
dards (AICPA, Professional Standards, vol. 1, AU sec. 150). Other Auditing 
Publications have no authoritative status; however, they may help the auditor 
understand and apply SASs.
Internal Control
2.41 SAS No. 55, Consideration of Internal Control in a Financial State­
ment Audit, as amended by SAS No. 78, Consideration of Internal Control in a 
Financial Statement Audit: An Amendment to SAS No. 55, and SAS No. 94, The 
Effect of Information Technology on the Auditor's Consideration of Internal Con­
trol in a Financial Statement Audit (AICPA, Professional Standards, vol. 1, AU 
sec. 319), describes the components of internal control and explains how an in­
dependent auditor should consider internal control in planning and performing 
an audit. Internal control is a process—effected by an entity's board of directors, 
management, and other personnel—designed to provide reasonable assurance 
regarding the achievement of objectives in the following categories: (a) relia­
bility of financial reporting, (b) effectiveness and efficiency of operations, and 
(c) compliance with applicable laws and regulations. Internal control consists 
of the following five interrelated components:
a. Control environment
h. Risk assessment
c. Control activities
d. Information and communication
e. Monitoring
2.42 The auditor should obtain an understanding of each of the five compo­
nents of internal control sufficient to plan the audit. A sufficient understanding 
is obtained by performing procedures to understand the design of controls rel­
evant to an audit of financial statements and whether the controls have been 
placed in operation. In obtaining this understanding, the auditor considers how 
an entity's use of information technology (IT) and manual procedures may affect 
controls relevant to the audit. IT encompasses automated means of originating, 
processing, storing, and communicating information, and includes recording de­
vices, communication systems, computer systems, and other electronic devices. 
The auditor is primarily interested in the entity's use of IT to initiate, record, 
process, and report transactions or other financial data.
2.43 After obtaining an understanding of the components of internal con­
trol, the independent auditor assesses control risk for the assertions embodied 
in the account balance, transaction class, and disclosure components of the
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financial statements. The independent auditor uses the understanding of in­
ternal control and the assessed level of control risk in determining the nature, 
timing, and extent of substantive tests for financial statement assertions.
2.44 PCAOB Auditing Standard No. 2, An Audit of Internal Control Over 
Financial Reporting Performed in Conjunction with An Audit of Financial State­
ments (AICPA, PCAOB Standards and Related Rules, AU sec. 320), establishes 
requirements that apply when an auditor is engaged to audit both the financial 
statements and management's assessment of the effectiveness of internal con­
trol over financial reporting in accordance with PCAOB Standards. The PCAOB 
has issued staff guidance on PCAOB Auditing Standard No. 2 in the form of a 
questions and answers (Q&A) document, Staff Questions and Answers: Audit­
ing Internal Control Over Financial Reporting. (See the Preface to this Guide 
for more information about management assessment of the effectiveness of in­
ternal control.) PCAOB Conforming Amendments to PCAOB Interim Standards 
Resulting from the Adoption of PCAOB Auditing Standard No. 2, "An Audit of 
Internal Control Over Financial Reporting Performed in Conjunction With An 
Audit of Financial Statements" (AICPA, PCAOB Standards and Related Rules,
AU sec. 319), amend SAS No. 55, as amended, for an integrated audit.
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Analytical Procedures
2.45 SAS No. 56, Analytical Procedures (AICPA, Professional Standards, 
vol. 1, AU sec. 329), provides guidance on the use of analytical procedures and 
requires their use in the planning and overall review stages of all audits. The 
AICPA Audit Guide Analytical Procedures, provides practical guidance to au­
ditors on the effective use of analytical procedures. That Audit Guide includes 
a discussion of SAS No. 56; concepts and definitions; a series of questions and 
answers; and a case study illustrating trend analysis, ratio analysis, reason­
ableness testing, and regression analysis. For planning purposes, these proce­
dures should focus on (a) enhancing the independent auditor's understanding 
of the client's business and the transactions and events that have occurred 
since the last audit date and (b) identifying areas that may represent specific 
risks relevant to the audit. Thus, the objective of the procedures is to identify 
such things as the existence of unusual transactions and events, as well as 
amounts, ratios, and trends that might indicate matters that have financial 
statement and audit planning ramifications. For overall review purposes, these 
procedures should focus on considering the adequacy of the evidence gathered 
in response to unusual or unexpected balances or relationships. The objective 
of the procedures is to assist the auditor in assessing the conclusions reached 
and evaluating the overall financial statement presentation. Analytical proce­
dures also may be used as substantive tests to identify potential misstatements. 
These procedures focus on comparing actual balances with expected balances 
and investigating and evaluating significant differences from the balances ex­
pected. SAS No. 96 amends SAS No. 56 (AICPA, Professional Standards, vol. 
1, AU sec. 329.22), to add a requirement that the auditor document all of the 
following when an analytical procedure is used as the principal substantive test 
of a significant financial statement assertion:
a. The expectation, where that expectation is not otherwise readily 
determinable from the documentation of the work performed, and 
factors considered in its development
b. Results of the comparison of the expectation to the recorded 
amounts or ratios developed from recorded amounts
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c. Any additional auditing procedures performed in response to signif­
icant unexpected differences arising from the analytical procedure 
and the results of such additional procedures 
[PCAOB Conforming Amendments to PCAOB Interim Standards Resulting 
from the Adoption of PCAOB Auditing Standard No. 2, "An Audit of Internal 
Control Over Financial Reporting Performed in Conjunction With An Audit of 
Financial Statements" (AICPA, PCAOB Standards and Related Rules, AU sec. 
329), amend SAS No. 56, as amended, for an integrated audit and for an audit 
of the financial statements.]
2.46 Examples of sources of information for developing expectations in­
clude prior-period financial information, budgets, and health care financial 
and statistical ratios. Additional information is available from the Center for 
Healthcare Industry Performance Studies' (CHIPS) Financial Analysis Service, 
which is published annually, as well as other health care industry associations.
2.47 Following are examples of analytical procedures the independent au­
ditor may find useful:
•  Comparison of account balances with budget and prior-period amounts
•  Analysis of changes in revenues during the current period based on sta­
tistical data (for example, admissions, patient days, visits, and profes­
sional service procedure counts for laboratory, radiology, and surgery) 
and information concerning price changes
•  Comparison between periods of the number of days of revenue in re­
ceivables
• Relationship between periods of the allowance for uncollectible ac­
counts to the balance of patient accounts receivable in the aggregate, 
based on known changes in the accounts receivable's aging and com­
position by payor
•  Relationship between periods of the liability for claims incurred but 
not reported (IBNR) to the related expense
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Accounting Estimates
2.48 In determining the scope of audit procedures to be performed, the 
independent auditor should recognize that certain areas of health care orga­
nization operations require accounting estimates that may be material in the 
preparation and presentation of financial statements. SOP 94-6, Disclosure of 
Certain Significant Risks and Uncertainties,3 requires entities to include in 
their financial statements information about the use of estimates in the prepa­
ration of financial statements. In addition, if certain specified disclosure criteria 
are met, the SOP requires entities to include disclosures about certain signif­
icant estimates in their financial statements. SAS No. 57, Auditing Account­
ing Estimates (AICPA, Professional Standards, vol. 1, AU sec. 342), provides 
guidance on obtaining and evaluating sufficient competent evidential matter 
to support significant accounting estimates in an audit of financial statements 
in accordance with GAAS. [PCAOB Conforming Amendments to PCAOB In­
terim Standards Resulting from the Adoption of PCAOB Auditing Standard 
No. 2, "An Audit of Internal Control Over Financial Reporting Performed in
3 SOP 94-6 does not pertain to governmental entities, unless the entity has elected to follow 
all FASB pronouncements under paragraph 7 of GASB Statement No. 20, Accounting and Finan­
cial Reporting for Proprietary Funds and Other Governmental Entities That Use Proprietary Fund 
Accounting. (See Chapter 1, footnote 1.)
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Conjunction With An Audit of Financial Statements" (AICPA, PCAOB Stan­
dards and Related Rules, AU sec. 342), amend SAS No. 57 for an integrated 
audit.] SOP 00-1 provides guidance for auditors regarding the sufficiency of 
evidential matter supporting accounting estimates recorded for the proper val­
uation of health care third-party revenues and related receivables. SOP 00-1 is 
included as Appendix E to this Guide.
2.49 Although management is responsible for making estimates, the inde­
pendent auditor is responsible for evaluating the reasonableness of estimates 
and should consider appropriate procedures in planning and performing the 
audit. These procedures should include both subjective and objective factors.
2.50 The independent auditor should acquire an understanding of the 
relevance of internal control to the accumulation of data and the preparation of 
accounting estimates. Internal control should also provide for adequate review 
and approval of accounting estimates by appropriate levels of authority.
2.51 Although significant accounting estimates may affect many elements 
of a health care organization's financial statements, they most often affect the 
following;
a. The provision for third-party payor contractual adjustments and al­
lowances and the provision for estimated receivables and payables 
for final settlements with those payors
b. The provision for uncollectible accounts
c. Accruals for uninsured medical malpractice claims
d. Accruals for obligations under continuing care contracts
e. Accruals by providers of prepaid health care services for IBNR costs
Individual Practice Associations
2.52 In planning the audit of an individual practice association (IPA), the 
auditor usually considers the following matters:
•  The size of a typical IPA accounting department and business office 
often is not large enough to result in effective segregation of duties. 
However, most IPAs have an active office manager who can exercise a 
high degree of influence and control over the operations.
• Physician compensation arrangements often use incentives or other 
features with complicated methodologies and formulas.
•  Contracts with managed care plans, often with capitated payment and 
risk pool settlement terms, frequently represent a significant amount 
of revenue for the IPA.
2.53 IPAs with capitated contracts accrue costs when the services are 
rendered, including cost estimates of IBNR claims. The IBNR accrual includes 
an estimate of the costs of services for which the IPA is responsible, including 
referrals outside the IPA. Risk pool settlements should be accrued during the 
contract period based on relevant factors, such as experience to date.
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Other Planning Considerations
2.54 In planning the audit, the independent auditor also should consider—
• Matters relating to the entity's business and the health care industry.
• Financial statement items likely to require adjustment.
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•  Conditions that might require extension or modification of audit tests 
(such as the existence of related party transactions or the existence of 
uninsured malpractice risks).
• The entity's experience with payment denials and other matters sub­
ject to review by medical review organizations.
•  The nature of reports expected to be rendered. Examples include re­
ports on consolidated or consolidating financial statements, reports on 
financial statements filed with the Securities and Exchange Commis­
sion (SEC), reports filed with third-party payors or other regulatory 
bodies, and other special reports.
2.55 Planning procedures usually include reviewing the independent au­
ditor's files relating to the entity and holding discussions with audit personnel 
and the personnel of the entity. Examples of these procedures include the fol­
lowing:
Review correspondence files, the prior year's audit documentation, 
permanent files, financial statements, and independent auditors' 
reports.
Review the minutes of meetings of the governing board of directors 
and board committees.
Review the relationship of affiliated organizations to the health care 
organization and determine the extent to which their financial infor­
mation should be included in the financial statements of the entity. 
(See the related discussion in Chapter 11.)
Review the status of unsettled cost (reimbursement) reports for prior 
periods filed with third-party payors.
Discuss matters that may affect the audit with the firm's personnel 
responsible for any nonaudit services to the entity.
Identify situations for which accounting estimates are required and 
relevant factors that may affect those estimates.
Inquire about current business developments affecting the entity.
Read the current year's interim financial statements and 10-Q 
forms.
Review periodic reports to third-party payors or other regulatory 
bodies.
Discuss the nature, scope, and timing of the engagement with the en­
tity's management, board of directors, or audit committee.
Consider the effects of all applicable accounting and auditing pro­
nouncements, particularly recent pronouncements.
Coordinate the assistance of entity personnel in data preparation. 
Determine the extent of involvement, if any, of consultants, specialists, 
and internal auditors.
• Establish the timing of the audit work.
2.56 SAS No. 96 (AICPA, Professional Standards, vol. 1, AU sec. 339), pro­
vides guidance regarding the content, ownership, and confidentiality of audit 
documentation. Audit documentation should include abstracts or copies of sig­
nificant contracts or agreements that were examined to evaluate the accounting
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for significant transactions.† [PCAOB Auditing Standard No. Audit Documen­
tation (AICPA, PCAOB Standards and Related Rules, AU sec. 339), supersedes 
SAS No. 96 and establishes general requirements for documentation the au­
ditor should prepare and retain in connection with engagements conducted 
pursuant to PCAOB standards. PCAOB Auditing Standard No. 2 requires that 
in addition to the documentation requirements of PCAOB Auditing Standard 
No. 3, auditors should document certain items related to their audits of internal 
control over financial reporting.]
2.57 The independent auditor may find it helpful to maintain a permanent 
file that includes copies of the following documents relating to the health care 
organization:
a. Articles of incorporation
b. Bylaws
c. Chart of accounts
d. Organization chart
e. Specific documents concerning restrictions on donor gifts and be­
quests
f. Contracts and agreements, including leases, agreements with 
physicians, agreements with third-party payors, and agreements 
with affiliated organizations
g. Description of internal control
h. Loan agreements, bond indentures, and other debt instruments
2.58 The independent auditor should understand the specific cost-finding 
or other rate-setting methods used by third-party payors to determine final 
amounts reimbursable to the health care organization. These payment meth­
ods may require that a health care organization accumulate and report vari­
ous statistical data, such as admissions, discharges, patient days, visits, beds, 
square footage, and pounds of laundry.
2.59 The independent auditor intending to use audit-sampling procedures 
should refer to SAS No. 39, Audit Sampling (AICPA, Professional Standards, 
vol. 1, AU sec. 350), when planning the work to be done. The AICPA Audit 
Guide Audit Sampling presents recommendations on the application of gener­
ally accepted auditing standards to audits involving the use of audit sampling 
methods, and guidance on applying audit sampling in accordance with SAS 
No. 39.
2.60 If the health care organization has an internal audit function, the 
independent auditor should also refer to SAS No. 65, The Auditor's Considera­
tion of the Internal Audit Function in an Audit of Financial Statements (AICPA, 
Professional Standards, vol. 1, AU sec. 322). [PCAOB Conforming Amendments 
to PCAOB Interim Standards Resulting from the Adoption of PCAOB Audit­
ing Standard No. 2, "An Audit of Internal Control Over Financial Reporting 
Performed in Conjunction With An Audit of Financial Statements" (AICPA,
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† The Auditing Standards Board (ASB) has released an exposure draft of a proposed Statement 
on Auditing Standards (SAS) entitled Audit Documentation that would replace SAS No. 96, Audit 
Documentation. The proposed SAS is not applicable to public accounting firms registered with the 
PCAOB and their associated persons in connection with their audits of issuers, as defined by the 
Sarbanes-Oxley Act, and other entities when prescribed by the rules of the Securities and Exchange 
Commission (SEC). Readers should be alert to the release of a final standard.
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PCAOB Standards and Related Rules, AU sec. 322), amend SAS No. 65 to re­
fer to PCAOB Auditing Standard No. 2 for further guidance for an integrated 
audit.]
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Transactions Processed by Service Organizations
2.61 Health care organizations may engage outside service organizations 
to perform services that are part of the health care provider's information sys­
tem. A service organization's services are part of an entity's information system 
if they affect any of the following—
• The classes of transactions in the entity's operations that are signifi­
cant to the entity's financial statements
•  The procedures, both automated and manual, by which the entity's 
transactions are initiated, recorded, processed, and reported from their 
occurrence to their inclusion in the financial statements
• The related accounting records, whether electronic or manual, support­
ing information, and specific accounts in the entity's financial state­
ments involved in initiating, recording, processing and reporting the 
entity's transactions
• How the entity's information system captures other events and condi­
tions that are significant to the financial statements
• The financial reporting process used to prepare the entity's financial 
statements, including significant accounting estimates and disclosures
Examples of service organizations used by health care organizations include 
the following:
•  Bank trust departments that invest and service assets for health care 
organizations
• Service organizations that process payroll
• Billing entities that prepare reimbursement claims to insurers and 
other third parties
•  Administrators of employee benefit plans who process and pay benefit 
claims and maintain participant records
2.62 SAS No. 55, as amended by SAS No. 78 and SAS No. 94, states that 
the auditor should obtain an understanding of an entity's internal control suf­
ficient to plan the audit. This understanding may encompass controls placed in 
operation by the health care organization and service organizations whose ser­
vices are part of the health care organization's information system. In planning 
the audit, such information should be used to—
• Identify types of potential misstatements.
• Consider factors that affect the risk of material misstatement.
•  Design tests of controls, when applicable.
• Design substantive tests.
2.63 SAS No. 70, Service Organizations, as amended (AICPA, Professional 
Standards, vol. 1, AU sec. 324), explains the considerations an auditor should 
make in obtaining an understanding of internal control and assessing control 
risk for entities that use a service organization to process transactions. The 
AICPA Audit Guide Service Organizations: Applying SAS No. 70, as Amended,
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provides additional guidance for user auditors engaged to audit the finan­
cial statements of entities that use service organizations. [PCAOB Conform­
ing Amendments to PCAOB Interim Standards Resulting from the Adoption of 
PCAOB Auditing Standard No. 2, "An Audit of Internal Control Over Financial 
Reporting Performed in Conjunction With An Audit of Financial Statements" 
(AICPA, PCAOB Standards and Related Rules, AU sec. 324), amend SAS No. 70, 
as amended, for an integrated audit.]
2.64 The auditor of a health care organization should determine whether 
the health care organization uses a service organization. Information about the 
nature of the services provided by the service organization and the service or­
ganization's controls over those services may be available from sources such as 
user manuals, system overviews, technical manuals, the contract between the 
health care organization and the service organization, and reports by service 
auditors, internal auditors, or regulatory authorities on the service organiza­
tion's controls.
2.65 After considering the available information, the auditor of the health 
care organization may conclude that he or she has the means to obtain a suffi­
cient understanding of internal control to plan the audit. If the auditor of the 
health care organization concludes that information is not available to obtain 
a sufficient understanding to plan the audit, he or she may consider contact­
ing the service organization, through the health care organization, to obtain 
specific information or request that a service auditor be engaged to perform 
procedures that will supply the necessary information, or the auditor of the 
health care organization may visit the service organization and perform such 
procedures. If the auditor of the health care organization is unable to obtain suf­
ficient evidence to achieve his or her audit objectives, the auditor of the health 
care organization should qualify his or her opinion or disclaim an opinion on 
the financial statements because of a scope limitation.
2.66 After obtaining an understanding of internal control, the auditor may 
assess control risk at the maximum level for some or all financial statement 
assertions related to the service organization's processing because, he or she 
believes controls are unlikely to pertain to an assertion, are unlikely to be effec­
tive, or because evaluating their effectiveness would be inefficient. Procedures 
to evaluate operating effectiveness include one or any combination of the fol­
lowing:
a. Performing tests of controls over the activities of the service orga­
nization at the health care organization
b. Performing tests of controls at the service organization
c. Obtaining a service auditor's report that describes the results of 
tests of the operating effectiveness of controls performed by the 
service auditor
Other Audit Considerations
Illegal Acts
2.67 The Social Security Act provides for criminal penalties for individu­
als or entities that offer, pay, solicit, or receive remuneration to induce business 
that is reimbursed under Medicare or state health care programs. The types 
of remuneration covered by the Medicare Anti-Kickback Statute include, with 
certain exceptions, kickbacks, bribes, and rebates made directly or indirectly,
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overtly or covertly, and in cash or in kind. In addition, prohibited conduct in­
cludes not only remuneration intended to induce referrals or patients but also 
remuneration intended to induce the purchasing, leasing, ordering, or arrang­
ing for any good, facility, service, or item paid for by Medicare or state health 
care programs. In addition, fraudulent activities may exist that are unrelated to 
Medicare or state programs, such as fraudulent billing and admitting practices.
2.68 The auditor's procedures will vary based on his or her assessment of 
the risk of material misstatement resulting from such illegal acts. SAS No. 54 
states that the auditor should plan and perform the audit to provide reasonable 
assurance of detecting illegal acts having a direct and material effect on the 
determination of financial statement amounts. SAS No. 54 also notes that an 
audit in accordance with GAAS does not include audit procedures specifically 
designed to detect illegal acts that have only an indirect effect on the financial 
statements (for example, illegal acts that have a material effect as the result of 
fines or penalties that may be imposed on the entity) and provides guidance on 
the auditor's responsibilities when specific information concerning the possible 
existence of this type of illegal act comes to the auditor's attention.
2.69 Examples of laws and regulations that are generally recognized by 
auditors to have a direct and material effect on the determination of amounts 
in financial statements of health care organizations include tax laws affecting 
tax accruals and tax expense as well as Medicare and Medicaid laws directly 
affecting the amount of revenue recognized during the accounting period (such 
as those concerning the submission of bills for fictitious patients).
2.70 Health care organizations also may be affected by many other laws 
and regulations such as those related to Medicare and Medicaid fraud and 
abuse, securities trading, occupational safety and health, food and drug ad­
ministration, environmental protection, equal employment opportunities, and 
price-fixing or other antitrust violations. Generally, these laws and regulations 
relate more to an entity's operating aspects than to its financial and accounting 
aspects, and their financial statement effect is only indirect. An auditor ordi­
narily does not have sufficient basis for recognizing possible violations of such 
laws and regulations. Their indirect effect is normally the result of the need 
to disclose a contingent liability because of the allegation or determination of 
illegality. For example, patients may be obtained based on illegal arrangements 
with physicians or other providers. While the direct effects of the services ren­
dered may be recorded appropriately, their indirect effects, the possible contin­
gent liability for violating Medicare and Medicaid fraud and abuse statutes, 
may not be appropriately disclosed. Even when violations of such laws and reg­
ulations can have consequences material to the financial statements, auditors 
may not become aware of the existence of the illegal act unless he or she is 
informed by the client, or there is evidence of a governmental agency investiga­
tion or enforcement proceeding in the records, documents, or other information 
normally inspected in an audit of financial statements.
2.71 Whether an act is, in fact, illegal is a determination that is normally 
beyond the auditor's professional competence. The auditor's training, experi­
ence, and understanding of the client and the industry may provide a basis 
for recognizing that some acts coming to the auditor's attention may be illegal. 
However, determining whether a particular client act is illegal generally would 
be based on the advice of an informed expert qualified to practice law or may 
have to await final determination by a court of law. For example, determining
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whether admitting a patient or providing a service is medically necessary or 
whether a particular procedure or device was properly approved is not within 
the auditor's professional competence.
Use of a  Specialist
2.72 SAS No. 73, Using the Work of a Specialist (AICPA, Professional 
Standards, vol. 1, AU sec. 336), provides guidance to the auditor who uses 
the work of a specialist in performing the audit of a health care organization's 
financial statements. Guidance is provided on deciding when to use a specialist, 
the auditor's responsibilities for evaluating the qualifications and the work 
of the specialist, and using the findings of the specialist. The Statement requires 
the auditor to evaluate the relationship of the specialist to the client and states 
that the auditor should perform additional procedures if the auditor concludes 
that the objectivity of the specialist may be impaired by such a relationship.
Clinical Coding Validations
2.73 Typically, a number of clinicians (e.g., the attending physician, con­
sulting physicians, radiologists, pathologists, therapists, and nurses) add doc­
umentation to a patient's medical record. Provider personnel generally review 
the medical record and assign a code (ICD-9-CM or CPT-4 code) to the record. 
The provider prepares and submits a bill that includes, among other things, the 
assigned ICD-9-CM or CPT-4 code. The Medicare Fiscal Intermediary or other 
third-party payor typically reviews the bill and assigns it a specific payment 
code, such as a Diagnostic Related Group (DRG) number. Payment is based on 
the DRG or other payment code assigned. The provider may check the payment 
code assigned and follow up on any discrepancies identified. However, since the 
assignment of the payment code is made by the third-party payor, responsibility 
for correct assignment rests with that payor.
2.74 Errors can occur throughout this process. Physicians or other clini­
cians may not document the appropriate procedure. Coding personnel may not 
notice or interpret certain items in the medical record correctly. Accordingly, an 
incorrect code may be assigned and an erroneous amount may be paid.
2.75 An auditor ordinarily would not find it necessary to consider the pro­
cess of assigning codes in planning and performing an audit of the provider's 
financial statements. However, the auditor should be alert for indications of 
potential material misstatements of the financial statements resulting indi­
rectly from such matters. For example, the auditor may become aware that 
a retrospective review has been performed or that an investigation has been 
completed or is in process. In such circumstances, the auditor should consider 
whether performance of additional substantive audit procedures is necessary 
to reduce audit risk to an acceptable level.
Going-Concern Considerations
2.76 SAS No. 59, The Auditor's Consideration of an Entity's Ability to Con­
tinue as a Going Concern (AICPA, Professional Standards, vol. 1, AU sec. 341), 
provides guidance to the independent auditor conducting an audit on how to 
evaluate whether there is substantial doubt about the entity's ability to con­
tinue as a going concern. Continuation of an entity as a going concern is as­
sumed in financial reporting in the absence of significant information to the con­
trary. Ordinarily, information that significantly contradicts the going-concern
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assumption relates to the entity's inability to continue to meet its obligations as 
they become due without substantial disposition of assets outside the ordinary 
course of business, restructuring of debt, externally forced revision of its oper­
ations, or similar actions. SAS No. 59 states that the independent auditor has 
a responsibility to evaluate whether there is substantial doubt about the en­
tity's ability to continue as a going concern for a reasonable period of time, not 
to exceed one year beyond the date of the financial statements being audited. 
SAS No. 96 amends SAS No. 59 (AICPA, Professional Standards, vol. 1, AU 
sec. 341.17), to add a requirement that the auditor document certain matters 
if, after considering the identified conditions and events in the aggregate, the 
auditor believes there is substantial doubt about the ability of the entity to 
continue as a going concern for a reasonable period of time, not to exceed one 
year beyond the date of the financial statements being audited.
2.77 Noncompliance with donor-imposed restrictions should be disclosed 
if there is a reasonable possibility that a material contingent liability has been 
incurred at the date of the financial statements or there is at least a reasonable 
possibility that the noncompliance could lead to a material loss of revenue or 
could cause an entity to be unable to continue as a going concern. If the non- 
compliance results from an organization's failure to maintain an appropriate 
composition of assets in amounts needed to comply with all donor restrictions, 
the amounts and circumstances should be disclosed.
Communication
Communication of Matters Related to Internal Control
2.78 SAS No. 60, Communication of Internal Control Related Matters 
Noted in an Audit (AICPA, Professional Standards, vol. 1, AU sec. 325), pro­
vides guidance in identifying and reporting conditions related to an entity's 
internal control that are observed during an audit of the financial statements.‡ 
It is contemplated that the communication generally would be to the audit 
committee or, in organizations that do not have an audit committee, to those 
with an equivalent level of authority and responsibility such as the board of 
directors, the owner in an owner-managed enterprise, or the individuals who 
engaged the independent auditor. Conditions noted by the independent auditor 
that are considered reportable under SAS No. 60 should be reported, prefer­
ably in writing. If information is communicated orally, the independent auditor 
should document the communication by appropriate memoranda or notations 
in the audit documentation. [PCAOB Conforming Amendments to PCAOB In­
terim Standards Resulting from the Adoption of PCAOB Auditing Standard 
No. 2, "An Audit of Internal Control Over Financial Reporting Performed in 
Conjunction With An Audit of Financial Statements" (AICPA, PCAOB Stan­
dards and Related Rules, AU sec. 325), supersede the guidance in SAS No. 60 
for an integrated audit, and amend the guidance in SAS No. 60 for an audit 
of the financial statements, including the guidance in this paragraph of the 
Guide.]
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‡ The ASB has released an exposure draft of a proposed SAS, Communication of Internal Control 
Related Matters Noted in an Audit. Among other matters, the proposed SAS would supersede SAS 
No. 60. This proposed SAS is not applicable to public accounting firms registered with the PCAOB and 
their associated persons in connection with their audits of issuers, as defined by the Sarbanes-Oxley 
Act, and other entities when prescribed by the rules of the SEC. Readers should be alert to the release 
of a revised exposure draft and issuance of a final standard.
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Communication W ith Audit Committees
2.79 SAS No. 61, Communication With Audit Committees, as amended by 
SAS No. 89, Audit Adjustments, and SAS No. 90, Audit Committee Commu­
nications (AICPA, Professional Standards, vol. 1, AU sec. 380), establishes a 
requirement for the independent auditor to determine that certain matters re­
lated to the conduct of an audit are communicated to those with responsibility 
for oversight of the financial reporting process. The communications required 
by SAS No. 61 are applicable to (a) entities that either have an audit commit­
tee or otherwise have formally designated oversight of the financial reporting 
process to a group equivalent to an audit committee (such as a finance com­
mittee or a budget committee) and (b) all SEC engagements as defined in SAS 
No. 61. In addition, communication with the audit committee or its equivalent 
by the independent auditor on certain specified matters when they arise in the 
conduct of an audit is required by other standards, including SAS No. 99 and 
SAS No. 54. [PCAOB Conforming Amendments to PCAOB Interim Standards 
Resulting from the Adoption of PCAOB Auditing Standard No. 2, "An Audit 
of Internal Control Over Financial Reporting Performed in Conjunction With 
An Audit of Financial Statements" (AICPA, PCAOB Standards and Related 
Rules, AU sec. 380), amend SAS No. 61, as amended, to include PCAOB Au­
diting Standard No. 2 among the other standards requiring audit committee 
communication for an integrated audit.]
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Management Representations
2.80 SAS No. 85, Management Representations, as amended by SAS No. 89, 
Audit Adjustments, and SAS No. 99 (AICPA, Professional Standards, vol. 1, AU 
sec. 333), establishes a requirement that an auditor performing an audit in ac­
cordance with GAAS, obtain written representations from management for all 
financial statements and periods covered by the auditor's report. The specific 
written representations to be obtained depend on the circumstances of the en­
gagement and the nature and basis of presentation of the financial statements. 
Paragraph 6 of SAS No. 85, as amended by SAS No. 89 and SAS No. 99, lists 
matters ordinarily included in management's representation letter. SAS No. 
85, as amended by SAS No. 89 and SAS No. 99, includes several examples as 
well. Appendix A of the SAS, as amended by SAS No. 89 and SAS No. 99, in­
cludes an illustrative management representation letter, Appendix B provides 
illustrative wording for additional representations that may be appropriate 
in certain situations, and Appendix C provides an illustrative updating man­
agement representation letter. [PCAOB Conforming Amendments to PCAOB 
Interim Standards Resulting from the Adoption of PCAOB Auditing Standard 
No. 2, "An Audit of Internal Control Over Financial Reporting Performed in Con­
junction With An Audit of Financial Statements" (AICPA, PCAOB Standards 
and Related Rules, AU sec. 333), amend SAS No. 85, as amended, to refer to 
PCAOB Auditing Standard No. 2 for additional representations required from 
management for an integrated audit.]
2.81 Auditors of governmental health care entities also should consider 
obtaining representations concerning the information provided in MD&A, as 
provided in SAS No. 52, Required Supplementary Information (AICPA, Profes­
sional Standards, vol. 1, AU sec. 558.07c).
2.82 Independent auditors of health care organizations also might obtain 
representations, if applicable, of the following:
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• The health care organization is in compliance with the provisions of 
Internal Revenue Code (IRC) sec. 501(c)(3) and is exempt from federal 
income tax under IRC sec. 501(a), as evidenced by a determination 
letter.
Information returns have been filed on a timely basis.
Provision has been made, when material, for estimated retroactive 
adjustments by third-party payors under reimbursement agreements. 
The health care organization is in compliance with bond indentures or 
other debt instruments.
Pending changes in the organizational structure, financing arrange­
ments, or other matters that could have a material effect on the finan­
cial statements of the entity are properly disclosed.
The health care organization is in compliance with contractual agree­
ments, grants, and donor restrictions.
The health care organization has maintained an appropriate composi­
tion of assets in amounts needed to comply with all donor restrictions. 
All assets and liabilities under the entity's control have been included 
in the financial statements.
The internal controls over the receipt and recording of contributions 
received are adequate.
Reclassifications between net asset classes is proper.
2.83 SOP 00-1 provides the following examples of specific representations 
for receivables, cost reports filed with third parties, and contingencies related 
to health care third-party revenue recognition:
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Receivables
Adequate consideration has been given to, and ap­
propriate provision made for, estimated adjustments 
to revenue, such as for denied claims and changes to 
diagnosis-related group (DRG) assignments. 
Recorded valuation allowances are necessary, appro­
priate, and properly supported.
All peer review organizations, fiscal intermediary, 
and third-party payor reports and information have 
been made available.
Cost reports filed with third parties
All required Medicare, Medicaid, and similar reports 
have been properly filed.
Management is responsible for the accuracy and pro­
priety of all cost reports filed.
All costs reflected on such reports are appropri­
ate and allowable under applicable reimbursement 
rules and regulations and are patient-related and 
properly allocated to applicable payors.
The reimbursement methodologies and principles 
employed are in accordance with applicable rules 
and regulations.
Adequate consideration has been given to, and ap­
propriate provision made for, audit adjustments by
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intermediaries, third-party payors, or other regula­
tory agencies.
-  All items required to be disclosed, including disputed 
costs that are being claimed to establish a basis for a 
subsequent appeal, have been fully disclosed in the 
cost report.
-  Recorded third-party settlements include differ­
ences between filed (and to be filed) cost reports and 
calculated settlements, which are necessary based 
on historical experience or new or ambiguous reg­
ulations that may be subject to differing interpre­
tations. While management believes the entity is 
entitled to all amounts claimed on the cost reports, 
management also believes the amounts of these dif­
ferences are appropriate.
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• Contingencies
— There are no violations or possible violations of laws 
or regulations, such as those related to the Medi­
care and Medicaid antifraud and abuse statutes, in­
cluding but not limited to the Medicare and Medi­
caid Anti-Kickback Statute, Limitations on Certain 
Physician Referrals (the Stark law), and the False 
Claims Act, in any jurisdiction, whose effects should 
be considered for disclosure in the financial state­
ments or as a basis for recording a loss contingency 
other than those disclosed or accrued in the financial 
statements.
— Billings to third-party payors comply in all material 
respects with applicable coding guidelines (for exam­
ple, ICD-9-CM and CPT-4) and laws and regulations 
(including those dealing with Medicare and Medi­
caid antifraud and abuse), and billings reflect only 
charges for goods and services that were medically 
necessary; properly approved by regulatory bodies 
(for example, the Food and Drug Administration), if 
required; and properly rendered.
— There have been no communications (oral or writ­
ten) from regulatory agencies, governmental repre­
sentatives, employees, or others concerning investi­
gations or allegations of noncompliance with laws 
and regulations in any jurisdiction (including those 
related to the Medicare and Medicaid antifraud and 
abuse statutes), deficiencies in financial reporting 
practices, or other matters that could have a mate­
rial adverse effect on the financial statements.
Single Audit Act and Related Audit Considerations
2.84 An independent auditor may be engaged to audit the financial state­
ments of a health care organization that expends federal awards from a gov­
ernmental agency in accordance with the Single Audit Act Amendments of
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1996 and Office of Management and Budget (0MB) Circular A-133, Audits of 
States, Local Governments, and Non-Profit Organizations. Federal awards may 
take the form of grants, contracts, loans, loan guarantees, property, cooperative 
agreements, interest subsidies, and insurance or direct appropriations.
2.85 0MB Circular A-133 prescribes policies, procedures, and guidelines 
to implement the Single Audit Act Amendments of 1996 and requires state 
and local governments and not-for-profit organizations that expend total fed­
eral awards equal to or in excess of $500,000 in a fiscal year to have an audit 
performed in accordance with the Act and 0MB Circular A-133.
2.86 Institutions covered by 0MB Circular A-133 include not-for-profit 
hospitals and public hospitals and institutions of higher education, and their 
affiliated hospitals, voluntary health and welfare organizations and other 
community-based organizations.4 Medicare payments to a non-federal entity 
for providing patient care services to Medicare eligible individuals are not con­
sidered federal awards expended under 0MB Circular A-133. Medicaid pay­
ments to a subrecipient for providing patient care services to Medicaid eligible 
individuals are not considered federal awards expended under 0MB Circular A- 
133 unless a state requires the funds to be treated as federal awards expended 
because reimbursement is on a cost-reimbursement basis.
2.87 0MB Circular A-110 establishes standard requirements (such as in­
surance, record retention, and banking) for obtaining consistency and unifor­
mity among federal agencies in the administration of grants to and agreements 
with public and private hospitals and other entities. 0MB Circular A-87, Cost 
Principles for State and Local Governments, establishes principles and stan­
dards for determining allowable costs incurred by state and local governments 
under grants, contracts, and other agreements. 0MB Circular A-21, Cost Prin­
ciples for Educational Institutions, and 0MB Circular A-122, Cost Principles 
for Nonprofit Organizations, establish principles and standards for determin­
ing allowable costs incurred by educational institutions and not-for-profit or­
ganizations under grants, contracts, and other agreements. Federal research 
and development awards under grants and contracts administered by hospi­
tals are exempt from OMB's cost principles circulars A-87, A-21 and A-122, 
but are subject to requirements provided in the U.S. Department of Health and 
Human Services regulations at 45 CFR part 74, Appendix E, "Principles for De­
termining Costs Applicable to Research and Development Under Grants and 
Contracts with Hospitals."
2.88 SAS No. 74, Compliance Auditing Considerations in Audits of Govern­
mental Entities and Recipients of Governmental Financial Assistance (AICPA, 
Professional Standards, vol. 1, AU sec. 801), provides general guidance for 
audits of governmental entities and entities that receive federal awards. The 
Statement explains the requirements of the financial audit standards contained 
in Government Auditing Standards, as amended (the Yellow Book) issued by 
the Comptroller General of the United States and their relationship to GAAS. *
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4 The Codification of Office of Management and Budget (0MB) Circular A-133 by the U.S. De­
partment of Health and Human Services also includes audit requirements for commercial organi­
zations (including for-profit hospitals) that receive federal awards under HHS programs. Generally, 
the organization has two options regarding audits: (1) a financial-related audit of a particular award 
in accordance with Government Auditing Standards, or (2) an audit that meets the requirements of 
0MB Circular A-133. See title 45 of the Code of Federal Regulations (CFR) section 74.26(d) for further 
information.
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It also provides general guidance on testing compliance with requirements ap­
plicable to federal awards. The Statement clarifies that the entity, rather than 
the independent auditor, is responsible for arranging for audits that meet all 
applicable requirements and provides guidance on communications the auditor 
should make upon becoming aware that the entity may be subject to an audit 
requirement that may not be satisfied by his or her engagement.
2.89 The Audit Guide Government Auditing Standards and Circular A- 
133 Audits, provides guidance on the auditor's responsibilities when conducting 
a single audit or program-specific audit in accordance with the Single Audit Act 
Amendments of 1996 and 0MB Circular A-133. It discusses the auditor's re­
sponsibility for considering internal control and for performing tests of compli­
ance with applicable laws, regulations, and program compliance requirements. 
Further, it provides reporting guidance including examples of the reports re­
quired by Government Auditing Standards and 0MB Circular A-133.
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Statutory Reporting Considerations for Managed 
Care Organizations
Risk-based Capital Requirements
2.90 Many managed care organizations (MCO) that bear financial risk 
are regulated by state departments of insurance. The risk-based capital (RBC) 
formula is one of the tools used by regulators to evaluate the financial health 
of regulated entities.
2.91 The National Association of Insurance Commissioners (NAIC) for­
mula for the RBC of managed care organizations became effective in the filing 
of 1998 annual statements. Five principal risk elements to the MCO RBC for­
mula are: affiliated investment risk, asset risk, underwriting risk, credit risk, 
and general business risk. Four action levels (in order of increasingly stringent 
level of regulatory response) are: company action level, regulatory action level, 
authorized control level, and mandatory control level. At a minimum, the com­
pany action-level event requires the filing with the respective state insurance 
commissioner an RBC plan detailing conditions leading to the event and pro­
posals of corrective action. State laws vary as to whether applicable legislation 
pertaining to compliance with the RBC formula has been passed. Additional 
information can be found on the NAIC Web site at www.naic.org.
Codification of Statutory Accounting Practices for M anaged  
C are  O rganizations
2.92 Generally speaking, regulated insurers have been required by their 
state of domicile to submit annually a set of audited financial statements that 
were prepared using that state's prescribed or permitted statutory accounting 
practices. These statutory accounting practices are considered to be an "other 
comprehensive basis of accounting" (OCBOA) under SAS No. 62, Special Re­
ports (AICPA, Professional Standards, vol. 1, AU sec. 623). Auditing Interpre­
tation No. 12, "Evaluation of the Appropriateness of Informative Disclosures in 
Insurance Enterprises' Financial Statements Prepared on a Statutory Basis," of 
SAS No. 62 (AICPA, Professional Standards, vol. 1, AU sec. 9623.60-.77), pro­
vides guidance in evaluating the adequacy and appropriateness of informative 
disclosures in financial statements prepared on a statutory basis.
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2.93 In 1999, the NAIC completed a process to codify statutory accounting 
practices for certain insurance entities (including regulated MCO), resulting in 
a revised Accounting Practices and Procedures Manual effective January 1, 
2001 (the "revised Manual"). This Manual has also been updated on an an­
nual basis and a new Accounting Practices and Procedure Manual (Manual) 
reflecting revisions or additions to SAP is published in March of each year. It is 
expected that most states will require insurers to comply with most, if not all, 
provisions of the Manual. States may adopt the Manual in whole, or in part, 
as an element of prescribed statutory accounting practices in those states. If, 
however, the requirements of state laws, regulations, and administrative rules 
differ from guidance provided in the Manual or those state laws, regulations, 
and administrative rules will take precedence. Preparers of financial state­
ments and auditors should monitor the status of the adoption of the Manual by 
the domiciliary state insurance regulatory authority.
2.94 Practitioners should consider whether going-concern issues exist as a 
result of the financial statement effect of adoption. This includes consideration 
of the effect on RBC.
2.95 Nine of the Statements of Statutory Accounting Principles (SSAPs) 
included in the revised Manual have been specifically modified or written to ad­
dress issues related to managed care. These include SSAP No. 25, Accounting 
for and Disclosures about Transactions with Affiliates and Other Related Par­
ties, No. 35, Guaranty Fund and Other Assessments, No. 47, Uninsured Plans, 
No. 50, Classifications and Definitions of Insurance or Managed Care Contracts 
in Force, No. 54, Individual and Group Accident and Health Contracts, No. 55, 
Unpaid Claims, Losses and Loss Adjustment Expenses, No. 66, Retrospectively 
Rated Contracts, No. 73, Health Care Delivery Assets-Supplies, Pharmaceuti­
cals and Surgical Supplies, Durable Medical Equipment, Furniture, Medical 
Equipment and Fixtures, and Leasehold Improvements in Health Care Facili­
ties and SSAP No. 84, Certain Health Care Receivables and Receivables Under 
Government Insured Plans. All other SSAPs will apply if applicable to the entity.
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Chapter 3
Cash and Cash Equivalents
Accounting and Financial Reporting
3.01 Cash and cash equivalents should include all cash and highly liquid 
investments that are both (a) readily convertible to cash and (b) so near to matu­
rity that they present insignificant risk of changes in value because of changes 
in interest rates, in accordance with paragraph 8 of FASB Statement No. 95, 
Statement of Cash Flows, and paragraph 9 of GASB Statement No. 9, Reporting 
Cash Flows of Proprietary and Nonexpendable Trust Funds and Governmental 
Entities That Use Proprietary Fund Accounting. For fiduciary purposes, sepa­
rate checking or savings accounts may be maintained for restricted donations. 
Such accounts, however, are not reported on a line separate from other cash 
and cash equivalents because donor restrictions generally relate to limitations 
on the use of net assets rather than on the use of specific assets.1 However, 
cash and claims to cash that (a) are restricted as to withdrawal or use for other 
than current operations, (b) are designated for expenditure in the acquisition 
or construction of noncurrent assets, (c) are required to be segregated for the 
liquidation of long-term debts, or (d) are required by a donor-imposed restric­
tion that limits their use to long-term purposes are reported separately and 
are excluded from current assets. (See paragraph 10.11.) Internally designated 
funds should be reported separately from externally designated funds either on 
the face of the balance sheet or in the notes to the financial statements. If the 
form of the assets is not evident from the description on the balance sheet, the 
form of the assets should be disclosed in the notes to the financial statements. 
GASB Statement No. 9, paragraph 8, provides that a governmental health care 
enterprise's statement of cash fl ows should explain the change in all cash and 
cash equivalents, regardless of any restrictions on their use. For governmental 
health care entities, restricted cash and cash equivalents should be reported 
when restrictions on the use of those assets change the nature or normal un­
derstanding of those assets, as discussed in GASB Statement No. 34, Basic 
Financial Statements—and Management's Discussion and Analysis—for State 
and Local Governments, paragraph 99. For example, cash and investments 
that can only be used to pay debt principal and interest would be reported as 
restricted cash and investments or as cash and investments held by trustee for 
debt service. The term restricted is defined by GASB Statement No. 34, para­
graphs 34, as amended,*  and 99. A restriction is a constraint placed on the use 
of assets or net assets that is either externally imposed (such as by creditors 
through debt covenants) or imposed by law through constitutional provisions 
or enabling legislation.
1 A columnar presentation that highlights the three classes of net assets (that is, permanently 
restricted, temporarily restricted, and unrestricted) is not precluded if the totals for the reporting 
entity as a whole are displayed.
* GASB Statement No. 46, Net Assets Restricted by Enabling Legislation, amends paragraph 34 of 
GASB Statement No. 34, Basic Financial Statements—and Management's Discussion and Analysis— 
for State and Local Governments, effective for financial statements for periods beginning after June 
15, 2005. Earlier application is encouraged.
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Agency Funds
3.02 Health care organizations may receive and hold assets owned by oth­
ers under agency relationships; for example, they may perform billing and col­
lection services for physicians. In accepting responsibility for those assets, an 
organization incurs a liability to the principal under the agency relationship 
to return the assets in the future or, if authorized, to disburse them to another 
party on behalf of the principal. Such agency funds are reported as unrestricted 
assets.
3.03 In other cases, not-for-profit health care organizations may act as 
agents, trustees, or intermediaries helping donors to make a contribution to 
another entity or individual. When acting in that capacity, those organizations 
do not receive a contribution when they receive the assets, nor do they make a 
contribution when they disburse the assets to the other entity or individual. In­
stead, they act as go-betweens, passing the assets from the donor through their 
organization to the specified entity or individual. FASB Statement No. 136, 
Transfers of Assets to a Not-for-Profit Organization or Charitable Trust That 
Raises or Holds Contributions for Others,2 establishes standards for transac­
tions in which a donor makes a contribution by transferring assets to a re­
cipient organization—a not-for-profit organization or a charitable trust—that 
accepts the assets from the donor and agrees to use the assets on behalf of 
or transfer the assets, their investment return, or both to another entity—the 
beneficiary—named by the donor.3 In general, if a donor specifies a beneficiary, 
the recipient organization should not recognize a contribution. (For exceptions, 
see the discussion of variance power at paragraph 10.05 in this Guide and fi­
nancially interrelated organizations at paragraphs 11.29 through 11.33 in this 
Guide.) Instead, as discussed in paragraph 11 of FASB Statement No. 136, the 
recipient organization should recognize its liability to the specified beneficiary 
concurrent with its recognition of cash or other financial assets received from 
the donor. Both the asset and the liability recognized should be measured at 
the fair value of the assets received. If the assets received from the donor are 
donated materials, supplies, or other nonfinancial assets, the recipient orga­
nization may choose either to (a) report the receipt of the assets as a liability 
to the beneficiary concurrent with recognition of the assets received or (b) not 
report the transaction at all. The choice is an accounting policy that should be 
applied consistently from period to period. An entity should consider the need 
for disclosure in the notes to the financial statements pursuant to APB Opinion 
No. 22, Disclosure of Accounting Policies, and paragraph 11 of FASB Statement 
No. 136. Standards for not-for-profit organizations that act as agents, trustees, 
or intermediaries are described further in Chapters 5 and 6 of the Audit and 
Accounting Guide Not-for-Profit Organizations.
2 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1 
in Chapter 1.)
3 FASB Statement No. 136 also establishes standards for transactions that take place in a similar 
manner but are not contributions because the transfers are revocable, repayable, or reciprocal. For 
example, if a resource provider transfers assets to a recipient organization and names itself or its 
affiliate as beneficiary, that transaction is reciprocal even if the resource provider grants variance 
power. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.21, 11.23 and 
11.24 in this Guide. This Guide does not use the word donor in discussing those transactions because 
they are not contributions.
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Disclosures
3.04 If the provider has concentrations of credit risk related to financial in­
struments such as certificates of deposit or money market mutual funds, the dis­
closure requirements of FASB Statement No. 107, Disclosures about Fair Value 
of Financial Instruments, as amended by FASB Statement No. Accounting
for Derivative Instruments and Hedging Activities,4 should be followed. Exam­
ples of potential exposure to credit risk include funds deposited with a single 
financial institution in excess of Federal Deposit Insurance Corporation (FDIC) 
limits and investments in obligations that are not insured or guaranteed by 
the government. For governmental health care enterprises, GASB Statement 
No. 3, Deposits with Financial Institutions, Investments (including Repurchase 
Agreements), and Reverse Repurchase Agreements, as amended, requires cer­
tain disclosures about deposits, including deposits exposed to custodial credit 
risk.
Auditing
3.05 There are no unique auditing considerations with respect to cash and 
cash equivalents recorded by health care organizations. *
4 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in 
Chapter 1.)
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Chapter 4 
Investments
Accountin g
4.01 This chapter discusses the accounting and reporting for investments 
of health care entities other than (a) equity investments accounted for under 
the equity method or (b) investments in consolidated subsidiaries. Discussions 
pertaining to those two types of investments are included in Chapter 11. In 
some cases, nongovernmental health care organizations may transfer assets to 
a not-for-profit organization (such as a community foundation or a financially 
interrelated organization) or a trust for investment and management. Para­
graphs 4.14 and 4.15 discuss a nongovernmental health care organization's 
reporting of investments held on its behalf by unrelated foundations and trusts 
or by related organizations that are not financially interrelated. Paragraphs
11.21 through 11.24 and 11.29 through 11.33 discuss the reporting by a non­
governmental health care organization of investments held on its behalf by 
financially interrelated organizations.
4.02 The accounting for investments in equity securities that have readily 
determinable fair values and all investments in debt securities is discussed in 
paragraphs 4.03 through 4.13. Other types of investments that are not financial 
instruments (such as real estate or certain oil and gas interests) are reported 
at amortized cost and are subject to impairment considerations consistent with 
FASB Statement No. 144, Accounting for the Impairment or Disposal of Long- 
Lived Assets.1 Appendix A to this chapter discusses Emerging Issues Task Force 
(EITF) consensus opinion guidance for equity securities whose fair value is not 
readily determinable.
Investments in Debt Securities and Certain Equity Securities
4.03 This section discusses the accounting and reporting for investments 
in equity securities that have readily determinable fair values* and all invest­
ments in debt securities held by (a) investor-owned entities, (b) not-for-profit 
organizations, and (c) governmental entities.
Investor-Owned Entities
4.04 Investor-owned providers are subject to the accounting and reporting 
requirements of FASB Statement No. 116, Accounting for Certain Investments 
in Debt and Equity Securities. FASB Statement No. 115 defines three categories 
into which an enterprise classifies investments. The accounting and reporting 
differ by category. Investments in debt securities that the enterprise has the 
positive intent and ability to hold to maturity are classified as held-to-maturity 
securities and are reported at amortized cost. Debt and equity securities that
1 This prouncement is not applicable to governmental health care enterprises that do not apply 
paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary Funds 
and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in Chapter 1.)
* The FASB has released an exposure draft of a proposed FASB Statement, Fair Value Measure­
ments, that would provide guidance on how to measure fair value, require certain disclosures, and 
amend certain pronouncements discussed in this chapter. Readers should be alert to the issuance of 
a final standard.
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are bought and held principally for the purpose of selling them in the near 
term are classified as trading securities and reported at fair value, with un­
realized holding gains and losses included in income. However, an enterprise 
is not precluded from classifying at acquisition a security it plans to hold for 
a longer period as a trading security. Investments in debt securities that are 
not classified as held-to-maturity or trading and equity securities that are not 
classified as trading are classified as available-for-sale securities and reported 
at fair value, with unrealized holding gains and losses excluded from income 
and reported in a separate component of other comprehensive income until 
realized, except all or a portion of the unrealized holding gain and loss of an 
available-for-sale security that is designated as being hedged in a fair value 
hedge shall be recognized in earnings during the period of the hedge.2
4.05 Investor-owned entities should follow the disclosure requirements of 
FASB Statement No. 115, as amended by FASB Statement No. Accounting 
for Derivative Instruments and Hedging Activities.3
Not-for-Profit Organizations
4.06 Not-for-profit organizations should report investments in equity se­
curities with readily determinable fair values and all debt securities at fair 
value on the balance sheet consistent with FASB Statement No. 124, Account­
ing for Certain Investments Held by Not-for-Profit Organizations. FASB State­
ment No. 124 does not apply to investments in derivative instruments that 
are subject to the requirements of FASB Statement No. 133. FASB Statement 
No. 133 establishes accounting and reporting standards for derivative instru­
ments, including certain derivative instruments embedded in other contracts 
and for hedging activities. Investment return, including realized and unreal­
ized gains and losses, should be included as changes in net assets consistent 
with paragraphs 4.07 through 4.10.
4.07 Investment return (including realized and unrealized gains and 
losses) not restricted by donors or by law should be classified as changes in 
unrestricted net assets as follows:
a. Included in the performance indicator (see paragraphs 10.19 and
10.20 ):
•  Dividend, interest, and other similar investment income
2 Emerging Issues Task Force (EITF) Issue No. 03-1, "The Meaning of Other-Than-Temporary 
Impairment and Its Application to Certain Investments," provides guidance to determine when an 
investment is considered impaired, whether that impairment is other-than-temporary, and the mea­
surement of an impairment loss. EITF Issue No. 03-1 also provides guidance regarding accounting 
considerations subsequent to the recognition of an other-than-temporary impairment, and requires 
certain disclosures about unrealized losses that have not been recognized as other-than-temporary im­
pairments. EITF No. 03-1 applies to debt and equity securities within the scope of FASB Statement No. 
115, Accounting for Certain Investments in Debt and Equity Securities, and FASB Statement No. 124, 
Accounting for Certain Investments Held by Not-for-Profit Organizations, (applicable to investments 
held by a not-for-profit health care organization in the scope of this Guide). See EITF Issue No. 03-1 for 
further information regarding investments within the scope of this Issue. The recognition and mea­
surement guidance is effective for reporting periods beginning after June 15, 2004. However, FASB 
Staff Position (FSP) EITF Issue No. 03-1-1, Effective Date of Paragraphs 10-20 of EITF Issue No. 03-1, 
The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments, de­
lays the effective date for implementing the measurement and recognition guidance in paragraphs 
10-20 of EITF Issue No. 03-1, until the final issuance of FSP EITF 03-1-a, Implementation Guidance 
for the Application of Paragraph 16 of EITF Issue No. 03-1, The Meaning of Other-Than-Temporary 
Impairment and Its Application to Certain Investments. Readers should be alert to the issuance of a 
final FSP. The disclosure guidance of EITF Issue No. 03-1 remains effective.
3 See footnote 2 in paragraph 4.04.
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•  Realized gains and losses
•  Unrealized gains and losses on trading securities4
•  Other than temporary impairment losses5
b. Excluded from the performance indicator:
•  Unrealized gains and losses on other than trading securities
4.08 Except as described in paragraphs 4.09 and 4.10, investment return 
(including realized and unrealized gains and losses) restricted by donors or by 
law, should be classified as changes in temporarily or permanently restricted 
net assets consistent with the applicable restrictions.
4.09 Gains and investment income that are limited to specific uses by 
donor-imposed restrictions may be reported as increases in unrestricted net 
assets if the restrictions are met in the same reporting period as the gains 
and income are recognized, provided that the organization has a similar policy 
for reporting contributions received, applies the policy consistently from period 
to period, and discloses its accounting policy. The classification of these gains 
and investment income in unrestricted net assets should be consistent with 
paragraph 4.07.
4.10 In the absence of donor stipulations or law to the contrary, losses on 
the investments of a donor-restricted endowment fund6 shall reduce temporar­
ily restricted net assets to the extent that donor-imposed temporary restrictions 
on net appreciation of the fund have not been met before the loss occurs. Any 
remaining loss shall reduce unrestricted net assets and shall be excluded from 
the determination of the performance indicator. If losses reduce the assets of a 
donor-restricted endowment fund below the level required by the donor stipula­
tions or law, gains that restore the fair value of the assets of the endowment fund 
to the required level shall be classified as increases in unrestricted net assets 
and shall be excluded from the determination of the performance indicator.
4.11 Not-for-profit organizations should follow the disclosure requirements 
of FASB Statement No. 124.7
Governmental Entities
4.12 Governmental health care entities are subject to the accounting and 
reporting requirements of GASB Statement No. 31, Accounting and Finan­
cial Reporting for Certain Investments and for External Investment Pools. Gov­
ernmental health care entities should report investments in (a) participating 
interest-earning investment contracts, (b) external investment pools, (c) open- 
ended mutual funds, (d) debt securities, and (e) equity securities, option con­
tracts, stock warrants, and stock rights that have readily determinable fair
Trading securities are defined in FASB Statement No. 115, including any interpretations 
thereof.
5 See footnote 2 in paragraph 4.04.
6 Donors that create endowment funds can require that their gifts be invested in perpetuity or 
for a specified term. Some donors may require that a portion of income, gains, or both be added to the 
gift and invested subject to similar restrictions. It is generally understood that at least the amount 
of the original gift(s) and any required accumulations are not expendable, although the value of the 
investments purchased may occasionally fall below that amount. Future appreciation of the invest­
ments generally restores the value to the required level. In states that have enacted its provisions, 
the Uniform Management of Institutional Funds Act describes "historic dollar value" as the amount 
that is not expendable.
7 See footnote 2 in paragraph 4.04.
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values at fair value on the balance sheet. Governmental entities are permitted 
to report certain money market investments and participating interest-earning 
investment contracts at amortized cost, provided that the investment has a re­
maining maturity of one year or less at time of purchase. All investment income, 
including changes in the fair value of investments, shall be recognized as rev­
enue in the statement of revenues, expenses, and changes in net assets/equity. 
Governmental health care entities are required to distinguish between oper­
ating revenues and expenses and nonoperating revenues and expenses. (See 
further discussion in paragraph 10.24 of this Guide.) Governmental health 
care entities should follow the disclosure requirements of GASB Statement 
No. 31. Also, GASB Statement No. 34, paragraph 121, requires that govern­
mental health care entities that receive donor-restricted endowments make 
certain disclosures about their use of investment income generated by those 
endowments.
4.13 GASB Statements No. 3, Deposits with Financial Institutions, In­
vestments (Including Repurchase Agreements), and Reverse Repurchase Agree­
ments, No. 28, Accounting and Financial Reporting for Securities Lending 
Transactions, and No. 40, Deposit and Investment Risk Disclosures, and GASB 
Interpretation No. 3, Financial Reporting for Reverse Repurchase Agreements, 
provide guidance on investment-related disclosures required by governmental 
entities as well as accounting for securities lending and reverse repurchase 
agreements.
Transfers of Assets to a  No- for-Profit O rganization or Charitable  
Trust for Investment
4.14 If a nongovernmental health care organization transfers assets to a 
not-for-profit organization or charitable trust (called a recipient organization) 
that accepts those assets and agrees to use them on behalf of or transfer them, 
their investment return, or both back to the health care organization or its 
affiliate, the transfer is reciprocal and thus is not a contribution (see para­
graphs 4,17 and 18 of FASB Statement No. 136, Transfers of Assets to a Not-for- 
Profit Organization or Charitable Trust That Raises or Holds Contributions for 
Others).8 Examples of that type of reciprocal transfer include (a) a nongovern­
mental health care organization transfers assets to a community foundation to 
establish an endowment for the benefit of the nongovernmental health care or­
ganization (or its affiliate) and (6) a nongovernmental health care organization 
transfers assets to a foundation it creates to hold those assets. Paragraphs 17 
and 18 of FASB Statement No. 136 describe two types of reciprocal transfers, 
which are:
•  An equity transaction—The nongovernmental health care organiza­
tion (a) specifies itself or its affiliate as the beneficiary, (b) the health 
care organization and the recipient organization are financially inter­
related organizations (paragraph 11.22 discusses financially interre­
lated organizations), and (c) neither the health care organization nor 
its affiliate expects payment of the transferred assets, although pay­
ment of investment return on the transferred assets may be expected. 
(All three criteria must be met.)
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in Chapter 1).
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•  The nongovernmental health care organization specifies itself or its 
affiliate as the beneficiary and the transfer is not an equity transaction. 
(The three criteria (a), (b), and (c) in the previous bullet are not met.)
4.15 If the reciprocal transaction is not an equity transaction, the non­
governmental health care organization reports an asset, in exchange for the 
assets transferred, as discussed in paragraph 17 of FASB Statement No. 136. 
(Accounting for equity transactions is discussed in paragraphs 11.21 through
11.24 of this Guide.) The nongovernmental health care organization should dis­
close the following information for each period for which a statement of finan­
cial position is presented, in accordance with paragraph 19 of FASB Statement 
No. 136;
•  The identity of the recipient organization to which the transfer was 
made
•  Whether variance power was granted to the recipient organization 
and, if so, a description of the terms of the variance power9
•  The terms under which amounts will be distributed to the health care 
organization or its affiliate
•  The aggregate amount recognized in the statement of financial position 
for those transfers and whether that amount is recorded as an interest 
in the net assets of the recipient organization or as another asset (for 
example, as a beneficial interest in assets held by others or a refundable 
advance).
Financial Statement Presentation
Entities Subject to FASB Statement No. 115, FASB Statement 
No. 124, or G A SB Statement No. 31
4.16 Securities should be reported as either current or noncurrent, as ap­
propriate, under the provisions of ARB No. 43, Restatement and Revision of 
Accounting Research Bulletins, Chapter 3A.10
4.17 For cash flow reporting purposes by nongovernmental entities, pur­
chases, sales, and maturities of trading securities should be classified as cash 
flows from operating activities; governmental entities should classify these 
items as investing activities. Cash flows from purchases, sales, and maturities 
of all other securities should be classified as cash flows from investing activities.
9 Because of their reciprocal nature, those tranfers were presumed by the FASB not to he contri­
butions received or made—even if the health care organization granted variance of power at the time 
of transfer. See paragraph 96 of FASB Statement No. 136.
10 Chapter 3A of ARB No. 43 indicates in paragraph 4 that "the term current assets is used to 
designate cash and other assets or resources commonly identified as those which are reasonably ex­
pected to be realized in cash or sold or consumed during the normal operating cycle of the business.” 
That paragraph further indicates that the term also comprehends "marketable securities represent­
ing the investment of cash available for current operations." Paragraph 5 indicates that "a one-year 
time period is to be used as a basis for the segregation of current assets in cases where there are 
several operating cycles occurring within a year." Paragraph 6 says that the "concept of the nature of 
current assets contemplates the exclusion from that classification of. . .  cash and claims to cash which 
are restricted as to withdrawal or use for other than current operations, are designated for expendi­
ture in the acquisition or construction of noncurrent assets, or are segregated for the liquidation of 
long-term debts." Cash and cash equivalents of permanent endowment funds held temporarily until 
suitable long-term investment opportunities are identified are included in the classification "long-term 
investments."
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If investments in debt securities are reported as cash equivalents in accordance 
with FASB Statement No. 95, Statement of Cash Flows, or GASB Statement 
No. 9, Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds 
and Governmental Entities That Use Proprietary Fund Accounting, the notes 
to the financial statements should reconcile the reporting classifications used 
in the statement of financial position.
4.18 All health care organizations with investments that meet the defini­
tion of financial instruments set forth in FASB Statement No. 107 are subject 
to the disclosure requirements of FASB Statement No. 107, Disclosures about 
Fair Value of Financial Instruments.11  Organizations with derivative instru­
ments that meet the definition of derivative instruments set forth in FASB 
Statement No. 133, as amended by FASB Statement No. 149, Amendment of 
Statement 133 on Derivative Instruments and Hedging Activities, are subject to 
the disclosure requirements in FASB Statement No. 133.12 SOP 02-2, Account­
ing for Derivative Instruments and Hedging Activities by Not-for-Profit Health 
Care Organizations and Clarification of the Performance Indicator, requires 
that not-for-profit health care organizations that are within the scope of this 
Guide provide disclosures that are analogous to those required by paragraph 
45 of FASB Statement No. 133 for for-profit enterprises, including the disclo­
sure of anticipated reclassifications into the performance indicator of gains and 
losses that have been excluded from that measure and reported in accumulated 
derivative gain or loss as of the reporting date. SOP 02-2 does not apply to gov­
ernmental entities that are within the scope of this Guide. SOP 02-2 is included 
as Appendix F to this Guide.
4.19 Governmental health care entities are also required to disclose infor­
mation about their investments in accordance with GASB Statements No. 3, 
No. 28, No. 31, and No. 40, and GASB Technical Bulletin No. 87-1, Applying 
Paragraph 68 of GASB Statement No. 3, No. 2003-1, Disclosure Requirements 
for Derivatives Not Reported at Fair Value on the Statement of Net Assets,† 
No. 97-1, Classifications of Deposits and Investments into Custodial Credit Risk 
Categories for Certain Bank Holding Company Transactions, and GASB Inter­
pretation No. 3. Among the required disclosures are the following:
•  The types of investments authorized by legal or contractual provisions 
(GASB Statement No. 3, paragraph 65, as amended)
•  Investment policies related to the risks that GASB Statement No. 40 
requires to be disclosed. (If a government has no investment policy 
that addresses a specific type of risk that it is exposed to, the disclosure 
should indicate that fact.) (GASB Statement No. 40, paragraph 6)
•  Significant violations during the period of legal or contractual provi­
sions for investments, and the actions taken to address such violations 
(GASB Statements No. 3, paragraph 66, and No. 38, paragraph 9)
•  The accounting methods for investments (GASB Statement No. 31, 
paragraph 15)
78 Health Care Organizations
1 Disclosures about the fair value of financial instruments prescribed in FASB Statement No. 
107 are optional for an entity that meets the criteria of FASB Statement No. 126, Exemption from 
Certain Required Disclosures about Financial Instruments for Certain Nonpublic Entities, as amended 
by FASB Statement No. Accounting for Derivative Instruments and Hedging Activities, and FASB
Statement No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging Activities.
12 FASB Statements No. 107 and No. 133 are not applicable to governmental health care enter­
prises that do not apply paragraph 7 of GASB Statement No. 20. (See footnote 1 in Chapter 1.)
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•  The credit quality ratings of investments in debt securities as de­
scribed by nationally recognized statistical rating organizations— 
rating agencies—as of the date of the financial statements (This dis­
closure does not apply to investments issued or explicitly guaranteed 
by the U.S. government, but it does apply to investments in external 
investment pools, money market funds, bond mutual funds, and other 
pooled investments of fixed-income securities. If a credit quality disclo­
sure is required and the investment is unrated, the disclosure should 
indicate that fact.) (GASB Statement No. 40, paragraph 7)
•  For investment securities, including securities underlying repurchase 
agreements, at the end of the period that are exposed to custodial 
credit risk, the investment's type, the reported amount, and how the 
investments are held (This disclosure does not apply to investments 
in external investment pools and in open-end mutual funds or to secu­
rities underlying reverse repurchase agreements.) (GASB Statement 
No. 40, paragraph 9)
•  Investments in any one issuer, by amount and issuer, that represent 
5 percent or more of total investments (This disclosure does not apply 
to investments issued or explicitly guaranteed by the U.S. government 
or investments in mutual funds, external investment pools, or other 
pooled investments. (GASB Statement No. 40, paragraph 11)
•  Information about interest rate risk using one of the five methods listed 
in GASB Statement No. 40 (If a method requires an assumption re­
garding timing of cash fl ows, interest rate changes, or other factors that 
affect interest rate information, that assumption should be disclosed. 
This disclosure does apply to investments in mutual funds, external 
investment pools, or other pooled investments that do not meet the 
definition of a 2a7-like pool.) (GASB Statement No. 40, paragraphs 14 
and 15)
•  The terms of investments with fair values that are highly sensitive 
to changes in interest rates to the extent investment terms are not 
considered in the interest rate risk disclosure requirements of GASB 
Statement No. 40, paragraph 15 (GASB Statement No. 40, paragraphs 
14 and 16)
•  Certain information about investments in external investment pools 
(GASB Statement No. 31, paragraph 15)
4.20 The following example illustrates the accounting treatment and finan­
cial statement presentation for other-than-trading securities of a not-for-profit 
health care organization:
Facts
Other than trading securities are purchased in year 1 at a cost of $100. At the 
end of year 1, the fair value of the securities is $300. In year 2, the securities 
are sold for $400.
Journal Entries
•  Entry at the end of year 1 to adjust the recorded value of the securities 
to fair value:
Valuation allowance 200
Change in net unrealized gains and losses on investments 200
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•  Entry at the end of year 2 to record the sale of the securities:
Cash
Realized gain 
Investments
Change in net unrealized gains and losses on investments 
Valuation allowance
400
200
300
100
200
As discussed in paragraph 4.07, unrealized gains and losses on other than 
trading securities are reported in the statement of operations below the perfor­
mance indicator and realized gains and losses are reported in the statement of 
operations above the performance indicator.
Auditing
Note: In referring to AICPA professional standards (GAAS), this chapter cites 
the applicable sections of the AICPA Professional Standards publication. In 
referring to Public Company Accounting Oversight Board (PCAOB) profes­
sional standards, this chapter cites the applicable sections of the AICPA's 
publication titled PCAOB Standards and Related Rules. In those cases in 
which the auditing standards of the AICPA and those of the PCAOB are the 
same, this chapter cites the applicable section of the AI CPA Professional Stan­
dards publication only.
4.21 Auditing objectives and procedures for investments of health care 
organizations generally are similar to those of other organizations. SAS No. 
92, Auditing Derivative Instruments, Hedging Activities, and Investments in 
Securities (AICPA, Professional Standards, vol. 1, AU sec. 332), among other 
matters, provides guidance to auditors in planning and performing auditing 
procedures for assertions about investments in securities that are made in an 
entity’s financial statements. The guidance in SAS No. 92 applies to all debt 
and equity securities. SAS No. 92 uses the definitions of debt security and eq­
uity security that are in FASB Statement No. 115, but applies to debt and 
equity securities without regard to whether they are subject to the require­
ments of FASB Statement No. 115, such as, for example, assertions about se­
curities accounted for under the equity method following the requirements of 
APB Opinion No. 18, The Equity Method of Accounting for Investments in Com­
mon Stock. [PCAOB Conforming Amendments to PCAOB Interim Standards 
Resulting from the Adoption of PCAOB Auditing Standard No. 2, "An Audit of 
Internal Control Over Financial Reporting Performed in Conjunction With An 
Audit of Financial Statements" (AICPA, PCAOB Standards and Related Rules, 
AU sec. 332), amend SAS No. 92 to refer to PCAOB Auditing Standard No. 2 for 
further guidance for an integrated audit.] A companion Audit Guide Auditing 
Derivative Instruments, Hedging Activities, and Investments in Securities, pro­
vides practical guidance for implementing SAS No. 92. Auditing Interpretation 
No. 1, "Auditing Investments in Securities Where a Readily Determinable Fair 
Value Does Not Exist" of SAS No. 92 (AICPA, Professional Standards, vol. 1, AU 
sec. 9332.01-.04),† provides guidance for auditors of nonissuers regarding the
† The Interpretation was issued in the third quarter of 2005.
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adequacy of audit evidence with respect to the existence and valuation asser­
tions in SAS No. 92, in confirmations received from third parties when auditing 
investments in securities where a readily determinable fair value does not ex­
ist, and the auditor determines auditing procedures should include verifying 
the existence and testing the measurement of the investments. In addition, the 
independent auditor may need to consider the examples of specific auditing ob­
jectives, selected control activities, and auditing procedures that are presented 
in Exhibit 4-1.
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Exhibit 4-1
Health Care Organizations
Auditing Considerations
Financial Statement Specific Auditing 
Assertions Objectives
Existence and 
completeness; 
rights and 
obligations; and 
valuation
Marketable 
securities are 
fairly stated, 
properly 
classified, 
described, and 
disclosed.
Selected Control 
Activities
An independent 
trustee manages 
the investments. 
The trustee's 
reports are 
reviewed by a 
responsible 
employee.
Auditing
Procedures
Verify existence
through
confirmation.
Test the valuation 
of equity and debt 
securities not 
intended to be held 
to maturity by 
comparing the 
recorded values 
with the fair 
market values 
reported by the 
trustee or another 
independent source. 
For fair value 
estimates obtained 
from third-party 
sources, the auditor 
should consider the 
applicability of the 
guidance in SAS 
No. 73, Using the 
Work of a Specialist 
(AICPA, 
Professional 
Standards, vol. 1, 
AU sec. 336), or 
SAS No. 70, Service 
Organizations 
(AICPA, 
Professional 
Standards, vol. 1, 
AU sec. 324). 
[PCAOB 
Conforming 
Amendments to 
PCAOB Interim 
Standards 
Resulting from the 
Adoption of PCAOB 
Auditing Standard 
No. 2, "An Audit of 
Internal Control 
Over Financial 
Reporting 
Performed in
AAG-HCO 4.21
Investments 83
Financial Statement Specific Auditing 
Assertions Objectives
Selected Control 
Activities
Auditing
Procedures
Valuation, rights, 
and obligations
Accuracy and 
completeness
Presentation and 
disclosure
Endowment 
funds are 
properly stated 
at their required 
value and 
related gains 
and losses are 
properly 
classified.
Investment 
income and 
gains/losses are 
recorded in 
accordance with 
donor
restrictions.
Securities are
properly
classified.
Value of 
endowment 
funds are 
reviewed 
periodically to 
ensure that the 
balance is at its 
required level.
Review of 
investment 
transactions to 
ensure they are 
recorded in 
compliance with 
donor
restrictions.
Classification is 
monitored 
periodically and 
is based on 
management's 
intent or ability 
to dispose of 
excess funds 
that are 
available for 
operations 
within an 
operating cycle.
Conjunction With 
An Audit of 
Financial 
Statements" 
(AICPA, PCAOB 
Standards and 
Related Rules, AU 
sec. 324), amend 
SAS No. 70, as 
amended, for an 
integrated audit.]1
Verified that value 
of endowments are 
at required levels 
through 
confirmation.
Review treatment 
of gains and losses 
on endowment 
funds to ensure that 
they are properly 
classified.
Test the recording 
of selected 
transactions to 
ensure amounts are 
properly classified 
in accordance with 
donor restrictions.
(continued)
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1 Paragraphs 35 through 46 of SAS No. 92, Auditing Derivative Instruments, 
Hedging Activities, and Investments in Securities (AICPA, Professional Stan­
dards, vol. 1, AU sec. 332.35—.46), and paragraphs 6.16 through 6.38 in the com­
panion Audit Guide Auditing Derivative Instruments, Hedging Activities, and 
Investments in Securities, provide guidance to auditors on audit evidence that 
may be used to support assertions about the fair value of securities. That guid­
ance should be considered in the context of specific accounting requirements. 
SAS No. 101, Auditing Fair Value Measurements and Disclosures (AICPA, Pro­
fessional Standards, vol. 1, AU sec. 328), provides additional guidance on audit­
ing fair value measurements and disclosures contained in financial statements. 
SAS No. 101 does not address specific types of assets, liabilities, components 
of equity, transactions, or industry-specific practices.
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Appendix A —Equity Securities Whose Fair Value Is Not 
Readily Determinable
EITF Consensus O pin ions— EITF Issue No. 03-1 , "The Meaning of 
Other-Tha n-Tempora ry  Impairment and Its Application to Certain  
Investments"
A-1. Emerging Issue Task Force (EITF) Consensus Opinions are category 
(c) GAAP as described in SAS No. 69, The Meaning of Present Fairly in Con­
formity With Generally Accepted Accounting Principles. Including the EITF 
Consensus Opinions within this Guide, which is category (b) GAAP, does not 
change their position in the GAAP hierarchy.* This consensus opinion does not 
apply to investments that are held in portfolios that are reported at current 
market value or fair value.
A-2. EITF Issue No. 03-1, "The Meaning of Other-Than-Temporary Im­
pairment and Its Application to Certain Investments," which was ratified by 
the FASB in March 2004, provides guidance about the meaning of other-than- 
temporary impairment and its application to certain debt and equity securities. 
When applied by investor owned and by not-for-profit health care organizations, 
it provides guidance for reporting equity securities whose fair value is not read­
ily determinable (that is, equity securities that are outside the scope of FASB 
Statements No. 115 and 124) if those securities are reported at cost. EITF Issue 
No. 03-1 refers to those equity securities as cost method investments.†
A-3. Because the fair value of a cost method investment is not readily de­
terminable, the evaluation of whether an investment is impaired should be de­
termined as follows. The organization should compare the carrying amount to 
an estimate of fair value determined for other purposes (for example, for FASB 
Statement No. 107 disclosure purposes). If the organization has not developed 
an estimate of fair value for a cost method investment (for example, because 
the organization is exempt from estimating fair value under FASB Statement 
No. 126), the organization should evaluate whether an event or change in cir­
cumstances has occurred in the period that might have a significant adverse 
effect on the fair value of the investment (an "impairment indicator"). If an 
impairment indicator is present, the investor should estimate the fair value of 
the investment. Impairment indicators include, but are not limited to:
•  A significant deterioration in the earnings performance, credit rating, 
asset quality, or business prospects of the investee
•  A significant adverse change in the regulatory, economic, or technolog­
ical environment of the investee *†
* See footnote * to the heading to paragraph 1.61 in this Guide for information about a FASB expo­
sure draft of a proposed FASB Statement, The Hierarchy of Generally Accepted Accounting Principles, 
that would supersede the hierarchy for nongovernmental entities currently presented in AICPA SAS 
No. 69, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles, 
and an ASB exposure draft of a proposed SAS that would amend SAS No. 69.
† The measurement and recognition guidance contained in paragraphs 10-20 of EITF Issue No. 
03-1 was deferred by FASB Staff Position EITF 03-1-1, Effective Date of Paragraphs 10-20 of EITF 
Issue No. 03-1, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain 
Investments, until the final issuance of FASB Staff Position EITF Issue 03-1-a. Readers should be 
alert to the issuance of a final FSP. The disclosure guidance of EITF Issue No. 03-1 remains effective.
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•  A significant adverse change in the general market condition of either 
the geographic area or the industry in which the investee operates
•  A bona fide offer to purchase (whether solicited or unsolicited), an offer 
by the investee to sell, or a completed auction process for the same or 
similar security for an amount less than the cost of the investment
•  Factors that raise significant concerns about the investee's ability to 
continue as a going concern, such as negative cash flows from oper­
ations, working capital deficiencies, or noncompliance with statutory 
capital requirements or debt covenants.
A-4. For all cost-method investments that are in an unrealized loss posi­
tion for which impairment losses have not been recognized, the organization 
should include the following information as of each date for which a statement 
of fi nancial position is presented in its annual financial statements:
(1) The aggregate amount of unrealized losses (that is, the amount by 
which cost or amortized cost exceeds fair value)
(2) The aggregate related fair value of investments with unrealized 
losses.
The information in (1) and (2) should be presented in tabular form, aggre­
gated by each category of investment that the organization discloses for its cost- 
method investments. The table should be segregated by those investments that 
have been in a continuous unrealized loss position for less than twelve months 
and those that have been in a continuous unrealized loss position for twelve 
months or longer. The reference point for determining how long an investment 
has been in a continuous unrealized loss position is the balance sheet date of 
the period in which the impairment is identified. The continuous unrealized 
loss position ceases upon either (a) the recognition of an other-than-temporary 
impairment or (b) the recovery of fair value up to (or beyond) the cost of the 
investment.
A-5. In addition, for all cost-method investments that are in an unrealized 
loss position for which impairment losses have not been recognized, the orga­
nization should explain as of the date of the most recent statement of financial 
position included in its annual financial statements why it concluded that the 
impairment was not other-than-temporary. That information could include:
•  The nature of the investment(s)
•  The cause(s) of the impairment(s)
•  The number of investment positions that are in an unrealized loss 
position
•  The severity and duration of the impairment(s)
•  The evidence (both positive and negative) considered by the organi­
zation in reaching its conclusion that the investment is not other- 
than-temporarily impaired, including, for example, industry analyst 
reports, sector credit ratings, volatility of the security's fair value, 
and/or any other information that the organization considers relevant.
A-6. As of each date for which a statement of financial position is presented 
in its annual financial statements, EITF Issue No. 03-1 requires the organiza­
tion to disclose (if applicable):
a. The aggregate carrying amount of all cost-method investments,
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The aggregate carrying amount of cost-method investments that 
the organization did not evaluate for impairment (for example, be­
cause estimated fair value was greater than cost or because no 
impairment indicator was present),
The fact that the fair value of a cost-method investment is not esti­
mated if there are no identified events or changes in circumstances 
that may have a significant adverse effect on the fair value of the 
investment, and that
(1) The organization determined, in accordance with para­
graphs 14 and 15 of FASB Statement No. 107, Disclosures 
about Fair Value of Financial Instruments, that it is not 
practicable to estimate the fair value of the investment, or
(2) The organization is exempt from estimating fair value 
under FASB Statement No. 126, Exemption from Certain 
Required Disclosures about Financial Instruments for Cer­
tain Nonpublic Entities.
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Chapter 5 
Receivables
5.01 Receivables may include amounts due for (a) health care services from 
patients, residents, third-party payors, and employers; (b) premiums and stop- 
loss insurance recoveries; (c) intercompany transactions; (d) promises to give 
in future periods (pledges); and (e) amounts due from employees, physicians, 
or others. All loans, such as loans to physicians, should be evaluated periodi­
cally for impairment. Loans that are included in the scope of FASB Statement 
No. 114, Accounting by Creditors for Impairment of a Loan,1 should be evalu­
ated based on the provisions of that statement. A loan is impaired when, based 
on current information and events, it is probable that the provider will be un­
able to collect all amounts due, including principal and interest, according to 
the contractual terms of the loan agreement. If the provider measures an im­
paired loan using a present value amount, the creditor should calculate that 
present value based on an estimate of the expected future cash flows of the 
impaired loan, discounted at the loan's effective interest rate.
5.02 Amounts realizable from third-party payors for health care services 
are usually less than the provider's full established rates for those services. 
The realizable amounts may be determined by (a) contractual agreement with 
others (such as Blue Cross plans, Medicare, Medicaid, or HMOs), (b) legisla­
tion or regulation (such as workers' compensation or no-fault insurance), or (c) 
provider policy or practice (such as courtesy discounts to medical staff members 
and employees or other administrative adjustments).
5.03 Revenue and the related receivables for health care services usually 
are recorded in the accounting records on an accrual basis at the provider's full 
established rates. The provision for contractual adjustments (that is, the differ­
ence between established rates and third-party payor payments) and discounts 
(that is, the difference between established rates and the amount collectible) 
are recognized on an accrual basis and deducted from gross service revenue to 
determine net service revenue. Contractual adjustments, discounts, and an al­
lowance for uncollectibles are recorded to report the receivables for health care 
services at net realizable value. Estimates of contractual adjustments, other 
adjustments, and the allowance for uncollectibles are reported in the period 
during which the services are provided even though the actual amounts may 
become known at a later date. This later date may be (a) when the person is 
discharged, (b) subsequent to discharge or completion of service, (c) when the 
third party is billed, or (d) when payment or partial paym ent is received. As 
discussed in paragraph 10.03, the provision of charity care does not qualify for 
recognition as receivables or revenue in the financial statements.
5.04 Nongovernmental health care organizations with loans and trade re­
ceivables should follow the recognition and measurement guidance in para­
graph 8 of Statement of Position (SOP) 01-6, Accounting by Certain Entities 
(Including Entities With Trade Receivables) That Lend to or Finance the Activ­
ities of Others, to the extent that that guidance is applicable.
1 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in 
Chapter 1.)
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Rate Setting
5.05 The independent auditor should be familiar with the rate-setting en­
vironment in which the entity operates and the regulations and contractual 
agreements that determine payments to be received for health care services. 
Payment rates established by regulations or contractual agreements may be 
determined either prospectively or retrospectively.
5.06 Prospective rate setting is a method used to set payment rates in ad­
vance of the delivery of health care services. Such payment rates determine 
what third parties will pay for health care services during the rate period 
(generally one year). Prospective rate setting may result from a contractual 
agreement with a third party, such as a Blue Cross plan, or it may be man­
dated through legislation. The intent of prospective rate setting is to establish 
payment rates before the period to which they will apply and that are not sub­
ject to change. The independent auditor should be aware, however, that some 
rate-setting methods described as prospective may include provision for ret­
rospective adjustments and that some third parties pay prospective rates for 
certain services and retrospective rates for other services.
5.07 Under retrospective rate setting, third parties usually determine an 
interim payment rate and, during the rate period (generally one year), pay the 
health care organization for services rendered using that rate. After the rate 
period has ended, a final settlement is made in accordance with federal or state 
regulations or contractual agreements.
Estimated Final Settlements
5.08 Under a retrospective system, an entity may be entitled to receive 
additional payments or may be required to refund amounts received in excess 
of amounts earned under the system. Although final settlements are not made 
until a subsequent period, they are usually subject to reasonable estimations 
and are reported in the financial statements in the period in which services 
are rendered. Differences between original estimates and subsequent revisions 
(including final settlements) are included in the statement of operations in 
the period in which the revisions are made and disclosed, if material. Those 
differences are not treated as prior period adjustments unless they meet the 
criteria for prior period adjustments as set forth in FASB Statement No. 16, 
Prior Period Adjustments.2
5.09 Rate-setting methods that are described as prospective but provide 
for retrospective adjustments are accounted for as retrospective rate-setting 
systems for the services to which they apply (see paragraph 5.08).
State W aiver Contingencies Under Medicare
5.10 Certain states (referred to as waiver states) have received permis­
sion to determine rates of payment for Medicare patients in accordance with 
a statewide rate-setting method different from the method used by the federal 
program. A condition for Medicare participation in a state waiver program typ­
ically requires that Medicare expenditures in that state not exceed prescribed 
limits. If Medicare expenditures exceed prescribed limits, the excess, depending
2 Paragraphs 37 of SOP 00-1, Auditing Health Care Third-Party Revenues and Related Receivables, 
provides a sample disclosure for material differences between an original estimate and subsequent 
revisions. SOP 00-1 is included in Appendix E to this Guide.
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on the conditions of the waiver, may be recoverable by the federal government. 
FASB Statement No. 5, Accounting for Contingencies, provides guidance with 
respect to accounting for loss contingencies, such as those arising under state 
Medicare waivers. GASB Statement No. 10, Accounting and Financial Report­
ing for Risk Financing and Related Insurance Issues, provides guidance with 
respect to accounting for contingencies by governmental entities.
Premiums and Stop-Loss Insurance Receivables
5.11 Some health care organizations contract to provide comprehensive 
health care services for a fixed period in return for fixed periodic premiums. 
Many of those organizations may transfer a portion of their financial risks under 
the contract to another organization by purchasing stop-loss insurance. Receiv­
ables of those organizations may include uncollected premiums and amounts re­
coverable from stop-loss insurers reduced by appropriate valuation allowances. 
Chapter 13 provides guidance on applying GAAP for stop-loss insurance costs of 
providers of prepaid health care services. FASB Statement No. 113, Accounting 
and Reporting for Reinsurance of Short-Duration and Long-Duration Contracts, 
also provides guidance on accounting for reinsurance contracts. Governmental 
entities should comply with the provisions of GASB Statement No. 10 which 
provides different guidance on accounting for reinsurance contracts than FASB 
Statement No. 113.
Promises to Give in Future Periods (Pledges) *
5.12 Providers involved in fund-raising campaigns frequently are the re­
cipients of promises to give3 with payments due in future periods; pledge drives 
are a common example. FASB Statement No. 116, Accounting for Contributions 
Received and Contributions Made,4 establishes the accounting and financial re­
porting guidance for pledges and similar promises to pay. Providers may also be 
the beneficiaries of fund-raising campaigns conducted by others. FASB State­
ment No. 136, Transfers of Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others,5 establishes standards for 
transactions in which a donor makes a contribution by transferring assets to 
a recipient organization—a not-for-profit organization or a charitable trust— 
that accepts the assets from the donor and agrees to use the assets on behalf of 
or transfer the assets, their investment return, or both to another entity—the 
beneficiary—named by the donor.6 In general, a nongovernmental health care
* The FASB has released an exposure draft of a proposed FASB Statement of Financial Account­
ing Standards, Fair Value Measurements, that would provide guidance for how to measure fair value.
It would amend certain guidance discussed in this section of the Guide, including the guidance in 
paragraph 15 of FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization or 
Charitable Trust That Raises or Holds Contributions for Others, that is discussed in paragraph 5.12 
and the guidance in paragraph 20 of FASB Statement No. 116, Accounting for Contributions, that is 
discussed in paragraph 5.16. Readers should be alert to the issuance of a final standard.
3 To be recognized in financial statements there must be sufficient evidence in the form of verifi­
able documentation that a promise was made and received (FASB Statement No. 116, paragraph 6).
This pronouncement is not applicable to governmental health care enterprises. (See footnote 1 
in Chapter 1.)
5 See footnote 4.
6 FASB Statement No. 136 also establishes standards for transactions that take place in a similar 
manner but are not contributions because the transfers are revocable, repayable, or reciprocal. Those 
standards and transactions are discussed in paragraphs 4.14, 4.15, 11.21, 11.23, and 11.24 of this 
Guide. This Guide does not use the word donor in discussing those transactions because they are not 
contributions.
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organization that is specified as a beneficiary recognizes its rights to the assets 
held by a recipient organization as an asset: either a beneficial interest or a 
receivable. (See paragraph 15 of FASB Statement No. 136.) (For exceptions, 
see the discussion of variance power at paragraph 10.05 and financially inter­
related organizations at paragraphs 11.29 through 11.33 of this Guide.) If the 
beneficiary has an unconditional right to receive all or a portion of the speci­
fied cash flows from a charitable trust or other identifiable pool of assets, the 
beneficiary has a beneficial interest. The beneficiary recognizes that beneficial 
interest as an asset and a contribution received, measuring and subsequently 
remeasuring it at fair value, using a valuation technique such as the present 
value of the estimated expected future cash flows. If the beneficiary has uncon­
ditional rights to receive the value of the transferred assets at a future date, 
the beneficiary has a receivable that should be recognized in accordance with 
the provisions of FASB Statement No. 116 for unconditional promises to give.
5.13 A general summary of the provisions of FASB Statement No. 116 for 
promises to give is presented below. Specific guidance is provided in Chapter 5 
of the AICPA Audit and Accounting Guide Not-for-Profit Organizations. By 
specifying that they will adhere to future payment dates, donors implicitly 
indicate that their gift is to support activities in each period in which a payment 
is scheduled. Therefore, in any promise to give with payments due in future 
periods, a time restriction is implicit unless the donor explicitly states that the 
gift is to support current activities or other circumstances clearly point to that 
intent.
5.14 Promises to give fall into two broad categories: conditional and uncon­
ditional. Conditional promises to give depend on the occurrence of a specified 
future and uncertain event (for example, a stipulation that the provider must 
meet a matching requirement) whose occurrence or failure of occurrence gives 
the donor the right of return of the assets or releases the donor from the obli­
gation to transfer assets in the future. Conditional promises to give are not 
recognized in financial statements until the conditions on which they depend 
are substantially met (that is, until the period in which the conditional promise 
becomes an unconditional promise). A transfer of assets in partial fulfillment of 
a conditional promise shall be accounted for as a refundable advance (that is, as 
a liability) until such time as the conditional promise becomes unconditional.7
5.15 Unconditional promises to give with payments due in future periods 
should be reported as receivables and as restricted support in the period the 
promise is received (unless explicit donor stipulations or circumstances sur­
rounding the receipt of the promise make clear that the donor intended the 
promise to be used to support activities of the current period). The expiration of 
those restrictions (or the expiration of a portion of the restriction) is recognized 
as the donor makes the future payment or payments. If the promise is to be 
paid in one future payment, the related temporarily restricted net assets will 
be transferred to unrestricted net assets in the period in which the payment is 
received. If the donor sets forth a schedule of future payments, a transfer from 
temporarily restricted net assets to unrestricted net assets is made in each pe­
riod a payment is received. If other explicit donor restrictions are attached to
7 For accounting purposes, a conditional promise to give is considered unconditional if the pos­
sibility that the condition will not be met is remote. In the case of ambiguous donor stipulations, if 
a promise contains stipulations that are not clearly unconditional (that is, if the donor's stipulations 
are ambiguous), the promise is presumed to be a conditional promise. Additional guidance on distin­
guishing conditional promises from unconditional promises is provided in FASB Statement No. 116, 
paragraphs 22 and 23.
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the promise, such as that the gift be used for a specific purpose, the expiration 
of the restriction is recognized in the time period(s) when the donor makes the 
future payment(s) and when the stipulated purpose for which the assets were 
restricted has been fulfilled. In the period (or periods) that the restrictions ex­
pire, the temporarily restricted net assets (or the portion of the temporarily 
restricted net assets that relate to the particular payment installment) are re­
classified as unrestricted net assets and reported in the statement of operations 
as net assets released from restriction.
5.16 In the year that unconditional promises to give cash are received, they 
should be measured at the present value8 of their estimated future cash flows. 
(Unconditional promises to give cash that are expected to be collected within 
one year of the financial statement date may be measured at their net realiz­
able value.) In determining the estimated future cash flows of unconditional 
promises to give cash, not-for-profit organizations should consider when the 
receivable is expected to be collected, the creditworthiness of the other parties, 
the organization's past collection experience and its policies concerning the en­
forcement of promises to give, and other factors concerning the receivable's col­
lectibility. If the present value of unconditional promises to give cash decreases 
after initial measurement because of decreases in estimated future cash flows, 
the decrease should be recognized in the period(s) in which the expectation 
changes. Such decreases should be reported as expenses or losses (bad debt) in 
the net asset class in which the net assets are represented.9 Accretion of the 
discount element of the unconditional promise to give is accounted for as con­
tribution income, which increases unrestricted, temporarily, or permanently 
restricted net assets, as appropriate.
5.17 With regard to pledges and other promises to pay in future periods, if 
a provider routinely conducts fund drives, an estimate of the future cash flows 
of a portfolio of short-term promises resulting from a mass fund-raising appeal 
may be made based on experience gained from similar appeals in prior years.
5.18 Chapter 5 of the Audit and Accounting Guide Not-for-Profit Organi­
zations provides further guidance regarding accounting for promises to give in 
future periods and for assets held by not-for-profit organizations or charitable 
trusts that raise or hold contributions for others.
Governm ental Health C are  Organizations
5.19 GASB Statement No. 33, Accounting and Financial Reporting for 
Nonexchange Transactions, as amended by GASB Statement No. 36, Recipi­
ent Reporting for Certain Shared Nonexchange Revenues, provides guidance on 
accounting and reporting contributions to governmental health care entities. 
Promises of cash or other assets that nongovernmental entities, including in­
dividuals, voluntarily make to governments may be referred to in practice as 
"pledges," "promises to give," or "promised donations" or by some other term. 
Promised assets may include permanently nonexpendable additions to endow­
ments and other trusts; term endowments; contributions of works of art and *
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8 FASB Statement No. 116 states that present value should be calculated using a discount rate 
commensurate with the risks involved.
9 As discussed in FASB Statement No. 116, all expenses should be reported as decreases in 
unrestricted net assets. Therefore, decreases in contributions because of changes in the estimated 
future cash flows should be reported as losses if they are decreases in temporarily restricted net 
assets or permanently restricted net assets.
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similar assets to capitalized collections; or other kinds of capital or financial as­
sets, with or without purpose restrictions or time requirements. For purposes 
of reporting under GASB Statement No. 33, these are classified as "voluntary 
nonexchange transactions." Governmental health care enterprises that receive 
promises to give from nongovernmental entities to provide cash or other as­
sets should recognize receivables and revenues (net of estimated uncollectible 
amounts) when all eligibility requirements are met, provided that the promise 
is verifiable and the resources are measurable and probable of collection. Trans­
actions that are not recognizable because they are not measurable should be 
disclosed.
5.20 As discussed in GASB Statement No. 33, paragraph 20, eligibility 
requirements comprise one or more of the following:
a. Required characteristics of recipients.
b. Time requirements.
c. Reimbursements.
d. Contingencies.
Detailed guidance on the application of eligibility requirements is provided in 
GASB Statement No. 33, paragraphs 21 through 26.
Financial Statement Presentation
Accounts Receivable
5.21 Receivables are reported net of an allowance for doubtful accounts. 
Although the aggregate amount of receivables may include balances due from 
patients and third-party payors (including final settlements and appeals), the 
amounts due from third-party payors for retroactive adjustments of items such 
as final settlements or appeals shall be reported separately in the financial 
statements.
5.22 Accounts receivable of health care organizations generally are subject 
to the same financial disclosure requirements as other business organizations.10 
Nongovernmental health care organizations with loans and trade receivables 
should follow the presentation and disclosure guidance in paragraph 13 of SOP 
01-6 to the extent that guidance is applicable. FASB Statement No. 107, Dis­
closures about Fair Value of Financial Instruments,11 sets forth disclosure re­
quirements regarding the carrying amount of patient accounts receivable.
5.23 GASB Statement No. 38, Certain Financial Statement Note Disclo­
sures, paragraph 13, requires that governmental health care entities provide 
details in the notes to their financial statements about receivable balances when 
significant components of those receivables have been obscured by aggregation.
5.24 FASB Statement No. 107, Disclosures about Fair Value of Financial 
Instruments, as amended by FASB Statement No. 133, Accounting for Deriva­
tive Instruments and Hedging A c tiv itie s ,12 provides guidance on the required 
disclosures about significant concentrations of credit risk arising from all finan­
cial instruments, including trade accounts receivable. Concentration of credit
 10See discussion of SOP 00-1 in paragraph 5.32.
1 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20. (See footnote 1 in Chapter 1.)
12 See footnote 11.
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risk frequently is an issue because most health care organizations generally 
tend to treat patients from their local or surrounding communities. Accord­
ingly, disclosure should be made of the primary geographic sources of patients.
It should be noted that concentration of credit risk may be a significant issue 
in stand-alone financial statements issued for a member hospital of a large na­
tional multi hospital system but may not be an issue for financial statements 
prepared for the hospital system. When the individual facilities' financial state­
ments are consolidated into statements prepared for the entire system, the 
credit risk is dispersed over a much larger base of health plans, patients, and 
geographies and, therefore, is not as concentrated. Health care organizations 
with significant concentrations of credit risk should comply with the disclo­
sure provisions of FASB Statement No. 107, as amended by FASB Statement 
No. 133.
5.25 Off-balance-sheet risk exists when the possible accounting loss from 
a financial instrument is not reflected on the balance sheet. Health care or­
ganizations (most notably hospitals) may enter into arrangements where they 
will finance their patient accounts receivable as a cash flow management strat­
egy. Nongovernmental health care organizations should follow the presentation 
and disclosure guidance in paragraph 13 of SOP 01-6 regarding credit losses 
on off-balance-sheet instruments to the extent that guidance is applicable.
5.26 FASB Statement No. 133, as amended, provides guidance on the 
required disclosures by entities that hold or issue derivative instruments.13 
SOP 02-2, Accounting for Derivative Instruments and Hedging Activities by 
Not-for-Profit Health Care Organizations and Clarification of the Performance 
Indicator, requires that not-for-profit health care organizations that are within 
the scope of this Guide provide disclosures that are analogous to those required 
by paragraph 45 of FASB Statement No. 133 for for-profit enterprises, including 
the disclosure of anticipated reclassifications into the performance indicator of 
gains and losses that have been excluded from that measure and reported in 
accumulated derivative gain or loss as of the reporting date. SOP 02-2 does 
not apply to governmental entities that are within the scope of this Guide. 
SOP 02-2 is included as Appendix F to this Guide. GASB Technical Bulletin 
No. 2003-1, Disclosure Requirements for Derivatives Not Reported at Fair Value 
on the Statement of Net Assets, applies to governmental health care enterprises.
Interfund Receivables
5.27 Interfund receivables (or payables) may exist in internal records. 
However, since general-purpose financial statements of not-for-profit health 
care organizations do not classify assets and liabilities into fund groups, in­
terfund receivables (or payables) are eliminated. Such interfund balances and 
transactions are different from interfund transactions between a governmen­
tal health care enterprise fund and another fund, such as the general fund 
or a special revenue fund of a primary government, when the two funds are 
included in the same financial reporting entity. Governmental health care en­
tities that are funds or component units of another governmental entity may 
report receivables (or payables) from other funds or from the primary govern­
ment or other component units. (The term primary government is defined in 
GASB Statement No. 14, The Financial Reporting Entity.) Interfund balances 
are eliminated in the government-wide financial statements of the financial
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reporting entity, when presented.14 Discretely presented component units that 
report amounts receivable (or payable) from the primary government or from 
other component units should report those assets on a separate line from other 
receivables (payables), as discussed in GASB Statement No. 34, Basic Financial 
Statements—and Management's Discussion and Analysis—for State and Local 
Governments, paragraph 61. GASB Statement No. 38, paragraph 14, also re­
quires disclosures about interfund balances and transfers.
Promises to G ive in Future Periods (Pledges)
5.28 Contributions receivable should be reported net of an allowance for 
uncollectible amounts. That allowance may be based on the receivable's age, 
the creditworthiness of the parties, the organization's past collection experience 
and its policies concerning the enforcement of promises to give, and other factors 
concerning the receivable's collectibility. After the date of initial measurement, 
bad debt expense should be reported for the amount of promises to give that 
are expected to be uncollectible (see paragraphs 5.14 and 5.19).
5.29 Investor owned health care enterprises and not-for-profit health care 
organizations that are recipients of unconditional pledges (promises to give in 
future periods) shall disclose—
a. The amounts of promises receivable in less than one year, in one to 
five years, and in more than five years.
b. The amount of the allowance for uncollectible promises receivable.
5.30 Investor owned health care enterprises and not-for-profit health care 
organizations that are recipients of conditional pledges (promises to give in 
future periods) shall disclose—
a. The total of the amounts promised.
b. A description and amount for each group of promises having sim­
ilar characteristics, such as amounts of promises conditioned on 
establishing new programs, completing a new building, or raising 
matching gifts by a specified date.
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Auditing
Note: In referring to AICPA professional standards (GAAS), this chapter cites 
the applicable sections of the AICPA Professional Standards publication. In 
referring to Public Company Accounting Oversight Board (PCAOB) profes­
sional standards, this chapter cites the applicable sections of the AICPA's 
publication titled PCAOB Standards and Related Rules. In those cases in 
which the auditing standards of the AICPA and those of the PCAOB are the 
same, this chapter cites the applicable section of the AICPA Professional Stan­
dards publication only.
5.31 In general, receivables, particularly those arising from health care 
services, are material to the financial position of health care organizations. 
Examples of specific auditing objectives, selected control activities, and auditing 
procedures that may be considered by the independent auditor as they relate to
14 If a governmental health care entity reports using multiple enterprise funds, interfund bal­
ances between those funds are eliminated in the total enterprise fund column.
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the major components of receivables of health care organizations are presented 
in Exhibit 5-1 at the end of this chapter.
5.32 SOP 00-1, Auditing Health Care Third-Party Revenues and Related 
Receivables, provides guidance to auditors in evaluating the reasonableness of 
management's estimates regarding the proper valuation of health care third- 
party revenues and receivables embodied in the financial statements.
5.33 Auditing Interpretation No. 1, "Auditing Interests in Trusts Held by a 
Third-Party Trustee and Reported at Fair Value," of SAS No. 101, Auditing Fair 
Value Measurements and Disclosures (AICPA, Professional Standards, vol. 1,
AU sec. 9328.01-.04),† provides guidance for auditors of nonissuers when the 
auditor determines auditing procedures should include verifying the existence 
and testing the measurement of investments held by a trust (for example, when 
auditing beneficial interests reported at fair value, pursuant to paragraph 15 
of FASB Statement No. 136; see paragraph 5.12 of this chapter). That Inter­
pretation includes guidance regarding the adequacy of audit evidence in con­
firmations received from trustees with respect to the existence assertion and 
requirements for auditing fair value measurements in accordance with SAS 
No. 101.
Accounts Receivable Confirmations
5.34 Direct confirmation of amounts due from discharged patients and 
third-party payors may be an appropriate audit procedure for obtaining evi­
dence about the existence and accuracy of amounts due. However, many pa­
tients whose accounts are expected to be paid by a third-party payor may not 
haive received bills, and many third-party payors may be unable to respond to 
confirmation requests on specific account balances. In addition, obtaining con­
firmation of receivables from patients who are not discharged may be imprac­
ticable because those patients may not know the amount of their indebtedness 
until they are discharged.
5.35 If confirmation of amounts due from patients and third-party pay­
ors is impracticable or determined not to be effective, the independent auditor 
should document this decision in accordance with SAS No. 67, The Confirma­
tion Process (AICPA, Professional Standards, vol. 1, AU sec. 330), and should 
use alternate procedures such as—
• Performing an analytical procedure or testing the details of subsequent 
receipts.
•  Reviewing third-party contracts or payment agreements.
•  Comparing billings with documentation in medical records.
•  Reviewing the results of third-party payor audits and, if available, peer 
review organization (PRO) reports.
•  Examining or confirming interim payments with third-party payors.
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Exhibit 5-1
Health Care Organizations
Auditing Considerations
Financial Statement Specific Auditing 
Assertions Objectives
Receivables for Health Care Services
Existence Amounts reported
in the financial 
statements 
represent valid 
receivables, which 
do not include 
charity care 
balances.
Selected Control 
Activities
Charges are 
generated 
automatically 
when services 
are performed.
A medical record 
is prepared.
Procedures 
ensure that 
amounts due 
from third-party 
payors for 
individual 
accounts are 
supported 
properly.
Procedures 
ensure the 
proper recording 
of cash receipts.
Procedures 
ensure charity 
care balances 
are identified 
and excluded 
from gross 
receivables.
Auditing
Procedures
Review and test
subsequent
receipts.
Compare billing 
information to the 
documentation 
contained in the 
medical records.
Review the 
results of PRO, if 
available, and 
insurance 
company reviews 
for evidence that 
might indicate 
receivables may 
not be realized.
Trace the receipts 
applicable to 
patient accounts 
to the accounts 
receivable 
records.
Review the 
management 
policy for 
determining 
charity care.
Review policy and 
reasonableness of 
charity care 
measurement.
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Financial Statement 
Assertions
Completeness Amounts reported 
in the financial 
statements are 
complete and are 
calculated and 
accumulated 
properly.
Specific Auditing
Objectives
Valuation Receivables are 
reported in the 
financial
statements at net 
realizable value.
Selected Control 
Activities
Procedures 
ensure that (a) 
detailed 
accounts 
receivable 
records are 
compared 
routinely with 
control accounts 
and third-party 
payor logs, (b) 
differences are 
investigated and 
reconciled, and 
(c) adjustments, 
if necessary, are 
made promptly.
Allowances for 
uncollectibles 
and contractual 
adjustments are 
reviewed 
periodically by 
management to 
ensure that 
receivables are 
reported at 
estimated net 
realizable value.
Write-offs and 
allowances for 
uncollectibles 
are identified 
and approved in 
accordance with 
the entity's 
established 
policy.
Auditing
Procedures
Compare detailed 
accounts
receivable records 
with control 
accounts and 
third-party payor 
logs, and 
investigate 
reconciling items.
Review 
third-party 
contracts and 
recompute patient 
receivables. 
Examine 
contracts or 
confirm interim 
third-party 
payments with 
third-party 
payors.
Review and test 
the method used 
to determine the 
allowances for 
uncollectible 
accounts.
Determine that 
patient accounts 
are classified 
appropriately by 
payor (for 
example,
Medicare or 
self-pay) to 
evaluate 
collectibility.
(continued)
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Financial Statement Specific Auditing
Assertions Objectives
Selected Control 
Activities
Auditing
Procedures
Presentation and Significant 
disclosure contractual
arrangements 
with third parties 
are disclosed.
Estimated Third-Party Settlements
Existence Amounts reported
in the financial 
statements 
represent valid 
receivables and/or 
payables.
Procedures 
ensure that 
estimated 
third-party 
settlements are 
determined in 
accordance 
with the 
reimbursement 
and rate-setting 
methodologies 
applicable to the 
entity.
Test Medicare 
logs for accuracy 
and completeness.
Test and analyze 
aged accounts 
receivable trial 
balances, 
collection trends, 
delinquent 
accounts, 
subsequent period 
write-offs and 
economic or other 
factors used to 
determine 
allowance for 
uncollectible 
accounts.
Review pledges 
and other 
receivables for 
collectibility.
Determine that 
significant 
contractual 
arrangements 
with third parties 
are disclosed.
Review
correspondence 
from significant 
third-party 
payors related to
(a) interim 
payment rates 
applicable to 
periods for which 
final settlements 
have not been 
made and (6) the 
amount of interim 
or final
settlements made 
during the period.
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Financial Statement 
Assertions
Completeness and 
valuation
Amounts included 
in the financial 
statements are 
accurate and 
complete.
Specific Auditing
Objectives
Selected Control 
Activities
Procedures 
ensure that 
estimated 
third-party 
settlements are 
reasonably 
calculated and 
reported.
Auditing
Procedures
Test the
reasonableness of 
settlement 
amounts, 
including specific 
and unallocated 
reserves, in light 
of the payors 
involved, the 
nature of the 
payment 
mechanism, the 
risks associated 
with future 
audits, and other 
relevant factors.
Review
third-party payor 
audit reports and 
adjustments for 
prior years' cost 
reports or 
settlements to 
consider whether 
(a) the effect of 
such adjustments 
has been reported 
properly in the 
financial 
statements and 
(b ) adjustments of 
a similar nature 
apply to the 
current period.
Obtain a 
representation 
from management 
that provisions 
for estimated 
retroactive 
adjustments by 
third-party 
payors under 
reimbursement 
agreements for 
open years are 
adequate.
(continued)
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Presentation and 
disclosure
Financial Statement Specific Auditing
Assertions Objectives
Selected Control 
Activities
Auditing
Procedures
Amounts reported 
in the financial 
statements are 
presented 
properly and all 
required 
disclosures are 
made.
Determine that 
the tentative 
nature of 
third-party 
settlement 
amounts is 
disclosed properly.
Determine that 
differences 
between original 
estimates and 
subsequent 
revisions 
(including final 
settlements) are 
included in the 
statement of 
operations in the 
period in which 
the revisions are 
made and 
disclosed, if 
material.
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Property and Equipment, Supplies, 
and Other Assets
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Overview
6.01 Health care organizations use various types of property and equip­
ment. Those assets may be material to the financial position of institutional 
health care organizations, such as hospitals and nursing homes. Typical ac­
counts used to record property and equipment transactions are land, land im­
provements, buildings and improvements, leasehold improvements, equipment 
(fixed and movable), leased property and equipment, accumulated depreciation 
and amortization, and construction in progress.
6.02 Supplies usually are not material to the financial position of health 
care organizations. However, because of the volume of supply transactions, they 
may materially affect operations. Supplies typically include medical and surgi­
cal supplies; pharmaceuticals; linens, uniforms, and garments; food and other 
commodities; and housekeeping, maintenance, and office supplies.
6.03 Other assets may include prepaid expenses, deposits, and deferred 
expenses. Prepaid costs, such as amounts paid to physicians for future services 
(for example, administering a hospital department or providing community 
services that further the organization's mission) may be deferred and amortized 
over the period benefited. Such assets are classified as current or noncurrent 
as appropriate.
Accounting
6.04 Accounting for property and equipment, supplies, and other assets of 
health care organizations is similar to that used by other business organiza­
tions.
6.05 Depreciation and amortization of property and equipment are 
recorded in conformity with GAAP. Useful lives assigned to depreciable as­
sets should be reasonable, based on the circumstances. The American Hospital 
Association publishes useful guidelines for classifications and estimated use­
ful lives for property and equipment used by hospitals. Those guidelines also 
may be useful to other health care organizations. If there is a potential that an 
asset is impaired, health care organizations should consider the guidance in 
FASB Statement No. 144, Accounting for the Impairment or Disposal of Long- 
Lived Assets.1 Governmental health care enterprises should also consider the 
guidance in GASB Statement No. 42, Accounting and Financial Reporting for 
Impairment of Capital Assets and for Insurance Recoveries, for impairment of 
capital assets, as defined in paragraph 19 of GASB Statement No. 34, Basic
1 This pronouncement is not applicable to governmental health care enterprises that do not 
apply. Paragraph 7 of GASB Statement No. 20, Accounting and financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in 
Chapter 1.)
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Financial Statements—and Management's Discussion and Analysis—for State 
and Local Governments.*
6.06 The recognition of contribution income related to donated long-lived 
assets (or assets recognized to be acquired with donated funds) is discussed in 
Chapter 10 of this Guide.
Financial Statement Presentation
6.07 Financial statement presentation of property and equipment of health 
care organizations is similar to that of other business organizations. Property 
held for investment purposes should be presented as part of investments. Donor 
or legal restrictions on the proceeds from the disposition of donated property 
and equipment (or of property and equipment purchased with cash restricted 
for acquisition of long-lived assets) are disclosed.
6.08 Financial statement presentation of supplies and other assets of 
health care organizations is similar to that of other business organizations.
6.09 Capital assets for governmental health care entities that are not being 
depreciated, if significant, should be reported separately in the statement of net 
assets from capital assets being depreciated, as discussed in GASB Statement 
No. 34, paragraph 20. GASB Statement No. 34 also establishes two capital-asset 
related-disclosure requirements for governmental health care entities. First, 
GASB Statement No. 34, paragraph 115e, requires entities to disclose their 
policy for capitalizing assets and for estimating the useful lives of those assets in 
their summary of significant accounting policies. Second, GASB Statement No. 
34, paragraphs 116 and 117, require certain information to be presented about 
major classes of capital assets, including beginning and ending balances, capital 
acquisitions, sales or other dispositions, current period depreciation expense, 
and accumulated depreciation. Capital assets that are not being depreciated 
should be disclosed separately from those that are being depreciated. GASB 
Statement No. 42, paragraph 20, requires disclosure of the carrying amount of 
impaired capital assets that are idle at year-end and the financial statement 
classification of impairment losses.†
Auditing *†
Note: In referring to AICPA professional standards (GAAS), this chapter cites 
the applicable sections of the AICPA Professional Standards publication. In 
referring to Public Company Accounting Oversight Board (PCAOB) profes­
sional standards, this chapter cites the applicable sections of the AICPA's 
publication titled PCAOB Standards and Related Rules. In those cases in 
which the auditing standards of the AICPA and those of the PCAOB are the 
same, this chapter cites the applicable section of the  AICPA Professional Stan­
dards publication only.
* GASB Statement No. 42, Accounting and Financial Reporting for Impairment of Capital Assets 
and for Insurance Recoveries, is effective for financial statements for periods beginning after December 
15, 2004. Earlier application is encouraged.
† GASB Statement No. 42 is effective for financial statements for periods beginning after Decem­
ber 15, 2004. Earlier application is encouraged.
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6.10 Auditing objectives for property and equipment, supplies, and other 
assets of health care organizations are similar to those in audits of other busi­
ness organizations. The auditor may be able to assess inherent risk for these 
accounts as being relatively low because the transactions therein are generally 
small in number, relatively simple in nature, and do not involve the use of com­
plex estimates. The auditor should consider the characteristics of the entity 
and of the transactions occurring during the period when assessing inherent 
risk for these accounts.
6.11 A health care organization may have access to the use of property 
and equipment under a variety of arrangements. It may (a) own property and 
equipment, (b) rent property and equipment from an independent or related 
organization, (c) use property and equipment provided by a related organi­
zation (such as a religious order) or by an unrelated organization under an 
affiliation program, or (d) use property and equipment provided by a govern­
ment agency or unit or a government-related hospital district. The independent 
auditor should inquire into (and the financial statements should disclose) the 
nature of any relationship between the health care organization and lessors, 
bailors, or other owners of property. With respect to leases, FASB Statement 
No. 13, Accounting for Leases, as amended and interpreted, provides account­
ing guidance.2 GASB Statement No. 13, Accounting for Operating Leases with 
Scheduled Rent Increases, provides additional guidance for operating leases of 
governmental health care enterprises.
6.12 In evaluating capitalization policies, the independent auditor should 
consider whether interest has been capitalized in accordance with the provi­
sions of FASB Statement No. 34, Capitalization of Interest Cost, and related 
amendments and FASB Statement No. 62, Capitalization of Interest Cost in 
Situations Involving Certain Tax-Exempt Borrowings and Certain Gifts and 
Grants.
6.13 In evaluating the entity's depreciation policies, the auditor may wish 
to refer to the American Hospital Association's Estimated Useful Lives of Depre­
ciable Hospital Assets, which is revised periodically and sets forth plant asset 
classifications and the estimated useful lives of depreciable assets. The audi­
tor also should be aware that social, economic, and scientific advances in the 
health care industry make obsolescence an important factor to be considered 
when evaluating depreciation policies and methods.
6.14 FASB Statement No. 144 requires that health care organizations re­
view long-lived assets for impairment whenever events or changes in circum­
stances indicate that the carrying amount of the asset may not be recoverable. In 
considering a health care organization's application of FASB Statement No. 144, 
auditors should obtain an understanding of the policies and procedures used 
by management to determine whether all impaired assets have been properly 
identified. In addition to evaluating the entity's procedures for identifying indi­
cators of impairment, the auditor should consider information obtained during 
the audit in determining whether the health care organization has identified 
appropriate indicators of impairment. For example, a change in the use of a fa­
cility from an acute-care hospital to an ambulatory surgery center may require
2 For governmental health care enterprises, National Council on Governmental Accounting 
(NCGA) Statement No. 5, Accounting and Financial Reporting Principles for Lease Agreements of 
State and Local Governments, requires the application of FASB Statement No. 13 for proprietary 
activities and provides additional guidance on specific matters unique to governmental entities.
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that the asset be reviewed for impairment using the method prescribed by FASB 
Statement No. 144.
6.15 For governmental health care entities, GASB Statement No. 42 re­
quires the evaluation of prominent events or changes in circumstances affecting 
capital assets to determine whether impairment has occurred. †
6.16 The independent auditor may need to consider the examples of specific 
auditing objectives, selected control activities, and auditing procedures relating 
to property and equipment that are presented in Exhibit 6-1.
† See footnote † in paragraph 6.09.
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Exhibit 6-1
Auditing Considerations
Financial Statement Specific Auditing 
Assertions Objectives
Donated Property Equipment
Valuation Donated property
and equipment is 
reported at fair 
market value at 
the date of 
donation.
Selected Control 
Activities
Procedures 
ensure that the 
donation of 
property and 
equipment is 
known and 
recorded and that 
documentation 
supports the 
determination of 
the fair market 
value.
Presentation and 
disclosure
The receipt of 
donated property 
and equipment is 
properly reported.
Property and Equipment Not Held for Use in Operations
Presentation and 
disclosure
Property and 
equipment not 
used for 
operations is 
reported 
separately.
Property and Equipment Additions
Rights and 
obligations
The appropriate 
health care 
planning agency 
or other
regulatory agency 
approvals, if 
required, have 
been obtained for 
property and 
equipment 
additions.
Auditing
Procedures
Review the 
documentation 
supporting the 
determination of 
the fair market 
value.1
Property records 
segregate 
property and 
equipment not 
used for operating 
purposes.
Management 
regularly 
monitors 
compliance with 
health care 
planning agency 
regulations 
related to 
additions of 
property and 
equipment.
Additions are 
authorized in the 
capital budget.
Review material 
donated property 
and equipment 
transactions to 
ensure the 
propriety of the 
reporting.
Determine that 
property held for 
nonoperating 
purposes is 
reported 
separately.
For material new 
construction, 
determine 
compliance with 
health care 
planning agency 
or other
regulatory agency 
requirements.
(continued)
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Financial Statement Specific Auditing 
Assertions Objectives
Existence and 
valuation
Recorded 
property and 
equipment are 
owned by the 
entity and are 
carried at the 
appropriate 
amounts.
Selected Control 
Activities
Inventory of fixed 
assets is taken 
periodically. 
Detailed property 
records
periodically are 
reconciled to the 
recorded 
amounts.
Auditing
Procedures
Review a 
summary of 
property and 
equipment (cost 
and accumulated 
depreciation) 
including 
additions, 
deletions, and 
transfers.
1 SAS No. 101, Auditing Fair Value Measurements and Disclosures (AICPA, 
Professional Standards, vol. 1, AU sec. 328), provides guidance on auditing fair 
value measurements and disclosures contained in financial statements. SAS 
No. 101 does not address specific types of assets, liabilities, components of equity, 
transactions, or industry-specific practices.
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Current Liabilities, Tax Considerations, and 
Long-Term Obligations
Overview
7.01 Current liabilities may include notes payable to banks; the cur­
rent portion of long-term debt; accounts payable; advances from and amounts 
payable to third-party payors for estimated and final reimbursement settle­
ments; refunds to and deposits from patients and others; deferred revenue; 
accrued salaries and payroll taxes; and other accruals such as pension or profit- 
sharing contributions, compensated absences, and income and other taxes. In 
addition, there may be a current portion of estimated malpractice costs and 
risk-contract recognized losses (see Chapter 8).
7.02 Long-term obligations may include notes, mortgages, capital leases, 
bonds, and obligations under continuing care contracts. They also may include 
estimated malpractice cost and risk-contract recognized losses.
Accounting for Current Liabilities
7.03 Accounting for current liabilities of health care organizations is sim­
ilar to that of other business enterprises. Health care organizations are usu­
ally labor-intensive and provide employees with compensated absences, such 
as for holidays, vacations, and illnesses. Liabilities related to such absences 
are accounted for in accordance with FASB Statement No. 43, Accounting for 
Compensated Absences. Governmental health care entities should follow the 
guidance in GASB Statement No. 16, Accounting for Compensated Absences.
7.04 Liabilities related to postretirement benefits other than pensions 
should be accounted for in accordance with FASB Statement No. 106, Employ­
ers' Accounting for Postretirement Benefits Other Than Pensions, and postem­
ployment benefits should be accounted for in accordance with FASB State­
ment No. 112, Employers' Accounting for Postemployment Benefits. These two 
pronouncements are not required to he applied by governmental health care 
enterprises. GASB Statement No. 12, Disclosure of Information on Postemploy­
ment Benefits Other Than Pension Benefits by State and Local Governmental 
Employers, however, does require certain disclosures about postemployment 
benefits.*
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* In 2004, the GASB issued GASB Statement No. 45, Accounting and Financial Reporting by 
Employers for Postemployment Benefits Other Than Pensions, that supersedes GASB Statement 
No. 12, Disclosure of Information on Postemployment Benefits Other Than Pension Benefits by 
State and Local Governmental Employers. GASB Statement No. 45 establishes standards for the 
measurement, recognition, and display of other postemployment benefit (OPEB) expenses and related 
liabilities (assets). The requirements of GASB Statement No. 45 are effective in three phases based on 
revenues: periods beginning after December 15, 2006 for phase 1 governments (total annual revenues 
of $100 million or more); periods beginning after December 15, 2007 for phase 2 governments (total 
annual revenues of $10 million or more but less than $100 million); and periods beginning after 
December 31, 2008 for phase 3 governments (total annual revenues of less than $10 million). Earlier 
application is encouraged. Conforming changes to reflect the issuance of GASB Statement No. 45 will 
be made in a future edition of this Guide.
(continued)
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7.05 Governmental health care enterprises sometimes report government- 
mandated or voluntary nonexchange revenues, such as expenditure-driven 
grants. These revenues are recognized when all eligibility requirements have 
been met, as discussed in GASB Statement No. 33, Accounting and Financial 
Reporting for Nonexchange Transactions. In some cases, it may become ap­
parent after revenue has been recognized in the financial statements that the 
eligibility requirements are no longer met, for example, because an audit of a 
particular grant program determined that certain expenses did not meet pur­
pose restrictions. GASB Statement No. 33 provides that, if it is probable that 
the recipient must return all or part of the resources, a liability (or reduction 
of receivables) and an expense should be recognized for the amount that the 
resource provider (grantor) is expected to cancel or reclaim. (See paragraphs 
5.19, 5.20, 10.06 and 10.13 for further discussion of GASB Statement No. 33.)
Tax Considerations for Not-for-Profit Health 
Care Organizations
7.06 Health care organizations that are owned and operated by a state 
or local government are exempt from federal income tax pursuant to IRC sec. 
115 and also are exempt from the federal income tax filing requirements. Such 
organizations are exempt not only from regular federal income tax but also 
from the tax on unrelated business income. If a health care entity is owned and 
operated by a separately constituted authority or other legal entity, the entity's 
management should consider whether such authority or other legal entity is 
organized properly to preserve qualification of the tax exemption pursuant to 
IRC sec. 115. In some cases, state or local governmental entities will secure 
tax-exempt status as an IRC sec. 501(c)(3) organization. If such an exemption 
is secured, the entity may become subject to federal income tax and the related 
filing requirements on the same basis as other tax-exempt entities.
Tax-Exempt Entities
7.07 Nongovernmental not-for-profit health care organizations usually 
seek exemption from federal income tax under IRC sec. 501(a). Under IRC 
sec. 501(a), entities organized and operated exclusively for religious, charita­
ble, or educational purposes, as described in IRC sec. 501(c)(3), are exempt 
from federal income taxes. The following are additional requirements for such 
entities:
a. No part of the entity's net earnings, either directly or indirectly, 
inures to any private shareholder or individual.
b. No substantial part of the entity's activities consists of carrying 
on propaganda or otherwise attempting to influence legislation.
(footnote continued)
In June 2005, the GASB issued GASB Statement No. 47, Accounting for Termination 
Benefits. GASB Statement No. 47 establishes accounting standards for the measurement, recogni­
tion, and disclosure of voluntary termination benefits and involuntary termination benefits. GASB 
Statement No. 47 is effective in two parts. For termination benefits provided through an existing 
defined benefit OPEB plan, GASB Statement No. 47 should be implemented simultaneously with the 
requirements of GASB Statement No. 45. For all other termination benefits, GASB Statement No. 47 
is effective for financial statements for periods beginning after June 15, 2005. Earlier application is 
encouraged. Conforming changes to reflect the issuance of GASB Statement No. 47 will be made in a 
future edition of this Guide.
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(IRC sec. 501(h) provides a limited exception to the general rule 
that public charities may not incur expenditures to influence legis­
lation.)
c. The entity does not participate in, or intervene in, any political 
campaign on behalf of any candidate for public office.
7.08 The term charitable is used in IRC sec. 501(c)(3) in its generally ac­
cepted legal sense. Providing health care to the community is considered a 
charitable activity. Therefore, provided a health care entity is not organized or 
operated for the benefit of private interests (such as designated individuals, the 
founder or the founder's family, shareholders of the entity, or persons controlled 
directly or indirectly by such private interests), it generally would qualify as 
an IRC sec. 501(c)(3) organization.
7.09 The Internal Revenue Service (IRS) has ruled that in order for a nurs­
ing home to establish its exemption as a public charitable organization under 
IRC sec. 501(c)(3), it must be operated to meet the primary needs of the elderly 
for housing, health care, and financial security. Operating for financial security 
generally means that an individual will be maintained in residence even if such 
individual can no longer pay residence fees.
Private Inurement
7.10 Under IRC sec. 501(c)(3) no part of the net earnings of the charitable 
organization shall inure to the benefit of any private shareholder or individ­
ual. A private shareholder or individual refers to a person or persons having a 
private or personal interest in the activities of the organization. The IRS has 
stated that physicians have a personal or private interest in the activities of a 
hospital and could be subject to the private inurement proscription.
Unrelated Business Income Tax
7.11 Although not-for-profit organizations may be exempt from federal in­
come tax, they nevertheless may be subject to tax on unrelated business income. 
The objective of the tax on unrelated business is to place such activities on the 
same basis as that of taxable entities. Unrelated business income is the in­
come from any regularly carried-on trade or business, the conduct of which is 
not substantially related to the exercise or performance of the organization's 
tax-exempt purpose or function. The fact that proceeds from an activity are 
used exclusively for the entity's tax-exempt purpose does not make the activity 
substantially related to its tax-exempt purpose or function. As is the case with 
most tax-related definitions, there are qualifications and exceptions. Some of 
the more significant exclusions from this tax include—
• An annual specific deduction for certain limited activities.
•  Income from activities of which substantially all the work is performed 
by unpaid volunteers.
•  Income from activities carried on for the convenience of the entity's 
patients, officers, or employees.
• Dividends, interest, annuities, royalties, capital gains and losses, and 
rents from real property—with two major exceptions. The first excep­
tion is that income from investments that are debt-financed and oth­
erwise not functionally related to the tax-exempt purpose is taxable.
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The second major exception makes taxable the interest, annuities, 
royalties, and rents received from a controlled (80-percent-owned) tax­
able corporation or partnership unless this entity is engaged in an ac­
tivity that would have been exempt if it were carried on directly by the 
not-for-profit organization.
Financial Statement Presentation
7.12 Financial reporting and disclosure requirements for current liabili­
ties and long-term obligations of health care organizations are the same as for 
other business organizations. In addition, with respect to CCRCs, the method of 
accounting for advance fees, the method of calculating the obligation to provide 
future services and use of facilities, and the refund policy for refundable fees 
are disclosed in the financial statements. Chapter 14 describes other disclosure 
requirements applicable to CCRCs. Taxable entities have the same financial 
reporting and disclosure requirements as other commercial enterprises. Tax- 
exempt entities should disclose their tax-exempt status.
7.13 GASB Statement No. 34, Basic Financial Statements—and Manage­
ment's Discussion and Analysis—for State and Local Governments, and GASB 
Statement No. 38, Certain Financial Statement Note Disclosures, provide guid­
ance about required disclosures for governmental health care entities about 
current and long-term liabilities, including the following:
• GASB Statement No. 38, paragraph 13, requires disclosures about ac­
counts payable balances when significant components of those bal­
ances have been obscured by aggregation.
• GASB Statement No. 38, paragraph 12, requires disclosures about 
short-term debt activity during the year, even if no short-term debt is 
outstanding at year-end. For this purpose, short-term debt consists of 
anticipation notes, use of lines of credit, and similar loans. Disclosures 
should include a schedule of changes in short-term debt as well as a 
discussion of the purposes for which short-term debt was issued.
• GASB Statement No. 34, paragraphs 116, 119, and 120, requires in­
formation to be presented about both long-term debt, such as bonds 
payable, and about long-term liabilities, such as compensated absences 
and claims and judgments. Required disclosures include beginning and 
ending balances, increases, decreases, and the portions of each item 
that are due within one year.
• GASB Statement No. 38, paragraphs 10 and 11, requires disclosure of 
debt service requirements to maturity for each of the five subsequent 
years and in five-year increments thereafter. Principal and interest 
requirements are required to be disclosed separately. Similar require­
ments apply to obligations under capital leases and noncancelable op­
erating leases.
• GASB Statement No. 38, paragraph 9, requires disclosure of actions 
taken to remedy significant violations of finance-related legal or con­
tractual provisions.
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Long-Term Debt
7.14 Significant sums of money are required to replace and upgrade build­
ings and expand the facilities of health care organizations. As a result, health
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care organizations are dependent on external sources of funds to satisfy their 
capital needs. Many health care organizations finance acquisitions, additions, 
and renovations with long-term debt.
7.15 In addition to serving as a financing source for government operations, 
tax-exempt debt frequently is issued by state and local governments on behalf 
of nongovernmental organizations (for example, not-for-profit organizations) 
to foster private-sector participation in certain desirable community activities 
such as the provision of health care services. Tax-exempt bonds usually can be 
issued to obtain a higher ratio of project financing (up to 100 percent), a longer 
maturity period (up to thirty years), and a lower interest cost than taxable 
bonds. The majority of tax-exempt bonds issued by health care organizations 
are revenue bonds, which are bonds secured by a pledge of the entity's revenues. 
General obligation bonds are secured by the revenues of the issuing authority.
Financing Authorities
7.16 Because most providers legally cannot issue tax-exempt revenue 
bonds directly, a significant number of states have enacted legislation permit­
ting health care organizations to borrow funds for capital projects by issuing 
bonds through financing authorities. Financing authorities are authorized to 
issue tax-exempt bonds or other obligations and use the proceeds for the ben­
efit of the health care organization. To obtain project financing, a health care 
organization sometimes is required by a financing authority to enter into a 
lease arrangement, a sublease arrangement, or both. At other times, a lease or 
sublease arrangement is not required.
7.17 When a financing authority issues tax-exempt bonds or similar debt 
instruments and uses the proceeds for the benefit of a health care organization, 
the obligation is reported as a liability in the organization's balance sheet if 
the health care organization is responsible for repayment. In some cases, this 
obligation may take the form of a liability arising from a capital lease. If a 
health care organization has no obligation to make payments of principal and 
interest on the debt or capital or operating lease payments on related buildings 
or equipment, the organization should not reflect the liability on its balance 
sheet. In such circumstances, proceeds from the bond issue are reported as 
contributions from the sponsoring organization.
Assets Whose Use is Limited
7.18 Among the many provisions normally included in the bond inden­
tures of tax-exempt issues are the requirements to set aside funds annually 
from operations to ensure that bond principal, interest payments, and other 
requirements are met. The treatment of funds established under the terms of 
debt-financing instruments is discussed in paragraphs 1.29 and 1.30.
Advance Refundings
7.19 In an advance refunding, new debt is issued for the purpose of replac­
ing an existing debt issue. Advance refundings enable providers to restructure 
their long-term liabilities, take advantage of reduced interest rates, or termi­
nate restrictive bond covenants. The terms by which the debt may be satisfied 
legally and the related lien released without the debt necessarily being retired 
are spelled out in the debt instrument. Under the Tax Reform Act of 1986, bonds
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issued before January 1, 1986, may be advance refunded only twice. Bonds is­
sued on or after that date may be advance refunded only once.
7.20 The accounting, financial reporting, and disclosure requirements for 
advance refundings entered into by health care organizations other than gov­
ernmental entities are described in APB Opinion No. 30, Reporting the Results 
of Operations—Reporting the Effects of Disposal of a Segment of a Business, and 
Extraordinary, Unusual and Infrequently Occurring Events and Transactions, 
FASB Statement No. 140, Accounting for Transfers and Servicing of Financial 
Assets and Extinguishments of Liabilities, and FASB Interpretation No. 39, 
Offsetting of Amounts Related to Certain Contracts.1 Generally speaking, these 
entities are required to report any gain or loss resulting from an advance re­
funding as an extraordinary item in the financial statements of the period in 
which the refunding occurred only if the criteria in APB Opinion No. 30 for 
classification as an extraordinary item are met. The accounting, financial re­
porting, and disclosure requirements for advance refundings (and for current 
refundings) entered into by governmental health care entities are set forth in 
GASB Statements No. 23, Accounting and Financial Reporting for Refundings 
of Debt Reported by Proprietary Activities, and No. 7, Advance Refundings Re­
sulting in Defeasance of Debt. Generally speaking, governmental entities are 
required to amortize any gain or loss resulting from a current or advance re­
funding to interest expense over the shorter of the life of the new bonds or the 
remaining life of the old bonds.
7.21 There are several types of advance refundings, including net advance 
refundings, full cash advance refundings, and crossover refundings (see the 
Glossary). In a crossover refunding, because the old bonds are not defeased 
until the crossover date, no immediate gain or loss should be recognized. If 
the retirement dates of the old debt have been established, the call premium, 
unamortized premium or discount, and initial issue costs should be recognized 
systematically in the income statement over the remaining life of the old debt 
as an adjustment of the cost of borrowing related to the old debt. In addition, 
the income earned on the funds used to consummate the advance refunding and 
the interest expense on both the old and new debts should be recognized in the 
statement of operations. The funds used to consummate the advance refunding 
should be reported as an asset and both the old and new debts should be reported 
as liabilities. The assets and liabilities should not be offset.
1 Emerging Issues Task Force (EITF) Issue No. 96-19, "Debtor's Accounting for a Modification or 
Exchange of Debt Instruments," addresses accounting for modifications or exchanges of debt instru­
ments. EITF Issue No. 96-19 requires that (1) an exchange of debt instruments with substantially 
different terms is a debt extinguishment and should he accounted for in accordance with paragraph 
16 of FASB Statement No. 125; and (2) a substantial modification of terms should he accounted for 
like, and reported in the same manner as an extinguishment. Also, transactions involving the mod­
ification or exchange of debt instruments can only result in gain or loss recognition by the debtor if 
the conditions for extinguishment of debt described in paragraph 16 of FASB Statement No. 125 are 
satisfied or if the consensus in Issue No. 96-19 requires that accounting. FASB Statement No. 140, 
among other matters, replaces FASB Statement No. 125. FASB Statement No. 140 does not change 
the guidance dealing with accounting for extinguishments of liabilities. EITF Consensus Opinions 
are category (c) GAAP as described in SAS No. 69, The Meaning of Present Fairly in Conformity With 
Generally Accepted Accounting Principles (AICPA, Professional Standards, vol. 1, AU sec. 411). In­
cluding the EITF Consensus Opinions within this Guide, which is category (b) GAAP, does not change 
their position in the GAAP hierarchy. See footnote * to paragraph 1.61 in this Guide for information 
about a FASB exposure draft of a proposed FASB Statement that would supersede the hierarchy for 
nongovernmental entities currently presented in AICPA SAS No. 69 and an ASB exposure draft of a 
proposed SAS that would amend SAS No. 69.
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7.22 FASB Statement No. 140 provides accounting and reporting stan­
dards for extinguishments of liabilities. Paragraph 16 of FASB Statement 
No. 140 says a debtor should derecognize a liability if and only if it has been 
extinguished. Paragraph 16 says a liability has been extinguished if either of 
the following conditions is met:
a. The debtor pays the creditor and is relieved of its obligation for 
the liability. Paying the creditor includes delivery of cash, other 
financial assets, goods, or services or reacquisition by the debtor of 
its outstanding debt securities whether the securities are canceled 
or held as so-called treasury bonds.
b. The debtor is legally released from being the primary obligor under 
the liability, either judicially or by the creditor [footnote omitted].
Paragraph 114 of FASB Statement No. 140 provides related guidance.
7.23 Paragraph 17b of FASB Statement No. 140 requires that, if an entity 
had debt that was considered to be extinguished by an in-substance defeasance 
under the provisions of FASB Statement No. 76 prior to the effective date of 
FASB Statement No. 125, the entity should provide a general description of the 
transaction and the amount of debt that is considered extinguished at the end 
of the period so long as that debt remains outstanding.
Arbitrage Rebate Liabilities
7.24 Advance refundings involving tax-exempt debt are subject to arbi­
trage rules under the IRC sec. 103(c) and related regulations that, in general, 
prohibit the yield realized from the investment of the proceeds of the new debt 
from exceeding the yield on the debt itself Compliance with those rules is nec­
essary for the interest on the debt to be exempt from federal income tax and, 
possibly, from state and local tax.
7.25 Whenever a provider invests tax-exempt bond proceeds and the ulti­
mate yield is higher than the interest rate on the bonds, the provider may be 
subject to an arbitrage rebate liability. The arbitrage determination is made as 
of the date of the issue; however, intentional acts undertaken after the date of 
the issue can disqualify the issue retroactively. The earnings in excess of inter­
est expense represent a liability that must be paid to the U.S. Treasury in order 
for the bonds to maintain their tax-exempt status. The arbitrage rebate liabil­
ity may be a substantial amount if the bond proceeds are not spent as quickly 
as planned. For example, this may occur if a provider encounters a delay in a 
major construction project.
Auditing
7.26 Auditing objectives and procedures for long-term debt issued by 
health care organizations generally are similar to those of other organizations.
In addition, the independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
that are presented in Exhibit 7-1.
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Exhibit 7-1
Health Care Organizations
Auditing Considerations
Financial Statement 
Assertions
Specific Auditing 
Objectives
Selected Control 
Activities
Auditing
Procedures
Tax-Exempt Debt
Presentation and 
disclosure
Amounts related 
to tax-exempt 
debt are properly 
classified in the 
financial 
statements and 
related
disclosures are 
adequate.
Procedures 
ensure that the 
providers 
monitor their 
compliance with 
restrictive debt 
covenants.
Review the debt 
instruments for 
the presence of any 
restrictive debt 
covenants.
Test compliance 
with restrictive 
debt covenants.
Income Taxes
Rights and 
obligations
The not-for-profit 
organization has 
obtained a 
qualifying income 
tax exemption 
from the 
governmental 
authority.
Management 
monitors 
compliance with 
applicable tax 
regulations.
Transactions are 
reviewed for 
their effect on 
tax status and 
tax liabilities.
Determine that the 
not-for-profit 
organization has 
obtained a 
determination of 
its tax-exempt 
status.
Inquire if tax 
returns have been 
filed on a timely 
basis.
Determine the 
status of the tax 
returns under 
examination.
Read the prior 
years' tax returns.
Read the minutes 
and the accounting 
for evidence of 
significant 
unrelated business 
activities.
Review for 
reasonableness the 
unrelated business 
income tax 
liability.
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Financial Statement 
Assertions
Presentation and 
disclosure
Specific Auditing 
Objectives
The entity's 
tax-exempt status 
and its tax 
contingencies are 
disclosed in the 
notes to the 
financial 
statements.
Selected Control 
Activities
Auditing
Procedures
Determine that the 
entity's tax-exempt 
status is disclosed 
in the notes to the 
financial 
statements.
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Chapter 8
Commitments and Contingencies
Note: In referring to AICPA professional standards (GAAS), this chapter cites 
the applicable sections of the AICPA Professional Standards publication. In 
referring to Public Company Accounting Oversight Board (PCAOB) profes­
sional standards, this chapter cites the applicable sections of the AICPA's 
publication titled PCAOB Standards and Related Rules. In those cases in 
which the auditing standards of the AICPA and those of the PCAOB are the 
same, this chapter cites the applicable section of the AICPA Professional Stan­
dards publication only.
Overview
8.01 Commitments and contingencies may include (a) losses arising from 
litigation, including malpractice and other claims; (6) contingencies related to 
risk contracting; (c) third-party payment and rate-setting programs; id) con­
struction contract commitments; (e) the Hill-Burton Act obligation to provide 
uncompensated care; (f) commitments and guarantees that include contractual 
agreements with physicians, specialists, and others who perform services by 
arrangement with health care organizations; and (g) commitments and con­
tingent liabilities related to pension plans, operating leases, purchase commit­
ments, and loan guarantees.
8.02 FASB Statement No. 5, Accounting for Contingencies, as amended, 
and interpreted by FASB Interpretation No. 14, Reasonable Estimation of the 
Amount of a Loss, and FASB Interpretation No. 45, Guarantor's Accounting 
and Disclosure Requirements for Guarantees, Including Indirect Guarantees 
of Indebtedness of Others, provides guidance on accounting for contingencies. 
FASB Statement No. 60, Accounting and Reporting by Insurance Enterprises, 
discusses accounting for claims costs, including estimates of costs relating to 
IBNR claims. Governmental health care entities should consider the accounting 
and disclosure requirements of GASB Statement No. 10, Accounting and Finan­
cial Reporting for Risk Financing and Related Insurance Issues, as amended by 
GASB Statement No. 30, Risk Financing Omnibus, and Interpretation No. 4, 
Accounting and Financial Reporting for Capitalization Contributions to Public 
Entity Risk Pools.
Medical Malpractice Claims
8.03 The extent of risk transfer is key in determining whether a liability 
should be recognized in a provider's financial statements pertaining to mal­
practice claims. The existence of an insurance policy, by itself, is no assurance 
that the risk of financial loss is transferred.
8.04 If the entity has purchased a claims-made insurance policy (see para­
graph 8.13), there is no transfer of risk for claims not reported to the insurance 
carrier within the policy term. With regard to retrospectively rated insurance 
policies (see paragraphs 8.14 and 8.15) and policies by captive insurance com­
panies (see paragraphs 8.16 through 8.19), the economic substance of the terms
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of the insurance policy may more closely resemble a claims funding mechanism 
than an instrument that transfers risk of loss to an external third party. If the 
health care organization has not transferred risk to an external third party, 
it should evaluate its exposure to losses arising from malpractice claims and 
record a liability, if appropriate.
Accruing M alpractice Liabilities
8.05 The ultimate costs of malpractice claims, which include costs associ­
ated with litigating or settling claims, are accrued when the incidents that give 
rise to the claims occur. Estimated losses from asserted and unasserted claims 
are accrued either individually or on a group basis, based on the best estimates 
of the ultimate costs of the claims and the relationship of past reported incidents 
to eventual claims payments. All relevant information, including industry ex­
perience, the entity's own historical experience, the entity's existing asserted 
claims, and reported incidents, is used in estimating the expected amount of 
claims. The accrual includes an estimate of the losses that will result from un­
reported incidents, which are probable of having occurred before the end of the 
reporting period.
8.06 In estimating the probability that unreported incidents have occurred, 
some health care organizations may develop a range of possible estimates of 
the number of unreported incidents, including zero. However, the greater the 
volume of a health care organization's operations, the greater the likelihood that 
the organization's minimum estimate of the number of probable unreported 
incidents will be greater than zero.
8.07 If it is probable that a loss has been incurred and the information 
available indicates the loss is within a range of amounts, the most likely amount 
of loss in the range is accrued. If no amount in the range is more likely than any 
other, the minimum amount in the range is accrued. The potential additional 
loss is disclosed if there is at least a reasonable possibility of a loss in excess of 
the amount accrued.
8.08 In estimating losses from malpractice claims, a health care organiza­
tion may need to modify data drawn from industry experience so it is relevant to 
developing an estimate that is specific to the organization. Various factors (such 
as the nature of operations, size, and the provider's past experience) are con­
sidered in assessing comparability. Further, industry data that are not current 
may not be relevant.
8.09 Estimated losses are reviewed and changed, if necessary, at each re­
porting date. The amounts of the changes are recognized currently as additional 
expense or as a reduction of expense.
8.10 Accrued unpaid claims and expenses that are expected to be paid 
during the normal operating cycle (generally within one year of the date of 
the financial statements) are classified as current liabilities. All other accrued 
unpaid claims and expenses are classified as noncurrent liabilities.
8.11 A health care organization discloses its program of medical malprac­
tice insurance coverages and the basis for any related loss accruals. If the orga­
nization cannot estimate losses relating to a particular category of malpractice 
claims (for example, asserted claims, reported incidents, or unreported inci­
dents) in accordance with paragraphs 8.03 through 8.10, the potential losses 
related to that category of claims are not accrued. However, the contingency is
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disclosed in the notes to the financial statements, as required by FASB State­
ment No. 5.
8.12 Health care organizations that discount accrued malpractice claims 
should disclose in the notes to the financial statements the carrying amount 
of accrued malpractice claims that are discounted in the financial statements 
and the interest rate or rates used to discount those claims. Also, the FASB 
has issued FASB Concepts Statement No. 7, Using Cash Flow Information and 
Present Value in Accounting Measurements. This Concepts Statement provides 
useful discussion of general principles governing the use of present value, and 
of the objective of present value in accounting measurements. Statements of 
Financial Accounting Concepts are not sources of established accounting prin­
ciples as described in SAS No. 69, The Meaning of Present Fairly in Conformity 
With Generally Accepted Accounting Principles, and, thus, do not amend, mod­
ify, or justify a change from generally accepted accounting principles currently 
in effect.*
Accounting for Cla ims-Made Insurance Policies 
and Toil Coverage
8.13 A claims-made insurance policy represents a transfer of risk within 
the policy limits to the insurance carrier for asserted claims and incidents re­
ported to the insurance carrier. The policy, however, does not represent a trans­
fer of risk for claims and incidents not reported to the insurance carrier dur­
ing the policy period. Consequently, a health care organization that is insured 
under a claims-made insurance policy recognizes the estimated cost of those 
claims and incidents not reported to the insurance carrier, in accordance with 
paragraphs 8.03 through 8.10. This estimation is done unless the health care 
organization has bought tail coverage (see the Glossary) and included the cost 
of the premium as an expense in the financial statements for that period.
Accounting for Retrospectively Rated Premiums
8.14 A health care organization with a retrospectively rated insurance pol­
icy whose ultimate premium is based primarily on the health care organization's 
loss experience accounts for the minimum premium as an expense over the pe­
riod of coverage under the policy and accrues estimated losses from asserted 
and unasserted claims in excess of the minimum premium, as indicated in 
paragraphs 8.03 through 8.10. Such estimated losses, however, are not accrued 
in excess of a stipulated maximum premium. If the health care organization 
cannot estimate losses from asserted or unasserted malpractice claims, as in­
dicated in paragraphs 8.03 through 8.10, the health care organization should 
disclose the existing contingency in the notes to the financial statements, as 
required by FASB Statement No. 5.
* The FASB has released an exposure draft of a proposed FASB statement, Fair Value Measure­
ments, that would clarify and incorporate, the guidance for using present value techniques in FASB 
Concepts Statement No. 7, Using Cash Flow Information and Present Value in Accounting Measure­
ments, elevating that guidance to Level A GAAP. That guidance would apply under all pronouncements 
in which present value is used to estimate fair value. See also footnote * to paragraph 1.61 in this 
Guide for information about a FASB exposure draft of a proposed Statement that would supersede the 
hierarchy for nongovernmental entities currently presented in SAS No. 69, The Meaning of Present 
Fairly in Conformity With Generally Accepted Accounting Principles, and an ASB exposure draft 
of a proposed SAS that would amend SAS No. 69. Readers should be alert to the issuance of final 
standards.
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8.15 A health care organization insured under a retrospectively rated pol­
icy whose ultimate premium is based primarily on the experience of a group 
of health care organizations amortizes the initial premium to expense on a pro 
rata basis over the policy term. The organization also accrues additional pre­
miums or refunds on the basis of the group's experience to date, which includes 
a provision for the ultimate cost of asserted and unasserted claims before the 
financial statement date, whether reported or unreported. The health care or­
ganization discloses that (a) it is insured under a retrospectively rated policy 
and (b) premiums are accrued based on the ultimate cost of the experience to 
date of a group of organizations. If the health care organization cannot esti­
mate losses from asserted or unasserted malpractice claims, as indicated in 
paragraphs 8.03 through 8.10, it should disclose the existing contingency in 
the notes to the financial statements, as required by FASB Statement No. 5.
Accounting for Medical Malpractice Claims Insured by 
Captive Insurance Companies
8.16 A majority-owned captive insurance company (for example, a wholly 
owned captive) is consolidated in accordance with FASB Statement No. 94, 
Consolidation of All Majority-owned Subsidiaries.1,† Multi provider captives, 
in which the ownership percentage is 50 percent or less, are accounted for in 
accordance with APB Opinion No. 18, The Equity Method of Accounting for 
Investments in Common Stock. (See Chapter 11 of the Guide for additional 
discussion of considerations related to consolidation and the use of the equity 
method.)
8.17 A health care organization insured by an unconsolidated multi 
provider captive insurance company for medical malpractice claims under a 
retrospectively rated insurance policy whose ultimate premium is based pri­
marily on the health care organization's experience up to a maximum premium, 
if any, accounts for such insurance as indicated in paragraph 8.14.
1 In 2003, the FASB issued FASB Interpretation No. 46, Consolidation of Variable Interest En­
tities, and FASB Interpretation No. 46, Consolidation of Variable Interest Entities (revised December 
2003), to address consolidation by business enterprises of variable interest entities. Special effective 
date provisions apply to enterprises that have fully or partially applied FASB Interpretation No. 46 
prior to the issuance of the revised Interpretation. Otherwise, application of FASB Interpretation No. 
46(R) or FASB Interpretation No. 46 is required in financial statements of public entities that have 
interests in variable interest entities or potential variable interest entities commonly referred to as 
special-purpose entities for periods ending after December 15, 2003. Application by public entities, 
other than small business issuers, for all other types of entities is required in financial statements 
for periods ending after March 15, 2004. Application by small business issuers to entities other than 
special-purpose entities and by nonpublic entities to all types of entities is required at various dates 
in 2004 and 2005. In some instances, enterprises have the option of applying or continuing to apply 
FASB Interpretation No. 46 for a short period of time before applying the revised Interpretation. Not- 
for-profit organizations are not subject to FASB Interpretation No. 46 (revised December 2003), except 
that they may be related parties for purposes of applying paragraphs 16 and 17 of that Interpretation. 
Also, if a not-for-profit entity is used by business enterprises in a manner similar to a variable inter­
est entity in an effort to circumvent the provisions of FASB Interpretation No. 46 (revised December 
2003), that not-for-profit entity is subject to that Interpretation.
† In June 2005, the FASB released an exposure draft of a proposed FASB Statement, Consolidated 
Financial Statements, Including Accounting and Reporting of Noncontrolling Interests in Subsidiaries, 
that would replace ARB No. 51 and supersede FASB Statement No. 94. The proposed FASB Statement 
would establish standards for the accounting and reporting for noncontrolling interests, and carry 
forward from ARB No. 51, as amended, the provisions related to consolidation purpose and policy 
and certain provisions related to consolidation procedure. Paragraphs 20 through 34 of the proposed 
Statement would not be applied by not-for-profit organizations until interpretative guidance related 
to those paragraphs is issued. Readers should be alert to the issuance of a final standard.
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8.18 A health care organization insured by an unconsolidated multi 
provider captive insurance company for medical malpractice claims under a ret­
rospectively rated policy based primarily on the experience of a group of health 
care organizations accounts for such insurance as indicated in paragraph 8.15. 
However, the health care organization considers whether the economic sub­
stance of the multi provider captive insurance company is sufficient to relieve 
the health care organization from further liability. The health care organization 
should disclose that (a) it is insured under a retrospectively rated policy of a 
multi provider captive insurance company and (b) the premiums are accrued 
based on the captive insurance company's experience to date.
8.19 A health care organization that is insured by a multi provider captive 
insurance company discloses in its financial statements that it is insured by 
such a company, and it should disclose its ownership percentage, if significant, 
in the captive company as well as the method of accounting for its investment 
in, and the operations of, the captive company. In addition, if the health care 
organization cannot make the necessary estimates of losses from asserted or 
unasserted claims, as indicated in paragraphs 8.03 through 8.10, the health 
care organization discloses the existing contingency in the notes to the financial 
statements, as required by FASB Statement No. 5.
Accounting for Trust Funds
8.20 In general, a trust fund, whether legally revocable or irrevocable, is 
included in the financial statements of the health care organization. A portion 
of the fund equal to the amount of assets expected to be liquidated to pay 
malpractice claims classified as current liabilities is classified as a current asset; 
the balance of the fund, if any, is classified as a noncurrent asset. Revenues 
and administrative expenses of the trust fund are included in the statement of 
operations (see Chapter 10). In some circumstances, the foregoing may not be 
possible (for example, if a common trust fund exists for a group of health care 
organizations; if the health care organization is part of a common municipality 
risk-financing internal service fund; or if the legal, regulatory, or indenture 
restrictions prevent the inclusion of a trust fund in a health care organization's 
financial statements). In those circumstances, the provisions of paragraphs 8.21 
and 8.22 apply.
8.21 In general, estimated losses from asserted and unasserted claims are 
accrued and reported, as indicated in paragraphs 8.03 through 8.12. The esti­
mated losses are not based on payments to the trust fund. However, accounting 
for a health care organization that participates in a pooled fund depends on 
the extent to which the associated risks and rewards have been transferred to 
another party. An organization that transfers its risk of loss to the common 
trust fund and forfeits its rights to any excess funding should expense its con­
tributions and account for its participation in the trust fund based on the type 
of coverage obtained (for example, occurrence basis, claims-made, or retrospec­
tively rated). Governmental health care entities that are component units of a 
state or local government reporting entity and that participate in that entity's 
risk-financing internal service fund should report claims expenses equal to the 
charges from the internal service fund if those charges meet the requirements 
of paragraphs 65 through 68, as amended, of GASB Statement No. 10.
8.22 The existence of the trust fund and whether it is irrevocable is dis­
closed in the financial statements.
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Governmental Health Care Enterprises
8.23 Governmental health care enterprises that are component units of a 
state or local governmental reporting entity and that participate in that entity's 
risk-financing internal service fund should report claims expenses equal to the 
charges from the internal service fund if those charges meet the requirements 
of paragraphs 65 through 68, as amended, of GASB Statement No. 10. A govern­
mental health care enterprise that participates in a public entity risk pool with 
transfer or pooling of risk should present its premium or required contribution 
as insurance expense, as discussed in GASB Statement No. 10, paragraphs 69, 
as amended, and 70. Enterprises participating in public entity risk pools with­
out transfer or pooling of risk should report payments to pools as deposits and 
recognize and measure claims liabilities in accordance with GASB Statement 
No. 10, paragraphs 53 through 58, as amended. GASB Statement No. 34, Basic 
Financial Statements—and Management's Discussion and Analysis—for State 
and Local Governments, paragraphs 116, 119, and 120, requires disclosures 
about long-term liabilities (such as claims and judgments). Information to be 
presented includes beginning and ending balances, increases, decreases, and 
the portions of each item that are due within one year.
Auditing Commitments and Contingencies
8.24 Auditing objectives and procedures for commitments and contingen­
cies generally are similar to those of other organizations. The independent au­
ditor may need to consider the specific auditing objectives, selected control ac­
tivities, and auditing procedures presented in Exhibit 8-1 at the end of this 
chapter.
Auditing Medical Malpractice Loss Contingencies
8.25 The existence of an insurance policy, by itself, is no assurance that 
malpractice contingencies are assumed by others. The auditor should review 
the insurance contracts and determine the extent of the risk retained by the 
provider. Specific auditing procedures to consider include the following:
•  Determine the type (such as occurrence basis or claims-made) and 
level (per occurrence or in the aggregate) of insurance protection the 
provider has obtained.
•  Determine if the coverage actually transfers the malpractice risks. Is 
the insurance with a related party (for example, a captive insurance 
company)? Does it provide for retrospective premiums or similar ad­
justments?
Once the extent of the risk retained is understood, the auditor will be able to 
determine the nature, extent, and timing of other auditing procedures.
8.26 If a health care organization has transferred the risk of loss to a fi­
nancially viable third party by purchasing insurance coverage of sufficient lim­
its on an occurrence basis, no additional auditing procedures are necessary. 
If the organization retains all or a portion of the risk through self-insurance 
or has purchased a claims-made policy, the independent auditor should per­
form additional auditing procedures to obtain reasonable assurance that the 
organization's accounting for medical malpractice losses is in accordance with 
GAAP.
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8.27 The independent auditor should consider the extent to which the re­
newal of a claims-made policy or the purchase of tail coverage after the balance- 
sheet date prior to the issuance of the financial statements limits the entity's 
liability exposure as of the balance-sheet date. If an entity either renews a 
claims-made policy or purchases tail coverage, and the new policy covers claims 
asserted during the new policy term (regardless of when the incident occurred), 
the entity has transferred to the insurer the risk for that portion of the entity 's 
claims that is expected to be reported during the new policy term (up to the new 
policy limits). Accordingly, the entity's liability for the IBNR claims transferred 
would not exceed the premium on the new policy, except for anticipated claims 
in excess of the new policy limits.
8.28 Management's intent to renew a claims-made policy is not sufficient 
to constitute a limit on IBNR claims as of the balance-sheet date unless man­
agement contractually obligates itself for renewal before the issuance date of 
the financial statements and the cost is expensed in the period covered by the 
financial statements. The requirement to renew a claims-made policy or to pur­
chase and expense tail coverage applies even if state regulations require that 
renewal of claims-made coverage be offered continually.
8.29 If the insured has the unilateral option to purchase tail coverage at a 
premium that may not exceed a stipulated maximum, and the provider intends 
to purchase that coverage, the amount of IBNR loss to be accrued may effectively 
be limited to the maximum tail-coverage premium stated in the policy. However, 
providers in these circumstances that do not intend to purchase tail coverage 
may not accrue the cost of obtaining that coverage as a substitute for the IBNR 
accrual.
Auditing Accounting Estimates
8.30 Management is responsible for making the accounting estimates that 
are included in the financial statements. Management is also responsible for 
providing proper disclosure of (1) the use of estimates in the preparation of 
financial statements and (2) certain significant estimates (SOP 94-6, Disclosure 
of Certain Significant Risks and Uncertainties).2 The auditor is responsible for 
evaluating the reasonableness of management's estimates and the adequacy of 
the related disclosures. The auditor does this using one or more of the following 
approaches:
a. Test the process used by management to develop the estimate.
b. Develop an independent expectation of the estimate to corroborate 
the reasonableness of management's estimate.
c. Review subsequent events or transactions occurring prior to com­
pletion of fieldwork.
8.31 In evaluating management's estimates of asserted and unasserted 
claims, the auditor should consider factors such as management's description 
and evaluation of asserted claims and unasserted claims arising from reported 
incidents; the lawyer's (and, if appropriate, the outside risk manager's) assess­
ment of asserted claims and reported incidents not covered by insurers; and
2 See paragraphs 8.40 through 8.43. SOP 94-6 does not pertain to governmental entities unless 
the entity has elected to follow all FASB pronouncements under paragraph 7 of GASB Statement 
No. 20, Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities 
That Use Proprietary Fund Accounting. (See footnote 1 in Chapter 1.)
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the actuary's evaluations of the aggregate liability covering asserted claims 
and unasserted claims arising from reported and unreported incidents.
8.32 Written assurances should be obtained from management that it has 
disclosed all such matters required to be disclosed by FASB Statement No. 5.
8.33 In evaluating the information provided by legal counsel, it may be 
necessary to supplement the written representations with inquiries if the rep­
resentations are not clear regarding the probability of the litigation outcome or 
the potential range of loss.3
8.34 The auditor should consider the frequency of losses due to unreported 
incidents and the magnitude of prior losses and underlying causes for the IBNR 
claims. If there is a basis for an accrual, the auditor should then determine 
whether the entity's prior history supports the estimation of the number of 
claims and the probable settlement value.
Use of Actuaries and Actuarial Methods
8.35 An actuary may be engaged to provide or review the estimate of the 
medical malpractice loss amount or range of amounts or to assist in developing 
certain factors and assumptions used in estimating the malpractice liability. 
The decision to use an actuary should be based on a consideration of whether 
(a) the estimated claim liability is potentially material to the fair presentation 
of financial statements in conformity with GAAP and (b) special knowledge is 
required to estimate the claim liability.
8.36 If an actuary is involved in a substantial way in determining the 
amount of a provider's malpractice self-insurance liability, the independent au­
ditor should follow the requirements of SAS No. 73, Using the Work of a Spe­
cialist (AICPA, Professional Standards, vol. 1, AU sec. 336). The independent 
auditor should consider the actuary's professional qualifications, reputation, 
prior experience in estimating malpractice claim losses, and relationship to the 
client. There should be an understanding among the auditor, the client, and the 
actuary of the objectives and scope of the analysis and the methods and assump­
tions used. The independent auditor should be aware of (a) the limitations of 
assurances in actuarial calculations due to uncertainties and (6) restrictions as 
to the use of the actuarial reports. The independent auditor is responsible for de­
termining the adequacy of the actuary's report for purposes of corroborating the 
representations in the financial statements. The independent auditor should 
perform an appropriate test of the accounting data provided by the client to 
the actuary. Such accounting data may include historical claim experience, pol­
icy terms (such as coverage, expiration, deductibles, presence of retrospectively 
determined premiums, and indemnity limitations), exposure data (such as the 
number of beds, high-risk medical specialties, outpatient visits, and emergency 
room visits), and information about risk management systems, personnel, and 
procedures.
3 According to SAS No. 12, Inquiry of a Client's Lawyer Concerning Litigation, Claims, and 
Assessments (AICPA, Professional Standards, vol. 1, AU sec. 337), a letter of audit inquiry to the lawyer 
handling the claims is the auditor's primary means of obtaining corroboration of the information 
furnished by management concerning claims made and known incidents for which claims have not 
been made that are either uninsured or in excess of the insurance coverage. Audit inquiry letters 
generally would not be required with respect to reported contingencies that were not considered to 
have a material potential loss. The inability or unwillingness of counsel to evaluate asserted claims 
and or reported incidents would give rise to a modification of the auditor’s opinion.
AAG-HCO 8.32
Commitments and Contingencies 127
8.37 An accrual for malpractice losses should be based on estimated ulti­
mate losses and costs associated with settling claims. Accruals should not be 
based on recommended funding amounts, which in addition to a provision for 
the actuarially determined liability also includes a provision for (a) credit for 
investment income and (b) a margin for risk of adverse deviation. The following 
are examples of factors to consider and adjustments that may be required to 
convert actuarially determined malpractice funding amounts to an appropriate 
loss accrual to be reported in the financial statements:
•  The risk of adverse deviation is an additional cost factor applied to 
bring a funding requirement to a selected confidence level. This factor 
does not meet the criteria for recognition as a liability in accordance 
with FASB Statement No. 5.
•  An evaluation should be made of the extent and validity of industry 
data when the credibility factor actuarial technique is used. The lower 
the credibility factor, the greater the blending of industry data. This 
may create an unacceptable level of industry data at lower confidence 
levels. Further, a low credibility factor may indicate that provider- 
specific data is not sufficient to support the claims liability estimation 
process.
•  A review of the discounting approach used is necessary to develop the 
required disclosure. The impact on the discounting calculation of any 
other adjustment made to the actuarially determined amounts (such 
as risk of adverse deviation or the credibility of the risk management 
system) has to be evaluated.
•  A review of the expenses included in the loss estimation process should 
be made. Such expenses include the expense of settlement and litiga­
tion (that is, allocated loss adjustment expenses).
8.38 Limitations on the availability of provider-specific data, lack of a suf­
ficient patient population for claims projection purposes, a very low credibility 
factor, and a variety of other factors may cause the actuary's estimate of loss to 
be of limited value in developing an estimate of the liability under GAAP.
Risks and Uncertainties
8.39 Uncertainties arise when the evidence available is insufficient for a 
reasonable estimation of the effects of the outcome of a particular future event 
on the current financial statements. Normally, the resolution of the uncertainty 
is prospective, and sufficient evidence cannot be expected to exist at the time 
of the audit. In these situations, it cannot be determined what adjustments, if 
any, to the financial statements may be appropriate. The existence of such an 
uncertainty, if material, ordinarily should result in the inclusion of an explana­
tory  paragraph in the auditor's report. In certain circumstances, the possible 
eff ects of the uncertainty on the financial statements may be so pervasive that 
the balance of the financial statements has little meaning. In these cases, a 
disclaimer of opinion may be appropriate.
8.40 SOP 94-6 requires entities to include in their financial statements 
information about—
a. The nature of their operations.
b. Use of estimates in the preparation of financial estimates.
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In addition, if certain specified disclosure criteria are met, it requires entities 
to include in their financial statements disclosures about—
a. Certain significant estimates.
b. Current vulnerability due to certain concentrations.
8.41 Paragraph 18 of SOP 94-6 gives examples of items that may be based 
on estimates that are particularly sensitive to changes in the near term. Exam­
ples of similar estimates that may be included in financial statements of health 
care organizations include, but are not limited to, the following;
•  Third-party revenue and related receivables
•  Assets subject to impairment, for example, goodwill
•  Environmental remediation-related obligations
•  Litigation-related contingencies, for example, fraud and abuse actions 
by regulators
•  Estimated risk pool settlements arising from managed care contract­
ing
•  Amounts reported for long-term obligations such as amount reported 
for pensions and postemployment benefits
•  Estimated net proceeds recoverable, the provisions for expected loss to 
be incurred, or both, on disposition of a business or assets
8.42 SOP 00-1 provides guidance to auditors regarding uncertainties in­
herent in health care revenue recognition. Examples of risks unique to the 
government-contracting environment are presented in paragraph 7 of the SOP. 
Also, in the health care environment, it is almost always at least reasonably 
possible that estimates regarding third-party payments could change in the 
near term as a result of one or more future confirming events (for example, 
regulatory action reflecting local or national audit or enforcement initiatives). 
For most entities with significant third-party revenues, the effect of the change 
could be material to the financial statements. Where material exposure exists, 
the uncertainty regarding revenue realization is disclosed in the notes to the 
financial statements.4
8.43 Examples of concentrations that may meet the criteria that require 
disclosure in the financial statements of health care organizations in accordance 
with paragraph 21 of SOP 94-6 include the following:
•  Concentrations in the volume of business transacted with a particular 
payor, supplier, lender, grantor, or contributor
•  Concentrations in revenue from particular products, services, or fund­
raising events
•  Concentrations in the available sources of supply of material, labor, or 
services, or of licenses or other rights used in the entity's operations
•  Concentrations in the market or geographic area in which an entity 
conducts its operations
4 A sample disclosure is provided in SOP 00-1 that among other things indicates laws and reg­
ulations governing the Medicare and Medicaid programs are extremely complex and subject to inter­
pretation. As a result, there is at least a reasonable possibility that recorded estimates will change 
by a material amount in the near term. SOP 00-1 is included as Appendix E to this Guide.
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Evaluating Lawyers' Responses
8.44 Determining the outcome of pending or threatened litigation, claims 
and assessments (including unasserted claims and assessments) normally is 
beyond the auditor's professional competence. Accordingly, the auditor's eval­
uation of the need for disclosures or report modifications is based primarily 
on the opinion of the lawyer handling the matter. The American Bar Associ­
ation (ABA) has adopted a Statement of Policy Regarding Lawyers' Responses 
to Auditors' Requests for Information under which lawyers accept certain re­
sponsibility for responses to auditors' inquiries. However, the ABA Statement 
of Policy is not enforceable by the ABA in the same way the AICPA is able to 
enforce its standards under the accounting profession's Code of Professional 
Conduct. As a result, lawyers' responses may vary widely.
8.45 Interpretation No. 7 of SAS No. 12, entitled "Assessment of a Lawyer's 
Evaluation of the Outcome of Litigation" (AICPA, Professional Standards, vol. 
1, AU sec. 9337.18-.22) includes the following examples of evaluations of litiga­
tion, which may be considered to communicate in a sufficiently clear manner a 
remote likelihood of an unfavorable outcome:
•  "We are of the opinion that this action will not result in any liability 
to the company."
•  "It is our opinion that the possible liability to the company in this 
proceeding is nominal in amount."
•  "We believe the company will be able to defend this action successfully."
•  "We believe that the plaintiff's case against the company is without 
merit."
•  "Based on the facts known to us, after a full investigation, it is our 
opinion that no liability will be established against the company in 
these suits."
8.46 On the other hand, the lawyer may use terms, such as meritorious 
defenses, that have different meanings to different lawyers. The Interpreta­
tion includes the following examples of lawyers' evaluations that are unclear 
regarding the likelihood of an unfavorable outcome: •
•  "This action involves unique characteristics wherein authoritative le­
gal precedents do not seem to exist. We believe that the plaintiff will 
have serious problems establishing the company's liability under the 
act; nevertheless, if the plaintiff is successful, the award may be sub­
stantial."
•  "It is our opinion that the company will be able to assert meritorious 
defenses to this action." (The term "meritorious defenses" indicates that 
the company's defenses will not be summarily dismissed by the court; 
it does not necessarily indicate the lawyer's opinion that the company 
will prevail.)
•  "We believe the action can be settled for less than the damages 
claimed."
•  "We are unable to express an opinion as to the merits of the litigation 
at this time. The company believes there is absolutely no merit to the 
litigation." (If the company's lawyer, with the benefit of all relevant 
information, is unable to conclude that the likelihood of an unfavorable
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outcome is "remote", it is unlikely that management would be able to 
form a judgment to that effect.)
•  "In our opinion, the company has a substantial chance of prevailing 
in this action." (A "substantial chance", a "reasonable opportunity", 
or similar terms indicate more uncertainty than an opinion that the 
company will prevail.)
8.47 When the lawyer's response is unclear, the auditor may request a con­
ference to clarify the lawyer's opinion. If the response is still unclear or the ma­
teriality of the uncertainty cannot be determined, the auditor should consider 
the guidance in paragraphs 29 through 32 of SAS No. 58, Reports on Audited 
Financial Statements, as amended by SAS No. 19, Amendment to Statement on 
Auditing Standards No. 58, Reports on Audited Financial Statements (AICPA, 
Professional Standards, vol. 1, AU sec. 508).
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Auditing
8.48 The independent auditor may need to consider the examples of spe­
cific auditing objectives, selected control activities, and auditing procedures for 
commitments and contingencies that are presented in Exhibit 8-1.
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Exhibit 8-1
Auditing Considerations
Financial Statement 
Assertions
Malpractice Loss Contingencies
Specific Auditing 
Objectives
Existence and 
occurrence, 
completeness, 
rights and 
obligations, and 
valuation
The liability for 
malpractice 
claims is reported 
properly in the 
balance sheet.
Selected Control 
Activities
Insurance 
coverage is 
reviewed 
regularly, 
including the 
financial 
viability of the 
insurer.
The risk 
management 
system identifies 
and monitors 
malpractice 
incidents and 
evaluates 
associated losses.
Outside legal 
counsel and 
insurance 
carriers review 
and monitor all 
claims.
The adequacy of 
malpractice 
accruals is 
reviewed 
regularly by 
management, 
including 
information 
obtained from 
qualified 
specialists. 
Information 
supplied to 
specialists is 
reviewed for 
accuracy and 
completeness. 
Actuarial 
assumptions are 
reviewed for 
compliance with 
GAAP.
Auditing
Procedures
Review the amount 
of insurance 
coverage, the type 
of coverage 
(claims-made or 
occurrence), the 
deductible 
provisions, and so 
forth, to determine 
the level of risk 
that is retained by 
the entity.
Consider the 
financial viability 
of the insurance 
carrier.
Send letters of 
inquiry to 
malpractice 
insurance carriers 
and legal counsel 
(in accordance 
with SAS No. 12).
Review and test 
the method of 
estimating 
accruals (for 
example, review 
actuarial reports 
and prior historical 
loss experience).
Determine that 
additional 
premiums charged 
by insurers for 
retrospectively 
related policies are 
reported as a 
liability.
(continued)
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Financial Statement Specific Auditing 
Assertions Objectives
Presentation and 
disclosure
Selected Control 
Activities
Changes in 
the risk 
management 
system are 
communicated 
on a timely basis.
Auditing
Procedures
Review prior 
estimates and 
historical loss 
experience.
Determine 
whether 
uncertainties 
related to medical 
malpractice claims 
need to be 
disclosed in the 
auditor's report.
The program of
medical
malpractice
insurance
coverage and the
basis for any loss
accruals are
disclosed
adequately in the
financial
statements.
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Chapter 9
Net Assets (Equity)
Investor-Owned Health Care Organizations
9.01 The equity accounts of investor-owned health care entities are similar 
to those of other investor-owned businesses.
Not-for-Profit Health Care Organizations
9.02 The balance sheets of not-for-profit health care organizations should 
report separate amounts for each of three classes of net assets:1 (a) permanently 
restricted net assets, (b) temporarily restricted net assets, and (c) unrestricted 
net assets. This is based on the existence or absence of donor-imposed restric­
tions.
9.03 Unrestricted net assets generally result from revenues from provid­
ing or agreeing to provide health care services, receiving unrestricted contribu­
tions and grants, or receiving dividends or interest from investing in income- 
producing assets minus expenses incurred in providing or agreeing to provide 
health care services, providing other community benefits, and performing ad­
ministrative functions. The only limits on the use of unrestricted net assets are 
the broad limits resulting from the nature of the provider's organization; the 
environment in which the organization operates; the purposes specified in its 
articles of incorporation or in its bylaws; or limits resulting from contractual 
agreements with suppliers, creditors, and others entered into in the course of 
business. Information about significant contractual limits, including the exis­
tence of restrictive debt covenants, generally is provided in the notes to the 
financial statements. Similarly, information about self-imposed limits may be 
provided either on the face of the balance sheet or in the notes to the financial 
statements. Such specifics include information about voluntary resolutions by 
the entity's governing board to designate a portion of its unrestricted net assets 
for identified purposes (for example, funded depreciation).
9.04 Information about the nature and amounts of different types of per­
manent restrictions or temporary restrictions should be provided either by re­
porting their amounts on the face of the financial statements or by including 
relevant details in the notes to the financial statements. Separate line items 
may be reported within permanently restricted net assets (or in the notes to the 
financial statements) to distinguish between permanent restrictions for hold­
ings of (a) assets, such as land or works of art, donated with stipulations that 
they be used for a specified purpose, be preserved, and not be sold, or (b) assets 
donated with stipulations that they be invested to provide a permanent source 
of income (that is, permanent endowment funds).
9.05 Similarly, separate line items may be reported within temporarily re­
stricted net assets (or in the notes to the financial statements) to distinguish 
between temporary restrictions for (a) support of particular operating activi­
ties, (6) investment for a specified term, (c) use in a specified future period, or
1 Though some health care organizations may use other terms, such as equity, this Guide uses 
the term net assets to describe residual interest.
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(d) acquisition of long-lived assets. Donors' temporary restrictions may require 
that resources be used in a later period or after a specified date (time restric­
tions) or that resources be used for a specified purpose (purpose restrictions) or 
both. For example, gifts of cash and other assets with stipulations that they be 
invested to provide a source of income for a specified term and that the income 
be used for a specified purpose are restricted both as to time and purpose.
9.06 The nature of the restrictions on donor-restricted resources should be 
disclosed in the financial statements.
Governmental Health Care Organizations *
9.07 The statements of net assets/balance sheets of governmental health 
care entities should report net assets/equity in three components: (1) invested 
in capital assets, net of related debt; (2) restricted (distinguishing between 
major categories of restrictions), and (3) unrestricted. Either term net assets or 
equity may be used to refer to the difference between assets and liabilities. The 
term fund balance should not be reported on the face of the statement. When 
governmental health care entities first apply GASB Statement No. 34, Basic 
Financial Statements—and Management's Discussion and Analysis—for State 
and Local Governments, classifying net assets into the three required categories 
should begin by adding together all previously reported fund balance amounts. 
Calculating each of the three required components is described in paragraphs
9.08 through 9.10.
9.08 As discussed in GASB Statement No. 34, paragraph 33, the net asset 
component, invested in capital assets, net of related debt should be the sum of 
capital assets (capital assets are defined in paragraph 19 of GASB Statement 
No. 34), net of accumulated depreciation less any debt issued to finance those 
assets. Invested in capital assets, net of related debt should not include any 
restricted resources that must be used to acquire capital assets, (such as unex­
pended debt proceeds, or capital grants and contributions), or debt attributable 
to significant amounts of unexpended debt proceeds. Capitalized costs of is­
suance are included with the same category as the related debt, as discussed in 
the GASB staff document Comprehensive Implementation Guide—2004 (GASB 
Q&A—2004 Edition), item 7.130 (see paragraph 1.11 in this Guide).
9.09 The term restricted is defined by GASB Statement No. 34, paragraphs 
34, as amended, and 99.† A restriction is a constraint placed on the use of assets 
or net assets that is either externally imposed (such as by creditors through 
debt covenants) or imposed by law through constitutional provisions or en­
abling legislation. Restricted net assets should be reported based on this defi­
nition of restricted. As discussed in paragraph 98 of GASB Statement No. 34, 
major categories of restrictions should be reported on the face of the state­
ment of net assets/balance sheet, for example, net assets restricted for capital 
acquisitions. As discussed in the GASB Q&A—2004 Edition, item 7.129 (see 
paragraph 1.11 in this Guide), unexpended debt proceeds that must be used to *†
* This section contains guidance that is limited to governmental health care organizations that 
report as proprietary activities. This section does not apply to governmental health care organizations 
that report using governmental funds.
† GASB Statement No. 46, Net Assets Restricted by Enabling Legislation, amends GASB State­
ment No. 34, Basic Financial Statements—and Management's Discussion and Analysis—for State 
and Local Governments, effective for financial statements for periods beginning after June 15, 2005. 
Earlier application is encouraged.
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acquire or construct capital assets and the portion of the debt attributable to 
the unexpended proceeds should be included in restricted net assets. When a 
governmental health care entity reports restricted net assets arising from per­
manent endowments, restricted net assets should be reported in two additional 
components—expendable and nonexpendable, as discussed in paragraph 35 of 
GASB Statement No. 34. As discussed in the GASB Q&A—2004 Edition, item 
7.485 (see paragraph 1.11 in this Guide), no category of restricted net assets 
can be negative. If liabilities that relate to restricted assets exceed those assets, 
no balance should be reported. The negative amount should be reported as a 
reduction of unrestricted net assets.
9.10 GASB Statement No. 34, paragraph 98, prohibits governmental en­
tities from reporting internal designations in the net assets section of their 
statements of net assets/balance sheets. Designations are management's plans 
for the use of resources. They should not be afforded the same status as re­
strictions. Internally designated net assets should be reported as unrestricted 
net assets and should not be displayed separately in the net assets section 
of the statement of net assets/balance sheet, as discussed in paragraph 37 of 
GASB Statement No. 34. (Designated assets, however, may be reported in the 
statement of net assets/balance sheet, as discussed in paragraph 3.01 in this 
Guide.)
9.11 Net assets at the end of the reporting period that are restricted by 
enabling legislation should be disclosed in the notes to the financial statements. ‡
Auditing
9.12 The independent auditor may need to consider the examples of specific 
auditing objectives, selected control activities, and auditing procedures relating 
to net assets (equity) that are presented in Exhibit 9-1. 
‡ Disclosure of net assets that are restricted by enabling legislation is required by GASB State­
ment No. 46, effective for financial statements for periods beginning after June 15, 2005. Earlier 
application is encouraged.
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Exhibit 9-1
Health Care Organizations
Auditing Considerations
Financial Statement Specific Auditing 
Assertions Objectives
Net Assets (Equity)
Rights and 
obligations
Presentation and 
disclosure
Resources are 
used and 
accounted for in 
accordance with 
donor and grantor 
restrictions.
Selected Control 
Activities
Management 
monitors 
compliance with 
these
restrictions.
Net assets are 
presented and 
disclosed properly 
in the financial 
statements.
Procedures 
ensure proper 
authorization, 
recording, and 
presentation.
Auditing
Procedures
Review the 
minutes of board 
and board 
committee 
meetings for 
evidence of donor 
restrictions.
Determine 
compliance with 
donor and grantor 
restrictions.
Test significant net 
asset transactions 
to determine that 
they are properly 
authorized and 
recorded.
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Revenue, Expenses, Gains, and Losses
Conceptual Framework for Reporting Revenue, Expenses, 
Gains, and Losses
10.01 FASB Concepts Statement No. 6, Elements of Financial Statements, 
provides a useful conceptual framework for preparers of financial statements to 
distinguish among elements of financial statements for purposes of display. Ad­
ditionally, not-for-profit organizations are subject to the requirements of FASB 
Statement No. 117, Financial Statements of Not-for-Profit Organizations.1 This 
chapter draws on the concepts contained in FASB Concepts Statement No. 6 
and FASB Statement No. 117 in discussing revenue, expenses, gains, and losses 
with respect to health care organizations. Expenses are not generally netted 
against revenues, whereas gains and losses may be displayed as net amounts. 
The application of these concepts to the classification of revenue, expenses, 
gains, and losses in the statement of operations of health care organizations is 
discussed in paragraphs 10.02 through 10.11.
10.02 FASB Concepts Statement No. 6, paragraph 78, defines revenues 
as "inflows or other enhancements of assets of an entity or settlements of its 
liabilities (or a combination of both) from delivering or producing goods, ren­
dering services, or other activities that constitute the entity's ongoing major or 
central operations." Similarly, paragraph 80 defines expenses as "outflows or 
other using up of assets or incurrences of liabilities (or a combination of both) 
from delivering or producing goods, rendering services, or carrying out other 
activities that constitute the entity's ongoing major or central operations."
Distinguishing Charity Care From Bad Debt Expense 
or Allowance
10.03 Charity care represents health care services that are provided but 
are never expected to result in cash flows. As a result, charity care does not 
qualify for recognition as receivables or revenue in the financial statements. 
Distinguishing charity care from bad-debt expense (or allowance, for govern­
mental health care entities2) requires the exercise of judgment. Charity care 
is provided to a patient with demonstrated inability to pay. Each organization 
establishes its own criteria for charity care consistent with its mission state­
ment and financial ability. Only the portion of a patient's account that meets 
the organization's charity care criteria is recognized as charity. Although it is 
not necessary for the entity to make this determination upon admission or reg­
istration of an individual, at some point the entity must determine that the 
individual meets the established criteria for charity care. (See paragraph 10.27 
for disclosure requirements relating to charity care.)
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1 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1 
in Chapter 1.)
2 See paragraph 10.27 in this chapter for a discussion about the reporting of allowances by 
governmental health care entities.
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10.04 Revenue usually is recorded when coverage is provided to an enrollee 
or the service is provided to a patient or resident. Revenue is classified based on 
the type of service rendered or contracted to be rendered. Examples of revenue 
include—
•  Patient service revenue, which is derived from fees charged for patient 
care. This may be based on diagnosis related group (DRG) payments, 
resource-based relative value scales (RBRVS) payments, per diems, 
discounts, or other fee-for-service arrangements.
•  Premium revenue, which is derived from capitation arrangements.
•  Resident service revenue, which may be related to maintenance fees, 
rental fees, or amortization of advance fees.
10.05 Some not-for-profit health care enterprises may receive relatively 
small amounts of contributions, grants, or tax support. Such amounts, whether 
temporarily restricted, permanently restricted, or unrestricted, are recognized 
as revenue or gains when they are received. Special considerations pertain­
ing to revenue recognition of promises to give in future periods (pledges) are 
discussed in Chapter 5 and in paragraphs 10.08 through 10.11 in this Guide. 
FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization 
or Charitable Trust That Raises or Holds Contributions for Others,3 establishes 
standards for transactions in which a donor makes a contribution by transfer­
ring assets to a recipient organization—a not-for-profit organization or a chari­
table trust—that accepts the assets from the donor and agrees to use the assets 
on behalf of or transfer the assets, their investment return, or both to another 
entity—the beneficiary—named by the donor.4 If a donor transfers assets to 
an agent, trustee, or intermediary (recipient organization) and specifies a non­
governmental health care organization as the ultimate recipient (the specified 
beneficiary) of the contribution or grant, that specified health care organiza­
tion should recognize its rights to the assets held by a recipient organization as 
an asset and contribution revenue unless the recipient organization is explic­
itly granted variance power. (See paragraph 15 of FASB Statement No. 136.) 
Variance power is the unilateral power to redirect the use of the transferred 
assets to an entity or individual other than the specified beneficiary. Explicitly 
grants means that the donor should explicitly refer to the recipient organiza­
tion's ability to exercise variance power in the instrument that transfers the 
assets. Unilateral power means that the recipient organization can override the 
donor's instructions without approval from the donor, the specified beneficiary, 
or any other interested party. (See paragraph 12 of FASB Statement No. 136.) 
If the recipient organization is explicitly granted variance power, the speci­
fied health care organization (beneficiary) should not recognize its potential for 
future distributions from the assets held by the recipient organization. (See 
paragraph 16 of FASB Statement No. 136.) Those distributions, if they occur.
3 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1 
in Chapter i.)
4 FASB Statement No. 136 also established standards for transactions that take place in a similar 
manner but are not contributions because the transfers are revocable, repayable, or reciprocal. For 
example, if a resource provider transfers assets to a recipient organization and names itself or its 
affiliate as beneficiary, that transaction is reciprocal even if the resource provider grants variance 
power. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.21, 11.23, and 
11.24 of this Guide. This Guide does not use the word donor in discussing those transactions because 
they are not contributions.
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should be recognized as contributions by the specified health care organization 
(beneficiary) when received or unconditionally promised. (See further discus­
sion at paragraph 5.11 in this Guide. Also, special considerations pertaining 
to transfers between related entities are discussed in paragraphs 10.08, 11.21 
through 11.24 and 11.29 through 11.33 in this Guide.)
10.06 Governmental health care enterprises may also receive contribu­
tions, grants, or tax support. Governmental health care enterprises classify 
these transactions into one of four classes of nonexchange transactions based 
on their principal characteristics, as discussed in GASB Statement No. 33, Ac­
counting and Financial Reporting for Nonexchange Transactions, paragraph 
7, as amended by GASB Statement No. 36, Recipient Reporting for Certain 
Shared Nonexchange Revenues. (GASB Statement No. 33, as amended, ap­
plies to transactions involving financial and capital resources. GASB Statement 
No. 33, as amended, does not apply to other resources, such as contributed ser­
vices.) Transactions that are not recognizable because they are not measurable 
should be disclosed.
10.07 Other revenue, gains, or losses are derived from services other than 
providing health care services or coverage to patients, residents, or enrollees. 
These typically include—
Interest and dividends from all funds held by a trustee, malpractice 
funds, or other miscellaneous investment activities.
Certain realized changes in market values of marketable securities 
(see Chapter 4).
Fees from educational programs, which include tuition for schools 
(such as nursing) or laboratory and X-ray technology.
Rental of health care facility space.
Sales of medical and pharmaceutical supplies to employees, physi­
cians, and others.
Fees charged for transcripts for lawyers, insurance companies, and 
others.
Proceeds from sale of cafeteria meals and guest trays to employees, 
medical staff, and visitors.
Proceeds from sale of scrap, used X-ray film, etc.
Proceeds from sales at gift shops, snack bars, newsstands, parking lots, 
vending machines, or other service facilities operated by the health 
care organization.
10.08 Interest earned and gains and losses on investments and other as­
sets (or liabilities) are reported by not-for-profit organizations as increases or 
decreases in unrestricted net assets, unless their use is temporarily or perma­
nently restricted by explicit donor stipulation or by law. Net assets released 
from restriction, such as those related to the fulfillment of time or purpose 
restrictions, should be reported separately in the financial statements or dis­
closed in the notes. Additional guidance on accounting for investments can be 
found in Chapter 4. Occasionally, nongovernmental health care organizations 
may receive funds from (or transfer funds to) a not-for-profit organization or 
a charitable trust. If the not-for-profit organization is an affiliate, those trans­
fers generally are either: (a) an equity transfer, (b) an equity transaction, or 
(c) a loan or advance. Equity transfers are discussed in paragraph 11.20. Eq­
uity transactions are discussed in paragraphs 11.21 through 11.24. Loans and
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advances to related entities are discussed in paragraph 11.26. In limited cir­
cumstances, those transfers are contributions. The circumstances in which a 
distribution from a not-for-profit organization or charitable trust to an affili­
ated nongovernmental health care organization is a contribution are described 
in paragraphs 11.32 and 11.33. If the not-for-profit organization or charitable 
trust is not an affiliate, the transaction is either (a) an investment transaction, 
(6) a refundable advance, or (c) a contribution. Investment transactions are 
discussed in paragraphs 4.14 and 4.15. The transfer is a refundable advance 
if it is revocable or repayable. The transfer is a contribution only if it meets 
the definition of a contribution in FASB Statement No. 116; that is, it is an 
unconditional, voluntary, nonreciprocal transfer by an entity acting other than 
as an owner.
10.09 Contributions of noncash assets that are not long-lived assets are 
recognized as revenue or gains in the period received and as assets or a reduc­
tion of liabilities or expenses, depending on the form of the benefits received. 
(For example, a donation of supplies would be reflected as revenue or gains and 
as an increase in inventory or supply expense.) The donations are measured 
at fair value.5 Donations received with no restrictions attached are reported 
as unrestricted support in the statement of operations. Donations with explicit 
donor restrictions attached (other than permanent restrictions) are reported 
as temporarily restricted support. The expiration of these restrictions is recog­
nized in the period when the time stipulated by the donor has elapsed, when the 
stipulated purpose for which the asset was restricted has been fulfilled, or both. 
When the restriction expires, the temporarily restricted net assets are reclas­
sified to unrestricted net assets and reported in the statement of operations as 
"net assets released from restriction." Donor-restricted contributions whose re­
strictions are met in the same reporting period may be reported as unrestricted 
support provided that an organization discloses its accounting policy and ap­
plies the policy consistently from period to period. Donations with explicit donor 
restrictions attached that permanently limit the health care organization's use 
of the contributed assets (for example, permanent endowments) are reported 
as increases in permanently restricted net assets.
10.10 Contributions of long-lived assets, including the use of long-lived as­
sets such as land, buildings, and equipment, are reported as support or gains 
in the period received. The donation is measured at its fair value. If the donor 
places no restrictions on the use of the asset, the contribution is reported as 
unrestricted support. Contributions of long-lived assets with explicit donor re­
strictions are reported as temporarily or permanently restricted support. The 
provider reports expirations of donor restrictions when the stipulation is ful­
filled and the assets are placed in service. At that time, temporarily restricted 
net assets are reclassified to unrestricted net assets and reported in the state­
ment of operations as "net assets released from restriction."
10.11 Donations of cash or other assets that must be used to acquire long- 
lived assets are reported as temporarily restricted support in the period re­
ceived. Expirations of donor restrictions are reported when the acquired long- 
lived assets are placed in service and donor-imposed restrictions are satisfied.
5 Information necessary to estimate the fair value of a donated asset may be obtained from 
various sources as described in FASB Statement No. 116, Accounting for Contributions Received and 
Contributions Made, paragraph 19. The FASB has released an exposure draft of a proposed FASB 
Statement, Fair Value Measurements, that would amend paragraph 19 of FASB Statement No. 116. 
Readers should be alert to the issuance of a final standard.
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The temporarily restricted net assets are reclassified to unrestricted net assets 
and reported in the statement of operations as "net assets released from re­
striction." For providers that prepare classified balance sheets, assets that are 
restricted by donors for acquisition of long-lived assets (such as cash or con­
tributions receivable) are not included in "cash and cash equivalents" or with 
other "contributions receivable.” Rather, those assets are reported in a separate 
section, such as "assets restricted to investment in property and equipment," 
and are sequenced near the "property and equipment" section of the balance 
sheet (see paragraph 3.01).
10.12 The nature and extent of donated services received by health care or­
ganizations varies and can range from the limited participation of many people 
in fund-raising activities to active participation in the entity's service programs; 
their values usually are not recorded. Contributed services should be reported 
as contribution revenue and as assets or expenses if the services create or en­
hance a nonfinancial (that is, nonmonetary) asset (for example, property and 
eq[uipment) or meet all of the following criteria:
a. Require specialized skills
b. Are provided by individuals with those skills (such as accounting, 
financial, construction, educational, electrical, legal, medical, and 
other services provided by accountants, investment advisers, con­
tractors, teachers, electricians, lawyers, doctors, and other profes­
sionals and craftspeople)
c. Would typically need to be purchased by the organization if they 
had not been provided by contribution
Additional guidance with regard to the accounting for and the reporting of 
donated services is provided in FASB Statement No. 116.
10.13 Contributions to governmental health care enterprises are governed 
by GASB Statement No. 33, discussed in paragraph 10.06. GASB Statement 
No. 33 applies to external transactions involving financial and capital resources.
As discussed in GASB Statement No. 33, paragraph 14, purpose restrictions on 
nonexchange revenues (such as grants, contributions, and endowments) do not 
affect when revenues are recognized. Rather, resulting net assets should be 
reported as restricted until the resources have been used for the specified pur­
pose (see paragraph 9.08 of this Guide) or for as long as the resource provider 
requires (for example, for endowments). Unlike not-for-profit health care en­
tities, the statement of revenues, expenses, and changes in net assets/equity 
does not require disaggregation of transactions based on the types of restric­
tions that may exist (such as unrestricted, temporarily restricted, or perma­
nently restricted revenues). Disaggregations such as net assets released from 
restrictions, changes in temporarily restricted net assets, and changes in per­
manently restricted net assets should not be reported in either the statement of 
revenues, expenses, and changes in net assets/equity or in the net assets section 
of the statement of net assets/balance sheet of governmental health care enti­
ties. Interfund transfers are reported after nonoperating revenues and expenses 
in the statement of revenues, expenses, and changes in net assets/equity as dis­
cussed in paragraphs 101 and 112 of GASB Statement No. 34, Basic Financial 
Statements—and Management's Discussion and Analysis—for State and Local 
Governments (see paragraph 1.20 of this Guide). Intra-entity activity between 
a primary government and its component units are accounted for in accordance 
with paragraph 61 of GASB Statement No. 34.
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10.14 Additional guidance regarding accounting for contributions dis­
cussed above can be found in Chapters 5 and 6 of the Audit and Accounting 
Guide Not-for-Profit Organizations, which also addresses the following:
Permanent endowments 
Split-interest agreements 
Gifts in kind
Contributed utilities, facilities, or use of long-lived assets 
Transfers to a not-for-profit organization or charitable trust that raises 
or holds contributions for others (refer to Chapter 5 in the Audit 
and Accounting Guide Not-for-Profit Organizations under the heading 
"Agency Transactions")
10.15 Foundations, business organizations, and other types of entities may 
provide resources to health care organizations under programs referred to as 
grants, awards, or sponsorships. Those asset transfers are contributions if the 
resource providers receive no value in exchange for the assets transferred or 
if the value received by the resource provider is incidental to the potential 
public benefit from using the assets transferred. For governmental health-care 
organizations, these transactions are referred to as nonexchange transactions, 
addressed in GASB Statement No. 33. The asset transfers are exchange or 
exchange-like transactions if the potential public benefit is secondary to the re­
source providers' potential direct benefits. For example, a research grant made 
by a foundation to a hospital would likely be a contribution if the research pro­
gram is to be planned and carried out by the hospital and the hospital has the 
right to publish the results. If, however, the grant is made by a pharmaceutical 
manufacturer that provides potential new medications to be tested in the hos­
pital's research facilities and retains the right to any patents or other results, 
the grant would likely be an exchange transaction.
10.16 For governmental health care entities, capital contributions and con­
tributions to term and permanent endowments are reported as a component 
of the all-inclusive statement of revenues, expenses, and changes in net as- 
sets/equity. Contributions of capital assets or of financial resources required 
to be used to acquire capital assets are required to be reported as revenues 
separately after nonoperating revenues and expenses, in the statement of rev­
enues, expenses, and changes in net assets/equity, as illustrated in paragraph 
1.18 of this Guide. Contributions to term and permanent endowments should 
be reported in the same manner as capital contributions. Capital contributions 
received from other funds of the same financial reporting entity should be re­
ported last as interfund transfers, after nonoperating revenues and expenses 
in the statement of revenues, expenses, and changes in net assets/equity, as 
discussed in paragraph 101 of GASB Statement No. 34 and paragraph 10.13 in 
this chapter.
10.17 Revenues from capital contributions as well as contributions to the 
principal of permanent and term endowments should be reported after nonop­
erating revenues and expenses, as discussed in GASB Statement No. 34, para­
graph 100. Income from permanent or term endowments should be recorded as 
nonoperating revenue, as discussed in the GASB staff document Comprehen­
sive Implementation Guide—2004 (GASB Q&A—2004 Edition), item 7.334 (see 
paragraph 1.11 in this Guide).
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Expenses
10.18 The basis and timing of the recognition of expenses for health care 
organizations generally are the same as for other business enterprises. Ex­
penses arising from nonexchange transactions (such as grants, taxes, and con­
tributions) reported by governmental health care enterprises are recognized 
based on their appropriate class of nonexchange transactions, as discussed in 
paragraph 10.06. Not-for-profit organizations report expenses as decreases in 
unrestricted net assets.
10.19 Statement of Position (SOP) 98-2, Accounting for Costs of Activities 
of Not-for-Profit Organizations and Local Governmental Entities That Include 
Fund Raising, provides guidance for not-for-profit and state and local govern­
mental entities (including health care organizations) that conduct fund-raising 
activities with activities related to other functions, such as program activities 
or supporting services (joint activities). This SOP establishes financial account­
ing standards for accounting for costs of joint activities, and requires financial 
statement disclosures about the nature of the activities for which joint costs 
have been allocated and the amounts of joint costs. SOP 98-2 is included as 
Appendix C to this Guide.
Financial Statement Presentation
10.20 The statement of operations for not-for-profit organizations should 
include a performance indicator that reports results of operations. This perfor­
mance indicator and the income from continuing operations reported by for- 
profit health care enterprises generally are consistent, except for transactions 
that clearly are not applicable to one kind of entity (for example, for-profit 
health care enterprises typically would not receive contributions, and not-for- 
profit health care organizations would not award stock compensation). That 
is, the performance indicator is analogous to income from continuing opera­
tions of a for-profit enterprise. Because of the importance of the performance 
indicator, it should be clearly labeled with a descriptive term such as revenues 
over expenses, revenues and gains over expenses and losses, earned income, or 
performance earnings. The notes to the financial statements should include a 
description of the nature and composition of the performance indicator. Not- 
for-profit organizations should report the performance indicator in a statement 
that also presents the total changes in unrestricted net assets. Other changes 
in net assets may be presented separately or in the same statement.
10.21 Health care organizations should report the following items sepa­
rately from the performance indicator—
a. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting 
entity, are controlled by the reporting entity, or are under common 
control with the reporting entity.
c. Receipt of restricted contributions, including temporary restric­
tions (such as time or purpose) or permanent restrictions.
d. Contributions of (and assets released from donor restrictions re­
lated to) long-lived assets.
e. Items that are required to be reported in or reclassified from other 
comprehensive income, such as minimum pension liabilities in ac­
cordance with paragraph 37 of FASB Statement No. 87, Employers'
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and the effective portion of the gain or loss on derivative instru­
ments designated and qualifying as cash flow hedging instruments.
f . Items that are required to be reported separately under special­
ized not-for-profit standards. These include extraordinary items, 
the effect of discontinued operations, and the cumulative effect of 
accounting changes pursuant to the provisions of FASB Statement 
No. 117;* and unrealized gains and losses on investments not re­
stricted by donors or by law (except for those investments classified 
as trading securities) and investment returns restricted by donors 
or by law, as required by paragraphs 4.07 through 4.10 of this Guide.
10.22 Classifying revenues, expenses, gains, and losses within classes of 
net assets does not preclude incorporating additional classifications within the 
performance indicator. For example, within a class or classes of changes in 
net assets, a not-for-profit organization may classify items as operating and 
nonoperating, expendable and nonexpendable, earned and unearned, recurring 
and nonrecurring, or in other ways. This Guide neither requires nor precludes 
reporting such intermediate measures or subtotals. However, because terms 
such as operating income are used with different meanings, if an intermediate 
measure of operations is reported and its use is not apparent from the details 
provided on the face of the statement, a note to the financial statements should 
describe the nature of the reported measure of operations or the items excluded 
from operations.
10.23 Governmental health care entities should separately report special 
items and extraordinary items at the bottom of the statement of revenues, 
expenses, and changes in net assets/equity, as illustrated in GASB Statement 
No. 34, paragraph 101. Governmental health care entities should report special 
items separately after capital contributions and contributions to permanent 
and term endowments but before extraordinary items, if any. GASB Statement 
No. 34, paragraph 56, defines a special item as a significant transaction or other 
event that is within the control of management and that is either unusual in 
nature or infrequent in occurrence.
10.24 Governmental health care entities are required to distinguish be­
tween operating revenues and expenses and nonoperating revenues and ex­
penses and provide an intermediate total for operating income or loss. GASB 
Statement No. 34, paragraph 102, does not establish a definition of operating. 
Rather, governments are required to establish their own policy defining oper­
ating revenues and expenses that is appropriate to the nature of the activity 
being reported. Once established, an entity's policy should be applied consis­
tently and disclosed in the notes to the financial statements. GASB Statement 
No. 34, paragraph 102, notes that a consideration for determining which rev­
enues and expenses should be reported as operating is how those transactions
Health Care Organizations
* In May 2005, the FASB issued FASB Statement No. 154, Accounting Changes and Error 
Corrections—a replacement of APB Opinion No. 20 and FASB Statement No. 3. FASB Statement No. 
154 changes the accounting and reporting requirements for changes in accounting principle, requir­
ing retrospective application to prior periods' financial statements or to the beginning of the earliest 
period for which retrospective application is practicable. Offsetting adjustments, if any, are made to 
the opening balance for net assets. FASB Statement No. 154 is effective for accounting changes made 
in fiscal years beginning after December 15, 2005. Early adoption is permitted for accounting changes 
made in fiscal years beginning after FASB Statement No. 154 was issued. Conforming changes to 
reflect the issuance of FASB Statement No. 154 will be made in a future edition of this Guide.
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would be classified in the statement of cash flows. Using this approach, transac­
tions that are considered investing, capital and related financing, and noncap­
ital financing activities would normally not be reported as operating revenues 
and expenses. This would include investment revenues and interest expense 
as well as most nonexchange transactions, including most grants, taxes, and 
contributions.
10.25 For governmental health care entities, changes in accounting prin­
ciples, addressed in APB Opinion No. 20, Accounting Changes, as amended, 
should be reported as restatements of beginning net assets/equity, as discussed 
in footnote 13 to paragraph 17 of GASB Statement No. 34.
10.26 For financial reporting purposes, patient service revenue is reported 
net of provisions for contractual and other adjustments in the operating state­
ment. Significant revenue earned under capitation arrangements is reported 
separately. The notes to the financial statements disclose the methods of rev­
enue recognition (for example, policies related to capitation revenue, patient 
service revenue, or contributions). In addition, with regard to contractual ad­
justments and third-party settlements, identification and explanation of the 
estimated amounts that are payable or receivable by the entity are disclosed.
10.27 GASB Statement No. 34, paragraph 100, requires revenues to be 
reported by major source, net of discounts and allowances, and separately iden­
tify pledged revenues. Therefore, governmental health care entities do not re­
port bad debt expense. The amount of discounts and allowances, including the 
increase or decrease in the estimate of uncollectible accounts, should be re­
ported parenthetically on the face of the financial statements, as a separate 
line directly below the revenue amount, or in the notes, as required by GASB 
Statement No. 34, footnote 41 to paragraph 100. Paragraph 10.04 in this chap­
ter provides additional discussion on classification of revenue, and examples of 
revenue, including patient service revenue. As discussed in paragraph 10.26 in 
this chapter, patient service revenue is reported net of contractual and other 
adjustments in the operating statement.
10.28 As discussed in paragraph 10.03, patient service revenue does not 
include charity care. Management's policy for providing charity care, as well 
as the level of charity care provided, should be disclosed in the financial state­
ments. Such disclosure generally is made in the notes to the financial state­
ments and is measured based on the provider's rates, costs, units of service, or 
other statistical measure.
10.29 Expenses may be reported on the face of the financial statements 
using either a natural classification or a functional presentation. Public com­
panies (that is, registrants with the SEC) are required to disclose segment in­
formation in accordance with FASB Statement No. 131, Disclosure about Seg­
ments of an Enterprise and Related Information. Not-for-profit organizations 
that report using a natural classification of expenses are required to disclose 
expenses by functional classification. For governmental health care entities, 
GASB Statement No. 34, paragraph 122, as amended by GASB Statement No.
37, paragraph 17, defines a segment as an identifiable activity (or grouping 
of activities) reported as or within an enterprise fund or an other stand-alone 
entity that: •
•  Has one or more bonds or other debt instruments outstanding with a 
revenue stream pledged in support of that debt, and
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•  Is required by an external party (such as through a bond indenture) to 
account separately for its assets, liabilities, revenues, and expenses.
GASB Statement No. 34, paragraph 122, also details the disclosure required 
for segments.
10.30 Governmental health care entities that receive restricted resources 
are required to disclose whether, when both restricted and unrestricted re­
sources are available, it is their policy to use restricted or unrestricted resources 
first, as discussed in GASB Statement No. 34, paragraph 115(h).
10.31 GASB Statement No. 34, paragraph 121, requires governmental 
health care entities that receive donor-restricted endowments to make certain 
disclosures about their policy for use of investment income generated by those 
endowments.
10.32 As noted in paragraph 10.24 of this chapter, governmental health 
care entities should disclose their policy for defining operating revenues and 
expenses.
10.33 The extent of classification and subclassification of expenses depends 
on many factors, such as the nature and complexity of the health care organi­
zation. For example, some entities may present only two categories: (a) health 
services (including inpatient services, outpatient procedures, home health ser­
vices, etc.) and (b) general and administrative. Others may present additional 
distinctions such as physician services, research, and teaching. Functional al­
locations should be based on full cost allocations. If a not-for-profit health care 
organization includes a ratio of fund-raising expenses to amounts raised in its 
financial statements, it should disclose how that ratio is computed (See para­
graph 20 of FASB Statement No. 136).
1 4 6  Health Care Organizations
Auditing6
10.34 The independent auditor may need to consider the examples of spe­
cific auditing objectives, selected control activities, and auditing procedures to 
audit revenue, expenses, gains, and losses that are presented in Exhibit 10-1.
6 SOP 00-1, Auditing Health Care Third-Party Revenues and Related Receivables, discusses mat­
ters for auditors to consider in testing third-party revenues and related receivables, and provides 
guidance to auditors regarding the sufficiency of evidential matter and reporting on financial state­
ments of health care entities exposed to material uncertainties. SOP 00-1 is included as Appendix E 
to this Guide.
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Exhibit 10-1
Financial Statement 
Assertions
Auditing Considerations
Specific Auditing 
Objectives
Selected Control 
Activities
Revenue and Gains for Health Care Services
Existence and 
occurrence, 
completeness, and 
presentation and 
disclosure
Revenue and 
gains are reported 
in the proper 
period using the 
accrual basis of 
accounting and 
are classified 
properly by the 
type of service 
rendered.
In the statement 
of operations, 
revenue from 
health care 
services is 
reported, net of 
contractual 
adjustments 
and other 
adjustments, in 
the proper period 
and is classified 
properly.
Auditing
Procedures
Procedures help 
ensure that 
revenue is 
accrued as 
services are 
performed or as 
contractual 
obligations are 
satisfied.
Management 
establishes and 
monitors 
controls over the 
recognition of 
revenue.
Controls ensure 
that deductions 
from revenue are 
recorded in the 
proper period 
and are classified 
properly.
Contractual and 
other
adjustments are 
authorized, 
controlled, and 
recorded 
properly.
Charity care, 
bad-debt 
writeoffs, and 
courtesy and 
policy discounts 
are authorized, 
controlled, and 
recorded 
properly.
Perform a 
walk-through of the 
revenue system.
Compare the 
current period's 
revenue with prior 
periods' revenue 
and/or budgets 
and obtain 
explanations for 
large or unusual 
variances.
Consider the 
adequacy of the 
controls over the 
revenue recognition 
process.
Review the 
financial 
statements to 
determine that 
revenue is reported 
net of contractual 
adjustments and 
other adjustments.
Test contractual 
adjustments, other 
adjustments, and 
bad debts to 
determine that they 
are accounted for 
both in accordance 
with the respective 
contracts and the 
entity's policy. 
Determine that 
specific and 
unallocated 
reserves appear 
reasonable and 
comparable to prior 
year.
(continued)
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Financial Statement Specific Auditing Selected Control 
Assertions Objectives Activities
Auditing
Procedures
Review third-party 
payor contracts 
and methods of 
payment and test 
the entity's 
computation of 
estimated 
adjustments to 
revenue as 
required under 
such contracts.
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Chapter 11
The Reporting Entity and Related 
Organizations
Note: In referring to AICPA professional standards (GAAS), this chapter 
cites the applicable sections of the AICPA Professional Standards publica­
tion. In referring to Public Company Accounting Oversight Board (PCAOB) 
professional standards, this chapter cites the applicable sections of the 
 AICPA's publication titled PCAOB Standards and Related Rules. In those 
cases in which the auditing standards of the AICPA and those of the PCAOB 
are the same, this chapter cites the applicable section of the AICPA Profes­
sional Standards publication only.
Overview
11.01 Networks among health care organizations, both vertical and hor­
izontal, are being formed continually and new organizational structures are 
being developed. The dynamics of change in the health care industry and their 
impact on evolving organizational structures must be considered in defining 
the reporting entity.
11.02 An integrated health care system typically consists of multiple re­
lated entities, operating both for-profit and not-for-profit organizations. A not- 
for-profit parent corporation may be the sole corporate member or, through other 
means, it may control other entities such as a not-for-profit hospital, a not-for- 
profit medical foundation that contracts with a for-profit physician group, or 
other not-for-profit providers such as a long-term care center, a substance abuse 
center, a surgery center, or an outpatient clinic. The system also may own stock 
in various for-profit ventures such as HMOs or insurance companies that may 
or may not provide patient care. Fund-raising typically is accomplished through 
a separate foundation. Foundations, auxiliaries, guilds, and similar organiza­
tions frequently assist and, in many instances, are related to the health care 
organization.
Financial Reporting of Governmental Health Care Entities
11.03 The GASB has issued GASB Statement No. 14, The Financial Re­
porting Entity, which addresses issues related to consolidations, application of 
the equity method of accounting, and accounting for various types of joint ven­
tures for governmental entities. GASB Statement No. 14 establishes standards 
for defining and reporting for the financial reporting entity and for reporting its 
participation in joint ventures. GASB Statement No. 39, Determining Whether 
Certain Organizations Are Component Units, amended GASB Statement No. 
14 to provide additional guidance for assessing potential component units in 
determining the financial reporting entity GASB Statement No. 39 may require 
the reporting of certain hospital foundations in the financial statements of gov­
ernmental health care entities, regardless of whether the foundations follow 
FASB or GASB Standards.
AAG-HCO 11.03
Financial Reporting of Nongovernmental Health 
Core Entities*
11.04 The guidance which follows in this chapter relates to for-profit 
and not-for-profit consolidations of parent-subsidiary relationships, whether 
through stock ownership or other means of control. Other circumstances may 
exist in the health care industry where combined financial statements involv­
ing commonly controlled entities are more meaningful than their separate 
financial statements. More specific guidance related to combined financial 
statements can be found in ARB No. 51, Consolidated Financial Statements, 
paragraphs 22 and 23.1
11.05 Whether the financial statements of a reporting health care organi­
zation and those of one or more other for-profit or not-for-profit entities should 
be consolidated, whether those other entities should be reported using the eq­
uity method, and the extent of disclosure that should be required (if any) if 
consolidated financial statements are not presented, should be based on the 
nature of the relationship between the entities.
11.06 Health care organizations may be related to one or more other enti­
ties in numerous ways, including ownership, control, and/or economic interest.
11.07 As discussed in paragraphs 11.10 through 11.17, the existence of 
various forms of control and economic interests result in various financial re­
porting. Certain kinds of control result in consolidation (see paragraph 11.10). 
Other kinds of control result in consolidation only if coupled with an economic 
interest (see paragraph 11.11). Still other kinds of control result in consoli­
dation being permitted but not required, if coupled with an economic interest 
(see paragraph 11.12). The existence of either control or an economic interest,
* In June 2005 the FASB released an exposure draft of a proposed FASB Statement, Consolidated 
Financial Statements, Including Accounting and Reporting of Noncontrolling Interests in Subsidiaries, 
that would replace ARB No. 51, Consolidated Financial Statements, and supersede FASB Statement 
No. 94, Consolidation of All Majority-owned Subsidiaries. The proposed FASB Statement would estab­
lish standards for the accounting and reporting for noncontrolling interests, and carry forward from 
ARB No. 51 the provisions related to consolidation purpose and policy and certain provisions related 
to consolidation procedure. Paragraphs 20 through 34 of the proposed FASB Statement would not be 
applied by not-for-profit organizations until interpretative guidance related to those paragraphs is 
issued. Readers should be alert to the issuance of a final standard. In 2003, the FASB issued FASB 
Interpretation No. 46, Consolidation of Variable Interest Entities, and FASB Interpretation No. 46 
(revised December 2003), Consolidation of Variable Interest Entities, to address consolidation by busi­
ness enterprises of variable interest entities. Special effective date provisions apply to enterprises that 
have fully or partially applied FASB Interpretation No. 46 prior to the issuance of the revised Inter­
pretation. Otherwise, application of FASB Interpretation No. 46(R) (or FASB Interpretation No. 46), 
is required in financial statements of public entities that have interests in variable interest entities 
or potential variable interest entities commonly referred to as special-purpose entities for periods 
ending after December 15, 2003. Application by public entities, other than small business issuers, for 
all other types of entities is required in financial statements for periods ending after March 15, 2004. 
Application by small business issuers to entities other than special-purpose entities and by nonpub­
lic entities to all types of entities is required at various dates in 2004 and 2005. In some instances, 
enterprises have the option of applying or continuing to apply FASB Interpretation No. 46 for a short 
period of time before applying the revised Interpretation. Not-for-profit organizations are not subject 
to FASB Interpretation No. 46(R), except that they may be related parties for purposes of applying 
paragraphs 16 and 17 of that Interpretation. Also, if a not-for-profit entity is used by business enter­
prises in a manner similar to a variable interest entity in an effort to circumvent the provisions of 
FASB Interpretation No. 46(R), that not-for-profit entity is subject to that Interpretation.
1 In some situations, debt agreements may require combined financial statements of affiliated 
entities, the assets or revenues of which serve as collateral for the related debt (sometimes called 
an "obligated group"). ARB No. 51 applies to those situations. However, if debt or other agreements 
prescribe a financial presentation that varies from GAAP (for example, exclusion of entities other­
wise required to be consolidated), the auditor should consider SAS No. 62, Special Reports (AICPA, 
Professional Standards, vol. 1, AU sec. 623), for reporting guidance.
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but not both, is discussed in paragraph 11.13; consolidation of variable interest 
entities is discussed in paragraph 11.14; disclosures concerning restrictions on 
distributions are discussed in paragraph 11.15; and reporting under the equity 
method of accounting is discussed in paragraph 11.17.
11.08 Control is the direct or indirect ability to determine the direction of 
management and policies through ownership, contract, or otherwise. However, 
the rights and powers of the controlling entity may vary depending on the legal 
structure of the controlled entity and the nature of control. The majority owner 
of a for-profit entity's voting stock or the sole corporate member of a not-for- 
profit entity may not only have the ability to determine the direction of the 
controlled entity but also have the proportionate right to (or the responsibility 
for) operating results and a residual interest in the net assets upon dissolution. 
However, in other situations, the rights of the controlling party may be more 
limited. For example, in the case of a sole general partner in a limited partner­
ship, the limited partners—and not the general partner—may be entitled to the 
net assets upon dissolution. Further, the existence of "super-majority" voting 
rights can entitle the holder to disproportionate voting powers, and could affect 
the determination of the "controlling entity." As a result, whether the financial 
statements of a controlled entity should be consolidated with the reporting en­
tity depends on the nature of control and whether an economic interest exists.2
11.09 An economic interest in another entity exists if (a) the other entity 
holds or utilizes significant resources that must be used for the unrestricted or 
restricted purposes of the reporting entity—either directly or indirectly—for 
producing income or providing services or (b) the reporting entity is responsible 
for the liabilities of the other entity The following are examples of economic 
interests;
• Other entities solicit funds in the name of, and with the expressed 
or implied approval of, the reporting entity In addition, substantially 
all of the funds solicited are intended by the contributor or are other­
wise required to be transferred to the reporting entity or used at its 
discretion or direction.
•  The reporting entity transfers significant resources to another entity 
whose resources are held for the benefit of the reporting entity.
• The reporting entity assigns certain significant functions to another 
entity
2 Emerging Issues Task Force (EITF) Issue No. 97-2, "Application of FASB Statement No. 94 
and APB Opinion No. 16 to Physician Practice Management Entities and Certain Other Entities 
with Contractual Management Arrangements," addresses the issue of consolidation and business 
combinations among physician practice management entities, and other situations in which one entity 
manages another under similar circumstances and arrangements. If a physician practice is a variable 
interest entity as described in FASB Interpretation No. 46 and FASB Interpretation No. 46(R), that 
entity is subject to the requirements of those Interpretations, and the consensus in EITF Issue No. 97- 
2 does not apply. Not-for-profit organizations are not subject to FASB Interpretation No. 46(R), except 
that they may be related parties for purposes of applying paragraphs 16 and 17 of that Interpretation. 
Also, if a not-for-profit entity is used by business enterprises in a manner similar to a variable interest 
entity in an effort to circumvent the provisions of FASB Interpretation No. 46(R), that not-for-profit 
entity is subject to that Interpretation. See footnote ‡ to paragraph 11.14 in this chapter for information 
regarding the effective date of FASB Interpretation No. 46 and FASB Interpretation No. 46(R). EITF 
Consensus Opinions are category (c) GAAP as described in SAS No. 69, The Meaning of Present Fairly 
in Conformity With Generally Accepted Accounting Principles (AICPA, Professional Standards, vol. 1, 
AU sec. 411). Including the EITF Consensus Opinions within this Guide, which is category (b) GAAP, 
does not change their position in the GAAP hierarchy. See footnote * to the heading to paragraph 
1.61 in this Guide for information about a FASB exposure draft of a proposed Statement that would 
supersede the hierarchy currently presented in AICPA SAS No. 69 and an ASB exposure draft of a 
proposed SAS that would amend SAS No. 69.
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•  The reporting entity provides or is committed to provide funds for 
another entity or the reporting entity guarantees significant debt of 
another entity.
•  The reporting entity has a right to, or the responsibility for, the operat­
ing results of another entity. Or, upon dissolution, the reporting entity 
is entitled to the net assets, or is responsible for any deficit, of another 
entity.
11.10 Health care organizations with a controlling financial interest in 
other entities through direct or indirect ownership of a majority voting interest3 
in those other entities should consolidate those other entities, unless control 
does not rest directly or indirectly with the majority owner or sole corpo­
rate member (for example, if the subsidiary is in legal reorganization or in 
ba nkrup tcy ) .4,† In such situations consolidation is prohibited, as discussed in 
paragraph 2 of ARB No. 51, as amended by FASB Statement No. 94, Con­
solidation of All Majority-owned Subsidiaries, and FASB Statement No. 144, 
Accounting for the Impairment or Disposal of Long-Lived Assets.5
11.11 In the case of (a) control through a majority voting interest in the 
board of another entity by means other than ownership or sole corporate 
membership6 and (b) an economic interest in such entities, consolidation is 
required, unless control is likely to be temporary or does not rest with the ma­
jority owner. In this situation consolidation is prohibited.7
11.12 Control of a separate not-for-profit organization in which the re­
porting entity has an economic interest may take forms other than majority 
ownership or voting interest; for example, control may be through contract or
152 Health Care Organizations
3 Because not-for-profit organizations may exist in various legal forms, ownership of not-for-profit 
organizations may be evidenced in various ways. Examples include corporations issuing stock, corpo­
rations issuing ownership certificates, membership corporations issuing membership certificates, joint 
ventures, and partnerships. A parent corporation typically owns stock in a for-profit entity, whereas 
a sole corporate member holds membership rights in a not-for-profit entity. As it relates to health 
care consolidations, sole corporate membership in a not-for-profit entity is considered to be equivalent 
to ownership of a majority voting interest in a for-profit entity, unless the sole corporate member's 
economic interest in the controlled entity is limited by state law or contractual agreement.
4 See footnote 2 in this chapter.
† AcSEC has released an exposure draft of a proposed Statement of Position (SOP), Clarification 
of the Scope of the Audit and Accounting Guide Audits of Investment Companies and Accounting by 
Parent Companies and Equity Method Investors for Investments in Investment Companies. Among 
other matters, this proposed SOP may modify this paragraph in this Guide. Readers should be alert 
for the issuance of a final Standard.
5 FASB Statement No. 144, among other matters, amends ARB No. 51 to eliminate the excep­
tion to consolidation for a subsidiary for which control is likely to be temporary. This Guide has been 
conformed to FASB Statement No. 144 to eliminate the exception to consolidation for a temporarily 
controlled subsidiary in circumstances in which this Guide requires consolidation based on a control­
ling financial interest (paragraph 11.10 of this Guide). No such conforming change to this Guide is 
appropriate in circumstances in which consolidation is required or permitted based on control through 
other than a controlling financial interest (paragraphs 11.11 and 11.12 in this Guide). Accordingly, this 
Guide retains the exception to consolidation for a temporarily controlled subsidiary in circumstances 
in which consolidation is required or permitted based on control through other than a controlling 
financial interest.
6 For purposes of this Guide, a majority voting interest in the board of another entity by means 
other than ownership or sole corporate membership is illustrated by the following example. Entity B 
has a five-member board, and a simple voting majority is required to approve board actions. Entity 
A will have a majority voting interest in the board of entity B if three or more of its board members, 
officers, or employees serve on (or may be appointed at entity As discretion to) the board of entity B. 
However, if three of entity As board members serve on the board of entity B but entity A does not have 
the ability to require that those members serve on entity B's board, entity A does not have a majority 
voting interest in the board of entity B.
7 See footnote 5 in this chapter.
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affiliation agreement.8 In circumstances such as these, consolidation is permit­
ted but not required, unless control is likely to be temporary.9 In this situation 
consolidation is prohibited.10 If the reporting entity controls a separate not-for- 
profit entity through a form other than majority ownership (paragraph 11.10) 
or voting interest (paragraph 11.11), has an economic interest in that other 
entity, and consolidated financial statements are not presented, the notes to 
the financial statements should include the following disclosures:
a. Identification of the other entity and the nature of its relationship 
with the reporting entity that results in control
b. Summarized financial data of the other entity, including total as­
sets, liabilities, net assets, revenue, and expenses; and resources 
that are held for the benefit of the reporting entity or that are un­
der its control
c. The disclosures set forth in FASB Statement No. 57, Related Party 
Disclosures
11.13 In some cases, one entity may have an economic interest in another 
entity without controlling it (for example, a noncontrolled entity may solicit 
funds in the name of, and with the expressed or implied approval of, the re­
porting entity and substantially all of the funds solicited are intended by the 
contributor to benefit the reporting entity). The existence of control (other than 
through ownership or sole corporate membership) or an economic interest, but 
not both, precludes consolidation but requires the disclosures set forth in FASB 
Statement No. 57.11
11.14 FASB Interpretation No. 46 (revised December 2003), Consolidation 
of Variable Interest Entities, which replaced FASB Interpretation No. 46, Con­
solidation of Variable Interest Entities, clarifies the application of ARB No. 51 
to certain entities in which equity investors do not have the characteristics of a 
controlling financial interest or do not have sufficient equity at risk for the en­
tity to finance its activities without additional subordinated financial support.‡ 
An entity subject to consolidation according to the provisions of FASB Interpre­
tation No. 46(R) is referred to in that Interpretation as a variable interest entity.
8 Evidence of control may include authority to amend articles of incorporation and bylaws or 
authority to approve operating, capital, and construction budgets; capital acquisitions; strategic plans, 
goals, and objectives; and mergers or dissolutions.
9 See footnote 2 in this chapter.
10 See footnote 7 in this chapter.
1 The existence of an economic interest does not necessarily cause the entities to be related 
parties, as defined in FASB Statement No. 57. However, the disclosures required by that statement 
are required under this Guide if an economic interest exists.
‡Special effective date provisions apply to enterprises that have fully or partially applied FASB 
Interpretation No. 46 prior to the issuance of FASB Interpretation No. 46(R). Otherwise, application 
of FASB Interpretation No. 46(R) (or FASB Interpretation No. 46) is required in financial statements 
of public entities that have interests in variable interest entities or potential variable interest entities 
commonly referred to as special-purpose entities for periods ending after December 15, 2003. Applica­
tion by public entities, other than small business issuers, for all other types of entities is required in 
financial statements for periods ending after March 15, 2004. Application by small business issuers 
to entities other than special-purpose entities and by nonpublic entities to all types of entities is re­
quired at various dates in 2004 and 2005. In some instances, enterprises have the option of applying or 
continuing to apply FASB Interpretation No. 46 for a short period of time before applying the revised 
Interpretation. Not-for-profit organizations are not subject to FASB Interpretation No. 46(R), except 
that they may be related parties for purposes of applying paragraphs 16 and 17 of that Interpretation. 
Also, if a not-for-profit entity is used by business enterprises in a manner similar to a variable interest 
entity in an effort to circumvent the provisions of FASB Interpretation No. 46(R), that not-for-profit 
entity is subject to that Interpretation.
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An entity shall be subject to consolidation according to the provisions of FASB 
Interpretation No. 46(R) if, by design, the conditions in paragraph 5 of that 
Interpretation exist. Paragraph 14 of FASB Interpretation No. 46(R) provides 
guidance for consolidation based on variable interests. FASB Interpretation 
No. 46(R) also requires certain disclosures. Not-for-profit organizations are not 
subject to FASB Interpretation No. 46(R), except that they may be related par­
ties for purposes of applying paragraphs 16 and 17 of that Interpretation. Also, 
if a not-for-profit entity is used by business enterprises in a manner similar to a 
variable interest entity in an effort to circumvent the provisions of FASB Inter­
pretation No. 46(R), that not-for-profit entity is subject to that Interpretation.
11.15 If consolidated financial statements are presented and they include 
a controlled not-for-profit organization, they should disclose any restrictions 
made by entities outside of the reporting entity on distributions from the con­
trolled not-for-profit organization to the reporting entity and any resulting un­
availability of the net assets of the controlled not-for-profit organization for use 
by the reporting entity.
11.16 When consolidated financial statements are required or permitted, 
a minority interest should be provided if such interest is represented by an 
economic interest whereby the minority interest would share in the operating 
results or residual interest upon dissolution.
11.17 Investments in common stock of for-profit entities in which the re­
porting entity has 50 percent or less of the voting stock in the investee should be 
reported under the equity method in conformity with APB Opinion No. 18, The 
Equity Method of Accounting for Investments in Common Stock, if the guidance 
in that opinion requires use of the equity method.12,† The equity method should 
be followed by an investor whose investment in voting stock gives it the ability 
to exercise significant influence over operating and financial policies of an in­
vestee. Determining the ability of an investor to exercise significant influence 
is not always clear, and applying judgment is necessary to assess the status 
of each investment. However, to achieve a reasonable degree of uniformity, the 
ownership of 20 percent or more of the voting stock leads to a presumption that 
the investor can exercise significant influence and, therefore, the investment 
should be accounted for under the equity method in accordance with APB Opin­
ion No. 18. However, this presumption can be overcome in certain instances. *•
12 The consensus opinion reached in EITF Issue No. 02-14, "Whether an Investor Should Apply 
the Equity Method of Accounting to Investments Other Than Common Stock," which was ratified by 
the FASB in July 2004, expands the use of the equity method of accounting described in APB Opinion 
No. 18, The Equity Method of Accounting for Investments in Common Stock, to certain investments 
that are deemed "in-substance common stock" (as defined in the consensus opinion). The consensus 
opinion limits the use of the equity method to:
•  Investment(s) in common stock
•  Investment(s) in-substance common stock, as that type of investment is defined in the con­
sensus opinion.
EITF Issue No. 02-14 does not change the application of the equity method for:
•  Investments in non-corporate entities accounted for under AICPA Statement of Position 
78-9, Accounting for Investments in Real Estate Ventures
• Investments in limited liability companies that maintain "specific ownership accounts" for 
each investor as discussed in EITF Issue No. 03-16, "Accounting for Investments in Limited 
Liability Companies."
•  Beneficial interests in trusts as required by FASB Statement No. 136, Transfers of Assets 
to a Not-for-Profit Organization or Charitable Trust That Raises or Holds Contributions for 
Others.
EITF Issue No. 02-14 is effective for reporting periods beginning after September 15, 2004.
† See footnote † in paragraph 11.10.
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FASB Interpretation No. 35, Criteria for Applying the Equity Method of Ac­
counting for Investments in Common Stock, paragraph 4, provides examples 
of indications that an investor may be unable to exercise significant influence. 
Health care organizations that report investments on the equity method should 
make the financial statement disclosures required by APB Opinion No. 18.
11.18 This Guide provides guidance concerning consolidated financial 
statements. Consolidation of a parent or subsidiary organization requires the 
presentation of a single set of amounts for the entire reporting entity. Combi­
nation, as discussed in paragraphs 22 and 23 of ARB No. 51, refers to financial 
statements prepared for organizations between which common control exists 
but for which the parent-subsidiary relationship does not exist. Both consoli­
dation and combination require elimination of interorganization transactions 
and balances. Paragraph 22 of ARB No. 51 states that "there are circumstances, 
however, where combined financial statements (as distinguished from consol­
idated statements) of commonly controlled companies are likely to be more 
meaningful than their separate statements." This Guide prohibits consolidated 
financial statements in certain circumstances. However, it provides no guid­
ance concerning combined financial statements of commonly controlled enti­
ties, which may be presented in certain circumstances in conformity with the 
guidance in ARB No. 51.
11.19 Paragraph 15 of FASB Statement No. 94 precludes the use of the par­
ent company's financial statements as the general-purpose financial statements 
of the primary reporting entity. Similarly, where consolidation is required, this 
Guide precludes the issuance of parent company financial statements as the 
general-purpose financial statements of the primary reporting entity. However, 
neither FASB Statement No. 94 nor this Guide discuss the use of the parent 
company's financial statements as other than the general-purpose financial 
statements for the primary reporting entity.13 GAAP does not preclude the is­
suance of financial statements for the subsidiary only. However, care should be 
taken to include all disclosures required by FASB Statement No. 57 and other 
relevant pronouncements.
Transfers
Equity Transfers
11.20 Equity transfers are similar to ownership transactions between a 
for-profit parent and its owned subsidiary (for example, additional paid-in cap­
ital or dividends).14 However, equity transfers can occur only between related 
not-for-profit entities when one controls the other or both are under common 
control. An equity transfer embodies no expectation of repayment, nor does the 
transferor receive anything of immediate economic value (such as a financial 
interest or ownership). Equity transfers are reported separately as changes in 
net assets, are excluded from the performance indicator, and do not result in 
any step-up in basis of the underlying assets transferred. (Certain transfers 
from a foundation to a related nongovernmental health care organization are 
discussed in paragraphs 11.32 and 11.33.)
13 Contractual agreements or regulatory provisions may require parent company only financial 
statements. SAS No. 62 provides guidance for reporting on financial presentations to comply with 
contractual agreements or regulatory provisions.
14 See paragraphs 1.12 and 10.12 in this Guide regarding the reporting of transfers by govern­
mental health care entities.
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Equity Transactions
11.21 Transfers from a nongovernmental health care organization to a not- 
for-profit organization or charitable trust are equity transactions, as described 
in FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organiza­
tion or Charitable Trust That Raises or Holds Contributions for Others, (see 
paragraphs 4 and 18), if the transfer meets all of the following criteria:
• A nongovernmental health care organization transfers assets to a not- 
for-profit organization or charitable trust (called a recipient organiza­
tion) that accepts those assets and agrees to use them on behalf of or 
transfer them, their investment return, or both back to the health care 
organization or its affiliate.
• The nongovernmental health care organization and the recipient or­
ganization are financially interrelated organizations.
• Neither the nongovernmental health care organization nor its affili­
ate expects payment of the transferred assets, although payment of 
investment return on the transferred assets may be expected.
11.22 Paragraph 13 of FASB Statement No. 136 provides that organiza­
tions are financially interrelated if the relationship between them has both of 
the following characteristics: (a) one organization has the ability to infl uence 
the operating and financial decisions of the other and (b) one organization has 
an ongoing economic interest in the net assets of the other. The ability to influ­
ence the operating and financial decisions of the other can be demonstrated in 
several ways:
a. The organizations are affiliates as defined in FASB Statement 
No. 57.
b. One organization has considerable representation on the governing 
board of the other organization.
c. The charter or bylaws of one organization limit its activities to those 
that are beneficial to the other organization.
d. An agreement between the organizations allows one organization 
to actively participate in the policymaking processes of the other, 
such as setting organizational priorities, budgets, and management 
compensation.
An ongoing economic interest in the net assets of another is a residual right to 
the other organization's net assets that results from an ongoing relationship. 
The value of those rights increases or decreases as a result of the investment, 
fundraising, operating, and other activities of the other organization.15
11.23 An equity transaction differs from an equity transfer in that an eq­
uity transaction, as described in FASB Statement No. 136, involves a financially 
interrelated party either as a third party in a transfer from an entity to one 
of its affiliates or as a counterparty in a transfer from an entity to itself An 
equity transfer, as described in the Guide, is a transaction directly between a 
transferor and a transferee. In addition, an equity transaction is reciprocal;
15 Paragraph 104 of FASB Statement No. 136 notes that although most of the relationships 
described in the definition of economic interest in the glossary of SOP 94-3, Reporting of Related 
Entities by Not-for-Profit Organizations, are potentially ongoing economic interests in the net assets 
of the other, some are not. (The guidance in SOP 94-3 is incorporated in paragraph 11.09 of this 
Guide). Only economic interests that are both ongoing and residual interests in the net assets meet 
the criterion of paragraph 13(b) of FASB Statement No. 136.
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the health care organization or its affiliate named as the beneficiary receives 
an ongoing economic interest in the assets held by the recipient organization. 
(See paragraphs 18 and 95 of FASB Statement No. 136). An equity transfer is 
nonreciprocal; there is no expectation of repayment and the transferor does not 
receive a financial interest or ownership. (See paragraph 11.20 of this Guide).
11.24 The reporting of an equity transaction depends upon whether the 
resource provider or its affiliate is the specified beneficiary. As discussed in 
paragraph 18 of FASB Statement No. 136, if the resource provider specifies itself 
as the beneficiary, the resource provider reports an asset—interest in the net 
assets of the recipient organization (or an increase in a previously recognized 
interest),16 and the recipient organization reports an equity transaction as a 
separate line in its statement of activities. If the resource provider specifies its 
affiliate as the beneficiary, the resource provider and the recipient organization 
report an equity transaction as separate lines in their statements of activities, 
and the affiliate named as beneficiary reports an interest in the net assets of the 
recipient organization.17 The resource provider should disclose the information 
described in paragraph 4.15 of this Guide for each period for which a statement 
of financial position is presented.
Other Transfers||
11.25 Other transfers may occur among related entities. If the entities are 
consolidated or combined, such transfers are eliminated in consolidation and/or 
combination. If the entities are not consolidated or combined (for example, in 
separate subsidiaries or obligated group financial statements),18 the method of 
accounting for such transfers is dictated by the substance of the transaction as 
well as the legal form. For example, certain transfers by a foundation to a related 
nongovernmental health care organization are reported as contributions, as 
discussed in paragraphs 11.32 and 11.33. In other situations, payments may 
be made for services provided between not-for-profit entities under common 
control, which should be accounted for as revenues and expenses depending on 
the types of services provided.
11.26 A health care organization may loan or advance resources to a re­
lated entity. If repayment is reasonably assured, a receivable or payable should 
be recorded by the entities. Subsequent to the time a receivable is recorded, the 
ability of the receiving entity to repay the receivable should be considered. If
16 That interest would be eliminated if the beneficiary (resource provider) and the recipient 
organization were included in consolidated financial statements. See footnote 6 to paragraph 15 of 
FASB Statement No. 136.
17 That interest would be eliminated if the beneficiary (affiliate) and the recipient organization 
were included in consolidated financial statements. See footnote 6 to paragraph 15 of FASB Statement 
No. 136.
|| In June 2005 the FASB released an exposure draft of a proposed FASB Statement, Consoli­
dated Financial Statements, Including Accounting and Reporting of Noncontrolling Interests in Sub­
sidiaries, that would replace ARB No. 51 and supersede FASB Statement No. 94. Appendix D of the 
proposed FASB Statement provides the amendments made to APB Opinion No. 18 by FASB Statement 
No. 94 that would be carried forward. See footnote * to the heading to paragraph 11.04 for further 
information about the proposed FASB Statement. In June 2005 the FASB also released an exposure 
draft of a proposed FASB Statement, Business Combinations, that would replace FASB Statement 
No. 141, Business Combinations. Appendix C of the proposed FASB Statement includes continuing 
authoritative guidance for transactions between entities under common control, which is provided 
in Appendix D of FASB Statement No. 141. See footnote †† to the heading to paragraph 11.38 for 
further discussion about the proposed FASB Statement. Readers should be alert to the issuance of 
final standards.
18 See paragraph 12.12 for additional discussion regarding obligated group financial statements.
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the receivable is not to be repaid, or if the receiving entity is perceived as un­
able to repay, it may be accounted for as an equity transfer with the transferor 
reducing net assets and the transferee increasing net assets at the date such 
determination is made (see paragraph 11.20).
11.27 Transfers that result in changes in ownership interest are accounted 
for as investments in accordance with APB Opinion No. 18 and FASB Statement 
No. 94.
11.28 Assets transferred from one commonly controlled entity to another 
should be recorded by the transferee at the carrying value of the transferring 
entity. This treatment is consistent with the guidance prescribed by Appendix 
D of FASB Statement No. 141, Business Combinations.#
Related Fund-Raising Organizations
11.29 A related entity may act as an agent, trustee, or intermediary for
contributions to the reporting entity. FASB Statement No. 136 establishes stan­
dards for transactions in which a donor makes a contribution by transferring 
assets to a recipient organization—a not-for-profit organization or a charitable 
trust—that accepts the assets from the donor and agrees to use the assets on 
behalf of or transfer the assets, their investment return, or both to another 
entity—the beneficiary—named by the donor.19,20 Paragraph 68 of FASB State­
ment No. 136 states that a donor may specify the beneficiary (a) by name, (b) 
by stating that all entities that meet a set of donor-defined criteria are benefi­
ciaries, or (c) by actions surrounding the transfer that made clear the identity 
of the beneficiary, such as by responding to a request from an organization that 
exists to raise assets for the beneficiary. Paragraphs 69 through 72 and Ap­
pendix A of FASB Statement No. 136 provide examples of donor stipulations 
and discuss whether those stipulations specify a beneficiary.
11.30 If a recipient organization and a specified beneficiary are financially 
interrelated organizations (as defined in paragraph 13 of FASB Statement 
No. 136 and described in paragraph 11.22 of this Guide) and the recipient 
organization is not a trustee, the recipient organization should recognize the 
fair value of any assets it receives from the donor that are specified by the 
beneficiary as a contribution received, rather than as a liability to the benefi­
ciary, as discussed in paragraph 14 of FASB Statement No. 136. For example, 
a foundation that exists to raise, hold, and invest assets for a specified health 
care organization or for a group of affiliates of which the specified health care 
organization is a member generally is financially interrelated with the organi­
zation or organizations it supports. A financially interrelated foundation should
# FASB Statement No. 141, Business Combinations, supersedes AICPA Accounting Interpreta­
tion No. 39 of APB Opinion No. 16, Business Combinations. However, the guidance in that Inter­
pretation, used in past practice to account for transfers of net assets between entities under common 
control, is carried forward without reconsideration in Appendix D, Continuing Authoritative Guidance, 
of FASB Statement No. 141.
19 FASB Statement No. 136 also establishes standards for transactions that take place in a 
similar manner but are not contributions because the transfers are revocable, repayable, or reciprocal. 
For example, if a resource provider transfers assets to a recipient organization and names itself or 
its affiliate as beneficiary, that transaction is reciprocal even if the resource provider grants variance 
power. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.21, 11.23, and 
11.24 of this Guide. This Guide does not use the word donor in discussing those transactions because 
they are not contributions.
20 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1 
in Chapter 1.)
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recognize contribution revenue when it receives assets from the donor.21 The 
specified health care organization should recognize its interest in the net assets 
of the foundation (the recipient organization) and adjust that interest for its 
share of the change in net assets of the recipient organization using a method 
similar to the equity method of accounting for investments in common stock 
(see paragraph 15 of FASB Statement No. 136).22
11.31 When measuring its interest in the recipient organization, the spec­
ified health care organization would include the net assets of the recipient 
organization that are restricted to use by that health care organization. If the 
recipient organization supports more than one beneficiary and an agreement 
with the recipient organization specifies how unrestricted gifts to the recipient 
organization should be divided between the organizations supported, the spec­
ified health care organization would also include its share of the recipient or­
ganization's unrestricted assets, computed in accordance with that agreement. 
Similarly, if a parent organization controls both the recipient organization and 
the specified health care organization and the parent directed that unrestricted 
gifts would be distributed to affiliates in accordance with a specified formula, 
each affiliate would include in its interest its share of unrestricted net assets, 
computed in accordance with that formula. (See paragraphs 41 through 45 of 
FASB Statement No. 136).
11.32 Distributions from a financially interrelated recipient organization 
to a nongovernmental health care organization that it supports are generally 
reported by the health care organization as a reduction of its interest in the 
recipient organization. However, if the distribution is made from net assets 
that are not includable in that interest because the health care organization 
does not have rights to them (that is, the recipient organization can determine 
to whom the assets will be distributed), the health care organization reports 
a contribution from the related recipient organization. For example, assume a 
foundation's mission is to raise contributions for two financially interrelated 
health care organizations, Hospital A and Hospital B. The foundation receives 
$10,000 in contributions from donors that do not specify which of the two hospi­
tals should benefit from their gifts. There is no agreement between the founda­
tion and Hospitals A and B that specifies how gifts to the foundation should be 
divided between the hospitals if the donor does not specify a beneficiary. Hos­
pital A would report contribution revenue for any portion of the $10,000 that it 
receives from the foundation. Likewise, Hospital B would report contribution 
revenue for any portion of the $10,000 that it receives, but neither Hospital A 
nor Hospital B would record an interest in those assets before the foundation 
either distributes them or unconditionally promises them.
11.33 As discussed in paragraphs 11 and 12 of FASB Statement No. 136, 
if the recipient organization and the specified health care organization are 
not financially interrelated organizations as defined in paragraph 13 of FASB 
Statement No. 136 (see paragraph 11.22 in this Guide), and the donor speci­
fies a beneficiary, the recipient organization should recognize a liability to the 
specified beneficiary unless the recipient is explicitly granted variance power. 
(See discussion of variance power at paragraph 10.05 of this Guide). If the assets 
received from the donor are donated materials, supplies, or other nonfinancial
21 Foundations that are not providers of health care services are not covered by this Guide and 
should follow the AICPA Audit and Accounting Guide Not-for-Profit Organizations.
2 That interest would be eliminated if the beneficiary and the recipient organization were in­
cluded in consolidated financial statements. See footnote 6 to paragraph 15 of FASB Statement No. 136.
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assets, the recipient organization may choose either to (a) report the receipt of 
the assets as a liability to the beneficiary concurrent with recognition of the 
assets received or (b) not to report the transaction at all. The choice is an ac­
counting policy that should be applied consistently from period to period and 
disclosed in the notes to the financial statements. The specified health care 
organization recognizes its rights to the assets (financial or nonfinancial) held 
by a recipient organization as an asset and contribution revenue unless the 
recipient organization is explicitly granted variance power. (See further discus­
sion at paragraphs 5.11 and 10.05.) In contrast, if the donor does not specify a 
beneficiary (see further discussion at paragraph 11.29) and the foundation and 
a hospital are under common control, but they are not financially interrelated, 
the recipient organization should recognize contribution revenue when it re­
ceives the gift. The gift should be accounted for as contributions received by the 
hospital, consistent with FASB Statement No. 116, Accounting for Contribu­
tions Received and Contributions Made, and Chapter 10 of this Guide, provided 
that the foundation is acting other than as an owner.
11.34 Additional guidance regarding accounting for contributions received 
by agents, trustees, and intermediaries can be found in Chapter 5 of the Audit 
and Accounting Guide Not-for-Profit Organizations.
Disclosure
11.35 Significant relationships and transactions not in the ordinary course 
of business with directors, management, medical staff, or other related parties 
(including unconsolidated related organizations) should be disclosed in accor­
dance with FASB Statement No. 57. SAS No. 45, Omnibus Statement on Audit­
ing Standards—1983, "Related Parties" (AICPA, Professional Standards, vol. 1, 
AU sec. 334), sets forth procedures for the auditor to consider in determining 
the existence of transactions with related parties and identifying them.
11.36 Hospital boards may contract with management companies to oper­
ate their facilities. Frequently, the management company will employ the ad­
ministrator as well as other key personnel. Further, services may be acquired 
from entities related to the management company.23 The auditor should eval­
uate the impact of these arrangements on the hospital's internal controls and 
disclose related party transactions as required by FASB Statement No. 57.
11.37 The reporting and disclosure requirements of the nongovernmental 
health care organization under the circumstances noted in paragraphs 11.10 
through 11.19 are summarized as follows:24
Circumstances Requirements
The entity owns a majority of a 
for-profit entity's voting stock.
The entity is the sole corporate 
member of a not-for-profit entity. 
(See paragraph 11.10, footnote 3.)
Consolidate unless control does not rest 
with the majority owner or the interest 
is limited by state law or contractual 
agreement.
Consolidate unless control does not rest 
with the majority owner or the sole 
corporate member's interest is limited 
by state law or contractual agreement.
(continued)
23 See footnote 2 in this chapter. 
24 See footnote 5 in this chapter.
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Circumstances Requirements
The entity controls another through 
a majority voting interest in the 
board and an economic interest 
exists.
The reporting entity owns 50 
percent or less of the common voting 
stock of an investee and can exercise 
significant infl uence over operating 
and financial policies.
There have been material 
transactions between the health 
care entity and the related 
organization. (This could be present 
in any of the foregoing 
circumstances.)
An entity has control over another 
not-for-profit organization or has an 
economic interest in the other, but 
not both.
The reporting entity controls a 
separate not-for-profit entity 
through a form other than majority 
ownership or voting interest and 
has an economic interest in that 
other entity.
The entity is a variable interest 
entity subject to the provisions of 
FASB Interpretation No. 46(R)
Consolidate unless control is likely to be 
temporary or does not rest with the 
majority owner or the sole corporate 
member; or the interest is limited by 
state law or contractual agreement.
The investment should be accounted for 
under the equity method in accordance 
with APB Opinion No. 18.
In the notes to the financial statements 
(a) disclose the existence and nature of 
the relationship and (b) describe and 
quantify the transactions.
In the notes to the financial statements 
(a) disclose the existence and nature of 
the relationship and (b) describe and 
quantify the transactions.
Consolidation is prohibited. 
Consolidation permitted but not 
required. If consolidated statements are 
not presented, the notes to the financial 
statements should disclose (a) the 
identification of the other entity and the 
nature of its relationship with the 
reporting entity, (b) summarized 
financial data of the other entity, and (c) 
the disclosures set forth in FASB 
Statement No. 57.
Apply the guidance in FASB 
Interpretation No. 46(R), including the 
disclosure requirements in that 
Interpretation. **
Business Combinations† 
11.38 As discussed in paragraph 11.02, the dynamics of change in the 
health care industry have resulted in increased business combinations as new 
organizational structures are being formed. FASB Statement No. 141 addresses *†
* For information about FASB Interpretation No. 46, which was replaced by FASB Interpretation 
No. 46(R), the effective date of FASB Interpretation No. 46(R), and the applicability of that revised 
Interpretation's requirements for not-for-profit organizations, see paragraph paragraph 11.14 in this 
chapter.
†† In June 2005 the FASB released an exposure draft of a proposed FASB Statement, Business 
Combinations, that would replace FASB Statement No. 141. The proposed Statement would not apply 
to combinations between not-for-profit organizations and the acquisition of a for-profit business by a 
not-for-profit organization. Readers should be alert to the issuance of a final standard. See footnote || 
to the heading to paragraph 11.25 for further discussion about the proposed FASB Statement.
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financial accounting and reporting for business combinations. FASB Statement 
No. 141 prescribes the use of the purchase method for those business combi­
nations. FASB Statement No. 141, however, does not apply to certain combi­
nations, including a combination involving two or more not-for-profit organiza­
tions, or the acquisition of a for-profit business by a not-for-profit organization. 
For those combinations, the guidance in APB Opinions No. 16 and No. 17 still 
apply and provides a useful framework when evaluating similar transactions 
entered into by not-for-profit health care business organizations.| A list of pos­
sible factors to be considered when evaluating these transactions in relation to 
APB Opinion No. 16 is summarized as follows:
Circumstances
Monetary consideration received or 
paid, change in legal title to assets, 
and/or assumption of liabilities.
Change in control (for example, 
change in sole corporate member).
Accounting and Disclosure Guidance
This is similar to a purchase under 
APB Opinion No. 16.25
This is similar to a pooling of interests 
transaction under APB Opinion No. 
16. No step-up in basis.
See paragraphs 1.49 and 1.50 for additional guidance regarding the application 
of APB Opinion No. 16 to not-for-profit organizations. Also see footnote |  in the 
section "APB Opinion No. 16, Business Combinations" in Chapter 1 in this 
Guide regarding pronouncements that were superseded by FASB Statement 
No. 141, including APB Opinion No. 16.
Auditing
11.39 The independent auditor may need to consider the examples of 
specific auditing objectives, control activities, and auditing procedures for re­
lated party organizations, balances, and transactions that are presented in 
Exhibit 11-1.
|||| The FASB has on its agenda a project on accounting for combinations of not-for-profit organi­
zations. An exposure draft of the proposed Standard is expected to be released in the fourth quarter 
of 2005. Readers should be alert to the issuance of a final Standard.
25 FASB Statement No. 141 supersedes AICPA Accounting Interpretation No. 39 of APB Opinion 
No. 16. Appendix D of FASB Statement No. 141 carries forward without reconsideration guidance in 
APB Opinion No. 16 and an interpretation that has been used in past practice to account for transfers 
of net assets or exchanges of shares between entities under common control. Paragraph D12 of FASB 
Statement No. 141 discusses the accounting for a transfer of assets or exchange of shares between 
entities under common control.
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Exhibit 11-1
Auditing Considerations
Financial Statement 
Assertions
Specific Auditing 
Objectives
Selected Control 
Activities
Reporting Entity and Related Organizations
Existence and The reporting Procedures 
entity is 
appropriate.
occurrence, 
completeness, and 
presentation and 
disclosure
ensure that 
investees, 
affiliates, and 
other related 
entities are 
accounted for 
appropriately.
Relationships 
and transactions 
with related 
organizations are 
identified and 
disclosed, if 
appropriate, 
because of 
economic
Auditing
Procedures
Procedures 
ensure that 
conflict-of- 
interest policies, 
procedures, and 
disclosure 
requirements are 
met.
Review the 
articles of 
incorporation, 
bylaws, and 
minutes of 
directors' 
meetings, 
shareholder lists, 
and filings with 
regulatory 
authorities to 
determine the 
existence of 
related parties.
Obtain
representations
from
management as 
to whether all 
investees, 
affiliates, and 
related entities 
have been 
accounted for 
properly or 
disclosed.
Review
transactions with 
investees, 
affiliates, and 
other related 
entities to 
determine that 
they are reported 
properly
Test significant 
related party 
transactions as 
follows:
• Determine 
substance.
• Examine 
documents
(continued)
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Financial Statement Specific Auditing Selected Control 
Assertions Objectives Activities
Auditing
Procedures
dependence of the 
entity.
Presentation and 
disclosure
Related party 
transactions and 
organizations are 
reported properly.
(invoices, 
contracts, and 
agreements)
• Determine the 
basis of 
pricing.
• Determine the 
collectibility of 
receivables 
and advances.
Review related 
party
transactions for
completeness
b y -
• Considering 
previously 
identified 
transactions or 
relationships.
• Reviewing the 
minutes of 
directors' and 
other 
meetings.
• Discussing 
related-party 
transactions 
with entity 
personnel.
• Reviewing 
unusual 
transactions.
• Reviewing the 
responses to 
related party 
(conflict-of- 
interest) 
questionnaires.
Review the 
presentation and 
disclosure of 
related party 
information for 
completeness.
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Chapter 12
Independent Auditor's Reports
Note: As discussed in paragraph 2.02 in this Guide, registered public account­
ing firms must comply with the standards of the Public Company Accounting 
Oversight Board (PCAOB) in connection with the preparation or issuance of 
any audit report on the financial statements of an issuer. Refer to the Preface 
of this Guide for important information about the applicability of the profes­
sional standards to audits of issuers and nonissuers (see the definitions in the 
Preface). This chapter presents auditing guidance included in both AICPA 
professional standards (GAAS) and in PCAOB professional standards, and 
dual referencing to both the AICPA and the PCAOB professional standards. 
In referring to AICPA professional standards, this chapter cites the applica­
ble sections of the AI CPA Professional Standards publication. In referring to 
PCAOB standards, this chapter cites the applicable sections of the AI CPA's 
publication titled PCAOB Standards and Related Rules. In those cases in 
which the auditing standards of the AICPA and those of the PCAOB are 
the same, this chapter cites the applicable section of the AICPA Professional 
Standards publication only. Readers should refer to the PCAOB Web site at 
www.pcaobus.org for effective date information for PCOAB Standards that 
are discussed in this chapter.
Overview
12.01 The guidance in SAS No. 58, Reports on Audited Financial State­
ments, as amended (AICPA, Professional Standards, vol. 1, AU sec. 508), ap­
plies to audit reports on the financial statements of health care organizations. 
Such a report may contain an unqualified opinion, an unqualified opinion with 
an explanatory paragraph, a qualified opinion, a disclaimer of opinion, or an ad­
verse opinion. The facts and circumstances of each particular audit govern the 
appropriate form of the report.1 [PCAOB Conforming Amendments to PCAOB 
Interim Standards Resulting from the Adoption of PCAOB Auditing Standard 
No. 2, "An Audit of Internal Control Over Financial Reporting Performed in 
Conjunction With An Audit of Financial Statements" (AICPA, PCAOB Stan­
dards and Related Rules, AU sec. 508), amend SAS No. 58, as amended, to 
include reporting requirements when performing an integrated audit of finan­
cial statements and internal control over financial reporting in accordance with 
PCAOB Standards.]
12.02 Auditing Interpretation No. 17, "Clarification in the Audit Report of 
the Extent of Testing of Internal Control Over Financial Reporting in Accor­
dance With Generally Accepted Auditing Standards," of SAS No. 58 (AICPA, 
Professional Standards, vol. 1, AU sec. 9508.85-.88), provides for audits of non­
issuers an example of additional language that may be added to an auditor's
1 SAS No. 79, Amendment to Statement on Auditing Standards No. 58, Reports on Audited 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 508), amends SAS No. 58 to 
eliminate the requirement that when certain criteria are met, the auditor add an uncertainties ex­
planatory paragraph to the auditor's report. It also clarifies and reorganizes the guidance in SAS 
No. 58 concerning emphasis paragraphs, uncertainties, and disclaimers of opinion.
AAG-HCO 12.02
1 6 6 Health Care Organizations
standard report to explain that an audit includes consideration of internal 
control over financial reporting as a basis for designing audit procedures but 
not for the purpose of expressing an opinion on the effectiveness of internal 
control over financial reporting. Auditing Interpretation No. 18, "Reference to 
PCAOB Standards in an Audit Report on a Nonissuer," of SAS No. 58 (AICPA, 
Professional Standards, vol. 1, AU sec. 9508.89-.92), provides guidance on the 
appropriate referencing of PCAOB auditing standards in audit reports for those 
auditors who are engaged to perform an audit in accordance with PCAOB stan­
dards when auditing nonissuers.
12.03 The Audit and Accounting Guide State and Local Governments, pro­
vides guidance on audit reports for state and local governments as well as 
on assessing materiality (opinion units). (See paragraph 2.01 of this Guide.) 
Also, Chapter 16 of that Guide discusses auditor association with municipal 
securities filings and the use of Government Auditing Standards in reports 
and references in the offering document—the official statement. Governments 
sometimes issue municipal securities to finance facilities for nongovernmental 
organizations, including not-for-profit health care organizations. Those non­
governmental organizations may be considered "obligated persons" with regard 
to the securities and thus also provide audited financial statements for the of­
ficial statement.
12.04 The report examples appearing in this chapter illustrate the form of 
certain auditor's reports issued by the independent auditor in auditing the fi­
nancial statements of a health care organization. The forms of report illustrated 
are prescribed by AICPA professional standards. Readers should consult the 
standards of the PCAOB, and related interpretive guidance, when preparing or 
issuing any audit report on the financial statements of an issuer in accordance 
with the standards of the PCAOB. For example, PCAOB Auditing Standard 
No. 1, References in Auditors' Reports to the Standards of the Public Company 
Accounting Oversight Board, replaces in auditors' reports the sentence "We con­
ducted our audits in accordance with auditing standards generally accepted in 
the United States of America" with the following sentence: "We conducted our 
audits in accordance with the standards of the Public Company Accounting 
Oversight Board (United States)" in a "Report of Independent Registered Pub­
lic Accounting Firm." The SEC simultaneously issued interpretive guidance 
in Release No. 33-8422 under the Securities Act of 1933 (1933 Act) (Release 
No. 34-49708 under the Securities Act of 1934) (1934 Act) to address certain 
implementation issues relating to the Standard.
Unqualified Opinion
12.05 The independent auditor's standard report states that the finan­
cial statements present fairly, in all material respects, an entity's financial 
position, results of operations, changes in net assets, and cash flows in confor­
mity with GAAP. The opinion should include an identification of the United 
States of America as the country of origin of those accounting principles. This 
conclusion may be expressed only when the independent auditor has formed 
such an opinion on the basis of an audit performed in accordance with GAAS 
and an identification of the United States of America as the country of ori­
gin of those standards, or in accordance with the standards of the PCAOB 
(United States), as discussed in paragraph 12.04. An example of the indepen­
dent auditor's standard report is presented in Exhibit 12-1 at the end of this 
chapter.
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Qualified Opinion
12.06 SAS No. 58 states that certain circumstances may require a qualified 
opinion. A qualified opinion states that except for the effects of the matter to 
which the qualification relates, the financial statements present fairly, in all 
material respects, the financial position, results of operations, and cash flows 
in conformity with GAAP. Such an opinion is expressed when—
a. There is a lack of sufficient competent evidential matter or there 
are restrictions on the scope of the audit that have led the inde­
pendent auditor to conclude that an unqualified opinion cannot be 
expressed and the independent auditor has concluded not to dis­
claim an opinion (see Exhibit 12-2).
b. The independent auditor believes, on the basis of the audit, that 
the financial statements contain a departure from GAAP, the effect 
of which is material, and has concluded not to express an adverse 
opinion (see Exhibit 12-3).
Additional Information
12.07 SAS No. 29, Reporting on Information Accompanying the Basic 
Financial Statements in Auditor-Submitted Documents (AICPA, Professional 
Standards, vol. 1, AU sec. 551), contains useful guidance on reporting on ad­
ditional information. The information covered by SAS No. 29 is presented to 
accompany the basic financial statements in an independent auditor-submitted 
document and is not considered necessary for a fair presentation of financial po­
sition, results of operations, changes in net assets, and cash flows in conformity 
with GAAP. Such information includes additional details or explanations of 
items in, or related to, the basic financial statements, consolidating/combining 
information, historical summaries of items extracted from the basic financial 
statements, statistical data, and other material, some of which may be from 
sources outside the accounting system or outside the health care organization.
12.08 With respect to supplementary and other information, guidance is 
contained in SAS No. 8, Other Information in Documents Containing Audited 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 550), 
and SAS No. 52, Omnibus Statement on Auditing Standards—1987, "Required 
Supplementary Information" (AICPA, Professional Standards, vol. 1, AU sec. 
558). Among other changes, SAS No. 52 amends SAS No. 29 regarding required 
supplementary information. SAS No. 8 (AICPA, Professional Standards, vol. 1,
AU sec. 550.07), SAS No. 29 (AICPA, Professional Standards, vol. 1, AU sec. 
551.12 and .15), and SAS No. 52 (AICPA, Professional Standards, vol. 1, AU 
sec. 558.08 and .10), were also amended by SAS No. 98, Omnibus Statement 
on Auditing Standards—2002, to address the appropriate reporting for supple­
mentary information and other information. The amendments to SAS No. 8 and 
SAS No. 52, among other matters, clarify that an auditor may issue a report 
providing an opinion, in relation to the basic financial statements taken as a 
whole, on supplementary information and other information that has been sub­
jected to the auditing procedures applied in the audit of those basic financial 
statements. The amendments to SAS No. 29, among other matters, clarify the 
reporting guidance with respect to required supplementary information in an 
auditor-submitted document. In addition, SAS No. 42, Reporting on Condensed 
Financial Statements and Selected Financial Data (AICPA, Professional Stan­
dards, vol. 1, AU sec. 552), contains guidance on reporting in a client-prepared
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document when condensed financial statements or selected financial data are 
presented by a public entity.
12.09 GASB Statement No. 34, Basic Financial Statements—and Manage­
ment's Discussion and Analysis—for State and Local Governments, paragraphs 
8 through 11, require presentation of management's discussion and analysis 
as required supplementary information. Paragraph 8 of SAS No. 52 (AU sec. 
558.08), as amended, and paragraph 16 of SAS No. 29 (AU sec. 551.16), as 
amended, require auditor reporting on required supplementary information if 
(a) the supplementary information that GAAP requires to be presented in the 
circumstances is omitted; (b) the auditor has concluded that the measurement 
or presentation of the supplementary information departs materially from pre­
scribed guidelines; (c) the auditor is unable to complete the prescribed proce­
dures; or (d) the auditor is unable to remove substantial doubts about whether 
the supplementary information conforms to prescribed guidelines. Paragraph 
8 of SAS No. 52 (AU sec. 558.08), as amended, provides example language for 
explanatory paragraphs that, except for an explanatory paragraph because all 
required supplementary information is omitted, include a disclaimer on the 
information.
12.10 When an auditor-submitted document contains required supplemen­
tary information and the conditions listed in paragraph 12.08 in this chapter do 
not exist, the auditor should (a) express an opinion on the information if engaged 
to examine the information; (b) report on such information using the guidance 
in AU sec. 551.12 and .14, provided such information has been subjected to the 
auditing procedures applied in the audit of the basic financial statements; or 
(c) disclaim an opinion on the information, as discussed in paragraph 15 of SAS 
No. 29 (AU sec. 551.15).
12.11 When a client-prepared document contains required supplementary 
information and the conditions listed in paragraph 12.09 in this chapter do not 
exist, the auditor has no reporting requirement but may voluntarily disclaim an 
opinion on the required supplementary information.2 Paragraph 7 of SAS No. 8 
(AICPA, Professional Standards, vol. 1, AU sec. 550.07), as amended, permits 
an auditor to issue a report providing an opinion, in relation to the financial 
statements taken as a whole, when required supplementary information has 
been subjected to auditing procedures applied in the audit of the basic financial 
statements.
Special Reports
12.12 If a health care organization is required to follow reporting require­
ments of a regulatory agency, to report under a cash receipts and disburse­
ments basis of accounting, or to report on another comprehensive basis of 
accounting other than GAAP, the auditor should follow the guidance in SAS No. 
62, Special Reports (AICPA, Professional Standards, vol. 1, AU sec. 623). SAS 
No. 62 also provides reporting guidance when reporting on specified elements, 
accounts, or items of a financial statement; compliance with aspects of contrac­
tual agreements or regulatory requirements related to audited financial state­
ments; financial presentations to comply with contractual agreements or regu­
latory provisions; and financial information presented in prescribed forms (see
2 Some auditors voluntarily disclaim an opinion on required supplementary information to in­
form the report user of the extent of auditor responsibility for the information.
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Exhibit 12-4). Accountants' reports on regulatory basis financial statements 
generally are prescribed by professional standards as restricted-use reports as 
described in SAS No. 87, Restricting the Use of an Auditor's Report (AICPA, 
Professional Standards, vol. 1, AU sec. 532). Where obligated group financial 
statements exclude entities that are required under GAAP to be consolidated in 
order to comply with loan agreements, the accountants' report should restrict 
the use to specified parties (see Exhibit 12-4).3 Use should be restricted to the 
company and other parties to the agreement. Health care providers that receive 
federal financial assistance should also refer to the Audit Guide Government 
Auditing Standards and Circular A-133 Audits.
3 Obligated group is a term used to denote a group of entities, sometimes a parent corporation 
and several of its subsidiaries, that is liable for the repayment of obligations, such as tax-exempt 
bonds.
AAG-HCO 12.12
170
Exhibit 12-1
Health Care Organizations
Unqualified Opinion—Comparative Financial Statements
Independent Auditor’s Report
To the Board of Trustees 
XYZ Health Care Organization
We have audited the accompanying balance sheets of XYZ Health Care Or­
ganization as of September 30, 20X2, and 20X1, and the related statements 
of operations, changes in net assets, and cash flows for the years then ended. 
These financial statements are the responsibility of XYZ Health Care Orga­
nization's management. Our responsibility is to express an opinion on these 
financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally ac­
cepted in the United States of America. These standards require that we plan 
and perform the audit to obtain reasonable assurance about whether the fi­
nancial statements are free of material misstatement. An audit includes exam­
ining, on a test basis, evidence supporting the amounts and disclosures in the 
financial statements. An audit also includes assessing the accounting principles 
used and significant estimates made by management, as well as evaluating the 
overall financial statement presentation. We believe that our audits provide a 
reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all 
material respects, the financial position of XYZ Health Care Organization as of 
September 30, 20X2, and 20X1, and the results of its operations, changes in net 
assets, and cash flows for the years then ended in conformity with accounting 
principles generally accepted in the United States of America.
[Signature]
[Date]
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Exhibit 12-2
Qualified Opinion—Scope Limitation
Independent Auditor's Report
To the Board of Trustees 
XYZ Health Care Organization
[Include same first paragraph as the standard report—see Exhibit 12-1]
Except as discussed in the following paragraph, we conducted our audits in 
accordance with auditing standards generally accepted in the United States 
of America. Those standards require that we plan and perform the audit to 
obtain reasonable assurance about whether the financial statements are free of 
material misstatement. An audit includes examining, on a test basis, evidence 
supporting the amounts and disclosures in the financial statements. An audit 
also includes assessing the accounting principles used and significant estimates 
made by management, as well as evaluating the overall financial statement 
presentation. We believe that our audits provide a reasonable basis for our 
opinion.
We were unable to obtain audited financial statements supporting XYZ's invest­
ment in an affiliate stated at $XXX,XXX and $XXX,XXX at September 30, 20X2, 
and 20X1, respectively, or its equity in earnings of that affiliate of $XXX,XXX 
and $XXX,XXX, which is included in the statement of operations for the years 
then ended as described in Note X to the financial statements; nor were we able 
to satisfy ourselves as to the carrying value of the investment in the affiliate or 
the equity in its earnings by other auditing procedures.
In our opinion, except for the effects of such adjustments, if any, as might have 
been determined to be necessary had we been able to examine evidence regard­
ing the affiliate investment and earnings, the financial statements referred to 
in the first paragraph present fairly, in all material respects, the financial po­
sition of XYZ Health Care Organization as of September 30, 20X2, and 20X1, 
and the results of its operations, changes in net assets, and cash flows for the 
years then ended in conformity with accounting principles generally accepted 
in the United States of America.
[Signature]
[Date]
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Exhibit 12-3
Health Care Organizations
Qualified Opinion—Departure From 
Generally Accepted Accounting Principles 
That Have a Material Effect on the Financial Statements
Independent Auditor's Report
To the Board of Trustees 
XYZ Health Care Organization
[Include same first and second paragraphs as the 
standard report—see Exhibit 12-1]
XYZ Health Care Organization has excluded, from property and debt in the 
accompanying balance sheets, certain lease obligations that, in our opinion, 
should be capitalized to conform with accounting principles generally accepted 
in the United States of America. If these lease obligations were capitalized, 
property would be increased by $XXX,XXX and $XXX,XXX, long-term debt 
would be increased by $XXX,XXX and $XXX,XXX, and unrestricted net assets 
would be increased by $XXX,XXX and $XXX,XXX as of September 31, 20X2, 
and 20X1, respectively. In addition, earnings would be increased by $XXX,XXX 
and $XXX,XXX, respectively, for the years then ended.
In our opinion, except for the effects of not capitalizing certain lease obligations 
as discussed in the preceding paragraph, the financial statements referred to in 
the first paragraph present fairly, in all material respects, the financial position 
of XYZ Health Care Organization as of September 30, 20X2, and 20X1, and the 
results of its operations, changes in net assets, and cash fl ows for the years 
then ended in conformity with accounting principles generally accepted in the 
United States of America.
[Signature]
[Date]
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Exhibit 12-4
Report on Financial Statements Prepared Pursuant to a 
Master Trust Indenture That Results in a Presentation Not 
in Conformity With Generally Accepted Accounting Principles 
or Other Comprehensive Basis of Accounting
Independent Auditor's Report
To the Board of Directors 
Sample Health Care Corporation
We have audited the accompanying special-purpose combined balance sheets 
of the Obligated Group (as defined in the Master Trust Indenture dated De­
cember X, 20X0, between Sample Health Care Corporation and Any Bank as 
Trustee) of Sample Health Care Corporation and Affiliates as of December 31, 
20X2, and 20X1, and the related special-purpose combined statements of oper­
ations, changes in net assets, and cash flows for the years then ended. These 
financial statements are the responsibility of management. Our responsibility 
is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally ac­
cepted in the United States of America. Those standards require that we plan 
and perform the audit to obtain reasonable assurance about whether the fi­
nancial statements are free of material misstatement. An audit includes exam­
ining, on a test basis, evidence supporting the amounts and disclosures in the 
financial statements. An audit also includes assessing the accounting principles 
used and significant estimates made by management, as well as evaluating the 
overall financial statement presentation. We believe that our audits provide a 
reasonable basis for our opinion.
As described in Note 1, these special-purpose financial statements were pre­
pared in accordance with the accounting requirements set forth in the Master 
Trust Indenture and are not intended to be a presentation in conformity with 
generally accepted accounting principles.
In our opinion, the special-purpose financial statements of the Obligated Group 
as of and for the years ended December 31, 20X2, and 20X1, are fairly presented, 
in all material respects, on the basis of accounting described in Note 1.
This report is intended solely for the information and use of the board of direc­
tors and management of Sample Health Care Corporation, the Trustee under 
the Master Trust Indenture, and bondholders, and is not intended to be and 
should not be used by anyone other than these specified parties.
[Signature]
[Date]
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Corporate Compliance Programs
12.13 SOP 99-1, Guidance to Practitioners in Conducting and Reporting 
on an Agreed-Upon Procedures Engagement to Assist Management in Evaluat­
ing the Effectiveness of Its Corporate Compliance Program, provides guidance 
to practitioners in conducting and reporting on an agreed-upon procedures en­
gagement performed pursuant to the AICPA Statements on Standards for At­
testation Engagements to assist a health care provider in evaluating the effec­
tiveness of its corporate compliance program consistent with the requirements 
of a Corporate Integrity Agreement entered into with the Office of the Inspector 
General of the U.S. Department of Health and Human Services. SOP 99-1 is 
included as Appendix D to this Guide.
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Chapter 13
Financial Accounting and Reporting by 
Providers of Prepaid Health Care Services
Overview
13.01 This chapter provides guidance on applying GAAP to providers of 
prepaid health care services for the accounting and reporting of health care 
costs, contract losses (premium deficiencies), stop-loss insurance (reinsurance), 
and contract acquisition costs.
Accounting for Health Core Costs
13.02 Health care costs should be accrued as services are rendered, in­
cluding estimates of the costs of services rendered but not yet reported. Fur­
thermore, if a provider of prepaid health care services is obligated to render 
services to specific members beyond the premium period due to provisions in 
the contract or regulatory requirements, the costs of such services to be incurred 
also should be accrued currently. Costs that will be incurred after a contract 
is terminated, such as guaranteed salaries, rent, and depreciation, net of any 
anticipated revenues, should be accrued when it is determined that a contract 
with a sponsoring employer or other group will be terminated. FASB Statement 
No. 146, Accounting for Costs Associated with Exit or Disposal Activities, pro­
vides accounting and reporting guidance for certain contract termination costs 
associated with an exit or disposal activity.1
13.03 Amounts payable to hospitals, physicians, or other health care 
providers under risk-retention, bonus, or similar programs should be accrued 
during the contract period based on relevant factors, such as experience to date.
13.04 The basis for accruing health care costs and significant business 
and contractual arrangements with hospitals, physicians, or other associated 
entities should be disclosed in the notes to the financial statements.
Accounting for Loss Contracts
13.05 A prepaid health care provider enters into contracts to provide mem­
bers with specified health care services for specified periods in return for fixed 
periodic premiums. The premium revenue is expected to cover health care costs 
and other costs over the terms of the contracts. Only in unusual circumstances 
would a provider be able to increase premiums on contracts in force to cover 
expected losses. A provider may be able to control or reduce future health care 
delivery costs to avoid anticipated losses, but the ability to avoid losses under 
existing contracts may be difficult to measure or to demonstrate. Associated 
entities such as hospitals, medical groups, and individual practice associations 
(IPAs) may enter into similar contracts with prepaid health care providers in
1 This pronouncement is not applicable to governmental health care entities that do not apply 
paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary Funds 
and, Other Governmental Entities That Use Proprietary Fund Accounting. (See Chapter 1, footnote 1.)
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which they agree to deliver identified health care services to the providers' 
members for specified periods in return for fixed fees.
13.06 FASB Statement No. 5, Accounting for Contingencies, states that a 
loss should be accrued in financial statements when it is probable that a loss 
has been incurred and the amount of the loss can be reasonably estimated. Ac­
cordingly, losses should be recognized when it is probable that expected future 
health care costs and maintenance costs under a group of existing contracts 
will exceed anticipated future premiums and stop-loss insurance recoveries on 
those contracts. The estimated future health care costs and maintenance costs 
to be considered in determining whether a loss has been incurred should in­
clude fixed and variable, direct and allocable indirect costs. Contracts should 
be grouped in a manner consistent with the provider's method of establishing 
premium rates, for example, by community rating practices, geographical area, 
or statutory requirements, to determine whether a loss has been incurred.
Accounting for Stop-Loss Insurance
13.07 In stop-loss insurance, prepaid health care providers or associated 
entities transfer portions of their financial risks to other companies. A provider 
typically contracts to recover health care costs in excess of stated amounts 
during the contract periods.
13.08 Stop-loss insurance premiums should be included in reported health 
care costs. Stop-loss insurance recoveries should be reported as reductions of 
related health care costs. Receivables representing amounts recoverable from 
insurers should be reported as assets, reduced by appropriate valuation al­
lowances. In addition, the nature, amounts, and effects of significant stop-loss 
insurance contracts should be disclosed.
13.09 For governmental health care entities, GASB Statement No. 42, Ac- 
counting and Financial Reporting for Impairment of Capital Assets and for 
Insurance Recoveries, provides accounting guidance for insurance recoveries.*
Accounting for Contract Acquisition Costs
13.10 Many prepaid health care providers incur costs that vary with, and 
are primarily related to, the marketing of subscriber contracts and member en­
rollment. These costs, sometimes referred to as acquisition costs, consist mainly 
of commissions paid to agents or brokers and incentive compensation based on 
new enrollments. Commissions and incentive compensation may be paid when 
the contracts are written, at later dates, or over the terms of the contracts as 
premiums are received. Some providers incur additional costs directly related 
to the acquisition of specific contracts, such as the costs of specialized brochures, 
marketing, and advertising. Providers also incur costs that are related to the 
acquisition of new members but that do not relate to specific contracts and are 
not considered acquisition costs. These costs include salaries of the marketing 
director and staff, general marketing brochures, and general advertising and 
promotion expenses.
* GASB Statement No. 42, Accounting and Financial Reporting for Impairment of Capital Assets 
and for Insurance Recoveries, is effective for financial statements for periods beginning after December 
15, 2004. Earlier application is encouraged.
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13.11 Although there is theoretical support for deferring certain acquisi­
tion costs, acquisition costs of providers of prepaid health care services—other 
than costs of advertising—should be expensed as incurred.2 Advertising costs 
should be accounted for in conformity with the guidance in SOP 93-7, Reporting 
on Advertising Costs.3
2 In accordance with existing practice, as mandated by SOP 89-5, Financial Accounting and 
Reporting by Providers of Prepaid Health Care Services. Although SOP 89-5 has been superseded with 
the issuance of this Audit and Accounting Guide, its provisions have been adopted in this chapter.
3 This pronouncement is not applicable to governmental health care enterprises that do not apply 
paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary Funds 
and Other Governmental Entities That Use Proprietary Fund Accounting. (See Chapter 1, footnote 1.)
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Chapter 14
Financial Accounting and Reporting by  
Continuing Care Retirement Communities
Overview
14.01 This chapter provides guidance on applying GAAP to continuing care 
retirement communities (CCRCs) for refundable and nonrefundable advance 
fees, for obligations to provide future services and the use of facilities to current 
residents, and for the costs of acquiring initial care contracts.1
14.02 The United States has over one thousand CCRCs. Most CCRCs are 
operated by not-for-profit organizations, and many are affiliated with religious 
organizations.
14.03 CCRC facilities may be independent or they may be affiliated with 
other health care facilities. They usually provide less intensive care than do 
hospitals. They generally supply required continuous nursing service or appro­
priate assistance to residents who have a wide range of medical conditions and 
needs.
14.04 Some states regulate CCRCs, although most states currently do not. 
There is, however, a growing trend toward regulation in this rapidly develop­
ing industry. States that do require some form of regulation specify that the 
CCRCs be certified by a state authority, such as a department of insurance or 
a department of social services. In addition, some states mandate that escrow 
or reserve funds be maintained for the protection of residents.
Types of Contracts
14.05 CCRCs use three basic types of contracts. They include all-inclusive 
(type A), modified (type B), and fee-for-service (type C) contracts.
Type A  Contracts
14.06 An all-inclusive continuing-care contract includes residential facil­
ities, meals, and other amenities. It also provides long-term nursing care for 
little or no increase in periodic fees, except to cover normal operating costs and 
inflation.
Type B Contracts
14.07 A modified continuing-care contract also includes residential facili­
ties, meals, and other amenities. However, only a specified amount of long-term 
nursing care is provided for little or no increase in periodic fees, except to cover 
normal operating costs and inflation. After the specified amount of nursing 
care is used, residents pay either a discounted rate or the full per diem rates 
for required nursing care.
1 The provisions of this chapter do not apply to governmental health care enterprises, unless the 
entity has elected to follow all FASB pronouncements under paragraph 7 of GASB Statement No. 20, 
Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities That 
Use Proprietary Fund Accounting. (See Chapter 1, footnote 1.)
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Type C Contracts
14.08 A fee-for-service continuing-care contract includes residential facil­
ities, meals, and other amenities as well as emergency and infirmary nursing 
care. Access to long-term nursing care is guaranteed, but it may be required at 
full per diem rates.
Types of Living Accommodations
14.09 CCRCs offer different types of living accommodations to residents, 
such as single or shared apartment units or individual homes. They also pro­
vide a variety of amenities, including social, recreational, dining, and laundry
services.
14.10 CCRCs may provide long-term nursing-care services, either at the 
same location or, by agreement, with another facility. Residents are transferred 
to or from a nursing center as medical care is required. As the health of a 
resident declines, he or she may be transferred permanently to a nursing center.
Fees and Payment Methods
14.11 Continuing-care contracts contain a number of different approaches 
to providing delivery of services. Contract provisions, for example, may stipulate 
the amount of the advance fee, whether periodic fees will be required, and, if so, 
whether they can be adjusted. In addition, contracts generally do the following: 
detail the future services that will be provided to residents; explain how a 
resident will be charged for services; describe the CCRC's refund policies and 
the formula for calculating the amount of the refund, which may be simple or 
complex; and describe the obligations of the CCRC and the resident if a contract 
is terminated or a residential unit is reoccupied.
14.12 A CCRC may require several different payment methods for services 
and the use of facilities. Paragraphs 14.13 through 14.19 discuss three of the 
most prevalent methods.
Advance Fee O n ly
14.13 Under this method, a resident pays an advance fee in return for 
future services and the use of facilities. Such services generally include CCRC 
housing-related services (for example, meals, laundry, housekeeping, and social 
services) and health care. These services usually are provided to the resident 
for the remainder of his or her life or until the contract is terminated. Addi­
tional periodic fees are not paid, regardless of how long a resident lives or if 
the resident requires more services than anticipated. Generally, the resident 
receives no ownership interest in the facility.
Advance Fee W ith Periodic Fees
14.14 Under this method, a resident pays an advance fee and periodic fees 
for services and the use of facilities. Such periodic fees may be fixed, or they 
may be subject to adjustment for increases in operating costs or inflation or for 
other economic reasons.
Periodic Fees O nly
14.15 Under this method, a resident pays a fee at periodic intervals for 
services and the use of the facilities provided by the CCRC. Such fees may be 
either fixed or adjustable.
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14.16 An advance fee may be met by transferring a resident's personal 
assets (which may include rights to future income) or by paying a lump sum of 
cash to the CCRC.
14.17 Advance fees received for future services may be refunded at the oc­
currence of some future event, such as death, withdrawal from the CCRC, ter­
mination of the contract, or reoccupancy of a residential unit. The amount of the 
refund generally is based on contractual provisions or statutory requirements.
14.18 Many continuing-care contracts are similar to annuity contracts. Un­
der those contracts, the CCRC assumes the risks associated with (a) estimat­
ing the amount of the advance fee and other fees to be paid by a resident and
(b) determining whether such fees will be sufficient to cover the cost of provid­
ing a resident's required services and the use of facilities. For some contracts, 
residents may share the future costs without limit.
14.19 The CCRC has an obligation to provide future services for the length 
of the contract or the life of the resident. In certain circumstances, this obliga­
tion continues regardless of whether advance fees or periodic fees are sufficient 
to meet the costs of providing services to a resident.
Accounting for Refundable Advance Fees
14.20 Payment of an advance fee generally is required before a resident 
acquires a right to reside in an apartment or residential unit for life. A portion 
of advance fees may he refundable by rescission within a legally set time period 
or if a certain future event occurs, such as the death or withdrawal of a resident 
or termination of the contract. Some refunds are paid only if a residential unit 
is reoccupied.
14.21 CCRC refund policies vary either by region or according to statutory 
requirements, but generally the amount of the refund is based on provisions 
specified in a contract. For example, some contracts require a refund of the 
advance fee, less a reasonable processing fee. Amounts refunded may be based 
on a fixed amount or percentage, an amount that declines to a fixed amount 
over time, an amount that declines to zero, or an amount based on the resale 
amount. Refunds may be contingent on vacating the unit, resale of the unit, or 
passage of a fixed period of time if the unit is not resold.
14.22 The estimated amount of advance fees that is expected to be refunded 
to current residents under the terms of the contracts should be accounted for 
and reported as a liability. The estimated amount should be based on the indi­
vidual facility's own experience or, if records are not available, on the experience 
of comparable facilities. The remaining amount of advance fees should be ac­
counted for as deferred revenue within the liability section of the balance sheet. 
Adjustments to the estimated liability should be accounted for as deferred rev­
enue and amortized together with nonrefundable advance fees as discussed 
in paragraph 14.23. The gross amount of contractual refund obligations un­
der existing contracts and the CCRC's refund policy should be disclosed in the 
notes to the financial statements. Amounts refunded should be disclosed in the 
statement of cash fl ows as a financing transaction.
14.23 The deferred revenue should be amortized to income over future pe­
riods based on the estimated life of the resident or on the contract term, if 
shorter. The period of amortization should be adjusted annually based on the 
actuarially determined, estimated, remaining life expectancy of each individ­
ual or on the joint and last survivor life expectancy of each pair of residents
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occupying the same unit. The straight-line method should be used to amortize 
deferred revenue except in certain circumstances when costs are expected to 
increase at a significantly higher rate than future revenues in the later years 
of residence. In those situations, deferred revenue may be amortized to income 
using a method that reflects the disproportionate ratio between the costs of the 
expected services and the expected revenues. The amortized amount should 
not exceed the amount available to the CCRC under state regulations, contract 
provisions, or management policy. Unamortized deferred revenue from nonre­
fundable advance fees should be recorded as revenue upon a resident's death or 
the termination of the contract. The method of amortization should be disclosed 
in the notes to the financial statements.
Accounting for Fees Refundable to Residents Only From 
Reoccupa ncy Proceeds of a Contract Holder's Unit
14.24 Some contracts between a CCRC and a resident stipulate that all 
or a portion of the advance fee may be refundable if the contract holder's unit 
is reoccupied by another person. The source of money for the payment is from 
the proceeds of the advance fees collected by the CCRC from the next resident 
of the reoccupied unit. The terms governing how the proceeds from the next 
resident are to be paid to the previous resident vary from contract to contract. 
In effect, the CCRC acts as if it were an agent for present and future residents.
14.25 The portion of the fees that will be paid to current residents or their 
designees, only to the extent of the proceeds of reoccupancy of a contract holder's 
unit, should be accounted for as deferred revenue, provided that legal and man­
agement policy and practice support the withholding of refunds under this con­
dition. Similar amounts received from new residents in excess of the amount 
to be paid to previous residents or their designees also should be deferred. The 
deferred revenue should be amortized to income over future periods based on 
the remaining useful life of the facility. The basis and method of amortization 
should be consistent with the method for calculating depreciation and should 
be disclosed in the notes to the financial statements.
Accounting for Nonrefundable Advance Fees
14.26 Under provisions of continuing-care contracts entered into by a 
CCRC and residents, nonrefundable advance fees represent payment for fu­
ture services and should be accounted for as deferred revenue. If a CCRC has 
sufficient historical experience and relevant statistical data about life expectan­
cies, it should consider that information when determining the remaining life of 
residents. A CCRC with insufficient historical experience or reliable actuarial 
data may use relevant data of similar communities within that area, relevant 
national industry statistics, or other appropriate data. Nonrefundable advance 
fees should be amortized in the manner discussed in paragraph 14.23.
14.27 The application of the conclusions in paragraphs 14.25 and 14.26 is 
presented in Exhibit 14-1 at the end of this chapter.
Accounting for the Obligation to Provide Future Services 
and the Use of Facilities to Current Residents
14.28 A CCRC expects to provide services and the use of facilities to indi­
viduals over their remaining lives under continuing-care contract agreements.
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The nature and extent of such services depend on such variables as the individ­
ual's age, health, sex, and economic status upon entering the CCRC. Thus, the 
CCRC assumes a risk in estimating the cost of future services and the use of 
facilities. Although many CCRCs are allowed contractually to increase periodic 
fees, some contracts may restrict increases in periodic fees and require continu­
ing services without additional compensation. If the advance fees and periodic 
fees charged are insufficient to meet the costs of providing future services and 
the use of facilities, the CCRC has a liability to provide future services and the 
use of facilities that is equal to the estimated cost of providing future services 
and the use of facilities (defined as amounts that are expected to be incurred to 
provide services and the use of facilities to individuals over their remaining lives 
under continuing care contracts, including resident-care, dietary, health care, 
facility, interest, depreciation, and amortization costs) in excess of the related 
anticipated revenues. The liability is based on actuarial assumptions (such as 
mortality and morbidity rates), on estimates of future costs and revenues, and 
on the specific CCRC's historical experience and statistical data.
14.29 The obligation to provide future services and the use of facilities to 
current residents should be calculated annually in order to determine whether 
a liability should be reported in the financial statements. The liability related 
to continuing-care contracts is the present value of future net cash flows, minus 
the balance of unamortized deferred revenue, plus depreciation of facilities to 
be charged related to the contracts, plus unamortized costs of acquiring the 
related initial continuing-care contracts, if applicable. The calculation should 
be made by grouping contracts by type, such as all contracts with a limit on 
annual increases in fees, contracts with unlimited fee increases, and so forth.
14.30 Cash inflows include revenue contractually committed to support 
the residents and inflows resulting from monthly fees including anticipated in­
creases in accordance with contract terms. This includes third-party payments, 
contractually or statutorily committed investment income from services related 
to CCRC activities, contributions pledged by donors to support CCRC activ­
ities, and the volume of deferred nonrefundable advance fees. Cash outflows 
are composed of operating expenses, including interest expense and excluding 
selling, and general and administrative expenses. Anticipated cost increases 
affecting these operating expenses should be considered in determining cash 
outflows. The expected inflation rate as well as other factors should be consid­
ered in determining the discount rate. In calculating the liability, the specific 
CCRC's historical experience or statistical data relating to the residents' life 
spans should be used. The life spans used should be the same as those used 
to amortize deferred revenue (see paragraph 14.23). For a new CCRC, either 
relevant data of similar communities in the area or relevant national industry 
statistics may be used if they are deemed to be representative.
14.31 A CCRC should disclose in its notes to the financial statements
(1) the carrying amount of the liability to provide future services and the use of 
facilities related to continuing-care contracts that is presented at present value 
in the financial statements (if not separately disclosed in the balance sheet) and
(2) the interest rate used to discount that liability. Also, the FASB has issued 
FASB Concepts Statement No. 7, Using Cash Flow Information and Present 
Value in Accounting Measurements. This Concepts Statement provides useful 
discussion of general principles governing the use of present value, and of the 
objective of present value in accounting measurements. Statements of Finan­
cial Accounting Concepts are not sources of established accounting principles
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as described in SAS No. 69, The Meaning of Present Fairly in Conformity With 
Generally Accepted Accounting Principles, and, thus, do not amend, modify, 
or justify a change from generally accepted accounting principles currently in 
effect.
14.32 The application of the conclusions in paragraph 14.30 is presented 
in Exhibit 14-2 at the end of this chapter.
Accounting for the Costs of Acquiring Initial 
Continuing-Core Contracts
14.33 Advertising costs incurred in connection with acquiring initial 
continuing-care contracts should be accounted for in conformity with the guid­
ance in SOP 93-7, Reporting on Advertising Costs. Start-up costs should be ex­
pensed as incurred in accordance with SOP 98-5, Reporting on the Costs of Start- 
Up Activities. However, costs of acquiring initial continuing-care contracts that 
are within the scope of FASB Statement No. 67, Accounting for Costs and Ini­
tial Rental Operations of Real Estate Projects, should be expensed or capitalized 
in accordance with that Statement. Capitalized costs should be amortized to 
expenses on a straight-line basis over the average expected remaining lives of 
the residents under the contract or the contract term, if shorter. The costs of 
acquiring continuing-care contracts after a CCRC is substantially occupied or 
one year following completion should be expensed when incurred.2
Financial Statements
14.34 A complete set of illustrative financial statements for a CCRC is 
included in Appendix A.
14.35 The notes to the financial statements for each year presented should 
include—
• A description of the CCRC and the nature of the related continuing- 
care contracts entered into by the CCRC.
•  The statutory escrow or similar requirements.
•  The refund policy of the CCRC and the general amount of refund obli­
gation under the existing contracts.
•  The interest rate used to discount the liability to provide future 
services.
Auditing
14.36 When auditing a CCRC, the independent auditor may need to con­
sider the examples of specific auditing objectives, selected control activities, 
and auditing procedures that are presented in Exhibit 14-3 at the end of this 
chapter.
2 In accordance with existing practice, as amended by SOP 90-8, Financial Accounting and Re­
porting by Continuing Care Retirement Communities. Although SOP 90-8 is superseded with the 
issuance of this Audit and Accounting Guide, its provisions have been adopted in this chapter.
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Exhibit 14-1
Accounting for Refundable and Nonrefundable Advance Fees
Assumptions:
a. The unit is occupied for twenty years.
b. The facility has an estimated thirty-year life.
c. The resident is admitted on the first day of the year indicated and 
dies on the last day of year indicated.
d. The estimated remaining life expectancy is taken from an appro­
priate actuarial table.
e. The cost of providing future services is expected to be incurred 
equally over the remaining life.
Example:
Year
Admitted Dies Resident
Entry
Age
Advance Fees Refunded to 
the Previous 
Occupant*Total
Nonrefundable
25%
Refundable
75%
1 4 A 68 $100,000 $25,000 $75,000 —
5 8 B 82 120,000 30,000 90,000 $75,000
9 13 C 79 150,000 37,500 112,500 90,000
14 — D 80 130,000 32,500 97,500 97,500
* Per contact, the amount is limited to 75% of proceeds of reoccupancy up to amount 
originally paid by previous occupant.
Amortization of Advance Fees Refundable to Residents
$75,000/30 years = $2,500 per year for years 1 through 4
15,000/26 years = $577 additional or $3,077 per year for years 5 through 8
22,500/22 years = $1,023 additional or $4,100 per year for years 9 through next change
in occupancy
Amortization of Nonrefundable Advance Fees:
Resident A 
Year 1 
2
3
4
Unamortized
Deferred
Revenue
$25,000
22,934
20,940
19,054
Estimated 
Remaining 
Life (in Years)
12.1 =
11.5 = 
11.1 =
10.6 =
Unamortized deferred revenue 
recognized upon the death of the resident
Total
Income
$2,066
1,994
1,886
1,798
17.256
$25.000
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Resident B
Unamortized
Deferred
Revenue
Estimated 
Remaining 
Life (in Years) Income
Year 5 $30,000 6.1 = $4,918
6 25,082 5.8 = 4,324
7 20,758 5.5 = 3,774
8 16,984 5.3 = 3,205
Unamortized deferred revenue
recognized upon the death of the resident 13,779
Total $30,000
Unamortized Estimated
Deferred Remaining
Resident C Revenue Life (in Years) Income
Year 9 $37,500 7.0 = $5,357
10 32,143 6.7 = 4,797
11 27,346 6.4 = 4,273
12 23,073 6.1 = 3,783
13 19,290 5.8 = 3,324
Unamortized deferred revenue
recognized upon the death of the resident 15,966
Total $37,500
Unamortized Estimated
Deferred Remaining
Resident D Revenue Life (in Years) Income
Year 14 $32,500 6.7 = $4,851
15 27,649 6.4 = 4,321
16 23,328 6.1 = 3,824
17 19,504 5.8 = 3,363
18 16,141 5.5 = 2,935
19 13,206 5.3 = 2,492
20 10,714 5.1 = 2,100
Amortization continues until the death of the resident.
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Exhibit 14-2
Accounting for the Obligation to Provide Future Services 
and the Use of Facilities to Current Residents
Assumptions:
а. All residents pay a $ 50,000 fee, which is refundable less 2 percent 
per month for the first 36 months. After that period, none of the fee 
is refundable. The CCRC opened on 1/1/X4. (See Exhibit 14-1 for an 
illustration of how to compute refundable and deferred revenue.)
b. An additional periodic fee of $1,000 is payable monthly with a 5 
percent increase annually.
c. The unamortized (deferred) costs of acquiring related initial con­
tracts on 12/31/X6 are assumed to be $17,000.
d. The unamortized deferred revenue on 12/31/X6 is assumed to be 
$27,027.
Present value of net cash flow on 12/31/ X6: 
Cash inflows:
Estimated
Remaining Life 
(in Months) 
on 12/ 31/X6
Estimated Cash Inflows
Resident 19X7 19X8 19X9 20X0
A 36 $12,000 $12,600 $13,230 —
B 22 12,000 10,500 — —
C 27 12,000 12,600 3,308 —
D 38 12,000 12,600 13,230 $2,315
Estimated cash inflows $48,000 $48,300 $29,768 $2,315
Cash outflows:
Estimated
Remaining Life 
(in Months) 
on 12/ 31/X6
Estimated Cash Outflows
Resident 19X7 19X8 19X9 20X0
A 36 $10,000 $12,000 $15,000 —
B 22 15,000 11,000 — —
C 27 14,000 17,000 5,000 —
D 38 8,000 12,000 14,000 $4,000
Estimated cash outflows $47,000 $52,000 $34,000 $4,000
Recapitulation 19X7 19X8 19X9 20X0
Cash inflows $ 48,000 $ 48,300 $29,768 $ 2,315
Cash outflows (47,000) (52,000) (34,000) (4,000)
$ 1.000 $(3,700) $ (4.232) $(1,685)
Present value of net cash flows discounted at 
10 percent $(7,137)
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Depreciation of facilities to be charged to current residents:
Original cost of facility $17,000,000
Cost of facility allocable to revenue-producing service 
areas $(2,000,000)
Cost of facility to be allocated to residents (including 
common areas) $15,000,000
Useful life 40 years
Annual depreciation using straight-line method $ 375,000
Number of residents expected to occupy the facility 200 
Annual depreciation per resident $ 1,875
Monthly depreciation per resident $ 156
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Total estimated depreciation of the use of facilities to 
be charged to the current residents
Resident
Estimated 
Remaining Life 
(in Months) 
on 12/31/X6 19X7 19X8 19X9 20X0
A 36 $1,875 $1,875 $1,875 —
B 22 1,875 1,560 — —
C 27 1,875 1,875 468 —
D 38 1,875 1,875 1,875 $ 312
Yearly estimated depreciation 
of facilities to be charged to 
current residents $7,500 $7,185 $4,218 $ 312
$19.215
Liability for providing future services and the use of facilities to current 
residents:
Present value of future net cash outflows 
Minus:
Unamortized deferred revenue on 12/31/X6 
Plus:
Depreciation to be charged to current residents 
Unamortized costs of acquiring initial 
contracts—see assumption c above 
Liability for providing future services and the use of 
facilities to current residents on 12/31/X6
$7,137
(27,027)
19,215
17,000*
$16.325
* These numbers are for illustrative purposes only and no inference has been 
made as to the recoverability of the $17,000.
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Exhibit 14-3
Auditing Considerations
Financial Statement 
Assertions
Specific Auditing 
Objectives
Selected Control 
Activities
Auditing
Procedures
Continuing Care Retirement Communities
Existence, 
completeness, and 
presentation and 
maturity
Liabilities 
relating to 
refundable fee 
arrangements 
are accounted 
for and reported 
properly.
Written 
documentation 
is prepared for 
refundable fee 
arrangements.
Review the 
refundable fee 
arrangements 
regarding 
stipulations for 
repayments and 
determine that 
such
arrangements 
are classified 
and disclosed 
properly in the 
financial 
statements.
Liabilities are All liabilities are Compare the
accounted for classified, account
and reported described, and balances with
properly. disclosed 
properly in the 
financial 
statements.
Management 
monitors 
compliance with 
restrictive 
covenants.
the prior 
periods' balance 
and the 
amortization 
schedules.
Confirm any 
significant new 
obligations.
Deferred Revenue
Completeness, Deferred Procedures Test the
rights and revenue and the ensure that procedures
obligations, and obligation to amounts related to the
presentation and provide future received as recognition of
disclosure services to, and advance fees are advance fees
the use of recognized in and determine
facilities by, the proper that the
current period and that obligation to
residents of the obligation to provide future
CCRCs are provide future services and the
recognized and services and the use of facilities
reported use of facilities is properly
properly. is reported. reported.
(continued)
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Financial Statement 
Assertions
Specific Auditing 
Objectives
Selected Control 
Activities
Auditing
Procedures
Long-Term Obligations
Existence, Liabilities Written Review the
completeness, and relating to documentation refundable fee
presentation and refundable fee is prepared for arrangements
maturity arrangements 
are accounted 
for and reported 
properly.
refundable fee 
arrangements.
regarding 
stipulations for 
repayments and 
determine that 
such
arrangements 
are classified 
and disclosed 
properly in the 
financial 
statements.
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Appendix A
Illustrative Financial Statements
The following illustrative financial statements illustrate the applications of 
the reporting practices discussed in this Guide. Specific types of health care or­
ganizations have been selected to illustrate a wide diversity of reporting prac­
tices. It is not intended that these illustrations represent either the only types 
of disclosure nor the only statement formats that would be appropriate. For ex­
ample, the reporting of revenue, expenses, gains, and losses vary depending on 
the relationship of the underlying transaction to the entity's operations. More 
or less detail should appear either in the financial statements or in the notes 
to the financial statements, depending on the circumstances.
Governmental health care entities are required to follow the accounting and 
reporting requirements of the GASB. GASB pronouncements may require gov­
ernmental health care entities to present information beyond or different 
from that presented by not-for-profit and investor-owned entities. For exam­
ple, GASB Statement No. 3, Deposits with Financial Institutions, Investments 
(including Repurchase Agreements), and Reverse Repurchase Agreements, and 
GASB Statement No. 40, Deposit and Investment Risk Disclosures, require 
governmental entities to make certain disclosures about the credit, interest 
rate and foreign currency risks of their investments. GASB Statement No. 
27, Accounting for Pensions by State and Local Governmental Employers, re­
quires certain accounting for and disclosures about pension benefits provided 
to employees of governmental health care entities. GASB Statement No. 9, 
Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds and 
Governmental Entities That Use Proprietary Fund Accounting, requires gov­
ernmental health care entities to present a statement of cash flows using a 
format that differs in some respects from that required by FASB Statement 
No. 95, Statement of Cash Flows, and that requires the reporting of cash flow 
information on both restricted and unrestricted funds. GASB Statement No. 12, 
Disclosure of Information on Postemployment Benefits Other Than Pension Ben­
efits by State and Local Governmental Employers, requires certain disclosures 
about other postemployment benefits (OPEB) provided to employees of gov­
ernmental health care entities.* GASB Statement No. 12 also provides that 
governmental health care entities are not required to change their recognition
* In 2004, the GASB issued GASB Statement No. 45, Accounting and Financial Reporting by Em­
ployers for Postemployment Benefits Other Than Pensions, that supersedes GASB Statement No. 12, 
Disclosure of Information on Postemployment Benefits Other Than Pension Benefits by State and Lo­
cal Governmental Employers. GASB Statement No. 45 establishes standards for the measurement, 
recognition, and display of other postemployment (OPEB) benefit expenses and related liabilities (as­
sets). The requirements of GASB Statement No. 45 are effective in three phases based on revenues: 
periods beginning after December 15, 2006 for phase 1 governments (total annual revenues of $100 
million or more); periods beginning after December 15, 2007 for phase 2 governments (total annual 
revenues of $10 million or more but less than $100 million); and periods beginning after December 
31, 2008 for phase 3 governments (total annual revenues of less than $10 million). Earlier application 
is encouraged. Conforming changes to reflect the issuance of GASB Statement No. 45 will be made in 
a future edition of this Guide.
In June 2005, the GASB issued GASB Statement No. 47, Accounting for Termination Bene­
fits. GASB Statement No. 47 establishes accounting standards for the measurement, recognition, and 
disclosure of voluntary termination benefits and involuntary termination benefits. GASB Statement
(continued)
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and measurement of OPEB to comply with FASB Statement No. 106, Account­
ing for Postretirement Benefits Other Than Pensions, or FASB Statement No. 
112, Employer's Accounting for Postemployment Benefits. GASB Statement No. 
34, Basic Financial Statements—and Management's Discussion and Analysis— 
for State and Local Governments, establishes new financial reporting require­
ments for state and local governments, and amends or supersedes various ex­
isting GASB and NCGA Statements and Interpretations.
Other GASB pronouncements may also have implications for governmental 
health care entities. For example, GASB Statement No. 13, Accounting for Op­
erating Leases with Scheduled Rent Increases (paragraph 6.11), may affect the 
accounting for and financial reporting of certain lease transactions. Discussed 
elsewhere in this Audit and Accounting Guide are GASB Statement No. 7, 
Advance Refundings Resulting in Defeasance of Debt (paragraph 7.20), GASB 
Statement No. 10, Accounting and Financial Reporting for Risk Financing and 
Related Insurance Issues (paragraph 8.02), GASB Statement No. 14, The Finan­
cial Reporting Entity (paragraph 11.03), GASB Statement No. 16, Accounting 
for Compensated Absences (paragraph 7.03), GASB Statement No. 20, Account­
ing and Financial Reporting for Proprietary Funds and Other Governmental 
Entities That Use Proprietary Fund Accounting (Chapter 1, footnote 1), GASB 
Statement No. 23, Accounting and Financial Reporting for Refundings of Debt 
Reported by Proprietary Activities (paragraph 7.20), GASB Statement No. 28, 
Accounting and Financial Reporting for Securities Lending Transactions (para­
graph 4.13), GASB Statement No. 29, The Use of Not-for-Profit Accounting 
and Financial Reporting Principles by Governmental Entities (Chapter 1, foot­
note 1), GASB Statement No. 30, Risk Financing Omnibus (paragraph 8.02), 
GASB Statement No. 31, Accounting and Financial Reporting for Certain In­
vestments and for External Investment Pools (paragraph 4.12), GASB Statement 
No. 33, Accounting and Financial Reporting for Nonexchange Transactions, as 
amended by GASB Statement No. 36, Recipient Reporting for Certain Shared 
Nonexchange Revenues (paragraphs 5.19, 5.20, 7.05, 10.06, and 10.13), GASB 
Statement No. 39, Determining Whether Certain Organizations Are Compo­
nent Units (paragraph 11.03), GASB Statement No. 40 (paragraphs 3.04, 4.13, 
and 4.19), GASB Statement No. 42, (paragraphs 6.05, 6.09, 6.15, and 13.09), 
GASB Interpretation No. 3 Financial Reporting for Reverse Repurchase Agree­
ments (paragraph 4.13), GASB Interpretation No. 4, Accounting and Financial 
Reporting for Capitalization Contributions to Public Entity Risk Pools (para­
graph 8.02), and GASB Technical Bulletin 2003-1, Disclosure Requirements for 
Derivatives Not Reported at Fair Value on the Statement of Net Assets (para­
graphs 4.19 and 5.26).
These illustrative financial statements are not intended to include items that 
should be accounted for under the requirements of FASB Statement No. 133, 
Accounting for Derivative Instruments and Hedging Activities, as amended, 
and do not refl ect the requirements of FASB Statement No. 133. FASB State­
ment No. 133, among other matters, amends the disclosure requirements for 
securities in FASB Statement No. 115, Accounting for Certain Investments in
(footnote continued)
No. 47 is effective in two parts. For termination benefits provided through an existing defined benefit 
OPEB plan, GASB Statement No. 47 should be implemented simultaneously with the requirements 
of GASB Statement No. 45. For all other termination benefits, GASB Statement No. 47 is effective 
for financial statements for periods beginning after June 15, 2005. Earlier application is encouraged. 
Conforming changes to reflect the issuance of GASB Statement No. 47 will be made in a future 
edition of this Guide.
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Debt and Equity Securities (see paragraph 534 of FASB Statement No. 133). 
In reporting disclosures about investments in securities, investor-owned en­
tities should comply primarily with the requirements of paragraphs 6, 17, 
19, 20, 21, and 22 of FASB Statement No. 115, as amended. Other disclo­
sure requirements for investments in securities may also be applicable. For 
example, Emerging Issues Task Force (EITF) Issue No. 03-1, "The Mean­
ing of Other-Than-Temporary Impairment and Its Application to Certain In­
vestments," requires certain disclosures for investments that are in an un­
realized loss position but for which other-than-temporary impairments have 
not been recognized. Practitioners should refer to FASB Statement No. 133, 
as amended, for guidance on reporting derivative instruments and hedging 
activities.
This appendix contains illustrative financial statements for the following types 
of health care organizations:
1. Not-for-profit hospital
2. Governmental hospital authority (includes illustrative manage­
ment's discussion and analysis)
3. Nursing home
4. Continuing care retirement community (CCRC)
5. Home health agency
6. Health maintenance organization (HMO)
7. Ambulatory care organization
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Sample Not-for-Profit Hospital 
Balance Sheets 
December 31, 20X7 and 20X6 
(in thousands)
Health Care Organizations
Assets
Current assets:
Cash and cash equivalents 
Short-term investments 
Assets limited as to use 
Patient accounts receivable, net of allowance 
for doubtful accounts of $2,500 in 20X7 
and $2,400 in 20X6 
Other current assets
Total current assets
Interest in net assets of Sample Hospital 
Foundation†
Assets limited as to use:
Internally designated for capital acquisition 
Held by trustee
Less amount required to meet current 
obligations
Long-term investments 
Long-term investments restricted for capital 
acquisition
Property and equipment, net 
Other assets
Total assets
20X7
$4,758
15,836
970
15,100
2,670
39,334
510
12,000
6,949
18,949
(970)
17,979
4,680
320
51,038
1,185
$115.046
20X6
$5,877
10,740
1,300
14,194
2,856
34,967
462
12,500
7,341
19,841
(1,300)
118,541
4,680
520
50,492
908
$110.570
(continued)
† These illustrative financial statements include a presentation of an interest in the net assets 
of a financially interrelated foundation that is based on the particular fact pattern described in Note 
11 to the illustrative financial statements and the following additional facts:
•  Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital 
Foundation to such an extent that it can determine the timing and amount of distributions 
from the Foundation. Thus, it is inappropriate for the Hospital to imply a time restriction 
on amounts held by the Foundation.
•  Contributions to Foundation are restricted by donors for property acquisitions. Those re­
strictions have been met by the Hospital even though the net assets remain at the Foun­
dation. Thus, the net assets related to the interest in the Foundation are classified as 
unrestricted in the Hospital's financial statements.
•  The Hospital's policy is to report restricted revenues as unrestricted if the restriction is met 
in the same period as the revenues are recognized.
Because the change in the interest in net assets of the foundation results from contributions restricted 
to property acquisitions, this presentation shows the change in that interest reported separately 
from the performance indicator, in the spirit of the guidance in paragraph 10.20 for contributions 
restricted to property acquisitions. Readers should be aware that FASB Statement No. 136 is silent 
on this classification. The AICPA has released a group of Technical Practice Aids (TPAs) (6400.36 
through 6400.42) that address recognition of the interests in the net assets of financially interrelated 
organizations and the classification of the changes in those interests. TPAs are nonauthoritative and 
are not sources of established accounting principles as described in SAS No. 69, The Meaning of 
Present Fairly in Conformity With Generally Accepted Accounting Principles.
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Balance Sheets 
(continued)
December 31, 20X7 and 20X6 
(in thousands)
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20X7 20X6
Liabilities and Net Assets
Current liabilities:
Current portion of long-term debt $1,470 $1,750
Accounts payable and accrued expenses 5,818 5,382
Estimated third-party payor settlements 2,143 1,942
Other current liabilities 1,969 2,114
Total current liabilities 11,400 11,188
Long-term debt, net of current portion 23,144 24,014
Other liabilities 3,953 3,166
Total liabilities 38,497 38,368
Net assets:
Unrestricted 70,846 66,199
Temporarily restricted 2,115 2,470
Permanently restricted 3,588 3,533
Total net assets 76,549 72,202
Total liabilities and net assets $115.046 $110,570
See accompanying notes to financial statements.
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Sample Not-for-Profit Hospital 
Statements of Operations 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
FORMAT A
20X7 20X6
Unrestricted revenues, gains and other support:
Net patient service revenue $85,156 $78,942
Premium revenue 11,150 10,950
Other revenue 2,601 5,212
Net assets released from restrictions used for operations 300
Total revenues, gains and other support 99,207 95,104
Expenses:
Operating expenses 88,521 80,585
Depreciation and amortization 4,782 4,280
Interest 1,752 1,825
Provision for bad debts 1,000 1,300
Other 2,000 1,300
Total expenses 98,055 89,290
Operating income 1,152 5,814
Other income:
Investment income 3,900 3,025
Other expense:
Loss from extinguishment of debt (500)
Excess of revenues over expenses 4,552 8,839
Change in net unrealized gains and losses on other than
trading securities 300 375
Net assets released from restrictions used for purchase of
property and equipment 200
Change in interest in net assets of Sample
Hospital Foundation† 283 536
Transfers to parent (688) (3,051)
Increase in unrestricted net assets $4,647 $6,699
See accompanying notes to financial statements.
† See footnote † in "Illustrative Financial Statements for a Not-for-Profit Hospital".
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FORMAT B
Unrestricted revenues, gains and other support;
Net patient service revenue 
Premium revenue
Other, primarily investment income
Net assets released from restrictions used for operations
Total revenues, gains and other support 
Expenses;
Salaries and benefits 
Medical supplies and drugs 
Insurance
Depreciation and amortization 
Interest
Allowance for bad debts 
Loss from extinguishment of debt 
Other
Total expenses
Excess of revenues, gains, and other support over expenses 
Change in net unrealized gains and losses on other than 
trading securities
Net assets released from restrictions used for purchase of 
property and equipment 
Change in interest in net assets of Sample 
Hospital Foundation†
Transfers to parent
Increase in unrestricted net assets
See accompanying notes to financial statements.
20X7 20X6
$85,156 $78,942
11,150 10,950
6,501 8,237
300
103,107 98,129
53,900 49,938
26,532 22,121
8,089 8,526
4,782 4,280
1,752 1,825
1,000 1,300
500
2,000 1,300
98,555 89,290
4,552 8,839
300 375
200 —
283 536
(688) (3,051)
$4,647 $6,699
† See footnote † in "Illustrative Financial Statements for a Not-for-Profit Hospital".
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Sample Not-for-Profit Hospital 
Statements of Changes in Net Assets 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
Health Care Organizations
20X7 20X6
Unrestricted net assets:
Excess of revenues over expenses $4,552 $8,839
Net unrealized gains on investments, other than trading
securities 300 375
Change in interest in net assets of Sample
Hospital Foundation† 283 536
Transfer to parent (688) (3,051)
Net assets released from restrictions used for purchase
of property and equipment 200
Increase in unrestricted net assets 4,647 6,699
Temporarily restricted net assets:
Contributions for charity care 140 996
Net realized and unrealized gains on investments 5 8
Net assets released from restrictions (500)
Increase (decrease) in temporarily restricted net assets (355) 1,004
Permanently restricted net assets:
Contributions for endowment funds 50 411
Net realized and unrealized gains on investments 5 2
Increase in permanently restricted net assets 55 413
Increase in net assets 4,347 8,116
Net assets, beginning of year 72,202 64,086
Net assets, end of year $76,549 $72,202
See accompanying notes to financial statements.
† See footnote † in "Illustrative Financial Statements for a Not-for-Profit Hospital".
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Statements of Cash Flows (Indirect Method) 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
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Cash flows from operating activities;
Change in net assets
Adjustments to reconcile change in net assets to net cash 
provided by operating activities:
Loss from extinguishment of debt 
Depreciation and amortization
Net realized and unrealized gains on investments, other 
than trading
Undistributed portion of change in interest in net assets 
of Sample Hospital Foundation 
Transfers to parent 
Allowance for bad debts
Restricted contributions and investment income 
received
(Increase) decrease in;
Patient accounts receivable 
Trading securities 
Other current assets 
Other assets 
Increase (decrease) in:
Accounts payable and accrued expenses 
Estimated third-party payor settlements 
Other current liabilities 
Other liabilities
Net cash provided by operating activities 
Cash flows from investing activities;
Proceeds from sale of investments 
Purchase of investments 
Capital expenditures
Net cash used in investing activities
Cash flows from fi nancing activities:
Transfer to parent
Proceeds from restricted contributions and restricted 
investment income 
Payments on long-term debt 
Payments on capital lease obligations 
Proceeds from issuance of long-term debt
Net cash used in financing activities
Net (decrease) increase in cash and cash equivalents 
Cash and cash equivalents, beginning of year 
Cash and cash equivalents, end of year
20X7 20X6
$ 4,347 $8,116
500
4,782 4,280
(450) (575)
(48)
688
1,000
(51)
3,051
1,300
(290) (413)
(1,906)
215
186
(277)
(2,036)
(2,481)
(190)
436
201
(145)
787
679
305
(257)
(128)
10,026 11,600
45,100
(48,869)
(4,728)
50,650
(52,800)
(5,860)
(8,497) (8,010)
(688) (3,051)
290
(24,700)
(150)
22,600
413
(804)
(100)
500
(2,648) (3,042)
(1,119)
5,877
548
5,329
$ 4,758 $5,877
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Supplemental Disclosures of Cash Flow Information:
The Hospital entered into capital lease obligations in the amount of $600,000 
for new equipment in 20X7.
Cash paid for interest (net of amount capitalized) in 20X7 and 20X6 was 
$1,780,000 and $1,856,000, respectively.
See accompanying notes to financial statements.
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Sample Not-for-Profit Hospital 
Notes to Financial Statements 
December 31, 20X7 and 20X6
1. Description of Organization and Summary of Significant Account­
ing Policies1
Organization. The Sample Not-for-Profit Hospital (the Hospital), located in 
Tulsa, Oklahoma, is a not-for-profit acute care hospital. The Hospital provides 
inpatient, outpatient and emergency care services for residents of northeastern 
Oklahoma. Admitting physicians are primarily practitioners in the local area. 
The Hospital was incorporated in Oklahoma in 20X1 and is affiliated with the 
Sample Health System.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include certain in­
vestments in highly liquid debt instruments with original maturities of three 
months or less.
The Hospital routinely invests its surplus operating funds in money market 
mutual funds. These funds generally invest in highly liquid U.S. government 
and agency obligations.
Investments. Investments in equity securities with readily determinable fair 
values and all investments in debt securities are measured at fair value in the 
balance sheet. Investment income or loss (including realized gains and losses 
on investments, interest and dividends) is included in the excess of revenues 
over expenses unless the income or loss is restricted by donor or law. Unrealized 
gains and losses on investments are excluded from the excess of revenues over 
expenses unless the investments are trading securities.
Assets limited as to use. Assets limited as to use primarily include assets held 
by trustees under indenture agreements and designated assets set aside by the 
Board of Trustees for future capital improvements, over which the Board retains 
control and may at its discretion subsequently use for other purposes. Amounts 
required to meet current liabilities of the Hospital have been reclassified in the 
balance sheet at December 31, 20X7 and 20X6.
Property and equipment. Property and equipment acquisitions are recorded 
at cost. Depreciation is provided over the estimated useful life of each class of 
depreciable asset and is computed using the straight-line method. Equipment 
under capital lease obligations is amortized on the straight-line method over 
the shorter period of the lease term or the estimated useful life of the equip­
ment. Such amortization is included in depreciation and amortization in the 
financial statements. Interest cost incurred on borrowed funds during the pe­
riod of construction of capital assets is capitalized as a component of the cost of 
acquiring those assets.
1 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade Re­
ceivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts.
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Gifts of long-lived assets such as land, buildings, or equipment are reported 
as unrestricted support, and are excluded from the excess of revenues over 
expenses, unless explicit donor stipulations specify how the donated assets must 
be used. Gifts of long-lived assets with explicit restrictions that specify how the 
assets are to be used and gifts of cash or other assets that must be used to 
acquire long-lived assets are reported as restricted support. Absent explicit 
donor stipulations about how long those long-lived assets must be maintained, 
expirations of donor restrictions are reported when the donated or acquired 
long-lived assets are placed in service.
Temporarily and permanently restricted net assets. Temporarily restricted net 
assets are those whose use by the Hospital has been limited by donors to a 
specific time period or purpose. Permanently restricted net assets have been 
restricted by donors to be maintained by the Hospital in perpetuity.
Excess of revenues over expenses. The statement of operations includes ex­
cess of revenues over expenses. Changes in unrestricted net assets which are 
excluded from excess of revenues over expenses, consistent with industry prac­
tice, include unrealized gains and losses on investments other than trading 
securities, permanent transfers of assets to and from affiliates for other than 
goods and services, and contributions of long-lived assets (including assets ac­
quired using contributions which by donor restriction were to be used for the 
purposes of acquiring such assets).
Net patient service revenue. The Hospital has agreements with third-party 
payors that provide for payments to the Hospital at amounts different from 
its established rates. Payment arrangements include prospectively determined 
rates per discharge, reimbursed costs, discounted charges, and per diem pay­
ments. Net patient service revenue is reported at the estimated net realizable 
amounts from patients, third-party payors, and others for services rendered, in­
cluding estimated retroactive adjustments under reimbursement agreements 
with third-party payors. Retroactive adjustments are accrued on an estimated 
basis in the period the related services are rendered and adjusted in future 
periods as final settlements are determined.
Premium revenue. The Hospital has agreements with various Health Mainte­
nance Organizations (HMOs) to provide medical services to subscribing partic­
ipants. Under these agreements, the Hospital receives monthly capitation pay­
ments based on the number of each HMO's participants, regardless of services 
actually performed by the Hospital. In addition, the HMOs make fee-for-service 
payments to the Hospital for certain covered services based upon discounted 
fee schedules.
Charity care. The Hospital provides care to patients who meet certain cri­
teria under its charity care policy without charge or at amounts less than its 
established rates. Because the Hospital does not pursue collection of amounts 
determined to qualify as charity care, they are not reported as revenue.
Donor-restricted gifts. Unconditional promises to give cash and other assets 
to the Hospital are reported at fair value at the date the promise is received. 
Conditional promises to give and indications of intentions to give are reported 
at fair value at the date the gift is received. The gifts are reported as either 
temporarily or permanently restricted support if they are received with donor 
stipulations that limit the use of the donated assets. When a donor restriction 
expires, that is, when a stipulated time restriction ends or purpose restriction is 
accomplished, temporarily restricted net assets are reclassified as unrestricted 
net assets and reported in the statement of operations as net assets released
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from restrictions. Donor-restricted contributions whose restrictions are met 
within the same year as received are reported as unrestricted contributions 
in the accompanying financial statements.
Estimated malpractice costs. The provision for estimated medical malpractice 
claims includes estimates of the ultimate costs for both reported claims and 
claims incurred but not reported.
Income taxes. The Hospital is a not-for-profit corporation and has been rec­
ognized as tax-exempt pursuant to Sec. 501(c)(3) of the Internal Revenue Code.
2. Net Patient Service Revenue
The Hospital has agreements with third-party payors that provide for pay­
ments to the Hospital at amounts different from its established rates. A sum­
mary of the payment arrangements with major third-party payors follows:
•  Medicare. Inpatient acute care services and outpatient services ren­
dered to Medicare program beneficiaries are paid at prospectively de­
termined rates. These rates vary according to a patient classification 
system that is based on clinical, diagnostic, and other factors. Inpatient 
nonacute services and defined capital and medical education costs re­
lated to Medicare beneficiaries are paid based on a cost reimbursement 
methodology. The Hospital is reimbursed for cost reimbursable items 
at a tentative rate with final settlement determined after submission of 
annual cost reports by the Hospital and audits thereof by the Medicare 
fiscal intermediary. Beginning in 20X3, the Hospital claimed Medi­
care payments based on an interpretation of certain "disproportionate 
share" rules. The intermediary disagreed and declined to pay the ex­
cess reimbursement claimed under that interpretation. Through 1996, 
the Hospital has not included the claimed excess in net patient rev­
enues pending resolution of the matter. In 20X7, the intermediary ac­
cepted the claims and paid the outstanding claims, including $950,000 
applicable to 20X6 and $300,000 applicable to 20X5 and prior, which 
has been included in 20X7 net revenues.
•  Medicaid. Inpatient and outpatient services rendered to Medicaid 
program beneficiaries are reimbursed under a cost reimbursement 
methodology. The Hospital is reimbursed at a tentative rate with final 
settlement determined after submission of annual cost reports by the 
Hospital and audits thereof by the Medicaid fiscal intermediary.
Revenue from the Medicare and Medicaid programs accounted for approxi­
mately XX percent and XX percent, respectively, of the Hospital's net patient 
revenue for the year ended 20X7, and XX percent and XX percent, respectively, 
of the Hospital's net patient revenue, for the year ended 20X6. Laws and regu­
lations governing the Medicare and Medicaid programs are extremely complex 
and subject to interpretation. As a result, there is at least a reasonable possibil­
ity that recorded estimates will change by a material amount in the near term.
The 20X6 net patient service revenue increased approximately $XXX due to re­
moval of allowances previously estimated that are no longer necessary as a re­
sult of final settlements and years that are no longer subject to audits, reviews, 
and investigations. The 20X7 net patient service revenue decreased approxi­
mately $XXX due to prior-year retroactive adjustments in excess of amounts 
previously estimated.
The Hospital also has entered into payment agreements with certain com­
mercial insurance carriers, health maintenance organizations, and preferred
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provider organizations. The basis for payment to the Hospital under these 
agreements includes prospectively determined rates per discharge, discounts 
from established charges, and prospectively determined daily rates.
3. Investments
Assets Limited as to Use
The composition of assets limited as to use at December 31, 20X7 and 20X6, 
is set forth in the following table. Investments are stated at fair value.
Health Care Organizations
Internally designated for capital acquisition: 
Cash
U.S. Treasury obligations 
Interest receivable
Held by trustee under indenture agreement: 
Cash and short-term investments 
U.S. Treasury obligation 
Interest receivable
20X7 20X6
$ 545,000 $ 350,000
11,435,000 12,115,000
20,000 35,000
12,000,000 12,500,000
352,000 260,000
6,505,000 7,007,000
92,000 74,000
6,949,000 7,341,000
$18,949,000 $19,841,000
Other Investments
Other investments, stated at fair value, at December 31, 20X7 and 20X6, 
include:
20X7 20X6
Trading:
U.S. Corporate Bonds 
Other
U.S. Treasury obligations 
Interest receivable
Less:
Long-term investments
Long-term investments restricted for capital 
acquisitions
Short-term investments
$1,260,000 $1,475,000
$19,266,000 $14,233,000
310,000 232,000
20,836,000
4,680,000
15,940,000
4,680,000
320,000 520,000
$15,836,000 $10,740,000
Investment income and gains for assets limited as to use, cash equivalents, 
and other investments are comprised of the following for the years ending De­
cember 31, 20X7 and 20X6:
20X7 20X6
Income:
Interest income
Realized gains on sales of securities 
Unrealized gains on trading securities
Other Changes in Unrestricted Net Assets: 
Unrealized gains on other than trading 
securities
$3,585,000
150,000
165,000 
$3,900,000
$2,725,000
200,000
100,000
$3.025.000
$ 300.000 $ 375.000
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4. Property and Equipment
A summary of property and equipment at December 31, 20X7 and 20X6, fol­
lows:
20X7 20X6
Land $3,000,000 $3,000,000
Land improvements 472,000 472,000
Buildings and improvements 46,852,000 46,636,000
Equipment 29,190,000 26,260,000
Equipment under capital lease obligations 2,851,000 2,752,000
82,365,000 79,120,000
Less accumulated depreciation and amortization 34,928,000 30,661,000
47,437,000 48,459,000
Construction in progress 3,601,000 2,033,000
Property and equipment, net $51,038,000 $50,492,000
Depreciation expense for the years ended December 31, 20X7 and 20X6 
amounted to approximately $4,782,000 and $4,280,000. Accumulated amortiza­
tion for equipment under capital lease obligations was $689,000 and $453,000 
at December 31, 20X7 and 20X6, respectively. Construction contracts of ap­
proximately $7,885,000 exist for the remodeling of Hospital facilities. At De­
cember 31, 20X7, the remaining commitment on these contracts approximated 
$4,625,000.
5. Long-Term Debt
A summary of long-term debt and capital lease obligations at December 31, 
20X7 and 20X6, follows:
20X7 20X6
7.25 percent 20X7 Tax-Exempt Revenue Bonds, 
principal maturing in varying annual 
amounts, due November 1, 20XX, 
collateralized by a pledge of the Hospital's 
gross receipts
8.50 percent 20X2 Tax-Exempt Revenue Bonds, 
principal maturing in varying annual 
amounts, due June 1, 20XX
7.75 percent mortgage loan, principal maturing 
in varying annual amounts, due January 
20XX, collateralized by a mortgage on certain 
property and equipment
7.75 percent note payable, payable in monthly 
installments of $12,000, including interest, 
due March 20XX, unsecured
Capital lease obligations, at varying rates of 
imputed interest from 6.8 percent to 9.3 
percent collateralized by leased equipment
Less current portion
$21,479,000
125,000
$22,016,000
2,010,000 2,127,000
671,000
1,000,000 950,000
24,614,000 25,764,000
1,470,000 1,750,000
$23.144,000 $24,014,000
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Under the terms of the 20X7 and 20X2 revenue bond indentures, the Hospi­
tal is required to maintain certain deposits with a trustee. Such deposits are 
included with assets limited as to use. The revenue note indenture also places 
limits on the incurrence of additional borrowings and requires that the Hospi­
tal satisfy certain measures of financial performance as long as the notes are 
outstanding.
Scheduled principal repayments on long-term debt and payments on capital 
lease obligations are as follows:
Health Care Organizations
Year Ending Capital Leases
December 31, Long-Term Debt Obligations
20X8 $ 970,000 $ 550,000
20X9 912,000 260,000
20Y0 983,000 260,000
20Y1 1,060,000 45,000
20Y2 1,143,000 —
Thereafter 18,546,000 —
$23,614,000 1,115,000
Less amount representing interest
under capital leases obligations 115,000
81.000.000
A summary of interest cost and investment income on borrowed funds held 
by the trustee under the 20X7 and 20X2 revenue bond indentures during the
years ended December 31, 20X7 and 20X6, follows:
20X7 20X6
Interest cost:
Capitalized $ 740,000 $ 700,000
Charged to operations 1,752,000 1,825,000
Total
Investment income:
$2,492,000 82.525.000
Capitalized $ 505,000 $ 663,000
Credited to other revenue 330,000 386,000
Total 8 835.000 81.049.000
6. Temporarily and Perm anently R estricted Net Assets
Temporarily restricted net assets are available for the following purposes or
periods at December 31, 20X7 and 20X6:
20X7 20X6
Health care services
Purchase of equipment $ 320,000 $ 520,000
Indigent care 840,000 950,000
Health education 350,000 400,000
For periods after December 31, 20X9 605,000 600,000
82.115.000 82.470.000
Permanently restricted net assets at December 31, 20X7 and 20X6, are re­
stricted to:
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Investments to be held in perpetuity, the income 
from which is expendable to support health care 
services (reported as operating income) 
Endowment requiring income to be added to 
original gift until fund value is $1,500,000
20X7 20X6
$2,973,000 $2,923,000
615,000
$3,588,000
610.000
$3,533,000
During 20X7, net assets were released from donor restrictions by incurring 
expenses satisfying the restricted purposes of indigent care and health care 
education in the amounts of $250,000 and $50,000, respectively.
7. Medical Malpractice Claims
The Hospital purchases professional and general liability insurance to cover 
medical malpractice claims. There are known claims and incidents that may 
result in the assertion of additional claims, as well as claims from unknown 
incidents that may be asserted arising from services provided to patients. The 
Hospital has employed independent actuaries to estimate the ultimate costs, 
if any, of the settlement of such claims. Accrued malpractice losses have been 
discounted at 7 percent and in management's opinion provide an adequate 
reserve for loss contingencies.
On March 15, 20X7, a patient filed a suit against the Hospital for malpractice 
during care received as an inpatient. The Hospital believes it has meritorious 
defenses against the suit; however, the ultimate resolution of the matter could 
result in a loss. The patient has claimed $16 million in actual damages. Under 
state law, punitive damages are determined at trial. The Hospital maintains in­
surance coverage for malpractice claims. The coverage does not include punitive 
damages awards. Trial is scheduled to occur within the next year.
8.  Pension Plan and Other Postretirement Benefit Plans2,‡
[The following two paragraphs are encouraged but not required.]
The Hospital has a defined benefit pension plan covering substantially all of 
its employees. The plan benefits are based on years of service and the employees' *
2 The disclosures for pensions and other postretirement benefits in this note to the illustrative 
financial statements have been modified to reflect the requirements of FASB Statement No. 132, Em­
ployers' Disclosures about Pensions and Other Postretirement Benefits (revised 2003). FASB Statement 
No. 132 (revised 2003), is effective for fiscal years ending after December 15, 2003, with certain excep­
tions. Interim-period disclosures are effective for interim periods beginning after December 15, 2003. 
The provisions of FASB Statement No. 132 remain in effect until the provisions of FASB Statement 
No. 132 (revised 2003), are adopted. This note to the financial statements illustrates the financial 
statement disclosures about pension and postretirement benefit plans for a public entity. Readers 
should refer to FASB Statement No. 132 (revised), when considering disclosure requirements for 
nonpublic entities.
‡ Readers may also need to consider the accounting and disclosure requirements of FASB Staff 
Position (FSP) No. 106-1, Accounting and Disclosure Requirements Related to the Medicare Prescrip­
tion Drug, Improvement and Modernization Act of 2003 and FSP No. 106-2, Accounting and Disclosure 
Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, 
when an employer provides postretirement prescription drug coverage. FSP No. 106-2, which super­
sedes FSP No. 106-1, is effective, with exception for certain nonpublic entities, for the first interim or 
annual period beginning after June 15, 2004. For a nonpublic entity, as defined in FASB Statement 
No. 87, Employers' Accounting for Pensions, that sponsors one or more defined benefit postretirement 
health care plans that provide prescription drug coverage but of which no plan has more than 100 
participants, FSP No. 106-2 is effective for fiscal years beginning after December 15, 2004. Earlier 
application is encouraged.
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compensation during the last five years of covered employment. Contributions 
are intended to provide not only for benefits attributed to service to date but 
also for those expected to be earned in the future.
The Hospital also sponsors two defined benefit postretirement plans that cover 
both salaried and nonsalaried employees. One plan provides medical and den­
tal benefits, and the other provides for the payment of life insurance premi­
ums. The postretirement health care plan is contributory, with retiree con­
tributions adjusted annually; the life insurance plan is noncontributory. The 
accounting for the health care plan anticipates future cost-sharing changes 
to the written plan that are consistent with the Hospital's expressed intent 
to increase retiree contributions each year to 50 percent of the excess of the 
expected general inflation rate over 6 percent. Beginning in 20X7, the Hos­
pital adopted a funding policy for its postretirement health care plan sim­
ilar to its funding policy for its life insurance plan—an amount equal to a 
level percentage of the employees' salaries is contributed to the plan annually. 
For 20X7, that percentage was 4.25, and the aggregate contribution for both 
plans was $34,000. The Hospital uses a December 31 measurement date for its 
plans.
The following table sets forth the changes in benefit obligations, changes in 
plan assets and components of net periodic benefit cost for both the pension 
plan and the other postretirement benefit plans:
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
Change in benefit obligation:
Benefit obligation at beginning of
year $9,710 $9,700 $585 $500
Service cost 905 770 14 15
Interest cost 700 650 50 44
Plan participants' contributions 34 34
Actuarial gain (20) (7)
Benefits paid (375) (1,410) (66) (8)
Benefit obligation at end of year 10,920 9,710 610 585
Change in plan assets:
Fair value of plan assets at
beginning of year 9,800 9,610 89 40
Actual return on plan assets 759 810 4 4
Employer contribution 866 790 39 19
Plan participants' contributions 34 34
Benefits paid (375) (1,410) (66)
Fair value of plan assets at end of
year 11,050 9,800 100 89
Funded status 130 90 (510) (496)
Unrecognized net actuarial gain (30) (40) (30) (40)
Unrecognized prior service cost 50 55 16 19
Unrecognized transition obligation 445 470
Unrecognized transition asset (15) (20)
Prepaid (accrued) benefit cost $135 $85 ($79) ($47)
The accumulated benefit obligation for the defined benefit pension plan was 
$XXX and $XXX at December 31, 20X7, and 20X6, respectively.
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Other Benefits
20X7 20X6 20X7 20X6
Components of net periodic benefit
cost:
Service cost $905 $770 $14 $15
Interest cost 700 650 50 44
Expected return on plan assets (784) (769) (6) (3)
Amortization of prior service cost 5 7 3 2
Recognized net actuarial (gain) 
Amortization of transition
(5) (2) (15) (1)
obligation
Amortization of transition asset (5) (1)
25 25
Net periodic benefit cost 
Additional Information 
Assumptions
Weighted-average assumptions
$816 $655 $71 $82
used to determine benefit 
obligations at December 31
Discount rate 7.00% 7.00% 7.00% 7.00%
Rate of compensation increase 
Weighted-average assumptions
6.00% 6.00%
used to determine net 
periodic benefit cost for 
years ended December 31
Discount rate
Expected long-term return on plan
7.00% 7.00% 7.00% 7.00%
assets 8.00% 8.00% 6.60% 6.60%
Rate of compensation increase 6.00% 6.00%
(Entity specific narrative description of the basis used to determine the overall
expected long-term rate of return on assets, as described in paragraph 5(d)(3)
of FASB Statement No. 132, Employers' Disclosures about Pensions and Other
Postretirement Benefits (revised 2003), would be included here.)
Assumed health care cost
trend rates at December 31
Health care cost trend rate 
assumed for next year 
Rate to which the cost trend
7% 7%
rate is assumed to decline 
(the ultimate trend rate)
5% 5%
Year that the rate reaches the
ultimate trend rate 20Y2 20Y2
Assumed health care cost trend rates have a significant effect on the amounts 
reported for the health care plans. A one-percentage-point change in assumed 
health care cost trend rates would have the following effects:
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Effect on total of service and interest cost 
Effect on postretirement benefit obligation
1-Percentage- 
Point Increase
$13
73
1-Percentage- 
Point Decrease
($ 11)
(67)
Plan Assets
The composition of plan assets at December 31, 20X7, and 20X6, is as follows:
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
Asset Category XX% xx% xx% xx%
Equity securities XX XX XX XX
Debt securities XX XX XX XX
Real estate XX XX XX XX
Other XX XX XX XX
Total 100% 100% 100% 100%
(Entity specific narrative description of investment policies and strategies for 
plan assets, including weighted-average target asset allocations [if used as part 
of those policies and strategies] as described in paragraph 5(d)(2) of FASB State­
ment No. 132 (revised), would be included here.)
Cash Flows 
Contributions
The Hospital expects to contribute $XXX to its pension plan and $XXX to its 
other postretirement benefit plan in 20X8.
Estimated Future Benefit Payments
The following benefit payments, which reflect expected future service, as ap­
propriate, are expected to be paid:
Pension Other
Benefits Benefits
20X8 $xxx $xxx
20X9 XXX XXX
20Y0 XXX XXX
20Y1 XXX XXX
20Y2 XXX XXX
Years 20Y3-20Y7 XXX XXX
9. Concentrations of Credit Risk
The Hospital grants credit without collateral to its patients, most of whom 
are local residents and are insured under third-party payor agreements. The 
mix of receivables from patients and third-party payors at December 31, 20X7
and 20X6, was as follows:
20X7 20X6
Medicare 51% 53%
Medicaid 17 14
Blue Cross 18 17
Other third-party payors 7 9
Patients 7 7
100% 100%
AAG-HCO APP A
Illustrative Financial Statements 2 1 1
10. Commitments and Contingencies
Operating leases. The Hospital leases various equipment and facilities under 
operating leases expiring at various dates through April 20Y2. Total rental 
expense in 20X7 and 20X6 for all operating leases was approximately $859,000 
and $770,000, respectively.
The following is a schedule by year of future minimum lease payments under 
operating leases as of December 31, 20X7, that have initial or remaining lease 
terms in excess of one year.
Year Ending 
December 31,
20X8
20X9
20Y0
20Y1
20Y2
Amount
$517,000
506,000
459,000
375,000
343,000
Litigation. The Hospital is involved in litigation and regulatory investiga­
tions arising in the course of business. After consultation with legal counsel, 
management estimates that these matters will be resolved without material 
adverse effect on the Hospital's future financial position or results from opera­
tions.
Allowance for doubtful accounts. Beginning in 20X5, the Hospital has pro­
vided care under an agreement with Associated HMO. The HMO currently 
owes the Hospital $950,000, substantially all of which is overdue. The Hospital 
has notified the HMO that further services under the contract cannot be pro­
vided without payment on the outstanding balance. The HMO has assured the 
Hospital that additional funds are being obtained in order to pay the overdue 
balance and continue service under the agreement, however, if the HMO is un­
able to make payments, additional allowances for bad debts would need to be 
accrued.
11. Related Party Transactions
During the years ended December 31, 20X7 and 20X6, the Hospital con­
tributed capital to Sample Health System, an affiliate with some board mem­
bers in common with the Hospital, in the amounts of $688,000 and $3,051,000, 
respectively.
The Sample Hospital Foundation (the Foundation), which is controlled by 
Sample Health System, was established to solicit contributions from the gen­
eral public solely for the funding of capital acquisitions by the Hospital. Funds 
are distributed to the Hospital as determined by the Foundation's Board of Di­
rectors. A summary of the foundation's assets, liabilities, net assets, results of 
operations, and changes in net assets follows. The Hospital's interest in the 
net assets of the Foundation is reported as a non-current asset in the balance 
sheets.
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At December 31,
20X7 20X6
Assets principally cash and cash equivalents $521,000 $472,000
Liabilities 11,000 10,000
Unrestricted net assets 510,000 462,000
Total liabilities and net assets $521,000 $472,000
Support and revenue 
Expenses
Distributions to Sample Hospital for property
$269,000 $535,000
acquisitions 235,000 485,000
Other 13,000 16,000
Total expenses 248,000 501,000
Excess of support and revenue over expenses 21,000 34,000
Other changes in net assets 27,000 17,000
Unrestricted net assets, beginning of year 462,000 411,000
Unrestricted net assets, end of year $510,000 $462,000
Liabilities include $10,000 payable at the end of each year to Sample Hospital. 
These amounts were paid after the end of each year.
12. Functional Expenses
The Hospital provides general health care services to residents within its 
geographic location. Expenses related to providing these services are as follows 
(in thousands);
At December 31,
Health care services 
General and administrative
20X7
$86,000
12,055
$98.055
20X6
$78,647
10,643
$89,290
13. Fair Value of Financial Instruments
The following methods and assumptions were used by the Hospital in esti­
mating the fair value of its financial instruments:
Cash and cash equivalents: The carrying amount reported in the bal­
ance sheet for cash and cash equivalents approximates its fair value. 
Investments: Fair values, which are the amounts reported in the bal­
ance sheet, are based on quoted market prices, if available, or esti­
mated using quoted market prices for similar securities.
Assets limited as to use: These assets consist primarily of cash and 
short-term investments and interest receivable. The carrying amount 
reported in the balance sheet is fair value.
Accounts payable and accrued expenses: The carrying amount re­
ported in the balance sheet for accounts payable and accrued expenses 
approximates its fair value.
Estimated third-party payor settlements: The carrying amount re­
ported in the balance sheet for estimated third-party payor settlements 
approximates its fair value.
Long-term debt: Fair values of the Hospital's revenue notes are based 
on current traded value. The fair value of the Hospital's remaining
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long-term debt is estimated using discounted cash flow analyses, based 
on the Hospital's current incremental borrowing rates for similar types 
of borrowing arrangements.
The carrying amounts and fair values of the Hospital's financial instru­
ments at December 31, 20X7 and 20X6, are as follows (In thousands):
20X7 20X6
Carrying Fair Carrying Fair
Amount Value Amount Value
Cash and cash 
equivalents $4,758 $4,758 $ 5,877 $5,877
Short-term investments 15,836 15,836 10,740 10,740
Assets limited as to use 18,949 18,949 19,841 19,841
Long-term investments 4,680 4,680 4,680 4,680
Long-term investments 
restricted for capital 
acquisition 320 320 520 520
Accounts payable and 
accrued expenses 5,818 5,818 5,382 5,382
Estimated third-party 
payor settlements 2,143 2,143 1,942 1,942
Long-term debt 24,614 23,980 25,764 24,918
14. Promises to Contribute
At December 31, 20X7, the Hospital had received $1,500,000 of conditional 
promises to contribute to the building of a new facility for outpatient services. 
These contributions will be recorded as temporarily restricted support when 
received. The Hospital had no material outstanding unconditional promises of 
support at December 31, 20X7.
15. Charity Care
The amount of charges foregone for services and supplies furnished under 
the Hospital's charity care policy aggregated approximately $4,500,000 and 
$4,100,000 in 20X7 and 20X6, respectively.
16. Subsequent Event
On February 9, 20X8, the Hospital signed a contract in the amount of 
$1,050,000 for the purchase of certain real estate.
Illustrative Management's Discussion and Analysis  
and Financial Statements
Sample Governmental Hospital Authority 
A Component Unit of Feeling County, State of Union 
Management's Discussion and Analysis
Our discussion and analysis of Sample Hospital Authority's (Authority's) fi­
nancial performance provides an overview of the Authority's financial activities 
for the fiscal years ended December 31, 20X7 and 20X6. Please read it in con­
junction with the Authority's financial statements, which begin on page XXX. 
Unless otherwise indicated, amounts are in thousands.
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Financial Highlights
The Authority’s net assets increased in each of the past two years with 
a $4,225 or 6.6 percent increase in 20X7 and a $9,460 or 17.4 percent 
increase in 20X6.
The Authority reported increased operating losses in both 20X7 
($24,403) and 20X6 ($13,365). Losses in 20X7 increased by $11,038 
or 82.6 percent over the loss reported in 20X6. Operating losses in 
20X6 increased by $4,020 or 43.0 percent.
Nonoperating revenues increased by $7,890 or 39.6 percent in 20X7 
compared to 20X6. Nonoperating revenues also increased in 20X6 by 
$1,139 or 6 percent compared to 20X5.
Using This Annual Report
The Authority's financial statements consist of three statements—a Balance 
Sheet; a Statement of Revenues, Expenses, and Changes in Net Assets; and a 
Statement of Cash Flows. These financial statements and related notes provide 
information about the activities of the Authority, including resources held by 
the Authority but restricted for specific purposes by contributors, grantors, or 
enabling legislation.
The Balance Sheet and Statement of Revenues, Expenses, 
and Changes in Net Assets
Our analysis of the Authority finances begins on page XXX. One of the most 
important questions asked about the Authority's finances is, "Is the Authority 
as a whole better or worse off as a result of the year's activities?" The Balance 
Sheet and the Statement of Revenues, Expenses, and Changes in Net Assets 
report information about the Authority's resources and its activities in a way 
that helps answer this question. These statements include all restricted and 
unrestricted assets and all liabilities using the accrual basis of accounting. All 
of the current year's revenues and expenses are taken into account regardless 
of when cash is received or paid.
These two statements report the Authority's net assets and changes in them. 
You can think of the Authority's net assets—the difference between assets and 
liabilities—as one way to measure the Authority’s financial health, or financial 
position. Over time, increases or decreases in the Authority's net assets are one 
indicator of whether its financial health is improving or deteriorating. You will 
need to consider other nonfinancial factors, however, such as changes in the 
Authority's patient base and measures of the quality of service it provides to 
the community, as well as local economic factors to assess the overall health of 
the Authority.
The Statement of Cash  Flows
The final required statement is the Statement of Cash Flows. The statement 
reports cash receipts, cash payments, and net changes in cash resulting from 
operations, investing, and financing activities. It provides answers to such ques­
tions as "Where did cash come from?" "What was cash used for?" and "What was 
the change in cash balance during the reporting period?"
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The Authority's Net Assets
The Authority's net assets are the difference between its assets and liabilities 
reported in the Balance Sheet on page X. The Authority's net assets increased 
in each of the past two years by $4,225 (6.6 percent) in 20X7 and $9,460 (17.4 
percent) in 20X6, as you can see from Table 1.
Table 1: Assets, Liabilities, and Net Assets
20X7 20X6 20X5
Assets:
Current assets $32,382 $30,135 $26,070
Capital assets, net 43,382 42,918 42,445
Other noncurrent assets 25,118 23,494 19,767
Total assets 100.882 96.547 88.282
Liabilities
Long-term liabilities 23,033 23,102 24,349
Other 9,690 9,511 9,459
Total liabilities 32.723 32.613 33.808
Net assets:
Invested in capital assets, net of 
related debt 22,460 21,018 18,649
Restricted for debt service 1,945 2,005 2,035
Restricted expendable net assets 1,845 2,100 2,075
Restricted nonexpendable net 
assets 3,003 2,919 2,652
Unrestricted 38,906 35,892 29,063
Total net assets $68,159 $63,934 854.474
A significant component of the change in the Authority's assets is the in­
crease in patient accounts receivable. Although operating revenues decreased 
in 20X7 by $3,445 (5.7 percent), patient accounts receivable, net of estimated 
uncollectible amounts, increased by $3,107 or 18.6 percent in 20X7. In addi­
tion, patient service revenue decreased by $2,105 in 20X6 compared to 20X5, 
but receivables increased by $2,114 or 14.5 percent. In both cases, the increase 
in accounts receivable is primarily the result of overall slowdowns by health 
insurers in making payments in attempting to cut costs by managing their cash 
flows.
Operating Results and Changes in The Authority's 
Net Assets
In 20X7, the Authority's net assets increased by $4,225 or 6.6 percent, as 
shown in Table 2. This increase is made up of very different components. And 
it represents a decline of 55.3 percent compared with the increase in net assets 
for 20X6 of $9,460.
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20X7 20X6 20X5
Operating Revenues:
Net patient service revenues $43,305 $43,736 $45,841
Premium revenues 9,876 13,058 12,976
Other operating revenues 3,416 3,248 2,910
Total operating revenues 56,597 60,042 61,727
Operating Expenses:
Salaries and benefits 46,845 43,235 40,640
Medical supplies and drugs 12,746 7,986 6,788
Depreciation and amortization 4,065 3,638 3,508
Other operating expenses 17,344 18,548 20,136
Total operating expenses 81,000 73,407 71,072
Operating loss (24,403) (13,365) (9,345)
Nonoperating Revenues and 
Expenses
Property taxes 23,895 15,309 14,875
Investment income 5,653 5,304 5,108
Noncapital grants and contributions 170 853 510
Other nonoperating revenues and
expenses, net (1,914) (1,552) (1,718)
Total nonoperating revenues
(expenses) 27,804 19,914 18,775
Excess of revenues over 
expenses before capital grants, 
contributions, and additions to
permanent endowments 3,401 6,549 9,430
Grants, Contributions, and 
Endowments
Capital grants and contributions 
Additions to permanent endowments
824 2,560
351
1,980
Increase in net assets $4,225 $9,460 $11,410
Net assets end of year $68,159 $63,934 $4,474
Operating Losses
The first component of the overall change in the Authority's net assets is its 
operating income (loss)—generally, the difference between net patient service 
and Premium revenues and the expenses incurred to perform those services. 
In each of the past two years, the Authority has reported an operating loss. 
This is consistent with the Authority's entire operating history. The Author­
ity's hospital operations were begun in 19XX as a municipal hospital, when 
it was agreed that a portion of its costs would be subsidized by property tax 
revenues, making the facility more affordable for the County's lower income 
residents. However, in each of the past two years, operating losses have in­
creased. Losses in 20X7 increased by $11,038 or 82.6 percent higher than 
the loss reported in 20X6. Operating losses in 20X6 increased by $4,020 or 
43.0 percent.
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The primary components of these increased operating losses are:
•  A decrease in premium revenue of $3,182 or 24.4 percent in 20X7. 
(Premium revenues in 20X6 were roughly the same as in the previous 
year.)
•  Increases in salary and benefit costs for the hospital's employees 
($3,610 or 8.4 percent in 20X7 and $2,595 or 6.4 percent in 20X6).
•  Increases in medical supply and drug costs of $4,760 or 59.6 percent 
in 20X7 and of $1,198 or 17.6 percent in 20X6.
•  An increase in the level of uncompensated care provided. These are 
services provided for which there is no expectation of payment.
Premium revenues from contracts with health maintenance organizations de­
creased in 20X7 primarily because of changes in the fixed amount per individual 
per month (capitation rate) paid by the Acme Health Maintenance Group. Acme 
is the HMO for the County's largest employer, the XYZ Motor Company. The 
Authority, (with the assistance of the County), negotiated a new 4-year contract 
with Acme in 20X6. Those negotiations resulted in a 15 percent reduction in 
capitation rates in 20X7. Under the contract, capitation rates increase by 3 per­
cent each year for the next three years. At the same time, the Authority (with 
the County's approval) agreed to increase its property tax levy by 10 percent, 
as discussed below.
Employee salary and benefits costs increased in 20X6 and again in 20X7 based 
on rates established in labor contracts negotiated in 20X5 and 20X6. Current 
labor contracts for all of the Authority's unionized employees extend until 20Y1.
The rate of healthcare inflation has a direct effect on the cost of services 
provided by the Authority. A component of the Authority's costs are expenses 
for medical supplies and prescription drugs. In 20X5, medical supplies and 
prescription drug costs totaled $6.8 million. In 20X6, they totaled $8.0 million 
or 10.7 percent of total expenses and an increase of 17.6 percent over 20X5. And, 
in 20X7, medical supplies and prescription drug costs totaled $12.7 million, 
representing 15.6 percent of total expenses and an increase of 59.6 percent 
over 20X6. Some of the major factors contributing to the increased medical 
supply and drug costs include the introduction of new drugs that cannot be 
obtained in generic form, and changes in therapeutic mix. In addition, in 20X7, 
the company that the Authority used as its major wholesale drug supplier filed 
for bankruptcy. The Authority negotiated new contracts with other suppliers at 
substantially higher costs. At its August 20X7 meeting, the Authority's Board 
of Trustees authorized management to explore other supplier options.
The Authority sometimes provides care for patients who have little or no 
health insurance or other means of repayment. As discussed, this service to 
the community is consistent with the goals established for the Authority when 
it was established in 19XX. The level of services provided to these patients 
increased by $1,200 in 20X6 compared to 20X5. In 20X7, the costs of uncom­
pensated care increased by $255. Because there is no expectation of repayment, 
charity care is not reported as patient service revenues of the Authority.
Nonoperating Revenues and Expenses
Nonoperating revenues consist primarily of property taxes levied by the Au­
thority and interest revenue and investment earnings. During its negotiations 
with Acme and XYZ, discussed earlier, the Authority agreed—with the County's 
approval—to increase its property tax levy to County residents by 10 percent.
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County voters approved this increase in November 20X6. In addition, a 35 per­
cent increase in the sales of new homes in the County in 20X6 and 20X5 as 
well as additions of new commercial and manufacturing facilities resulted in 
an increase in the County's grand list. The grand list is calculated as of July 1 
each year and used as the basis for tax levies on January 1. As a result of both 
of these factors, nonoperating tax revenues increased by $8,586 or 56.1 percent 
in 20X7 compared to a $434 (2.9 percent) increase in 20X6.
G rants, Contributions, and Endowments
The Authority receives both capital and operating grants from various state 
and federal agencies for specific programs. These are discussed in detail in Note 
2 to the financial statements. Capital and operating grants received in 20X7 
from the State of Union declined due to fiscal/budgetary issues at the state 
from $3,085 in 20X6 ($2,300 capital and $785 operating) to $800 in 20X7 ($650 
capital and $150 operating). Although $1,640 in grants have been budgeted by 
the state for the Authority in 20X8, it is not clear whether monies to fund these 
grants will be appropriated.
The Authority received $351 in permanent endowments in 20X6 from the ALA 
Foundation. Earnings from investing the principal of this endowment must be 
used to support expenditures for Program A research. This is in contrast to an 
increase in state funding of $580 in 20X6 compared to 20X5. The Authority has 
received other permanent endowments in the past. Restrictions established by 
these endowments are detailed in Note 2 to the financial statements.
The Authority's Cash Flows
Changes in the Authority's cash fl ows are consistent with changes in operating 
losses and nonoperating revenues and expenses, discussed earlier, with one 
exception. Cash flows used by operating activities increased slightly more than 
operating losses in both 20X7 and 20X6 due to increases in the Authority's 
patient accounts receivable, discussed earlier.
Capital Asset and Debt Administration 
Capital Assets
At the end of 20X7, the Authority had $43.3 million invested in capital as­
sets, net of accumulated depreciation, as detailed in Note 7 to the financial 
statements. In 20X7, the Authority purchased new equipment costing $4,529. 
Of this, $510 was acquired through capital leases. Nearly the same amount— 
$4,111—was spent to acquire new equipment in 20X6. Both of these amounts 
are less than 20X5, when the Authority spent $7,308 for new equipment. The 
Authority has recently found it more economical to lease much of its equipment. 
This allows the Authority to avoid some of the costs of obsolescence caused by 
technological changes.
In August 20X5, the Authority's Board of Trustees approved a resolution set­
ting aside $15 million of its unrestricted net assets for future expansion of the 
hospital and possible addition of a cancer care wing. The Board of Trustees 
held a special meeting in September 20X7 to reconsider the feasibility of the 
project and held initial meetings with several local architectural firms in Jan­
uary 20X8. No decisions have been reached as of the date of this annual report.
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Debt
At year-end, the Authority had $20.9 in revenue notes, mortgage loans, and 
capital lease obligations outstanding as detailed in Note 8 to the financial state­
ments. Except for capital leases of $510 initiated in 20X7, the Authority issued 
no new debt in 20X7 or 20X6. The Authority's formal debt issuances—revenue 
notes—cannot be issued without approval of the Feeling County Board of Com­
missioners. The amount of debt issued is subject to limitations that apply to 
the County and its component units as a whole. There have been no changes in 
the Authority's debt ratings in the past two years.
Other Economic Factors
The County's largest employer, the XYZ Motor Company, has a number of 
operating plants throughout the country. In late 20X5, XYZ announced that it 
would close its plant in New City, Ohio and move the majority of that plant's 
operations (including up to 2,000 full-time employees) to its Feeling County 
plant. Work on that move began in May 20X6.
Contacting The Authority's Financial Management
This financial report is designed to provide our patients, suppliers, taxpayers, 
and creditors with a general overview of the Authority's finances and to show 
the Authority's accountability for the money it receives. If you have questions 
about this report or need additional financial information, contact the Authority 
Controller's Office, at Sample Hospital Authority, 92 Third Street, Anytown, 
UN 01000.
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Sample Governmental Hospital Authority 
A Component Unit of Feeling County, State of Union 
Balance SheetsA
December 31, 20X7 and 20X6 
(in thousands)
2 2 0  Health Care Organizations
20X7 20X6
Assets
Current assets:
Cash and cash equivalents 
Short-term investments
$7,136
3,142
$7,557
3,423
Patient accounts receivable, net of estimated
uncollectibles of $2,125 (20X7) and $2,040 
(20X6) 19,834 16,727
Supplies and other current assets 2,270 2,428
Total current assets 32,382 30,135
Noncurrent cash and investments:
Internally designated for capital acquisitions 15,000 15,000
Other long-term investments 2,605 1,327
Held by trustee for debt service 
Restricted by contributors and grantors for
1,945 2,005
capital acquisitions and research 1,124 1,078
Principal of permanent endowments 3,003 2,919
Delinquent property taxes 
Capital Assets:
385 229
Land
Depreciable capital assets, net of accumulated
3,590 3,590
depreciation
Total capital assets, net of accumulated
39.792 39.328
depreciation 43,382 42,918
Other assets 1.056 936
Total assets $100.882 $96.547
(continued)
A As discussed in paragraph 1.17 in this Guide, either a balance sheet or a statement of net 
assets format may be used.
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20X7 20X6
Liabilities and Net Assets
Current liabilities:
Current maturities of long-term debt $1,250 $1,488
Accounts payable and accrued expenses 4,945 4,575
Estimated third-party payor settlements 1,822 1,651
Other current liabilities 1,673 1,797
Total current liabilities 9,690 9,511
Long-term debt, net of current maturities 19,672 20,412
Other long-term liabilities 3,361 2,690
Total liabilities 32,723 32,613
Net Assets:B
Invested in capital assets net of related debt 22,460 21,018
Restricted:
For debt service 1,945 2,005
Expendable for capital acquisitions 733 628
Expendable for research 781 899
Expendable for specific operating activities 331 573
Nonexpendable permanent endowments 3,003 2,919
Unrestricted 38,906 35,892
Total net assets 68,159 63,934
Total liabilities and net assets $100,882 $96,547
See accompanying notes to financial statements.
B As discussed in paragraph 1.18 in this Guide, either "net assets" or "equity" may be used as 
the label for the difference between assets and liabilities.
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Sample Governmental Hospital Authority 
A Component Unit of Feeling County, State of Union 
Statements of Revenues, Expenses, and Changes in Net AssetsC 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
2 2 2  Health Care Organizations
20X7 20X6
Operating revenues:
Net patient service revenue (net of provision 
for bad debts of $859 in 20X7 and $938 in 20X6) $43,305 $43,736
Premium revenue 9,876 13,058
Other 3,416 3,248
Total operating revenues 56,597 60,042
Operating expenses: 
Salaries and benefits 46,845 43,235
Medical supplies and drugs 12,746 7,986
Insurance 7,030 7,382
Other supplies 10,314 11,166
Depreciation and amortization 4,065 3,638
Total operating expenses 81,000 74,407
Operating loss (24,403) (13,365)
Nonoperating revenues (expenses): 
Property taxes 23,895 15,309
Investment income 5,653 5,304
Interest expense (1,489) (1,552)
Noncapital grants and contributions 170 853
Other (425) —
Total nonoperating revenues (expenses) 27,804 19,914
Excess of revenues over expenses before 
capital grants, contributions, and additions 
to permanent endowments 3,401 6,549
Capital grants and contributions 824 2,560
Additions to permanent endowments — 351
Increase in net assets $4,225 $9,460
Net assets beginning of the year 63,934 54,474
Net assets end of the year $68,159 $63,934
See accompanying notes to financial statements.
C As discussed in paragraph 1.20 of this Guide, GASB Statement No. 34, paragraph 101, requires 
proprietary funds and special purpose governments engaged only in business-type activities to present 
an operating statement that uses an "all-inclusive" format, presenting all changes in both restricted 
and unrestricted net assets and presenting a final total, "Increase (decrease) in net assets/equity." As 
discussed in paragraph 1.18 of this Guide, governmental healthcare entities may use either the term 
"net assets" or "equity" as a label for the difference between assets and liabilities.
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Sample Governmental Hospital Authority 
A Component Unit of Feeling County, State of Union 
Statements of Cash Flows 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
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20X7 20X6
Cash flows from operating activities:
Receipts from and on behalf of patients $ 50,074 $ 54,680
Payments to suppliers and contractors (30,029) (26,634)
Payments to employees (46,955) (43,460)
Other receipts and payments, net 4,591 3,597
Net cash provided by operating activities (22,319) (11,817)
Cash flows from noncapital fi nancing 
activities:
Property taxes 20,739 12,224
Noncapital grants and contributions 170 853
Contributions to permanent endowments — 351
Other (425) —
Net cash provided by noncapital financing
activities 20,484 13,428
Cash flows from capital and related 
financing activities:
Capital grants and contributions 824 2,560
Property taxes restricted to capital acquisitions 3,000 3,000
Principal paid on long-term debt (1,488) (1,896)
Interest paid on long-term debt (1,489) (1,552)
Purchase of capital assets (4,019) (4,111)
Net cash used by capital and related
financing activities (3,172) (1,999)
Cash flows from investing activities:
Interest and dividends on investments 2,737 2,124
Purchases of investments (1,045) (289)
Proceeds from sale of investments 2,327 683
Net cash provided by investing activities 4,019 2,518
Net increase (decrease) in cash and cash
equivalents (988) 2,130
(continued)
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20X7 20X6
Cash and cash equivalents, beginning of year 9,101 6,971
Cash and cash equivalents, end of year $8,113 $9,101
Reconciliation of cash and cash equivalents to 
the statement of net assets:
Cash and cash equivalents in current assets 7,136 7,557
Restricted cash and cash equivalents 977 1,544
Total cash and cash equivalents $8,113 $9,101
Reconciliation of operating income (loss) to net cash 
provided (used) by operating activities:
Operating loss ($24,403) ($13,365)
Adjustments to reconcile operating income 
to net cash flows used in operating activities; 
Depreciation and amortization 4,065 3,638
Provision for bad debts 859 938
Changes in:
Patient accounts receivable (3,966) (2,909)
Supplies and other current assets 158 100
Other assets (120) —
Accounts payable, accrued expenses, and 
other current Liabilities 246 (225)
Estimated third-party payor settlements 171 (235)
Other liabilities related to operating activities 671 241
Net cash used in operating activities ($22,319) ($11,817)
Noncash Investing, Capital, and Financing Activities:
The Authority entered into capital lease obligations of $510,000 for 
new equipment in 20X7.
The Authority held investments at December 31, 20X7 with a fair 
value of $XXX. During 20X7, the net increase in the fair value of 
these investments was $XXX.
See accompanying notes to financial statements.
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Notes to Financial StatementsD
December 31, 20X7 and 20X6  
(in thousands)
1. Description of Reporting Entity and Summary of Significant Ac­
counting Policies
Reporting entity. The Sample Hospital Authority (the Authority) is a public 
corporation. It was created on January 1, 19XX, by the Board of County Com­
missioners of Feeling County, State of Union, to operate, control, and manage 
all matters concerning the County's health care functions. The Board of County 
Commissioners appoints the Board of Trustee members of the Authority, and 
the Authority may not issue debt or levy taxes without the county's approval. 
For this reason, the Authority is considered to be a component unit of Feeling 
County and is included as a discretely presented component unit in the basic 
financial statements of the County.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Enterprise fund accounting. The Authority uses enterprise fund accounting. 
Revenues and expenses are recognized on the accrual basis using the economic 
resources measurement focus. Based on Governmental Accounting Standards 
Board (GASB) Statement No. 20, Accounting and Financial Reporting for Pro­
prietary Funds and Other Governmental Entities That Use Proprietary Fund 
Accounting, as amended, the Authority has elected to apply the provisions of all 
relevant pronouncements of the Financial Accounting Standards Board (FASB), 
including those issued after November 30, 1989, that do not conflict with or con­
tradict GASB pronouncements.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months or 
less.
Capital assets. The Authority's capital assets are reported at historical cost. 
Contributed capital assets are reported at their estimated fair value at the time 
of their donation. All capital assets other than land are depreciated or amortized 
(in the case of capital leases) using the straight-line method of depreciation 
using these asset lives:
Land improvements 15 to 20 years
Buildings and building improvements 20 to 40 years
Equipment, computers, and furniture 3 to 7 years
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The notes to the financial statements in these illustrative financial statements generally in­
clude only disclosures unique to a governmental hospital. The disclosures regarding the accounting 
policies for the use of estimates and cost of borrowing in Note 1; and charity care in Note 5 are not 
unique to a governmental hospital. Also, the notes to the financial statements include disclosures that 
are not required.
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Costs of borrowing. Except for capital assets acquired through gifts, contri­
butions, or capital grants, interest cost on borrowed funds during the period of 
construction of capital assets is capitalized as a component of the cost of acquir­
ing those assets. None of the Authority's interest cost was capitalized in either 
20X7 or 20X6.
Property taxes. The Authority received approximately 29 percent in 20X7 and 
19 percent in 20X6 of its financial support from property taxes. These funds 
were used as follows:
20X7 20X6
Used to support operations 
Levied for debt service
$20,895
3,000
$12,309
3,000
Property taxes are levied by the County on the Authority's behalf on January 
1 and are intended to finance the Authority's activities of the same calendar 
year. Amounts levied are based on assessed property values as of the preceding 
July 1.
Property taxes are considered delinquent on the day following each payment 
due date.
Grants and contributions. From time to time, the Authority receives grants 
from Feeling County and the State of Union as well as contributions from in­
dividuals and private organizations. Revenues from grants and contributions 
(including contributions of capital assets) are recognized when all eligibility 
requirements, including time requirements are met. Grants and contributions 
may be restricted for either specific operating purposes or for capital purposes. 
Amounts that are unrestricted or that are restricted to a specific operating 
purpose are reported as nonoperating revenues. Amounts restricted to capital 
acquisitions are reported after nonoperating revenues and expenses.
Endowments. Endowments are provided to the Authority on a voluntary ba­
sis by individuals and private organizations. Permanent endowments require 
that the principal or corpus of the endowment be retained in perpetuity. If a 
donor has not provided specific instructions. Union state law permits the Au­
thority's Board of Trustees to authorize for expenditure the net appreciation of 
the investments of endowment funds, as discussed in Note 2.
Restricted resources. When the Authority has both restricted and unre­
stricted resources available to finance a particular program, it is the Authority's 
policy to use restricted resources before unrestricted resources.
Net assets. Net assets of the Authority are classified in four components. Net 
assets invested in capital assets net of related debt consist of capital assets net of 
accumulated depreciation and reduced by the current balances of any outstand­
ing borrowings used to finance the purchase or construction of those assets. 
Restricted expendable net assets are noncapital net assets that must be used 
for a particular purpose, as specified by creditors, grantors, or contributors ex­
ternal to the Authority, including amounts deposited with trustees as required 
by revenue bond indentures, discussed in Note 8. Restricted nonexpendable net 
assets equal the principal portion of permanent endowments. Unrestricted net 
assets are remaining net assets that do not meet the definition of invested in 
capital assets net of related debt or restricted.
Operating revenues and expenses. The Authority's statement of revenues, ex­
penses and changes in net assets distinguishes between operating and non­
operating revenues and expenses. Operating revenues result from exchange
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transactions associated with providing health care services—the Authority's 
principal activity. Nonexchange revenues, including taxes, grants, and contri­
butions received for purposes other than capital asset acquisition, are reported 
as nonoperating revenues. Operating expenses are all expenses incurred to 
provide health care services, other than financing costs.
Compensated absences. The Authority's employees earn vacation days at vary­
ing rates depending on years of service. Vacation time does not accumulate. 
Generally, any days not used at year-end expire. Employees also earn sick leave 
benefits based on varying rates depending on years of service. Employees may 
accumulate sick leave up to a specified maximum. Employees are not paid for 
accumulated sick leave if they leave before retirement. However, employees 
who retire from the Authority may convert accumulated sick leave to termi­
nation payments at varying rates, depending on the employee's contract. The 
estimated amount of sick leave payable as termination payments is reported 
as a noncurrent liability in both 20X7 and 20X6.
Risk management. The Authority is exposed to various risks of loss from torts; 
theft of, damage to, and destruction of assets; business interruption; errors and 
omi ssions; employee injuries and illnesses; natural disasters; medical malprac­
tice; and employee health, dental, and accident benefits. Commercial insurance 
coverage is purchased for claims arising from such matters. Settled claims have 
not exceeded this commercial coverage in any of the three preceding years.
Investments in debt and equity securities. Investments in debt and equity 
securities are reported at fair value except for short-term highly liquid invest­
ments that have a remaining maturity at the time they are purchased of one 
year or less. These investments are carried at amortized cost. Interest, divi­
dends, and gains and losses, both realized and unrealized, on investments in 
debt and equity securities are included in nonoperating revenue when earned.
2. Endowments and Restricted Net Assets
Restricted, expendable net assets are available for the following purposes:
20X7 20X6
Program A activities:
Purchase of equipment $404 $321
Research 553 683
General 46 63
Program B activities:
Purchase of equipment 235 235
Research 184 151
General 79 110
Program C activities:
General 206 400
Buildings and equipment 94 72
Research 44
Total expendable, restricted net assets $1,845 $2,100
Unless the contributor provides specific instructions, Union state law permits 
the Authority Board of Trustees to authorize for expenditure the net appreci­
ation (realized and unrealized) of the investments in its endowments. When 
administering its power to spend net appreciation, the Board of Trustees is 
required to consider the Authority's "long- and short-term needs, present and
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anticipated financial requirements, expected total return on its investments, 
price-level trends, and general economic conditions." Any net appreciation that 
is spent is required to be spent for the purposes designated by the contributor.
The Board of Trustees chooses to spend only a portion of the investment in­
come (including changes in the value of investments) each year. Under the policy 
established by the Board, 5 percent of the average market value of endowment 
investments at the end of the previous three years has been authorized for 
expenditure. The Authority retains the remaining amount, if any, to be used 
in future years when the amount computed using the spending policy exceeds 
investment income. At December 31, 20X7 and 20X6, net appreciation of $864 
and $953, respectively, is available to be spent, of which $402 and $682, re­
spectively, is reported as restricted expendable net assets, and the balance is 
in unrestricted net assets.
Restricted nonexpendable net assets as of December 31, 20X7 and 20X6, rep­
resent the principal amounts of permanent endowments, restricted to invest­
ment in perpetuity. Investment earnings from the Authority's permanent en­
dowments are expendable to support these programs as established by the 
contributor:
Health Care Organizations
20X7 20X6
Program A activities $ 158 $ 158
Program B activities 176 176
Program C activities 423 423
Any activities of the Authority 854 854
Endowment requiring income to be added to
1,611 1,611
original gift until the fund's value is $2,125 1,392 1,308
Total restricted nonexpendable net assets 3,003 2,919
3. Designated Net Assets
Of the $40,851 and $37,897 of unrestricted net assets reported in 20X7 and 
20X6, respectively, $15,000 has been designated by the Authority's Board of 
Trustees for capital acquisitions. Designated funds remain under the control of 
the Board of Trustees, which may at its discretion later use the funds for other 
purposes.
4. Deposits and Investments
State law requires collateralization of all deposits with federal depository in­
surance and other acceptable collateral in specific amounts. The Authority's 
bylaws require that all bank balances be insured or collateralized by U.S. gov­
ernment securities held by the pledging financial institution's trust department 
in the name of the Authority.
The Authority's investments generally are reported at fair value, as discussed 
in Note 1. At December 31, 20X7 and 20X6, the Authority had the following 
investments and maturities, all of which were held in the Authority's name by 
a custodial bank that is an agent of the Authority:E
E This illustrative note presents interest rate information using the segmented time distribution 
method. Other methods for illustrating interest rate information are described in paragraph 15 of 
GASB Statement No. 40, Deposit and Investment Risk Disclosures.
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December 31, 20X7 Investment Maturities (in Years)
Carrying Less More
Investment Type Amount Than 1 1-5 6-10 Than 10
U.S. Treasuries 
Federal National
$21,7749 $xxx $xxx $xxx $xxx
Mortgage Association 
Government National
3,580 XXX XXX XXX XXX
Mortgage Association 3,5806 XXX XXX XXX XXX
Total $28,934 $xxx $xxx $xxx $xxx
December 31, 20X6 Investment Maturities (in Years)
Carrying Less More
Investment Type Amount Than 1 1-5 6-10 Than 10
U.S. Treasuries 
Federal National
$20,039 $xxx $xxx $xxx $xxx
Mortgage Association 
Government National
3,365 XXX XXX XXX XXX
Mortgage Association 3,366 XXX XXX XXX XXX
Total $26,770 $xxx $xxx $xxx $xxx
Interest Rate Risk. The Authority does not have a formal investment policy 
that limits investment maturities as a means of managing its exposure to fair 
value losses arising from changing interest rates.
Credit Risk. Statutes authorize the Authority to invest in obligations of the 
U.S. Treasury, agencies, and instrumentalities, commercial paper rated A-1 by 
Standard & Poor's Corporation or P-1 by Moody's Commercial Paper Record, 
and bankers' acceptances. However, the Authority's bylaws require that invest­
ments be made only in U.S. government obligations held by the Authority's 
third-party agent. As of December 31, 20X7 and 20X6, the Authority's invest­
ments in Federal National Mortgage Association were rated AAA by Standard 
and Poor's and Fitch Ratings and Aaa by Moody's Investor Services.
Concentration of Credit Risk. The Authority places no limit on the amount it 
may invest in any one issuer. More than 5 percent of the Authority's investments 
at December 31, 20X7 and 20X6 are invested in the Federal National Mortgage 
Association. These investments are 12.37% and 12.57%, respectively, of the 
Authority's total investments at December 31, 20X7 and 20X6.
The carrying amounts of deposits and investments are included in the 
Authority's balance sheets as follows:
20X7 20X6
Carrying amount 
Deposits $ 5,021 $ 6,539
Investments 28,934 26,770
$33,955 $33,309
Included in the following balance sheet captions 
Cash and cash equivalents $7,136 $7,557
Short-term investments 3,142 3,423
Noncurrent cash and investments: 
Other long-term investments 2,605 1,327
Restricted by contributors and grantors for 
capital acquisitions and research 1,124 1,078
Internally designated for capital acquisitions 15,000 15,000
Held by trustee for debt service 1,945 2,005
Principal of permanent endowments 3,003 2,919
$33,955 $33,309
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5. Charity Care
Charges excluded from revenue under the Authority's charity care policy were 
$7,100 and $6,845 for 20X7 and 20X6, respectively.
6. Accounts Receivable and Payable
Patient accounts receivable and accounts payable (including accrued ex­
penses) reported as current assets and liabilities by the Authority at Decem­
ber 31, 20X7 and 20X6 consisted of these amounts;
Patient Accounts Receivable
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Receivable from patients and their insurance carriers 
Receivable from Medicare 
Receivable from Medicaid
Total patient accounts receivable 
Less allowance for uncollectibles amounts 
Patient accounts receivable, net
Accounts Payable and Accrued Expenses
Payable to employees (including payroll taxes)
Payable to suppliers 
Other
Total accounts payable and accrued expenses
7. Capital Assets
Capital asset additions, retirements, and balances for the years ended Decem­
ber 31, 20X7 and 20X6 were as follows:
20X7 20X6
$13,976 $11,868
4,286 3,002
3,697 3,897
21,959 18,767
2,125 2,040
$19,834 $16,727
20X7 20X6
$2,437 $1,970
2,481 2,591
27 14
$4,945 $4,575
Balance 
December 31, 
20X6 Additions
Retire­
ments
Balance 
December 31, 
20X7
LandF $ 3,590 — — $ 3,590
Land improvements 645 17 — 662
Buildings and
improvements 29,265 965 (810) 29,420
Equipment 30,375 3,547 (1,860) 32,062
Totals at historical cost $ 63,875 $4,529 ($2,670) $ 65,734
Less accumulated 
depreciation for:
Land improvements (291) (65) — (356)
Buildings and
improvements (5,352) (582) 810 (5,124)
Equipment (15,314) (3,418) 1,860 (16,872)
Total accumulated
depreciation (20,957) (4,065) 2,670 (22,352)
Capital assets, net $ 42,918 $ 464 $ 0 $ 43,382
F  When present, construction-in-progress should be reported in a separate line in this schedule. 
(See the GASB staff document Comprehensive Implementation Guide—2004, item 7.353). See para­
graph 1.11 in this Guide regarding references to GASB staff Implementation Guides. Also, GASB 
Statement No. 34, paragraph 20, requires non-depreciable capital assets to be shown separately on 
the face of the balance sheet when these balances are significant.
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Balance 
December 31, 
20X5
Balance 
December 31, 
20X6
Land $ 3,590 — — $ 3,590
Land improvements 
Buildings and
608 112 (75) 645
improvements 29,187 78 — 29,265
Equipment 26,710 3,921 (256) 30,375
Totals at historical cost $ 60,095 $4,111 ($ 331) $ 63,875
Less accumulated
depreciation for: 
Land improvements 
Buildings and
(309) (57) 75 (291)
improvements (4,826) (526) — (5,352)
Equipment (12,515) (3,055) 256 (15,314)
Total accumulated
depreciation (17,650) (3,638) 331 (20,957)
Capital assets, net $ 42,445 $ 473 $ 0 8 42.918
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8. Long-Term Debt and Other Noncurrent Liabilities
A schedule of changes in the Authority's noncurrent liabilities for 20X7 and 
20X6 follows:
Balance 
December 31, 
20X6 Additions Reductions
Balance 
December 31, 
20X7
Amounts 
Due Within 
One Year
Bonds and Notes 
Payable: 
Revenue notes 
Mortgage loan 
Note payable 
Total long-term 
debt
Capital lease 
obligations 
Other Liabilities: 
Compensated 
absences
Net pension 
obligation
Total other 
liabilities
Total
noncurrent
liabilities
$18,714 — ($457) $18,257 $620
1,808 — (99) 1,709 99
570 — (464) 106 106
21,092 — (1,020) 20,072 825
808 510 (468) 850 425
2,625 662 (6) 3,281 —
65 15 — 80 See Note 9
2,690 677 (6) 3,361 —
$24,590 $1,187 ($1,494) $24,283 $1,250
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Balance 
December 31, 
20X5 Additions Reductions
Balance 
December 31, 
20X6
Amounts 
Due Within 
One Year
Bonds and Notes 
Payable: 
Revenue notes 19,568 (854) 18,714 457
Mortgage loan 1,907 — (99) 1,808 99
Note payable 1,045 — (475) 570 464
Total long-term 
debt 22,520 (1,428) 21,092 1,020
Capital lease 
obligations 1,276 (468) 808 468
Other Liabilities: 
Compensated 
absences 2,400 236 (11) 2,625
Net pension 
obligation 49 16 65 See Note 9
Total other 
liabilities 2,449 252 (11) 2,690
Total
noncurrent
liabilities $26,245 $252 ($1,907) $24,590 $1,488
Long-term debt. The terms and due dates of the Authority's long-term debt, 
including capital lease obligations, at December 31, 20X7 and 20X6, follow:
•  7.25 percent Revenue Notes, due November 1, 20Z7, collateralized by 
a pledge of the Authority's gross receipts. Thus all operating and non­
operating revenues of the authority are similarly pledged.
•  9.25 percent mortgage loan, due January 20Y4, collateralized by a 
mortgage on property and equipment with a depreciated cost of $1,530 
at December 31, 20X7
•  9.75 percent note payable, due March 20X8, unsecured
•  Capital lease obligations, at varying rates of imputed interest from 9.8 
percent to 12.3 percent collateralized by leased equipment with cost of 
$1,275 at December 31, 20X7
Under the terms of the Revenue Note Indenture, the Authority is required 
to maintain certain deposits with a trustee. Such deposits are included with 
restricted cash and investments in the balance sheet. The Revenue Note Inden­
ture also places limits on the incurrence of additional borrowings and requires 
that the Authority satisfy certain measures of financial performance as long as 
the notes are outstanding.
Scheduled principal and interest repayments on long-term debt and payments 
on capital lease obligations are as follows:
Year Ending December 31:
Long-term Debt Capital Lease Obligations
Principal Interest Principal Interest
20X8 $ 825 $ 553 $ 425 $58
20X9 775 487 213 27
20Y0 836 465 212 13
20Y1 900 448
20Y2 972 432
20Y3 to 20Y7 5,764 1,769
20Y8 to 20Z2 4,824 1,492
20Z3 to 20Z7 5.176 1.116
Total $20,072 86.762 8850 898
AAG-HCO APP A
Illustrative Financial Statements 233
9. Commitments under Noncancelable Operating Leases
The Authority is committed under various noncancelable operating leases, 
all of which are for equipment and computers. These expire in various years 
through 20Y9. Future minimum operating lease payments are as follows:
Year ending December 31:
20X8 $3,109
20X9 2,898
20Y0 2,795
20Y1 2,780
20Y2 2,575
20Y3-20Y7 4,215
20Y8-20Y9 1.065
Total $19,437
10. Pension PlanG
Plan description. Sample Hospital Pension Plan (SHPP) provides retirement 
and disability benefits, annual cost-of-living adjustments, and death benefits 
to plan members and beneficiaries. SHPP is affiliated with County Employees 
Pension Plan (CEPP), an agent multiple-employer pension plan administered 
by the Union Retirement System. Article 39 of the Regulations of the State 
of Union assigns the authority to establish and amend the benefit provisions 
of the plans that participate in CEPP to the respective employer entities; for 
CEPP, that authority rests with the County of Feeling, Union. The Union Retire­
ment System issues a publicly available financial report that includes financial 
statements and required supplementary information for SHPP. That report 
may be obtained by writing to Union Retirement System, State Government 
Lane, Anytown, Union 01000 or by calling 1-800-555-PLAN.
Funding policy. The contribution requirements of plan members and the Au­
thority are established and may be amended by the CEPP Board of Trustees. 
Plan members are required to contribute 7.8 percent of their annual covered 
salary. The Authority is required to contribute at an actuarially determined 
rate; the current rate for both 20X7 and 20X6 is 11.9 percent of annual covered 
payroll.
Annual pension cost and net pension obligation. The Authority's annual pen­
sion cost and net pension obligation to SHPP for 20X7 and 20X6 were as follows:
20X7 20X6
Annual required contribution $26 $23
Interest on net pension obligation 3 2
Adjustment to annual required contribution (3) (2)
Annual pension cost 26 23
Contributions made (11) (7)
Increase (decrease) in net pension obligation 15 16
Net pension obligation beginning of year 65 49
Net pension obligation, end of year $80 $65
G The preparer of the financial statements should consider the need for required supplementary 
information (RSI) as required by GASB Statement No. 27, Accounting for Pensions by State and Local
Governmental Employers, paragraph 22.
AAG-HCO APP A
234 Health Care Organizations
The annual required contribution for the current year was determined as part 
of the December 31, 20X6, actuarial valuation using the entry age actuarial 
cost method. The actuarial assumptions included (a) 7.5% investment rate of 
return (net of administrative expenses) and (b) projected salary increases rang­
ing from 5.5% to 9.5% per year. Both (a) and (b) included an inflation component 
of 5.5%. The actuarial assumptions also include a 2% per year cost-of-living ad­
justment. The actuarial value of assets was determined using techniques that 
smooth the effects of short-term volatility in the market value of investments 
over a four-year period. The same actuarial assumptions were used to determine 
the actuarial required contributions for 20X6. The unfunded actuarial accrued 
liability is being amortized as a level percentage of projected payroll on an open 
basis. The remaining amortization period at December 31, 20X6, was 23 years.
Three-Year Trend Information
Fiscal Year 
Ending
Annual 
Pension 
Cost (APC)
Percentage 
of APC 
Contributed
Net
Pension
Obligation
12/31/X5 $20 94% $49
12/31/X6 23 30 65
12/31/X7 26 42 80
11. Postretirement Plan||
In addition to the pension benefits described above, the Authority provides 
postretirement health care benefits, in accordance with the Authority's bylaws, 
to all employees who retire from the Authority on or after attaining age 60 with 
at least 15 years of service. Currently 250 retirees (245 in 20X6) meet these 
eligibility requirements. The Authority reimburses 75 percent of the amount of 
validated claims for medical, dental, and hospitalization costs incurred by pre- 
Medicare retirees and their dependents. The Authority also reimburses a fixed 
amount of $25 per month for a Medicare supplement for each retiree eligible 
for Medicare. Expenses for postretirement health care benefits are recognized 
as retirees report claims and include a provision for estimated claims incurred 
but not yet reported to the Authority. Expenses of $764 were recognized for 
postretirement health care in 20X7; expenses recognized in 20X6 were $636. 
Approximately $64 of the $128 increase in expenses over the previous year was 
caused by the addition of dental benefits, effective July 1, 20X7.
NOTE—Although not presented in these sample illustrative financial state­
ments, other disclosures required by GASB pronouncements may be applicable, 
including the following:
•  Short-term debt (GASB Statement No. 38, paragraph 12)
•  Interfund balances and transfers (GASB Statement No. 38, paragraph 
14, when a governmental health care entity reports multiple enterprise
|| In 2004, the GASB issued GASB Statement No. 45, Accounting and Financial Reporting by 
Employers for Postemployment Benefits Other Than Pensions, that would supersede or amend previous 
authoritative guidance on accounting and financial reporting for an employer's other postemployment 
benefits (OPEB) expense and related information, including GASB Statement No. 12, Disclosure of In­
formation on Postemployment Benefits Other Than Pension Benefits by State and Local Governmental 
Employers. GASB Statement No. 45 requires reporting of the annual cost of OPEB, and the outstand­
ing obligations and commitments related to OPEB in essentially the same manner as required for 
pensions in GASB Statement No. 27. Paragraphs 24 and 25 of GASB Statement No. 45 require disclo­
sures in the notes to the financial statements for OPEB plans. Conforming changes to modify these 
illustrative financial statements to reflect the issuance of GASB Statement No. 45 will be made in a 
future edition of this Guide.
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funds or is reported as an enterprise fund of a general purpose govern­
ment. See Appendix F, footnote 5.)
•  Segment information (GASB Statement No. 34, paragraphs 122 and 
123, as amended by GASB Statement No. 37, paragraph 17)
•  Violations of finance-related legal or contractual provisions (GASB 
Statement No. 38, paragraph 9)
•  Risk financing (Requirements for disclosures about claims and judg­
ments and risk financing by governmental health care entities that 
retain a portion of risk for claims and judgments (including malprac­
tice claims and judgments) are provided in GASB Statement No. 10, 
Accounting and Financial Reporting for Risk Financing and Related 
Insurance Issues, as amended). Additionally, GASB Statement No. 34, 
paragraph 119 requires disclosure of certain information about the 
long-term portion of accrued claims and judgments, if applicable.
Other required disclosures, which may be applicable, and that would be similar 
to the disclosures contained in the notes to the sample illustrative financial 
statements for a not-for-profit hospital, are not repeated here. They include the 
following:
Off-Balance Sheet Risk and Concentration of Credit Risk 
Fair Value of Financial Instruments 
Commitments and Contingencies 
Subsequent Events 
Net patient service revenue 
Related party transactions
Description of Reporting Entity and Summary of Significant Account­
ing Policies—Supplies, Net Patient Service Revenue, Charity Care, Pre­
mium Revenue
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Sample For-Profit Nursing Home, Inc.
Balance Sheets 
December 31, 20X5 and 20X4
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20X5 20X4
Assets
Current assets:
Cash and cash equivalents $ 95,000 $ 129,000
Investments 150,000
Assets limited as to use 50,000 50,000
Patient accounts receivable, net of allowance for 
doubtful accounts of $6,700 in 20X5 and $5,300
in 20X4 162,000 152,000
Estimated third-party payor settlements 71,000 62,000
Interest receivable 7,000
Supplies 47,000 43,000
Prepaid expenses 3,000 2,000
Deferred tax asset 12,000 14,000
Total current assets 597,000 452,000
Assets limited as to use, net of amount required
for current liabilities 173,000 150,000
Property and equipment:
Land 205,000 205,000
Land improvements 37,000 32,000
Buildings 1,399,000 1,399,000
Furniture, fixtures, and equipment 228,000 189,000
1,869,000 1,825,000
Less accumulated depreciation 210,000 141,000
Property and equipment, net 1,659,000 1,684,000
Other assets 150,000 127,000
Total assets $2,579,000 $2,413,000
(continued)
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Sample For-Profit Nursing Home, Inc. 
Balance Sheets 
(continued)
December 31, 20X5 and 20X4
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Liabilities and Shareholders' Equity
Current liabilities;
Current maturities of long-term debt 
Accounts payable 
Accrued expenses 
Deposits from patients 
Other current liabilities
Total current liabilities 
Deferred tax liability 
Long-term debt, net of current maturities 
Shareholders' equity:
Common stock $20 par value; authorized
5,000 shares; issued and outstanding 
3,500 shares 
Retained earnings
Total shareholders' equity 
Total liabilities and shareholders' equity
See accompanying notes to financial statements.
20X5 20X4
$ 50,000 $ 50,000
78,000 52,000
175,000 188,000
50,000 45,000
74,000 15,000
427,000 350,000
6,000 14,000
1,700,000 1,750,000
70,000 70,000
376,000 229,000
446,000 299,000
$2,579,000 $2,413,000
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Sample For-Profit Nursing Home, Inc. 
Statements of Income and Retained Earnings 
Years Ended December 31, 20X5 and 20X4
Health Care Organizations
20X5 20X4
Revenue:
Net patient service revenue $2,163,000 $1,949,000
Other revenue 67,000 22,000
Interest on investments held by trustee 13,000 7,000
Total revenue 2,243,000 1,978,000
Expenses:
Salaries and benefits 969,000 919,000
Medical supplies and drugs 511,000 499,000
Insurance and other 216,000 176,000
Provision for bad debts 92,000 83,000
Depreciation 69,000 57,000
Interest 164,000 172,000
Total expenses 2,021,000 1,906,000
Operating income 222,000 72,000
Nonoperating income:
Other interest income 
Income before provision for income taxes
5,000
227,000 72,000
Provision for income taxes 80,000 29,000
Net income 147,000 43,000
Retained earnings, beginning of year 229,000 186,000
Retained earnings, end of year $ 376,000 $ 229.000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc. 
Statements of Cash Flows 
Years Ended December 31, 20X5 and 20X4
Cash flows from operating activities;
Cash received from residents and 
third party payors 
Cash received from others 
Cash paid to employees and suppliers 
Interest and dividends received, 10,000 
Interest paid 
Taxes paid
Deposits received from patients 
Deposits refunded to patients
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of investments 
Proceeds from sale of property 
Capital expenditures 
Purchase of assets limited as to use
Net cash used in investing activities
Cash flows from financing activities: 
Repayment of long-term debt
Net cash used in financing activities
Net increase (decrease) in cash and cash 
equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Reconciliation of net income to net cash provided 
by operating activities:
Net income
Adjustments to reconcile net income to net cash 
provided by operating activities:
Depreciation 
Provision for bad debts 
Loss on sale of property 
Change in deferred income taxes 
(Increase) decrease in:
Patient accounts receivable
Other current assets
Estimated third-party payor settlements
Interest receivable
Other assets
Increase (decrease) in:
Accounts payable and accrued expenses 
Deposits from patients 
Other current liabilities
Net cash provided by operating activities
See accompanying notes to financial statements.
20X5 20X4
$2,019,000 $1,796,000
67,000 22,000
(1,679,000) (1,495,000)
10,000 10,000
(160,000) (170,000)
(29,000) (30,000)
35,000 15,000
(30,000) (20,000)
233,000 128,000
(150,000)
2,000
(44,000) (79,000)
(23,000)
(217,000) (77,000)
(50,000) (50,000)
(50,000) (50,000)
(34,000) 1,000
129,000 128,000
$ 95.000 $ 129.000
$147,000 $43,000
69,000 57,000
92,000 83,000
— 11,000
(6,000) (14,000)
(102,000) (41,000)
(21,000) (15,000)
(9,000) (10,000)
(7,000) (3,000)
(7,000) (10,000)
13,000 43,000
5,000 (5,000)
59,000 (11,000)
$233,000 $128,000
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Sample For-Profit Nursing Home, Inc.
Notes to Financial Statements 
December 31 , 20X5 and 20X4
1. Description of Organization and Summary of Significant Account­
ing Policies3
Organization. The Sample Nursing Home, Inc. (the Company) was incorpo­
rated in New State in 20X1 and operates a 128-bed nursing home in Abacus, 
New State. A summary of the Company's significant accounting policies follows:
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months or 
less, excluding amounts whose use is limited by note indenture.
Investments. Investments in debt instruments, including assets limited as to 
use, are classified as held-to-maturity because the Company has the positive 
intent and ability to hold the securities until maturity. Held-to-maturity secu­
rities are carried at cost adjusted for amortization of premiums and accretion 
of discounts.
Assets limited as to use. Assets deposited with a trustee under terms of the 
note indenture and assets set aside by the Board of Directors for capital im­
provements are classified as assets limited as to use. Amounts required to meet 
current liabilities have been reclassified in the balance sheet.
Property and equipment. Property and equipment are recorded at cost. De­
preciation is calculated on the straight-line method over the estimated useful 
lives of depreciable assets.
Bond issuance costs. Costs incurred in issuing the Series 20X1 bonds are 
being amortized based on the effective interest method.
Net patient service revenue. Net patient service revenue is reported at the 
estimated net realizable amounts from residents, third-party payors, and others 
for service rendered.
Revenue under third-party payor agreements is subject to audit and retroac­
tive adjustment. Provisions for estimated third-party payor settlements are 
provided in the period the related services are rendered. Differences between 
the estimated amounts accrued and interim and final settlements are reported 
in operations in the year of settlement.
Income taxes. The provisions for income taxes are based on amounts esti­
mated to be currently payable and those deferred because of temporary differ­
ences between the financial statement and tax bases of assets and liabilities. 
These differences consist principally of bad debts and depreciation.
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ceivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts.
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2. Assets Limited as to Use
Assets limited as to use include:
Assets held by trustee under the Series 20X1 note indenture agreement at
December 31, 20X5 and 20X4.
20X5 20X4
U.S. Government obligations $150,000 $130,000
Cash 24,000 21,000
Accrued interest income 2,000 2,000
176,000 153,000
Internally designated by the Board of 
Directors for capital improvements
Certificate of deposit $45,000 $45,000
Accrued interest 2,000 2,000
47,000 47,000
$223,000 $200,000
3. Investments#
4. Long-Term Debt
Long-term debt at December 31, 20X5 and 20X4, was as follows:
20X5 20X4
9,5 percent bonds payable to the City of 
Abacus, maturing $50,000 annually through 
November 1, 20YY, with a final maturity of 
$1 million on November 1, 20YY 
Less current maturities
$1,750,000
50,000
$1,700,000
$1,800,000
50,000
$1.750.000
The notes are collateralized by a first mortgage lien on all property and equip­
ment of the Company and a security interest in all of its receipts. The note 
indenture requires the maintenance of certain deposits with a trustee, which 
are included in assets limited as to use.
Future maturities of long-term debt as of December 31, 20X5, follow:
Year Ending December 31, 
20X6 
20X7 
20X8 
20X9 
20Y0
Thereafter
Total
Amount
$ 50,000
50,000
50,000
50,000
50,000 
1,500,000
$1.750.000
# In reporting disclosures about investments in securities, entities should comply primarily with 
the requirements of paragraphs 6, 17, 19, 20, 21, and 22 of FASB Statement No. 115, as amended. 
Other disclosure requirements may also be applicable.
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5. Income Taxes
The provisions for income taxes are as follows:
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20X5 20X4
Current:
Federal $72,000 $15,000
State 2,000
Total current 74,000 15,000
Deferred:
Federal 6,000 13,000
State 1,000
Total deferred 6,000 14,000
Total provision for income taxes $80,000 $29,000
Deferred income taxes are provided for the temporary differences between
the financial reporting basis and the tax basis of the Company's assets and 
liabilities.
For the years ended December 31, 20X5 and 20X4, the effective tax rate ap­
proximated the statutory rate of 34 percent and 40 percent, respectively.
The net current and noncurrent components of deferred income taxes recog­
nized in the balance sheet at December 31, 20X5 and 20X4, follows:
20X5 20X4
Net current assets $12,000 $14,000
Net noncurrent liabilities 6,000 14,000
$ 6.000 $ 0
Management has determined that no valuation allowance related to deferred 
tax assets is necessary at December 31, 20X5 and 20X4, respectively.
6. Concentration in State Medicaid Program
The Company has 100 of its 128 beds designated for care of patients under 
the state's Medicaid program. The current funding of that program is 90 days 
behind filed claims. The current state budget has no provision for reducing that 
lag and, while the proposed budget for 20X6 includes additional funding, there 
is no assurance that the final budget will include the needed additional funds.
7. Third Party Rate Adjustments and Revenue
Revenue from the Medicaid program accounted for approximately XX per­
cent for the year ended 20X5, and XX percent for the year ended 20X4, of the 
Company's net patient revenue. Laws and regulations governing the Medicaid 
program are extremely complex and subject to interpretation. As a result, there 
is at least a reasonable possibility that recorded estimates will change by a ma­
terial amount in the near term. The 20X5 net patient service revenue increased 
approximately $XXX due to removal of allowances previously estimated that 
are no longer necessary as a result of final settlements and years that are 
no longer subject to audits, reviews, and investigations. The 20X4 net patient 
service revenue decreased approximately $XXX due to prior-year retroactive 
adjustments in excess of amounts previously estimated.
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8. Risks and Uncertainties Disclosures**
9. Pension Plan**
10. Postretirement Benefits**
11. Fair Values of Financial Instruments**
12. Concentrations of Credit Risk**
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* The disclosures contained in these notes would he similar to the disclosures contained in the 
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A CONTINUING CARE 
RETIREMENT COMMUNITY
Sample Not-for-Profit Continuing Care Retirement Community
Balance Sheets 
December 31, 20X5 and 20X4
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20X5 20X4
Assets
Current assets:
Cash $ 375,000 $ 330,000
Assets limited as to use 265,000 170,000
Accounts receivable, net of allowance for 
doubtful accounts of $4,000 in 20X5 and
$5,000 in 20X4 187,000 197,000
Supplies 40,000 21,000
Prepaid expenses 115,000 73,000
Total current assets 982,000 791,000
Assets limited as to use, net of amount required
for current liabilities 1,865,000 1,583,000
Property and equipment, net 14,893,000 15,280,000
Deferred financing costs, net of accumulated 
amortization of $28,000 in 20X5 and $21,000
in 20X4 83,000 90,000
Total assets $17,823,000 $17,744,000
Liabilities and Net Assets
Liabilities:
Current maturities of long-term debt $ 90,000 $ 77,000
Accounts payable 180,000 174,000
Accrued expenses 161,000 178,000
Deposits on unoccupied units 22,000 40,000
Total current liabilities 453,000 469,000
Long-term debt, less current maturities 8,871,000 8,935,000
Refundable fees 59,000 144,000
Estimated obligation to provide future services,
in excess of amounts received or to be received 88,000 100,000
Deferred revenue from advance fees 6,304,000 6,585,000
Total liabilities 15,775,000 16,233,000
Net assets:
Unrestricted 1,286,000 833,000
Temporarily restricted 311,000 294,000
Permanently restricted 451,000 384,000
Total net assets 2,048,000 1,511,000
Total liabilities and net assets $17,823,000 $17,744,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Operations 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Resident services, including amortization of 
advance fees of $935,000 in 20X5 
and $915,000 in 20X4 $3,946,000 $3,152,000
Patient revenue from nonresidents 249,000 275,000
Change in obligation to provide future services 12,000 (82,000)
Contributions 54,000 39,000
Net assets released from restrictions used for 
operations 24,000 50,000
Investment income 29,000 30,000
Other 75,000 68,000
Total revenue, gains, and other support 4,389,000 3,532,000
Expenses:
Salaries and benefits 1,708,000 1,250,000
Medical supplies and drugs 543,000 742,000
Insurance 291,000 311,000
Depreciation 452,000 447,000
Interest 967,000 955,000
Total expenses 3,961,000 3,705,000
Operating income (loss) 428,000 (173,000)
Net assets released from restriction—purchase 
of equipment 25,000 45,000
Increase (decrease) in unrestricted net assets $ 453,000 $ (128,000)
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Changes in Net Assets 
Years Ended December 31, 20X5 and 20X4
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20X5 20X4
Unrestricted net assets:
Operating income (loss)
Net assets released from restriction—purchase
$ 428,000 $ (173,000)
of equipment 25,000 45,000
Increase (decrease) in unrestricted net assets 
Temporarily restricted net assets:
453,000 (128,000)
Contributions
Net assets released from restrictions used for
40,000 15,000
operations
Net assets released from restriction—purchase
(24,000) (50,000)
of equipment (25,000) (45,000)
Investment income 26,000 15,000
Increase (decrease) in temporarily restricted 
net assets 17,000 (65,000)
Permanently restricted net assets:
Contributions 67,000 52,000
Increase in permanently restricted net assets 67,000 52,000
Increase (decrease) in net assets 537,000 (141,000)
Net assets, beginning of year 1,511,000 1,652,000
Net assets, end of year $2,048,000 $1,511,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Cash Flows 
Years Ended December 31, 20X5 and 20X4
Cash flows from operating activities:
Cash received from residents and third 
party payors 
Advance fees received 
Other receipts from operations 
Investment income received 
Contributions received 
Cash paid to employees and suppliers 
Interest paid
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of property and equipment 
Purchase of assets limited as to use
Net cash used in investing activities
Cash flows from financing activities: 
Permanently restricted funds received 
Refunds of deposits and refundable fees 
Proceeds from issuance of long-term debt 
Principal payments of long-term debt 
Net cash used in financing activities
Net increase in cash
Cash, beginning of year
Cash, end of year
Reconciliation of change in net assets to net 
cash provided by operating activities:
Change in net assets
Adjustments to reconcile change in net assets to 
net cash provided by operating activities: 
Advance fees received 
Restricted net assets received 
Amortization of advance fees 
Loss (gain) on obligation to provide future 
services 
Depreciation
Amortization of deferred financing costs 
Provision for bad debts
(Increase) decrease in:
Accounts receivable 
Other assets
Increase (decrease) in:
Accounts payable and accrued expenses
Net cash provided by operating activities
See accompanying notes to financial statements.
20X5 20X4
$ 3,252,000 $ 2,341,000
654,000 857,000
75,000 68,000
68,000 53,000
51,000 44,000
(2,576,000) (2,040,000)
(950,000) (945,000)
574,000 378,000
(65,000) (250,000)
(377,000) 229,000
(442,000) (21,000)
67,000 52,000
(103,000) (52,000)
26,000
(77,000) (307,000)
(87,000) (307,000)
45,000 50,000
330,000 280,000
$ 375,000 $ 330,000
$ 537,000 $(141,000)
654,000 857,000
(67,000) (52,000)
(935,000) (915,000)
(12,000) 82,000
452,000 447,000
7,000 34,000,
3,000 3,000
7,000 (33,000)
(61,000) (4,000)
(11,000) 100,000
$ 574,000 $ 378.000
AAG-HCO APP A
Sample Not-for-Profit Continuing Care Retirement Community 
Notes to Financial Statements4
December 31 , 20X5 and 20X 4
1. Description of Organization and Summary of Significant Account­
ing Policies††,5
Organization. The Sample Continuing Care Retirement Community (the CC. 
is a nonprofit organization that principally provides housing, health care, and 
other related services to residents through the operation of a retirement fa­
cility containing 249 apartments and a 78-bed health care facility located in 
Evergreen Park, Illinois. The CCRC was incorporated in Illinois in 20X1. A 
summary of significant accounting policies follows.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Investments. Investments, which consist of U.S. Treasury obligations, are 
measured at fair value in the balance sheet. Investment income (including 
realized gains and losses on investments, interest, and dividends) is included 
in operating income (loss) unless restricted by donor or law. Unrealized gains 
and losses on investments, if any, are excluded from operating income (loss).
Deferred financing costs. Deferred financing costs are amortized using the 
effective interest method over the term of the related financing agreement.
Advance fees. Fees paid by a resident upon entering into a continuing care 
contract, net of the portion thereof that is refundable to the resident, are 
recorded as deferred revenue and are amortized to income using the straight- 
line method over the estimated remaining life expectancy of the resident.
Obligation to provide future services. The CCRC annually calculates the 
present value of the net cost of future services and the use of facilities to be 
provided to current residents and compares that amount with the balance of 
deferred revenue from advance fees. If the present value of the net cost of future 
services and the use of facilities exceeds the deferred revenue from advance fees, 
a liability is recorded (obligation to provide future services and use of facilities) 
with the corresponding charge to income. The obligation is discounted at 9 per­
cent, based on the expected long-term rate of return on government obligations.
Donor restrictions. The CCRC reports gifts of cash and other assets as re­
stricted support if they are received with donor stipulations that limit the use of 
the donated assets. When a donor restriction expires (that is, when a stipulated 
time restriction ends or a purpose restriction is accomplished), temporarily
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4 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue recog­
nition and includes a sample disclosure in paragraph 37 of the SOP for material differences between 
an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is included 
in Appendix E to this Guide.
†† Does not include all disclosures common to all health care entities.
5 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade Re­
ceivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts.
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restricted net assets are reclassified as unrestricted net assets and reported 
in the statement of operations as net assets released from restrictions. Donor- 
restricted contributions whose restrictions are met within the same year as 
received are reflected as unrestricted contributions in the accompanying finan­
cial statements.
The CCRC reports gifts of property and equipment (or other long-lived assets) 
as unrestricted support unless explicit donor stipulations specify how the do­
nated assets must be used. Gifts of long-lived assets with explicit restrictions 
that specify how the assets are to be used and gifts of cash or other assets that 
must be used to acquire long-lived assets are reported as restricted support. 
Absent explicit donor stipulations about how long those long-lived assets must 
be maintained, the CCRC reports expirations of donor restrictions when the 
donated or acquired long-lived assets are placed in service.
Income taxes. The CCRC has been recognized by the Internal Revenue Ser­
vice as a not-for-profit corporation as described in Sec. 501(c)(3) of the Internal 
Revenue Code (IRC) and is exempt from federal income taxes pursuant to Sec. 
501(a) of the IRC.
Property and equipment. Property and equipment are stated at cost. Donated 
property is recorded at its estimated fair value at the date of receipt. Deprecia­
tion is computed on the straight-line method based on the following estimated 
useful lives:
Land improvements 20 years
Buildings and improvements 40 years
Furniture and equipment 5-15 years
Operating income (loss). The statement of operations includes operating in­
come (loss). Changes in unrestricted net assets which are excluded from oper­
ating income (loss), consistent with industry practice, include unrealized gains 
and losses on investments other than trading securities, permanent transfers 
of assets to and from affiliates for other than goods and services, and contribu­
tions of long-lived assets (including assets acquired using contributions which 
by donor restriction were to be used for the purposes of acquiring such assets).
2. Property and Equipment
A summary of property and equipment at December 31, 20X5 and 20X4, 
follows:
20X5 20X4
Land $ 557,000 $ 557,000
Land improvements 205,000 203,000
Buildings and improvements 14,573,000 14,564,000
Furniture and equipment 752,000 698,000
16,087,000 16,022,000
Less accumulated depreciation (1,194,000) (742,000)
$14,893,000 $15,280,000
3. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:
20X5 20X4
Purchase of equipment $169,000 $152,000
Charity care 142,000 142,000
$311,000 $294,000
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Net assets were released from donor restrictions by incurring expenses sat­
isfying the restricted purposes or by occurrence of other events specified by 
donors:
Health Care Organizations
20X5 20X4
Charity care $24,000 $50,000
Purchase of equipment $25,000 $45,000
4. Permanently Restricted Net Assets
Permanently restricted net assets are restricted to investment in 
the income from which is expendable to support:
perpetuity,
20X5 20X4
Charity care $168,000 $168,000
Community activities 283,000 216.000
5. Long-Term Debt
$451,000 $384,000
Long-term debt at December 31, 20X5 and 20X4, is as follows:
20X5 20X4
10.75 percent mortgage note payable $8,901,000 $8,965,000
Notes payable to bank—unsecured 34,000 14,000
Other 26,000 33.000
8,961,000 9,012,000
Less current maturities 90,000 77.000
$8,871,000 $8,935,000
The mortgage note is payable in consecutive monthly installments of princi­
pal and interest of $85,425 to May 20XX. The note is collateralized by a first 
mortgage on property and equipment with a depreciated cost at December 31, 
20X5, of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, the CCRC established an initial 
debt service reserve fund of $1,000,000 at April 15, 20X3. All resident fees re­
ceived thereafter, net of resident fee refunds and debt service payments not to 
exceed $300,000 annually in the first four years and $200,000 annually there­
after, are to be added to the debt service reserve fund until the total sum of 
$2,050,000 is accumulated. Since June 1, 20X4, the CCRC has been required 
to deliver to the trustee $5,500 per month to establish maintenance reserves 
until the aggregate of such payments equals a residential unit reserve and a 
health care center reserve of $240,000 and $90,000, respectively. At December 
31, 20X5 and 20X4, the trustee held investments aggregating $2,130,000 and 
$1,753,000, respectively. Such amount has been classified as assets limited as 
to use.
Scheduled annual principal maturities of long-term debt for the next five years 
are as follows:
Year Ending December 31, Amount
20X6 $90,000
20X7 90,000
20X8 95,000
20X9 105,000
20Y0 105,000
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Program activities 
General and administrative
20X5 20X4
3,368,000 3,135,000
593,000 570,000
$3,961,000 $3,705,000
7. Assets Limited as to Use**
8. Risks and Uncertainties Disclosures**
9. Pension Plan**
10. Postretirement Benefits**
11. Fair Values of Financial Instruments*
12. Concentrations of Credit Risk**
13. Investments**
* See footnote ** in Note "8. Risks and Uncertainties Disclosures” to "Illustrative Financial 
Statements for a Nursing Home."
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Sample Not-for-Profit Home Health Agency 
Balance Sheets 
December 31, 20X5 and 20X4
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20X5 20X4
Assets
Current assets:
Cash and cash equivalents $ 74,000 $41,000
Investments 147,000 137,000
Accounts receivable, net of allowance for 
doubtful accounts of $61,000 in 20X5 and
$30,000 in 20X4 752,000 476,000
Other receivables 27,000 22,000
Total current assets 1,000,000 676,000
Investments 100,000 100,000
Equipment:
Medical and office equipment 56,000 39,000
Vehicles 50,000 37,000
106,000 76,000
Less accumulated depreciation (45,000) (24,000)
Equipment, net 61,000 52,000
Deferred finance charges, net of accumulated 
amortization of $15,000 in 20X5 and $10,000
in 20X4 20,000 25,000
Total assets $1,181,000 $853,000
Liabilities and Net Assets
Current liabilities:
Current maturities of long-term debt $ 13,000 $13,000
Accounts payable 40,000 21,000
Accrued payroll and vacation costs 496,000 352,000
Estimated third-party payor settlements 28,000 31,000
Advances from third-party payors 70,000 66,000
Total current liabilities 647,000 483,000
Long-term debt, less current maturities 105,000 118,000
Total liabilities 752,000 601,000
Net assets:
Unrestricted 330,000 167,000
Temporarily restricted 9,000 5,000
Permanently restricted 90,000 80,000
Total net assets 429,000 252,000
Total liabilities and net assets $1,181,000 $853,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency 
Statements of Operations 
Years Ended December 31, 20X5 and 20X4
2 5 3
FORMAT A
20X5 20X4
Revenue, gains, and other support;
Net patient service revenue $4,042,000 $2,687,000
Contributions 5,000 22,000
Net assets released from restrictions 5,000 —
Investment income 13,000 6,000
Other revenue 27,000 32,000
Total revenue, gains, and other support 4,092,000 2,747,000
Expenses;
Salaries and benefits 2,714,000 1,835,000
Medical supplies and drugs 1,042,000 675,000
Insurance and other 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses 3,929,000 2,648,000
Excess of revenue over expenses and change in
unrestricted net assets $ 163.000 $ 99.000
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency 
Statements of Operations 
Years Ended December 31, 20X5 and 20X4
FORMAT B
20X5 20X4
Revenue, gains, and other support;
Net patient service revenue $4,042,000 $2,687,000
Contributions 5,000 22,000
Net assets released from restrictions 5,000 —
Other revenue 27,000 32,000
Total revenue, gains, and other support 4,079,000 2,741,000
Expenses:
Salaries and benefits 2,714,000 1,835,000
Medical supplies and drugs 1,042,000 675,000
Insurance and other 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses 3,929,000 2,648,000
Operating income 150,000 93,000
Other income:
Investment income 13,000 6,000
Excess of revenue over expenses and change in
unrestricted net assets $ 163,000 $ 99,000
See accompanying notes to financial statements.
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Years Ended December 31, 20X5 and 20X4
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20X5 20X4
Unrestricted net assets:
Excess of revenue over expenses $163,000 $99,000
Increase in unrestricted net assets 163,000 99,000
Temporarily restricted net assets:
Contributions 9,000 5,000
Net assets released from restrictions (5,000) —
Increase in temporarily restricted net assets 4,000 5,000
Permanently restricted net assets:
Contributions 10,000 6,000
Increase in permanently restricted net assets 10,000 6,000
Increase in net assets 177,000 110,000
Net assets, beginning of year 252,000 142,000
Net assets, end of year $429,000 $252,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency 
Statements of Cash Flows 
Years Ended December 31, 20X5 and 20X4
Cash flows from operating activities:
Cash received from patients and third party 
payors
Other receipts from operations 
Cash paid to employees and suppliers 
Interest paid 
Nonoperating revenue 
Net cash provided by operating activities 
Cash flows from investing activities:
Purchase of equipment 
Purchase of investments 
Net cash used in investing activities 
Cash flows from financing activities:
Proceeds from contributions restricted for: 
Endowment
Other financing activities:
Payment of long-term debt 
Net cash provided by (used in) financing 
activities
Net increase in cash and cash equivalents 
Cash and cash equivalents, beginning of year 
Cash and cash equivalents, end of year
Reconciliation of change in net assets to net 
cash provided by operating activities:
Change in net assets
Adjustments to reconcile change in net assets to 
net cash provided by operating activities: 
Increase in permanently restricted net assets 
Provision for bad debts 
Depreciation
Amortization of deferred financing charges 
(Increase) decrease in:
Accounts receivable 
Other receivables 
Increase (decrease) in:
Accounts payable, accrued payroll, and 
vacation costs
Estimated third-party payor settlements 
Net cash provided by operating activities
See accompanying notes to financial statements.
20X5 20X4
$3,721,000 $2,542,000
22,000 32,000
(3,679,000) (2,541,000)
(11,000) (14,000)
23,000 22,000
76,000 41,000
(30,000) (19,000)
(10,000) (15,000)
(40,000) (34,000)
10,000 6,000
(13,000) —
(3,000) 6,000
33,000 13,000
41,000 28,000
$ 74,000 $ 41.000
$177,000 $110,000
(10,000) (6,000)
46,000 21,000
21,000 15,000
5,000 5,000
(322,000) (150,000)
(5,000) 4,000
163,000 38,000
1,000 4,000
$76,000 $41,000
AAG-HCO APP A
Sample Not-for-Profit Home Health Agency 
Notes to Financial Statements 
Years Ended December 31 , 20X5 and 20X4
1. Description of Organization and Summary of Significant Account­
ing Policies6
Organization. The Sample Home Health Agency (the Agency) was incorpo­
rated in 20X0 in New State as a not-for-profit corporation. The Agency provides 
health and supportive services to individuals at their homes, primarily in the 
New State area.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in 
highly liquid debt instruments with an original maturity of three months or less.
Investments. Investments, which consist of U.S. Treasury obligations, are 
measured at fair value in the balance sheet. Investment income (including 
realized gains and losses on investments, interest and dividends) is included in 
excess of revenues over expenses unless restricted by donor or law. Unrealized 
gains and losses on investments, if any, are excluded from excess of revenues 
over expenses.
Equipment. Equipment is recorded at cost. Depreciation is computed using 
the straight-line method over the estimated useful lives of the assets.
Deferred financing costs. Deferred financing costs are being amortized using 
the effective interest method over the term of the related financing agreement.
Donor restrictions. The Agency reports gifts of cash and other assets as re­
stricted support if they are received with donor stipulations that limit the use 
of the donated assets. When a donor restriction expires, that is, when a stipu­
lated time restriction ends or purpose restriction is accomplished, temporarily 
restricted net assets are reclassified as unrestricted net assets and reported 
in the statement of operations as net assets released from restrictions. When 
long-lived assets are placed in service, thus satisfying purpose restrictions, 
the amount is included as a change in net assets, restricted and unrestricted. 
Donor-restricted contributions whose restrictions are met within the same year 
as received are reflected as unrestricted contributions in the accompanying fi­
nancial statements.
The Agency reports gifts of equipment (or other long-lived assets) as unre­
stricted support unless explicit donor stipulations specify how the donated 
assets must be used. Gifts of long-lived assets with explicit restrictions that 
specify how the assets are to be used and gifts of cash or other assets that 
must be used to acquire long-lived assets are reported as restricted support. 
Absent explicit donor stipulations about how long those long-lived assets must
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6 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade Re­
ceivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts.
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be maintained, the Agency reports expirations of donor restrictions when the 
donated or acquired long-lived assets are placed in service.
Net patient service revenue. Net patient service revenue represents the esti­
mated net realizable amounts from patients, third-party payors, and others for 
services rendered.
Charity care. The Agency has a policy of providing charity care to patients 
who are unable to pay. Such patients are identified based on financial infor­
mation obtained from the patient and subsequent analysis. Since the Agency 
does not expect payment, estimated charges for charity care are not included 
in revenue.
Income taxes. The Agency has been recognized by the Internal Revenue Ser­
vice as a not-for-profit corporation as described in Sec. 501(c)(3) of the Internal 
Revenue Code (IRC) and is exempt from federal income taxes on related income 
pursuant to Sec. 501(a) of the IRC.
Excess of revenue over expenses. The statement of operations includes excess 
of revenue over expenses. Changes in unrestricted net assets which are excluded 
from excess of revenue over expenses, consistent with industry practice, include 
unrealized gains and losses on investments other than trading securities, per­
manent transfers of assets to and from affiliates for other than goods and ser­
vices, and contributions of long-lived assets (including assets acquired using 
contributions which by donor restriction were to be used for the purposes of 
acquiring such assets).
2. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes;
Charity care 
Purchase of equipment
20X5
$ —
9,000 
$9,000
20X4
$5,000
$5,000
Net assets were released from donor restrictions by incurring expenses sat­
isfying the restricted purposes or by occurrence of other events specified by 
donors:
Charity care expenditures
20X5
$5.000
20X4 
$ -
3. Permanently Restricted Net Assets
Permanently restricted net assets are restricted in perpetuity, the income from 
which is expendable to support:
Program A activities 
Any activities of the Agency
20X5
$10,000
80,000
$90,000
20X4
$ —
80,000 
$80,000
4. Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 20X5 and 37 percent in 20X4 of net patient 
service revenue was derived under federal and state third-party reimbursement
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programs. These revenues are based, in part, on cost reimbursement principles 
and are subject to audit and retroactive adjustment by the respective third- 
party fiscal intermediaries. Laws and regulations governing these programs are 
extremely complex and subject to interpretation. As a result, there is at least a 
reasonable possibility that recorded estimates will change by a material amount 
in the near term. The 20X5 net patient service revenue increased approximately 
$XXX due to removal of allowances previously estimated that are no longer 
necessary as a result of final settlements and years that are no longer subject 
to audits, reviews, and investigations. The 20X4 net patient service revenue 
decreased approximately $XXX due to prior-year retroactive adjustments in 
excess of amounts previously estimated.
5. Internally-Designated Assets
The Board of Directors has designated investments aggregating $100,000 to 
be used for future major capital improvements. Those assets are classified in 
the balance sheet as long-term investments.
6. Long-Term Debt
Long-term debt at December 31, 20X5 and 20X4, is as follows:
Note payable to bank, interest at 15 percent, 
payable in monthly installments of $2,200 per 
month, including interest, collateralized by 
equipment with a depreciated cost of $42,000 
Less current maturities
20X5
$118,000
13,000
$105,000
20X4
$131,000
13,000
$118.000
Scheduled maturities of long-term debt at December 31, 20X5, are as follows:
AmountYear Ending December 31,
20X6
20X7
20X8
20X9
20Y0
Thereafter
Total
$13,000
13,000
13,000
13,000
13,000
53,000 
$118,000
7. Classification of Expenses
Program
Total A B C Administrative
Expenses incurred for the
year ended December
31, 20X5, were for:
Salaries and benefits $2,714,000 $1,363,000 $699,000 $363,000 $289,000
Medical supplies and
drugs 1,042,000 511,000 246,000 285,000
Insurance and other 90,000 58,000 32,000
Provision for bad debts 46,000 16,000 30,000
Depreciation 21,000 5,000 16,000
Interest 16.000 10,000 3,000 3.000
Total expenses $3,929,000 $1,963,000 $978,000 $648,000 $340,000
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Total A B
General and 
Administrative
Expenses incurred for the 
year ended December 
31, 20X4, were for;
Salaries and benefits $1,835,000 $ 915,000 $463,000 $216,000 $241,000
Medical supplies and
drugs 675,000 335,000 211,000 129,000
Insurance and other 83,000 64,000 19,000
Provision for bad debts 21,000 21,000
Depreciation 15,000 6,000 9,000
Interest 19,000 12.000 5,000 2.000
Total expenses $2,648,000 $1,353,000 $679,000 $345,000 $271,000
(The preparer of the financial statements may wish to include a brief descrip­
tion of the types of programs.)
8. Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in 
20X5 and 20X4, respectively.
9. Risks and Uncertainties Disclosures**
10. Pension Plan**
11. Postretirement Benefits**
12. Fair Value of Financial Statements**
13. Concentrations of Credit Risk**
14. Investments**
** See footnote ** in Note "8. Risks and Uncertainties Disclosures" to "Illustrative Financial 
Statements for a Nursing Home."
AAG-HCO APP A
ILLUSTRATIVE FINANCIAL STATEMENTS FOR A
HEALTH MAINTENANCE ORGANIZATION
Sample Not-for-Profit Health Maintenance Organization 
Balance Sheets 
June 30, 20X5 and 20X4
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20X5 20X4
Assets
Current assets:
Cash and cash equivalents $2,937,000 $1,021,000
Premiums receivable, net of allowance for 
doubtful accounts of $36,000 in 20X5 and
$42,000 in 20X4 358,000 407,000
Other receivables 263,000 261,000
Supplies 190,000 184,000
Prepaid expenses 197,000 99,000
Total current assets 3,945,000 1,972,000
Property and equipment, net 5,756,000 5,626,000
State guaranty fund deposit 150,000 150,000
Debt issuance costs, net of accumulated 
amortization of $42,000 in 20X5 and $39,000
in 20X4 18,000 21,000
Total assets $9,869,000 $7,769,000
Liabilities and Net Assets
Current liabilities:
Unsecured 12 percent note payable to a bank $ — $ 44,000
Current maturities of long-term debt 241,000 109,000
Accounts payable—medical services 2,245,000 1,471,000
Other accounts payable and accrued expenses 829,000 661,000
Unearned premium revenue 141,000 202,000
Total current liabilities 3,456,000 2,487,000
Long-term debt, less current maturities 4,295,000 2,382,000
Total liabilities 7,751,000 4,869,000
Net assets—unrestricted 2,118,000 2,900,000
Total liabilities and net assets $9,869,000 $7,769,000
See accompanying notes to financial statements.
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Statements of Operations and Changes in Net Assets 
Years Ended June 30, 20X5 and 20X4
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20X5 20X4
Revenue:
Premiums earned $27,682,000 $22,500,000
Coinsurance 689,000 500,000
Interest and other income 242,000 100,000
Total revenue 28,613,000 23,100,000
Expenses:
Salaries and benefits 16,154,000 13,328,000
Medical supplies and drugs 8,507,000 5,988,000
Insurance 3,963,000 2,463,000
Provision for bad debts 19,000 20,000
Depreciation 367,000 336,000
Interest 385,000 375,000
Total expenses 29,395,000 22,510,000
Operating income (loss) (782,000) 590,000
Net assets, beginning of year 2,900,000 2,310,000
Net assets, end of year $2,118,000 $2,900,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization 
Statements of Cash Flows 
Years Ended June 30, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities:
Cash received from premiums, stop-loss 
insurance recoveries, and coinsurance 
Cash paid to employees and to providers of 
health care services 
Interest and other income received 
Interest paid
Net cash provided by operating activities 
Cash flows from investing activities:
Capital expenditures 
Net cash used in investing activities 
Cash flows from financing activities:
Proceeds from long-term debt 
Principal payments on long-term debt 
Principal payments on note payable 
Net cash provided by (used in) financing 
activities
Net increase in cash and cash equivalents 
Cash and cash equivalents, beginning of year 
Cash and cash equivalents, end of year 
Reconciliation of change in net assets to net 
cash provided by operating activities:
Change in net assets 
Adjustments to reconcile change in net 
assets to net cash provided by operating 
activities:
Depreciation and amortization 
Provision for bad debts 
(Increase) decrease in:
Premiums receivables 
Other current assets 
Increase (decrease) in:
Accounts payable—medical services 
Other accounts payable and accrued 
expenses
Unearned premium revenue
Net cash provided by operating activities
See accompanying notes to financial statements.
$28,969,000 $24,410,000
(28,405,000)
230,000
(382,000)
412,000
(497,000)
(497,000)
2,300,000
(255,000) 
(44,000)
2,001,000
1,916,000
1,021,000
$2,937,000
$(782,000)
370,000
19,000
30,000
230,000
774,000
(168,000) 
(61,000) 
$ 412.000
(22,818,000)
90,000
(372,000) 
1,310,000
( 121,000) 
( 121,000)
( 1,000,000)
( 1,000 ,000)
189,000
832,000 
$ 1,021,000
$ 590,000
339,000
20,000
64,000
(93,000)
335,000
(60,000)
115,000 
$1,310,000
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Sample Not-for-Profit Health Maintenance Organization  
Notes to Financial Statements7
June 3 0 , 20X5 and 20X4
1. Organization
The Sample Health Maintenance Organization (the HMO) was incorporated 
in 20X0 in New State as a not-for-profit corporation for the purpose of providing 
comprehensive health care services on a prepaid basis and for the purpose 
of establishing and operating organized health maintenance and health care 
delivery systems.
The HMO has been determined to be a qualified health maintenance organi­
zation under Title XIII of the Public Health Service Act.
2. Summary of Significant Accounting Policies8
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months or 
less.
Supplies. Inventories of drugs and other supplies are stated at the lower of 
cost (first-in, first-out) or market.
Property and equipment. Property and equipment are recorded at cost. Main­
tenance and repairs are charged to expense, and betterments are capital­
ized. Property and equipment costing approximately $700,000 was financed by 
health maintenance organization initial development grants received in 20X1 
and 20X2 from the U.S. Department of Health and Human Services (HHS). This 
property will be owned by the HMO as long as the equipment and facilities are 
used for projects related to the objectives of the Public Health Service Act.
Depreciation is computed using the straight-line method over the estimated 
useful lives of the related assets as follows:
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Building
Improvements
Data processing and laboratory 
equipment and automobiles 
Medical equipment 
Office equipment
40 years 
20-25 years
3-7 years 
10 years 
5-10 years
7 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue recog­
nition and includes a sample disclosure in paragraph 37 of the SOP for material differences between 
an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is included 
in Appendix E to this Guide.
8 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade Re­
ceivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts.
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Amortization of debt issuance costs. Debt issuance costs are deferred and 
amortized using the effective interest method over the term of the related debt.
Health care service cost recognition. The HMO contracts with various health 
care providers for the provision of certain medical care services to its members. 
The HMO compensates these providers on a capitation basis. As part of a cost 
control incentive program, the HMO retains up to 20 percent of the capitation 
as a risk-sharing fund. In the event of hospital utilization in excess of bud­
get, those providers bear the risk to the extent of 15 percent of the capitation 
fee. Operating expenses include all amounts incurred by the HMO under the 
aforementioned contracts.
The cost of other health care services provided or contracted for is accrued 
in the period in which it is provided to a member based in part on estimates, 
including an accrual for medical services provided but not reported to the HMO.
Premiums revenue. Membership contracts are on a yearly basis subject to 
cancellation by the employer group or the HMO upon 30 days written notice. 
Premiums are due monthly and are recognized as revenue during the period in 
which the HMO is obligated to provide services to members.
Reinsurance (stop-loss insurance). Reinsurance premiums are reported as 
health care costs, and reinsurance recoveries are reported as a reduction of 
related health care costs.
Federal income tax. The HMO is exempt from federal income taxes under 
Sec. 501(c)(4) of the Internal Revenue Code; accordingly, no provision for federal 
income taxes has been made in the accompanying financial statements.
3.  Property and Equipment
Property and equipment at June 30, 20X5 and 20X4, consists of the following:
Land
Buildings and improvements 
Furniture and equipment
Less accumulated depreciation
20X5
$ 300,000
5,473,000
1,786,000
7,559,000 
(1,803,000) 
$5,756,000
20X4
$ 300,000
5,459,000
1,303,000
7,062,000 
(1,436,000) 
$5,626,000
4.  Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost of 
$4,943,000. A summary of long-term debt at June 30, 20X5 and 20X4, follows.
20X5 20X4
HHS loan, interest at 7.5 percent, payable in 
monthly installments of $50,000, including 
interest
HHS loan, interest at 9.25 percent, payable in 
monthly installments of $10,000, including 
interest
Secured equipment loans, payable in monthly 
installments of $15,000, including interest
Less current maturities
$2,020,000 $ 111,000
1,658,000 1,694,000
858,000 
4,536,000
241,000 
$4,295,000
686,000
2,491,000
109,000
$2.382.000
AAG-HCO APP A
266 Health Care Organizations
Scheduled principal payments on long-term debt are as follows:
Year Ending December 31,
20X6
20X7
20X8
20X9
20Y0
Amount
$ 241,000
259,000
280,000 
800,000
2,956,000
$4,536,000
5. State Guarantee Fund Deposit
In August 20X4 the state in which the HMO is domiciled enacted legislation 
specifically governing HMOs. Under this legislation, the corporation is required 
to maintain a deposit of $150,000 with the director of the division of insurance 
of the state.
6. Employee Retirement Plan
The HMO has a contributory defined contribution retirement plan covering 
substantially all employees. Expense determined in accordance with the plan 
formula (4 percent to 10 percent of eligible covered compensation) was $354,000 
and $275,000 for the years ended June 30, 20X5 and 20X4, respectively.
7. Stop-Loss Insurance
The HMO entered into a stop-loss insurance agreement with an insurance 
company to limit its losses on individual claims. Under the terms of this agree­
ment, the insurance company will reimburse the HMO approximately 25 per­
cent of the cost of each member's annual hospital services, in excess of a $1,000 
deductible, up to a lifetime limitation of $500,000 per member. In the event 
the HMO ceases operations, (a) plan benefits will continue for members who 
are confined in an acute care hospital on the date of insolvency until their dis­
charge, and (b) plan benefits will continue for any other member until the end 
of the contract period for which premiums have been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are 
included in insurance expense (Note 9) in 20X5 and 20X4, respectively. Approx­
imately $600,000 and $400,000 in stop-loss insurance recoveries are deducted 
from insurance expense in 20X5 and 20X4, respectively.
Included in other receivables is approximately $50,000 recoverable from
8. Malpractice Claims
Malpractice claims have been asserted against the HMO by various claimants. 
The claims are in various stages of processing, and some may ultimately be 
brought to trial. In the opinion of counsel, the outcome of these actions will not 
have a significant effect on the financial position or the operating income of the 
HMO. Incidents occurring through June 30, 20X5, may result in the assertion 
of additional claims. Other claims may be asserted arising from past services 
provided. Management believes that these claims, if asserted, would be settled 
within the limits of insurance coverage.
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Program activities 
General and administrative
20X5
26,921,000
2,474,000
$29,395,000
20X4
20,909,000
1.601.000
$22,510,000
10. Risks and Uncertainties Disclosures
11. Pension Plan**
12. Postretirement Benefits**
13. Fair Value of Financial Instruments**
14. Concentrations of Credit Risk**
* See footnote ** in Note "8. Risks and Uncertainties Disclosures" to "Illustrative Financial 
Statements for a Nursing Home."
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR AN
AMBULATORY CARE ORGANIZATION
Sample Not-for-Profit Ambulatory Care, Inc. 
Balance Sheets 
December 31, 20X5 and 20X4
Health Care Organizations
20X5 20X4
Assets
Current assets:
Cash $ 65,000 $ 76,000
Patient accounts receivable, net of allowance 
for doubtful accounts of $15,000 in 20X5 and
$5,000 in 20X4 290,000 278,000
Estimated retroactive
adjustments—third-party payors 19,000 32,000
Accounts receivable—other 13,000 8,000
Supplies 21,000 18,000
Prepaid expenses and deposits 5.000 9,000
Total current assets 413.000 421,000
Property and equipment, at cost:
Land 100,000 100,000
Land improvements 322,000 322,000
Buildings 682,000 682,000
Equipment 1.390.000 1,389,000
2,494,000 2,493,000
Less accumulated depreciation 217.000 100,000
Property and equipment, net 2.277.000 2,393,000
Other assets:
Advances receivable 14,000 5,000
Total assets $2,704,000 $2,819,000
Liabilities and Net Assets
Current liabilities:
Notes payable $ 138,000 $ 144,000
Accounts payable 42,000 77,000
Accrued payroll, benefits, and taxes 33,000 22,000
Estimated retroactive
adjustments—third-party payors 30,000 24,000
Financing advance from third-party payors — 1,000
Total current liabilities 243,000 268,000
Guarantee liability 10,000 10,000
Total liabilities 253,000 278,000
Net assets—unrestricted 2,451,000 2,541,000
Total liabilities and net assets $2,704,000 $2,819,000
See accompanying notes to financial statements.
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Statements of Operations and Changes in Net Assets 
Years Ended December 31, 20X5 and 20X4
Illustrative Financial Statements 269
20X5 20X4
Revenue and gains:
Net patient service revenue $ 860,000 $ 357,000
Other 29,000 15,000
Total revenue and gains 889,000 372,000
Expenses:
Salaries and benefits 485,000 243,000
Medical supplies and drugs 189,000 66,000
Insurance 154,000 98,000
Provision for bad debts 14,000 4,000
Depreciation 117,000 100,000
Interest 20,000 18,000
Total expenses 979,000 529,000
Operating loss (90,000) (157,000)
Net assets, beginning of year 2,541,000 2,698,000
Net assets, end of year $2,451,000 $2,541,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Ambulatory Care, Inc. 
Statements of Cash Flows 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities:
Cash received from patients and third-party 
payors
Cash received from others 
Interest received 
Interest paid
Cash paid to employees and suppliers 
Net cash provided by (used in) operating 
activities
Cash flows from investing activities:
Purchase of equipment 
Advances made to XYZ Affiliate
Net cash used in investing activities 
Cash flows from fi nancing activities:
Proceeds from notes payable 
Payments on notes payable 
Net cash provided by (used in) fi nancing 
activities
Net increase (decrease) in cash
Cash, beginning of year
Cash, end of year
Reconciliation of change in net assets to net 
cash provided by (used in) operating 
activities:
Change in net assets
Adjustments to reconcile change in net assets 
to net cash provided by (used in) operating 
activities:
Depreciation 
Provision for bad debts 
(Increase) decrease in:
Patient accounts receivable 
Other current assets 
Increase (decrease) in:
Accounts payable and accrued payroll, 
benefits, and taxes 
Other current liabilities 
Net cash provided by (used in) operating 
activities
See accompanying notes to financial statements.
$866,000
21,000
3,000
(15,000) 
(870,000)
5,000
( 1,000)
(9,000)
( 10,000)
(6 ,000)
(6 ,000)
( 11,000)
76,000
$65,000
117,000
14,000
( 12,000)
1,000
(24,000)
( 1,000)
$368,000
6,000
11,000
(16,000)
(432,000)
(63,000)
(4,000)
(5,000)
(9,000)
144,000
144,000
72,000
4,000
$76,000
$ (90,000) $(157,000)
100,000
4,000
(19,000)
(2 ,000)
10,000
1,000
$ 5,000 $(63,000)
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Sample Not-for-Profit Ambulatory Care, Inc.
Notes to Financial Statements 
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Account­
ing Policies9
Organization. Ambulatory Care, Inc. was incorporated on September 7, 20X3, 
in New State, to operate an ambulatory care health facility to treat or prevent 
injury and disease, to provide funds or to expend funds to further the treatment 
or prevention of injury or disease, and to develop and participate in activities 
designed to promote the general health of the community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and 
GHI Hospital—entered into a members' agreement to develop this ambula­
tory care center. In accordance with this agreement, each hospital contributed 
capital of $947,000 to Ambulatory Care, Inc. Ambulatory Care, Inc. began op­
erations in October 20X3.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Supplies. Supplies are stated at the lower of cost (first-in, first-out) or net 
realizable value.
Depreciation. Depreciation of property and equipment is computed on the 
straight-line method over the estimated lives of depreciable assets.
Third-party contractual adjustments. Retroactively calculated third-party 
contractual adjustments are accrued on an estimated basis in the period the re­
lated services are rendered. Net patient service revenue is adjusted as required 
in subsequent periods based on final settlements.
Net patient service revenue. Patient service revenue is reported at the esti­
mated net realizable amounts from patients, third-party payors, and others for 
services rendered.
Charity care. Ambulatory Care, Inc. has a policy of providing charity care to 
patients who are unable to pay. Such patients are identified and related charges 
are estimated, based on financial information obtained from the patient and 
subsequent analysis. Since management does not expect payment for charity 
care, the estimated charges are excluded from revenue.
Income taxes. Ambulatory Care, Inc. has been recognized by the Internal 
Revenue Service as a not-for-profit corporation as described in Sec. 501(c)(3) of 
the Internal Revenue Code (IRC) and is exempt from federal income taxes on 
related income pursuant to Sec. 501(a) of the IRC.
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9 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade Re­
ceivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts.
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2. Advances Receivable
In May 20X4, Ambulatory Care, Inc. entered into a five-year agreement with 
XYZ Affiliates (XYZ). Under this agreement, XYZ is to provide emergency med­
ical services as well as charge and bill each patient treated at Ambulatory Care, 
Inc. Ambulatory Care, Inc. has guaranteed that XYZ will collect at least $18,000 
per month during the term of this agreement. In any month in which XYZ does 
not collect the minimum guarantee, Ambulatory Care, Inc. advances funds to 
XYZ to cover the deficiency. Such advances are to be repaid to the extent XYZ's 
net cash collections exceed the minimum guarantee amount. Management es­
timates that the advances will be fully recovered in 20X8.
3. Related-Party Transactions
During 20X3, Ambulatory Care, Inc. entered into a contract with one of the 
member hospitals (the managing hospital) for the management of the business 
and affairs of Ambulatory Care, Inc. Under this agreement, Ambulatory Care, 
Inc. pays $4,000 per month to the managing hospital. The agreement with the 
managing hospital was to remain in effect through December 31, 20X5, but has 
been extended on a month-to-month basis.
In addition, during 20X4 each hospital loaned $48,000 to Ambulatory Care, 
Inc. in the form of promissory notes at an interest rate of prime rate plus 1 per­
cent (effective rates of 10 percent and 9 percent in 20X5 and 20X4, respectively). 
Of the total $144,000 liability, $48,000 is payable on demand after November 
28, 20X5, to one member hospital, with the remaining portion ($96,000) payable 
on demand after December 8, 20X5, to the other two member hospitals. Dur­
ing 20X5, Ambulatory Care, Inc. paid $2,000 to each member hospital, thereby 
reducing the obligation to $138,000.
4. Revenue From Contracting Agencies
Ambulatory Care, Inc. participates as a provider of health care services to 
Blue Cross, Medicare, and County Indigent Plan patients. Reimbursement for 
covered services is based on tentative payment rates. Final reimbursement is 
determined after submission of annual cost reports and audits thereof by the 
fiscal intermediaries. Provisions for estimated reimbursement adjustments are 
reported in the financial statements in the period that the services are rendered.
Revenue from the Medicare program accounted for approximately XX percent 
for the year ended 20X5, and XX percent for the year ended 20X4, of Ambulatory 
Care, Inc.'s net patient revenue. Laws and regulations governing the Medicare 
program are extremely complex and subject to interpretation. As a result, there 
is at least a reasonable possibility that recorded estimates will change by a ma­
terial amount in the near term. The 20X5 net patient service revenue increased 
approximately $XXX due to removal of allowances previously estimated that 
are no longer necessary as a result of final settlements and years that are 
no longer subject to audits, reviews, and investigations. The 20X4 net patient 
service revenue decreased approximately $XXX due to prior-year retroactive 
adjustments in excess of amounts previously estimated.
5. Charity Care
Ambulatory Care, Inc. has a policy of providing charity care to indigent pa­
tients in emergency situations. These services, which are excluded from rev­
enues, amounted to $27,000 and $13,000 in 20X5 and 20X4, respectively, when 
measured at Ambulatory Care, Inc.'s established rates.
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Program
Total A B C Administrative
Expenses incurred for 
the year ended 
December 31, 20X5, 
were for:
Salaries and benefits $485,000 $216,000 $102,000 $121,000 $46,000
Medical supplies and
drugs 189,000 98,000 43,000 48,000 —
Insurance 154,000 79,000 45,000 14,000 16,000
Provision for bad debts 14,000 9,000 — 5,000 —
Depreciation 117,000 100,000 — 17,000 —
Interest 20.000 9.000 — — 11.000
Total expenses $979,000 $511,000 $190,000 $205,000 $73,000
Total A
Program
B C
General and 
Administrative
Expenses incurred for the 
year ended December 
31, 20X4, were for;
Salaries and benefits $243,000 $111,000 $46,000 $57,000 $29,000
Medical supplies and 
drugs 66,000 31,000 15,000 20,000
—
Insurance 98,000 45,000 19,000 26,000 8,000
Provision for bad debts 4,000 — 4,000 — —
Depreciation 100,000 56,000 — 44,000 —
Interest 18.000 7.000 — — 11.000
Total expenses $529,000 $250,000 $84,000 $147,000 $48,000
(The preparer of the financial statements may wish to include a brief descrip­
tion of the types of programs.)
7. Risks and Uncertainties Disclosures**
8. Pension Plan**
9. Postretirement Benefits**
10. Fair Value of Financial Instruments**
11. Concentrations of Credit Risk**
See footnote ** in Note "8. Risks and Uncertainties Disclosures" to "Illustrative Financial 
Statements for a Nursing Home."
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Appendix B
Background Information and Basis 
for Conclusions
1. This Appendix provides background information and discusses the com­
ments received on the April 14, 1995 exposure draft that preceded this Audit 
and Accounting Guide (Guide)—Proposed Audit and Accounting Guide Health 
Care Organizations and the basis for key conclusions in this Guide.
Background Information
2. In 1989, the AICPA Health Care Committee ("the Committee") com­
pleted a total rewrite of the Guide. Since then, conforming changes have been 
made to update the Guide for newly issued technical pronouncements. In June 
1993, the FASB issued FASB Statement No. 116, Accounting for Contribu­
tions Received and Contributions Made ("Contributions"), and FASB Statement 
No. 117, Financial Statements of Not-for-Profit Organizations ("Display"). These 
Statements provide broad standards and introduce new concepts for which 
there is no detailed implementation guidance. FASB Statement No. 117 permits 
the AICPA to provide more specific reporting guidance. Specifically, paragraph 
3 of FASB Statement No. 117 states:
"Within the parameters of the Statement, the AICPA or another ap­
propriate body, following the process described in AICPA Statement 
of Auditing Standards (SAS) No. 69, The Meaning of Present Fairly 
in Conformity With Generally Accepted Accounting Principles, may 
provide more specific reporting guidance for certain not-for-profit or­
ganizations."
The Guide provides this guidance as it relates to providers of health care ser­
vices.
3. In April 1995, the Committee released an exposure draft of a proposed 
Audit and Accounting Guide Health Care Organizations (ED) for public com­
ment. The committees received 40 comment letters on the ED. The committees 
redeliberated the issues based on the comments received. This appendix dis­
cusses the key issues in the ED and comments received on those issues, as well 
as the basis for AcSEC's conclusions on those and certain other issues.
Basis for Conclusions
Contributions and Display
4. FASB Statements No. 116 and No. 117 allow more flexibility in finan­
cial reporting than currently exists within the health care industry. The most 
prominent flexibility relates to the elimination of the requirements to present 
a classified balance sheet and income statement as compared to the statement 
of activities.
5. FASB Statements No. 116 and No. 117 apply to all not-for-profit enter­
prises, regardless of whether or not the entity is a business enterprise. The 
majority of tax-exempt health care organizations, however, operate as business 
enterprises (i.e., are essentially self-sustaining from fees charged for goods and
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services). The Committee believes that the uniformity and usefulness of finan­
cial reporting for business enterprise organizations would be enhanced if the 
implementation guidance for FASB Statements No. 116 and No. 117 were con­
sistent with the objectives of business enterprise financial reporting. The Com­
mittee points to the provisions in FASB Concept Statement No. 4, paragraph 
8, which clearly supports the use of business enterprise financial reporting ob­
jectives for those organizations:
"Some organizations have no ownership interest but are essentially 
self-sustaining from fees they charge for goods and services. Exam­
ples are those private nonprofit hospitals...that may receive relatively 
small amounts of contributions and grants, but finance their capital 
needs largely from the proceeds of debt issues and their operating 
needs largely from service charges rather than from private philan­
thropy or governmental grants. As a result, assessments of amounts, 
timing, and uncertainty of cash flows become the dominate interest of 
their creditors and other resource providers and profitability becomes 
an important indicator of performance. Consequently, the objectives 
of Concepts Statement 1 may be more appropriate for those organiza­
tions."
6. Based on the theoretical support provided in FASB Concepts State­
ment No. 4, as well as the FASB allowance for more specific guidance (see 
paragraph 2 of this Appendix), Chapter 1 of the Guide defines four types of oper­
ating structures that are found within the industry: (1) not-for-profit business- 
oriented organizations, (2) investor-owned health care enterprises, (3) govern­
mental health care organizations, and (4) not-for-profit, nonbusiness-oriented 
organizations. This Guide provides specific reporting guidance for not-for-profit 
business-oriented organizations, investor-owned enterprises and governmental 
entities. (Not-for-profit nonbusiness organizations follow guidance for not-for- 
profit entities provided in the Audit and Accounting Guide Not-for-Profit Or­
ganizations.) The Guide recommends that these entities provide a classified 
balance sheet and a statement of operations. The Guide also encourages nat­
ural class reporting on the face of the financial statements, with disclosure of 
functional details in the footnotes.
7. A number of respondents to the ED were concerned that because the 
exposure draft of the Guide did not require an entity to distinguish between 
operating activities and nonoperating activities that such distinctions were no 
longer permissible. In response to these concerns, the Guide was clarified to 
incorporate paragraph 23 of FASB Statement No. 117. This paragraph specif­
ically allows additional classifications within a statement of operations. Like 
FASB Statement No. 117, however, the Guide neither requires nor precludes 
such classifications.
Assets W hose Use is Limited
8. Several comments were received on the ED requesting specific guidance 
to allow internally designated funds to be disclosed on the face of the financial 
statements. In response to these comments, the Committee clarified the Guide 
to require cash and claims to cash that meet one of the following criteria to be 
reported separately and excluded from current assets:
a. restricted as to withdrawal or use for other than current operations,
b. designated for expenditure in the acquisition or construction of non- 
current assets,
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c. required to be segregated for the liquidation of long-term debts, or
d. required by a donor-imposed restriction that limits their use to long­
term purposes.
Consistent with comments received from a rating agency, the Guide requires in­
ternally designated funds to be reported separately from externally designated 
funds either in the notes to or on the face of the financial statements. The 
Committee believes this separation is beneficial due to the degree of control an 
organization maintains over internally designated funds.
Investments
9. Chapter 4, as presented in the Exposure Draft, was re-drafted to con­
form with the provisions of FASB Statement No. 124, Accounting for Certain 
Investments Held by Not-for-Profit Organizations. This Standard requires fair 
value accounting for marketable equity and debt securities. The majority of re­
spondents to the ED favored an income recognition approach similar to FASB 
Statement No. 115, Accounting for Certain Investments in Debt and Equity 
Securities. They believe such an approach is essential because it would foster 
greater consistency among not-for-profit and for-profit entities. Accordingly, an 
approach similar to FASB Statement No. 115 (i.e., the differentiation of trad­
ing securities vs. available-for-sale securities) was incorporated into the Guide. 
(The FASB specifically prohibited the use of a held-to-maturity category by 
not-for-profit organizations.)
Accounting for Donor-Imposed Restricted Contributions on 
Long-Lived Assets
10. The majority of comments received on accounting for donor-imposed 
restrictions on contributions of long-lived assets concurred with the Health 
Care Committee's conclusion that the expiration of donor imposed restrictions 
on long-lived assets should be recognized when the asset is placed in service 
(rather than as depreciated as permitted by FASB Statement No. 116). Other 
respondents disagreed with the Health Care Committee's position for various 
reasons. After considering each comment on the issue, the Committee concluded 
that it would maintain the position set forth in the ED. The Committee believes 
this approach is easier to implement, it provides for uniformity in reporting 
within the industry and, because the donations are excluded from operating 
results, an appropriate matching of revenues and expenses occurs.
Use of a  Perform ance Indicator
11. The Guide stresses the importance of the performance indicator and, in 
an effort to ensure consistency within the industry, provides specific guidance on 
what the performance indicator should represent. This guidance is consistent 
with performance criteria historically used in the health care industry, to the 
extent allowed under the provisions of FASB Statement No. 117. Specifically, 
the Guide states that health care organizations should report the results of 
their operations separately from—
a. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting 
entity, are controlled by the reporting entity, or are under common 
control with the reporting entity.
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c. Receipt of restricted contributions, including temporary restric­
tions (such as time or purpose) or permanent restrictions.
d. Contributions of (and assets released from donor restrictions re­
lated to) long-lived assets.
e. Unrealized gains and losses on investments not restricted by donors 
or by law, except for those investments classified as trading securi­
ties.
f. Investment returns restricted by donors or by law.
g. Other items that are required by GAAP to be reported separately 
(such as extraordinary items, the effect of discontinued operations, 
or the cumulative effect of accounting changes).1
12. In its deliberations, the FASB discussed the use of the word net income 
to describe the performance indicator of not-for-profit health care organizations. 
The Board concluded that the term net income is an inappropriate term to de­
scribe the performance indicator of a not-for-profit organization and that de­
scriptive terms such as revenues over expenses, revenues and gains over expenses 
and losses, earned income or performance earnings would be more appropriate. 
Accordingly, this Guide requires the use of such descriptive terms instead of net 
income to describe the performance indicator of not-for-profit organizations.
Definition of a Governmental Entity
13. Subsequent to the release of the ED, the FASB and the GASB agreed 
on the definition of a governmental entity. Paragraph 1.02 of the Guide incor­
porates that definition.
Effective Dote
14. Several comment letters were received expressing concern about the 
effective date of the Guide. In response to these comments, the Committee 
revised the effective date to fiscal years beginning after June 15, 1996, with 
earlier application permitted.
Status of Audit and Accounting Guides in the 
GAAP Hierarchy
15. In several instances the Guide provides more specific reporting require­
ments than FASB Statements No. 116 and No. 117 (see paragraphs 4 through 
6, 8, 10, and 11). In the deliberation of the Guide, the question has arisen re­
garding the status of the Guide in the GAAP hierarchy, given the fact that 
AICPA Audit and Accounting Guides are "Level B" GAAP while FASB State­
ments are "Level A." In discussing the issue the Committee and the Accounting 
Standards Executive Committee referred to paragraph 49 of FASB Statement 
No. 117, which states that the AICPA:
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1 Governmental enterprises should report extraordinary items and the effect of discontinued op­
erations in the statement of operations immediately preceding net income; the cumulative effect of an 
accounting change should be reported as an adjustment to beginning fund balance in the period of the 
change. Investor-owned enterprises should report extraordinary items, the effect of discontinued oper­
ations and the cumulative effect of an accounting change in the statement of operations immediately 
preceding net income.
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"may provide more specific reporting guidance for certain not-for profit 
organizations. SAS 69 requires that an entity adopt cleared AICPA 
Industry Audit and Accounting Guides, and cleared AICPA Statements 
of Position that become effective after March 15, 1992. As used in SAS 
69, cleared means that the FASB has indicated that it does not object 
to the issuance of the proposed pronouncement."
The FASB has indicated that it does not object to the more specific reporting 
requirements contained in this Guide for health care organizations.
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Appendix C
Statement of Position 98-2, 
Accounting for Costs of 
Activities of Not-for-Profit 
Organizations and State and 
Local Governmental Entities 
That Include Fund Raising
March 11 , 1998
Amendment to
AICPA Audit and Accounting Guides 
H ealth Care O rganizations,
Not-for-Profit O rganizations, and
A udits o f  S ta te  and Local Governm ental U nits§
Issued by the Accounting 
Standards Executive Committee §
§ The AICPA Audit and Accounting Guide State and Local Governments, supersedes the 1994 
AICPA Audit and Accounting Guide Audits of State and Local Governmental Units, and subsequent 
editions of that Guide with conforming changes made by the AICPA staff. AICPA Audit and Accounting 
Guide State and Local Governments, provides guidance on the application of this Statement of Position 
(SOP) to state and local governments. [Footnote added, June 2004, to reflect conforming changes 
necessary due to the issuance of the AICPA Audit and Accounting Guide State and Local Governments.]
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NOTE
Statements of Position on accounting issues present the conclusions 
of at least two-thirds of the Accounting Standards Executive Commit­
tee, which is the senior technical body of the Institute authorized to 
speak for the Institute in the areas of financial accounting and report­
ing. Statement on Auditing Standards No. 69, The Meaning 0f  Present 
Fairly in Conformity With Generally Accepted Accounting Principles, 
identifies AICPA Statements of Position that have been cleared by either 
the Financial Accounting Standards Board (for financial statements of 
nongovernmental entities) or the Governmental Accounting Standards 
Board (for financial statements of state and local governmental enti­
ties), as sources of established accounting principles in category b of 
the hierarchy of generally accepted accounting principles that it estab­
lishes. AICPA members should consider the accounting principles in this 
Statement of Position if a different accounting treatment of a transac­
tion or event is not specified by a pronouncement covered by Rule 203 
of the AICPA Code of Professional Conduct. In such circumstances, the 
accounting treatment specified by this Statement of Position should be 
used, or the member should be prepared to justify a conclusion that an­
other treatment better presents the substance of the transaction in the 
circumstances.
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Sum m ary
This Statement of Position (SOP) applies to all nongovernmental not-for-profit 
organizations (NPOs) and all state and local governmental entities that solicit 
contributions.
This SOP requires—
•  If the criteria of purpose, audience, and content as defined in this SOP 
are met, the costs of joint activities that are identifiable with a particu­
lar function should be charged to that function and joint costs should be 
allocated between fund raising and the appropriate program or man­
agement and general function.
•  If any of the criteria of purpose, audience, and content are not met, all 
costs of the activity should be reported as fund-raising costs, including 
costs that otherwise might be considered program or management and 
general costs if they had been incurred in a different activity, subject 
to the exception in the following sentence. Costs of goods or services 
provided in exchange transactions that are part of joint activities, such 
as costs of direct donor benefits of a special event (for example, a meal), 
should not be reported as fund raising.
•  Certain financial statement disclosures if joint costs are allocated.
•  Some commonly used and acceptable allocation methods are described 
and illustrated although no methods are prescribed or prohibited.
This SOP amends existing guidance in AICPA Audit and Accounting Guides 
Health Care Organizations, Not-for-Profit Organizations (which was issued in 
August 1996 and supersedes SOP 87-2, Accounting for Joint Costs of Informa­
tional Materials and Activities of Not-for-Profit Organizations That Include a 
Fund-Raising Appeal, because the provisions of SOP 87-2 are incorporated into 
the Guide), an d Audits of State and Local Governmental Units*
This SOP is effective for financial statements for years beginning on or after 
December 15, 1998. Earlier application is encouraged in fiscal years for which 
financial statements have not been issued. If comparative financial statements 
are presented, retroactive application is permitted but not required.
* The AICPA Audit and Accounting Guide State and Local Governments supersedes the 1994 
AICPA Audit and Accounting Guide Audits of State and Local Governmental Units and subsequent 
editions of that Guide with conforming changes made by the AICPA staff The AICPA Audit and 
Accounting Guide State and Local Governments provides guidance on the application of this Statement 
of Position (SOP) to state and local governments. [Footnote added, June 2004, to reflect conforming 
changes necessary due to the issuance of the AICPA Audit and Accounting Guide State and Local 
Governments.]
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Foreword
The accounting guidance contained in this document has been cleared by the 
Financial Accounting Standards Board (FASB) and the Governmental Account­
ing Standards Board (GASB). The procedure for clearing accounting guidance 
in documents issued by the Accounting Standards Executive Committee (Ac­
SEC) involves the FASB and the GASB reviewing and discussing in public board 
meetings (1) a prospectus for a project to develop a document, (2) a proposed 
exposure draft that has been approved by at least ten of AcSEC's fifteen mem­
bers, and (3) a proposed final document that has been approved by at least ten 
of AcSEC’s fifteen members. The document is cleared if at least five of the seven 
FASB members and three of the five GASB members do not object to AcSEC 
undertaking the project, issuing the proposed exposure draft or, after consid­
ering the input received by AcSEC as a result of the issuance of the exposure 
draft, issuing the final document.†
The criteria applied by the FASB and the GASB in their review of proposed 
projects and proposed documents include the following:
1. The proposal does not conflict with current or proposed accounting 
requirements, unless it is a limited circumstance, usually in spe­
cialized industry accounting, and the proposal adequately justifies 
the departure.
2. The proposal will result in an improvement in practice.
3. The AICPA demonstrates the need for the proposal.
4. The benefits of the proposal are expected to exceed the costs of 
applying it.
In many situations, prior to clearance, the FASB and the GASB will propose 
suggestions, many of which are included in the documents. †
† This document was cleared prior to July 1, 1997. In July 1997, the GASB increased to seven 
members. Documents considered by the GASB after July 1, 1997 are cleared if at least four of the 
seven GASB members do not object. [Footnote renumbered, June 2004, to reflect conforming changes 
necessary due to the issuance of the AICPA Audit and Accounting Guide State and Local Governments.]
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Introduction
Health Care Organizations
.01 Some nongovernmental not-for-profit organizations (NPOs) and some 
state and local governmental entities,1 such as governmental colleges and uni­
versities and governmental health care providers, solicit support through a 
variety of fund-raising activities.2 These activities include direct mail, tele­
phone solicitation, door-to-door canvassing, telethons, special events, and oth­
ers. Sometimes fund-raising activities are conducted with activities related to 
other functions, such as program activities or supporting services, such as 
management and general activities.3 Sometimes fund-raising activities in­
clude components that would otherwise be associated with program or support­
ing services, but in fact support fund raising.
.02 External users of financial statements—including contributors, credi­
tors, accreditation agencies, and regulators—want assurance that fund-raising 
costs, as well as program costs and management and general costs, are stated 
fairly.
.03 In 1987, the AICPA issued Statement of Position (SOP) 87-2, Account­
ing for Joint Costs of Informational Materials and Activities of Not-for-Profit Or­
ganizations That Include a Fund-Raising Appeal.4 SOP 87-2 required that all 
circumstances concerning informational materials and activities that include a 
fund-raising appeal be considered in accounting for joint costs of those mate­
rials and activities and that certain criteria be applied in determining whether 
joint costs of those materials and activities should be charged to fund raising 
or allocated to program or management and general. Those criteria include
1 This Statement of Position (SOP) uses the term entity to refer to both nongovernmental not- 
for-profit organizations (NPOs) and state and local governments.
2 Terms that appear in the Glossary [paragraph .30] are set in boldface type the first time they 
appear.
3 The functional classifications of fund raising, program, and management and general are dis­
cussed throughout this SOP for purposes of illustrating how the guidance in this SOP would be applied 
by entities that use those functional classifications. Some entities have a functional structure that 
does not include fund raising, program, or management and general, or that includes other functional 
classifications, such as membership development. This SOP is not intended to require reporting the 
functional classifications of fund raising, program, and management and general. In circumstances in 
which entities that have a functional structure that includes other functional classifications conduct 
joint activities, all costs of those joint activities should be charged to fund raising (or the category in 
which fund raising is reported—see the following two parenthetical sentences), unless the purpose, 
audience, and content of those joint activities are appropriate for achieving those other functions. (An 
example of an entity that reports fund raising in a category other than fund raising is a state and 
local governmental entity applying the accounting and financial reporting principles in the AICPA 
Industry Audit Guide Audits of Colleges and Universities, as amended by SOP 74-8. As discussed in 
paragraph D.5 of this SOP [paragraph .24], those entities are required to report fund raising as part 
of the "institutional support" function. See also footnote ** to paragraph D.5.) [Footnote revised, June 
2004, to refl ect conforming changes necessary due to the issuance of GASB Statements No. 34 and 
No. 35.]
4 In August 1996, the AICPA issued the Audit and Accounting Guide Not-for-Profit Organiza­
tions. The Guide supersedes SOP 87-2, Accounting for Joint Costs of Informational Materials and 
Activities of Not-for-Profit Organizations That Include a Fund-Raising Appeal, because the provisions 
of SOP 87-2 are incorporated into paragraphs 13.36 to 13.45 of Not-for-Profit Organizations. Not-for- 
Profit Organizations applies to all nongovernmental NPOs other than those required to follow the 
Audit and Accounting Guide Health Care Organizations. The discussion in this SOP of SOP 87-2 
refers to both SOP 87-2 and the guidance included in paragraphs 13.36 to 13.45 of Not-for-Profit Or­
ganizations. Also, SOP 87-2 was not applicable to entities that are within the scope of Governmental 
Accounting Standards Board (GASB) Statement No. 29, The Use of Not-for-Profit Accounting and 
Financial Reporting Principles by Governmental Entities.
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requiring verifiable indications of the reasons for conducting the activity, such 
as the content, audience, and action, if any, requested of the participant, as well 
as other corroborating evidence. Further, SOP 87-2 required that all joint costs 
of those materials and activities be charged to fund raising unless the appeal 
is designed to motivate its audience to action other than providing financial 
support to the organization.
.04 The provisions of SOP 87-2 have been difficult to implement and have 
been applied inconsistently in practice. (Appendix B [paragraph .22], "Back­
ground," discusses this further.)
.05 This SOP establishes financial accounting standards for accounting for 
costs of joint activities. In addition, this SOP requires financial statement 
disclosures about the nature of the activities for which joint costs have been 
allocated and the amounts of joint costs. Appendix F [paragraph .26] provides 
explanations and illustrations of some acceptable allocation methods.
Scope
.06 This SOP applies to all nongovernmental NPOs and all state and local 
governmental entities that solicit contributions.
Conclusions
Accounting for Joint Activities
.07 If the criteria of purpose, audience, and content are met, the costs of a 
joint activity that are identifiable with a particular function should be charged 
to that function and joint costs should be allocated between fund raising and 
the appropriate program or management and general function. If any of the 
criteria are not met, all costs of the joint activity should be reported as fund­
raising costs, including costs that otherwise might be considered program or 
management and general costs if they had been incurred in a different activity, 
subject to the exception in the following sentence. Costs of goods or services 
provided in exchange transactions that are part of joint activities, such as costs 
of direct donor benefits of a special event (for example, a meal), should not be 
reported as fund raising.
Purpose
.08 The purpose criterion is met if the purpose of the joint activity includes 
accomplishing program or management and general functions. (Paragraphs .09 
and .10 provide guidance that should be considered in determining whether 
the purpose criterion is met. Paragraph .09 provides guidance pertaining to 
program functions only. Paragraph .10 provides guidance pertaining to both 
program and management and general functions.)
.09 Program functions. To accomplish program functions, the activity 
should call for specific action by the audience that will help accomplish the 
entity's mission. For purposes of applying the guidance in this SOP, the fol­
lowing are examples of activities that do and do not call for specific action by 
the audience that will help accomplish the entity's mission: •
•  An entity's mission includes improving individuals' physical health.
For that entity, motivating the audience to take specific action that
AAG-HCO APP C
will improve their physical health is a call for specific action by the 
audience that will help accomplish the entity's mission. An exam­
ple of an activity that motivates the audience to take specific ac­
tion that will improve their physical health is sending the audience a 
brochure that urges them to stop smoking and suggests specific meth­
ods, instructions, references, and resources that may be used to stop 
smoking.
•  An entity's mission includes educating individuals in areas other than 
the causes, conditions, needs, or concerns that the entity's programs 
are designed to address (referred to hereafter in this SOP as "causes"). 
For that entity, educating the audience in areas other than causes 
or motivating the audience to otherwise engage in specific activities 
that will educate them in areas other than causes is a call for specific 
action by the audience that will help accomplish the entity's mission. 
Examples of entities whose mission includes educating individuals in 
areas other than causes are universities and possibly other entities. An 
example of an activity motivating individuals to engage in education in 
areas other than causes is a university inviting individuals to attend 
a lecture or class in which the individuals will learn about the solar 
system.
•  Educating the audience about causes or motivating the audience to 
otherwise engage in specific activities that will educate them about 
causes is not a call for specific action by the audience that will help ac­
complish the entity's mission. Such activities are considered in support 
of fund raising. (However, some educational activities that might oth­
erwise be considered as educating the audience about causes may im­
plicitly call for specific action by the audience that will help accomplish 
the entity's mission. For example, activities that educate the audience 
about environmental problems caused by not recycling implicitly call 
for that audience to increase recycling. If the need for and benefits of 
the specific action are clearly evident from the educational message, 
the message is considered to include an implicit call for specific action 
by the audience that will help accomplish the entity's mission.)
•  Asking the audience to make contributions is not a call for specific 
action by the audience that will help accomplish the entity's mission.
If the activity calls for specific action by the audience that will help accomplish 
the entity's mission, the guidance in paragraph .10 should also be considered 
in determining whether the purpose criterion is met.
.10 Program and management and general functions. The following fac­
tors should be considered, in the order in which they are listed,5 to determine 
whether the purpose criterion is met:
a. Whether com pensation or fees for performing the activity are 
based on contributions raised. The purpose criterion is not met if 
a majority of compensation or fees for any party's performance of
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5 In considering the guidance in paragraph .10, the factor in paragraph .10a (the compensation or 
fees test) is the preeminent guidance. If the factor in paragraph .10a is not determinative, the factor 
in paragraph .10b (whether a similar program or management and general activity is conducted 
separately and on a similar or greater scale) should be considered. If the factor in paragraph .10b is 
not determinative, the factor in paragraph .10c (other evidence) should be considered.
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any component of the discrete joint activity varies based on contri­
butions raised for that discrete joint activity.6,7
b. Whether a similar program or management and general activity is 
conducted separately and on a similar or greater scale. The purpose 
criterion is met if either of the following two conditions is met:
(1) Condition 1:
— The program component of the joint activity calls 
for specific action by the recipient that will help 
accomplish the entity's mission and
— A similar program component is conducted with­
out the fund-raising component using the same 
medium and on a scale that is similar to or 
greater than the scale on which it is conducted 
with the fund raising.8
(2) Condition 2:
A management and general activity that is similar to 
the management and general component of the joint 
activity being accounted for is conducted without the 
fund-raising component using the same medium and 
on a scale that is similar to or greater than the scale 
on which it is conducted with the fund raising 
If the purpose criterion is met based on the factor in paragraph 
.10b, the factor in paragraph .10c should not be considered.
c. Other evidence. If the factors in paragraph .10a or .10b do not de­
termine whether the purpose criterion is met, other evidence may 
determine whether the criterion is met. All available evidence, both 
positive and negative, should be considered to determine whether, 
based on the weight of that evidence, the purpose criterion is met.
.11 The following are examples of indicators that provide evidence for de­
termining whether the purpose criterion is met:
a. Evidence that the purpose criterion may be met includes—
•  Measuring program results and accomplishments of the 
activity. The facts may indicate that the purpose criterion
6 Some compensation contracts provide that compensation for performing the activity is based on 
a factor other than contributions raised, but not to exceed a specified portion of contributions raised. 
For example, a contract may provide that compensation for performing the activity is $10 per contact 
hour, but not to exceed 60 percent of contributions raised. In such circumstances, compensation is not 
considered based on amounts raised, unless the stated maximum percentage is met. In circumstances 
in which it is not yet known whether the stated maximum percentage is met, compensation is not 
considered based on amounts raised, unless it is probable that the stated maximum percentage will 
be met.
7 The compensation or fees test is a negative test in that it either (a) results in failing the purpose 
criterion or (b) is not determinative of whether the purpose criterion is met. Therefore, if the activity 
fails the purpose criterion based on this factor (the compensation or fees test), the activity fails the 
purpose criterion and the factor in paragraph .10b should not be considered. If the purpose criterion 
is not failed based on this factor, this factor is not determinative of whether the purpose criterion is 
met and the factor in paragraph .10b should be considered.
8 Determining the scale on which an activity is conducted may be a subjective determination. 
Factors to consider in determining the scale on which an activity is conducted may include dollars 
spent, the size of the audience reached, and the degree to which the characteristics of the audience 
are similar to the characteristics of the audience of the activity being evaluated.
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is met if the entity measures program results and accom­
plishments of the activity (other than measuring the ex­
tent to which the public was educated about causes).
•  Medium. The facts may indicate that the purpose crite­
rion is met if the program component of the joint activ­
ity calls for specific action by the recipient that will help 
accomplish the entity's mission and if the entity conducts 
the program component without a significant fund-raising 
component in a different medium. Also, the facts may indi­
cate that the purpose criterion is met if the entity conducts 
the management and general component of the joint ac­
tivity without a significant fund-raising component in a 
different medium.
h. Evidence that the purpose criterion may not be met includes—
•  Evaluation or compensation. The facts may indicate that 
the purpose criterion is not met if (a) the evaluation of 
any party's performance of any component of the discrete 
joint activity varies based on contributions raised for that 
discrete joint activity or (6) some, but less than a majority, 
of compensation or fees for any party's performance of any 
component of the discrete joint activity varies based on 
contributions raised for that discrete joint activity.
c. Evidence that the purpose criterion may be either met or not met 
includes—
•  Evaluation of measured results of the activity. The entity 
may have a process to evaluate measured program results 
and accomplishments of the activity (other than measur­
ing the extent to which the public was educated about 
causes). If the entity has such a process, in evaluating the 
effectiveness of the joint activity, the entity may place sig­
nificantly greater weight on the activity's effectiveness in 
accomplishing program goals or may place significantly 
greater weight on the activity's effectiveness in raising 
contributions. The former may indicate that the purpose 
criterion is met. The latter may indicate that the purpose 
criterion is not met.
•  Qualifications. The qualifications and duties of those per­
forming the joint activity should be considered.
— If a third party, such as a consultant or contractor, 
performs part or all of the joint activity, such as 
producing brochures or making telephone calls, 
the third party's experience and the range of ser­
vices provided to the entity should be considered 
in determining whether the third party is per­
forming fund-raising, program (other than edu­
cating the public about causes), or management 
and general activities on behalf of the entity.
— If the entity's employees perform part or all of 
the joint activity, the full range of their job duties 
should be considered in determining whether
290 Health Care Organizations
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those employees are performing fund-raising, 
program (other than educating the public about 
causes), or management and general activities on 
behalf of the entity. For example, (a) employees 
who are not members of the fund-raising depart­
ment and (b) employees who are members of the 
fund-raising department but who perform non­
fund-raising activities are more likely to perform 
activities that include program or management 
and general functions than are employees who 
otherwise devote significant time to fund raising.
Tangible evidence of intent. Tangible evidence indicating 
the intended purpose of the joint activity should be con­
sidered. Examples of such tangible evidence include
— The entity's written mission statement, as stated 
in its fund-raising activities, bylaws, or annual 
report.
— Minutes of board of directors', committees', or 
other meetings.
— Restrictions imposed by donors (who are not re­
lated parties) on gifts intended to fund the joint 
activity.
— Long-range plans or operating policies.
— Written instructions to other entities, such as 
script writers, consultants, or list brokers, con­
cerning the purpose of the joint activity, audience 
to be targeted, or method of conducting the joint 
activity.
— Internal management memoranda.
Audience
.12 A rebuttable presumption exists that the audience criterion is not met 
if the audience includes prior donors or is otherwise selected based on its ability 
or likelihood to contribute to the entity. That presumption can be overcome if 
the audience is also selected for one or more of the reasons in paragraph .13a, 
.13b, or .13c. In determining whether that presumption is overcome, entities 
should consider the extent to which the audience is selected based on its ability 
or likelihood to contribute to the entity and contrast that with the extent to 
which it is selected for one or more of the reasons in paragraph .13a, .13b, 
or .13c. For example, if the audience's ability or likelihood to contribute is a 
significant factor in its selection and it has a need for the action related to the 
program component of the joint activity, but having that need is an insignificant 
factor in its selection, the presumption would not be overcome.
.13 In circumstances in which the audience includes no prior donors and 
is not otherwise selected based on its ability or likelihood to contribute to the 
entity, the audience criterion is met if the audience is selected for one or more 
of the following reasons:
a. The audience's need to use or reasonable potential for use of the 
specific action called for by the program component of the joint 
activity
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h. The audience's ability to take specific action to assist the entity in 
meeting the goals of the program component of the joint activity
c. The entity is required to direct the management and general compo­
nent of the joint activity to the particular audience or the audience 
has reasonable potential for use of the management and general 
component
Content
.14 The content criterion is met if the joint activity supports program or 
management and general functions, as follows:
a. Program. The joint activity calls for specific action by the recipient 
that will help accomplish the entity's mission. If the need for and 
benefits of the action are not clearly evident, information describing 
the action and explaining the need for and benefits of the action is 
provided.
b. Management and general. The joint activity fulfills one or more 
of the entity's management and general responsibilities through a 
component of the joint activity.9
.15 Information identifying and describing the entity, causes, or how the 
contributions provided will be used is considered in support of fund raising.
Allocation Methods
.16 The cost allocation methodology used should be rational and system­
atic, it should result in an allocation of joint costs that is reasonable, and it 
should be applied consistently given similar facts and circumstances.
Incidental Activities
.17 Some fund-raising activities conducted in conjunction with program or 
management and general activities are incidental to such program or manage­
ment and general activities. For example, an entity may conduct a fund-raising 
activity by including a generic message, "Contributions to Organization X may 
be sent to [address]" on a small area of a message that would otherwise be con­
sidered a program or management and general activity based on its purpose, 
audience, and content. That fund-raising activity likely would be considered in­
cidental to the program or management and general activity being conducted. 
Similarly, entities may conduct program or management and general activities 
in conjunction with fund-raising activities that are incidental to such fund­
raising activities. For example, an entity may conduct a program activity by 
including a generic program message such as "Continue to pray for [a partic­
ular cause]" on a small area of a message that would otherwise be considered 
fund raising based on its purpose, audience, and content. That program ac­
tivity would likely be considered incidental to the fund-raising activity being 
conducted. Similarly, an entity may conduct a management and general activity 
by including a brief management and general message—"We recently changed 
our phone number. Our new number is 123-4567"—on a small area of a message 
that would otherwise be considered a program or fund-raising activity based
292 Health Care Organizations
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iting contributions. For purposes of applying the guidance in this SOP, communications that include 
such required disclosures are considered fund-raising activities and are not considered management 
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on its purpose, audience, and content. That management and general activity 
would likely be considered incidental to the program or fund-raising activity 
being conducted. In circumstances in which a fund-raising, program, or man­
agement and general activity is conducted in conjunction with another activity 
and is incidental to that other activity, and the conditions in this SOP for alloca­
tion are met, joint costs are permitted but not required to be allocated and may 
therefore be charged to the functional classification related to the activity that 
is not the incidental activity. However, in circumstances in which the program 
or management and general activities are incidental to the fund-raising activi­
ties, it is unlikely that the conditions required by this SOP to permit allocation 
of joint costs would be met.
Disclosures
.18 Entities that allocate joint costs should disclose the following in the 
notes to their financial statements:
a. The types of activities for which joint costs have been incurred
b. A statement that such costs have been allocated
c. The total amount allocated during the period and the portion allo­
cated to each functional expense category
.19 This SOP encourages, but does not require, that the amount of joint 
costs for each kind of joint activity be disclosed, if practical.
Effective Date
.20 This SOP is effective for financial statements for years beginning on 
or after December 15, 1998. Earlier application is encouraged in fiscal years 
for which financial statements have not been issued. If comparative financial 
statements are presented, retroactive application is permitted but not required.
The provisions of this Statement of Position need 
not be applied to immaterial items.
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continued
Note: This flowchart summarizes certain guidance in this SOP and is not intended as a sub­
stitute for the SOP.
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Appendix B 
Background
B.1. As stated in paragraph .04, the provisions of Statement of Position (SOP) 
87-2, Accounting for Joint Costs of Informational Materials and Activities of 
Not-for-Profit Organizations That Include a Fund-Raising Appeal, have been 
difficult to implement and applied inconsistently in practice. That difficulty has 
been due in part to the following:
•  The second sentence of paragraph 1 of SOP 87-2 stated that "some 
of the costs incurred by such organizations are clearly identifiable 
with fundraising, such as the cost of fund-raising consulting services." 
It is unclear whether activities that would otherwise be considered 
program activities should be characterized as program activities if 
they are performed or overseen by professional fund raisers. Also, 
it is unclear whether activities would be reported differently (for ex­
ample, as program rather than fund raising) depending on whether 
the fund-raising consultant is compensated by a predetermined fee 
or by some other method, such as a percentage of contributions 
raised.
•  SOP 87-2 was unclear about whether allocation of costs to fund­
raising expense is required if the activity for which the costs were 
incurred would not have been undertaken without the fund-raising 
component.
•  SOP 87-2 defined joint costs through examples, and it is therefore 
unclear what kinds of costs were covered by SOP 87-2. For example, it 
is unclear whether salaries and indirect costs can be joint costs.
•  Some believe the guidance in SOP 87-2 was inadequate to determine 
whether joint activities, such as those that request contributions and 
also list the warning signs of a disease, are designed to motivate their 
audiences to action other than to provide contributions to the entity. 
It is unclear what attributes the targeted audience should possess in 
order to conclude that a program function is being conducted.
B.2. In 1992, the Accounting Standards Executive Committee (AcSEC) un­
dertook a project to supersede SOP 87-2, to provide clearer guidance than that 
provided by SOP 87-2, as well as to provide guidance that would improve on the 
guidance in SOP 87-2. In September 1993, AcSEC released an exposure draft 
of a proposed SOP, Accounting for Costs of Materials and Activities of Not-for- 
Profit Organizations and State and Local Governmental Entities That Include 
a Fund-Raising Appeal, for public comment. AcSEC received more than 300 
comment letters on the exposure draft. AcSEC redeliberated the issues based 
on the comments received.
B.3. In 1996, after redeliberating the issues based on the comments received 
and making certain revisions to the draft SOP, AcSEC conducted a field test of 
the draft SOP. The objectives of the field test were to determine whether the 
provisions of the draft SOP were sufficiently clear and definitive to generate con­
sistent and comparable application of the SOP. Based on the field test results, 
AcSEC concluded that the provisions of the draft SOP, with certain revisions,
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were sufficiently clear and definitive to generate consistent and comparable 
application of the SOP.
B.4. Some respondents who commented on the exposure draft, as well as 
some interested parties who followed the project through its due process sub­
sequent to the exposure draft, commented that the SOP should be reexposed 
for public comment. Reasons cited include:
•  Approximately three years had passed between the end of the comment 
period and AcSEC's decision to issue the SOP.
•  AcSEC made significant revisions to the SOP subsequent to releasing 
the exposure draft for comment.
Considering whether a proposed standard should be reexposed for public 
comment is inherently a subjective process. Factors that AcSEC considered 
include—
• The significance of changes made to the exposure draft and whether 
those changes result in guidance that the public did not have an op­
portunity to consider.
•  Whether the scope was revised in such a way that affected entities did 
not have an opportunity to comment.
•  New information about or changes in the nature of the transactions 
being considered, practice, or other factors.
AcSEC believes that the length of time between exposure and final issuance is 
not pertinent to whether the SOP should be reexposed for public comment.
B.5. Based on consideration of the factors identified, AcSEC believes that the 
SOP should not be reexposed for public comment. AcSEC notes that although 
the SOP has been revised based on comments received on the exposure draft, 
those revisions do not change the overall model in the SOP. Those revisions 
were made primarily to clarify the SOP and improve its operationality. Further, 
AcSEC believes that the project received a high level of attention from inter­
ested parties. AcSEC provided working drafts to interested parties and those 
parties provided input throughout the process, up to and including the Finan­
cial Accounting Standard Board's and the Governmental Accounting Standards 
Board's clearance of the SOP for issuance.
B.6. Appendix C [paragraph .23] discusses the key issues in the exposure 
draft and comments received on those issues, as well as the basis for AcSEC's 
conclusions on those and certain other issues.
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A ppendix C  
Basis for Conclusions
C.1. This section discusses considerations that were deemed significant by 
members of the Accounting Standards Executive Committee (AcSEC) in reach­
ing the conclusions in this Statement of Position (SOP). It includes reasons for 
accepting certain views and rejecting others. Individual AcSEC members gave 
greater weight to some factors than to others.
Overall Framework
C.2. This SOP uses the model in SOP 87-2, Accounting for Joint Costs of 
Informational Materials and Activities of Not-for-Profit Organizations That In­
clude a Fund-Raising Appeal, as a starting point and clarifies guidance that 
was unclear, provides more detailed guidance, revises some guidance, and ex­
pands the scope of costs covered to include all costs of joint activities. The model 
established by SOP 87-2 was to account for joint costs as fund raising unless an 
entity could demonstrate that a program or management and general function 
had been conducted. SOP 87-2 used verifiable indications of the reasons for 
conducting the activity, such as content, audience, the action requested, if any, 
and other corroborating evidence as a basis for determining whether a program 
or management and general function had been conducted.
C.3. On an overall basis, the majority of respondents who commented on 
the September 1993 exposure draft of a proposed SOP, Accounting for Costs 
of Materials and Activities of Not-for-Profit Organizations and State and Local 
Governmental Entities That Include a Fund-Raising Appeal, opposed it, for 
various reasons, including the following:
•  The guidance in SOP 87-2 is operational, results in sound financial 
reporting, and should be retained.
•  The guidance in SOP 87-2 should be retained but clarified.
•  The guidance proposed in the exposure draft should be revised. (Some 
commented that it overstates fund raising; others commented that it 
understates fund raising.)
C.4. AcSEC concluded that it supports the model in the exposure draft, sub­
ject to certain revisions. AcSEC believes that this SOP provides clear, detailed 
accounting guidance that, when applied, will increase comparability of financial 
statements. Those statements will also include more meaningful disclosures 
without incurring increased costs.
C.5. Some respondents commented that the model in the exposure draft 
would adversely affect entities both financially and operationally. Various rea­
sons were given, including the following: •
•  It would inhibit the ability of entities, particularly small entities and 
entities that raise contributions through direct solicitations, to gener­
ate the necessary revenue to perform their program services.
•  Most entities would not meet the criteria in this SOP for reporting 
costs of joint activities as program or management and general, be­
cause they must combine their mission statements, public information
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and education, and fund-raising appeals due to a lack of resources. 
Some noted that this may result in unsatisfactory ratings from public 
watchdog groups.
AcSEC did not find these arguments compelling. This SOP provides accounting 
guidance; it provides no guidance concerning how entities should undertake 
their activities. Also, this SOP does not prohibit allocation merely because ac­
tivities carrying out different functions are combined. In fact, this SOP provides 
guidance for reporting costs as program or management and general in circum­
stances in which those activities are combined with fund-raising. Moreover, 
actions taken by financial statement users are not the direct result of the re­
quirements of this SOP. Rather, those actions may result from more relevant 
and useful information on which to base decisions.
C.6. Some respondents commented that the exposure draft is biased toward 
reporting expenses as fund raising. AcSEC believes that determining whether 
the costs of joint activities should be classified as program, management and 
general, or fund raising sometimes is difficult, and such distinctions sometimes 
are subject to a high degree of judgment. AcSEC believes that external finan­
cial statement users focus on and have perceptions about amounts reported as 
program, management and general, and fund raising. That focus and those per­
ceptions provide incentives for entities to report expenses as program or man­
agement and general rather than fund raising. Therefore, in circumstances in 
which joint activities are conducted, a presumption exists that expenses should 
be reported as fund raising rather than as program or management and gen­
eral. The criteria in this SOP provide guidance for entities to overcome that 
presumption.
Accounting for Joint Activities
C.7. This SOP requires that if any of the criteria of purpose, audience, and 
content are not met, all costs of the activity should be reported as fund raising, 
including costs that otherwise might be considered program or management 
and general costs if they had been incurred in a different activity, subject to 
the exception in the following sentence. Costs of goods or services provided in 
exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event (for example, a meal), should not be reported 
as fund raising. (This SOP expands on the model established by SOP 87-2 by 
including all costs of joint activities other than costs of goods or services pro­
vided in exchange transactions, rather than merely joint costs.) AcSEC believes 
that the criteria of purpose, audience, and content are each relevant in deter­
mining whether a joint activity should be reported as fund raising, program, 
or management and general because each provides significant evidence about 
the benefits expected to be obtained by undertaking the activity.
C.8. Some respondents commented that reporting costs that otherwise might 
be considered program or management and general costs if they had been in­
curred in a different activity as fund raising is misleading and that the scope 
of the SOP should include only joint costs of joint activities. Some commented 
that reporting costs that otherwise might be considered program or manage­
ment and general costs if they had been incurred in a different activity as fund 
raising conflicts with Financial Accounting Standards Board (FASB) Statement 
of Financial Accounting Standards No. 117, Financial Statements o f  Not-for- 
Profit Organizations, which defi nes fund raising, program, and management 
and general and requires not-for-profit organizations (NPOs) to report infor­
mation about expenses using those functional classifications.
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C.9. AcSEC believes that the purpose for which costs other than joint costs 
are incurred may be fund raising, program, or management and general, de­
pending on the context in which they are used in the activity undertaken. For 
example, a program-related pamphlet may be sent to an audience in need of 
the program. In that context, the pamphlet is used for program purposes. How­
ever, in order to demonstrate to potential donors that the entity's programs are 
worthwhile, that same pamphlet may be sent to an audience that is likely to 
contribute, but that has no need or reasonable potential for use of the program. 
In that context, the pamphlet is used for fund raising. AcSEC believes this 
broader scope will result in more comparability and more meaningful financial 
reporting by covering all costs of activities that include fund raising and by as­
signing those costs to the function for which they are incurred, consistent with 
the guidance in Statement No. 117.
C.10. AcSEC believes that costs of goods or services provided in exchange 
transactions should not be charged to fund raising because those costs are 
incurred in exchange for revenues other than contributions.
Criteria of Purpose, Audience, and Content
Call For Action
C.11. The definition of program in FASB Statement No. 117 includes public 
education. As noted in paragraph C.6, AcSEC believes that in circumstances in 
which joint activities are conducted, a presumption exists that expenses should 
be reported as fund raising rather than as program or management and general. 
AcSEC believes that in order to overcome that presumption, it is not enough 
that (a) the purpose of the activity include educating the public about causes, 
(b) the audience has a need or reasonable potential for use of any educational 
component of the activity pertaining to causes, or (c) the audience has the 
ability to assist the entity in meeting the goals of the program component of 
the activity by becoming educated about causes. Therefore, AcSEC concluded 
that for purposes of this SOP, in order to conclude that the criteria of purpose, 
audience, and content are met program activities are required to call for specific 
action by the recipient (other than becoming educated about causes) that will 
help accomplish the entity's mission. As discussed in paragraph .09, in certain 
circumstances educational activities may call for specific action by the recipient 
that will help accomplish the entity's mission.
Purpose
C.12. AcSEC believes meeting the purpose criterion demonstrates that the 
purpose of the activity includes accomplishing program or management and 
general functions. Inherent in the notion of a joint activity is that the activity 
has elements of more than one function. Accordingly, the purpose criterion 
provides guidance for determining whether the purpose of the activity includes 
accomplishing program or management and general functions in addition to 
fund raising.
Compensation and Evaluation Tests
C.13. The exposure draft proposed that all costs of the joint activity should 
be charged to fund raising if (a) substantially all compensation or fees for per­
forming the activity are based on amounts raised or (6) the evaluation of the 
party performing the activity is based on amounts raised. Some respondents 
commented that basing the method of compensation or evaluating the perfor­
mance of the party performing the activity based on contributions raised should 
not lead to the conclusion that all costs of the activity should be charged to fund
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raising. Others commented that the method of compensation is unrelated to 
whether the purpose criterion is met. The reasons given included the following;
•  It is counterintuitive to imply that those performing multipurpose ac­
tivities that include fund raising would not be compensated or evalu­
ated based on amounts raised.
•  Such guidance would create a bias toward entities that use employees 
to raise contributions and against entities that hire professional fund 
raisers and public relations firms and is therefore not neutral.
Some respondents gave examples of circumstances in which substantially all 
compensation is based on contributions raised and asserted that the activity 
was nevertheless a program activity. In each of those examples, AcSEC consid­
ered all the facts presented and concluded that the activity was fund raising.
C.14. AcSEC continues to support the spirit of the proposed guidance, be­
cause AcSEC believes that basing a majority of compensation on funds raised 
is persuasive evidence that the activity is a fund-raising activity. Nevertheless, 
AcSEC believes that the proposed guidance was unclear and would be difficult 
to implement, primarily because of the broad definition of "based on contri­
butions raised" included in the glossary of the exposure draft. In connection 
with that issue, AcSEC was concerned that any joint activities performed by 
a fund-raising department or by individuals whose duties include fund rais­
ing, such as executive officers of small NPOs who are employed based on their 
ability to raise contributions, would be required to be reported as fund raising 
because the compensation of the parties performing those activities is based 
on amounts raised. Also, AcSEC had concerns that it would be difficult to de­
termine whether fixed contract amounts were negotiated based on expected 
contributions. Therefore, AcSEC concluded that the compensation test should 
be revised to provide that the purpose criterion is not met if a majority of com­
pensation or fees for any party's performance of any component of the discrete 
joint activity varies based on contributions raised for that discrete joint activity. 
AcSEC believes that guidance is sound and is operational.
C.15. AcSEC believes that the guidance in paragraph .10a is not biased 
against entities that hire professional fund raisers, because it applies to the 
entity's employees as well as professional fund raisers. For example, if a ma­
jority of an employee's compensation or fees for performing a component of a 
discrete joint activity varies based on contributions raised for that discrete joint 
activity, the purpose criterion is not met.
Similar Function-Similar Medium Test
C.16. Some respondents misinterpreted the exposure draft as providing that, 
in order to meet the purpose criterion, the program or management and gen­
eral activity must be conducted without the fund-raising component, using the 
same medium and on a scale that is similar to or greater than the program or 
management and general component of the activity being accounted for. That 
was not a requirement proposed by the exposure draft. The exposure draft pro­
posed that meeting that condition would result in meeting the purpose criterion. 
Failing the criterion merely leads to consideration of other evidence, such as 
the indicators in paragraph .11. AcSEC has revised the SOP to state this more 
clearly.
Other Evidence
C.17. The compensation test and the similar function-similar medium test 
may not always be determinative because the attributes that they consider
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may not be present. Therefore, this SOP includes indicators that should be 
considered in circumstances in which the compensation test and the similar 
function-similar medium test are not determinative. The nature of those in­
dicators is such that they may be present in varying degrees. Therefore, all 
available evidence, both positive and negative, should be considered to deter­
mine whether, based on the weight of that evidence, the purpose criterion is 
met.
Audience
C.18. The exposure draft proposed that if the audience for the materials or 
activities is selected principally on its ability or likelihood to contribute, the 
audience criterion is not met and all the costs of the activity should be charged 
to fund raising. Further, the exposure draft proposed that if the audience is 
selected principally based on its need for the program or because it can assist 
the entity in meeting its program goals other than by financial support provided 
to the entity, the audience criterion is met. Some respondents commented that 
that audience criterion is too narrow, because it is based on the principal reason 
for selecting the audience. They asserted that for some activities no principal 
reason exists for selecting an audience; entities select the audience for those 
activities for multiple reasons, such as both the audience's ability to contribute 
and its ability to help meet program goals. Some commented that for some 
activities, entities select audiences that have provided past financial support 
because, by providing financial support, those audiences have expressed an 
interest in the program.
C.19. AcSEC believes that meeting the audience criterion should demon­
strate that the audience is selected because it is a suitable audience for accom­
plishing the activity's program or management and general functions. There­
fore, the reasons for selecting the audience should be consistent with the 
program or management and general content of the activity. However, AcSEC 
believes it is inherent in the notion of joint activities that the activity has ele­
ments of more than one function, including fund raising, and acknowledges that 
it may be difficult to determine the principal reason for selecting the audience. 
Accordingly, AcSEC concluded that if the audience includes prior donors or is 
otherwise selected based on its ability or likelihood to contribute, a rebuttable 
presumption should exist that the audience was selected to raise funds. AcSEC 
believes that the reasons for selecting the audience that can overcome that pre­
sumption, which are included in paragraph .13 of this SOP, demonstrate that 
the audience is selected because it is a suitable audience for accomplishing the 
activity's program or management and general functions based on the program 
or management and general content of the activity.
Content
C.20. AcSEC believes that meeting the content criterion demonstrates that 
the content of the activity supports program or management and general func­
tions. AcSEC believes that accounting guidance should not impose value judg­
ments about whether the entity's mission, programs, and responsibilities are 
worthwhile. Therefore, whether the content criterion is met depends on the 
relationship of the content to the entity's mission, programs, and management 
and general responsibilities.
C.21. Paragraph .14 provides that, to meet the content criterion, program 
activities should call for specific action by the recipient that will help accom­
plish the entity's mission. The exposure draft proposed that slogans, general 
calls to prayer, and general calls to protest do not meet the content criterion;
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some respondents disagreed. AcSEC concluded that this SOP should be silent 
concerning whether slogans, general calls to prayer, and general calls to protest 
are calls to action that meet the content criterion. AcSEC believes that deter­
mining whether those items are calls to action that meet the content criterion 
requires judgments based on the particular facts and circumstances.
C..22. Some respondents commented that educating the public about causes 
without calling for specific action should satisfy the content criterion. They 
noted that this is particularly relevant for NPOs subject to Internal Revenue 
Code (IRC) Section 501(c)4, because those NPOs are involved in legislative 
reform. Also, some noted that it may be the entity's mission or goal to educate 
the public about causes. They believe that, in those cases, the NPO's program is 
to educate the public about causes without necessarily calling for specific action 
by the recipient.
C..23. As discussed in paragraph C.11, AcSEC concluded that education that 
does not motivate the audience to action is in fact done in support of fund raising. 
However, this SOP acknowledges that some educational messages motivate 
the audience to specific action, and those messages meet the content criterion. 
AcSEC believes that that provision will result in the activities of some NPOs 
subject to IRC Section 501(c)4 (and some other entities, whose mission or goal 
is to educate the public) meeting the content criterion.
C.24. Paragraph .13c provides that one way that the audience criterion is met 
is if the entity is required to direct the management and general component of 
the activity to the particular audience. Further, as discussed in paragraph D.13, 
in Discussion of Conclusions, an audience that includes prior donors and is se­
lected because the entity is required to send them certain information to comply 
with requirements of the Internal Revenue Service (IRS) is an example of an au­
dience that is selected because the entity is required to direct the management 
and general component of the activity to that audience. Paragraph .14b pro­
vides that one way that the content criterion is met is if the activity fulfills one 
or more of the entity's management and general responsibilities through a com­
ponent of the joint activity. However, footnote 9 to paragraph .14b provides that 
disclosures made when soliciting contributions to comply with requirements of 
states or other regulatory bodies are considered fund-raising activities, and are 
not considered management and general activities. AcSEC considered whether 
it is inconsistent to conclude both that (a) activities conducted to comply with 
requirements of regulatory bodies concerning contributions that have been re­
ceived are management and general activities, and that (6) activities conducted 
to comply with requirements of regulatory bodies concerning soliciting contri­
butions are fund-raising activities. AcSEC believes that those provisions are not 
inconsistent. AcSEC believes there is a distinction between (a) requirements 
that must be met as a result of receiving contributions and (6) requirements 
that must be met in order to solicit contributions. AcSEC believes that activi­
ties that are undertaken as a result of receiving contributions are management 
and general activities while activities that are undertaken in order to solicit 
contributions are fund-raising activities.
Incidental Activities
C.25. Many entities conduct fund-raising activities in conjunction with pro­
gram or management and general activities that are incidental to such program 
or management and general activities. Similarly, entities may conduct program 
or management and general activities in conjunction with fund-raising activ­
ities that are incidental to such fund-raising activities. Such efforts may be
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a practical and efficient means for entities to conduct activities, although the 
principal purpose of the activity may be to fulfill either fund-raising, program, 
or management and general functions. The exposure draft proposed that inci­
dental activities need not be considered in applying this SOP. Some respondents 
disagreed with that guidance, while others commented that it was confusing. 
AcSEC continues to support that guidance. AcSEC believes that guidance is 
necessary to avoid requiring complex allocations in circumstances in which the 
criteria of purpose, audience, and content are met but the activity is overwhelm­
ingly either fund raising, program, or management and general.
Allocation Methods
C.26. Respondents had various comments concerning allocation methods, in­
cluding the following:
•  The SOP should focus on allocation methods rather than on circum­
stances in which entities should allocate.
•  The SOP should prescribe allocation methods.
•  The approach taken in the SOP—discussing, rather than requiring or 
prohibiting allocation methods—is sound.
•  Certain allocation methods should be prohibited.
•  The SOP should set maximum allocation percentages.
AcSEC believes that no particular allocation method or methods are neces­
sarily more desirable than other methods in all circumstances. Therefore, this 
SOP neither prescribes nor prohibits any particular allocation methods. AcSEC 
believes entities should apply the allocation methods that result in the most 
reasonable cost allocations for their activities. Appendix F [paragraph .26] of 
this SOP illustrates several allocation methods, any one of which may result 
in a reasonable or unreasonable allocation of costs in particular circumstances. 
The methods illustrated are not the only acceptable methods. However, AcSEC 
believes that the methods illustrated in this SOP are among those most likely 
to result in meaningful cost allocations.
C.27. Accounting Principles Board (APB) Opinion No. 20, Accounting 
Changes, states in paragraph 7 that "the term accounting principle includes 
not only accounting principles and practices but also the methods of applying 
them.'" APB Opinion 20 also states in paragraphs 15 and 16 that
...In the preparation of financial statements there is a presumption 
that an accounting principle once adopted should not be changed in 
accounting for events and transactions of a similar type....The pre­
sumption that an entity should not change an accounting principle 
may be overcome only if the enterprise justifies the use of an alterna­
tive acceptable accounting principle [allocation method] on the basis 
that it is preferable.
A change in cost allocation methodology may be a change in accounting principle 
for entities covered by this SOP. Accordingly, paragraph .16 of this SOP provides 
that the cost allocation methodology used should be applied consistently, given 
similar facts and circumstances.
Disclosures
C.28. Respondents made various comments concerning the required and en­
couraged disclosures, including recommendations for additional disclosures and
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recommendations that certain disclosures be deleted. AcSEC was not persuaded 
that the costs of the other disclosures recommended by respondents are justified 
by their benefits. AcSEC believes that, with the exception of one disclosure, the 
disclosures prescribed by the exposure draft provide relevant information about 
the kinds of activities for which joint costs have been incurred and the man­
ner in which those costs are reported in the financial statements. In considering 
disclosures proposed by the exposure draft about the allocation method, AcSEC 
observed that there are no requirements to disclose methods of allocating other 
expenses and questioned the utility of disclosing the allocation method in this 
circumstance. AcSEC concluded that the requirement to disclose the allocation 
method should be deleted.
C.29. Paragraph .19 encourages, but does not require, certain disclosures. Ac­
SEC believes those disclosures provide useful information but that they should 
be encouraged rather than required because the costs of making them may not 
be justified by the benefits in all cases.
Effective Date
C.30. Some respondents commented that the effective date should be de­
ferred. AcSEC believes that the accounting systems required to implement this 
SOP are already in place and that implementation should be relatively straight­
forward. However, AcSEC acknowledges that some entities may change their 
operations based on the reporting that would result from this SOP. Therefore, 
AcSEC concluded that this SOP should be effective for financial statements for 
years beginning on or after December 15, 1998.
Cost-Benefit
C.31. Some respondents commented that the guidance would increase record 
keeping costs. AcSEC believes that implementing this SOP will not significantly 
increase record keeping costs, which are primarily the costs of documenting rea­
sons for undertaking joint activities. Further, AcSEC believes that the costs of 
making the disclosures required by this SOP should be minimal, because enti­
ties should already have the information that is required to be disclosed. AcSEC 
believes that implementing this SOP will result in more relevant, meaningful, 
and comparable financial reporting and that the cost of implementing this SOP 
will be justified by its benefits.
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Appendix D
Discussion of Conclusions 
Scope
D.1. This Statement of Position (SOP) applies only to costs of joint activities. 
It does not address allocations of costs in other circumstances.
Reporting Models and Related Requirements
D.2. Paragraph 26 of Financial Accounting Standards Board (FASB) State­
ment of Financial Accounting Standards No. 117, Financial Statements of Not- 
for-Profit Organizations, specifies that a statement of activities or notes to the 
financial statements should provide information about expenses reported by 
their functional classification, such as major classes of program services and 
supporting activities. Paragraph 13.34 of the AICPA Audit and Accounting 
Guide Not-for-Profit Organizations provides that the financial statements of 
not-for-profit organizations (NPOs) should disclose the total fund-raising ex­
penses. [Revised, June 2004, to reflect conforming changes necessary due to 
conforming changes made to the AICPA Audit and Accounting Guide Not-for- 
Profit Organizations.]
D.3. Governmental Accounting Standards Board (GASB) Statement No. 29, 
The Use of Not-for-Profit Accounting and Financial Reporting Principles by Gov­
ernmental Entities, provides that governmental entities should not change their 
accounting and financial reporting to apply the provisions of FASB Statements 
No. 116, Accounting for Contributions Received and Contributions Made, and 
No. 117. GASB Statement No. 29 permits governmental entities that have ap­
plied the accounting and financial reporting principles in SOP 78-10, Account­
ing Principles and Reporting Practices for Certain Nonprofit Organizations, or 
in the AICPA Industry Audit Guide Audits of Voluntary Health and Welfare Or­
ganizations modified by all applicable FASB pronouncements issued through 
November 30, 1989, and by most applicable GASB pronouncements) to con­
tinue to do so, pending GASB pronouncements on the accounting and financial 
reporting model for governmental entities. Alternatively, those governmental 
entities are permitted to change to the current governmental financial report­
ing model.‡
D.4. GASB Statement No. 15, Governmental College and University Account­
ing and Financial Reporting Models, requires governmental colleges and uni­
versities to use one of two accounting and financial reporting models. One 
model, referred to as the "AICPA College Guide Model," encompasses the ac­
counting and financial reporting guidance in the 1973 AICPA Industry Audit 
Guide Audits of Colleges and Universities, as amended by SOP 74-8, Finan­
cial Accounting and Reporting by Colleges and Universities, and as modified by ‡
‡ GASB Statement No. 34, Basic Financial Statements—and Management's Discussion and 
Analysis—for State and Local Governments, supersedes the provisions of GASB Statement No. 29, 
The Use of Not-for-Profit Accounting and Financial Reporting Principles by Governmental Entities, 
relating to the use of the AICPA Not-for-Profit model. See GASB Statement No. 34, including para­
graph 147. The AICPA Audit and Accounting Guide State and Local Governments provides guidance 
on the application of this SOP to state and local governments. [Footnote revised, June 2004, to reflect 
conforming changes necessary due to the issuance of GASB Statement No. 34.]
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applicable FASB pronouncements issued through November 30, 1989, and all 
applicable GASB pronouncements. (The other model, referred to as the "Gov­
ernmental Model," is based on the pronouncements of the National Council on 
Governmental Accounting [NCGA] and the GASB.)||
D.5. For state and local governmental entities, some are required to report 
expenses by function using the functional classifications of program, manage­
ment and general, and fund raising. Other state and local governmental entities 
that report expenses or expenditures by function have a functional structure 
that does not include fund raising, program, or management and general. Still 
other state and local governmental entities do not report expenses or expen­
ditures by function. Examples of those various reporting requirements are as 
follows:#
•  Entities applying the accounting and financial reporting principles in
the AICPA Industry Audit Guide of Voluntary Health and Wel­
fare Organizations, as well as those that follow SOP 78-10 and that 
receive significant amounts of contributions from the public, are re­
quired to report separately the costs of the fund-raising, program, and 
management and general functions.
•  Entities applying the accounting and financial reporting principles in 
the AICPA Industry Audit Guide Audits of Colleges and Universities, 
as amended by SOP 74-8, are required to report fund raising as part 
of the "institutional support" function.
D.6. As discussed in footnote 3 to paragraph .01 of this SOP, this SOP is 
not intended to require reporting the functional classifications of fund raising, 
program, and management and general. Rather, those functional classifica­
tions are discussed throughout this SOP for purposes of illustrating how the 
guidance in this SOP would be applied by entities that use those functional 
classifications. Entities that do not use the functional classifications of fund 
raising, program, and management and general should apply the guidance in 
this SOP for purposes of accounting for joint activities, using their reporting 
model. For example, some entities may conduct membership-development ac­
tivities. As discussed in the Glossary [paragraph .30] of this SOP, if there are 
no significant benefits or duties connected with membership, the substance of 
the membership-development activities may, in fact, be fund raising. In such 
circumstances, the costs of those activities should be charged to fund raising. 
To the extent that member benefits are received, membership is an exchange 
transaction. In circumstances in which membership development is in part 
soliciting revenues from exchange transactions and in part soliciting contribu­
tions and the purpose, audience, and content of the activity are appropriate for 
achieving membership development, joint costs should be allocated between 
fund raising and the exchange transaction. 
|| GASB Statement No. 35, Basic Financial Statements—and Management's Discussion and 
Analysis—for Public Colleges and Universities, supersedes GASB Statement No. 15, Governmental 
College and University Accounting and Financial Reporting Models. See GASB Statements No. 34 
and No. 35. The AICPA Audit and Accounting Guide State and Local Governments provides guidance 
on the application of this SOP to governmental (public) colleges and universities. [Footnote revised, 
June 2004, to reflect conforming changes necessary due to the issuance of GASB Statement No. 35.]
# This discussion is no longer applicable. See footnotes ‡ and || in paragraphs D.3 and D.4, 
respectively. [Footnote added, June 2004, to reflect conforming changes necessary due to the issuance 
of GASB Statements No. 34 and No. 35.]
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Assigning Costs of Joint Activities
D.7. Paragraph .07 provides: "If the criteria of purpose, audience, and con­
tent are met, the costs of a joint activity that are identifiable with a particular 
function should be charged to that function and joint costs should be allocated 
between fund raising and the appropriate program or management and general 
function. If any of the criteria are not met, all costs of the joint activity should 
be reported as fund-raising costs, including costs that otherwise might be con­
sidered program or management and general costs if they had been incurred in 
a different activity...." For example, if the criteria are met, the costs of materi­
als that accomplish program goals and that are unrelated to fund raising, such 
as the costs of a program-related pamphlet included in a joint activity, should 
be charged to program, while joint costs, such as postage, should be allocated 
between fund raising and program. However, if the pamphlet is used in fund­
raising packets and the criteria are not met, the costs of the pamphlets used in 
the fund-raising packets, as well as the joint costs, should be charged to fund 
raising. (If some pamphlets are used in program activities that include no fund 
raising, the cost of the pamphlets used in those separate program activities 
that include no fund raising should be charged to program.)
Educational Activities
D.8. Some entities have missions that include educating the public (students) 
in areas other than causes. Paragraph .09 provides that, for those entities, 
educating the audience in areas other than causes or motivating the audience 
to engage in specific activities, such as attending a lecture or class, that will 
educate them in areas other than causes is considered a call for specific action 
by the recipients that will help accomplish the entity's mission. Educating the 
audience about causes or motivating the audience to engage in specific activities 
that will educate them about causes without educating them in other subjects is 
not considered a call for specific action by the audience that will help accomplish 
the entity’s mission. An example of a lecture or class that will educate students 
in an area other than causes is a lecture on the nesting habits of the bald eagle, 
given by the Save the Bald Eagle Society, an NPO whose mission is to save 
the bald eagle from extinction and educate the public about the bald eagle. An 
example of a lecture or class that will address particular causes is a lecture by 
the Bald Eagle Society on the potential extinction of bald eagles and the need 
to raise contributions to prevent their extinction. For purposes of applying the 
guidance in this SOP, motivating the audience to attend a lecture on the nesting 
habits of the bald eagle is a call for specific action that will help accomplish the 
entity's mission. If the lecture merely addresses the potential extinction of bald 
eagles and the need to raise contributions to prevent their extinction, without 
addressing the nesting habits of the bald eagle, motivating the audience to 
attend the lecture is not considered a call for specific action by the recipient 
that will help accomplish the entity's mission.
D.9. AcSEC notes that most transactions in which a student attends a lecture 
or class are exchange transactions and are not joint activities. Such transactions 
are joint activities only if the activity includes fund raising.
Audience
D.10. Paragraph .12 provides that a rebuttable presumption exists that the 
audience criterion is not met if the audience includes prior donors or is other­
wise selected based on its ability or likelihood to contribute to the entity. That
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presumption can be overcome if the audience is also selected for the program 
or management and general reasons specified in paragraph .13. Further, para­
graph .12 provides that in determining whether that presumption is overcome, 
entities should consider the extent to which the audience is selected based on 
its ability or likelihood to contribute to the entity and contrast that with the 
extent to which it is selected for the reasons that may overcome that presump­
tion. Some organizations conduct joint activities that are special events, such 
as symposia, dinners, dances, and theater parties, in which the attendee re­
ceives a direct benefit (for example, a meal or theater ticket) and for which the 
admission price includes a contribution. For example, it may cost $500 to at­
tend a dinner with a fair value of $50. In that case, the audience is required to 
make a $450 contribution in order to attend. In circumstances in which the au­
dience is required to make a contribution to participate in a joint activity, such 
as attending a special event, the audience's ability or likelihood to contribute 
is a significant factor in its selection. Therefore, in circumstances in which the 
audience is required to make a contribution to participate in a joint activity, the 
extent to which the audience is selected for the program or management and 
general reasons in paragraph .13 must be overwhelmingly significant in order 
to rebut the presumption that the audience criterion is not met.
D.11. The source of the names and the characteristics of the audience should 
be considered in determining the reason for selecting the audience. Some en­
tities use lists compiled by others to reach new audiences. The source of such 
lists may indicate the purpose or purposes for which they were selected. For 
example, lists acquired from entities with similar or related programs are more 
likely to meet the audience criterion than are lists acquired from entities with 
dissimilar or unrelated programs. Also, the characteristics of those on the lists 
may indicate the purpose or purposes for which they were selected. For example, 
a list based on a consumer profile of those who buy environmentally friendly 
products may be useful to an entity whose mission addresses environmental 
concerns and could therefore indicate that the audience was selected for its 
ability to take action to assist the entity in meeting program goals. However, a 
list based on net worth would indicate that the audience was selected based on 
its ability or likelihood to contribute, unless there was a correlation between 
net worth and the program or management and general components of the 
activity.
D.12. Some audiences may be selected because they have an interest in or 
affinity to the program. For example, homeowners may have an interest in the 
homeless because they are Sympathetic to the plight of the homeless. Never­
theless, including homeowners in the audience of a program activity to provide 
services to the homeless would not meet the audience criterion, because they 
do not have a need or reasonable potential for use of services to the homeless.
D.13. Paragraph .13c provides that the audience criterion is met if the en­
tity is required to direct the management and general component of the joint 
activity to the particular audience or the audience has reasonable potential for 
use of the management and general component. An example of a joint activ­
ity in which the audience is selected because the entity is required to direct 
the management and general component of the joint activity to the particular 
audience is an activity in which the entity sends a written acknowledgment or 
other information to comply with requirements of the Internal Revenue Service 
to prior donors and includes a request for contributions. An example of a joint 
activity in which the audience is selected because the audience has reasonable 
potential for use of the management and general component is an activity in
AAG-HCO APP C
310 Health Care Organizations
which the entity sends its annual report to prior donors and includes a request 
for contributions.
Content
D.14. Paragraph .14 provides that, to meet the content criterion, program 
activities should call for specific action by the recipient that will help accomplish 
the entity's mission. As discussed in the Glossary [paragraph .30], the action 
should benefit the recipient or society. Examples of actions that benefit the 
recipient (such as by improving the recipient's physical, mental, emotional, 
or spiritual health and well-being) or society (such as by addressing societal 
problems) include the following:
a. Actions that benefit the recipient:
•  Stop smoking. Specific methods, instructions, references, 
and resources should be suggested.
•  Do not use alcohol or drugs. Specific methods, instructions, 
references, and resources should be suggested.
b. Actions that benefit society:
•  Write or call. The party to communicate with and the sub­
ject matter to be communicated should be specified.
•  Complete and return the enclosed questionnaire. The re­
sults of the questionnaire should help the entity achieve 
its mission. For example, if the entity discards the ques­
tionnaire, it does not help the entity achieve its mission.
•  Boycott. The particular product or company to be boy­
cotted should be specified.
D.15. Paragraph .146 provides that to meet the content criterion, manage­
ment and general functions are required to fulfill one or more of the entity's 
management and general responsibilities through a component of the joint ac­
tivity. Some states or other regulatory bodies require that certain disclosures 
be included when soliciting contributions. Paragraph .14, footnote 9, of this 
SOP provides that for purposes of applying the guidance in this SOP, commu­
nications that include such required disclosures are considered fund-raising 
activities and are not considered management and general activities. Some 
examples of such disclosures include the following: •
•  Information filed with the attorney general concerning this charitable 
solicitation may be obtained from the attorney general of [the state] 
by calling 123-4567. Registration with the attorney general does not 
imply endorsement.
•  A copy of the registration and financial information may be obtained 
from the Division of Consumer Services by calling toll-free, within 
[the state], 1-800-123-4567. Registration does not imply endorsement, 
approval, or recommendation by [the state].
•  Information about the cost of postage and copying, and other informa­
tion required to be filed under [the state] law, can be obtained by calling 
123-4567.
•  The organization's latest annual report can be obtained by calling 123- 
4567.
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Allocation Methods
D.16. Paragraph .16 of this SOP states, "The cost allocation methodology 
used should be rational and systematic, it should result in an allocation of joint 
costs that is reasonable, and it should be applied consistently given similar facts 
and circumstances." The allocation of joint costs should be based on the degree 
to which costs were incurred for the functions to which the costs are allocated 
(that is, program, management and general, or fund raising). For purposes of 
determining whether the allocation methodology for a particular joint activity 
should be consistent with methodologies used for other particular joint activi­
ties, facts and circumstances that may be considered include factors related to 
the content and relative costs of the components of the activity. The audience 
should not be considered in determining whether the facts and circumstances 
are similar for purposes of determining whether the allocation methodology 
for a particular joint activity should be consistent with methodologies used for 
other particular joint activities.
Practicability of Measuring Joint Costs
D.17. The Glossary [paragraph .30] of this SOP includes a definition of joint 
costs. Some costs, such as utilities, rent, and insurance, commonly referred to 
as indirect costs, may be joint costs. For example, the telephone bill for a de­
partment that, among other things, prepares materials that include both fund­
raising and program components may commonly be referred to as an indirect 
cost. Such telephone bills may also be joint costs. However, for some entities, it 
is impracticable to measure and allocate the portion of the costs that are joint 
costs. Considerations about which joint costs should be measured and allocated, 
such as considerations about materiality and the costs and benefits of develop­
ing and providing the information, are the same as considerations about cost 
allocations in other circumstances.
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Appendix E
Illustrations of Applying the Criteria of Purpose, Audience, 
and Content to Determine W hether a  Program or M anagem ent 
and G eneral Activity H as Been Conducted
Illustration 1
Facts
E.1. Entity A's mission is to prevent drug abuse. Entity A's annual report 
states that one of its objectives in fulfilling that mission is to assist parents in 
preventing their children from abusing drugs.
E.2. Entity A mails informational materials to the parents of all junior high 
school students explaining the prevalence and dangers of drug abuse. The ma­
terials encourage parents to counsel children about the dangers of drug abuse 
and inform them about how to detect drug abuse. The mailing includes a re­
quest for contributions. Entity A conducts other activities informing the public 
about the dangers of drug abuse and encouraging parents to counsel their chil­
dren about drug abuse that do not include requests for contributions and that 
are conducted in different media. Entity As executive director is involved in 
the development of the informational materials as well as the request for con­
tributions. The executive director's annual compensation includes a significant 
bonus if total annual contributions exceed a predetermined amount.
Conclusion
E.3. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.4. The activity calls for specific action by the recipient (encouraging par­
ents to counsel children about the dangers of drug abuse and informing them 
about how to detect drug abuse) that will help accomplish the entity's mission. 
Therefore, the guidance in paragraph .10 should be considered. Neither of the 
factors in paragraph ,10a or .10b is determinative of whether the purpose cri­
terion is met. (Although Entity A's executive director's annual compensation 
varies based on annual contributions, the executive director's compensation 
does not vary based on contributions raised for this discrete joint activity.) 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because 
(a) the program component of this activity calls for specific action by the re­
cipient (encouraging parents to counsel children about the dangers of drug 
abuse) that will help accomplish the entity's mission, and it otherwise conducts 
the program activity in this illustration without a request for contributions, 
and (6) performing such programs helps accomplish Entity A's mission. (Note 
that had Entity A conducted the activity using the same medium on a scale 
that is similar to or greater than the scale on which it is conducted with the 
request for contributions, the purpose criterion would have been met under 
paragraph .10b.)
E.5. The audience criterion is met because the audience (parents of junior 
high school students) is selected based on its need to use or reasonable potential 
for use of the action called for by the program component.
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E.6. The content criterion is met because the activity calls for specific action 
by the recipient (encouraging parents to counsel children about the dangers of 
drug abuse and informing them about how to detect drug abuse) that will help 
accomplish the entity's mission (assisting parents in preventing their children 
from abusing drugs), and it explains the need for and benefits of the action (the 
prevalence and dangers of drug abuse).
Illustration 2
Facts
E.7. Entity B's mission is to reduce the incidence of illness from ABC disease, 
which afflicts a broad segment of the population. One of Entity B's objectives 
in fulfilling that mission is to inform the public about the effects and early 
warning signs of the disease and specific action that should be taken to prevent 
the disease.
E.8. Entity B maintains a list of its prior donors and sends them donor re­
newal mailings. The mailings include messages about the effects and early 
warning signs of the disease and specific action that should be taken to pre­
vent it. That information is also sent to a similar-sized audience but without 
the request for contributions. Also, Entity B believes that recent donors are 
more likely to contribute than nondonors or donors who have not contributed 
recently. Prior donors are deleted from the mailing list if they have not con­
tributed to Entity B recently, and new donors are added to the list. There is no 
evidence of a correlation between recent contributions and participation in the 
program component of the activity. Also, the prior donors' need to use or rea­
sonable potential for use of the messages about the effects and early warning 
sign s of the disease and specific action that should be taken to prevent it is an 
insignificant factor in their selection.
Conclusion
E.9. The purpose and content criteria are met. The audience criterion is not 
met.11 All costs, including those that might otherwise be considered program or 
management and general costs if they had been incurred in a different activity, 
should be charged to fund raising.
E.10. The activity calls for specific action by the recipient (action that should 
be taken to prevent ABC disease) that will help accomplish the entity's mission. 
Therefore, the guidance in paragraph .10 should be considered. The purpose 
criterion is met because (a) the program component of the activity calls for 
specific action by the recipient that will help accomplish the entity's mission 
(to reduce the incidence of illness from the disease), and (6) the program is 
also conducted using the same medium on a scale that is similar to or greater 
than the scale on which it is conducted with the request for contributions (a 
similar mailing is done without the request for contributions, to a similar-sized 
audience).
E.11. The audience criterion is not met. The rebuttable presumption that the 
audience criterion is not met because the audience includes prior donors is not
Paragraph .07 of this SOP provides that all costs of joint activities, except for costs of goods 
or services provided in exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event (for example, a meal), should be charged to fund raising if any of 
the criteria of purpose, audience, or content are not met. Accordingly, if one or more criteria are not 
met, the other criteria need not be considered. However, the illustrations in this Appendix provide 
conclusions about whether each of the criteria would be met in circumstances in which one or more 
criteria are not met in order to provide further guidance.
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overcome in this illustration. Although the audience has a need to use or rea­
sonable potential for use of the program component, that was an insignificant 
factor in its selection.
E.12. The content criterion is met because the activity calls for specific action 
by the recipient (actions to prevent ABC disease) that will help accomplish the 
entity's mission (to reduce the incidence of ABC disease), and it explains the 
need for and benefits of the action (to prevent ABC disease).
Illustration 3
Facts
E.13. Entity C's mission is to reduce the incidence of illness from ABC dis­
ease, which afflicts a broad segment of the population. One of Entity C's objec­
tives in fulfilling that mission is to increase governmental funding for research 
about ABC disease.
E.14. Entity C maintains a list of its prior donors and its employees call 
them on the telephone reminding them of the effects of ABC disease, asking for 
contributions, and encouraging them to contact their elected officials to urge 
increased governmental funding for research about ABC disease. The callers 
are educated about ABC, do not otherwise perform fund-raising functions, and 
are not compensated or evaluated based on contributions raised. Entity C's 
research indicates that recent donors are likely to contact their elected officials 
about such funding while nonrecent donors are not. Prior donors are deleted 
from the calling list if they have not contributed to Entity C recently, and new 
donors are added to the list.
Conclusion
E.15. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.16. The activity calls for specific action by the recipient (contacting elected 
officials concerning funding for research about ABC disease) that will help ac­
complish the entity's mission. Therefore, the guidance in paragraph .10 should 
be considered. Neither of the factors in paragraph .10a or .10b is determina­
tive of whether the purpose criterion is met. Therefore, other evidence, such as 
the indicators in paragraph .11, should be considered. The purpose criterion 
is met based on the other evidence, because (a) the qualifications and duties 
of the personnel performing the activity indicate that it is a program activity 
(the callers are educated about ABC and do not otherwise perform fund-raising 
functions), (6) the method of compensation for performing the activity does not 
indicate that it is a fund-raising activity (the employees are not compensated 
or evaluated based on contributions raised), and (c) performing such programs 
helps accomplish Entity C's mission.
E.17. The audience criterion is met because the audience (recent donors) 
is selected based on its ability to assist Entity C in meeting the goals of the 
program component of the activity (recent donors are likely to contact their 
elected officials about such funding while nonrecent donors are not).
E.18. The content criterion is met because the activity calls for specific action 
by the recipient (contacting elected officials concerning funding for research 
about ABC disease) that will help accomplish the entity's mission (to reduce 
the incidence of ABC disease), and it explains the need for and benefits of the 
action (to prevent ABC disease).
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Illustration 4
Facts
E.19. Entity D's mission is to improve the quality of life for senior citizens. 
One of Entity D's objectives included in that mission is to increase the physical 
activity of senior citizens. One of Entity D's programs to attain that objective 
is to send representatives to speak to groups about the importance of exercise 
and to conduct exercise classes.
E.20. Entity D mails a brochure on the importance of exercise that encour­
ages exercise in later years to residents over the age of sixty-five in three zip code 
areas. The last two pages of the four-page brochure include a perforated contri­
bution remittance form on which Entity D explains its program and makes an 
appeal for contributions. The content of the first two pages of the brochure is 
primarily educational; it explains how seniors can undertake a self-supervised 
exercise program and encourages them to undertake such a program. In addi­
tion, Entity D includes a second brochure on various exercise techniques that 
can be used by those undertaking an exercise program.
E.21. The brochures are distributed to educate people in this age group about 
the importance of exercising, to help them exercise properly, and to raise contri­
butions for Entity D. These objectives are documented in a letter to the public 
relations firm that developed the brochures. The audience is selected based on 
age, without regard to ability to contribute. Entity D believes that most of the 
recipients would benefit from the information about exercise.
Conclusion
E.22. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated. (Note that the costs of the second brochure should 
be charged to program because all the costs of the brochure are identifiable 
with the program function.)
E.23. The activity calls for specific action by the recipient (exercising) that 
will help accomplish the entity's mission. Therefore, the guidance in paragraph 
.10 should be considered. Neither of the factors in paragraph .10a or .10b is 
determinative of whether the purpose criterion is met. Therefore, other evi­
dence, such as the indicators in paragraph .11, should be considered. The pur­
pose criterion is met based on the other evidence, because (a) performing such 
programs helps accomplish Entity D's mission, and (b) the objectives of the pro­
gram are documented in a letter to the public relations firm that developed the 
brochure.
E.24. The audience criterion is met because the audience (residents over 
sixty-five in certain zip codes) is selected based on its need to use or reasonable 
potential for use of the action called for by the program component.
E1.25. The content criterion is met because the activity calls for specific action 
by the recipient (exercising) that will help accomplish the entity's mission (in­
creasing the physical activity of senior citizens), and the need for and benefits 
of the action are clearly evident (explains the importance of exercising).
Illustration 5
Facts
E.26. The facts are the same as those in Illustration 4, except that Entity E 
employs a fund-raising consultant to develop the first brochure and pays that 
consultant 30 percent of contributions raised.
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Conclusion
E.27. The content and audience criteria are met. The purpose criterion is not 
met, however, because a majority of compensation or fees for the fund-raising 
consultant varies based on contributions raised for this discrete joint activity 
(the fund-raising consultant is paid 30 percent of contributions raised). All costs 
should be charged to fund raising, including the costs of the second brochure and 
any other costs that otherwise might be considered program or management 
and general costs if they had been incurred in a different activity.
Illustration 6
Facts
E.28. Entity F's mission is to protect the environment. One of Entity F's 
objectives included in that mission is to take action that will increase the portion 
of waste recycled by the public.
E.29. Entity F conducts a door-to-door canvass of a community that recycles a 
low portion of its waste. The purpose of the activity is to help increase recycling 
by educating the community about environmental problems created by not re­
cycling, and to raise contributions. Based on the information communicated by 
the canvassers, the need for and benefits of the action are clearly evident. The 
ability or likelihood of the residents to contribute is not a basis for communi­
ties selected, and all neighborhoods in the geographic area are covered if their 
recycling falls below a predetermined rate. The canvassers are selected from 
individuals who are well-informed about the organization's environmental con­
cerns and programs and who previously participated as volunteers in program 
activities such as answering environmental questions directed to the organi­
zation and developing program activities designed to influence legislators to 
take actions addressing those concerns. The canvassers have not previously 
participated in fund-raising activities.
Conclusion
E.30. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.31. The activity calls for specific action by the recipient (implicitly—to help 
increase recycling) that will help accomplish the entity's mission. Therefore, the 
guidance in paragraph .10 should be considered. Neither of the factors in para­
graph .10a or .10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because 
(a) the qualifications and duties of the personnel performing the activity indi­
cate that it is a program activity (the canvassers are selected from individuals 
who are well-informed about the organization's environmental concerns and 
programs and who previously participated as volunteers in program activities 
such as answering environmental questions directed to the organization and 
developing program activities designed to influence legislators to take actions 
addressing those concerns), and (6) performing such programs helps accomplish 
Entity F's mission (to protect the environment).
E.32. The audience criterion is met because the audience (neighborhoods 
whose recycling falls below a predetermined rate) is selected based on its need 
to use or reasonable potential for use of the action called for by the program 
component.
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E.33. The content criterion is met because the activity calls for specific action 
by the recipient (implicitly—to help increase recycling) that will help accom­
plish the entity's mission (to protect the environment), and the need for and 
benefits of the action are clearly evident (increased recycling will help alleviate 
environmental problems).
Illustration 7
Facts
E.34. Entity G's mission is to provide summer camps for economically disad­
vantaged youths. Educating the families of ineligible youths about the camps 
is not one of the program objectives included in that mission.
E.35. Entity G conducts a door-to-door solicitation campaign for its camp 
programs. In the campaign, volunteers with canisters visit homes in middle- 
class neighborhoods to collect contributions. Entity G believes that people in 
those neighborhoods would not need the camp's programs but may contribute.
The volunteers explain the camp's programs, including why the disadvantaged 
children benefit from the program, and distribute leaflets to the residents re­
gardless of whether they contribute to the camp. The leaflets describe the camp, 
its activities, who can attend, and the benefits to attendees. Requests for con­
tributions are not included in the leaflets.
Conclusion
E.36. The purpose, audience, and content criteria are not met. All costs 
should be charged to fund raising.
E.37. The activity does not include a call for specific action because it only 
educates the audience about causes (describing the camp, its activities, who 
can attend, and the benefits to attendees). Therefore, the purpose criterion is 
not met.
E.38. The audience criterion is not met, because the audience is selected 
based on its ability or likelihood to contribute, rather than based on (a) its need 
to use or reasonable potential for use of the action called for by the program 
component, or (b) its ability to take action to assist the entity in meeting the 
goals of the program component of the activity. (Entity G believes that people in 
those neighborhoods would not need the camp's programs but may contribute.)
E.39. The content criterion is not met because the activity does not call for 
specific action by the recipient. (The content educates the audience about causes 
that the program is designed to address without calling for specific action.)
Illustration 8
Facts
E.40. Entity H's mission is to educate the public about lifesaving techniques 
in order to increase the number of lives saved. One of Entity H's objectives in 
fulfilling that mission, as stated in the minutes of the board's meetings, is to 
produce and show television broadcasts including information about lifesaving 
techniques.
E.41. Entity H conducts an annual national telethon to raise contributions 
and to reach the American public with lifesaving educational messages, such 
as summary instructions concerning dealing with certain life-threatening situ­
ations. Based on the information communicated by the messages, the need for 
and benefits of the action are clearly evident. The broadcast includes segments
AAG-HCO APP C
318 Health Care Organizations
describing Entity H's services. Entity H broadcasts the telethon to the entire 
country, not merely to areas selected on the basis of giving potential or prior 
fund raising results. Also, Entity H uses national television broadcasts devoted 
entirely to lifesaving educational messages to conduct program activities with­
out fund raising.
Conclusion
E.42. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.43. The activity calls for specific action by the recipient (implicitly—to save 
lives) that will help accomplish the entity's mission. Therefore, the guidance 
in paragraph .10 should be considered. The purpose criterion is met because 
(a) the program component of the activity calls for specific action by the recipi­
ent that will help accomplish Entity H's mission (to save lives by educating the 
public), and (b) a similar program activity is conducted without the fund raising 
using the same medium and on a scale that is similar to or greater than the 
scale on which it is conducted with the appeal (Entity H uses national televi­
sion broadcasts devoted entirely to lifesaving educational messages to conduct 
program activities without fund raising).
E.44. The audience criterion is met because the audience (a broad segment 
of the population) is selected based on its need to use or reasonable potential 
for use of the action called for by the program activity.
E.45. The content criterion is met because the activity calls for specific action 
by the recipient (implicitly—to save lives) that will help accomplish the entity's 
mission (to save lives by educating the public), and the need for and benefits of 
the action are clearly evident (saving lives is desirable).
Illustration 9
Facts
E.46. Entity I's mission is to provide food, clothing, and medical care to chil­
dren in developing countries.
E.47. Entity I conducts television broadcasts in the United States that de­
scribe its programs, show the needy children, and end with appeals for con­
tributions. Entity I's operating policies and internal management memoranda 
state that these programs are designed to educate the public about the needs 
of children in developing countries and to raise contributions. The employees 
producing the programs are trained in audiovisual production and are familiar 
with Entity I's programs. Also, the executive producer is paid $25,000 for this 
activity, with a $5,000 bonus if the activity raises over $1,000,000.
Conclusion
E.48. The purpose, audience, and content criteria are not met. All costs 
should be charged to fund raising.
E.49. The activity does not include a call for specific action because it only 
educates the audience about causes (describing its programs and showing the 
needy children). Therefore, the purpose criterion is not met. (Also, note that if 
the factor in paragraph .10a were considered, it would not be determinative of 
whether the purpose criterion is met. Although the executive producer will be 
paid $5,000 if the activity raises over $1,000,000, that amount would not be a 
majority of the executive producer's total compensation for this activity, because
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$5,000 would not be a majority of the executive producer's total compensation of 
$30,000 for this activity. Also, note that if other evidence, such as the indicators 
in paragraph .11, were considered, the purpose criterion would not be met based 
on the other evidence. Although the qualifications and duties of the personnel 
performing the activity indicate that the employees producing the program are 
familiar with Entity I's programs, the facts that some, but less than a majority, 
of the executive producer's compensation varies based on contributions raised, 
and that the operating policies and internal management memoranda state 
that these programs are designed to educate the public about the needs of 
children in developing countries [with no call for specific action by recipients] 
and to raise contributions, indicate that the purpose is fund raising.)
E.50. The audience criterion is not met because the audience is selected based 
on its ability or likelihood to contribute, rather than based on (a) its need to 
use or reasonable potential for use of the action called for by the program com­
ponent, or (b) its ability to take action to assist the entity in meeting the goals 
of the program component of the activity. (The audience is a broad segment of 
the population of a country that is not in need of or has no reasonable potential 
for use of the program activity.)
E..51. The content criterion is not met because the activity does not call for 
specific action by the recipient that will help accomplish the entity's mission. 
(The content educates the audience about the causes without calling for specific 
action.)
Illustration 10
Facts
E..52. Entity J  is a university that distributes its annual report, which in­
cludes reports on mission accomplishments, to those who have made signif­
icant contributions over the previous year, its board of trustees, and its em­
ployees. The annual report is primarily prepared by management and general 
personnel, such as the accounting department and executive staff. The activ­
ity is coordinated by the public relations department. Internal management 
memoranda indicate that the purpose of the annual report is to report on how 
management discharged its stewardship responsibilities, including the univer­
sity's overall performance, goals, financial position, cash flows, and results of 
operations. Included in the package containing the annual report are requests 
for contributions and donor reply cards.
Conclusion
E..53. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E..54. The activity has elements of management and general functions. 
Therefore, no call for specific action is required. Neither of the factors in para­
graph .10a or .10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because 
(a) the employees performing the activity are not members of the fund-raising 
department and perform other non-fund-raising activities and (6) internal man­
agement memoranda indicate that the purpose of the annual report is to fulfill 
one of the university's management and general responsibilities.
E.55. The audience criterion is met because the audience is selected based 
on its reasonable potential for use of the management and general component.
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Although the activity is directed primarily at those who have previously made 
significant contributions, the audience was selected based on its presumed in­
terest in Entity J's annual report (prior donors who have made significant con­
tributions are likely to have an interest in matters discussed in the annual 
report).
E.56. The content criterion is met because the activity (distributing annual 
reports) fulfills one of the entity's management and general responsibilities 
(reporting concerning management's fulfillment of its stewardship function).
Illustration 11
Facts
E.57. Entity K is an NPO. In accordance with internal management mem­
oranda documenting its policies requiring it to comply with Internal Revenue 
Service (IRS) regulations, it mails prior donors who have made quid pro quo 
payments in excess of $75 documentation required by the IRS. The documen­
tation is included on a perforated piece of paper. The information above the 
perforation line pertains to the documentation required by the IRS. The infor­
mation below the perforation line includes a request for contributions and may 
be used as a donor reply card.
Conclusion
E.58. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated. (Note that the costs of the information below the perforation 
line are identifiable with fund raising and therefore should be charged to fund 
raising.)
E.59. The activity has elements of management and general functions. 
Therefore, no call for specific action is required. Neither of the factors in para­
graph .10a or .10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because 
internal management memoranda indicate that the purpose of the activity is 
to fulfill one of Entity K's management and general responsibilities.
E.60. The audience criterion is met because the entity is required to direct the 
management and general component of the activity to the particular audience. 
Although the activity is directed at those who have previously contributed, the 
audience was selected based on its need for the documentation.
E.61. The content criterion is met because the activity (sending documenta­
tion required by the IRS) fulfills one of the entity's management and general 
responsibilities (complying with IRS regulations).
Illustration 12
Facts
E.62. Entity L is an animal rights organization. It mails a package of material 
to individuals included in lists rented from various environmental and other 
organizations that support causes that Entity L believes are congruent with 
its own. In addition to donor response cards and return envelopes, the package 
includes (a) materials urging recipients to contact their legislators and urge 
the legislators to support legislation to protect those rights, and (5) postcards 
addressed to legislators urging support for legislation restricting the use of 
animal testing for cosmetic products. The mail campaign is part of an overall
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strategy that includes magazine advertisements and the distribution of similar 
materials at various community events, some of which are undertaken without 
fund-raising appeals. The advertising and community events reach audiences 
similar in size and demographics to the audience reached by the mailing.
Conclusion
E.63. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.64. The activity calls for specific action by the recipient (mailing postcards 
to legislators urging support for legislation restricting the use of animal testing 
for cosmetic products) that will help accomplish the entity's mission. Therefore, 
the guidance in paragraph .10 should be considered. Neither of the factors in 
paragraph .10a or .10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because 
(a) the program component of this activity calls for specific action by the recip­
ient that will help accomplish the entity's mission, and it otherwise conducts 
the program activity in this illustration without a request for contributions, 
and (b) performing such programs helps accomplish Entity L's mission.
E.65. The audience criterion is met because the audience (individuals in­
cluded in lists rented from various environmental and other organizations that 
support causes that Entity L believes are congruent with its own) is selected 
based on its ability to take action to assist the entity in meeting the goals of the 
program component of the activity.
E.66. The content criterion is met because the activity calls for specific action 
by the recipient (mailing postcards to legislators urging support for legislation 
restricting the use of animal testing for cosmetic products) that will help ac­
complish the entity's mission (to protect animal rights), and the need for and 
benefits of the action are clearly evident (to protect animal rights).
Illustration 13
Facts
E.67. Entity M is a performing arts organization whose mission is to make 
the arts available to residents in its area. Entity M charges a fee for attending 
performances and sends advertisements, including subscription forms, for the 
performances to residents in its area. These advertisements include a return 
envelope with a request for contributions. Entity M evaluates the effectiveness 
of the advertising based on the number of subscriptions sold as well as contri­
butions received. In performing that evaluation. Entity M places more weight 
on the number of subscriptions sold than on the contributions received. Also, 
Entity M advertises the performances on local television and radio without a 
request for contributions but on a smaller scale than the mail advertising.
Conclusion
E.68. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.69. The activity calls for specific action by the recipient (attending the per­
formances) that will help accomplish the entity's mission. Therefore, the guid­
ance in paragraph .10 should be considered. Neither of the factors in paragraph 
.10a or .10b is determinative of whether the purpose criterion is met. Therefore, 
other evidence, such as the indicators in paragraph .11, should be considered.
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The purpose criterion is met based on the other evidence, because (a) the en­
tity measures program results and accomplishments of the joint activity and 
in evaluating the effectiveness of the activity, the entity places significantly 
greater weight on the activity's effectiveness in accomplishing program goals 
than on the activity's effectiveness in raising contributions (Entity M evaluates 
the effectiveness of the advertising based on the number of subscriptions sold 
as well as contributions received and places more weight on the number of sub­
scriptions sold than on the contributions received), (b) it otherwise conducts the 
program activity without a request for contributions, and (c) performing such 
programs helps accomplish Entity M's mission (to make the arts available to 
residents in its area).
E.70. The audience criterion is met because the audience (a broad segment 
of the population in Entity M's area) is selected based on its need to use or 
reasonable potential for use of the action called for by the program component.
E.71. The content criterion is met because the activity calls for specific action 
by the recipient (attending the performances) that will help accomplish the 
entity's mission (making the arts available to area residents), and the need 
for and benefits of the action are clearly evident (attending the performance is 
a positive cultural experience). (Note that the purchase of subscriptions is an 
exchange transaction and, therefore, is not a contribution.)
Illustration 14
Facts
E.72. Entity N is a university whose mission is to educate the public (stu­
dents) in various academic pursuits. Entity N's political science department 
holds a special lecture series in which prominent world leaders speak about 
current events. The speakers command relatively high fees and, in order to 
cover costs and make a modest profit, the university sets a relatively expensive 
fee to attend. However, the tickets are priced at the fair value of the lecture and 
no portion of the ticket purchase price is a contribution. Entity N advertises 
the lectures by sending invitations to prior attendees and to prior donors who 
have contributed significant amounts, and by placing advertisements in local 
newspapers read by the general public. At some of the lectures, including the 
lecture being considered in this illustration, deans and other faculty members 
of Entity N solicit significant contributions from attendees. Other lectures in 
the series are conducted on a scale similar to the scale of the lecture in this 
illustration without requesting contributions. Entity N's records indicate that 
historically 75 percent of the attendees have attended prior lectures. Of the 75 
percent who have attended prior lectures, 15 percent have made prior contri­
butions to Entity N. Of the 15 percent who have made prior contributions to 
Entity N, 5 percent have made contributions in response to solicitations made at 
the events. (Therefore, one-half of one percent of attendees make contributions 
in response to solicitations made at the events. However, those contributions 
are significant.) Overall, the audience's ability or likelihood to contribute is an 
insignificant factor in its selection. Entity N evaluates the effectiveness of the 
activity based on the number of tickets sold, as well as contributions received. 
In performing that evaluation, Entity N places more weight on the number of 
tickets sold than on the contributions received.
Conclusion
E.73. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
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E1.74. The activity calls for specific action by the recipient (attending the 
lecture) that will help accomplish the entity's mission. Therefore, the guidance 
in paragraph .10 should be considered. The purpose criterion is met because (a) 
the program component of the activity calls for specific action by the recipient 
that will help accomplish the entity's mission (educating the public [students] 
in various academic pursuits), and (b) the program is also conducted using the 
same medium on a scale that is similar to or greater than the scale on which 
it is conducted with the request for contributions (other lectures in the series 
are conducted on a scale similar to the scale of the lecture in this illustration 
without requesting contributions).
E .7 5 . The audience criterion is met. The rebuttable presumption that the au­
dience criterion is not met because the audience includes prior donors is over­
come in this illustration because the audience (those who have shown prior 
interest in the lecture series, prior donors, a broad segment of the population 
in Entity N's area, and those attending the lecture) is also selected for its rea­
sonable potential for use of the program component (attending the lecture). 
Although the audience may make significant contributions, that was an in­
significant factor in its selection.
E .7 6 . The content criterion is met because the activity calls for specific action 
by the recipient (attending the lecture) that will help accomplish the entity's 
mission (educating the public [students] in various academic pursuits), and the 
need for and benefits of the action are clearly evident (attending the lecture 
is a positive educational experience). (Note that the purchase of the tickets 
is an exchange transaction and, therefore, is not a contribution. As discussed 
in paragraph .07 of this SOP, costs of goods or services provided in exchange 
transactions that are part of joint activities, such as costs of direct donor benefits 
of a special event, should not be reported as fund raising. 12)
Illustration 15
Facts
E1.77. Entity O is a university whose mission is to educate the public (stu­
dents) in various academic pursuits. Entity O's political science department 
holds a special lecture series in which prominent world leaders speak about 
current events. Admission is priced at $250, which is above the $50 fair value 
of the lecture and, therefore, $200 of the admission price is a contribution. 
Therefore, the audience's likelihood to contribute to the entity is a significant 
factor in its selection. Entity O advertises the lectures by sending invitations to 
prior attendees and to prior donors who have contributed significant amounts, 
and by placing advertisements in local newspapers read by the general public. 
Entity O presents similar lectures that are priced at the fair value of those 
lectures.
Conclusion
E .7 8 . The purpose and content criteria are met. The audience criterion is not 
met. All costs, including those that might otherwise be considered program or 
management and general costs if they had been incurred in a different activity.
12 Paragraphs 13.21 to 13.26 of the Audit and Accounting Guide Not-for-Profit Organizations 
provide guidance concerning reporting special events. [Footnote revised, June 2004, to reflect con­
forming changes necessary due to conforming changes made to the AICPA Audit and Accounting 
Guide Not-for-Profit Organizations.]
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except for the costs of the direct donor benefit (the lecture), should be charged 
to fund raising.
E.79. The activity calls for specific action by the recipient (attending the 
lecture) that will help accomplish the entity's mission. Therefore, the guidance 
in paragraph .10 should be considered. The purpose criterion is met because (a) 
the program component of the activity calls for specific action by the recipient 
that will help accomplish the entity's mission (educating the public [students] 
in various academic pursuits), and (b) the program is also conducted using the 
same medium on a scale that is similar to or greater than the scale on which 
it is conducted with the request for contributions (other lectures in the series 
are conducted on a scale similar to the scale of the lecture in this illustration 
without including a contribution in the admission price.)
E.80. The audience criterion is not met. The rebuttable presumption that the 
audience criterion is not met because the audience is selected based on its like­
lihood to contribute to the entity is not overcome in this illustration. The fact 
that the $250 admission price includes a $200 contribution leads to the conclu­
sion that the audience's ability or likelihood to contribute is an overwhelmingly 
significant factor in its selection, whereas there is no evidence that the extent 
to which the audience is selected for its need to use or reasonable potential for 
use of the action called for by the program component (attending the lecture) 
is overwhelmingly significant.
E.81. The content criterion is met because the activity calls for specific action 
by the recipient (attending the lecture) that will help accomplish the entity's 
mission (educating the public [students] in various academic pursuits), and the 
need for and benefits of the action are clearly evident (attending the lecture 
is a positive educational experience). (Note that the purchase of the tickets 
is an exchange transaction and, therefore, is not a contribution. As discussed 
in paragraph .07 of this SOP, costs of goods or services provided in exchange 
transactions that are part of joint activities, such as costs of direct donor benefits 
of a special event, should not be reported as fund raising.13)
Illustration 16
Facts
E.82. Entity P's mission is to reduce the incidence of illness from ABC disease, 
which primarily afflicts people over sixty-five years of age. One of Entity P's 
objectives in fulfilling that mission is to have all persons over sixty-five screened 
for ABC disease.
E.83. Entity P rents space at events attended primarily by people over sixty- 
five years of age and conducts free screening for ABC disease. Entity P's em­
ployees, who are educated about ABC disease and screening procedures and do 
not otherwise perform fund-raising functions, educate interested parties about 
the effects of ABC disease and the ease and benefits of screening for it. Entity P 
also solicits contributions at the events. The effectiveness of the activity is eval­
uated primarily based on how many screening tests are performed, and only 
minimally based on contributions raised. The employees are not compensated 
or evaluated based on contributions raised.
Paragraphs 13.21 to 13.26 of the Audit and Accounting Guide Not-for-Profit Organizations 
provide guidance concerning reporting special events. [Footnote revised, June 2004, to reflect con­
forming changes necessary due to conforming changes made to the AICPA Audit and Accounting 
Guide Not-for-Profit Organizations.]
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Conclusion
E.84. The purpose, audience, and content criteria are met, and the joint costs 
should he allocated.
E.85. The activity calls for specific action by the recipient (being screened 
for ABC disease) that will help accomplish the entity's mission. Therefore, the 
guidance in paragraph .10 should be considered. Neither of the factors in para­
graph .10a or .10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because 
(a) a process exists to evaluate measured program results and accomplishments 
and in evaluating the effectiveness of the joint activity, the entity places signif­
icantly greater weight on the activity's effectiveness in accomplishing program 
goals than on the activity's effectiveness in raising contributions (Entity P eval­
uates the effectiveness of the activity based on the number of screening tests 
conducted as well as contributions received and places more weight on the 
number of tests conducted than on the contributions received); (6) the quali­
fications and duties of the personnel performing the activity indicate that it 
is a program activity (the employees are educated about ABC disease and the 
testing procedures and do not otherwise perform fund-raising functions); (c) the 
method of compensation for performing the activity does not indicate that it is 
a fund-raising activity (the employees are not compensated or evaluated based 
on contributions raised); and (d) performing such programs helps accomplish 
Entity P's mission (to prevent ABC disease).
E.86. The audience criterion is met because the audience (people over sixty- 
five years of age) is selected based on its need to use or reasonable potential for 
use of the action called for by the program component.
E.87. The content criterion is met because the activity calls for specific action 
by the recipient (being screened for ABC disease) that will help accomplish the 
entity's mission (to reduce the incidence of ABC disease), and it explains the 
need for and benefits of the action (to prevent ABC disease).
Illustration 17
Facts
E.88. Entity Q's mission is to provide cultural and educational television 
programming to residents in its area. Entity Q owns a public television station 
and holds a membership drive in which it solicits new members. The drive is 
conducted by station employees and consists of solicitations that are shown 
during long breaks between the station's regularly scheduled programs. Entity 
Q's internal management memoranda state that these drives are designed to 
raise contributions. Entity Q evaluates the effectiveness of the activity based 
on the amount of contributions received. Entity Q shows the programs on a 
similar scale, without the request for contributions. The audience is members 
of the general public who watch the programs shown during the drive. Station 
member benefits are given to those who contribute and consist of tokens of 
appreciation with a nominal value.
Conclusion
E.89. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated. (Note that there would be few, if any, joint costs. Costs as­
sociated with the fund-raising activities, such as costs of airtime, would be 
separately identifiable from costs of the program activities, such as licensing
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costs for a particular television program. Also, note that because no significant 
benefits or duties are associated with membership, member dues are contribu­
tions. Therefore, the substance of the membership-development activities is, in 
fact, fund raising.)
E.90. The activity calls for specific action by the recipient (watching the tele­
vision program) that will help accomplish the entity's mission. Therefore, the 
guidance in paragraph .10 should be considered. The purpose criterion is met 
because (a) the program component of the activity calls for specific action by the 
recipient that will help accomplish the entity's mission, and (b) the program is 
also conducted using the same medium on a scale that is similar to or greater 
than the scale on which it is conducted with the request for contributions (En­
tity Q shows the television programs on a similar scale, without the request for 
contributions).
E.91. The audience criterion is met. The rebuttable presumption that the 
audience criterion is not met because the audience is selected based on its like­
lihood to contribute is overcome in this illustration because the audience (mem­
bers of the general public who watch the television programs shown during the 
drive) is also selected for its reasonable potential for use of the program com­
ponent (watching the television programs). Although the audience may make 
contributions, that was an insignificant factor in its selection.
E.92. The content criterion is met because the activity calls for specific action 
by the recipient (watching the television programs) that will help accomplish 
the entity's mission (providing cultural and educational television program­
ming to residents in its area), and the need for and benefits of the action are 
clearly evident (watching the programs is a positive cultural and educational 
experience).
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Illustrations of Allocation Methods
F.1. Some commonly used cost allocation methods follow.
Physical Units Method
F.2. Joint costs are allocated to materials and activities in proportion to the 
number of units of output that can be attributed to each of the materials and 
activities. Examples of units of output are lines, square inches, and physical 
content measures. This method assumes that the benefits received by the fund­
raising, program, or management and general component of the materials or ac­
tivity from the joint costs incurred are directly proportional to the lines, square 
inches, or other physical output measures attributed to each component of the 
activity. This method may result in an unreasonable allocation of joint costs if 
the units of output, for example, line counts, do not reflect the degree to which 
costs are incurred for the joint activity. Use of the physical units method may 
also result in an unreasonable allocation if the physical units cannot be clearly 
ascribed to fund raising, program, or management and general. For example, 
direct mail and telephone solicitations sometimes include content that is not 
identifiable with fund raising, program, or management and general; or the 
physical units of such content are inseparable.
Illustration
F.3. Assume a direct mail campaign is used to conduct programs of the entity 
and to solicit contributions to support the entity and its programs. Further, 
assume that the appeal meets the criteria for allocation of joint costs to more 
than one function.
F.4. The letter and reply card include a total of one hundred lines. Forty-five 
lines pertain to program because they include a call for action by the recipient 
that will help accomplish the entity's mission, while fifty-five lines pertain to 
the fund-raising appeal. Accordingly, 45 percent of the costs are allocated to 
program and 55 percent to fund-raising.
Relative Direct Cost Method
F.5. Joint costs are allocated to each of the components on the basis of their 
respective direct costs. Direct costs are those costs that are incurred in con­
nection with the multipurpose materials or activity and that are specifically 
identifiable with a function (program, fund raising, or management and gen­
eral). This method may result in an unreasonable allocation of joint costs if the 
joint costs of the materials and activity are not incurred in approximately the 
same proportion and for the same reasons as the direct costs of the materials 
and activity. For example, if a relatively costly booklet informing the reader 
about the entity's mission (including a call for action by the recipient that will 
help accomplish the entity's mission) is included with a relatively inexpensive 
fund-raising letter, the allocation of joint costs based on the cost of these pieces 
may be unreasonable, particularly if the booklet and letter weigh approximately 
the same and therefore contribute equally to the postage costs.
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F.6. The costs of a direct mail campaign that can be specifically identified with 
program services are the costs of separate program materials and a postcard 
which calls for specific action by the recipient that will help accomplish the 
entity's mission. They total $20,000. The direct costs of the fund-raising com­
ponent of the direct mail campaign consist of the costs to develop and produce 
the fund-raising letter. They total $80,000. Joint costs associated with the di­
rect mail campaign total $40,000 and would be allocated as follows under the 
relative direct cost method:
Program $20,000/$100,000 x $40,000 = $8,000 
Fund raising $80,000/$100,000 x $40,000 = $32,000
Stand-Alone Joint-Cost-Allocation Method
F.7. Joint costs are allocated to each component of the activity based on a ratio 
that uses estimates of costs of items included in joint costs that would have been 
incurred had the components been conducted independently. The numerator 
of the ratio is the cost (of items included in joint costs) of conducting a single 
component independently; the denominator is the cost (of items included in joint 
costs) of conducting all components independently. This method assumes that 
efforts for each component in the stand-alone situation are proportionate to the 
efforts actually undertaken in the joint cost situation. This method may result 
in an unreasonable allocation because it ignores the effect of each function, 
which is performed jointly with other functions, on other such functions. For 
example, the programmatic impact of a direct mail campaign or a telemarketing 
phone message may be significantly lessened when performed in conjunction 
with a fund-raising appeal.
Illustration
F.8. Assume that the joint costs associated with a direct mail campaign in­
cluding both program and fund-raising components are the costs of stationery, 
postage, and envelopes at a total of $100,000. The costs of stationery, postage, 
and envelopes to produce and distribute each component separately would have 
been $90,000 for the program component and $70,000 for the fund-raising com­
ponent. Under the stand-alone joint-cost-allocation method, the $100,000 in 
joint costs would be allocated as follows: $90,000/$160,000 x $100,000 = $56,250 
to program services and $70,000/$160,000 x $100,000 = $43,750 to fund raising.
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Illustrations of Disclosures
G.1. The disclosures discussed in paragraphs .18 and .19 are illustrated be­
low. Alternative 1 reports the required and encouraged information in narrative 
format. Alternative 2 reports that information in tabular format, as well as in­
formation concerning joint costs incurred for each kind of activity by functional 
classification, which is neither required nor encouraged, but which is not pro­
hibited.
Alternative 1
Note X. Allocation of Joint Costs
In 19XX, the organization conducted activities that included 
requests for contributions, as well as program and manage­
ment and general components. Those activities included di­
rect mail campaigns, special events, and a telethon. The costs 
of conducting those activities included a total of $310,000 of 
joint costs, which are not specifically attributable to particular 
components of the activities (joint costs). [Note to reader: The 
following sentence is encouraged but not required.] Joint costs 
for each kind of activity were $50,000, $150,000, and $110,000 
respectively. These joint costs were allocated as follows;
Fund raising $180,000
Program A 80,000
Program B 40,000
Management and general 10,000
Total $310,000
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Alternative 2
Note X. Allocation of Joint Costs
In 19XX, the organization conducted activities that included 
appeals for contributions and incurred joint costs of $310,000. 
These activities included direct mail campaigns, special 
events, and a telethon. Joint costs were allocated as follows:
Special
Direct Mail Events Telethon Total
Fund raising $40,000 $50,000 $90,000 $180,000
Program A 10,000 65,000 5,000 80,000
Program B 25,000 15,000 40,000
Management and general 10,000 10,000
Total $50,000 $150,000 $110,000 $310,000
[Note to reader: Shading is used to highlight information that is neither required 
nor encouraged, but which is not prohibited. However, entities may prefer to 
disclose it. Disclosing the total joint costs for each kind of activity ($50,000, 
$150,000, and $110,000) is encouraged but not required.]
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Appendix H
Contrast of Guidance in This SO P W ith the Guidance  
in SO P 8 7 -2 14,**
This SOP
Applies to all entities that solicit con­
tributions, including state and local 
governments.
Covers all costs of joint activities. 
(Costs that otherwise might be con­
sidered program or management 
and general costs if they had been 
incurred in a different activity, ex­
cept for costs of goods or services pro­
vided in exchange transactions that 
are part of joint activities, such as 
costs of direct donor benefits of a 
special event [for example, a meal], 
should be charged to fund raising un­
less the criteria in the SOP are met.)
Criteria of purpose, audience, and 
content should all be met in order 
to charge costs of the activity to pro­
gram or management and general. *
SOP 87-2
Applied to entities that follow the 
AICPA Industry Audit Guide Au­
dits of Voluntary Health and Welfare 
Organizations or SOP 78-10. (SOP 
87-2 was not applicable to entities 
that are within the scope of Govern­
mental Accounting Standards Board 
Statement No. 29, The Use of Not-for- 
Profit Accounting and Financial Re­
porting Principles by Governmental 
Entities.)
Covers only joint costs of joint 
activities.
Unclear concerning whether all cri­
teria should be met in order to charge 
costs of the activity to program or 
management and general.
14 In August 1996, the AICPA issued the Audit and Accounting Guide Not-for-Profit Orga­
nizations, which superseded SOP 87-2, Accounting for Joint Costs of Informational Materials and 
Activities of Not-for-Profit Organizations That Include a Fund-Raising Appeal, because the guidance 
in SOP 87-2 is incorporated into paragraphs 13.36 to 13.45 of the Guide. Also, Not-for-Profit Or­
ganizations superseded the AICPA Industry Audit Guide Audits of Voluntary Health and Welfare 
Organizations and SOP 78-10. Not-for-Profit Organizations applies to all nongovernmental not-for- 
profit organizations other than those required to follow the Audit and Accounting Guide Health Care 
Organizations. Therefore, incorporating the guidance in SOP 87-2 into Not-for-Profit Organizations 
broadened the scope of the guidance previously included in SOP 87-2 to all not-for-profit organizations 
other than those required to follow Health Care Organizations. The discussion in this SOP of SOP 
87-2 refers to both SOP 87-2 and the guidance included in paragraphs 13.36 to 13.45 of Not-for-Profit 
Organizations, except that the guidance in Not-for-Profit Organizations applies to all not-for-profit 
organizations other than those required to follow Health Care Organizations.
* See footnotes ‡ and || in paragraphs D.3 and D.4, respectively. [Footnote revised, June 2004, 
to reflect conforming changes necessary due to the issuance of GASB Statements No. 34 and No. 35.]
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This SOP
Neither prescribes nor prohibits any 
allocation methods. Includes a dis­
cussion to help users determine 
whether an allocation is reasonable, 
and provides some illustrations.
Requires note disclosures about the 
types of activities for which joint 
costs have been incurred, amounts 
allocated during the period, and 
amounts allocated to each functional 
expense or expenditure category.
SOP 87-2
Neither prescribes nor prohibits any 
allocation methods. No illustrations 
are provided.
Requires less extensive note disclo­
sures: total amount allocated during 
the period and amounts allocated to 
each functional expense category.
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Effects on Other Guidance
I.1. For nongovernmental organizations, this Statement of Position (SOP) 
amends the AICPA Audit and Accounting Guide Health Care Organizations 
and paragraphs 13.35 to 13.44 of the AICPA Audit and Accounting Guide Not- 
for-Profit Organizations. [Revised, June 2004, to reflect conforming changes 
necessary due to conforming changes made to the AICPA Audit and Accounting 
Guide Not-for-Profit Organizations.]
I.2. Also, this SOP amends the AICPA Audit and Accounting Guide Not- 
for-Profit Organizations to clarify that costs of goods or services provided in 
exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event (for example, a meal), should not be reported as 
fund-raising. In particular, paragraphs 13.21, 13.23, and 13.24 of Not-for-Profit 
Organizations are amended as follows:
13.21 Some organizations conduct joint activitiesfn 9 that 
are special events, including special social and educational 
events (such as symposia, dinners, dances, and theater par­
ties) in which the attendee receives a direct benefit (for ex­
ample, a meal or theater ticket). FASB Statement No. 117 
requires the reporting of the gross amounts of revenues and 
expenses from special events and other fund-raising activities 
that are ongoing major or central activities, but permits (but 
does not require) reporting net amounts if the receipts and 
related costs result from special events that are peripheral or 
incidental activities.
13.23 For example, assume that an organization has a spe­
cial event that is an ongoing and major activity with a ticket 
price of $100. Assume that the activity does not meet the au­
dience criterion in SOP 98-2, Accounting for Costs of Activities 
of Not-for-Profit Organizations and State and Local Govern­
mental Entities That Include Fund Raising, and, therefore, 
all costs of the activity, other than the direct donor benefi ts, 
should be reported as fund raising. The event includes a din­
ner that costs the organization $25 and that has a fair value of 
$30. (Chapter 5, "Contributions Received and Agency Trans­
actions," of this Guide, discusses the appropriate reporting 
if the meal or other items of value are donated to the or­
ganization for resale.) In addition, the organization incurs 
other direct costs of the event in connection with promot­
ing and conducting the event, including incremental direct 
costs incurred in transactions with independent third parties 
and the payroll and payroll-related costs for the activities of 
employees who are directly associated with, and devote time 
to, the event. Those other direct costs, which include (a) $5 
that otherwise might be considered management and gen­
eral costs if they had been incurred in a different activity, 
and (b) fund-raising costs of $10, are unrelated to the direct 
benefits to donors and, accordingly, should not be included as 
costs of benefi ts to donors. In addition, the organization has
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the following transactions, which are unrelated to the special 
event; unrestricted contributions of $200, program expenses 
of $60, management and general expenses of $20, and fund­
raising expenses of $20.
13.24 Some ways in which the organization could display 
the results of the special event as part of its statement of 
activities are illustrated as follows:
Illustration 1
Changes in unrestricted net assets: 
Contributions 
Special event revenue 
Less: Costs of direct benefits to donors 
Net revenues from special events 
Contributions and net revenues 
from special events 
Other expenses:
Program
Management and general 
Fund raising
Total other expenses 
Increase in unrestricted net assets
Illustration 2
Changes in unrestricted net assets: 
Revenues:
Contributions 
Special event revenue
Total revenues 
Expenses:
Program
Costs of direct benefits to donors 
Management and general 
Fund raising 
Total expenses
Increase in unrestricted net assets
Illustration 3
Changes in unrestricted net assets: 
Contributions 
Dinner sales
Less: Costs of direct benefits to donors 
Gross profit on special events
Contributions and net revenues 
from special events 
Other expenses:
Program
Management and general 
Fund raising
Total other expenses 
Increase in unrestricted net assets
100
(25)
$200
275
60
20
35
115
$160
$200
100
300
60
25
20
140
$160
$270
30
(25)
5
275
60
20
35
115
$160
AAG-HCO APP C
334 Health Care Organizations
See footnote 1.
[Revised, June 2004, to reflect conforming changes necessary due to conforming 
changes made to the AICPA Audit and Accounting Guide Not-for-Profit Orga­
nizations.]
I.3. For governmental entities that have applied the accounting and financial 
reporting principles in SOP 78-10, Accounting Principles and Reporting Prac­
tices for Certain Nonprofit Organizations, or the AICPA Industry Audit Guide 
Audits of Voluntary Health and Welfare Organizations (modified by all appli­
cable Financial Accounting Standards Board [FASB] pronouncements issued 
through November 30, 1989, and by most applicable Governmental Accounting 
Standards Board [GASB] pronouncements) in conformity with GASB State­
ment No. 29, The Use of Not-for-Profit Accounting and Financial Reporting 
Principles by Governmental Entities, this SOP amends the principles—based 
on SOP 78-10 and Audits of Voluntary Health and Welfare Organizations, as 
modified—that those entities apply. For governmental entities that have ap­
plied the accounting and financial reporting principles in the 1973 AICPA In­
dustry Audit Guide Audits of Colleges and Universities, as amended by SOP 
74-8, Financial Accounting and Reporting by Colleges and Universities, and 
as modified by applicable FASB pronouncements issued through November 30, 
1989, and all applicable GASB pronouncements in conformity with GASB State­
ment No. 15, Governmental College and University Accounting and Financial 
Reporting Models, this SOP amends the principles—based on Audits of Colleges 
and Universities, as amended and modified—that those entities apply. For other 
governmental organizations, this SOP amends the Audit and Accounting Guide 
Audits of State and Local Governmental Units.†
† See footnotes ‡ and || in paragraphs D.3 and D.4, respectively. Also, the AICPA Audit and 
Accounting Guide State and Local Governments supersedes the 1994 AICPA Audit and Accounting 
Guide Audits of State and Local Governmental Units and subsequent editions of that Guide with 
conforming changes made by the AICPA staff. The AICPA Audit and Accounting Guide State and 
Local Governments, provides guidance on the application of this SOP to state and local governments. 
[Footnote added, June 2004, to reflect conforming changes necessary due to the issuance of GASB 
Statements No. 34, No. 35, and the AICPA Audit and Accounting Guide Audits of State and Local 
Governmental Units.]
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Glossary
Activities. Activities are efforts to accomplish specific objectives. Some activi­
ties include producing and distributing materials. For example, if an entity 
undertakes a mass mailing that includes a letter and a pamphlet, produc­
ing and distributing the letter and pamphlet are part of the activity. Other 
activities may include no materials, such as an annual dinner or a radio 
commercial.
Compensation or fees. Reciprocal transfers of cash or other assets in ex­
change for services performed.
Contributions. Contributions are unconditional transfers of cash or other as­
sets to an entity or a settlement or cancellation of its liabilities in a vol­
untary nonreciprocal transfer by another entity acting other than as an 
owner.
Costs of joint activities. Costs of joint activities are costs incurred for a joint 
activity. Costs of joint activities may include joint costs and costs other 
than joint costs. Costs other than joint costs are costs that are identifiable 
with a particular function, such as fund raising, program, management and 
general, and cost of sales. For example, some costs incurred for printing, 
paper, professional fees, and salaries to produce donor cards are not joint 
costs, although they may be incurred in connection with conducting joint 
activities.
Fund-raising activities. Fund-raising activities are activities undertaken to 
induce potential donors to contribute money, securities, services, materi­
als, facilities, other assets, or time. They include publicizing and conducting 
fund-raising campaigns; maintaining donor mailing lists; conducting spe­
cial fund-raising events; preparing and distributing fund-raising manuals, 
instructions, and other materials; and conducting other activities involved 
with soliciting contributions from individuals, foundations, governments, 
and others.
Help accomplish the entity's mission. Actions that help accomplish the 
entity's mission are actions that either benefit the recipient (such as by 
improving the recipient's physical, mental, emotional, or spiritual health 
and well-being) or benefit society (by addressing societal problems).
Joint activity. A joint activity is an activity that is part of the fund-raising 
function and has elements of one or more other functions, such as pro­
gram, management and general, membership development, or any other 
functional category used by the entity.
Joint costs. Joint costs are the costs of conducting joint activities that are 
not identifiable with a particular component of the activity. For example, 
the cost of postage for a letter that includes both fund-raising and program 
components is a joint cost. Joint costs may include the costs of salaries, con­
tract labor, consultants, professional fees, paper, printing, postage, event 
advertising, telephones, airtime, and facility rentals.
Management and general activities. Management and general activities 
are those that are not identifiable with a single program, fund-raising ac­
tivity, or membership-development activity but that are indispensable to
.30
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the conduct of those activities and to an organization's existence. They 
include oversight, business management, general recordkeeping, budget­
ing, financing, soliciting revenue from exchange transactions, such as gov­
ernment contracts and related administrative activities, and all manage­
ment and administration except for direct conduct of program services or 
fund-raising activities. Disseminating information to inform the public of 
the organization’s "stewardship" of contributed funds, announcements con­
cerning appointments, and the annual report, among other activities, are 
management and general activities, as are soliciting funds other than con­
tributions, including exchange transactions (whether program-related or 
not).
Medium. A medium is a means of mass communication, such as direct mail, 
direct response advertising, or television.
Membership-development activities. Membership-development activities 
include soliciting for prospective members and membership dues, member­
ship relations, and similar activities. If there are no significant benefits or 
duties connected with membership, however, the substance of membership- 
development activities may, in fact, be fund-raising.
Program activities. Program activities are the activities that result in goods 
or services being distributed to beneficiaries, customers, or members that 
fulfill the purposes or mission for which the organization exists. Those ser­
vices are the major purpose for and the major output of the organization 
and often relate to several major programs. For example, a large univer­
sity may have programs for student instruction, research, and patient care, 
among others. Similarly, a health and welfare organization may have pro­
grams for health and family services, research, disaster relief, and public 
education, among others.
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NOTE
This Statement of Position presents the recommendations of the 
AICPA Health Care Pilot Task Force regarding the application of State­
ments on Standards for Attestation Engagements to agreed-upon pro­
cedures attestation engagements performed to assist a health care 
provider in evaluating the effectiveness of its corporate compliance pro­
gram consistent with the requirements of a Corporate Integrity Agree­
ment entered into with the Office of Inspector General of the U.S. De­
partment of Health and Human Services. The Auditing Standards Board 
has found the recommendations in this Statement of Position to be con­
sistent with existing standards covered by Rule 202 of the AICPA Code 
of Professional Conduct. AICPA members should be prepared to justify 
departures from the recommendations in this Statement of Position.
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Sum m ary
This Statement of Position (SOP) provides guidance to practitioners in con­
ducting and reporting on an agreed-upon procedures engagement performed 
pursuant to the AICPA Statements on Standards for Attestation Engagements 
to assist a health care provider in evaluating the effectiveness of its corporate 
compliance program consistent with the requirements of a Corporate Integrity 
Agreement (CIA) entered into with the Office of Inspector General (OIG) of the 
U.S. Department of Health and Human Services. CIAs are specific to the entity 
involved; consequently, users of this SOP should be familiar with the specific 
requirements of the entity's CIA.
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Introduction and Background
.01 Within the past several years, the health care industry has experienced 
a significant increase in the number and magnitude of allegations of fraud 
and abuse involving federal health care programs (for example, Medicare and 
Medicaid) and private health care insurance. These allegations have triggered 
regu latory scrutiny, litigation, significant monetary settlements, and negative 
publicity related to—among other things—coding and billing practices, patient 
referrals, cost reporting, quality of care, and clinical practices. Typically, as 
part of the global resolution of these allegations, the entity enters into a Cor­
porate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of 
the U.S. Department of Health and Human Services. Such agreements require 
that management annually report on its compliance with the terms of the CIA 
and that there be an assessment of the entity's compliance with the CIA. This 
assessment includes a billing analysis, which may be performed by an indepen­
dent review organization (such as a practitioner or consultant) or the provider 
(if permitted by the OIG), and an agreed-upon procedures engagement.
.02 This SOP provides guidance to practitioners in conducting and re­
porting on an agreed-upon procedures engagement performed pursuant to the 
American Institute of Certified Public Accountants (AICPA) Statements on 
Standards for Attestation Engagements (SSAEs) to assist an entity in eval­
uating the effectiveness of its corporate compliance program consistent with 
the requirements of a CIA.1 The terms of a CIA are unique to the entity; con­
sequently, users of this SOP need to be familiar with the actual CIA and its 
requirements.
.03 This SOP applies to agreed-upon procedures engagements to assist 
in evaluating an entity's compliance for a specified period. Such engagements 
should follow the AICPA attestation standards, including SSAE No. 1, Attesta­
tion Standards] SSAE No. 3, Compliance Attestation] and SSAE No. A, Agreed- 
Upon Procedures Engagements. The engagement should be conducted in accor­
dance with standards established by the AICPA, including the criteria set forth 
in this SOP. However, this SOP is not intended to provide all the required crite­
ria set forth in individual CIAs, nor all the applicable standards established by 
the AICPA. Additionally, the SOP contains some guidance that may be applied 
in evaluating an organization's corporate compliance program, even though the 
program was not imposed by a CIA.
O verv iew  of a  Typical Corporate Integrity Agreem ent
.04 A CIA is an agreement between a health care provider and the OIG in 
conjunction with a global settlement of a fraud investigation. Such an agree­
ment typically seeks to establish a compliance program within the health care 
provider (for example, hospital, clinical lab, physician group) that will promote 
compliance with the requirements of Medicare, Medicaid, and all other federal 
health care programs.
1 The practitioner also might be engaged to assist in other areas beyond an agreed-upon pro­
cedures engagement such as providing consulting services in connection with evaluating the com­
pany's billing practices, policies, and procedures as required by the CIA or in implementing, assessing, 
and reporting on voluntarily adopted compliance programs. In addition, the practitioner may assist 
in preparing an entity's self-disclosure reports to federal health agencies related to billing errors 
and other compliance matters. Similarly, practitioners may be involved in an entity's preparation of 
government-required (but not CIA-imposed) compliance reporting (for example, contract requirements 
for Medicare part C) beyond an agreed-upon procedures engagement.
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.05 CIAs are case-specific. Their terms are tailored to address the organi­
zational and operating deficiencies related to providing and billing for health 
care services that have been identified by the OIG, the entity, or others. Detailed 
compliance requirements are imposed as a condition for continued participa­
tion in federal health care programs. A sample CIA, provided by the OIG and 
intended to identify potential requirements, is included in appendix A [para­
graph .32], "Sample Corporate Integrity Agreement." Typical agreements cover 
five years and require the entity to address the following areas:
•  Appointment of a compliance officer and establishment of a compliance
committee
Establishment of a code of conduct
Establishment of policies and procedures regarding the compliance 
program
Development of an information and education program as to CIA re­
quirements, compliance program and code of conduct 
Annual assessment of billing policies, procedures, and practices 
Establishment of a confidential disclosure program 
Prohibition of employment of excluded or convicted persons 
Notification to OIG of investigation or legal proceedings 
Reporting of credible evidence of misconduct 
Notifications to OIG of new provider locations 
Provision of implementation and annual reports 
Proper notification and submission of required reports 
Granting of OIG access to documents and individuals to conduct as­
sessments
Documentation of record retention requirements 
Awareness of disclosure criteria
Agreement to comply with certain default provisions, penalties, and 
remedies
Review of rights as to dispute resolution 
Review of effective and binding agreement clauses
Conditions for Engagem ent Perform ance
.06 A practitioner may perform an agreed-upon procedures engagement 
related to management's compliance with a CIA if all of the conditions specified 
in SSAE No. 4 and SSAE No. 3 are met.
.07 As discussed more fully in the SSAEs noted in paragraph .06, manage­
ment's assertions as to its compliance must be capable of evaluation against 
reasonable criteria that either have been established by a recognized body or are 
stated in or attached to the practitioner's report in a sufficiently clear and com­
prehensive manner. Generally, to avoid confusion, management's assertions, 
which are based on the specific terms of its CIA, should be attached to the prac­
titioner's report. If the entity is not subject to a CIA, management may develop 
its assertions using the model CIA. A sample based on the model CIA, which 
is not meant to be all-inclusive, is included as appendix B [paragraph .33], 
"Sample Statement of Management's Assertions."
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Establishing an Understanding With the Client
.08 The practitioner should document the understanding in the working 
papers, preferably through a written communication with the client, such as 
an engagement letter. Appendix C [paragraph .34], "Sample Engagement Let­
ter," contains a sample engagement letter that may be used for this kind of 
engagement.
Users' Responsibilities
.09 Users typically would be the management of the health care provider 
and the OIG. Management is responsible for ensuring that the entity complies 
with the requirements of the CIA. That responsibility encompasses (a) iden­
tifying applicable compliance requirements, (b) establishing and maintaining 
internal control policies and procedures to provide reasonable assurance that 
the entity complies with those requirements, (c) evaluating and monitoring the 
entity's compliance, and (d) preparing reports that satisfy legal, regulatory, or 
contractual requirements. Management's evaluation may include documenta­
tion such as accounting or statistical data, policy manuals, accounting manu­
als, narrative memoranda, procedural write-ups, flowcharts, completed ques­
tionnaires, internal auditors' reports, and other special studies or analyses. The 
form and extent of documentation will vary depending on the nature of the com­
pliance requirements and the size and complexity of the entity. Management 
may engage the practitioner to gather information to assist it in evaluating the 
entity's compliance. Regardless of the procedures performed by the practitioner, 
management must accept responsibility for its assertions and must not base 
such assertions solely on the practitioner's procedures.
.10 Specified users are responsible for the sufficiency (nature, timing, and 
extent) of the agreed-upon procedures because they best understand their own 
needs. The specified users assume the risk that such procedures might be insuf­
ficient for their purposes. In addition, the specified users assume the risk that 
they might misunderstand or otherwise inappropriately use findings properly 
reported by the practitioner.
Practitioner's Responsibilities
.11 The objective of the practitioner's agreed-upon procedures is to present 
specific findings to assist users in evaluating an entity's compliance with the 
rec[uirements specified in the CIA. (See appendix D [paragraph .35], "Sample 
Procedures.")
.12 The practitioner's procedures generally may be as limited or extensive 
as the specified users desire, as long as the specified users agree upon the pro­
cedures performed or to be performed and take responsibility for the sufficiency 
of the agreed-upon procedures for their purposes.
.13 To satisfy the requirements that the practitioner and the specified users 
agree upon the procedures performed or to be performed and that the specified 
users take responsibility for the sufficiency of the agreed-upon procedures for 
their purposes, ordinarily the practitioner should communicate directly with 
and obtain affirmative acknowledgment from each of the specified users. For 
the purposes of these engagements, an effective way to obtain this agreement 
ordinarily is to distribute a draft of the report, detailing the procedures, that is 
expected to be issued to the OIG with a request for any comments it may have.
.14 To avoid possible misunderstandings, the practitioner should circulate 
the draft with a legend stating that these are the procedures expected to be
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performed, and unless informed otherwise, the practitioner assumes that there 
are no additional procedures that he or she is expected to perform. A legend 
such as the following might be used.
This draft is furnished solely for the purpose of indicating 
the form of report that we would expect to be able to fur­
nish pursuant to the request by Management of [Provider] for 
our performance of limited procedures relating to [Provider's] 
compliance with the Corporate Integrity Agreement with the 
Office of Inspector General (OIG) of the U.S. Department of 
Heath and Human Services. Based on our discussions with 
[Provider], it is our understanding that the procedures out­
lined in this draft report are those we are expected to follow. 
Unless informed otherwise within ninety (90) days of this 
transmittal, we shall assume that there are no additional 
procedures that we are expected to follow. The text of the 
definitive report will depend, of course, on the results of the 
procedures.
Involvement of a  Specialist2
.15 The practitioner’s education and experience enable him or her to be 
knowledgeable about business matters in general, but he or she is not expected 
to have the expertise of a person trained for or qualified to engage in the prac­
tice of another profession or occupation. In certain circumstances, it may be 
appropriate to involve a specialist to assist the practitioner in the performance 
of one or more procedures. The following are examples:
•  An attorney might provide assistance concerning the application of 
laws, regulations, or rules to a client's situation.
•  A medical specialist might provide assistance in understanding the 
characteristics of diagnosis codes documented in patient medical 
records.
.16 The practitioner and the specified users should agree to the involve­
ment of a specialist in assisting a practitioner in the performance of an agreed- 
upon procedures engagement. This agreement may be reached when obtaining 
agreement on the procedures performed or to be performed and acknowledg­
ment of responsibility for the sufficiency of the procedures, as discussed pre­
viously. The practitioner's report should describe the nature of the assistance 
provided by the specialist.
.17 A practitioner may agree to apply procedures to the report or work 
product of a specialist that does not constitute assistance by the specialist 
to the practitioner in an agreed-upon procedures engagement. For example, 
the practitioner may make reference to information contained in a report 
of a specialist in describing an agreed-upon procedure. However, it is inap­
propriate for the practitioner to agree to merely read the specialist's report 
solely to describe or repeat the findings, or to take responsibility for all or a 
portion of any procedures performed by a specialist or the specialist's work 
product.
2 A specialist is a person (or firm) possessing special skill or knowledge in a particular field 
other than the attest function. As used herein, a specialist does not include a person employed by the 
practitioner’s firm who participates in the attestation engagement.
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Internal Auditors and Other Personnel3
.18 The agreed-upon procedures to be enumerated or referred to in the 
practitioner's report are to be performed entirely by the practitioner except 
as discussed in paragraphs .16-.18 of this SOP. However, internal auditors or 
other personnel may prepare schedules, accumulate data, perform an internal 
assessment of management's compliance, or provide other information for the 
practitioner's use in performing the agreed-upon procedures.
.19 A practitioner may agree to perform procedures on information docu­
mented in the working papers of internal auditors. For example, the practitioner 
may agree to—
•  Repeat all or some of the procedures.
•  Determine whether the internal auditors' working papers contain doc­
umentation of procedures performed and whether the findings docu­
mented in the working papers are presented in a report by the internal 
auditors.
.20 However, it is inappropriate for the practitioner to—
• Agree to merely read the internal auditor's report solely to describe or 
repeat its findings.
•  Take responsibility for all or a portion of any procedures performed by 
internal auditors by reporting those findings as the practitioner's own.
•  Report in any manner that implies shared responsibility for the pro­
cedures with the internal auditors.
Planning the Engagem ent
.21 Planning an agreed-upon procedures engagement involves working 
with the users to develop an overall strategy for the expected conduct and 
scope of the engagement. To develop such a strategy, practitioners should have 
adequate technical training and proficiency in the attestation standards and 
have adequate knowledge in health care regulatory matters to enable them to 
sufficiently understand the events, transactions, and practices that, in their 
judgment, have a significant effect on the presentation of the assertions.
W orking Papers
.22 The practitioner should prepare and maintain working papers in con­
nection with an engagement under the attestation standards; such working 
papers should be appropriate to the circumstances and the practitioner's needs 
on the engagement to which they apply.
.23 Concern over access to the practitioner's working papers might cause 
some clients to inquire about working paper requirements. In situations where 
the practitioner is requested to not maintain copies of certain client documen­
tation, or to not prepare and maintain documentation similar to client docu­
ments, the practitioner may refer to the Auditing Interpretation, "The Auditor's 
Consideration of the Completeness Assertion" (AICPA, Professional Standards, 
vol. 1, AU sec. 9326.06-.17), for guidance. See the Attest Interpretation, "Pro­
viding Access to or Photocopies of Working Papers to a Regulator," for guidance
3 SAS No. 65, The Auditor's Consideration of the Internal Audit Function in an Audit of Finan­
cial Statements (AICPA, Professional Standards, vol. 1, AU sec. 322), does not apply to agreed-upon 
procedures engagements.
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related to providing access to or photocopies of working papers to a regulator 
in connection with work performed on an attestation engagement.
M anagem ent's Representations
.24 The practitioner should obtain written representation from manage­
ment on various matters including the following:
a. Acknowledging management's responsibility for complying with 
the CIA
b. Acknowledging management's responsibility for establishing and 
maintaining effective internal control over compliance
c. Stating that management has performed an evaluation of the en­
tity's compliance with CIA-specified requirements
d. Stating management's assertions about the entity's compliance 
with all aspects of the CIA, including the specific issues that gave 
rise to the CIA4
e. Stating that management has disclosed to the practitioner all 
known noncompliance with the CIA
f. Stating that management has made available all documentation 
relating to compliance with the CIA
g. Stating management's interpretation of any compliance require­
ments that have varying interpretations
h. Stating that management has disclosed any communication from 
regulatory agencies, internal auditors, legal counsel, and other par­
ties concerning matters regarding the design, implementation, and 
monitoring of the policies and procedures in place, including com­
munication received between the end of the reporting period and 
the date of the practitioner's report (the date of signature)
i. Stating that management has disclosed any known noncompliance 
occurring subsequent to the end of the reporting period
j. Describing any related material fraud or abuse, other fraud, abuse 
or illegal acts that, whether or not material, involve management or 
other employees who have a significant role in the entity's design, 
implementation, and monitoring of the policies and procedures in 
place upon which compliance is based
k. Stating that management has disclosed to the practitioners, orally 
or in writing, information about past noncompliance issues cov­
ered in the settlement agreement that gave rise to the CIA and the 
related corrective measures taken to support compliance in those 
areas *•
4 Depending on the circumstances, representations in the following areas might be appropriate.
•  Violations or possible violations of laws or regulations, such as those related to the Medicare 
and Medicaid antifraud and abuse statutes
•  Compliance of third-party billings with applicable coding guidelines (for example, ICD-9- 
CM, CPT) and laws and regulations (including medical necessity, proper approvals, and 
proper rendering of care)
•  Proper filing of all required Medicare, Medicaid, and similar reports under the applicable 
reimbursement rules and regulations (including nature of costs—allowable, patient-related, 
properly allocated, in accordance with applicable rules and regulations, properly adjusted 
to refl ect prior audit adjustments) and adequacy of disclosures (including disputed costs)
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Management’s refusal to furnish all appropriate written representations con­
stitutes a limitation on the scope of the engagement sufficient to require with­
drawal from the engagement.
Reporting Considerations
.25 A practitioner should present the results of applying agreed-upon pro­
cedures to the specific subject matter in the form of findings. The practitioner 
should not provide negative assurance about whether the assertion is fairly 
stated in accordance with established or stated criteria. For example, the prac­
titioner should not include a statement that "nothing came to my attention that 
caused me to believe that the assertion is not fairly stated in accordance with 
(established or stated) criteria."
.26 The practitioner should report all findings from the application of the 
agreed-upon procedures. The concept of materiality does not apply to findings 
to be reported in an agreed-upon procedures engagement unless the definition 
of materiality is agreed to by the specified users. Any agreed-upon materiality 
limits should be described in the practitioner's report.
.27 The practitioner has no obligation to perform procedures beyond the 
agreed-upon procedures. However, if noncompliance related to management's 
assertion comes to the practitioner's attention by other means, such information 
ordinarily should be included in his or her report.
.28 The practitioner may become aware of noncompliance related to man­
agement's assertion that occurs subsequent to the reporting period but before 
the date of the practitioner's report. The practitioner should consider including 
information regarding such noncompliance in his or her report. However, the 
practitioner has no responsibility to perform procedures to detect such noncom­
pliance other than obtaining management's representation about noncompli­
ance in the subsequent period.
.29 The practitioner should follow the reporting guidance in SSAE No. 4. 
A sample report is included in appendix E [paragraph .36], "Sample Report."
.30 Evaluating compliance with certain requirements may require inter­
pretation of the laws, regulations, rules, contracts, or other agreements that 
establish those requirements. In such situations, the practitioner should con­
sider whether he or she is provided with the reasonable criteria required to 
evaluate an assertion under the third general attestation standard. If these in­
terpretations are significant, the practitioner may include a paragraph stating 
the description and the source of interpretations made by the entity's manage­
ment. An example of such a paragraph, which should precede the procedures 
and findings paragraph(s), follows:
We have been informed that, under [name of entity's] inter­
pretation of [identify the compliance requirement], [explain 
the nature and source of the relevant interpretation].
.31 The date of completion of the agreed-upon procedures should be used 
as the date of the practitioner's report.
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A ppendix A
Sam ple Corporate integrity Agreem ent 
Between the O ffice of Inspector G eneral 
of the Departm ent of Health and  
Hum an Services and [Provider]
I. Preamble
[Provider] ("[Provider]") hereby enters into this Corporate Integrity Agree­
ment ("CIA") with the Office of Inspector General ("OIG") of the United States 
Department of Health and Human Services ("HHS") to ensure compliance by its 
employees with the requirements of Medicare, Medicaid and all other Federal 
health care programs (as defined in 42 U.S.C. 1320a-7b(f)) (hereinafter collec­
tively referred to as the "Federal health care programs"). [Provider's] compli­
ance with the terms and conditions in this CIA shall constitute an element of 
[Provider's] present responsibility with regard to participation in the Federal 
health care programs. Contemporaneously with this CIA, [Provider] is entering 
into a Settlement Agreement with the United States, and this CIA is incorpo­
rated by reference into the Settlement Agreement.
II. Term of the CIA
The period of the compliance obligations assumed by [Provider] under this CIA 
shall be 5 years from the effective date of this CIA (unless otherwise specified). 
The effective date of this CIA will be the date on which the final signatory of 
this CIA executes this CIA (the "effective date").*
III. Corporate Integrity Obligations
[Provider] shall establish a compliance program that includes the following 
elements;
A . Compliance Officer
Within ninety (90) days after the effective date of this CIA, 
[Provider] shall appoint an individual to serve as Compliance 
Officer, who shall be responsible for developing and imple­
menting policies, procedures, and practices designed to en­
sure compliance with the requirements set forth in this CIA 
and with the requirements of the Federal health care pro­
grams. The Compliance Officer shall be a member of senior 
management of [Provider], shall make regular (at least quar­
terly) reports regarding compliance matters directly to the 
CEO and/or to the Board of Directors of [Provider] and shall 
be authorized to report to the Board of Directors at any time. 
The Compliance Officer shall be responsible for monitoring 
the day-to-day activities engaged in by [Provider] to further its 
compliance objectives as well as any reporting obligations cre­
ated under this CIA. In the event a new Compliance Officer is 
appointed during the term of this CIA, [Provider] shall notify 
the OIG, in writing, within fifteen (15) days of such a change.
* Source: Office of the Inspector General of the United States Department of Health and Human 
Services.
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[Provider] shall also appoint a Compliance Committee within 
ninety (90) days after the effective date of this CIA. The Com­
pliance Committee shall, at a minimum, include the Compli­
ance Officer and any other appropriate officers as necessary 
to meet the requirements of this CIA within the provider's 
corporate structure (e.g., senior executives of each major de­
partment, such as billing, clinical, human resources, audit, 
and operations). The Compliance Officer shall chair the Com­
pliance Committee and the Committee shall support the Com­
pliance Officer in fulfilling his/her responsibilities.
B. W ritten S tan dards
1. Code of Conduct. Within ninety (90) days of the effec­
tive date of this CIA, [Provider] shall establish a Code 
of Conduct. The Code of Conduct shall be distributed 
to all employees within ninety (90) days of the effective 
date of this CIA. [Provider] shall make the promotion 
of, and adherence to, the Code of Conduct an element 
in evaluating the performance of managers, supervi­
sors, and all other employees. The Code of Conduct 
shall, at a minimum, set forth:
a. [Provider's] commitment to full compliance 
with all statutes, regulations, and guidelines 
applicable to Federal health care programs, 
including its commitment to prepare and sub­
mit accurate billings consistent with Federal 
health care program regulations and pro­
cedures or instructions otherwise communi­
cated by the Health Care Financing Admin­
istration ("HCFA") (or other appropriate reg­
ulatory agencies) and/or its agents;
b. [Provider's] requirement that all of its em­
ployees shall be expected to comply with all 
statutes, regulations, and guidelines applica­
ble to Federal health care programs and with 
[Provider's] own policies and procedures (in­
cluding the requirements of this CIA);
c. the requirement that all of [Provider's] em­
ployees shall be expected to report suspected 
violations of any statute, regulation, or guide­
line applicable to Federal health care pro­
grams or with [Provider's] own policies and 
procedures;
d. the possible consequences to both [Provider] 
and to any employee of failure to comply with 
all statutes, regulations, and guidelines ap­
plicable to Federal health care programs and 
with [Provider's] own policies and procedures 
or of failure to report such non-compliance; 
and
e. the right of all employees to use the con­
fidential disclosure program, as well as
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[Provider's] commitment to confidentiality 
and non-retaliation with respect to disclo­
sures.
Within ninety (90) days of the effective date of the 
CIA, each employee shall certify, in writing, that he 
or she has received, read, understands, and will abide 
by [Provider's] Code of Conduct. New employees shall 
receive the Code of Conduct and shall complete the 
required certification within two (2) weeks after the 
commencement of their employment or within ninety 
(90) days of the effective date of the CIA, whichever is 
later.
[Provider] will annually review the Code of Conduct 
and will make any necessary revisions. These revi­
sions shall be distributed within thirty (30) days of 
initiating such a change. Employees shall certify on 
an annual basis that they have received, read, under­
stand and will abide by the Code of Conduct.
2. Policies and Procedures. Within ninety (90) days of 
the effective date of this CIA, [Provider] shall de­
velop and initiate implementation of written Policies 
and Procedures regarding the operation of [Provider's] 
compliance program and its compliance with all fed­
eral and state health care statutes, regulations, and 
guidelines, including the requirements of the Federal 
health care programs. At a minimum, the Policies 
and Procedures shall specifically address [insert lan­
guage relevant to allegations in the case]. In addition, 
the Policies and Procedures shall include disciplinary 
guidelines and methods for employees to make dis­
closures or otherwise report on compliance issues to 
[Provider] management through the Confidential Dis­
closure Program required by section III.E. [Provider] 
shall assess and update as necessary the Policies and 
Procedures at least annually and more frequently, as 
appropriate. A summary of the Policies and Proce­
dures will be provided to OIG in the Implementation 
Report. The Policies and Procedures will be available 
to OIG upon request.
Within ninety (90) days of the effective date of the 
CIA, the relevant portions of the Policies and Proce­
dures shall be distributed to all appropriate employ­
ees. Compliance staff or supervisors should be avail­
able to explain any and all policies and procedures.
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C. Training an d  E ducation
General Training. Within ninety (90) days of the effec­
tive date of this CIA, [Provider] shall provide at least 
two (2) hours of training to each employee. This gen­
eral training shall explain [Provider's]:
a. Corporate Integrity Agreement require­
ments;
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b. Compliance Program (including the Policies 
and Procedures as they pertain to general 
compliance issues); and
c. Code of Conduct.
These training materials shall be made available to 
the OIG, upon request.
New employees shall receive the general training de­
scribed above within thirty (30) days of the beginning 
of their employment or within ninety (90) days after 
the effective date of this CIA, whichever is later. Each 
year, every employee shall receive such general train­
ing on an annual basis.
Specific Training. Within ninety (90) days of the effec­
tive date of this CIA, each employee who is involved 
directly or indirectly in the delivery of patient care 
and/or in the preparation or submission of claims for 
reimbursement for such care (including, but not lim­
ited to, coding and billing) for any Federal health care 
programs shall receive at least [insert number of train­
ing hours] hours of training in addition to the general 
training required above. This training shall include a 
discussion of:
a. the submission of accurate bills for services 
rendered to Medicare and/or Medicaid pa­
tients;
b. policies, procedures and other requirements 
applicable to the documentation of medical 
records;
c. the personal obligation of each individual in­
volved in the billing process to ensure that 
such billings are accurate;
d. applicable reimbursement rules and statutes;
e. the legal sanctions for improper billings; and
f. examples of proper and improper billing prac­
tices.
These training materials shall be made available to 
OIG, upon request. Persons providing the training 
must be knowledgeable about the subject area.
Affected new employees shall receive this training 
within thirty (30) days of the beginning of their em­
ployment or within ninety (90) days of the effective 
date of this CIA, whichever is later. If a new employee 
has any responsibility for the delivery of patient care, 
the preparation or submission of claims and/or the as­
signment of procedure codes prior to completing this 
specific training, a [Provider] employee who has com­
pleted the substantive training shall review all of the 
untrained person's work regarding the assignment of 
billing codes.
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Each year, every employee shall receive such specific 
training on an annual basis.
3. Certification. Each employee shall certify, in writing, 
that he or she has attended the required training. The 
certification shall specify the type of training received 
and the date received. The Compliance Officer shall 
retain the certifications, along with specific course ma­
terials. These shall be made available to OIG upon 
request.
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D. Review Procedures
[Provider] shall retain an entity, such as an accounting, audit­
ing or consulting firm (hereinafter "Independent Review Or­
ganization"), to perform review procedures to assist [Provider] 
in assessing the adequacy of its billing and compliance prac­
tices pursuant to this CIA. This shall be an annual require­
ment and shall cover a twelve (12) month period. The In­
dependent Review Organization must have expertise in the 
billing, coding, reporting and other requirements of the Fed­
eral health care programs from which [Provider] seeks reim­
bursement. The Independent Review Organization must be 
retained to conduct the assessment of the first year within 
ninety (90) days of the effective date of this CIA. For pur­
poses of complying with this review procedures requirement, 
the OIG at its discretion, may permit the [Provider] to uti­
lize internal auditors to perform the review(s). In such case, 
the [Provider] will engage the Independent Review Organiza­
tion to verify the propriety of the internal auditors' methods 
and accuracy of their results. The [Provider] will request the 
Independent Review Organization to produce a report on its 
findings which report shall be included in the Annual Report 
to the OIG.
The Independent Review Organization (or the [Provider], 
if permitted by the OIG, as set forth above) will con­
duct two separate engagements. One will be an analysis of 
[Provider's] billing to the Federal health care programs to as­
sist the [Provider] and OIG in determining compliance with 
all applicable statutes, regulations, and directives/guidance 
("billing engagement"). The second engagement will assist the 
[Provider] and OIG in determining whether [Provider] is in 
compliance with this CIA ("compliance engagement").
1. Billing Engagement. The billing engagement shall 
consist of a review of a statistically valid sample of 
claims for the relevant period. The sample size shall 
be determined through the use of a probe sample.1 At 
a minimum, the full sample must be within a ninety 
(90) percent confidence level and a precision of twenty- 
five (25) percent. The probe sample must contain at 
least thirty (30) sample units and cannot be used as 
part of the full sample. Both the probe sample and
1 Probe sample is defined as a small, random preliminary sample.
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the sample must be selected through random num­
bers. [Provider] shall use OIG's Office of Audit Ser­
vices Statistical Sampling Software, also known as 
"RAT-STATS", which is available through the Inter­
net at www.hhs.gov/progorg/ratstat.html.
Each annual billing engagement analysis shall in­
clude the following components in its methodology:
a. Billing Engagement Objective: Provide a 
statement stating clearly the objective in­
tended to be achieved by the billing engage­
ment and the procedure or combination of 
procedures that will be applied to achieve the 
objective.
h. Billing Engagement Population: Identify the 
population, which is the group about which 
information is needed. Explain the method­
ology used to develop the population and pro­
vide the basis for this determination.
c. Sources of Data: Provide a full description of 
the source of the information upon which the 
billing engagement conclusions will be based, 
including the legal or other standards ap­
plied, documents relied upon, payment data, 
and/or any contractual obligations.
d. Sampling Unit: Define the sampling unit, 
which is any of the designated elements that 
comprise the population of interest.
e. Sampling Frame: Identify the sampling 
frame, which is the totality of the sampling 
units from which the sample will be selected.
As part of the billing engagement:
a. Inquire of management as to the procedures 
and controls affecting the billing process sub­
ject to the annual assessment as specified in 
the CIA. Document that aspect of the billing 
process (e.g., flow of documents, processing 
activities), and those controls that will be 
tested in the sample. The documentation may 
consist of flow charts, excerpts from policies 
and procedures manuals, control question­
naires, etc.
b. Report the sample results, including the over­
all error rate and the nature of the er­
rors found (e.g., no documentation, inade­
quate documentation, assignment of incor­
rect code).
c. Document findings related to [Provider's] 
procedures to correct inaccurate billings and 
codings to the Federal health care programs 
and findings regarding the steps [Provider] is
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taking to bring its operations into compliance 
or to correct problems identified by the audit.
2. Agreed-upon Procedures or Compliance Engage­
ment. An Independent Review Organization (or the 
[Provider], if permitted by the OIG) shall also con­
duct an agreed-upon procedures or compliance en­
gagement, which shall assist the users in determining 
whether [Provider's] program, policies, procedures, 
and operations comply with the terms of this CIA. This 
engagement shall include a section by section analysis 
of the requirements of this CIA.
A complete copy of the Independent Review Organi­
zation's billing and agreed-upon procedures or com­
pliance engagement shall be included in each of 
[Provider's] Annual Reports to OIG.
3. Disclosure of Overpayments and Material Deficien­
cies. If, as a result of these engagements, [Provider] 
or the Independent Review Organization identifies 
any hilling, coding or other policies, procedures and/or 
practices that result in an overpayment, [Provider] 
shall notify the payor (e.g., Medicare fiscal intermedi­
ary or carrier) within 30 days of discovering the defi­
ciency or overpayment and take remedial steps within 
60 days of discovery (or such additional time as may 
be agreed to by the payor) to correct the problem, in­
cluding preventing the deficiency from recurring. The 
notice to the payor shall include:
a. a statement that the refund is being made 
pursuant to this CIA;
b. a description of the complete circumstances 
surrounding the overpayment;
c. the methodology by which the overpayment 
was determined;
d. the amount of the overpayment;
e. any claim-specific information used to de­
termine the overpayment (e.g., beneficiary 
health insurance number, claim number, ser­
vice date, and payment date);
f . the cost reporting period; and
g. the provider identification number under 
which the repayment is being made.
If [Provider] determines an overpayment repre­
sents a material deficiency, contemporaneous with 
[Provider's] notification to the payor as provided 
above, [Provider] shall also notify OIG of:
a. a complete description of the material defi­
ciency;
b. amount of overpayment due to the material 
deficiency;
Health Care Organizations
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c. [Provider's] action(s) to correct and prevent 
such material deficiency from recurring;
d. the payor's name, address, and contact per­
son where the overpayment was sent;
e. the date of the check and identification num­
ber (or electronic transaction number) on 
which the overpayment was repaid.
For purposes of this CIA, an "overpayment" shall 
mean the amount of money the provider has received 
in excess of the amount due and payable under the 
Federal health care programs' statutes, regulations or 
program directives, including carrier and intermedi­
ary instructions.
For purposes of this CIA, a "material deficiency" shall 
mean anything that involves: (i) a substantial over­
payment or improper payment relating to the Medi­
care and/or Medicaid programs; (ii) conduct or policies 
that clearly violate the Medicare and/or Medicaid 
statute, regulations or directives issued by HCFA 
and/or its agents; or (iii) serious quality of care im­
plications for federal health care beneficiaries or re­
cipients. A material deficiency may be the result of an 
isolated event or a series of occurrences.
Verification/ Validation. In the event that the OIG de­
termines that it is necessary to conduct an indepen­
dent review to determine whether or the extent to 
which [Provider] is complying with its obligations un­
der this CIA, [Provider] agrees to pay for the reason­
able cost of any such review or engagement by the OIG 
or any of its designated agents.
E. Confidential Disclosure Program
Within ninety (90) days after the effective date of this CIA, 
[Provider] shall establish a Confidential Disclosure Program, 
which must include measures (e.g., a toll-free compliance tele­
phone line) to enable employees, contractors, agents or other 
individuals to disclose, to the Compliance Officer or some 
other person who is not in the reporting individual's chain of 
command, any identified issues or questions associated with 
[Provider's] policies, practices or procedures with respect to 
the Federal health care program, believed by the individual 
to be inappropriate. [Provider] shall publicize the existence of 
the hotline (e.g., e-mail to employees or post hotline number 
in prominent common areas).
The Confidential Disclosure Program shall emphasize a non­
retribution, non-retaliation policy, and shall include a report­
ing mechanism for anonymous, confidential communication. 
Upon receipt of a complaint, the Compliance Officer (or de­
signee) shall gather the information in such a way as to elicit 
all relevant information from the individual reporting the al­
leged misconduct. The Compliance Officer (or designee) shall 
make a preliminary good faith inquiry into the allegations
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set forth in every disclosure to ensure that he or she has ob­
tained all of the information necessary to determine whether 
a further review should be conducted. For any disclosure that 
is sufficiently specific so that it reasonably: (1) permits a de­
termination of the appropriateness of the alleged improper 
practice, and (2) provides an opportunity for taking corrective 
action, [Provider] shall conduct an internal review of the alle­
gations set forth in such a disclosure and ensure that proper 
follow-up is conducted.
The Compliance Officer shall maintain a confidential dis­
closure log, which shall include a record and summary of 
each allegation received, the status of the respective inves­
tigations, and any corrective action taken in response to the 
investigation.
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F. Ineligible Persons
[Provider] shall not hire or engage as contractors any "Ineli­
gible Person." For purposes of this CIA, an "Ineligible Person" 
shall be any individual or entity who: (i) is currently excluded, 
suspended, debarred or otherwise ineligible to participate in 
the Federal health care programs; or (ii) has been convicted 
of a criminal offense related to the provision of health care 
items or services and has not been reinstated in the Federal 
health care programs after a period of exclusion, suspension, 
debarment, or ineligibility.
Within ninety (90) days of the effective date of this CIA, 
[Provider] will review its list of current employees and con­
tractors against the General Services Administration's List of 
Parties Excluded from Federal Programs (available through 
the Internet at http://www.arnet.gov/epls) and the HHS/OIG 
Cumulative Sanction Report (available through the Inter­
net at http://www.dhhs.gov/progorg/oig) to ensure that it is 
not currently employing or contracting with any Ineligible 
Person. Thereafter, [Provider] will review the list once semi­
annually to ensure that no current employees or contractors 
are or have become Ineligible Persons.
To prevent hiring or contracting with any Ineligible Person, 
[Provider] shall screen all prospective employees and prospec­
tive contractors prior to engaging their services by (i) requir­
ing applicants to disclose whether they are Ineligible Persons, 
and (ii) reviewing the General Services Administration's List 
of Parties Excluded from Federal Programs (available through 
the Internet at http://www.arnet.gov/epls) and the HHS/OIG 
Cumulative Sanction Report (available through the Internet 
at http://www.dhhs.gov/progorg/oig).
If [Provider] has notice that an employee or agent is charged 
with a criminal offense related to any Federal health care pro­
gram, or is suspended or proposed for exclusion during his or 
her employment or contract with [Provider], within 10 days 
of receiving such notice [Provider] will remove such employee 
from responsibility for, or involvement with, [Provider's] busi­
ness operations related to the Federal health care programs
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until the resolution of such criminal action, suspension, or 
proposed exclusion. If [Provider] has notice that an employee 
or agent has become an Ineligible Person, [Provider] will re­
move such person from responsibility for, or involvement with, 
[Provider's] business operations related to the Federal health 
care programs and shall remove such person from any po­
sition for which the person's salary or the items or services 
rendered, ordered, or prescribed by the person are paid in 
whole or in part, directly or indirectly, by Federal health care 
programs or otherwise with Federal funds at least until such 
time as the person is reinstated into participation in the Fed­
eral health care programs.
G. N otification o f  Proceedings
Within thirty (30) days of discovery, [Provider] shall notify 
OIG, in writing, of any ongoing investigation or legal pro­
ceeding conducted or brought by a governmental entity or its 
agents involving an allegation that [Provider] has commit­
ted a crime or has engaged in fraudulent activities or any 
other knowing misconduct. This notification shall include a 
description of the allegation, the identity of the investigating 
or prosecuting agency, and the status of such investigation or 
legal proceeding. [Provider] shall also provide written notice 
to OIG within thirty (30) days of the resolution of the mat­
ter, and shall provide OIG with a description of the findings 
and/or results of the proceedings, if any.
H. Reporting
1. Credible evidence of misconduct. [Provider] discov­
ers credible evidence of misconduct from any source 
and, after reasonable inquiry, has reason to believe 
that the misconduct may violate criminal, civil, or 
administrative law concerning [Provider's] practices 
relating to the Federal health care programs, then 
[Provider] shall promptly report the probable viola­
tion of law to OIG. Defendants shall make this disclo­
sure as soon as practicable, but, not later than thirty 
(30) days after becoming aware of the existence of the 
probable violation. The [Provider's] report to OIG shall 
include;
a. the findings concerning the probable viola­
tion, including the nature and extent of the 
probable violation;
b. [Provider's] actions to correct such probable 
violation; and
c. any further steps it plans to take to address 
such probable violation and prevent it from 
recurring.
To the extent the misconduct involves an overpay­
ment, the report shall include the information listed 
in section III.D.3 regarding material deficiencies.
2. Inappropriate Billing. If [Provider] discovers inappro­
priate or incorrect billing through means other than
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the Independent Review Organization's engagement, 
the provider shall follow procedures in section IILD.3 
regarding overpayments and material deficiencies.
IV. New Locations
In the event that [Provider] purchases or establishes new business units after 
the effective date of this CIA, [Provider] shall notify OIG of this fact within 
thirty (30) days of the date of purchase or establishment. This notification shall 
include the location of the new operation(s), phone number, fax number, Federal 
health care program provider number(s) (if any), and the corresponding payor(s) 
(contractor specific) that has issued each provider number. All employees at 
such locations shall be subject to the requirements in this CIA that apply to 
new employees (e.g., completing certifications and undergoing training).
V. Implementation and Annual Reports
A. Im plem entation Report
Within one hundred and twenty (120) days after the effec­
tive date of this CIA, [Provider] shall submit a written report 
to OIG summarizing the status of its implementation of the 
requirements of this CIA. This Implementation Report shall 
include:
1. the name, address, phone number and position de­
scription of the Compliance Officer required by section
III.A;
2. the names and positions of the members of the Com­
pliance Committee required by section III.A;
3. a copy of [Provider's] Code of Conduct required by sec­
tion III.B.1;
4. the summary of the Policies and Procedures required 
by section III.B.2;
5. a description of the training programs required by sec­
tion III.C including a description of the targeted au­
diences and a schedule of when the training sessions 
were held;
6. a certification by the Compliance Officer that:
a. the Policies and Procedures required by sec­
tion III.B have been developed, are being im­
plemented, and have been distributed to all 
pertinent employees;
b. all employees have completed the Code of 
Conduct certification required by section
III.B.1; and
c. all employees have completed the training 
and executed the certification required by 
section III.C;
7. a description of the confidential disclosure program 
required by section III.E;
8. the identity of the Independent Review Organiza- 
tion(s) and the proposed start and completion date of 
the first audit; and
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9. a summary of personnel actions taken pursuant to sec­
tion III.F.
B. Annual Reports
[Provider] shall submit to OIG an Annual Report with respect 
to the status and findings of  Provider's] compliance activities. 
The Annual Reports shall include:
1. any change in the identity or position description of 
the Compliance Officer and/or members of the Com­
pliance Committee described in section III.A;
2. a certification by the Compliance Officer that:
a. all employees have completed the annual 
Code of Conduct certification required by sec­
tion III.B.1; and
b. all employees have completed the training 
and executed the certification required by 
section III.C;
3. notification of any changes or amendments to the Poli­
cies and Procedures required by section III.B and the 
reasons for such changes (e.g., change in contractor 
policy);
4. a complete copy of the report prepared pursuant to the 
Independent Review Organization's billing and com­
pliance engagement, including a copy of the method­
ology used;
5. [Provider's] response/corrective action plan to any is­
sues raised by the Independent Review Organization;
6. a summary of material deficiencies reported through­
out the course of the previous twelve (12) months pur­
suant to III.D.3 and III.H;
7. a report of the aggregate overpayments that have been 
returned to the Federal health care programs that 
were discovered as a direct or indirect result of imple­
menting this CIA. Overpayment amounts should be 
broken down into the following categories: Medicare, 
Medicaid (report each applicable state separately) and 
other Federal health care programs;
8. a copy of the confidential disclosure log required by 
section III.E;
9. a description of any personnel action (other than hir­
ing) taken by [Provider] as a result of the obligations 
in section III.F;
10. a summary describing any ongoing investigation or le­
gal proceeding conducted or brought by a government 
entity involving an allegation that [Provider] has com­
mitted a crime or has engaged in fraudulent activities, 
which have been reported pursuant to section III.G. 
The statement shall include a description of the alle­
gation, the identity of the investigating or prosecuting 
agency, and the status of such investigation, legal pro­
ceeding or requests for information;
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11. a corrective action plan to address the probable viola­
tions of law identified in section III.H; and
12. a listing of all of the [Provider's] locations (including 
locations and mailing addresses), the corresponding 
name under which each location is doing business, the 
corresponding phone numbers and fax numbers, each 
location's Federal health care program provider iden­
tification number(s) and the payor (specific contractor) 
that issued each provider identification number.
The first Annual Report shall be received by the OIG no later 
than one year and thirty (30) days after the effective date of 
this CIA. Subsequent Annual Reports shall be submitted no 
later than the anniversary date of the due date of the first 
Annual Report.
C. Certifications
The Implementation Report and Annual Reports shall include 
a certification by the Compliance Officer under penalty of per­
jury, that: (1) [Provider] is in compliance with all of the re­
quirements of this CIA, to the best of his or her knowledge; 
and (2) the Compliance Officer has reviewed the Report and 
has made reasonable inquiry regarding its content and be­
lieves that, upon such inquiry, the information is accurate 
and truthful.
VI. Notifications and Submission of Reports
Unless otherwise stated in writing subsequent to the effective date of this 
CIA, all notifications and reports required under this CIA shall be submitted 
to the entities listed below:
OIG:
Civil Recoveries Branch—Compliance Unit
Office of Counsel to the Inspector General
Office of Inspector General
US. Department of Health and Human Services
Cohen Building, Room 5527
330 Independence Avenue, SW
Washington, DC 20201
Phone 202-619-2078; Fax 202-205-0604
[Provider]:
[Address and Telephone number of Provider's Compliance Contact]
VII. OIG Inspection, Audit and Review Rights
In addition to any other rights OIG may have by statute, regulation, or con­
tract, OIG or its duly authorized representative(s), may examine [Provider's] 
books, records, and other documents and supporting materials for the purpose of 
verifying and evaluating: (a) [Provider's] compliance with the terms of this CIA; 
and (b) [Provider's] compliance with the requirements of the Federal health care 
programs in which it participates. The documentation described above shall be 
made available by [Provider] to OIG or its duly authorized representative(s) 
at all reasonable times for inspection, audit or reproduction. Furthermore, for 
purposes of this provision, OIG or its duly authorized representative(s) may
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interview any of [Provider's] employees who consent to be interviewed at the 
employee's place of business during normal business hours or at such other 
place and time as may be mutually agreed upon between the employee and 
OIG. [Provider] agrees to assist OIG in contacting and arranging interviews 
with such employees upon OIG's request. [Provider's] employees may elect to 
be interviewed with or without a representative of [Provider] present.
VIII. Document and Record Retention
[Provider] shall maintain for inspection all documents and records relating to 
reimbursement from the Federal health care programs or to compliance with 
this CIA one year longer than the term of this CIA (or longer if otherwise 
required by law).
IX. Disclosures
Subject to HHS's Freedom of Information Act ("FOIA") procedures, set forth 
in 45 C.F.R. Part 5, the OIG shall make a reasonable effort to notify [Provider] 
prior to any release by OIG of information submitted by [Provider] pursuant 
to its obligations under this CIA and identified upon submission by [Provider] 
as trade secrets, commercial or financial information and privileged and confi­
dential under the FOIA rules. [Provider] shall refrain from identifying any in­
formation as trade secrets, commercial or financial information and privileged 
and confidential that does not meet the criteria for exemption from disclosure 
under FOIA.
X. Breach and Default Provisions
[Provider] is expected to fully and timely comply with all of the obligations 
herein throughout the term of this CIA or other time frames herein agreed to.
A. S tipu la ted  Penalties for Failure to Comply w ith  Certain O bligations
As a contractual remedy, [Provider] and OIG hereby agree 
that failure to comply with certain obligations set forth in 
this CIA may lead to the imposition of the following monetary 
penalties (hereinafter referred to as "Stipulated Penalties") in 
accordance with the following provisions.
1. A Stipulated Penalty of $2,500 (which shall begin to 
accrue on the day after the date the obligation became 
due) for each day, beginning 120 days after the effec­
tive date of this CIA and concluding at the end of the 
term of this CIA, [Provider] fails to have in place any 
of the following:
a. a Compliance Officer;
b. a Compliance Committee;
c. a written Code of Conduct;
d. written Policies and Procedures;
e. a training program; and
f. a Confidential Disclosure Program;
2. A Stipulated Penalty of $2,500 (which shall begin to 
accrue on the day after the date the obligation became 
due) for each day [Provider] fails to meet any of the 
deadlines to submit the Implementation Report or the 
Annual Reports to the OIG.
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3. A Stipulated Penalty of $2,000 (which shall begin to 
accrue on the date the failure to comply began) for 
each day [Provider]:
a. hires or contracts with an Ineligible Person 
after that person has been listed by a fed­
eral agency as excluded, debarred, suspended 
or otherwise ineligible for participation in 
the Medicare, Medicaid or any other Fed­
eral health care program (as defined in 42 
U.S.C. 1320a7b(f)). This Stipulated Penalty 
shall not be demanded for any time period 
if [Provider] can demonstrate that it did not 
discover the person's exclusion or other ineli­
gibility after making a reasonable inquiry (as 
described in section III.F) as to the status of 
the person;
b. employs or contracts with an Ineligible Per­
son and that person: (i) has responsibility for, 
or involvement with, [Provider's] business op­
erations related to the Federal health care 
programs or (ii) is in a position for which the 
person's salary or the items or services ren­
dered, ordered, or prescribed by the person 
are paid in whole or in part, directly or indi­
rectly, by the Federal health care programs or 
otherwise with Federal funds (this Stipulated 
Penalty shall not be demanded for any time 
period during which [Provider] can demon­
strate that it did not discover the person's ex­
clusion or other ineligibility after making a 
reasonable inquiry (as described in III.F) as 
to the status of the person);
c. employs or contracts with a person who: (i) 
has been charged with a criminal offense re­
lated to any Federal health care program, or 
(ii) is suspended or proposed for exclusion, 
and that person has responsibility for, or in­
volvement with, [Provider's] business opera­
tions related to the Federal health care pro­
grams (this Stipulated Penalty shall not be 
demanded for any time period before 10 days 
after [Provider] received notice of the rele­
vant matter or after the resolution of the mat­
ter).
4. A Stipulated Penalty of $1,500 (which shall begin to 
accrue on the date the [Provider] fails to grant access) 
for each day [Provider] fails to grant access to the in­
formation or documentation as required in section V 
of this CIA.
5. A Stipulated Penalty of $1,000 (which shall begin to 
accrue ten (10) days after the date that OIG pro­
vides notice to [Provider] of the failure to comply)
Health Care Organizations
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for each day [Provider] fails to comply fully and ade­
quately with any obligation of this CIA. In its notice to 
[Provider], the OIG shall state the specific grounds for 
its determination that the [Provider] has failed to com­
ply fully and adequately with the CIA obligation(s) at
B. Paym ent o f  S tipu la ted  Penalties
1. Demand Letter. Upon a finding that [Provider] has 
failed to comply with any of the obligations described 
in section X.A and determining that Stipulated Penal­
ties are appropriate, OIG shall notify [Provider] by 
personal service or certified mail of (a) [Provider's] 
failure to comply; and (6) the OIG's exercise of its con­
tractual right to demand payment of the Stipulated 
Penalties (this notification is hereinafter referred to 
as the "Demand Letter").
Within fifteen (15) days of the date of the Demand 
Letter, [Provider] shall either (a) cure the breach to 
the OIG's satisfaction and pay the applicable stip­
ulated penalties, or (b) request a hearing before an 
HHS administrative law judge ("ALJ") to dispute the 
OIG's determination of noncompliance, pursuant to 
the agreed-upon provisions set forth below in section 
X.D. In the event [Provider] elects to request an ALJ 
hearing, the Stipulated Penalties shall continue to ac­
crue until [Provider] cures, to the OIG's satisfaction, 
the alleged breach in dispute. Failure to respond to the 
Demand Letter in one of these two manners within 
the allowed time period shall be considered a material 
breach of this CIA and shall be grounds for exclusion 
under section X.C.
2. Timely Written Requests for Extensions. [Provider] 
may submit a timely written request for an extension 
of time to perform any act or file any notification or re­
port required by this CIA. Notwithstanding any other 
provision in this section, if OIG grants the timely writ­
ten request with respect to an act, notification, or re­
port, Stipulated Penalties for failure to perform the 
act or file the notification or report shall not begin to 
accrue until one day after [Provider] fails to meet the 
revised deadline as agreed to by the OIG-approved ex­
tension. Notwithstanding any other provision in this 
section, if OIG denies such a timely written request, 
Stipulated Penalties for failure to perform the act or 
file the notification or report shall not begin to accrue 
until two (2) business days after [Provider] receives 
OIG's written denial of such request. A "timely writ­
ten request" is defined as a request in writing received 
by OIG at least five (5) business days prior to the date 
by which any act is due to be performed or any notifi­
cation or report is due to be filed.
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3. Form of Payment. Paym ent of the Stipulated Penalties 
shall he made by certified or cashier's check, payable to 
"Secretary of the Department of Health and Human 
Services," and submitted to OIG at the address set 
forth in section VI .
4. Independence from Material Breach Determination. 
Except as otherwise noted, these provisions for pay­
ment of Stipulated Penalties shall not affect or other­
wise set a standard for the OIG's determination that 
[Provider] has materially breached this CIA, which de­
cision shall be made at the OIG's discretion and gov­
erned by the provisions in section X.C, below.
C. Exclusion for M aterial Breach o f  th is CIA
1. Notice of Material Breach and Intent to Exclude. 
The parties agree that a material breach of this 
CIA by [Provider] constitutes an independent ba­
sis for [Provider's] exclusion from participation in 
the Federal health care programs (as defined in 42 
U.S.C. 1320a7b(f)). Upon a determination by OIG that 
[Provider] has materially breached this CIA and that 
exclusion should be imposed, the OIG shall notify 
[Provider] by certified mail of (a) [Provider's] mate­
rial breach; and (b) OIG's intent to exercise its con­
tractual right to impose exclusion (this notification 
is hereinafter referred to as the "Notice of Material 
Breach and Intent to Exclude").
2. Opportunity to Cure. [Provider] shall have thirty-five 
(35) days from the date of the Notice of Material 
Breach and Intent to Exclude Letter to demonstrate 
to the OIG's satisfaction that:
a. [Provider] is in full compliance with this CIA;
b. the alleged material breach has been cured; 
or
c. the alleged material breach cannot be cured 
within the 35-day period, but that: (i) 
[Provider] has begun to take action to cure 
the material breach, (ii) [Provider] is pursu­
ing such action with due diligence, and (iii) 
[Provider] has provided to OIG a reasonable 
timetable for curing the material breach.
3. Exclusion Letter. If at the conclusion of the thirty-five 
(35) day period, [Provider] fails to satisfy the require­
ments of section X.C.2, OIG may exclude [Provider] 
from participation in the Federal health care pro­
grams. OIG will notify [Provider] in writing of its de­
termination to exclude [Provider] (this letter shall be 
referred to hereinafter as the "Exclusion Letter"). Sub­
ject to the Dispute Resolution provisions in section 
X.D, below, the exclusion shall go into effect thirty (30) 
days after the date of the Exclusion Letter. The exclu­
sion shall have national effect and will also apply to
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all other federal procurement and non-procurement 
programs. If [Provider] is excluded under the provi­
sions of this CIA, [Provider] may seek reinstatement 
pursuant to the provisions at 42 C.F.R. §§1001.3001- 
.3004.
4. Material Breach. A material breach of this CIA means:
a. a failure by [Provider] to report a material 
deficiency, take corrective action and pay the 
appropriate refunds, as provided in section
III.D;
b. repeated or flagrant violations of the obliga­
tions under this CIA, including, but not lim­
ited to, the obligations addressed in section 
X.A of this CIA;
c. a failure to respond to a Demand Letter con­
cerning the payment of Stipulated Penalties 
in accordance with section X.B above; or
d. a failure to retain and use an Independent 
Review Organization for review purposes in 
accordance with section III.D.
D. D ispute Resolution
2.
Review Rights. Upon the OIG's delivery to [Provider] 
of its Demand Letter or of its Exclusion Letter, and 
as an agreed-upon contractual remedy for the reso­
lution of disputes arising under the obligation of this 
CIA, [Provider] shall be afforded certain review rights 
comparable to the ones that are provided in 42 U.S.C. 
§§1320a7(f) and 42 C.F.R. §1005 as if they applied 
to the Stipulated Penalties or exclusion sought pur­
suant to this CIA. Specifically, the OIG's determina­
tion to demand payment of Stipulated Penalties or to 
seek exclusion shall be subject to review by an ALJ 
and, in the event of an appeal, the Departmental Ap­
peals Board ("DAB"), in a manner consistent with the 
provisions in 42 C.F.R. §§1005.2-.21. Notwithstand­
ing the language in 42 C.F.R. §1005.2(c), the request 
for a hearing involving stipulated penalties shall be 
made within fifteen (15) days of the date of the De­
mand Letter and the request for a hearing involving 
exclusion shall be made within thirty (30) days of the 
date of the Exclusion Letter.
Stipulated Penalties Review. Notwithstanding any 
provision of Title 42 of the United States Code or 
Chapter 42 of the Code of Federal Regulations, the 
only issues in a proceeding for stipulated penalties 
under this CIA shall be (a) whether [Provider] was 
in full and timely compliance with the obligations of 
this CIA for which the OIG demands payment; and (b) 
the period of noncompliance. [Provider] shall have the 
burden of proving its full and timely compliance and 
the steps taken to cure the noncompliance, if any. If
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the ALJ finds for the OIG with regard to a finding of a 
breach of this CIA and orders [Provider] to pay Stip­
ulated Penalties, such Stipulated Penalties shall be­
come due and payable twenty (20) days after the ALJ 
issues such a decision notwithstanding that [Provider] 
may request review of the ALJ decision by the DAB.
3. Exclusion Review. Notwithstanding any provision of 
Title 42 of the United States Code or Chapter 42 of 
the Code of Federal Regulations, the only issues in a 
proceeding for exclusion based on a material breach of 
this CIA shall be (a) whether [Provider] was in mate­
rial breach of this CIA; (b) whether such breach was 
continuing on the date of the Exclusion Letter; and
(c) the alleged material breach cannot be cured within 
the 35-day period, but that (i) [Provider] has begun to 
take action to cure the material breach, (ii) [Provider] 
is pursuing such action with due diligence, and (iii) 
[Provider] has provided to OIG a reasonable timetable 
for curing the material breach.
For purposes of the exclusion herein, exclusion shall 
take effect only after an ALJ decision that is favorable 
to the OIG. [Provider's] election of its contractual right 
to appeal to the DAB shall not abrogate the OIG's au­
thority to exclude [Provider] upon the issuance of the 
ALJ's decision. If the ALJ sustains the determination 
of the OIG and determines that exclusion is autho­
rized, such exclusion shall take effect twenty (20) days 
after the ALJ issues such a decision, notwithstanding 
that [Provider] may request review of the A U  decision 
by the DAB.
4. Finality of Decision. The review by an A U  or DAB 
provided for above shall not be considered to be an ap­
peal right arising under any statutes or regulations. 
Consequently, the parties to this CIA agree that the 
d a b 's decision (or the AU's decision if not appealed) 
shall be considered final for all purposes under this 
CIA and [Provider] agrees to waive any right it may 
have to appeal the decision administratively, judicially 
or otherwise seek review by any court or other adju­
dicative forum.
XI. Effective and Binding Agreement
Consistent with the provisions in the Settlement Agreement pursuant to 
which this CIA is entered, and into which this CIA is incorporated, [Provider] 
and OIG agree as follows:
a. This CIA shall be binding on the successors, assigns and transferees 
of [Provider];
b. This CIA shall become final and binding on the date the final sig­
nature is obtained on the CIA;
c. Any modifications to this CIA shall be made with the prior written 
consent of the parties to this CIA; and
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The undersigned [Provider] signatories represent and warrant that 
they are authorized to execute this CIA. The undersigned OIG sig­
natory represents that he is signing this CIA in his official capacity 
and that he is authorized to execute this CIA.
On Behalf of [Provider]
Date
Date
[Please identify all signatories]
Date
ON BEHALF OF THE OFFICE OF INSPECTOR GENERAL 
OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Lewis Morris [Date]
Assistant Inspector General for Legal Affairs 
Office of Inspector General 
U.S. Department of Health and Human Services
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Appendix B
Sam ple Statement of Management's Assertions
[Date]
In connection with the Corporate Integrity Agreement (CIA) entered into with 
the Office of the Inspector General of the United States Department of Health 
and Human Services dated [date], we make the following assertions, which are 
true to the best of our knowledge and belief
Governance
Within 90 days of the date of the CIA, we—
1. Established a Compliance Committee, which meets at least 
monthly and requires a quorum to meet.
2. Appointed to our Compliance Committee members who include at 
a minimum those individuals specified in the CIA.
3. Delegated to the Compliance Committee the authority to imple­
ment and monitor the CIA, as evidenced by the organization chart 
or the Compliance Committee's charter.
4. Appointed a compliance officer, who reports directly to the individ­
ual specified in the CIA.
We appointed a compliance officer who—
1. Has sufficient staff and resources to carry out his or her responsi­
bilities.
2. Actively participates in compliance training.
3. Has authority to conduct full and complete internal investigations 
without restriction.
4. Periodically revises the compliance program to meet changing cir­
cumstances and risks.
Billing Practices, Policies, and Procedures
Although no system of internal controls can provide absolute assurance that all 
bills comply in all respects with Medicare, Medicaid, and other federal health 
care program guidelines, we are not aware of any material weaknesses in our 
billing practices, policies, and procedures. Billings to third-party payors comply 
in all material respects with applicable coding principles and laws and regula­
tions (including those dealing with Medicare and Medicaid antifraud and abuse) 
and only reflect charges for goods and services that were medically necessary, 
properly approved by regulatory bodies (e.g., the Food and Drug Administra­
tion), if required and properly rendered. [Insert other assertions as necessary to 
address matters covered in the CIA.] Any Medicare, Medicaid, and other fed­
eral health program billing deficiencies that we identified have been properly 
reported to the applicable payor within 60 days of discovery of the deficiency.
Corporate Integrity Policy
1. Our policy was developed and implemented within [number] days 
of execution of the CIA.
2. The policy addresses the Company's commitment to preparation 
and submission of accurate billings consistent with the standards 
set forth in federal health care program statutes, regulations,
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procedures and guidelines or as otherwise communicated by Health 
Care Financing Administration (HCFA), its agents or any other 
agency engaged in the administration of the applicable federal 
health care program.
3. The policy addressed the specific issues that gave rise to the settle­
ment, as well as other risk areas identified by the OIG in published 
Fraud Alerts issued through [date].
4. Further details on the development and implementation of our pol­
icy were provided to the OIG in our letter dated [date].
5. Our policy was distributed to all employees, physicians and inde­
pendent contractors involved in submitting or preparing requests 
for reimbursement.
6. We have prominently displayed a copy of our policy on the Com­
pany's premises.
Information and Education Program
As discussed more fully in our letter to the OIG dated [date], we conducted an 
Information and Education Program within [number] days of the CIA. The In­
formation and Education Program requires that each officer, employee, agent 
and contractor charged with administering federal health care programs (in­
cluding, but not limited to billers, coders, nurses, physicians, medical records, 
hospital administration and other individuals directly involved in billing fed­
eral health care programs) receive at least [number] hours of training.
The training provided to employees involved in billing, coding, and/or charge 
capture consisted of instructions on submitting accurate bills, the personal 
obligations of each individual to ensure billings are accurate, the nature of 
company-imposed disciplinary actions on individuals who violate company poli­
cies and/or laws and regulations, applicable federal health care program rules, 
legal sanctions against the company for submission of false or fraudulent in­
formation, and how to report potential abuses or fraud. The training material 
addresses those issues underlying our settlement with the OIG.
The experience of the trainers is consistent with the topics presented. 
Confidential Disclosure Program 
Our Confidential Disclosure Program—
4.
5.
Was established within [number] days of the CIA.
Enables any employee to disclose any practices or billing procedures 
relating to federal health care programs.
Provides a toll-free telephone line maintained by the Company, 
which Company representatives have indicated is maintained 
twenty-four hours a day, seven days a week, for the purpose of 
making any disclosures regarding compliance with the Company's 
Compliance Program, the obligations in the CIA, and Company's 
overall compliance with federal and state standards.
Includes policies requiring the review of any disclosures to permit a 
determination of the appropriateness of the billing practice alleged 
to be involved and any corrective action to be taken to ensure that 
proper follow-up is conducted.
A detailed summary of the communications (including the number 
of disclosures by employees and the dates of such disclosures) con­
cerning billing practices reported as, and found to be, inappropriate
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under the Confidential Disclosure Program, and the results of any 
internal review and the follow-up on such disclosures are summa­
rized in Attachment [title] to our Annual Report.
Excluded Individuals or Entities
Company policy—
1. Prohibits the employment of or contracting with an individual or 
entity that is listed by a federal agency as convicted of abuse or 
excluded, suspended or otherwise ineligible for participation in fed­
eral health care programs.
2. Includes a process to make an inquiry into the status of any poten­
tial employee or independent contractor.
3. Provides for an annual review of the status of all existing employ­
ees and contractors to verify whether any individual had been sus­
pended or excluded or charged with a criminal offense relating to 
the provision of federal health care services.
We are not aware of any individuals employed in contravention of the prohibi­
tions in the CIA.
Record Retention
Our record retention policy is consistent with the requirements of the CIA.
Signed by:
[Chief Executive Officer]
[Chief Financial Officer]
[Corporate Compliance Officer]
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Appendix C
Sam ple Engagem ent Letter
The following is an illustration of a sample engagement letter that may he used 
for this kind of engagement.
[CPA Firm Letterhead]
[Client's Name and Address]
Dear____________ ;
This will confirm our understanding of the arrangements for our performance of 
certain agreed-upon procedures in connection with management's compliance 
with the terms of the Corporate Integrity Agreement (CIA) with the Office of 
Inspector General (OIG) of the U.S. Department of Health and Human Services 
(HHS) dated [date of CIA] for the period ending [date].
We will perform those procedures enumerated in the attachment to this letter. 
Our responsibility is to carry out these procedures and report our findings. We 
will conduct our engagement in accordance with standards established by the 
American Institute of Certified Public Accountants. Our planned procedures 
were agreed to by management and will be communicated to the OIG for its 
review and are based on the terms specified in the CIA. The sufficiency of 
these procedures is solely the responsibility of the specified users of the report. 
Consequently, it is understood that we make no representation regarding the 
sufficiency of the procedures described in the attachment for the purpose for 
which this report has been requested or for any other purpose.
Management is responsible for the Company's compliance with all applicable 
laws, regulations, and contracts and agreements, including the CIA. Manage­
ment also is responsible for the design, implementation, and monitoring of the 
policies and procedures upon which compliance is based.
Our engagement to perform agreed-upon procedures is substantially less in 
scope than an examination, the objective of which is the expression of an opinion 
on management's compliance with the CIA. Accordingly, we will not express 
such an opinion or any other form of assurance thereon.1
Working papers that are prepared in connection with this engagement are the 
property of the independent accountant. The working papers are prepared for 
the purpose of providing the principal support for the independent accountant's
.34
1 The independent accountant may wish to include an understanding with the client about any 
limitation or other arrangements regarding liability of the practitioner or the client in the engagement 
letter. For example, the following might be included in the letter:
Our maximum liability relating to services rendered under this letter (regardless of form 
of action, whether in contract, negligence or otherwise) shall be limited to the charges paid 
to us for the portion of the services or work products giving rise to liability. We will not 
be liable for consequential or punitive damages (including lost profits or savings) even if 
aware of their possible existence.
You will indemnify us against any damage or expense that may result from any third- 
party claim relating to our services or any use by you of any work product, and you will 
reimburse us for all expenses (including counsel fees) as incurred by us in connection with 
any such claim, except to the extent such claim (i) is finally determined to have resulted 
from our gross negligence or willful misconduct or (ii) is covered by any of the preceding 
indemnities.
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report. At the completion of our work, we expect to issue an agreed-upon pro­
cedures report in the attached form.
If, however, we are not able to complete all of the specified procedures, we will 
so advise you. At that time, we will discuss with you the form of communication, 
if any, that you desire for our findings. We will ask you to confirm your request 
in writing at that time. If you request that we delay issuance of our report until 
corrective action is taken that will result in compliance with all aspects of the 
CIA, we will do so only at your written request. Our working papers will be 
retained in accordance with our firm's working paper retention policy.
The distribution of the independent accountant's report will be restricted to the 
governing board and management of the Company and the OIG.
Our fees will be billed as work progresses and are based on the amount of time 
required at various levels of responsibility plus actual out-of-pocket expenses. 
Invoices are payable upon presentation. We will notify you immediately of any 
circumstances we encounter that could significantly affect our initial estimate 
of total fees.
We agree that to the extent required by law, we will allow the Comptroller 
General of the United States, HHS, and their duly authorized representatives 
to have access to this engagement letter and our documents and records to 
the extent necessary to verify the nature and amount of costs of the services 
provided to the Company, until the expiration of four years after we have con­
cluded providing services to the Company that are performed pursuant to this 
Engagement Letter. In the event the Comptroller General, HHS, or their duly 
authorized representatives request such records, we agree to notify the Com­
pany of such request as soon as practicable.
In the event we are requested or authorized by the Company or are required 
by government regulation, subpoena, or other legal process to produce our doc­
uments or our personnel as witnesses with respect to our engagements for the 
Company, the Company will, so long as we are not a party to the proceeding in 
which the information is sought, reimburse us for our professional time and ex­
penses, as well as the fees and expenses of our counsel, incurred in responding 
to such requests.
If this letter correctly expresses your understanding of this engagement, please 
sign the enclosed copy where indicated and return it to us. We appreciate the 
opportunity to serve you.
Sincerely,__________________
[Partner's Signature]
[Firm Name or Firm Representative]
Accepted and agreed to:__________
[Client Representative's Signature]
[Title]___________________
[Date]___________________
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Appendix D 
Sam ple Procedures
Procedure Findings
Governance
1. We read the Company's corporate minutes and organization 
chart and ascertained that, within [number] days of the date of 
the Corporate Integrity Agreement (CIA), the Company—
a. Established a Compliance Committee, which is to 
meet meets at least monthly and requires a quorum 
to meet.
b. Appointed to its Compliance Committee members who 
include, at a minimum, those individuals specified in 
the CIA.
c. Delegated to the Compliance Committee the authority 
to implement and monitor the CIA, as evidenced by 
the organization chart or the Compliance Committee's 
charter.
d. Appointed a compliance officer who reports directly to 
the individual specified in the CIA.
2. We interviewed the compliance officer and were informed that, 
in his or her opinion, the Compliance Officer—
a. Has sufficient staff and resources to carry out his or 
her responsibilities.
b. Actively participates in compliance training.
c. Has the authority to conduct full and complete inter­
nal investigations without restriction.
d. Periodically revises the compliance program to meet 
changing circumstances and risks.
3. We read the OIG notification letter as specified in the CIA and 
noted that the appropriate official signed the letter, that it was ad­
dressed to the OIG, that it covered items (a) through (d) in Step 1, 
and that it was dated within [number of] days of the execution of 
the CIA.
Billing Practices, Policies, and Procedures
The practitioner might be engaged to provide consulting services in 
connection with the evaluation of the company's billing practices, 
policies, and procedures. I f  so, generally no agreed-upon procedures 
would be performed relating to this area.
Alternatively, if  the procedures relating to the Company's billing 
practices, policies, and procedures are performed by others such as 
the Company's internal audit staff, the practitioner performs Steps 
4 through 9.
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service
(iii) Improper diagnosis or treat­
ment plan giving rise to the pro­
vision of a medically unneces­
sary service or treatment 
Service or treatment does not 
conform medically with the doc­
umented diagnosis or treatment 
plan
Services incorrectly coded 
(2) Billing and coding, as follows:
(i) Noncovered or unallowable ser­
vice
(iv)
(v)
Findings
4. We read the compliance work plan and noted the following:
a. The work plan's stated objectives include the deter­
mination that billings are accurate and complete, for 
services rendered that have been deemed by medical 
specialists as being necessary, and are submitted in 
accordance with federal program guidelines.
b. The work plan sampling methodology sets confidence 
levels consistent with those defined in the CIA.
c. The work plan identifies risk areas, as defined in the 
CIA (if applicable), and specifies testing procedures by 
risk area.
d. The work plan specifies that samples are taken in risk 
areas (if applicable) identified by the CIA.
e. The work plan includes testing procedures, which the 
practitioner should modify as required by the CIA, for 
the following risks areas (if applicable) identified in 
the CIA:
(1) Clinical documentation, as follows:
(i) No documentation of service
(ii) Insufficient documentation of
(ii) Duplicate paym ent
(iii) DRG window error
(iv) Unbundling
(v) Utilization
(vi) Medicare credit balances
[Note to Practitioner: Modify the preceding list as required by the 
CIA.]
5. We selected [quantity] probe samples performed by the inde­
pendent review organization for the following risk areas [list risk 
areas tested]. For the probe samples selected, we noted that the—
а. Sample patient billing files were randomly selected.
b. Sample size reflected confidence levels specified in the 
CIA.
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Findings
c. Sample plan describes how missing items (if any) 
would be treated.
d. Patient billing files tested were pulled per the listing 
of random numbers and all patient billing files were 
accounted for in the working papers.
e. Work plans for the specific sample described the risk 
areas (if applicable) being tested and the testing ap- 
proach/procedures.
f. Working papers noted the completion of each work 
plan step.
g. Working papers contained a summary of findings for 
the sample.
6. We reperformed the work plan steps [list of specific steps per­
formed] for the sample patient billing files. The reperformance of 
work plan steps related to the medical review of the sample patient 
billing files was performed by the following individuals [note the 
professional qualifications of individuals without listing names]. 
Any exceptions between our findings and the Company's are sum­
marized in the Attachment to this report.
7. We read the summary findings of all internal compliance re­
views that the Company's Internal Audit department indicated 
it had performed for the Company and noted that all material 
billing deficiencies [specify material threshold as defined by the 
Company] noted therein were discussed in written communica­
tions addressed to the appropriate payor (for example, Medicare 
Part B carrier) and were dated within 60 days from the time the 
deficiency occurred.1
8. We inquired of [individual] as to whether the Company took 
remedial steps within [number of] days (or such additional time as 
agreed to by the payor) to correct all material billing deficiencies 
noted in Step 7. We were informed that such remedial steps had 
been taken.
9. By reading applicable correspondence, we noted that any ma­
terial billing deficiencies noted in Step 7 were communicated to 
the OIG, including specific findings relative to the deficiency, the 
Company's actions taken to correct the deficiency, and any further 
steps the Company plans to take to prevent any similar deficien­
cies from recurring.
Corporate Integrity Policy
10. We read the Company's Corporate Integrity Policy and noted 
the following.
a. The policy was developed and implemented within 
[number of] days of execution of the CIA.
1 The CIA provides its own legal definition of a "material deficiency." Determination of whether a 
billing or other act meets this definition is normally beyond the auditor's professional competence and 
may have to await final determination by a court of law. Accordingly, to avoid confusion, a working 
definition different from that provided in the CIA (e.g., a specified dollar threshold) may be necessary.
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b. The policy addressed the Company's commitment to 
preparation and submission of accurate billings con­
sistent with the standards set forth in federal health 
care program statutes, regulations, procedures, and 
guidelines or as otherwise communicated by HCFA, 
its agents, or any other agency engaged in the ad­
ministration of the applicable federal health care pro­
gram.
c. The policy addressed the specific issues that gave rise 
to the settlement, as well as other risk areas identified 
by the OIG in published Fraud Alerts issued through 
[agency].
d. Correspondence addressed to the OIG covered the de­
velopment and implementation of the policy.
e. Documentation indicating that the policy was dis­
tributed to all employees, physicians, and indepen­
dent contractors involved in submitting or preparing 
requests for reimbursement.
f. The prominent display of a copy of the policy on the
Company's premises.
11. We selected a sample of ten employees (involved in submitting 
and preparing requests for reimbursement) and examined written 
confirmation in the employee's personnel file indicating receipt of 
a copy of the Corporate Integrity Policy.
Information and Education Program
12. We read the Company's Information and Education Program 
and noted the following.
a. The Information and Education Program agenda was 
dated within [number of] days of execution of the CIA.
b. Correspondence covering the development and imple­
mentation of the Information and Education Program 
was addressed to the OIG.
c. The Information and Education Program requires that 
each officer, employee, agent, and contractor charged 
with administering federal health care programs (in­
cluding, but not limited to billers, coders, nurses, 
physicians, medical records, hospital administration 
and other individuals directly involved in billing fed­
eral health care programs) receive at least [number 
of] hours of training.
13. We selected a sample of ten employees involved in billing, 
coding and/or charge capture and examined sign-in logs of the 
training classes and noted that each had signed indicating that 
they had received at least [number of] hours of training as specified 
in the Information and Education Program. We also reviewed tests 
and surveys completed by each of the ten trained employees noting 
evidence that they were completed.
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14. We inquired as to the training of individuals not present dur­
ing the regularly scheduled training programs and were informed 
that each such individual is trained either individually or in a 
separate make-up session. We inquired as to the names of in­
dividuals not initially present and selected one such individual 
and examined that individual's post-training test and survey for 
completion.
15. We read the course agenda and noted that the training pro­
vided to employees involved in billing, coding, and/or charge cap­
ture consisted of instructions on submitting accurate bills, the per­
sonal obligations of each individual to ensure billings are accurate, 
the nature of company-imposed disciplinary actions on individuals 
who violate company policies and/or laws and regulations appli­
cable to federal health care program rules, legal sanctions against 
the company for submission of false or fraudulent information, 
and how to report potential abuses or fraud. We also noted that 
the training material addressed the following issues which gave 
rise to the settlement [practitioner list].
16. We inquired of the Corporate Compliance Officer as to the 
qualifications and experience of the trainers and were informed 
that, in the Corporate Compliance Officer's opinion, they were con­
sistent with the topics presented.
17. We noted that the Company's draft Annual Report to the OIG 
dated [date] addresses certification of training.
Confidential Disclosure Program
18. We read documentation of the Company's Confidential Dis­
closure Program and noted that it—
a. Includes the printed effective date that was within 
[number of] days of execution of the CIA.
b. Consists of a confidential disclosure program enabling 
any employee to disclose any practices or billing pro­
cedures relating to federal health care programs.
c. Provides a toll-free telephone line maintained by the 
Company, which Company representatives have indi­
cated is maintained twenty-four hours a day, seven 
days a week, for the purpose of making any dis­
closures regarding compliance with the Company's 
Compliance Program, the obligations in the CIA, and 
Company's overall compliance with federal and state 
standards.
d. Includes policies requiring the review of any disclo­
sures to permit a determination of the appropriate­
ness of the billing practice alleged to be involved and 
any corrective action to be taken to ensure that proper 
follow-up is conducted.
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19. We made five test calls to the toll free telephone line (hotline) 
and noted the following.
a. Each call was captured in the hotline logs and reported 
with all other incoming calls.
h. Anonymity is not discouraged.
20. We noted that the Company included in its draft Annual Re­
port addressed to OIG dated [date] a detailed summary of the 
communications (including the number of disclosures by employ­
ees and the dates of such disclosures) concerning billing practices 
reported as, and found to be, inappropriate under the Confidential 
Disclosure Program, and the results of any internal review and the 
follow-up on such disclosures.
21. We observed the display of the Company's Confidential Dis­
closure Program, including notice of the availability of its hotline, 
on the Company's premises.
Excluded Individuals or Entities
22. We read the Company's written policy relating to dealing 
with excluded or convicted persons or entities and noted that the 
policy—
a. Prohibits the hiring of or contracting with an indi­
vidual or entity that is listed by a federal agency as 
convicted of abuse or excluded, suspended, or other­
wise ineligible for participation in federal health care 
programs.
b. Includes a process to make an inquiry into the status 
of any potential employee or independent contractor.
c. Provides for a semi-annual review of the status of all 
existing employees and contractors to verify whether 
any individual had been suspended or excluded or 
charged with a criminal offense relating to the pro­
vision of federal health care services.
23. We selected a sample of ten employees hired over the course 
of the test period as defined in the CIA and examined support in 
the employee's personnel file documenting inquiries made into the 
status of the employee, including documentation of comparison to 
the [source specified in the CIA].
24. We performed the following procedures related to the Com­
pany's semi-annual review of employee status.
а. Read documentation of the semi-annual review as ev­
idence that a review was performed.
b. Selected and reviewed the lesser of ten or all excep­
tions and determined that such employees were re­
moved from responsibility for or involvement with 
Provider business operations related to the Federal 
health care programs.
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c. Examined a notification letter addressed to the OIG 
and dated within 30 days of the employee's removal 
from employment.
d. Inquired of [officer] as to whether he or she was aware 
of any individuals employed in contravention of the 
prohibitions in the CIA. If so, we further noted that 
[indicate specific procedures] to confirm that such sit­
uation was cured within 30 days by [indicate how sit­
uation was cured].
Annual Report
25. We read the Company’s draft Annual Report dated [date] and 
determined that it included the following items, to be modified as 
appropriate, by the practitioner:
a. Compliance Program Charter and organization chart
b. Amendments to policies
c. Detailed descriptions of reviews and audits
d. Summary of hotline communications
e. Summary of annual review of employees
f. Cross-referencing to items noted in the CIA
Record Retention
26. We read the Company's record retention policy and noted that 
it was consistent with the requirements as outlined in the CIA.
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A ppendix E 
Sam ple Report
Independent Accountant's Report
[Date]
[Sample Health Care Provider]
Office of Inspector General of the U.S. Department of Health and Human Ser­
vices
We have performed the procedures enumerated in the Attachment, which were 
agreed to by Sample Health Care Provider (Company) and the Office of In­
spector General (OIG) of the U.S. Department of Health and Human Services, 
solely to assist the users in evaluating management's assertion about [name 
of entity's] compliance with the Corporate Integrity Agreement (CIA) with the 
OIG dated [date of CIA] for the [period] ending [date], which is included as 
Attachment A to this report. This agreed-upon procedures engagement was 
performed in accordance with standards established by the American Institute 
of Certified Public Accountants. The sufficiency of these procedures is solely 
the responsibility of the specified users of the report. Consequently, we make 
no representation regarding the sufficiency of the procedures described in At­
tachment B either for the purpose for which this report has been requested or 
for any other purpose.
We were not engaged to and did not perform an examination, the objective of 
which would be the expression of an opinion on management's compliance with 
the CIA. Accordingly, we do not express such an opinion. Had we performed 
additional procedures, other matters might have come to our attention that 
would have been reported to you.
This report is intended solely for the information and use of the Compliance 
Committee and management of the Company and the OIG, and is not intended 
to be and should not be used by anyone other than those specified parties.
[Include as Attachments the CIA and the summary that enumerates procedures 
and findings.]
[Signature]
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NOTE
This Statement of Position presents the recommendations of the 
AICPA Health Care Third-Party Revenue Recognition Task Force with 
regard to auditing financial statement assertions about third-party rev­
enues and related receivables of health care entities. The Auditing Stan­
dards Board has found the recommendations in this Statement of Posi­
tion to be consistent with existing standards covered by Rule 202 of the 
AICPA Code of Professional Conduct. AICPA members should be pre­
pared to justify departures from the recommendations in this Statement 
of Position.
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Sum m ary
This Statement of Position (SOP) provides guidance to auditors regarding un­
certainties inherent in health care third-party revenue recognition. It discusses 
auditing matters to consider in testing third-party revenues and related receiv­
ables, and provides guidance regarding the sufficiency of evidential matter and 
reporting on financial statements of health care entities exposed to material 
uncertainties.
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Introduction and Background
.01 Most health care providers participate in payment programs that pay 
less than full charges for services rendered. For example, some cost-based pro­
grams retrospectively determine the final amounts reimbursable for services 
rendered to their beneficiaries based on allowable costs. With increasing fre­
quency, even non-cost-based programs (such as the Medicare Prospective Pay­
ment System) have become subject to retrospective adjustments (for example, 
billing denials and coding changes). Often, such adjustments are not known for 
a considerable period of time after the related services were rendered.
.02 The lengthy period of time between rendering services and reaching 
final settlement, compounded further by the complexities and ambiguities of 
reimbursement regulations, makes it difficult to estimate the net patient service 
revenue associated with these programs. This situation has been compounded 
due to the frequency of changes in federal program guidelines.
.03 The AICPA Audit and Accounting Guide Health Care Organizations 
(the Guide) requires that patient revenues be reported net of provisions for 
contractual and other adjustments (paragraph 10.20). As a result, patient re­
ceivables, including amounts due from third-party payors, are also reported net 
of expected contractual and other adjustments. However, amounts ultimately 
realizable will not be known until some future date, which may be several years 
after the period in which the services were rendered.
.04 This SOP provides guidance to auditors regarding uncertainties inher­
ent in health care third-party revenue recognition. It discusses auditing matters 
to consider in testing third-party revenue and related receivables, including the 
effects of settlements (both cost-based and non-cost-based third-party payment 
programs), and provides guidance regarding the sufficiency of evidential mat­
ter and reporting on financial statements of health care entities exposed to 
material uncertainties.
Scope and Applicability
.05 This SOP applies to audits of health care organizations falling within 
the scope of the Guide. Its provisions are effective for audits of periods ending 
on or after June 30, 2000. Early application of the provisions of this SOP is 
permitted.
Third-Party Revenues and Related Receivables—
Inherent Uncertainties
.06 Health care entities need to estimate amounts that ultimately will be 
realizable in order for revenues to be fairly stated in accordance with generally 
accepted accounting principles (GAAP). The basis for such estimates may range 
from relatively straightforward calculations using information that is readily 
available to highly complex judgments based on assumptions about future de­
cisions.
.07 Entities doing business with governmental payors (for example, Medi­
care and Medicaid) are subject to risks unique to the government-contracting 
environment that are hard to anticipate and quantify and that may vary from 
entity to entity. For example— •
•  A health care entity's revenues may be subject to adjustment as a 
result of examination by government agencies or contractors. The audit
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process and the resolution of significant related matters (including 
disputes based on differing interpretations of the regulations) often 
are not finalized until several years after the services were rendered.
•  Different fiscal intermediaries (entities that contract with the federal 
government to assist in the administration of the Medicare program) 
may interpret governmental regulations differently.
•  Differing opinions on a patient's principal medical diagnosis, including 
the appropriate sequencing of codes used to submit claims for payment, 
can have a significant effect on the payment amount.1
•  Otherwise valid claims may be determined to be nonallowable after 
the fact due to differing opinions on medical necessity.
•  Claims for services rendered may be nonallowable if they are later 
determined to have been based on inappropriate referrals.2
•  Governmental agencies may make changes in program interpreta­
tions, requirements, or "conditions of participation," some of which 
may have implications for amounts previously estimated.
.08 Such factors often result in retrospective adjustments to interim pay­
ments. Reasonable estimates of such adjustments are central to the third-party 
revenue recognition process in health care, in order to avoid recognizing rev­
enue that the provider will not ultimately realize. The delay between rendering 
services and reaching final settlement, as well as the complexities and ambi­
guities of billing and reimbursement regulations, makes it difficult to estimate 
net realizable third-party revenues.
Management's Responsibilities
.09 Management is responsible for the fair presentation of its financial 
statements in conformity with GAAP. Management also is responsible for adopt­
ing sound accounting policies and for establishing and maintaining internal 
control that will, among other things, record, process, summarize, and report 
transactions (as well as events and conditions) consistent with management's 
assertions embodied in the financial statements. Despite the inherent uncer­
tainties, management is responsible for estimating the amounts recorded in the 
financial statements and making the required disclosures in accordance with 
GAAP, based on management's analysis of existing conditions.
.10 Management's assertions regarding proper valuation of its revenues 
and receivables are embodied in the financial statements. Management is re­
sponsible for assuring that revenues are not recognized until their realization 
is reasonably assured. As a result, management makes a reasonable estimate 
of amounts that ultimately will be realized, considering—among other things— 
adjustments associated with regulatory reviews, audits, billing reviews, inves­
tigations, or other proceedings. Estimates that are significant to management's
1 Historically, the Health Care Financing Administration (HCFA) contracted with Peer Review 
Organizations (PROs) to validate the appropriateness of admissions and the clinical coding from which 
reimbursement was determined. Such reviews were typically performed within ninety days of the 
claim submission date. However, the government has modified its policies with respect to such reviews 
and now analyzes coding errors through other means, including in conjunction with investigations 
conducted by the Office of the Inspector General (OIG) of the U.S. Department of Health and Human 
Services.
2 Effective January 1 ,  1995, the Limitation on Certain Physician Referrals law prohibited physi­
cians from referring Medicare and Medicaid patients to health care organizations with which they had 
a financial relationship for the furnishing of designated health services. Implementing regulations 
have not yet been adopted as of the date of this publication.
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assertions about revenue include the provision for third-party payor contrac­
tual adjustments and allowances.
.11 Management also is responsible for preparing and certifying cost re­
ports submitted to federal and state government agencies in support of claims 
for payment for services rendered to government program beneficiaries.
The Auditor's Responsibilities
.12 The auditor's responsibility is to express an opinion on the financial 
statements taken as a whole. In reaching this opinion, the auditor considers 
the evidence in support of recorded amounts. If amounts are not known with 
certainty, the auditor considers the reasonableness of management's estimates 
in the present circumstances. The auditor also considers the fairness of the 
presentation and adequacy of the disclosures made by management.
.13 In planning the audit, the auditor considers current industry condi­
tions, as well as specific matters affecting the entity.3 Among a number of things, 
the auditor's procedures typically include an analysis of historical results (for 
example, prior fiscal intermediary audit adjustments and comparisons with in­
dustry benchmarks and norms) that enable the auditor to better assess the risk 
of material misstatements in the current period. When there are heightened 
risks, the auditor performs more extensive tests covering the current period. 
Exhibit 5.1 of the Guide includes a number of examples of procedures that 
auditors may consider.
.14 With respect to auditing third-party revenues, in addition to the usual 
revenue recognition considerations, the auditor considers whether amounts ul­
timately realizable are or should be presently known or are uncertain because 
they are dependent on some other future, prospective actions or confirming 
events. For example, under a typical fee-for-service contract with a commer­
cial payor, if the provider has performed a service for a covered individual, the 
revenue to which the provider is entitled should be determinable at the time 
the service is rendered. On the other hand, if the service was provided under 
a cost-based government contract, the revenue ultimately collectible may not 
be known until certain future events occur (for example, a cost report has been 
submitted and finalized after desk review or audit). In this case, management 
estimates the effect of such potential future adjustments.
.15 As stated previously, management is responsible for preparing the es­
timates contained in the financial statements. The auditor evaluates the ade­
quacy of the evidence supporting those estimates, reviews the facts supporting 
management's judgments, and evaluates the judgments made based on condi­
tions existing at the time of the audit. The fact that net revenues recorded at 
the time services are rendered differ materially from amounts that ultimately 
are realized does not necessarily mean the audit was not properly planned or 
carried out. Similarly, the fact that future events may differ materially from 
management's assumptions or estimates does not necessarily mean that man­
agement's estimates were not valid or the auditor did not follow generally ac­
cepted auditing standards (GAAS) as described in this SOP with respect to 
auditing estimates.
3 Risk factors, including ones related to legislative and regulatory matters, are discussed annu­
ally in the AICPA Audit Risk Alert Health Care Industry Developments.
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.16 The measurement of estimates is inherently uncertain and depends on 
the outcome of future events. Statement on Auditing Standards (SAS) No. 57, 
Auditing Accounting Estimates (AICPA, Professional Standards, vol. 1, AU sec. 
342), and SAS No. 79, Amendment to SAS No. 58, Reports on Audited Finan­
cial Statements (AICPA, Professional Standards, vol. 1, AU sec. 508) provide 
guidance to the auditor when the valuation of revenues is uncertain, pending 
the outcome of future events. In the current health care environment, conclu­
sive evidence concerning amounts ultimately realizable cannot be expected to 
exist at the time of the financial statement audit because the uncertainty as­
sociated with future program audits, administrative reviews, billing reviews, 
regulatory investigations, or other actions will not be resolved until sometime 
in the future.
.17 The fact that information related to the effects of future program au­
dits, administrative reviews, regulatory investigations, or other actions does 
not exist does not lead to a conclusion that the evidential matter supporting 
management's assertions is not sufficient to support management's estimates. 
Rather, the auditor's judgment regarding the sufficiency of the evidential mat­
ter is based on the evidential matter that is available or can reasonably be 
expected to be available in the circumstances. If, after considering the existing 
conditions and available evidence, the auditor concludes that sufficient eviden­
tial matter supports management's assertions about the valuation of revenues 
and receivables, and their presentation and disclosure in the financial state­
ments, an unqualified opinion ordinarily is appropriate.
.18 If relevant evidential matter exists that the auditor needs and is unable 
to obtain, the auditor should consider the need to express a qualified opinion or 
to disclaim an opinion because of a scope limitation. For example, if an entity 
has conducted an internal evaluation (for example, of coding or other billing 
matters) under attorney—client privilege and management and its legal counsel 
refuse to respond to the auditor's inquiries and the auditor determines the 
information is necessary, ordinarily the auditor qualifies his or her opinion for 
a scope limitation.
.19 The auditor considers the reasonableness of management's assump­
tions in light of the entity's historical experience and the auditor's knowledge 
of general industry conditions, because the accuracy of management's assump­
tions will not be known until future events occur. For certain matters, the best 
evidential matter available to the auditor (particularly as it relates to clinical 
and legal interpretations) may be the representations of management and its le­
gal counsel, as well as information obtained through reviewing correspondence 
from regulatory agencies.
.20 Pursuant to SAS No. 85, Management Representations (AICPA, Profes­
sional Standards, vol. 1, AU sec. 333), the auditor should obtain written repre­
sentations from management concerning the absence of violations or possible 
violations of laws or regulations whose effects should be considered for disclo­
sure in the financial statements or as a basis for recording a loss contingency. 
Examples of specific representations include the following:
•  Receivables
— Adequate consideration has been given to, and appropriate pro­
vision made for, estimated adjustments to revenue, such as for
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denied claims and changes to diagnosis-related group (DRG) as­
signments.
— Recorded valuation allowances are necessary, appropriate, and 
properly supported.
— All peer review organizations, fiscal intermediary, and third-party 
payor reports and information have been made available.
Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports have been 
properly filed.
— Management is responsible for the accuracy and propriety of all 
cost reports filed.
— All costs reflected on such reports are appropriate and allowable 
under applicable reimbursement rules and regulations and are 
patient-related and properly allocated to applicable payors.
— The reimbursement methodologies and principles employed are 
in accordance with applicable rules and regulations.
— Adequate consideration has been given to, and appropriate pro­
vision made for, audit adjustments by intermediaries, third-party 
payors, or other regulatory agencies.
— All items required to be disclosed, including disputed costs that 
are being claimed to establish a basis for a subsequent appeal, 
have been fully disclosed in the cost report.
— Recorded third-party settlements include differences between 
filed (and to be filed) cost reports and calculated settlements, which 
are necessary based on historical experience or new or ambiguous 
regulations that may be subject to differing interpretations. While 
management believes the entity is entitled to all amounts claimed 
on the cost reports, management also believes the amounts of 
these differences are appropriate.
Contingencies
— There are no violations or possible violations of laws or regula­
tions, such as those related to the Medicare and Medicaid an­
tifraud and abuse statutes, including but not limited to the Medi­
care and Medicaid Anti-Kickback Statute, Limitations on Certain 
Physician Referrals (the Stark law), and the False Claims Act, 
in any jurisdiction, whose effects should be considered for disclo­
sure in the financial statements or as a basis for recording a loss 
contingency other than those disclosed or accrued in the financial 
statements.
— Billings to third-party payors comply in all material respects with 
applicable coding guidelines (for example, ICD-9-CM and CPT- 
4) and laws and regulations (including those dealing with Medi­
care and Medicaid antifraud and abuse), and billings reflect only 
charges for goods and services that were medically necessary; 
properly approved by regulatory bodies (for example, the Food and 
Drug Administration), if required; and properly rendered.
— There have been no communications (oral or written) from regu­
latory agencies, governmental representatives, employees, or oth­
ers concerning investigations or allegations of noncompliance with
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laws and regulations in any jurisdiction (including those related 
to the Medicare and Medicaid antifraud and abuse statutes), de­
ficiencies in financial reporting practices, or other matters that 
could have a material adverse effect on the financial statements.
.21 Management's refusal to furnish written representations constitutes a 
limitation on the scope of the audit sufficient to preclude an unqualified opin­
ion and is ordinarily sufficient to cause an auditor to disclaim an opinion or 
withdraw from the engagement. However, based on the nature of the repre­
sentations not obtained or the circumstances of the refusal, the auditor may 
conclude that a qualified opinion is appropriate.
Potential Departures From G A A P Related to Estimates 
and Uncertainties
.22 In addition to examining the evidence in support of management's esti­
mates, the auditor determines that there has not been a departure from GAAP 
with respect to the reporting of those estimates in the financial statements. 
Such departures generally fall into one of the following categories:
•  Unreasonable accounting estimates
•  Inappropriate accounting principles
•  Inadequate disclosure
Therefore, in order to render an opinion, the auditor's responsibility is to eval­
uate the reasonableness of management's estimates based on present circum­
stances and to determine that estimates are reported in accordance with GAAP 
and adequately disclosed.
.23 As discussed in SAS No. 31, Evidential Matter (AICPA, Professional 
Standards, vol. 1, AU sec. 326), the auditor's objective is to obtain sufficient 
competent evidential matter to provide him or her with a reasonable basis for 
forming an opinion. As discussed previously. Exhibit 5-1 of the Guide provides 
a number of sample procedures that the auditor might consider in auditing an 
entity's patient revenues and accounts receivable, including those derived from 
third-party payors. For example, the Guide notes that the auditor might "test 
the reasonableness of settlement amounts, including specific and unallocated 
reserves, in light of the payors involved, the nature of the payment mechanism, 
the risks associated with future audits, and other relevant factors."4
Unreasonable Accounting Estimates
.24 In evaluating the reasonableness of management's estimates, the au­
ditor considers the basis for management's assumptions regarding the nature 
of future adjustments and management's calculations as to the effects of such 
adjustments.5 The auditor cannot determine with certainty whether such esti­
mates are right or wrong, because the accuracy of management's assumptions 
cannot be confirmed until future events occur.
.25 Though difficult to predict, it is reasonable for the auditor to expect 
that management has made certain assumptions (either in detail or in the 
aggregate) in developing its estimates regarding conditions likely to result in 
adjustments. The auditor gathers evidence regarding the reasonableness of 
the estimates (for example, consistency with historical experience and basis
4 See paragraphs ,25-.28.
5 The lack of such analyses may call into question the reasonableness of recorded amounts.
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of management's underlying assumptions). In evaluating reasonableness, the 
auditor should obtain an understanding of how management developed the 
estimate. Based on that understanding, the auditor should use one or a combi­
nation of the following approaches:
a. Review and test the process used by management to develop the 
estimate.
b. Develop an independent expectation of the estimate to corroborate 
the reasonableness of management's estimates.
c. Review subsequent events or transactions occurring prior to com­
pletion of fieldwork (AU sec. 342.10).
.26 Since no one accounting estimate can be considered accurate with cer­
tainty, the auditor recognizes that a difference between an estimated amount 
best supported by the audit evidence and the estimated amount included in 
the financial statements may be reasonable, and such difference would not be 
considered to be a likely misstatement. However, if the auditor believes the 
estimated amount included in the financial statements is unreasonable, he or 
she should treat the difference between that estimate and the closest reason­
able estimate in the range as a likely misstatement and aggregate it with other 
likely misstatements. The auditor also should consider whether the difference 
between estimates best supported by the audit evidence and the estimates in­
cluded in the financial statements, which are individually reasonable, indicate 
a possible bias on the part of the entity's management. For example, if each 
accounting estimate included in the financial statements was individually rea­
sonable, but the effect of the difference between each estimate and the estimate 
best supported by the audit evidence was to increase income, the auditor should 
reconsider the reasonableness of the estimates taken as a whole (SAS No. 47, 
Audit Risk and Materiality in Conducting an Audit [AICPA, Professional Stan­
dards, vol. 1, AU sec. 312.36]).
.27 The auditor recognizes that approaches and estimates will vary from 
entity to entity. Some entities with significant prior experience may attempt to 
quantify the effects of individual potential intermediary or other governmental 
(for example, the Office of Inspector General and the Department of Justice) or 
private payor adjustments, basing their estimates on very detailed calculations 
and assumptions regarding potential future adjustments. Some may prepare 
cost report6 analyses to estimate the effect of potential adjustments. Others may 
base their estimates on an analysis of potential adjustments in the aggregate, 
in light of the payors involved; the nature of the payment mechanism; the risks 
associated with future audits; and other relevant factors.
.28 Normally, the auditor considers the historical experience of the entity 
(for example, the aggregate amount of prior cost-report adjustments and previ­
ous regulatory settlements) as well as the risk of potential future adjustments. 
The fact that an entity currently is not subject to a governmental investiga­
tion does not mean that a recorded valuation allowance for potential billing
6 Medicare cost reimbursement is based on the application of highly complex technical rules, 
some of which are ambiguous and subject to different interpretations even among Medicare’s fiscal 
intermediaries. It is not uncommon for fiscal intermediaries to reduce claims for reimbursement that 
were based on management's good faith interpretations of pertinent laws and regulations. Addition­
ally, the Provider Reimbursement Review Board (PRRB) or the courts may be required to resolve 
controversies regarding the application of certain rules. To avoid recognizing revenues before their 
realization is reasonably assured, providers estimate the effects of such potential adjustments. This 
is occasionally done by preparing a cost report based on alternative assumptions to help estimate con­
tractual allowances required by generally accepted accounting principles. The existence of reserves 
or a reserve cost report does not by itself mean that a cost report was incorrectly or fraudulently filed.
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adjustments is not warranted. Nor do these emerging industry trends neces­
sarily indicate that an accrual for a specific entity is warranted.
.29 In evaluating valuation allowances, the auditor may consider the en­
tity's historical experience and potential future adjustments in the aggregate. 
For example, assume that over the past few years after final cost report audits 
were completed, a hospital's adjustments averaged 3 percent to 5 percent of 
total filed reimbursable costs. Additionally, the hospital is subject to potential 
billing adjustments, including errors (for example, violations of the three-day 
window, discharge and transfer issues, and coding errors). Even though spe­
cific incidents are not known, it may be reasonable for the hospital to estimate 
and accrue a valuation allowance for such potential future retrospective adjust­
ments, both cost-based and non-cost-based. Based on this and other information 
obtained, the auditor may conclude that a valuation allowance for the year un­
der audit of 3 percent to 5 percent of reimbursable costs plus additional amounts 
for potential non-cost-based program billing errors is reasonable.
.30 Amounts that ultimately will be realized by an entity are dependent on 
a number of factors, many of which may be unknown at the time the estimate 
is first made. Further, even if two entities had exactly the same clinical and 
coding experience, amounts that each might realize could vary materially due 
to factors outside of their control (for example, differing application of payment 
rules by fiscal intermediaries, legal interpretations of courts, local enforcement 
initiatives, timeliness of reviews, and quality of documentation). As a result, be­
cause estimates are a matter of judgment and their ultimate accuracy depends 
on the outcome of future events, different entities in seemingly similar circum­
stances may develop materially different estimates. The auditor may conclude 
that both estimates are reasonable in light of the differing assumptions.
Inappropriate Accounting Principles
.31 The auditor also determines that estimates are presented in the fi­
nancial statements in accordance with GAAP. If the auditor believes that the 
accounting principles have not been applied correctly, causing the financial 
statements to be materially misstated, the auditor expresses a qualified or ad­
verse opinion.
.32 Valuation allowances are recorded so that revenues are not recognized 
until the revenues are realizable. Valuation allowances are not established 
based on the provisions of Financial Accounting Standards Board (FASB) State­
ment of Financial Accounting Standards No. 5, Accounting for Contingencies.
.33 The auditor should be alert for valuation allowances not associated 
with any particular program, issue, or time period (for example, cost-report year 
or year the service was rendered). Such a reserve may indicate measurement 
bias. The auditor also considers the possibility of bias resulting in distorted 
earnings trends over time (for example, building up specific or unallocated val­
uation allowances in profitable years and drawing them down in unprofitable 
years).
Inadequate Disclosure
.34 If the auditor concludes that a matter involving a risk or an uncer­
tainty is not adequately disclosed in the financial statements in conformity with 
GAAP, the auditor should express a qualified or adverse opinion. SOP 94-6, Dis­
closure of Certain Significant Risks and Uncertainties [section 10,640], provides 
guidance on the information that reporting entities should disclose regarding 
risks and uncertainties existing as of the date of the financial statements.
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.35 In the health care environment, it is almost always at least reason­
ably possible that estimates regarding third-party payments could change in 
the near term as a result of one or more future confirming events (for exam­
ple, regulatory actions reflecting local or national audit or enforcement initia­
tives). For most entities with significant third-party revenues, the effect of the 
change could be material to the financial statements. Where material expo­
sure exists, the uncertainty regarding revenue realization is disclosed in the 
notes to the financial statements. Because representations from legal counsel 
are often key audit evidence in evaluating the reasonableness of management's 
estimates of potential future adjustments, the inability of an attorney to form 
an opinion on matters about which he or she has been consulted may be in­
dicative of an uncertainty that should be specifically disclosed in the financial 
statements.
.36 Differences between original estimates and subsequent revisions might 
arise due to final settlements, ongoing audits and investigations, or passage 
of time in relation to the statute of limitations. The Guide (paragraph 5.07) 
requires that these differences be included in the statement of operations in 
the period in which the revisions are made and disclosed, if material. Such 
differences are not treated as prior period adjustments unless they meet the 
criteria for prior period adjustments as set forth in FASB Statement No. 16, 
Prior Period Adjustments.
.37 Disclosures such as the following may be appropriate:
General Hospital (the Hospital) is a (not-for-profit, for-profit, 
or governmental hospital or health care system) located in 
(City, State). The Hospital provides health care services pri­
marily to residents of the region.
Net patient service revenue is reported at estimated net 
realizable amounts from patients, third-party payors, and 
others for services rendered and includes estimated retroac­
tive revenue adjustments due to future audits, reviews, 
and investigations. Retroactive adjustments are considered 
in the recognition of revenue on an estimated basis in the 
period the related services are rendered, and such amounts 
are adjusted in future periods as adjustments become known 
or as years are no longer subject to such audits, reviews, and 
investigations.
Revenue from the Medicare and Medicaid programs ac­
counted for approximately 40 percent and 10 percent, re­
spectively, of the Hospital's net patient revenue for the year 
ended 1999. Laws and regulations governing the Medicare 
and Medicaid programs are extremely complex and subject 
to interpretation. As a result, there is at least a reasonable 
possibility that recorded estimates will change by a material 
amount in the near term. The 1999 net patient service rev­
enue increased approximately $10,000,000 due to removal of 
allowances previously estimated that are no longer necessary 
as a result of final settlements and years that are no longer 
subject to audits, reviews, and investigations. The 1998 net 
patient service revenue decreased approximately $8,000,000 
due to prior-year retroactive adjustments in excess of amounts 
previously estimated.
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Appendix
Other Considerations Related to Governm ent Investigations
In recent years, the federal government and many states have aggressively in­
creased enforcement efforts under Medicare and Medicaid anti-fraud and abuse 
legislation. Broadening regulatory and legal interpretations have significantly 
increased the risk of penalties for providers; for example, broad interpretations 
of "false claims" laws are exposing ordinary billing mistakes to scrutiny and 
penalty consideration. In such circumstances, evaluating the adequacy of ac­
cruals for or disclosure of the potential effects of illegal acts in the financial 
statements of health care organizations is a matter that is likely to require a 
high level of professional judgment.
As previously discussed in this SOP, the far-reaching nature of alleged fraud 
and abuse violations creates an uncertainty with respect to the valuation of 
revenues, because future allegations of illegal acts could, if proven, result in a 
subsequent reduction of revenues. In addition, management makes provisions 
in the financial statements and disclosures for any contingent liabilities asso­
ciated with fines and penalties due to violations of such laws. FASB Statement 
No. Accounting for Contingencies, provides guidance in evaluating contingent 
liabilities, such as fines and penalties under applicable laws and regulations. 
Estimates of potential fines and penalties are not accrued unless their payment 
is probable and reasonably estimable.
The auditor's expertise is in accounting and auditing matters rather than oper­
ational, clinical, or legal matters. Accordingly, the auditor's procedures focus on 
areas that normally are subject to internal controls relevant to financial report­
ing. However, the further that potential illegal acts are removed from the events 
and transactions ordinarily refl ected in the financial statements, the less likely 
the auditor is to become aware of the act, to recognize its possible illegality, and 
to evaluate the effect on the financial statements. For example, determining 
whether a service was medically necessary, obtained through a legally appro­
priate referral, properly performed (including using only approved devices, ren­
dered in a quality manner), adequately supervised, accurately documented and 
classified, or rendered and billed by nonsanctioned individuals typically is not 
within the auditor's professional expertise. As a result, an audit in accordance 
with generally accepted auditing standards (GAAS) is not designed to detect 
such matters.
Further, an audit conducted in accordance with GAAS does not include render­
ing an opinion or any form of assurance on an entity's compliance with laws 
and regulations.1
Nor does an audit under GAAS include providing any assurance on an entity's 
billings or cost report. In fact, cost reports typically are not prepared and sub­
mitted until after the financial statement audit has been completed.
Certain audit procedures, although not specifically designed to detect illegal 
acts, may bring possible illegal acts to an auditor's attention. When a potentially
1 Even when auditors undertake a special engagement designed to attest to compliance with 
certain provisions of laws, regulations, contracts, and grants (for example, an audit in accordance 
with 0MB Circular A-133), the auditor's procedures do not extend to testing compliance with laws 
and regulations related to Medicare and Medicaid fraud and abuse.
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illegal act is detected, the auditor's responsibilities are addressed in SAS No. 
54, Illegal Acts by Clients (AICPA, Professional Standards, vol. 1, AU sec. 317). 
Disclosure of an illegal act to parties other than the client's senior manage­
ment and its audit committee or board of directors is not ordinarily part of the 
auditor's responsibility, and such disclosure would be precluded by the audi­
tor's ethical or legal obligation of confidentiality, unless the matter affects the 
auditor's opinion on the financial statements.2
2 Statement on Auditing Standards No. 54, Illegal Acts by Clients (AICPA, Professional Stan­
dards, vol. 1, AU sec. 317.23) discusses circumstances in which a duty to notify parties outside the 
client of detected illegal acts may exist.
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NOTE
Statements of Position on accounting issues present the conclusions 
of at least two-thirds of the Accounting Standards Executive Committee, 
which is the senior technical body of the Institute authorized to speak for 
the Institute in the areas of financial accounting and reporting. State­
ment on Auditing Standards No. 69, The Meaning 0f  Present Fairly in 
Conformity With Generally Accepted Accounting Principles, identifies 
AICPA Statements of Position that have been cleared by the Financial 
Accounting Standards Board as sources of established accounting prin­
ciples in category b of the hierarchy of generally accepted accounting 
principles that it establishes. AICPA members should consider the ac­
counting principles in this Statement of Position if a different accounting 
treatment of a transaction or event is not specified by a pronouncement 
covered by Rule 203 of the AICPA Code of Professional Conduct. In such 
circumstances, the accounting treatment specified by the Statement of 
Position should be used, or the member should be prepared to justify a 
conclusion that another treatment better presents the substance of the 
transaction in the circumstances.
AAG-HCO APP F
TABLE OF CONTENTS
Paragraph
Summary
Foreword
Introduction......................................................................................................................................... .01-.05
Scope.......................................................................................................................................... .06
Conclusions..........................................................................................................................................07-.09
Application of FASB Statement No. 133 .............................................................07-.08
Performance Indicator ...................................................................................... .09
Effective Date and Transition..................................................................................................... .10-.11
Background..........................................................................................................................................12-.16
Views on the Issue ............................................................................................................ .17-.21
Basis for Conclusions........................................................................................................................22-.37
Scope ...................................................................................................................................... .22-.23
Other Not-for-Profit O rganizations......................................................... .22
Governmental Health Care Enterprises .............................................  .23
Reporting a Separate Component of Equ ity ..................................................... .24-.25
Income Statement Classification of Derivative Gains
and Losses .................................................................................................................... .26-.27
Definition of Performance Indicator....................................................................... .28-.30
Transition............................................................................................................................... .31-.37
Statement of Position 02-2 403
AAG-HCO APP F
404 Health Care Organizations
Sum m ary
This Statement of Position (SOP) amends the AICPA Audit and Accounting 
Guide Health Care Organizations (Guide) to address how nongovernmental 
not-for-profit health care organizations should report gains or losses on hedging 
and nonhedging derivative instruments under Financial Accounting Standards 
Board (FASB) Statement of Financial Accounting Standards No. 133, Account­
ing for Derivative Instruments and Hedging Activities, as amended. This SOP 
requires the following:
•  Not-for-profit health care organizations should apply the provisions of 
FASB Statement No. 133 (including the provisions pertaining to cash 
flow hedge accounting) in the same manner as for-profit enterprises.
•  Not-for-profit health care organizations should provide all the dis­
closures required by paragraph 45 of FASB Statement No. 133, in­
cluding disclosures related to reclassifications into earnings of gains 
and losses that are reported in accumulated other comprehensive in­
come. Although those organizations are not otherwise required to re­
port changes in the components of comprehensive income pursuant to 
paragraph 26 of FASB Statement No. 130, Reporting Comprehensive 
Income, such organizations should separately disclose the beginning 
and ending accumulated derivative gain or loss that has been excluded 
from the performance indicator (earnings measure), the related net 
change associated with current period hedging transactions, and the 
net amount of any reclassifications into the performance indicator in a 
manner similar to that described in paragraph 47 of FASB Statement 
No. 133.
The SOP also amends the Guide to clarify that the performance indicator 
(earnings measure) reported by not-for-profit health care organizations is anal­
ogous to income from continuing operations of a for-profit enterprise.
The provisions of the SOP are effective for fiscal years beginning after June 
15, 2003. Earlier application of this SOP is encouraged but is permitted only as 
of the beginning of any fiscal quarter that begins after issuance of this SOP. The 
provisions of the SOP should be applied prospectively. Not-for-profit health care 
organizations that reported derivative gains or losses in a manner inconsistent 
with the conclusions of the SOP in financial statements issued prior to adoption 
of the SOP are not permitted to reclassify those gains or losses upon adoption.
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Foreword
The accounting guidance contained in this document has been cleared by the 
Financial Accounting Standards Board (FASB). The procedure for clearing ac­
counting guidance in documents issued by the Accounting Standards Execu­
tive Committee (AcSEC) involves the FASB reviewing and discussing in pub­
lic board meetings (1) a prospectus for a project to develop a document, (2) a 
proposed exposure draft that has been approved by at least 10 of AcSEC’s 15 
members, and (3) a final document that has been approved by at least 10 of Ac- 
SEC's 15 members. The document is cleared if at least four of the seven FASB 
members do not object to AcSEC undertaking the project, issuing the proposed 
exposure draft or, after considering the input received by AcSEC as a result of 
the issuance of the exposure draft, issuing the final document.
The criteria applied by the FASB in its review of proposed projects and proposed 
documents include the following:
1. The proposal does not conflict with current or proposed accounting 
requirements, unless it is a limited circumstance, usually in spe­
cialized industry accounting, and the proposal adequately justifies 
the departure.
2. The proposal will result in an improvement in practice.
3. The AICPA demonstrates the need for the proposal.
4. The benefits of the proposal are expected to exceed the costs of 
applying it.
In many situations, prior to clearance, the FASB will propose suggestions, many 
of which are included in the document.
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Introduction
Health Care Organizations
.01 Financial Accounting Standards Board (FASB) Statement of Finan­
cial Accounting Standards No. 133, Accounting for Derivative Instruments and 
Hedging Activities, as amended, establishes accounting and reporting stan­
dards for derivative instruments and hedging activities. If certain conditions 
are met, a derivative may be specifically designated as a hedge of the exposure 
to changes in the fair value of a recognized asset or liability or an unrecognized 
firm commitment (fair value hedge), a hedge of the exposure to variable cash 
flows of an existing recognized asset or liability or a forecasted transaction (cash 
flow hedge), or a hedge of foreign currency exposure.1
.02 The accounting for derivative gains and losses depends on the intended 
use of the derivative and the resulting designation.
•  For a fair value hedge, the gain or loss on the derivative is recognized 
in earnings in the period of change together with the offsetting loss or 
gain on the hedged item attributable to the risk being hedged.
•  For a cash flow hedge, the effective portion of the derivative's gain or 
loss is initially reported as a component of other comprehensive income 
(outside earnings) and subsequently reclassified into earnings when 
the forecasted transaction affects earnings. Any ineffective portion of 
the gain or loss is reported in earnings immediately.
•  For a derivative not designated as a hedging instrument, the gain or 
loss is recognized in earnings in the period of change.
.03 The application of FASB Statement No. 133 to entities that do not re­
port earnings as a separate caption in a statement of financial performance 
(for example, a not-for-profit organization) is described in paragraph 43 of that 
Statement. Paragraph 43 indicates that such organizations shall recognize the 
gain or loss on hedging and nonhedging derivative instruments, and changes 
in the carrying amount of the hedged item in a fair value hedge, as a change in 
net assets in the period of change. Paragraph 43 also indicates that cash flow 
hedge accounting is not available to a not-for-profit or other entity that does 
not report earnings as a separate caption in a statement of financial perfor­
mance. Consistent with the provisions of FASB Statement No. 117, Financial 
Statements of Not-for-Profit Organizations, FASB Statement No. 133 does not 
prescribe how a not-for-profit organization should determine the components 
of an operating measure, if one is presented.
.04 Many health care entities are organized as not-for-profit organizations, 
and thus would appear to be subject to the provisions of paragraph 43 of FASB 
Statement No. 133. The thrust of the guidance in paragraph 43 appears to be di­
rected at the fact that FASB Statement No. 117 does not require not-for-profit 
entities to report earnings. However, not-for-profit health care organizations 
must report a defined measure of earnings (performance indicator) as a sepa­
rate caption in the statement of operations, based on requirements contained 
in paragraph 10.17 and 10.18 of the AICPA Audit and Accounting Guide Health 
Care Organizations (the Guide). Consequently, some not-for-profit health care 
organizations believed that paragraph 43 of FASB Statement No. 133 (includ­
ing its provisions related to cash flow hedge accounting) did not affect them.
1 Not-for-profit health care organizations do not frequently enter into foreign currency hedges. 
Therefore, this SOP focuses on matters pertaining to fair value and cash fl ow hedges.
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Those entities applied the provisions of FASB Statement No. 133 in the same 
manner as for-profit enterprises. Other not-for-profit health care organizations 
believed they were subject to the guidance in paragraph 43, but interpreted that 
guidance in different ways. As a result, diversity in practice arose among not- 
for-profit health care organizations with respect to their accounting for deriva­
tives.
.05 This SOP addresses how not-for-profit health care organizations should 
report gains or losses on hedging and nonhedging derivative instruments un­
der FASB Statement No. 133 and clarifies certain matters with respect to the 
performance indicator (earnings measure) reported by such organizations.
Scope
.06 This SOP applies to not-for-profit health care organizations that are 
within the scope of the Guide. It does not apply to governmental entities that 
are within the scope of the Guide.
Conclusions
Application  of FASB Statement No. 133
.07 Except as provided in paragraph .08 of this SOP, not-for-profit health 
care organizations should apply the provisions of FASB Statement No. 133 
(including the provisions pertaining to cash flow hedge accounting) in the same 
manner as for-profit enterprises. That is, the gain or loss items that affect 
a for-profit enterprise's income from continuing operations similarly should 
affect the not-for-profit health care organization's performance indicator, and 
the gain or loss items that are excluded from a for-profit enterprise's income 
from continuing operations (such as items reported in other comprehensive 
income) similarly should be excluded from the performance indicator by the 
not-for-profit health care organization.
.08 Paragraph 47 of FASB Statement No. 133 discusses requirements to 
report changes in the components of comprehensive income pursuant to para­
graph 26 of FASB Statement No. 130, Reporting Comprehensive Income. Al­
though not-for-profit health care organizations are not subject to the require­
ments of FASB Statement No. 130, this SOP requires those organizations to 
separately disclose the beginning and ending accumulated derivative gain or 
loss that has been excluded from the performance indicator (also see para­
graph .10 of this SOP), the related net change associated with current period 
hedging transactions, and the net amount of any reclassifications into the per­
formance indicator in a manner similar to that described in paragraph 47 of 
FASB Statement No. 133. Similarly, this SOP requires not-for-profit health 
care organizations to provide disclosures that are analogous to those required 
by paragraph 45 of FASB Statement No. 133 for for-profit enterprises, including 
the disclosure of anticipated reclassifications into the performance indicator of 
gains and losses that have been excluded from that measure and reported in 
accumulated derivative gain or loss as of the reporting date.
Performance Indicator
.09 Paragraph 10.17 and 10.18 of the Guide are amended as follows. The 
following text is added after the first sentence of paragraph 10.17:
This performance indicator and the income from continu­
ing operations reported by for-profit health care enterprises
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generally are consistent, except for transactions that clearly 
are not applicable to one kind of entity (for example, for-profit 
health care enterprises typically would not receive contribu­
tions, and not-for-profit health care organizations would not 
award stock compensation). That is, the performance indica­
tor is analogous to income from continuing operations of a 
for-profit enterprise.
In paragraph 10.18, item e is eliminated, item f is renumbered e, and item g is 
deleted and replaced with the following two subpoints:
f. Items that are required to be reported in or reclas­
sified from other comprehensive income, such as 
minimum pension liabilities in accordance with 
paragraph 37 of FASB Statement No. 87, Em­
ployers' Accounting for Pensions; foreign currency 
translation adjustments; and the effective portion 
of the gain or loss on derivative instruments des­
ignated and qualifying as cash fl ow hedging in­
struments.
g. Items that are required to be reported sepa­
rately under specialized not-for-profit standards. 
These include extraordinary items, the effect of 
discontinued operations, and the cumulative ef­
fect of accounting changes pursuant to the provi­
sions of FASB Statement No. 117; and unrealized 
gains and losses on investments not restricted by 
donors or by law (except for those investments 
classified as trading securities) and investment 
returns restricted by donors or by law, as required 
by paragraphs 4.07 through 4.10 of this Guide.
Effective Date and Transition
.10 The provisions of this SOP are effective for fiscal years beginning after 
June 15, 2003. Earlier application of this SOP is encouraged but is permitted 
only as of the beginning of any fiscal quarter that begins after issuance of this 
SOP. This SOP should be applied prospectively for all contracts existing on 
the initial date of application of this SOP and for transactions after that date. 
Derivative gains or losses reported in a manner inconsistent with the provisions 
of this SOP in financial statements for periods prior to the initial date of applica­
tion of this SOP should not be reclassified upon adoption. Any derivative gains 
and losses excluded from the performance indicator in the financial statements 
issued for periods ended before the initial date of application of this SOP that 
did not meet the cash fl ow hedging criteria of FASB Statement No. 133 should 
not be reclassified and included as a component of the performance indicator in 
any period subsequent to the initial date of application of this SOP. In addition, 
the derivative gains and losses referred to in the preceding sentence should 
not be included in the disclosure of the accumulated derivative gain or loss (as 
described in paragraph .08 of this SOP). However, to the extent that derivative 
gains or losses on cash fl ow hedges qualifying under FASB Statement No. 133 
had been reported in a manner consistent with the provisions of this SOP in 
financial statements for periods prior to the initial date of application of this 
SOP, such amounts should be included in that disclosure and should be reclas­
sified and included in the performance indicator when the hedged transaction
408 Health Care Organizations
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affects the performance indicator. When the financial statements of the year of 
adoption are presented separately or included in comparative financial state­
ments, the notes to the financial statements should disclose (a) the fact that 
this SOP has been adopted and the effective date of adoption, and (b) the nature 
of any differences in accounting principles or financial statement presentation 
applicable to the financial statements presented that resulted from adoption of 
the SOP. Disclosure of pro forma amounts is not required.
.11 Entities initially applying hedge accounting upon adoption of this SOP 
are reminded that all the hedge accounting criteria in FASB Statement No. 133 
must be met for the entire period to which hedge accounting is being applied. 
Derivative instruments should not be retroactively designated as hedges if 
appropriate contemporaneous documentation of the election and periodic as­
sessment of effectiveness2 did not occur in conformity with FASB Statement 
No. 133.
The provisions of this SOP need not be applied 
to immaterial items.
Background
.12 Issues surrounding the reporting of derivatives by not-for-profit health 
care organizations and the resulting diversity in practice were brought to the 
attention of the planning subcommittee of the AICPA's Accounting Standards 
Executive Committee (AcSEC) in December 2000. Specifically, questions had 
been raised about whether the guidance in paragraph 43 of FASB Statement 
No. 133, Accounting for Derivative Instruments and Hedging Activities, as 
amended, applied to not-for-profit health care organizations that are required 
under industry-specific generally accepted accounting principles (GAAP) to re­
port a performance indicator.
.13 The planning subcommittee discussed the paragraph 43 issue and con­
cluded that, because not-for-profit health care organizations are required to re­
port a standardized performance indicator that is considered analogous to in­
come from continuing operations reported by for-profit enterprises, they should 
apply the provisions of FASB Statement No. 133 in the same manner as do 
for-profit enterprises. Because that conclusion was not considered controver­
sial, the planning subcommittee directed the AICPA staff to draft clarifying 
guidance in the form of a proposed AICPA Technical Practice Aid (TPA).
.14 The planning subcommittee also discussed a footnote that had been 
added as a conforming change to paragraph 10.18 of the Guide in May 2000. 
That footnote contained the following statement:
Not-for-profit health care organizations that have early- 
adopted FASB Statement No. 133, Accounting for Deriva­
tive Instruments and Hedging Activities, should also report
2 FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities, as 
amended, establishes the general requirement that, to use hedge accounting, an entity should assess 
a hedge's effectiveness at the time it enters into a hedge and at least every three months thereafter, 
unless the hedge qualifies for use of the short-cut method. The requirement to assess hedge effective­
ness at least every three months applies to entities that issue financial statements only on an annual 
basis as well as to entities that issue quarterly financial statements.
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unrealized gains and losses on derivatives that do not qualify 
as a fair value hedge under FASB Statement No. 133, except 
for the effect of changes in interest accruals, separate from 
the performance indicator.
In light of the planning subcommittee's conclusion that the provisions of FASB 
Statement No. 133 should be applied to not-for-profit health care organizations 
in the same manner as for-profit enterprises, it was decided that the May 2000 
conforming change should be deleted from future editions of the Guide.
.15 In January 2001, the planning subcommittee discussed a letter re­
ceived by AcSEC's Chair from The Bond Market Association (TBMA). The letter 
indicated TBMA's awareness of the planning subcommittee's discussions and 
expressed concern that the proposed guidance would be issued in the form of 
a nonauthoritative TPA. TBMA was concerned that not-for-profit health care 
organizations and their independent auditors would not be aware of such guid­
ance, resulting in the inconsistent application of derivative accounting among 
organizations in the sector. TBMA also wanted to ensure that all affected parties 
would have an opportunity to review and comment on the proposed guidance, 
because it could represent a significant change in reporting for some not-for- 
profit health care organizations.
.16 In March 2001, after further discussing the draft TPA and considering 
input received from various sources, the planning subcommittee and AcSEC 
decided that an SOP should be issued to amend the Guide to address these 
issues. Although the planning subcommittee and AcSEC did not disagree with 
the conclusions in the draft TPA, it was concluded that an SOP subject to due 
process would be the most appropriate vehicle for communicating the guid­
ance. AcSEC issued an exposure draft of a proposed SOP on June 14, 2002 and 
received four comment letters.
Views on the Issue
.17 Some believed that because not-for-profit health care organizations are 
required by the AICPA Audit and Accounting Guide Health Care Organiza­
tions to report a performance indicator that is analogous to income from contin­
uing operations of a for-profit enterprise, they should apply the provisions of 
FASB Statement No. 133 (including the cash flow hedge accounting provisions) 
in the same manner as for-profit enterprises. That is, the gain or loss items that 
under FASB Statement No. 133 would affect a for-profit enterprise's earnings 
similarly should affect the not-for-profit health care organization's performance 
indicator, and the gain or loss items that under FASB Statement No. 133 are 
reported in other comprehensive income by the for-profit enterprise similarly 
should be excluded from the performance indicator by the not-for-profit health 
care organization. They interpreted paragraph 43 of FASB Statement No. 133 
as applying only to organizations that are not required to report an earnings 
measure.
.18 Others believed that paragraph 43 precludes the use of cash flow hedge 
accounting by not-for-profit health care organizations because the FASB has not 
defined the performance indicator to be used by those organizations. They cited 
the following sentence in paragraph 501 of FASB Statement No. 133 as support 
for their position:
For this Statement to permit a not-for-profit entity, for ex­
ample, to apply cash flow hedge accounting, the Board would
Health Care Organizations
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first have to define a subcomponent of the total change in net 
assets during a period that would be analogous to earnings 
for a business enterprise.
They believed that the definition of performance indicator used by not-for-profit 
health care organizations does not qualify as earnings for FASB Statement 
No. 133 purposes because it was promulgated by AcSEC, rather than the FASB. 
Opponents of that view pointed to paragraph 49 of FASB Statement No. 117, 
Financial Statements of Not-for-Profit Organizations, which allows AICPA in­
dustry Audit and Accounting Guides to provide implementing guidance with 
respect to that Statement that, if cleared by the FASB, should be adopted by 
users of those guides. The FASB did not object to the definition of performance 
indicator promulgated in the Guide.
.19 Others acknowledged that not-for-profit health care organizations re­
port a performance indicator that is analogous to income from continuing opera­
tions of a for-profit enterprise, but believed that the cash fl ow hedge accounting 
prohibitions in paragraph 43 should apply because the concept of other com­
prehensive income is limited to for-profit enterprises that are subject to FASB 
Statement No. 130, Reporting Comprehensive Income. Opponents of that view 
responded that not-for-profit health care organizations employ other compre­
hensive income reporting concepts in their statement of operations and their 
definition of a performance indicator. They pointed to the fact that among the ex­
clusions from the performance indicator listed in paragraph 10.18 of the Guide 
are the items that for-profit organizations are required to include in other com­
prehensive income under FASB Statement No. 130 (foreign currency items, 
minimum pension liability adjustments, and unrealized gains and losses on 
certain investments in debt and equity securities). Further, they pointed to 
paragraphs 500 and 501 of FASB Statement No. 133, which indicate that the 
total change in net assets of a not-for-profit organization is analogous to the 
total comprehensive income of a for-profit enterprise.
.20 Still others believed that, although not-for-profit health care organi­
zations conceptually are capable of applying the mechanics of cash flow hedge 
accounting in their financial statements, they are precluded from doing so be­
cause the list in paragraph 10.18 of the Guide of items to be excluded from 
the performance indicator does not explicitly include "the effective portion of 
the gain or loss on derivative instruments designated and qualifying as cash 
flow hedging instruments." They believed that all transactions except those 
explicitly listed in paragraph 10.18 should be included in the performance 
indicator.
.21 Among those who believed that paragraph 43 prohibits not-for-profit 
health care organizations from applying cash flow hedge accounting, some be­
lieved that all hedging and nonhedging derivative gains and losses should be 
included in the performance indicator. Others interpreted paragraph 43 as re­
quiring all hedging and nonhedging derivative gains and losses to be excluded 
from the performance indicator and reported in "other changes in net assets." 
Still others employed a hybrid approach to reporting derivative gains and losses 
based on guidance provided in a conforming change (that subsequently was 
rescinded3 contained in a footnote to paragraph 10.18 of the May 2000 edition 
of the Guide.
3 See paragraph .14 of this SOP.
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Basis for Conclusions 
Scope
Other Not-for-Profit Organizations
.22 AcSEC discussed whether the scope of the SOP should extend to other 
types of not-for-profit organizations (that is, not-for-profit organizations other 
than health care organizations) in situations in which those organizations vol­
untarily choose to provide a performance indicator. Those organizations are 
subject to the AICPA Audit and Accounting Guide Not-for-Profit Organizations, 
rather than the Audit and Accounting Guide Health Care Organizations. Ac­
SEC chose not to address similar issues for those organizations in the context 
of this SOP because, unlike health care organizations, other types of not-for- 
profit organizations are not subject to a standardized or prescribed performance 
measure.
Governmental Health Care Enterprises
.23 Because the concept of reporting "other comprehensive income" con­
flicts with the reporting requirements of Governmental Accounting Standards 
Board (GASB) Statement No. 34, Basic Financial Statements—and Manage­
ment's Discussion and Analysis—for State and Local Governments, cash flow 
hedge accounting is not available to governmental health care enterprises that 
are within the scope of the Guide. Therefore, governmental health care en­
terprises are excluded from the scope of the SOP. FASB Statement No. 133 
applies to governmental enterprises only to the extent that provisions in that 
Statement do not conflict with the provisions of GASB pronouncements (see 
paragraph 94 of GASB Statement No. 34).
Reporting a Separate Component of Equity
.24 Pursuant to paragraph 26 of FASB Statement No. 130, for-profit enti­
ties report accumulated other comprehensive income as a component of equity 
that is displayed separately from retained earnings and additional paid-in cap­
ital in a statement of financial position. When FASB Statement No. 130 was 
issued, the FASB considered whether not-for-profit organizations should also be 
included within the scope of that Statement. The FASB decided to exclude those 
organizations, noting that not-for-profit organizations' financial statements al­
ready were displaying the equivalent of comprehensive income as a result of 
the requirements of FASB Statement No. 117. Thus, not-for-profit organiza­
tions are not required to report accumulated other comprehensive income as a 
separate component of equity.
.25 AcSEC discussed whether the absence of a requirement to report ac­
cumulated other comprehensive income as a separate component of equity was 
a significant enough difference to preclude not-for-profit health care organiza­
tions from being able to use cash flow hedge accounting under FASB Statement 
No. 133. AcSEC determined that the concept of reporting accumulated other 
comprehensive income as a separate component of equity is unique to for-profit 
enterprises that report retained earnings and additional paid-in capital and 
that, further, the concept primarily appears to be a carryforward of the report­
ing practices followed by such entities before the issuance of FASB Statement 
No. 130. Moreover, AcSEC was concerned that such reporting may conflict with 
the provisions of FASB Statement No. 117 requiring not-for-profit organiza­
tions to report three classes of net assets (unrestricted, temporarily restricted,
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and permanently restricted). Therefore, AcSEC concluded that the absence of 
a requirement to report a separate component of equity in the balance sheet 
of not-for-profit health care organizations should not preclude those organi­
zations from using comprehensive income reporting for qualifying gains and 
losses on cash flow hedges. Although accumulated other comprehensive income 
will inherently be carried forward in a not-for-profit health care organization's 
net assets, there is no compelling need for it to be reported separately in the 
balance sheet.
Income Statement Classification of Derivative Gains and Losses
.26 Although FASB Statement No. 133 provides comprehensive disclosure 
guidance for derivatives, it does not explicitly address or prescribe the income 
statement classification for derivative gains and losses that are included in 
earnings.
.27 Paragraph 45 of FASB Statement No. 133 requires an entity to disclose 
where in the income statement it has chosen to report the net gain or loss on 
fair value and cash flow hedges (and the related hedged transaction or item), 
but the paragraph does not specify where or in what captions such gains and 
losses should be displayed. That allows for flexibility in reporting based on an 
entity's economic rationale for entering into the hedge. For derivatives that are 
not designated as hedges, FASB Statement No. 133 does not require disclosure 
of where gains and losses are reported in the income statement, nor does it 
specify where within the income statement those gains and losses should be 
reported. AcSEC decided not to provide more specific guidance regarding in­
come statement classification in this SOP because it did not want to prescribe 
more restrictive guidance for not-for-profit health care organizations than that 
applicable to other organizations subject to FASB Statement No. 133.
Definition of Performance Indicator
.28 The term performance indicator was introduced in 1996 when the 
AICPA issued the Audit and Accounting Guide Health Care Organizations.4 
The 1996 revision of the industry Guide was necessitated largely by the is­
suance of FASB Statements No. 116, Accounting for Contributions Received 
and Contributions Made, and No. 117, which (among other things) changed the 
financial statement display requirements for not-for-profit organizations. The 
1995 exposure draft of the Guide had referred to the earnings measure using 
terms such as net income and operating income. The FASB subsequently ob­
jected to that terminology, deeming it inappropriate for describing an earnings 
measure of a not-for-profit organization. Accordingly, the final Guide used the 
generic term performance indicator to denote the earnings measure.
.29 Paragraph 1.04 of the Guide states, in part:
The financial reporting for not-for-profit, business-oriented 
organizations and investor-owned health care enterprises 
generally is consistent except for transactions that clearly are 
not applicable. For example, not-for-profit business organiza­
tions would have nothing to report for shareholders' equity. 
On the other hand, investor-owned health care enterprises 
typically would not have anything to report for contributions.
4 Health Care Organizations replaced the AICPA Industry Audit Guide Audits of Providers of 
Health Care Services.
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Consequently, in developing the definition of performance indicator (paragraph 
10.17 and 10.18 of the Guide), AcSEC intended that the linkage between the 
new performance indicator measure and the earnings measure previously re­
ported by not-for-profit health care organizations be preserved to the greatest 
extent possible, due to its importance to users of health care organizations' fi­
nancial statements. The phrase "other items that are required by GAAP to be 
reported separately" was included in paragraph 10.18g of the Guide to enable 
the performance indicator to remain "evergreen," that is, to permit it to be up­
dated by conforming changes to incorporate the issuance of future accounting 
standards.
.30 Subsequent to issuance of the Guide, AcSEC determined that the provi­
sions of paragraph 10.17 and 10.18 were not being interpreted by some readers 
of the Guide in the manner intended by AcSEC. In addition, when new account­
ing standards have been issued, some readers of the Guide have been uncertain 
how to apply them with respect to the performance indicator. Consequently, 
paragraph .09 of this SOP revises the definition of performance indicator to 
state explicitly that the performance indicator should be regarded as the func­
tional equivalent of income from continuing operations of a for-profit enterprise. 
Additionally, this SOP amends paragraph 10.18 of the Guide to clarify that the 
reference to "other items that are required by GAAP to be reported separately" 
refers to GAAP applicable to for-profit enterprises (for example, items that are 
required under existing accounting standards to be reported in other compre­
hensive income5 as well as GAAP specific to not-for-profit organizations, and 
that additional items may result from issuance of future accounting standards.
Transition
.31 Paragraph 515 of FASB Statement No. 133 states, in part:
Because hedge accounting is based on an entity's intent at the 
time a hedging relationship is established, the Board decided 
that retroactive application of the provisions of this Statement 
was not appropriate.
Similarly, Derivatives Implementation Group (DIG) Issue No. K5, Transition 
Provisions for Applying the Guidance in Statement 133 Implementation Issues, 
indicates that when an entity has applied "the recognition and measurement of 
derivatives differently than required by subsequently issued cleared implemen­
tation guidance, [the entity] should account for the effects of initially complying 
with that implementation guidance prospectively for all existing contracts and 
future transactions, as of the effective date for that guidance." Consequently, 
AcSEC determined that the effects of initially complying with the guidance in 
this SOP should also be accounted for prospectively.
.32 AcSEC also considered whether to allow an alternative for retroactive 
application of this SOP. Although this SOP does not change the "recognition 
and measurement of derivatives," it may change an entity’s accounting policy 
and thus may affect certain actions taken by an entity. For example, based 
on their interpretation of authoritative literature, certain health care entities 
may have had economic hedges that they did not designate as cash flow hedges 
because they did not believe that cash flow hedging derivatives were accounted
5 For example, in June 1997 the phrase "minimum pension liabilities in accordance with para­
graph 37 of FASB Statement No. 87, Employers' Accounting for Pensions, or foreign currency trans­
lation adjustments" was added to paragraph 10.18(g) as a conforming change necessitated by the 
issuance of FASB Statement No. 130, Reporting Comprehensive Income.
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for differently from non-hedging derivatives. AcSEC recognized that the 
historical actions undertaken to document, designate, or assess effectiveness 
by entities that, in prior periods, had adopted accounting policies inconsistent 
with those set forth in this SOP may have differed had this SOP been effective 
during those prior periods. In recognition of this fact, and because hedging 
relationships cannot be documented retroactively under FASB Statement 
No. 133, AcSEC decided that retroactive application of the provisions of this 
SOP was not appropriate.
.33 Because the effect of an entity's hedging activities on its financial state­
ments in the initial year of adoption of this SOP may not be comparable to the 
preceding year, AcSEC discussed whether pro forma disclosures in the year 
of adoption would address concerns related to consistency and comparability 
of financial information. Disclosure of the pro forma effects of retroactive ap­
plication of hedge accounting for prior periods (in a manner similar to the re­
quirements of paragraph 19(d) of Accounting Principles Board Opinion No. 20, 
Accounting Changes) was considered and rejected for the same reasons that 
AcSEC rejected retroactive restatement as a transition option, as described in 
paragraph .32. The exposure draft solicited comments on an alternative pro 
forma measure that would require entities to disclose the effect on their perfor­
mance indicator for the year of adoption of continuing to apply their prior year's 
reporting practices, if such practices differed from those required by the SOP. 
One commenter stated that such a requirement was inappropriate and would 
not provide users of the financial statements with meaningful comparative in­
formation. For example, for an entity that prior to adoption of the SOP believed 
that paragraph 43 of Statement No. 133 prohibited cash flow hedge account­
ing but that upon adoption of the SOP adopted cash flow hedge accounting, 
the information derived from disclosing what the performance indicator would 
have been had the entity continued to not take advantage of hedge account­
ing has little (if any) meaning for users of financial statements. Similarly, for 
an entity that prior to adoption of the SOP was excluding gains and losses 
from the performance indicator in a manner other than that allowed by this 
SOP, disclosing what the performance indicator would have been had the en­
tity continued to exclude those derivative gains/losses from the performance 
indicator subsequent to its adoption of the SOP does not provide meaningful 
information and, further, results in comparing a performance indicator derived 
in accordance with GAAP with a measure that is no longer considered to be 
in accordance with GAAP. Therefore, although acknowledging that the use­
fulness of financial information about an entity increases if that information 
can be compared with similar information in prior periods, AcSEC concluded 
that the potential usefulness of that information is diminished or eliminated 
if the information has no comparative value. Additionally, AcSEC considered 
this SOP's guidance as similar in nature to the guidance provided in Statement 
No. 133 and DIG Issue No. K5. Neither Statement No. 133 nor Issue No. K5 
requires disclosure of any pro forma information. Consequently, AcSEC con­
cluded that pro forma disclosures of any type would not be appropriate for the 
year of adoption of this SOP. However, when the financial statements of the 
year of adoption are presented separately or included in comparative financial 
statements, the entity should disclose in the notes to the financial statements 
(a) the fact that the SOP has been adopted and the effective date of adoption 
(for example, beginning of a year or beginning of a quarter), and (6) the nature 
of any differences in accounting principles or financial statement presentation 
applicable to the financial statements presented that resulted from adoption 
of the SOP (for example, "The effective portion of unrealized gains and losses
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on cash flow hedges, which prior to adoption of SOP 02-2 were included in the 
performance indicator, are now reported below the performance indicator").
.34 The exposure draft would have required entities to adopt the SOP as of 
the beginning of a fiscal year. Several respondents to the exposure draft objected 
to precluding entities from early adopting this SOP, based on their understand­
ing that a number of entities had already been applying the provisions of FASB 
Statement No. 133 pertaining to cash flow hedge accounting prior to issuance 
of the exposure draft. They also were concerned about allowing diversity in 
practice to continue over the extended period that would result from requiring 
adoption as of the beginning of a fiscal year. AcSEC concluded that in the in­
terest of remedying diversity in practice as quickly as possible, entities should 
be allowed to early adopt the SOP.
.35 AcSEC observed that some not-for-profit health care organizations may 
have employed a methodology that excluded derivative gains and losses from 
the performance indicator until those gains or losses were realized. Upon real­
ization, those organizations would have recognized the derivative's gain or loss 
in the performance indicator. Consistent with its decision to require prospec­
tive application of this SOP, AcSEC decided that upon initial application of this 
SOP, any prior gains or losses on derivative instruments recognized by those 
not-for-profit health care organizations that had been excluded from the per­
formance indicator in years before adoption and that did not meet the hedging 
criteria of FASB Statement No. 133 (including the requirements of contempora­
neous documentation and testing of effectiveness) should not subsequently be 
reclassified and included as a component of the performance indicator. Rather, 
any such derivative gains and losses should be permanently excluded from the 
performance indicator.
.36 AcSEC did agree, however, that to the extent that a not-for-profit health 
care organization had reported derivative gains or losses in a manner consistent 
with the provisions of this SOP (including compliance with the documentation 
and designation requirements of FASB Statement No. 133) in financial state­
ments for periods prior to the initial application of this SOP, such amounts 
should be reclassified and included in the performance indicator when the 
hedged item affects the performance indicator.
.37 For entities that initially apply hedge accounting upon adoption of this 
SOP or thereafter, paragraph .11 states that all the hedge accounting criteria 
in FASB Statement No. 133 must be met for the entire period to which hedge 
accounting is being applied in order for hedge accounting to be used. AcSEC 
noted that when an organization designates an existing derivative as a hedg­
ing instrument upon adoption of the SOP or thereafter, the fair value of the 
derivative instrument typically will not be zero at the inception of the hedg­
ing relationship. Because paragraph 68(b) of FASB Statement No. 133 requires 
that the fair value of the hedging instrument at the inception of the hedging 
relationship be zero in order for the short-cut method to be used, application 
of the short-cut method will not be possible and hedge ineffectiveness for cash 
flow hedges must be measured under either the hypothetical derivative method 
or the change in fair value method as described in DIG Issue No. G7, Cash Flow 
Hedges: Measuring the Ineffectiveness of a Cash Flow Hedge under Paragraph 
30(b) When the Shortcut Method is Not Applied. For cash flow hedging relation­
ships that were designated and accounted for pursuant to the hedge accounting 
criteria in FASB Statement No. 133 prior to the adoption of this SOP, the adop­
tion of this SOP will not affect how hedge effectiveness is assessed or hedge 
ineffectiveness is measured for such relationships.
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Appendix G
Information Sources
Further information on matters addressed in this Guide is available through 
various publications and services listed in the table that follows. Many non­
government and some government publications and services involve a charge 
or membership requirement.
Fax services allow users to follow voice cues and request that selected docu­
ments be sent by fax machine. Some fax services require the user to call from 
the handset of the fax machine, others allow the user to call from any phone. 
Most fax services offer an index document, which lists titles and other informa­
tion describing available documents.
Recorded announcements allow users to listen to announcements about a vari­
ety of recent or scheduled actions or meetings.
All telephone numbers listed are voice lines, unless otherwise designated as fax 
(f) or data (d) lines.
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Appendix H
References to AICPA Technical Practice Aids
The following nonauthoritative questions and answers, commonly referred 
to as Technical Practice Aids (TPAs), have been prepared by AIPCA staff and are 
included in AICPA Technical Practice Aids. The TPAs have not been approved, 
disapproved, or otherwise acted upon by the Accounting Standards Executive 
Committee (AcSEC) or any other senior technical committee of the AICPA. 
They are not sources of established accounting principles as described in SAS 
No. 69, The Meaning of Present Fairly in Conformity With Generally Accepted 
Accounting Principles, nor are they sources of authoritative generally accepted 
auditing standards. Staff believes the TPAs listed below may be useful and 
relevant for users of this Guide. Other TPAs, as well as Consensus Positions 
of the FASB's Emerging Issues Task Force, may also be useful and relevant to 
users of this Guide depending on the facts and circumstances.
TPA Reference No. Title
6400.04 Hospital as Collecting Agent for Physicians
6400.12 General Obligation Bonds Issued for Current Use by 
City Owned Hospital
6400.16 Disclosure Required in Consolidated or Combined 
Financial Statements
6400.17 Elimination of Profit on Intercompany Sales
6400.19 Offsetting of Limited Use Assets
6400.20 Format of Combined or Consolidated Financial 
Statements
6400.25 Accounting for Transfer of Assets From 
Not-for-Profit to For-Profit Entities
6400.26 Transfer of Assets From Subsidiary For-Profit Entity 
to Not-for-Profit Stockholder Parent
6400.28 Valuation of Assets Transferred Between Related 
Entities Under Common Control
6400.29 Timing of Recording Transfers Between Related 
Entities
6400.30 Accounting for Transactions Involving Medicaid 
Voluntary Contribution or Taxation Programs
6400.32 Use of Pooling-of-Interests Method
6400.33 Accounting for a Joint Operating Agreement
6400.34 Accounting for Computer Systems Costs Incurred in 
Connection With the Health Insurance Portability 
and Accountability Act of 1996 (HIPAA)
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TPA Reference No. Title
6400.35 Note to TIS Section 6400.36 to
6400.42—Implementation of FASB Statement
No. 136—Classification of a Beneficiary's Interest in
the Net Assets of a Financially Interrelated
Fund-Raising Foundation (in the Beneficiary's
Financial Statements)
6400.36 Application of FASB Statement 
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (The beneficiary can 
infl uence the operating and financial decisions of the 
foundation to such an extent that the beneficiary can 
determine the timing and amount of distributions 
from the foundation.)
6400.37 Application of FASB Statement 
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (The beneficiary cannot 
infl uence the operating and financial decisions of the 
foundation to such an extent that the beneficiary can 
determine the timing and amount of distributions 
from the foundation.)
6400.38 Application of FASB Statement 
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation—Does Common Control 
Lead to the Conclusion That the Beneficiary Can 
Determine the Timing and Amount of Distributions 
from the Recipient?
6400.39 Application of FASB Statement 
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (More Than One 
Beneficiary—Some Contributions Are Designated)
6400.40 Application of FASB Statement 
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (The beneficiary makes an 
expenditure that meets a purpose restriction on net 
assets held for its benefit by the recipient 
organization—The beneficiary can influence the 
operating and financial decisions of the recipient to 
such an extent that the beneficiary can determine 
the timing and amount of distributions from the 
recipient.)
AAG-HCO APP H
References to AICPA Technical Practice Aids 425
TPA Reference No. Title
6400.41 Application of FASB Statement 
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (The beneficiary makes an 
expenditure that is consistent with a purpose 
restriction on net assets held for its benefit by the 
recipient organization—The beneficiary cannot 
infl uence the operating and financial decisions of the 
recipient to such an extent that the beneficiary can 
determine the timing and amount of distributions 
from the recipient.)
6400.42 Application of FASB Statement 
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (Recipient 
Organization)—Accounting for Unrealized Gains 
and Losses on Investments Held by the Foundation
6400.43 Application of FASB Statement
No. 136—Classification of Distributions From a
Financially Interrelated Fund-Raising Foundation
(Recipient Organization) to a Health Care
Beneficiary
6400.44 Other-Than-Temporary Impairment Losses on 
Investments by Not-for-Profit Health Care 
Organizations
6400.45 Applicability of FASB Interpretation
No. 45—Guarantor's Accounting and Disclosure
Requirements for Guarantees, Including Indirect
Guarantees of Indebtedness of Others—Physician
Loans
6400.46 Applicability of FASB Interpretation
No. 45—Guarantor's Accounting and Disclosure
Requirements for Guarantees, Including Indirect
Guarantees of Indebtedness of Others—Mortgage
Guarantees
9110.15 Reporting on Medicaid/Medicare Cost Reports
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As of May 2005
Beginning May 2001, all schedules of changes reflect only current year activity 
for improved clarity.
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Reference Change
Preface Revised to clarify presentation of auditing guid­
ance and to reflect ASB project developments; 
Updated discussion about Sarbanes-Oxley Act of 
2002 and related SEC regulations and PCAOB 
standards; Footnote 9 deleted.
Chapter 1 (Title) Note added.
Paragraph 1.01 
(footnote *)
Added to reflect the release of FASB and AICPA 
exposure drafts.
Paragraphs 1.15, 1.22, 
and 1.23
Revised references for release of GASB Compre­
hensive Implementation Guide—2004.
Paragraph 1.19 Revised to reflect the issuance of GASB State­
ment No. 46; Footnote † added.
Paragraph 1.39 
(heading) (footnote *)
Added to reflect the release of FASB and AICPA 
exposure drafts.
Paragraph 1.49 
(heading) (footnote ‡)
Revised to reflect FASB project developments 
and release of FASB exposure draft.
Paragraph 1.51 Corrected reference to FASB Statement No. 145; 
Footnote || added to reflect the issuance of FASB 
Statement No. 154.
Paragraphs 1.55, 1.56, 
1.57, 1.58, 1.59, and 
1.60
Revised to reflect the issuance of recent au­
thoritative pronouncements, release of proposed 
guidance, FASB project developments, and SEC 
release.
Paragraph 1.61 
(heading) (footnote *)
Added to reflect the release of FASB and AICPA 
exposure drafts.
Chapter 2 (Title) Note added.
Paragraph 2.02 Added cross reference to Preface.
Paragraph 2.03 Guidance moved in part to new paragraphs 2.04 
and 2.05; Subsequent paragraphs renumbered.
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Reference Change
Paragraph 2.03 and 
renumbered 
paragraphs 2.06, 2.11, 
2.13, 2.18, 2.36 
(footnote 1), 2.38, 2.44, 
2.45, 2.48, 2.60, 2.63, 
2.78, 2.79, and 2.80
Revised to reflect the issuance of PCAOB Con­
forming Amendments to PCAOB Interim Stan­
dards Resulting from the Adoption of PCAOB Au­
diting Standard No. 2.
Renumbered 
paragraph 2.11
Guidance moved in part to new paragraph 2.12; 
Subsequent paragraphs further renumbered.
Renumbered 
paragraph 2.13
Revised to reflect the issuance of Auditing Inter­
pretation No. 1 of AU sec. 332; Footnote * added.
Renumbered 
paragraph 2.30 
(heading) (footnote *)
Deleted.
Renumbered 
paragraph 2.41 
(heading) (footnote †)
Deleted.
Paragraph 2.44 Added to reflect the issuance of PCAOB Audit­
ing Standard No. 2, PCAOB Conforming Amend­
ments to PCAOB Interim Standards Resulting 
from the Adoption of PCAOB Auditing Stan­
dard No. 2, and the PCAOB staff document Staff 
Questions and Answers: Auditing Internal Con­
trol Over Financial Reporting; Subsequent para­
graphs further renumbered.
Renumbered 
paragraph 2.56
Revised to reflect the release of PCAOB Auditing 
Standards No. 2 and No. 3; Footnote ‡ deleted; 
Footnote † added to reflect the release of ASB 
exposure draft.
Renumbered 
paragraph 2.78 
(footnote ‡)
Revised.
Renumbered 
paragraph 2.80
Guidance moved in part to new paragraphs 
2.81 and 2.82; Subsequent paragraphs further 
renumbered.
Renumbered 
paragraph 2.85 
(footnote #)
Deleted.
Renumbered 
paragraph 2.92
Revised to reflect the issuance of Auditing Inter­
pretation No. 12 of SAS No. 62.
Paragraph 3.01 Revised to reflect the issuance of GASB State­
ment No. 46; Footnote * added.
Paragraph 3.04 Revised to reflect the issuance of GASB State­
ment No. 40; Footnote * deleted.
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Reference Change
Paragraph 4.02 Revised to add reference to new Appendix to 
Chapter 4.
Paragraph 4.03 
(footnote *)
Added to reflect release of FASB exposure draft.
Paragraph 4.04 
(footnote 2)
Revised to reflect the issuance of FASB FSP EITF 
03-1-1 and release of proposed FSP.
Paragraph 4.13 Revised to reflect the issuance of GASB State­
ment No. 40; Footnote * deleted.
Paragraph 4.18 Guidance for governmental health care entities 
moved to new paragraph 4.19; Subsequent para­
graphs renumbered; New paragraph 4.19 revised 
to reflect the issuance of GASB Statement No. 40; 
Footnote † deleted.
Renumbered 
paragraph 4.21 
(heading)
Note added.
Renumbered 
paragraph 4.21
Revised to reflect the issuance of PCAOB Con­
forming Amendments to PCAOB Interim Stan­
dards Resulting from the Adoption of PCAOB 
Auditing Standard No. 2 and Auditing Interpre­
tation No. 1 of AU sec. 332; Footnote † added.
Renumbered 
paragraph 4.21 
(Exhibit 4-1)
Revised to reflect the issuance of PCAOB Con­
forming Amendments to PCAOB Interim Stan­
dards Resulting from the Adoption of PCAOB 
Auditing Standard No. 2.
Renumbered 
paragraph 4.22 
(Appendix A)
Added to reflect the issuance of EITF Issue No. 
03-1; Footnote * added to reflect the release of 
FASB and ASB exposure drafts; Footnote † added 
to reflect the issuance of FSP EITF 03-1-1 and 
release of proposed FSP.
Paragraph 5.12 
(heading) (footnote *)
Added to reflect the release of FASB exposure 
draft.
Paragraph 5.19 
(heading)
Added.
Paragraph 5.26 
(footnote *)
Deleted.
Paragraph 5.31 
(heading)
Note added.
Paragraph 5.33 Added to reflect the issuance of Auditing Inter­
pretation No. 1 of AU sec. 328; Subsequent para­
graphs renumbered; Footnote † added.
Paragraph 6.05 Revised to reflect the issuance of GASB State­
ment No. 42; Footnote * revised.
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Reference Change
Paragraph 6.09 Revised to reflect the issuance of GASB State­
ment No. 42; Footnote † added.
Paragraph 6.10 
(heading)
Note added.
Paragraph 6.15 Added to reflect the issuance of GASB Statement 
No. 42; Footnote * redesignated as footnote † and 
modifi ed; Subsequent paragraphs renumbered.
Paragraph 7.04 
(footnote *)
Revised to reflect the issuance of GASB State­
ments No. 45 and No. 47.
Paragraph 7.20 
(footnote 1)
Revised to clarify guidance and reflect release of 
FASB and AICPA exposure drafts.
Paragraph 7.21 
(footnote †)
Deleted to reflect release of SEC SAB 103.
Chapter 8 (Title) Noted added.
Paragraph 8.12 
(footnote *)
Added to reflect release of FASB and ASB expo­
sure drafts.
Paragraph 8.16 
(footnote *)
Revised and numbered as footnote 1; Subsequent 
footnotes renumbered; Footnote † added to reflect 
release of FASB exposure draft.
Paragraphs 9.07 and 
9.11
Revised to clarify guidance.
Paragraphs 9.08 and 
9.09
Revised references for release of GASB Compre­
hensive Implementation Guide—2004.
Paragraph 9.09 Revised to reflect the issuance of GASB State­
ment No. 46; Footnote † added; Revised refer­
ences for release of GASB Comprehensive Imple­
mentation Guide—2004.
Paragraph 9.11 Revised to reflect the issuance of GASB State­
ment No. 46; Footnote |  added.
Paragraph 10.05 Guidance for governmental health care enti­
ties moved to new paragraph 10.06; Subsequent 
paragraphs renumbered.
Renumbered 
paragraph 10.09 
(footnote 5)
Revised to reflect release of FASB exposure draft.
Renumbered 
paragraph 10.17
Revised references for release of GASB Compre­
hensive Implementation Guide—2004.
Renumbered 
paragraph 10.21 
(footnote *)
Added to reflect the issuance of FASB Statement 
No. 154.
Renumbered 
paragraph 10.27
Revised to clarify guidance.
Chapter 11 (Title) Noted added.
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Reference Change
Paragraph 11.04 
(heading) (footnote *)
Revised to reflect release of FASB exposure draft.
Paragraph 11.08 
(footnote 2)
Revised to clarify guidance and reflect release of 
FASB and AICPA exposure drafts.
Paragraph 11.14 Revised to clarify guidance; Footnote ‡ revised 
to reflect the issuance of FASB Interpretation 
No. 46 and FASB Interpretation No. 46(R).
Paragraph 11.17 
(footnote 12)
Added to reflect the issuance of EITF Issue 
No. 02-14; Subsequent footnotes renumbered.
Paragraph 11.25 
(heading) (footnote ||)
Added to reflect the release of FASB exposure 
drafts.
Paragraph 11.38 
(heading) (footnote ††)
Added to reflect the release of FASB exposure 
draft; Footnote |||| deleted; Footnote †† revised to 
reflect FASB project developments.
Chapter 12 (Title) Noted added.
Paragraph 12.01 Revised to reflect the issuance of PCAOB Con­
forming Amendments to PCAOB Interim Stan­
dards Resulting from the Adoption of PCAOB 
Auditing Standard No. 2; Guidance from para­
graph 12.01 moved to new paragraph 12.03; 
Subsequent paragraphs renumbered; Footnote * 
deleted.
Paragraph 12.02 Added to reflect the issuance of Auditing Inter­
pretations No. 17 and No. 18 of SAS No. 58.
Renumbered 
paragraphs 12.04 and 
12.05
Revised to clarify guidance.
Paragraph 13.09 Added to reflect the issuance of GASB State­
ment No. 42; Subsequent paragraphs renum­
bered; Footnote * revised.
Appendix A Introductory paragraphs revised to reflect the is­
suance of recent GASB pronouncements; Foot­
note * added; Illustrative financial statements 
for Sample Not-for-Profit Hospital revised to clar­
ify guidance; Illustrative financial statements 
for Sample Governmental Hospital Authority re­
vised to reflect the issuance GASB Statements 
No. 40 and No. 45.
Appendix G Revised.
Appendix H Added; Subsequent Appendixes relettered.
AAG-HCO APP I
Glossary 433
Glossary
acquisition costs. Marketing costs that are (a) directly related to the acquisi­
tion of specific subscriber contracts and member enrollment and (b) incre­
mental to general marketing activities.
acute care. Inpatient general routine care provided to patients who are in 
a phase of illness that does not require the concentrated and continuous 
observation and treatment provided in intensive-care units.
advance fee. A payment required to be made by a continuing care retirement 
community (CCRC) resident prior to, or at the time of, admission to the 
CCRC for future services and the use of facilities specified in a contract 
that remains in effect for as long as the resident resides in the CCRC.
advance refunding. A transaction in which refunding debt is issued to pay 
the refunded debt at a specified future date(s), with the proceeds placed in 
trust or otherwise restricted to pay the refunded debt.
affiliate. A party that, directly or indirectly through one or more intermedi­
aries, controls, is controlled by, or is under common control with an en­
terprise. (FASB Statement No. 57, Related Party Disclosures, paragraph 
24(a))
agent. An entity that acts for and on behalf of another. A recipient organization 
acts as an agent for and on behalf of a donor if it receives assets from 
the donor and agrees to use those assets on behalf of or transfer those 
assets, the return on investment of those assets, or both to a specified 
beneficiary. A recipient organization acts as an agent for and on behalf of 
a beneficiary if it agrees to solicit assets from potential donors specifically 
for the beneficiary's use and to distribute those assets to the beneficiary. A 
recipient organization also acts as an agent if a beneficiary can compel the 
organization to make distributions on its behalf (FASB Statement No. 136, 
Transfers of Assets to a  Not-for-Profit Organization or Charitable Trust That 
Raises or Holds Contributions for Others, paragraph 10)
allocated loss adjustment expense (ALAE). Claim expense that can be as­
signed to individual claims (for example, attorney's fees, claim adjusting 
service fees, or court costs).
ambulatory care organization. A partnership, association, corporation, or 
other legal entity organized to deliver health care services to patients that 
come or are brought to a health care facility for a purpose other than admis­
sion as an inpatient (for example, emergency room services, clinic services, 
or outpatient surgery).
ancillary services. Services performed for diagnostic or therapeutic purposes. 
Ancillary services generally are those special services for which charges in 
addition to routine charges customarily are made (for example, laboratory, 
radiology, surgical, or other services).
anticipated revenues. Amounts including third-party payments (for exam­
ple, those from Blue Cross), contractually or statutorily committed invest­
ment income from sources related to the activities of a continuing care 
retirement community (CCRC), contributions pledged by donors to sup­
port CCRC activities, periodic fees expected to be collected, or the balance 
of deferred nonrefundable advance fees.
asserted claim. A claim made against a health care organization by or on 
behalf of a patient alleging improper professional service.
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assets limited as to use. Assets that are segregated and limited either by 
the Board or management (for example, designated for expenditure in the 
acquisition of property and equipment or for the liquidation of long-term 
debt) or by outside third parties other than a donor or grantor (for example, 
funds under bond agreements or malpractice arrangements) as to how the 
assets may be used.
associated entity. An individual practice association, hospital, medical group, 
or similar health care organization that contracts with a prepaid health 
care provider to provide health care services.
bad-debt expense. The current period charge for actual or expected doubtful 
accounts resulting from the extension of credit.
capitation fee. A fixed amount per individual that is paid periodically (usu­
ally monthly) to a provider as compensation for providing comprehensive 
health care services for the period. The fee is set by contract between a 
prepaid health care plan and the provider. These contracts are generally 
with medical groups, independent practice associations (IPAs), hospitals, 
and other similar providers. Capitation fees may be determined actuarially 
or negotiated based on expected costs to be incurred.
charity care. Health care services that never were expected to result in cash 
inflows. Charity care results from a provider's policy to provide health care 
services free of charge to individuals who meet certain financial criteria.
claims-made insurance policy. A policy that covers only malpractice claims 
reported to the insurance carrier during the policy term, regardless of the 
date of the incident giving rise to the claim.
clinic. A freestanding facility or part of another health care organization used 
for diagnosis and treatment of outpatients.
commercial paper. Short-term, unsecured promissory notes that represent 
a flexible and low-cost form of short-term financing. Taxable commercial 
paper is sold on a discount basis, rather than on an interest-bearing basis, 
with the discount determined by the maturity of the notes, the creditwor­
thiness of the issuer or its credit support, and general market demand. The 
primary risk is the variable interest rate exposure. Issuance often requires 
some form of credit enhancement or liquidity support.
comprehensive medical plan (CMP). A health plan option that may be avail­
able to Medicare beneficiaries and provides a more limited range of services 
than health maintenance organizations but includes physician services, 
laboratory, radiology, emergency, preventive, and inpatient services. A CMP 
assumes the financial risk for the provision of services and for out-of-area 
coverage.
conditional promise to give. A promise to give that depends on the occur­
rence of a specified future or uncertain event to bind the promisor.
continuing-care contract. An agreement between a resident and a CCRC 
specifying the services and facilities to be provided by the CCRC to a res­
ident over an established period of time (usually the remaining life of the 
resident).
continuing care retirement community (CCRC). A legal entity sponsoring 
or guaranteeing residential facilities, meals, and health care services for a 
community of retired persons who may reside in apartments, other living 
units, or in some cases a nursing center. (Also referred to as a residential 
care facility or a life-care retirement community.)
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contract period. The period (typically one year) for which premium rates are 
fixed by contract.
contractual adjustments. The differences between revenue at established 
rates and the amounts realizable from third-party payors under contrac­
tual agreements.
contribution. An unconditional transfer of cash or other assets to an entity or 
a settlement or cancellation of its liabilities in a voluntary nonreciprocal 
transfer by another entity acting other than as an owner.
costs of acquiring initial continuing-care contracts. Costs incurred to 
originate a contract that result from and are essential to the acquisition 
of the initial contracts and are incurred through the date of substantial 
occupancy but no later than one year from the date of completion of con­
struction.
These costs include—
•  The costs of processing the contract, such as evaluating the prospec­
tive resident's financial condition; evaluating and recording guaran­
tees, collateral, and other security arrangements; negotiating contract 
terms; preparing and processing contract documents; and closing the 
transaction.
•  The costs from activities in connection with soliciting potential initial 
residents (such as model units and their furnishings, sales brochures, 
semipermanent signs, tours, grand openings, and sales salaries). These 
costs do not include advertising, interest, administrative costs, rent, 
depreciation, or any other occupancy or equipment costs.
•  The portion of an employee's compensation and benefits that relates 
to the initial contract acquisitions.
courtesy and policy discounts. The differences between revenue recorded at 
established rates and amounts realizable for services provided to specific 
individuals such as employees, medical staff, and clergy.
credibility. A measure of the statistical significance of a provider's own 
data, dependent on its stability and volume in relation to the stabil­
ity and volume of the industry data. Actuaries use credibility to blend 
an estimate from a provider's own experience with a broader estimate 
based on the experience of similar institutions. A provider's own expe­
rience may be assigned a credibility weight less than 100 percent due 
to year-to-year volatility. Such volatility is often a function of the size 
of the provider. Large providers generally have less volatility than small 
providers. In such an instance, a broader and more stable body of experience 
of similar providers would be used to supplement the specific provider's 
experience.
credit enhancement. Typically, a bank letter of credit that guarantees in­
vestors will receive principal and interest in the event of an issuer default. 
A line of credit provides liquidity support to an issuer but does not provide 
a guarantee of the repayment of principal and interest in the event of is­
suer default. The liquidity support provides a loan to issuers in the event 
the issuer is unable to place large amounts of maturing commercial paper 
with investors.
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crossover refunding (also called a delayed defeasance). A type of advance 
refunding in which the old debt is not immediately replaced. The proceeds 
from the new debt, additional cash deposits (if any), and the income earned 
on the related investments are sufficient to pay the principal and any call 
premium of the old debt and the interest on the new debt until the date 
of crossover. Until the crossover, the proceeds from the new debt serve as 
collateral for that debt. The old debt is serviced by the entity until the date 
of crossover, at which time the proceeds from the new debt are used to retire 
the old debt and the entity becomes obligated to service the new debt. The 
old debt remains as a liability on the issuer's books until the crossover, 
when it is called in accordance with the call provisions of its indenture.
deductions from revenue. Reductions in gross revenue arising from contrac­
tual adjustments, courtesy and policy discounts, or other adjustments and 
deductions.
defeasance. Legal satisfaction of refunded debt without the debt necessarily 
being retired.
development factor. A computed factor used to project future changes in 
estimated losses from the date of the occurrence of the incident to the date- 
of-claim payment resulting from inflation, claimed cost growth, industry 
trends, and court awards. The development factor can be applied to in­
curred losses, paid losses, claim counts, and average values.
diagnosis-related group (DRG). A patient classification scheme that cate­
gorizes patients who are related medically with respect to primary and 
secondary diagnosis, age, or complications.
donor-imposed condition. A donor stipulation that specifies a future and 
uncertain event whose occurrence or failure to occur gives the promisor 
a right of return of the assets it has transferred or releases the promisor 
from its obligation to transfer its assets.
donor-imposed restriction. A donor stipulation that specifies the use for a 
contributed asset that is more specific than broad limits resulting from the 
nature of the organization, the environment in which it operates, and the 
purposes specified in its articles of incorporation or bylaws of comparable 
documents for an unincorporated association. A restriction on an organi­
zation's use of the asset contributed may be temporary or permanent.
endowment fund. An established fund of cash, securities, or other assets used 
to provide income for the maintenance of a not-for-profit organization. The 
use of the assets of the fund may be permanently restricted, temporarily 
restricted, or unrestricted. Endowment funds generally are established by 
donor-restricted gifts and bequests to provide a permanent endowment (to 
provide a permanent source of income) or a term endowment (to provide 
income for a specific period). The principal of a permanent endowment 
must be maintained permanently, that is, not used up, expended, or oth­
erwise exhausted—and is classified as permanently restricted net assets. 
The principal of a term endowment must be maintained for a specified 
term and is classified as temporarily restricted net assets. An organiza­
tion's governing board may earmark a portion of its unrestricted net assets 
as a board-designated endowment (sometimes called funds functioning as 
endowment or quasi-endowment funds) to be invested to provide income for 
a long but unspecified period. The principal of a board-designated endow­
ment, which results from an internal designation, is not donor restricted 
and is classified as unrestricted net assets.
AAG-HCO GLO
Glossary 437
enrollee. An individual who is a subscriber or an eligible dependent of a sub­
scriber in a prepaid health care plan.
estimated costs of future services. Amounts that are expected to be incurred 
to provide services and the use of facilities to individuals over their remain­
ing lives under continuing-care contracts. Examples include resident care, 
dietary, health care, facility, general and administrative, interest, depreci­
ation, and amortization costs.
exposure. The amount of potential claim risk. The basis for reflecting dif­
ferences in the claim potential among providers’ bases for charging in­
surance premiums or allocating member contributions to a captive. Expo­
sure bases for hospital professional liability include number of occupied 
beds, outpatient visits, emergency room visits, and number of residents by 
specialty.
floating rate note (FRN). A debt instrument that allows issuers to borrow at 
a floating short-term rate with a long-term stated maturity without some 
of the risks traditionally associated with commercial paper. The investor 
is subject to principal risk to the degree the issuer's credit deteriorates or 
investor demand for FRNs decreases. Most health care issuers of FRNs 
require credit enhancement and a bank liquidity facility in conjunction 
with an FRN program.
functional classification. A method of grouping expenses according to the 
purpose for which costs are incurred. The primary functional classifications 
are program services and supporting activities.
fund. A self-contained accounting entity set up to account for a specific activity 
or project.
gross service revenues. All revenues from the provision of health care ser­
vices excluding charity care.
health care services. Services provided to individuals related to the diagnosis 
or treatment of physical or mental illness.
health maintenance organization (HMO). A generic group of medical care 
entities organized to provide defined health care services to members in 
return for fixed, periodic premiums (usually paid monthly) that are paid 
in advance.
home health agency. An agency organized to provide health and supportive 
services in a person's home. These services may include nursing, nutri­
tional, and therapeutic aid (such as physical therapy and dialysis) and the 
rental, as well as sale of medical equipment.
increased limit factor. The relationship between losses limited to a per- 
occurrence limit at which the provider's own experience is meaningful to 
losses limited to the provider's total retained limit per occurrence.
incremental costs. Costs that vary with and are directly attributable to 
changes in business, such as an additional employer or HMO contract. 
Fixed costs such as building depreciation or general overhead that do not 
change with the addition or loss of a contract are not incremental costs.
incurred but not reported (IBNR) costs. Costs associated with health care 
services incurred during a financial reporting period but not reported to 
the health care organization until after the financial reporting date.
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indenture. An agreement between two or more persons specifying the recip­
rocal rights and duties of the parties under a contract (such as a lease, 
mortgage, or contract between bondholders and the issuer of the bond).
individual practice association (IPA). A partnership, association, corpora­
tion, or other legal entity organized to provide or arrange for the delivery 
of health care services to members of a prepaid health care plan and non­
member patients. In return, the IPA receives either a capitation fee or a 
specified fee for services rendered.
inpatient. Under most circumstances, a patient who is provided with room, 
board, and general nursing service and is expected to remain in the health 
care facility at least overnight and occupy a bed.
in-substance defeasance. A form of advance refunding in which the debtor 
places into an irrevocable trust an amount of assets estimated to be suf­
ficient to satisfy all future principal and interest payments of a specific 
obligation. In such cases, the debt is not considered extinguished because 
the debtor is not legally released from being the primary obligor.
integrated delivery system. A provider or group of providers that is orga­
nized to deliver and finance acute and preventive health care services. 
An integrated delivery system generally will provide (or arrange to pro­
vide) a complete continuum of health care services (inpatient acute care, 
ambulatory care, outpatient surgery, home health care, including long­
term care) to an enrolled population, generally for fixed prepaid fees called 
premiums.
interest rate swaps. An agreement to exchange interest payments without 
actually exchanging the underlying principal. The two parties each agree 
to make interest payments based on the calculation formula for the other's 
debt. Swaps can be used for a variety of purposes, such as to reduce the 
overall cost of borrowing, lock in forward rates, reduce interest rate risk, 
or adjust the ratio of variable and fixed-rate debt liabilities. Interest rate 
swaps do not change the amount or type of debt outstanding, but they do 
affect the issuer's debt portfolio and risk profile.
intermediary. An entity that acts as a facilitator for the transfer of assets be­
tween a potential donor and a potential beneficiary (donee) but is neither 
an agent or trustee nor a donee and donor as contemplated by FASB State­
ment No. 116, Accounting for Contributions Received and Contributions 
Made. (FASB Statement No. 136, Transfers of Assets to a Not-for-Profit 
Organization or Charitable Trust That Raises or Holds Contributions for 
Others, paragraph 8)
intermediate care facility (ICF). A facility that provides care to individuals 
whose mental or physical conditions require services that are above the 
level of room and board and that can be made available only through insti­
tutional facilities. The care provided at an ICF does not require hospitals 
or skilled nursing facilities.
maintenance costs. Costs associated with maintaining enrollment records 
and processing premium collections and payments.
margin for risk of adverse deviation. Actuarially determined estimate of 
the additional funding requirement to obtain a specific confidence level 
that losses will not exceed the amount paid into the self-insurance fund. 
Margins are determined using statistical simulation techniques.
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medical group. An association of physicians and other licensed health care 
professionals organized on a group basis to practice medicine.
medium-term notes. An intermediate-term security offered on a continuous 
basis providing flexibility for an issuer to vary the amount of outstanding 
notes as its funding requirements change. The broad range of possible 
maturities enables an issuer to borrow at the most attractive yield at the 
time of each issuance. They can be issued domestically or abroad.
member. An individual who is enrolled as a subscriber or as an eligible depen­
dent of a subscriber in a prepaid health care plan.
multiprovider captive. An insurance company owned by two or more 
health care organizations that underwrites malpractice insurance for its 
owners.
natural classification. A method of classifying expenditures according to the 
nature of the expense such as salaries and wages, employee benefits, sup­
plies, and purchased services.
net advance refunding. A type of advance refunding in which the proceeds 
from the new debt, additional cash deposits (if any) and the income earned 
on the related investments are sufficient to pay the interest, principal, and 
call premium on the old debt. After the advance refunding, the old debt is 
serviced by the investments in trust and the new debt is serviced by the 
entity.
net service revenue. Gross service revenue less provisions for contractual 
adjustments with third-party payors.
nonexchange transaction. An external transaction in which a government 
gives (or receives) value without directly receiving (or giving) equal value 
in exchange.
nonfinancial assets. Nonmonetary assets such as inventories or property, 
plant, and equipment.
not-for-profit organization. An entity that possesses the following charac­
teristics that distinguish it from a business enterprise: (a) contributions of 
significant amounts of resources from resource providers that do not expect 
commensurate or proportionate pecuniary return, (b) operating purposes 
other than to provide goods or services at a profit, and (c) absence of own­
ership interests like those of business enterprises. Not-for-profit organiza­
tions possess these characteristics in varying degrees.
nursing center. A facility that provides nursing care to residents with a variety 
of needs or medical conditions. A nursing center may be a component of a 
continuing care retirement community. (Also called a health center, skilled- 
nursing facility, intermediate-care facility, continuing-care facility, or basic- 
care home.)
occurrence-basis policy. A policy that covers claims resulting from incidents 
that occur during the policy term, regardless of when the claims are re­
ported to the insurance carrier.
outliers. In referring to the Medicare Prospective Payment System, additional 
payments that are made for cases that either have unusually long lengths 
of stay or have charges in excess of the cost outlier threshold.
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outpatient. A patient who is not confined overnight in a health care institution.
peer review organization (PRO). Under federal statutory provision, PROs 
are required in each state to monitor hospital activity under the prospec­
tive payment system. Each hospital must contract with a PRO, which 
will review (a) the validity of diagnostic information, which establishes 
the diagnosis-related group; (b) the appropriateness of admissions; (c) 
the appropriateness of care to outliers; and (d) the adequacy of care 
provided.
periodic fees. Amounts paid to a continuing care retirement community by a 
resident at periodic intervals for continuing-care services. Such fees may 
be fixed or adjustable. (Also called maintenance fees or monthly fees.)
periodic interim payment (PIP). A plan under which the health care organi­
zation receives cash payments from a third-party payor (usually Medicare) 
in constant amounts periodically.
permanent restriction. A donor-imposed restriction that stipulates that re­
sources be maintained permanently but permits the organization to use 
up or expend part or all of the income (or other economic benefits) derived 
from the donated assets.
permanently restricted net assets. The part of the net assets of a not-for- 
profit organization resulting from (a) contributions and other inflows of 
assets whose use by the organization is limited by donor-imposed stipu­
lations that neither expire by the passage of time nor can be fulfilled or 
otherwise removed by the actions of the organization, (b) other asset en­
hancements and diminishments subject to the same kind of stipulations, 
and (c) reclassification from (or to) other classes of net assets as a conse­
quence of donor-imposed stipulations.
premium. The consideration paid for providing contract coverage. (Also called 
a subscriber fee.)
premium period. The period to which a premium payment applies (generally 
one month) that entitles a member to health care services according to the 
contract provisions.
prepaid health care plan. A plan in which the provider is compensated in 
advance by the sponsoring organization. The sponsoring organization pays 
or compensates the provider based on either a fixed sum or a per-enrollee 
amount. Prepaid health care plans include health maintenance organiza­
tions, preferred provider organizations, eye care plans, dental care plans, 
and similar plans. Under such plans, the financial risk of delivering the 
health care is transferred to the provider of services.
prepaid health care services. Any form of health care service provided to a 
member in exchange for a scheduled payment (or payments) established 
before care is provided, regardless of the level of service subsequently pro­
vided.
prevailing charge. A charge that falls within the range of charges most fre­
quently used in a locality for a particular service or procedure.
primary care. Care that is rendered in an ambulatory fashion, such as in an 
emergency room, an outpatient clinic, or other outpatient department.
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prospective payment system (PPS). Medicare payment made at a prede­
termined, specific rate for each Medicare discharge, based on the patient's 
diagnosis. Each discharge is classified according to a series of diagnosis- 
related groups. (See also diagnosis-related group.)
provider. A person or entity that undertakes to provide health care services.
providers of prepaid health care services (prepaid health care 
providers). Organizations that provide or arrange for the delivery of 
health care services in accordance with the terms and provisions of a pre­
paid health care plan. Providers assume the financial risk of the cost of 
delivering health care services in excess of preestablished fixed premiums. 
However, some or all of the financial risk may be contractually transferred 
to other providers (affiliated entities) or by purchasing stop-loss insurance. 
Other providers of prepaid health care services may include comprehen­
sive medical plans, physicians groups (for example, independent practice 
associations), and hospitals.
refundable advance fees. The portion of an advance fee that is payable to a 
resident of a continuing care retirement community or the resident's estate.
refunded debt. Debt for which payment at a specified future date has been 
provided by the issuance of refunding debt.
refunding debt. Debt issued to provide funds to pay for refunded debt at a 
specified future date.
reported incident. An occurrence identified by a health care organization as 
one in which improper professional service may be alleged at a future time 
that would result in a malpractice claim.
retrospectively rated insurance policy. An insurance policy with a pre­
mium that is adjustable based on the experience of the insured health 
care organization or group of health care organizations during the policy 
term.
risk contract. A contract between a provider of health care services and a 
prepaid health care plan that exposes the provider to the uncertainty of 
financial gain or loss by obligating the provider to provide specified health 
care services to enrollees of the plan for a negotiated price, which may be an 
amount per case, service, or day. The price may vary based on the volume 
of services furnished during the contract period.
secondary care. Care that is rendered to inpatients in hospitals that offer 
short-term, acute-care services of either a general or a specialized nature.
self-insurance. That portion of risk or loss assumed by a health care organi­
zation. There is no external insurance coverage.
skilled nursing facilities (SNF). These facilities provide services on a daily, 
inpatient basis. The services provided by an SNF are ordered by a physician 
and require the skilled services of technical or professional personnel.
stop-loss (or reinsurance) insurance. A contract in which a company agrees 
to indemnify providers for certain health care costs incurred by members.
subscriber. The person who is responsible for the payment of premiums or 
whose employment is the basis for eligibility for membership in a prepaid 
health care plan.
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tail coverage. Insurance designed to cover malpractice claims incurred before, 
but reported after, cancellation or expiration of a claims-made insurance 
policy.
taxable variable rate demand notes. Issuers may call the notes on any 
monthly interest payment date, which provides issuers the opportunity to 
refinance short-term obligations with long-term bonds if market conditions 
make this alternative attractive.
temporarily restricted net assets. The part of the net assets of a not-for- 
profit organization resulting (a) from contributions and other inflows of 
assets whose use by the organization is limited by donor-imposed stipu­
lations that either expire with the passage of time or can be fulfilled and 
removed by actions of the organization pursuant to those stipulations, (b) 
from other asset enhancements and diminishments subject to the same 
kinds of stipulations, or (c) from reclassification to (or from) other classes 
of net assets as a consequence of donor-imposed stipulations, their expira­
tion by passage of time, or their fulfillment and removal by actions of the 
organization pursuant to those stipulations.
tertiary care. Care that is rendered in hospitals that possess the personnel, 
equipment, and expertise to handle complex cases.
third-party payor. Any agency (such as Blue Cross, Medicare, or commercial 
insurance companies) that contracts with health care organizations and 
patients to pay for the care of covered patients.
trend factor. A factor used in actuarial methodology to adjust ultimate losses 
from historical experience periods to the loss cost levels of the projection 
period, due to the impact of economic, jurisdictional, and social changes 
affecting hospital professional liability loss costs.
trust fund. A fund established with an outside entity to be used for a specific 
purpose, such as to pay malpractice claims and related expenses as they 
arise.
trustee. An entity that has a duty to hold and manage assets for the benefit 
of a specified beneficiary in accordance with a charitable trust agreement. 
(FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organi­
zation or Charitable Trust That Raises or Holds Contributions for Others, 
paragraph 9)
ultimate cost. Total claims payments, including costs associated with litigat­
ing or setting claims.
unasserted claim. A medical malpractice claim that has not been asserted 
formally against a health care provider by or on behalf of a patient alleging 
improper professional service. It may relate to either reported incidents or 
to unreported incidents.
unreported incident. An occurrence in which improper professional service 
may have been administered by a health care provider, which may result 
in a malpractice claim of which the provider is not yet aware.
unrestricted net assets. The part of net assets of a not-for-profit organization 
that is neither permanently restricted nor temporarily restricted by donor- 
imposed stipulations.
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voluntary health and welfare organizations. Organizations formed for the 
purpose of performing voluntary services for various segments of society. 
They are tax-exempt (organized for the benefit of the public), supported by 
the public, and operated on a not-for-profit basis. Most voluntary health 
and welfare organizations concentrate their efforts and expend their re­
sources in an attempt to solve health and welfare problems of society and, 
in many cases, those of specific individuals. As a group, voluntary health 
and welfare organizations include not-for-profit organizations that derive 
their revenue primarily from voluntary contributions from the general pub­
lic to be used for general or specific purposes connected with health, welfare, 
or community services.
wholly owned captive. An insurance company subsidiary of a health care 
organization that provides malpractice insurance primarily to its parent 
corporation.
AAG-HCO GLO
AICPA RESOURCE: Accounting & Auditing Literature
AlCPA's unique online research tool combines the power and speed of the Web 
with comprehensive accounting and auditing standards. AICPA RESOURCE 
includes AlCPA's and FASB's literature libraries—and includes:
• AICPA Professional Standards
• AICPA Technical Practice Aids
• AlCPA's Accounting Trends & Techniques
• AICPA Audit and Accounting Guides
• AICPA Audit Risk Alerts
• FASB Original Pronouncements
• FASB Current Text
• EITF Abstracts
• FASB Implementation Guides
• FASB’s Comprehensive Topical Index
Search for pertinent information from both databases by keyword and get the 
results ranked by relevancy. Print out important AICPA RESOURCE segments 
and integrate the literature into your engagements and financial statements. 
Available from anywhere you have Internet access, this comprehensive 
reference library is packed with the A & A guidance you need—and use—the 
most. Both libraries are updated with the latest standards and conforming 
changes.
AlCPA+FASB reference libraries, one-year individual online subscription
No. ORF-XX 
AICPA Member $890.00 
Nonmember $1,112.50
AICPA reference library, one-year individual online subscription
No. ORS-XX 
AICPA Member $395.00 
Nonmember $493.75
AICPA RESOURCE also offers over 50 additional subscription options— log 
onto www.cpa2biz.com/AICPAresource for details.
For more information or to order, log onto 
www.cpa2biz.com/AICPAresource, 
or call 888-777-7077
Sign up for the Standing Order Option and receive the next edition of this 
Guide as soon as its published— call 1-888-777-7077.
Additional Resources
General Risk Alert 2005-2006
Find out about current economic, regulatory and professional developments 
before you perform your audit engagement. This Risk Alert will make your audit 
planning process more efficient by giving you concise, relevant information that 
shows you how current developments may impact your clients and your audits. 
(No. 022336)
Audit and Accounting Guides— Industry Guides
With conforming changes as of May 1, 2005
• Agricultural Producers and Agricultural Cooperatives (012685)
Brokers and Dealers in Securities (012705)
Casinos (012715)
Common Interest Realty Associations (012575)
Construction Contractors (012585)
Depository and Lending Institutions: Banks and Savings Institutions,
Credit Unions, Finance Companies, and Mortgage Companies (012735) 
Government Auditing Standards and Circular A-133 Audits (012745) 
Employee Benefit Plans (as of March 1 , 2005) (012595)
Entities With Oil and Gas Producing Activities (012655)
Federal Government Contractors (012605)
Health Care Organizations (012615)
Investment Companies (as of May 1, 2004) (012624)
Life & Health Insurance Entities (012635)
Not-for-Profit Organizations (012645)
Property and Liability Insurance Cos. (012675)
State and Local Governments (012665)
Audit and Accounting Guides— General Guides
• Analytical Procedures (2005) (012545)
• Audit Sampling (2005) (012535)
• Auditing Derivative Instruments, Hedging Activities, and Investments 
in Securities (2005) (012523)
• Auditing Revenue in Certain Industries (2005) (012515)
• Consideration of Internal Control in a Financial Statement 
Audit (1996) (012451)
• Personal Financial Statements (2005) (012755)
• Prospective Financial Information (2005) (012725)
• Service Organizations: Applying SAS No. 70, as Amended (2005)
(012775)
• Use of Real Estate Appraisal Information (1997) (013159)
To order online log on to www.cpa2biz.com, 
phone 1-888-777-7077, or fax 1-800-362-5066
AICPA Member and 
Public Information; 
www.aicpa.org
AICPA Online Store: 
www.cpa2biz.com
ISO Certified 012615
